PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cheah, MT; Wachter, A; Sudarsan, N; Breaker, RR				Cheah, Ming T.; Wachter, Andreas; Sudarsan, Narasimhan; Breaker, Ronald R.			Control of alternative RNA splicing and gene expression by eukaryotic riboswitches	NATURE			English	Article							MESSENGER-RNA; NEUROSPORA-CRASSA; ASPERGILLUS-NIDULANS; YEAST THI4P; THIAMINE; BINDING; TRANSCRIPTION; FREQUENCY; PROMOTER; CYPBP37	Bacteria make extensive use of riboswitches(1,2) to sense metabolites and control gene expression, and typically do so by modulating premature transcription termination or translation initiation. The most widespread riboswitch class known in bacteria responds to the coenzyme thiamine pyrophosphate (TPP)(3,4), which is a derivative of vitamin B-1. Representatives of this class have also been identified(5,6) in fungi and plants, where they are predicted(5,7) to control messenger RNA splicing or processing. We examined three TPP riboswitches in the filamentous fungus Neurospora crassa, and found that one activates and two repress gene expression by controlling mRNA splicing. A detailed mechanism involving riboswitch-mediated base-pairing changes and alternative splicing control was elucidated for precursor NMT1 mRNAs, which code for a protein involved in TPP metabolism. These results demonstrate that eukaryotic cells employ metabolite-binding RNAs to regulate RNA splicing events that are important for the control of key biochemical processes.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Wachter, Andreas/P-9038-2014; Breaker, Ronald/E-9679-2010	Wachter, Andreas/0000-0002-3132-5161; Breaker, Ronald/0000-0002-2165-536X				Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Borsuk P, 2007, BIOL CHEM, V388, P135, DOI 10.1515/BC.2007.015; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Davis R.H., 2000, NEUROSPORA CONTRIBUT; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; EDDY SR, INFERNAL VERSION 0 5; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Faou P, 2004, J MOL BIOL, V344, P1147, DOI 10.1016/j.jmb.2004.09.097; Faou P, 2003, J MOL BIOL, V333, P831, DOI 10.1016/j.jmb.2003.09.003; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Kim DS, 2005, RNA, V11, P1667, DOI 10.1261/rna.2162205; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; LOROS JJ, 1991, MOL CELL BIOL, V11, P558, DOI 10.1128/MCB.11.1.558; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; McColl D, 2003, CURR GENET, V44, P216, DOI 10.1007/s00294-003-0441-0; MEHRA A, 2002, SOC RES BIOL RHYTHMS, V27; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; ORBACH MJ, 1986, MOL CELL BIOL, V6, P2452, DOI 10.1128/MCB.6.7.2452; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Vann DC, 1995, FUNGAL GENET NEWSL A, V42, P53; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; WELZ R, 2007, RNA             0216, DOI DOI 10.1261/RNA.407707; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; [No title captured]	36	297	324	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					497	U7		10.1038/nature05769	http://dx.doi.org/10.1038/nature05769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17468745				2022-12-24	WOS:000246693100052
J	Hedenstrom, A; Johansson, LC; Wolf, M; von Busse, R; Winter, Y; Spedding, GR				Hedenstrom, A.; Johansson, L. C.; Wolf, M.; von Busse, R.; Winter, Y.; Spedding, G. R.			Bat flight generates complex aerodynamic tracks	SCIENCE			English	Article							WIND-TUNNEL; PLECOTUS-AURITUS; FLAPPING FLIGHT; SLOW FLIGHT; WAKE; KINEMATICS; SPEEDS; UPSTROKE; NUMBERS	The flapping flight of animals generates an aerodynamic footprint as a time-varying vortex wake in which the rate of momentum change represents the aerodynamic force. We showed that the wakes of a small bat species differ from those of birds in some important respects. In our bats, each wing generated its own vortex loop. Also, at moderate and high flight speeds, the circulation on the outer ( hand) wing and the arm wing differed in sign during the upstroke, resulting in negative lift on the hand wing and positive lift on the arm wing. Our interpretations of the unsteady aerodynamic performance and function of membranous-winged, flapping flight should change modeling strategies for the study of equivalent natural and engineered flying devices.	Univ Munich, Dept Biol, D-80539 Munich, Germany; Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden; Max Planck Inst Ornithol, Seewiesen, Germany; Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA	University of Munich; Lund University; Max Planck Society; University of Southern California	Hedenstrom, A (corresponding author), Univ Munich, Dept Biol, D-80539 Munich, Germany.	anders.hedenstrom@teorekol.lu.se	Johansson, Christoffer/B-2189-2013; Hedenström, Anders/F-5377-2010; Spedding, Geoffrey R/A-1860-2010; Wolf, Marta/B-4599-2013	Johansson, Christoffer/0000-0002-1851-3635; Hedenström, Anders/0000-0002-1757-0945; Spedding, Geoffrey R/0000-0003-3033-7897; Winter, York/0000-0002-7828-1872				ALDRIDGE HDJN, 1986, J EXP BIOL, V126, P479; ALDRIDGE HDJN, 1987, J EXP BIOL, V130, P275; Hedenstrom A, 2006, J R SOC INTERFACE, V3, P263, DOI 10.1098/rsif.2005.0091; KOKSHAYSKY NV, 1979, NATURE, V279, P146, DOI 10.1038/279146a0; Laitone EV, 1997, EXP FLUIDS, V23, P405, DOI 10.1007/s003480050128; Lian YS, 2005, J AIRCRAFT, V42, P865, DOI 10.2514/1.5909; Norberg UML, 2006, J EXP BIOL, V209, P3887, DOI 10.1242/jeb.02446; NORBERG UM, 1976, J EXP BIOL, V65, P459; NORBERG UM, 1976, J EXP BIOL, V65, P179; PRANDTL L, 1957, FUNDAMENTALS HYDRO A; PRANDTL L, 1957, APPL HYDR AEROMECHAN; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; ROSEN M, J R SOC INTERFACE; SPEDDING GR, 1987, J EXP BIOL, V127, P59; SPEDDING GR, 1984, J EXP BIOL, V111, P81; SPEDDING GR, 1986, J EXP BIOL, V125, P287; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Swartz SM, 1996, J ZOOL, V239, P357, DOI 10.1111/j.1469-7998.1996.tb05455.x; SWARTZ SM, 2006, FUNCTIONAL EVOLUTION, P110; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; von Helversen O., 1986, BAT FLIGHT, P107; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; Winter Y, 1999, J EXP BIOL, V202, P1917	23	159	170	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					894	897		10.1126/science.1142281	http://dx.doi.org/10.1126/science.1142281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495171				2022-12-24	WOS:000246369800039
J	Stracker, TH; Morales, M; Couto, SS; Hussein, H; Petrini, JHJ				Stracker, Travis H.; Morales, Monica; Couto, Suzana S.; Hussein, Hussein; Petrini, John H. J.			The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex	NATURE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; CELLULAR-RESPONSE; ATM ACTIVATION; CHECKPOINT; MICE; PROTEIN; RECRUITMENT; METABOLISM	The MRE11 complex (MRE11, RAD50 and NBS1) and the ataxia-telangiectasia mutated (ATM) kinase function in the same DNA damage response pathway to effect cell cycle checkpoint activation and apoptosis(1-3). The functional interaction between the MRE11 complex and ATM has been proposed to require a conserved C-terminal domain of NBS1 for recruitment of ATM to sites of DNA damage(4,5). Human Nijmegen breakage syndrome (NBS) cells and those derived from multiple mouse models of NBS express a hypomorphic NBS1 allele that exhibits impaired ATM activity despite having an intact C-terminal domain(3,6-11). This indicates that the NBS1 C terminus is not sufficient for ATM function. We derived Nbs1(Delta C/Delta C) mice in which the C-terminal ATM interaction domain is deleted. Nbs1(Delta C/Delta C) cells exhibit intra-S-phase checkpoint defects, but are otherwise indistinguishable from wild-type cells with respect to other checkpoint functions, ionizing radiation sensitivity and chromosome stability. However, multiple tissues of Nbs1(Delta C/Delta C) mice showed a severe apoptotic defect, comparable to that of ATM- or CHK2-deficient animals. Analysis of p53 transcriptional targets and ATM substrates showed that, in contrast to the phenotype of Chk2(-/-) mice, NBS1(Delta C) does not impair the induction of proapoptotic genes. Instead, the defects observed in Nbs1(Delta C/Delta C) result from impaired phosphorylation of ATM targets including SMC1 and the proapoptotic factor, BID.	Sloan Kettering Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Petrini, JHJ (corresponding author), Sloan Kettering Inst, New York, NY 10021 USA.	petrinij@mskcc.org	Stracker, Travis H/I-2815-2015; Morales-Ballús, Mònica/AAE-3086-2021	Stracker, Travis H/0000-0002-8650-2081; Morales-Ballús, Mònica/0000-0002-9478-6280; Petrini, John/0000-0001-5102-5679	NCI NIH HHS [R13 CA162528] Funding Source: Medline; NIGMS NIH HHS [R01 GM056888-09, R01 GM056888, R01 GM059413, R01 GM059413-08, R01 GM056888-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056888, R01GM059413] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Theunissen JWF, 2006, METHOD ENZYMOL, V409, P251, DOI 10.1016/S0076-6879(05)09015-4; Theunissen JWF, 2003, MOL CELL, V12, P1511, DOI 10.1016/S1097-2765(03)00455-6; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; XU Y, 1996, GENE DEV, V10, P24111; Yamazaki V, 1998, CANCER RES, V58, P2316; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	29	96	102	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					218	U7		10.1038/nature05740	http://dx.doi.org/10.1038/nature05740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17429352	Green Accepted			2022-12-24	WOS:000246338700046
J	Senoo, M; Pinto, F; Crum, CP; McKeon, F				Senoo, Makoto; Pinto, Filipa; Crum, Christopher P.; McKeon, Frank			p63 is essential for the proliferative potential of stem cells in stratified epithelia	CELL			English	Article						u	THYMIC EPITHELIUM; HAIR-FOLLICLES; POLYCOMB-GROUP; SELF-RENEWAL; P53 HOMOLOG; BMI-1; DIFFERENTIATION; EXPRESSION; KERATINOCYTES; PROGENITOR	The distinguishing feature of adult stem cells is their extraordinary capacity to divide prior to the onset of senescence. While stratified epithelia such as skin, prostate, and breast are highly regenerative and account disproportionately for human cancers, genes essential for the proliferative capacity of their stem cells remain unknown. Here we analyze p63, a gene whose deletion in mice results in the catastrophic loss of all stratified epithelia. We demonstrate that p63 is strongly expressed in epithelial cells with high clonogenic and proliferative capacity and that stem cells lacking p63 undergo a premature proliferative rundown. Additionally, we show that p63 is dispensable for both the commitment and differentiation of these stem cells during tissue morphogenesis. Together, these data identify p63 as a key, lineage-specific determinant of the proliferative capacity in stem cells of stratified epithelia.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McKeon, F (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	fmckeon@hms.harvard.edu		Senoo, Makoto/0000-0002-0155-0683				ADKINS B, 1988, IMMUNOGENETICS, V27, P180, DOI 10.1007/BF00346584; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chilosi M, 2003, VIRCHOWS ARCH, V443, P175, DOI 10.1007/s00428-003-0857-4; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ropke Carsten, 2002, Methods Mol Biol, V188, P27; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; Senoo M, 2004, CANCER CELL, V6, P85, DOI 10.1016/j.ccr.2004.06.005; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	50	663	681	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					523	536		10.1016/j.cell.2007.02.045	http://dx.doi.org/10.1016/j.cell.2007.02.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482546	Bronze			2022-12-24	WOS:000246373600019
J	van der Steeg, WA; Boekholdt, SM; Stein, EA; El-Harchaoui, K; Stroes, ESG; Sandhu, MS; Wareham, NJ; Jukema, JW; Luben, R; Zwinderman, AH; Kastelein, JJP; Khaw, KT				van der Steeg, Wim A.; Boekholdt, S. Matthijs; Stein, Evan A.; El-Harchaoui, Karim; Stroes, Erik S. G.; Sandhu, Manjinder S.; Wareham, Nicholas J.; Jukema, J. Wouter; Luben, Robert; Zwinderman, Aeilko H.; Kastelein, John J. P.; Khaw, Kay-Tee			Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: A case--control analysis in EPIC-Norfolk	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; CHEMISTRY STANDARDIZATION PROJECT; LOW-DENSITY-LIPOPROTEIN; ISCHEMIC-HEART-DISEASE; APPARENTLY HEALTHY-MEN; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; INTERNATIONAL-FEDERATION; HDL CHOLESTEROL; POPULATION	Background: An elevated apolipoprotein B-apolipoprotein A-I (apo B-apo A-I) ratio is a risk factor for future coronary artery disease (CAD). It is not known whether this ratio is better than traditional lipid values for risk assessment and prediction and whether it adds predictive value to the Framingham risk score. Objective: To evaluate whether the ape B-apo A-I ratio is associated with future CAD events independent of traditional lipid measurements and the Framingham risk score and to evaluate the ability of this ratio to predict occurrence of future CAD. Design: Prospective, nested case-control study. Setting: Norfolk, United Kingdom. Participants: Apparently healthy men and women (45 to 79 years of age) in the European Prospective Investigation into Cancer and Nutrition-Norfolk. Cases (n = 869) were persons who developed fatal or nonfatal CAD. Controls (n = 1511) were persons without CAD who were matched for age, sex, and enrollment period. Measurements: Total cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride, apolipoprotein, and C-reactive protein levels were measured directly. Low-density lipoprotein (LDL) cholesterol values were calculated by using the Friedewald formula. Results: The apo B-apo A-I ratio was associated with future CAD events, independent of traditional lipid values (adjusted odds ratio, 1.85 [95% Cl, 1.15 to 2.98]), including the total cholesterol-HDL cholesterol ratio, and independent of the Framingham risk score (adjusted odds ratio, 1.77 [Cl, 1.31 to 2.39]). However, it did no better than lipid values at discriminating between CAD cases and controls (area under the receiver-operating characteristic curve, 0.670 for total cholesterol-HDL cholesterol ratio vs. 0.673 for ape B-apo A-I ratio [P = 0.38]) and added little to the predictive value of the Framingham risk score (area under the receiver-operating characteristic curve, 0.594 for Framingham risk score alone vs. 0.613 for Framingham risk score plus ape 6-apo A-I ratio [P < 0.001]), In addition, it incorrectly classified 41.1% of cases and 50.4% of controls. Limitations: No participant was taking lipid-lowering medication, and diabetes was uncommon. Conclusions: The apo B-apo A-I ratio is independently associated with, but adds little to, existing measures for CAD risk assessment and discrimination in the general population. Other characteristics of the test, such as the ability to perform it on nonfasting samples, may still make it useful in some settings.	Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands; Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA; MRC, Epidemiol Unit, Cambridge, England; Inst Publ Hlth, Cambridge, England	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge	Kastelein, JJP (corresponding author), Acad Med Ctr, Dept Vasc Med, Room F4-159-2,POB 22660, NL-1100 DD Amsterdam, Netherlands.	j.j.kastelein@amc.uva.nl	Luben, Robert N/H-5519-2015; Boekholdt, Matthijs S.M./G-7562-2014; Khaw, Kay-Tee/AAZ-3209-2021; Jukema, J. Wouter/ABD-6503-2021; Kastelein, John/AAF-7950-2020	Luben, Robert N/0000-0002-5088-6343; Jukema, J. Wouter/0000-0002-3246-8359; Boekholdt, Matthijs/0000-0002-0861-0765	Medical Research Council [G0401527, MC_U106179471] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBERS JJ, 1992, CLIN CHEM, V38, P658; *ATH RISK COMM STU, 2001, CIRCULATION, V104, P1108; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Boekholdt SM, 2004, CIRCULATION, V110, P1418, DOI 10.1161/01.CIR.0000141730.65972.95; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Bruins P, 1997, CIRCULATION, V96, P3542; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Corsetti JP, 2004, ATHEROSCLEROSIS, V177, P367, DOI 10.1016/j.atherosclerosis.2004.07.019; CREMER P, 1994, EUR J CLIN INVEST, V24, P444, DOI 10.1111/j.1365-2362.1994.tb02373.x; Day N, 1999, BRIT J CANCER, V80, P95; Efron B., 1993, INTRO BOOSTRAP; FIELDING CJ, 1972, BIOCHIM BIOPHYS ACTA, V270, P513, DOI 10.1016/0005-2760(72)90116-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HONG MK, 1991, AM J CARDIOL, V68, P1646, DOI 10.1016/0002-9149(91)90323-D; Jiang R, 2004, DIABETES CARE, V27, P1991, DOI 10.2337/diacare.27.8.1991; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; MARCOVINA SM, 1993, CLIN CHEM, V39, P773; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; MOISE A, 1985, COMPUT BIOMED RES, V18, P125, DOI 10.1016/0010-4809(85)90039-4; Navab M, 2000, J LIPID RES, V41, P1495; Njolstad I, 1996, CIRCULATION, V93, P450; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pepe MS, 2004, STAT EVALUATION MED; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; SALONEN JT, 1985, AM J CARDIOL, V56, P226, DOI 10.1016/0002-9149(85)90839-2; SIGURDSSON G, 1992, AM J CARDIOL, V69, P1251, DOI 10.1016/0002-9149(92)91215-P; St-Pierre AC, 2001, CIRCULATION, V104, P2295, DOI 10.1161/hc4401.098490; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Sweetnam PM, 2000, EUR J CLIN INVEST, V30, P947, DOI 10.1046/j.1365-2362.2000.00725.x; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; Wagner AM, 1999, DIABETES CARE, V22, P812, DOI 10.2337/diacare.22.5.812; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; Wallis EJ, 2000, BMJ-BRIT MED J, V320, P671, DOI 10.1136/bmj.320.7236.671; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	45	121	124	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2007	146	9					640	648		10.7326/0003-4819-146-9-200705010-00007	http://dx.doi.org/10.7326/0003-4819-146-9-200705010-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162EV	17470832				2022-12-24	WOS:000246070500003
J	Wang, XD; Song, JH; Liu, J; Wang, ZL				Wang, Xudong; Song, Jinhui; Liu, Jin; Wang, Zhong Lin			Direct-current nanogenerator driven by ultrasonic waves	SCIENCE			English	Article							PIEZOELECTRIC NANOGENERATORS; NANOWIRE; GROWTH; TRANSISTOR	We have developed a nanowire nanogenerator that is driven by an ultrasonic wave to produce continuous direct-current output. The nanogenerator was fabricated with vertically aligned zinc oxide nanowire arrays that were placed beneath a zigzag metal electrode with a small gap. The wave drives the electrode up and down to bend and/or vibrate the nanowires. A piezoelectric-semiconducting coupling process converts mechanical energy into electricity. The zigzag electrode acts as an array of parallel integrated metal tips that simultaneously and continuously create, collect, and output electricity from all of the nanowires. The approach presents an adaptable, mobile, and cost-effective technology for harvesting energy from the environment, and it offers a potential solution for powering nanodevices and nanosystems.	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	zhong.wang@mse.gatech.edu	Wang, Xudong/A-7067-2009; Wang, Zhong Lin/E-2176-2011; wang, jie/GRS-0942-2022; Song, Jinhui/C-7524-2013; Dee, Chang Fu/G-4842-2010	Wang, Zhong Lin/0000-0002-5530-0380; Song, Jinhui/0000-0002-0042-2014; Dee, Chang Fu/0000-0003-1015-9181				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Fruhauf J, 2005, MICROSYST TECHNOL, V11, P1287, DOI 10.1007/s00542-005-0612-7; Gao PX, 2007, ADV MATER, V19, P67, DOI 10.1002/adma.200601162; Hsu JWP, 2005, NANO LETT, V5, P83, DOI 10.1021/nl048322e; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; LI V, 2006, MATER TODAY, V9, P18; Mitcheson PD, 2004, J MICROELECTROMECH S, V13, P429, DOI 10.1109/JMEMS.2004.830151; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Patolsky F, 2005, MATER TODAY, V8, P20, DOI 10.1016/S1369-7021(05)00791-1; Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640; Song JH, 2006, NANO LETT, V6, P1656, DOI 10.1021/nl060820v; Tian ZRR, 2003, NAT MATER, V2, P821, DOI 10.1038/nmat1014; Wang XD, 2005, J AM CHEM SOC, V127, P7920, DOI 10.1021/ja050807x; Wang XD, 2004, NANO LETT, V4, P423, DOI 10.1021/nl035102c; Wang XD, 2006, NANO LETT, V6, P2768, DOI 10.1021/nl061802g; Wang ZL, 2007, MRS BULL, V32, P109, DOI 10.1557/mrs2007.42; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005	21	1910	1999	57	1390	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					102	105		10.1126/science.1139366	http://dx.doi.org/10.1126/science.1139366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412957				2022-12-24	WOS:000245470500041
J	Lo, I; Denef, VJ; VerBerkmoes, NC; Shah, MB; Goltsman, D; DiBartolo, G; Tyson, GW; Allen, EE; Ram, RJ; Detter, JC; Richardson, P; Thelen, MP; Hettich, RL; Banfield, JF				Lo, Ian; Denef, Vincent J.; VerBerkmoes, Nathan C.; Shah, Manesh B.; Goltsman, Daniela; DiBartolo, Genevieve; Tyson, Gene W.; Allen, Eric E.; Ram, Rachna J.; Detter, J. Chris; Richardson, Paul; Thelen, Michael P.; Hettich, Robert L.; Banfield, Jillian F.			Strain-resolved community proteomics reveals recombining genomes of acidophilic bacteria	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; MICROBIAL COMMUNITY; SP-NOV; MICROORGANISMS; LEPTOSPIRILLUM; POPULATION; PROTEINS; BIOFILM; OCEAN	Microbes comprise the majority of extant organisms, yet much remains to be learned about the nature and driving forces of microbial diversification. Our understanding of how microorganisms adapt and evolve can be advanced by genome-wide documentation of the patterns of genetic exchange, particularly if analyses target coexisting members of natural communities. Here we use community genomic data sets to identify, with strain specificity, expressed proteins from the dominant member of a genomically uncharacterized, natural, acidophilic biofilm. Proteomics results reveal a genome shaped by recombination involving chromosomal regions of tens to hundreds of kilobases long that are derived from two closely related bacterial populations. Inter-population genetic exchange was confirmed by multilocus sequence typing of isolates and of uncultivated natural consortia. The findings suggest that exchange of large blocks of gene variants is crucial for the adaptation to specific ecological niches within the very acidic, metal-rich environment. Mass-spectrometry-based discrimination of expressed protein products that differ by as little as a single amino acid enables us to distinguish the behaviour of closely related coexisting organisms. This is important, given that microorganisms grouped together as a single species may have quite distinct roles in natural systems(1-3) and their interactions might be key to ecosystem optimization. Because proteomic data simultaneously convey information about genome type and activity, strain-resolved community proteomics is an important complement to cultivation-independent genomic ( metagenomic) analysis(4-6) of microorganisms in the natural environment.	Univ Calif Berkeley, Berkeley, CA 94720 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Banfield, JF (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Hettich, Robert L/N-1458-2016; Thelen, Michael P/G-2032-2014; Tyson, Gene W/C-6558-2013; Thelen, Michael/C-6834-2008	Hettich, Robert L/0000-0001-7708-786X; Thelen, Michael P/0000-0002-2479-5480; Tyson, Gene W/0000-0001-8559-9427; Thelen, Michael/0000-0002-2479-5480; Banfield, Jill/0000-0001-8203-8771				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Coram NJ, 2002, APPL ENVIRON MICROB, V68, P838, DOI 10.1128/AEM.68.2.838-845.2002; Dalluge JJ, 2002, CURR PROTEIN PEPT SC, V3, P181, DOI 10.2174/1389203024605377; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; JOHNSON DB, 1995, J MICROBIOL METH, V23, P205, DOI 10.1016/0167-7012(95)00015-D; Johnson DB, 2003, RES MICROBIOL, V154, P466, DOI 10.1016/S0923-2508(03)00114-1; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Majewski J, 1999, GENETICS, V152, P1459; Majewski J, 1999, GENETICS, V153, P1525; Manabe T, 1999, ELECTROPHORESIS, V20, P3116, DOI 10.1002/(SICI)1522-2683(19991001)20:15/16<3116::AID-ELPS3116>3.0.CO;2-0; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Nesbo CL, 2006, GENETICS, V172, P759, DOI 10.1534/genetics.105.049312; Papke RT, 2004, SCIENCE, V306, P1928, DOI 10.1126/science.1103289; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Whitaker RJ, 2005, MOL BIOL EVOL, V22, P2354, DOI 10.1093/molbev/msi233	25	179	185	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					537	541		10.1038/nature05624	http://dx.doi.org/10.1038/nature05624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17344860				2022-12-24	WOS:000245242900049
J	Shimizu, K; Phan, T; Mansuy, IM; Storm, DR				Shimizu, Kimiko; Phan, Trongha; Mansuy, Isabelle M.; Storm, Daniel R.			Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory	CELL			English	Article							LONG-TERM-MEMORY; MEDIATED GENE-EXPRESSION; SIGNAL-REGULATED KINASE; ELEMENT-BINDING PROTEIN; SYNAPTIC PLASTICITY; NEUROTRANSMITTER RELEASE; SUPRACHIASMATIC NUCLEUS; DEPENDENT ACTIVATION; NEURONAL PLASTICITY; NEUROTROPHIC FACTOR	Because activation of ERK1/2 MAP kinase (MAPK) is critical for hippocampus-dependent memory, there is considerable interest in mechanisms for regulation of MAPK during memory formation. Here we report that MAPK and CREB-mediated transcription are negatively regulated by SCOP (suprachiasmatic nucleus [SCN] circadian oscillatory protein) and that SCOP is proteolyzed by calpain when hippocampal neurons are stimulated by brain-derived neurotrophic factor (BDNF), KCl depolarization, or NMDA. Moreover, training for novel object memory decreases SCOP in the hippocampus. To determine if hippocampus-dependent memory is influenced by SCOP in vivo, we generated a transgenic mouse strain for the inducible overexpression of SCOP in the forebrain. Overexpression of SCOP completely blocked memory for novel objects. We conclude that degradation of SCOP by calpain contributes to activation of MAPK during memory formation.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Zurich, Swiss Fed Inst Technol, Brain Res Inst, CH-8057 Zurich, Switzerland	University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu	Mansuy, Isabelle M/N-3042-2015; Kimiko, Shimizu/ACS-9013-2022; Shimizu, Kimiko/G-4956-2014	Mansuy, Isabelle M/0000-0001-7785-5371; Kimiko, Shimizu/0000-0003-4943-2552; Shimizu, Kimiko/0000-0003-4943-2552	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH073601] Funding Source: Medline; NINDS NIH HHS [NS 20498, R01 NS020498] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Blum S, 1999, J NEUROSCI, V19, P3535; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Chan D, 1998, NETW COMPUT, V9, P18; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Cline H, 2003, CURR BIOL, V13, pR514, DOI 10.1016/S0960-9822(03)00443-3; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DINGLEDINE R, 1983, FED PROC, V42, P2881; DIVIRGILIO F, 1987, J BIOL CHEM, V262, P9189; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Frankland PW, 2003, NEUROSCIENTIST, V9, P104, DOI 10.1177/1073858403252225; Grammer M, 2005, NEUROBIOL LEARN MEM, V84, P222, DOI 10.1016/j.nlm.2005.07.007; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2003, J NEUROSCI, V23, P5354; Li YX, 1998, J NEUROSCI, V18, P10231; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; NIXON RA, 1986, J NEUROSCI, V6, P1264; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Ohno M, 2001, NAT NEUROSCI, V4, P1238, DOI 10.1038/nn771; ONIZUKA K, 1995, BRAIN RES, V697, P179, DOI 10.1016/0006-8993(95)00838-H; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	51	89	91	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1219	1229		10.1016/j.cell.2006.12.047	http://dx.doi.org/10.1016/j.cell.2006.12.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382888	Green Accepted, Bronze			2022-12-24	WOS:000245396200025
J	Triboulet, R; Mari, B; Lin, YL; Chable-Bessia, C; Bennasser, Y; Lebrigand, K; Cardinaud, B; Maurin, T; Barbry, P; Baillat, V; Reynes, J; Corbeau, P; Jeang, KT; Benkirane, M				Triboulet, Robinson; Mari, Bernard; Lin, Yea-Lih; Chable-Bessia, Christine; Bennasser, Yamina; Lebrigand, Kevin; Cardinaud, Bruno; Maurin, Thomas; Barbry, Pascal; Baillat, Vincent; Reynes, Jacques; Corbeau, Pierre; Jeang, Kuan-Teh; Benkirane, Monsef			Suppression of microRNA-silencing pathway by HIV-1 during virus replication	SCIENCE			English	Article							CLUSTER; LATENCY; SIRNA; GENE	MicroRNAs ( miRNAs) are single-stranded noncoding RNAs of 19 to 25 nucleotides that function as gene regulators and as a host cell defense against both RNA and DNA viruses. We provide evidence for a physiological role of the miRNA-silencing machinery in controlling HIV-1 replication. Type III RNAses Dicer and Drosha, responsible for miRNA processing, inhibited virus replication both in peripheral blood mononuclear cells from HIV-1-infected donors and in latently infected cells. In turn, HIV-1 actively suppressed the expression of the polycistronic miRNA cluster miR-17/92. This suppression was found to be required for efficient viral replication and was dependent on the histone acetyltransferase Tat cofactor PCAF. Our results highlight the involvement of the miRNA-silencing pathway in HIV-1 replication and latency.	Inst Genet Humaine, Mol Virol Lab, Montpellier, France; Inst Genet Humaine, Lab Lentivirus & Transfert Genes, Montpellier, France; UNSA, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, Sophia Antipolis, France; Hop Gui de Chauliac, Serv Malad Infect & Trop, Montpellier, France; NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montpellier; CHU de Montpellier; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Benkirane, M (corresponding author), Inst Genet Humaine, Mol Virol Lab, Montpellier, France.	bmonsef@igh.cnrs.fr	Jeang, Kuan-Teh/A-2424-2008; Barbry, Pascal/O-5021-2016; Mari, Bernard P/D-7445-2015; Mari, Bernard P/F-8960-2013; Mari, Bernard P/GVS-3100-2022; Mari, Bernard/Q-5832-2019; Bennasser, Yamina/M-4833-2017; maurin, thomas O/O-7494-2016	Barbry, Pascal/0000-0001-9632-6483; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard/0000-0002-0422-9182; maurin, thomas O/0000-0002-8467-3135	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000547, Z01AI000547] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; Marcello A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-7; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Ott Melanie, 2004, Novartis Found Symp, V259, P182; Pomerantz Roger J, 2002, Curr Opin Investig Drugs, V3, P1133; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Saumet A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-3; Tagawa H, 2005, LEUKEMIA, V19, P2013, DOI 10.1038/sj.leu.2403942; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Voinnet O, 2002, CURR OPIN PLANT BIOL, V5, P444, DOI 10.1016/S1369-5266(02)00291-1; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81	22	496	558	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1579	1582		10.1126/science.1136319	http://dx.doi.org/10.1126/science.1136319			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17322031				2022-12-24	WOS:000244934800054
J	Csete, J				Csete, Joanne			AIDS and public security: the other side of the coin	LANCET			English	Editorial Material									Canadian HIV AIDS Legal Network, Toronto, ON M5R 2A7, Canada		Csete, J (corresponding author), Canadian HIV AIDS Legal Network, Toronto, ON M5R 2A7, Canada.	jcsete@aidslaw.ca						Azimi Negar, 2006, NEW YORK TIMES  1203, P63; PANT S, 2006, 16 INT AIDS C TOR CA; *UN DEV PROGR, 2004, THAIL RESP HIV AIDS, P54; *UNAIDS, 2006, UNAIDSPCB19067; *UNAIDS, 2006, RUSS FED COUNTR UPD; WOLFE D, 2004, NATION          0408; 2004, HUMAN RIGHTS WAT APR; 2002, HUMAN RIGHTS WAT JUL; 2004, PRAVDA          1019; 2004, ISN SECURITY WA 1018	10	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					720	721		10.1016/S0140-6736(07)60334-1	http://dx.doi.org/10.1016/S0140-6736(07)60334-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336630				2022-12-24	WOS:000244726700006
J	Lipscombe, LL; Hux, JE				Lipscombe, Lorraine L.; Hux, Janet E.			Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; RISING PREVALENCE; OBESITY; MELLITUS; BURDEN; RISK; LIFE	Background The prevalence of diabetes has been increasing greatly, but WHO's predicted 39% rise in the global rate of diabetes from 2000 to 2030 might be an underestimate. We aimed to assess diabetes trends in Ontario, Canada. Methods Using population-based data, including a validated diabetes database from the province of Ontario, Canada, we examined trends in diabetes prevalence and mortality from 1995 to 2005, and incidence from 1997 to 2003, in adults aged 20 years or older. Findings Age-adjusted and sex-adjusted diabetes prevalence increased by 69%, from 5.2% in a population of 7908 562 in 1995 to 8.8% of 9 276 945 in 2005. Prevalence increased by 27% from 6.9% in a population of 8 457 720 in 2000 to 8.8% of 9 276 945 in 2005. Although prevalence rates have remained higher in people aged 50 years or older (7.1% of 3 675 554) than in those aged 20-49 years (3.5% of 5 601391), rates increased to a greater extent in the younger population (94% vs 63%, p<0.0001). A 31% increase occurred in yearly incidence over 6 years, from 6.6 per 1000 in 1997 to 8.2 per 1000 in 2003. The adjusted mortality rate in people with diabetes fell by 25% from 1995 to 2005. Interpretation The prevalence of diabetes in Ontario, Canada increased substantially during the past 10 years, and by 2005 already exceeded the global rate that was predicted for 2030. This increase in prevalence is attributable to both rising incidence and declining mortality. Effective public-health interventions aimed at diabetes prevention are needed, as well as improved resources to manage the greater number of people living longer with the disease.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Womens Coll Hosp, Toronto, ON M5S 1B2, Canada	University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, LL (corresponding author), Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada.	Lorraine.Lipscombe@ices.on.ca	Greiver, Michelle/N-8764-2015; Northe, Hilda/I-1916-2012	Greiver, Michelle/0000-0001-8957-0285; Northe, Hilda/0000-0002-8873-5014; Lipscombe, Lorraine/0000-0001-7412-7993				American Diabetes Association, 2004, DIABETES CARE, V27, pS11, DOI [10.2337/diacare.27.2007.S11, DOI 10.2337/DIACARE.27.2007.S11]; American Diabetes Association: Diagnosis and classification of diabetes mellitus, 2005, DIABETES CARE S1, V28, P537; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; ATKINS RC, 2005, KIDNEY INT S, V94, P14, DOI DOI 10.1111/J.1523-1755.2005.09403.X; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Katzmarzyk PT, 2006, CAN MED ASSOC J, V174, P156, DOI 10.1503/cmaj.050806; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; McBean AM, 2004, DIABETES CARE, V27, P2317, DOI 10.2337/diacare.27.10.2317; Meltzer S, 1998, CAN MED ASSOC J, V159, pS1; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; *OTT STAT CAN, 2006, ANN DEM STAT 2005; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; *STAT CAN, 2002, IMM CIT; *STAT CAN, 2006, HLTH STAT HLTH IND; *STAT CAN, 2002, 2001 COMM PROF; Stovring H, 2003, LANCET, V362, P537, DOI 10.1016/S0140-6736(03)14116-5; Tavani A, 2002, J CLIN EPIDEMIOL, V55, P1082, DOI 10.1016/S0895-4356(02)00486-9; Thomas RJ, 2003, ARCH INTERN MED, V163, P445, DOI 10.1001/archinte.163.4.445; *US BUR CENS, 2003, CURR POP REP; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2006, GLOB STRAT DIET PHYS; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	29	461	475	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	2007	369	9563					750	756		10.1016/S0140-6736(07)60361-4	http://dx.doi.org/10.1016/S0140-6736(07)60361-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143MP	17336651				2022-12-24	WOS:000244726700031
J	Tuffs, A				Tuffs, Annette			Medicine and the media - Thalidomide: the true story?	BRITISH MEDICAL JOURNAL			English	Editorial Material												ATuffs@web.de							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2007	334	7600					933	933		10.1136/bmj.39199.637986.59	http://dx.doi.org/10.1136/bmj.39199.637986.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478844	Green Published			2022-12-24	WOS:000246343800035
J	Mehta, DK; Aronson, JK				Mehta, Dinesh K.; Aronson, Jeffrey K.			Give a drug a good name	LANCET			English	Editorial Material									Royal Pharmaceut Soc Great Britain, London SE1 7JN, England; Univ Oxford, Dept Clin Pharmacol, Oxford, England	University of Oxford	Mehta, DK (corresponding author), Royal Pharmaceut Soc Great Britain, London SE1 7JN, England.	dmehta@bnf.org						Aronson J, 2004, BRIT J GEN PRACT, V54, P559; Aronson Jeffrey K, 2004, Expert Opin Drug Saf, V3, P167; Aronson JK, 2000, BMJ-BRIT MED J, V320, P506, DOI 10.1136/bmj.320.7233.506; SASHKOVA G, 2004, WHO DRUG INFO, V18, P123; 2002, WHO DRUG INFO, V16, P194; 1965, WHO CHRONICLE, V19, P446	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1326	1328		10.1016/S0140-6736(07)60612-6	http://dx.doi.org/10.1016/S0140-6736(07)60612-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448803				2022-12-24	WOS:000245856100008
J	Liu, S; Li, P; Dybkov, O; Nottrott, S; Hartmuth, K; Luhrmann, R; Carlomagno, T; Wahl, MC				Liu, Sunbin; Li, Ping; Dybkov, Olexandr; Nottrott, Stephanie; Hartmuth, Klaus; Luehrmann, Reinhard; Carlomagno, Teresa; Wahl, Markus C.			Binding of the human Prp31 nop domain to a composite RNA-protein platform in U4 snRNP	SCIENCE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; TRI-SNRNP; MOLECULAR-BASIS; HUMAN U4/U6.U5; SPLICEOSOME; COMPLEX; RECOGNITION; ASSOCIATION; INTERACT; GENE	Although highly homologous, the spliceosomal hPrp31 and the nucleolar Nop56 and Nop58 (Nop56/58) proteins recognize different ribonucleoprotein (RNP) particles. hPrp31 interacts with complexes containing the 15.5K protein and U4 or U4atac small nuclear RNA (snRNA), whereas Nop56/58 associate with 15.5K-box C/D small nucleolar RNA complexes. We present structural and biochemical analyses of hPrp31-15.5K-U4 snRNA complexes that show how the conserved Nop domain in hPrp31 maintains high RNP binding selectivity despite relaxed RNA sequence requirements. The Nop domain is a genuine RNP binding module, exhibiting RNA and protein binding surfaces. Yeast two-hybrid analyses suggest a link between retinitis pigmentosa and an aberrant hPrp31-hPrp6 interaction that blocks U4/U6-U5 tri-snRNP formation.	Max Planck Inst Biophys Chem, Abt Zellulaire Biochem, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, AG Flussig NMR Spektroskopie, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, AG Makromol Rontgenkristallog, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulaire Biochem, Fassberg 11, D-37077 Gottingen, Germany.	Reinhard.Luehrmann@mpi-bpc.mpg.de; taco@nmr.mpibpc.mpg.de; mwahl@gwdg.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307; Carlomagno, Teresa/0000-0002-2437-2760				Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; BRINGMANN P, 1984, EMBO J, V3, P1357, DOI 10.1002/j.1460-2075.1984.tb01977.x; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burge CB, 1999, RNA WORLD, P525; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; HASHIMOTO C, 1984, NUCLEIC ACIDS RES, V12, P3283, DOI 10.1093/nar/12.7.3283; Kuhn-Holsken E, 2005, RNA, V11, P1915, DOI 10.1261/rna.2176605; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; REED R, 1997, EUKARYOTIC MRNA PROC, P103; Schneider C, 2002, MOL CELL BIOL, V22, P3219, DOI 10.1128/MCB.22.10.3219-3229.2002; Schultz A, 2006, J BIOL CHEM, V281, P28278, DOI 10.1074/jbc.M603350200; Schultz A, 2006, MOL CELL BIOL, V26, P5146, DOI 10.1128/MCB.02374-05; SHAKKED Z, 1994, NATURE, V368, P469, DOI 10.1038/368469a0; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Szewczak LBW, 2005, RNA, V11, P1407, DOI 10.1261/rna.2830905; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; WU JC, 1983, J BIOL CHEM, V258, P4694	31	102	104	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					115	120		10.1126/science.1137924	http://dx.doi.org/10.1126/science.1137924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412961	Green Published			2022-12-24	WOS:000245470500045
J	Giocomo, LM; Zilli, EA; Fransen, E; Hasselmo, ME				Giocomo, Lisa M.; Zilli, Eric A.; Fransen, Erik; Hasselmo, Michael E.			Temporal frequency of subthreshold oscillations scales with entorhinal grid cell field spacing	SCIENCE			English	Article							CORTEX LAYER-II; HEAD DIRECTION CELLS; PATH-INTEGRATION; PLACE CELLS; NEURONS; MODEL; REPRESENTATION; HIPPOCAMPUS; MECHANISMS; DYNAMICS	Grid cells in layer II of rat entorhinal cortex fire to spatial locations in a repeating hexagonal grid, with smaller spacing between grid fields for neurons in more dorsal anatomical locations. Data from in vitro whole-cell patch recordings showed differences in frequency of subthreshold membrane potential oscillations in entorhinal neurons that correspond to different positions along the dorsal-to-ventral axis, supporting a model of physiological mechanisms for grid cell responses.	Boston Univ, Dept Psychol, Ctr Memory & Brain, Program Neurosci, Boston, MA 02215 USA; Royal Inst Technol, Sch Comp Sci & Commun, SE-10044 Stockholm, Sweden; Stockholm Brain Inst, SE-10044 Stockholm, Sweden	Boston University; Royal Institute of Technology	Giocomo, LM (corresponding author), Boston Univ, Dept Psychol, Ctr Memory & Brain, Program Neurosci, 2 Cummington St, Boston, MA 02215 USA.	giocomo@bu.edu; hasselmo@bu.edu		Hasselmo, Michael/0000-0002-9925-6377; Giocomo, Lisa/0000-0003-0416-2528	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071702, R01MH061492, R01MH060013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016454] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA016454-04, R01 DA016454-05, R01 DA016454, DA16454] Funding Source: Medline; NIMH NIH HHS [MH71702, P50 MH071702, P50 MH071702-01A20004, R01 MH061492, R01 MH060013-05, R01 MH060013-06, R01 MH060013, MH60013, R01 MH061492-05] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Acker CD, 2003, J COMPUT NEUROSCI, V15, P71, DOI 10.1023/A:1024474819512; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; [Anonymous], CONDITIONING CONSCIO; BLAIR HT, IN PRESS J NEUROSCI; BURGESS N, IN PRESS HIPPOCAMPUS; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Fransen E, 2004, HIPPOCAMPUS, V14, P368, DOI 10.1002/hipo.10198; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PAKINOS G, 1998, RAT BRAIN STEREOTAXI; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262	28	283	291	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1719	1722		10.1126/science.1139207	http://dx.doi.org/10.1126/science.1139207			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379810	Green Accepted			2022-12-24	WOS:000245106900042
J	Luo, J; Ye, W; Zendehdel, K; Adami, J; Adami, HO; Boffetta, P; Nyren, O				Luo, Juhua; Ye, Weimin; Zendehdel, Kazem; Adami, Johanna; Adami, Hans-Olov; Boffetta, Paolo; Nyren, Olaf			Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study	LANCET			English	Article							SMOKELESS TOBACCO USE; SQUAMOUS-CELL CARCINOMA; N-NITROSAMINES; ALCOHOL-CONSUMPTION; NORTHERN SWEDEN; UNITED-STATES; SMOKING; CARCINOGENICITY; MORTALITY; ETIOLOGY	Background Although classified as carcinogenic, snuff is used increasingly in several populations. Scandinavian moist snuff (snus) has been proposed as a less harmful alternative to smoking, but precise data on the independent associations of snus use with site-specific cancers are sparse. We aimed to assess the risks for cancer of the oral cavity, lung, and pancreas. Methods Detailed information about tobacco smoking and snus use was obtained from 279 897 male Swedish construction workers in 1978-92. Complete follow-up until end of 2004 was accomplished through links with population and health registers. To distinguish possible effects of snus from those of smoking, we focused on 125 576 workers who were reported to be never-smokers at entry. Adjusted relative risks were derived from Cox proportional hazards regression models. Findings 60 cases of oral, 154 of lung, and 83 of pancreatic cancer were recorded in never-smokers. Snus use was independently associated with increased risk of pancreatic cancer (relative risk for ever-users of snus 2.0; 95% Ci 1.2-3.3, compared with never-users of any tobacco), but was unrelated to incidence of oral (0.8, 95% CI 0.4-1.7) and lung cancer (0.8, 0.5-1.3). Interpretation Use of Swedish snus should be added to the list of tentative risk factors for pancreatic cancer. We were unable to confirm any excess of oral or lung cancer in snus users.	Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17177 Stockholm, Sweden; Univ Tehran, Canc Inst Res Ctr, Tehran, Iran; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Int Agcy Res Canc, F-69372 Lyon, France	Karolinska Institutet; Karolinska Institutet; University of Tehran; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; International Agency for Research on Cancer (IARC)	Nyren, O (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, SE-17177 Stockholm, Sweden.	olof.nyren@ki.se	Adami, Johanna/AAA-3312-2021; Boffetta, Paolo/AAI-7767-2021; Ye, Weimin/A-5939-2008	Boffetta, Paolo/0000-0002-3811-2791; luo, juhua/0000-0002-8901-4462; Zendehdel, Kazem/0000-0002-0269-4945				Accortt NA, 2005, CANCER CAUSE CONTROL, V16, P1107, DOI 10.1007/s10552-005-0247-0; Alguacil J, 2004, CANCER EPIDEM BIOMAR, V13, P55, DOI 10.1158/1055-9965.EPI-03-0033; [Anonymous], 1985, IARC Monogr Eval Carcinog Risk Chem Hum, V37, P1; BJELKE E, 1982, P 13 INT C CANC SEAT, P207; Boffetta P, 2006, INT J CANCER, V118, P1586, DOI 10.1002/ijc.21319; Boffetta P, 2005, INT J CANCER, V114, P992, DOI 10.1002/ijc.20811; Cogliano V, 2004, LANCET ONCOL, V5, P708, DOI 10.1016/S1470-2045(04)01633-X; EKBOM A, 2002, TXB CANC EPIDEMIOLOG, P233; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; FARROW DC, 1990, INT J CANCER, V45, P816, DOI 10.1002/ijc.2910450504; Furberg H, 2006, ADDICTION, V101, P1509, DOI 10.1111/j.1360-0443.2006.01550.x; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Gilljam H, 2003, ADDICTION, V98, P1183, DOI 10.1046/j.1360-0443.2003.00379.x; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Henley SJ, 2005, CANCER CAUSE CONTROL, V16, P347, DOI 10.1007/s10552-004-5519-6; Hoffmann D, 1997, Adv Dent Res, V11, P322; HOFFMANN D, 1995, J NATL CANCER I, V87, P1862, DOI 10.1093/jnci/87.24.1862; Lewin F, 1998, CANCER-AM CANCER SOC, V82, P1367, DOI 10.1002/(SICI)1097-0142(19980401)82:7&lt;1367::AID-CNCR21&gt;3.0.CO;2-3; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Muscat JE, 1997, CANCER EPIDEM BIOMAR, V6, P15; Nyren O, 1996, JNCI-J NATL CANCER I, V88, P1302, DOI 10.1093/jnci/88.18.1302; Persson PG, 2000, J INTERN MED, V248, P103, DOI 10.1046/j.1365-2796.2000.00708.x; Prokopczyk B, 2002, CHEM RES TOXICOL, V15, P677, DOI 10.1021/tx0101088; PROKOPCZYK B, 1991, CANCER LETT, V60, P153, DOI 10.1016/0304-3835(91)90222-4; RAMSTROM L, 1997, REDUCTION SMOKING SM; RIVENSON A, 1988, CANCER RES, V48, P6912; Rodu B, 2005, TOB CONTROL, V14, P405, DOI 10.1136/tc.2005.011429; Rodu B, 2004, CRIT REV ORAL BIOL M, V15, P252, DOI 10.1177/154411130401500502; Rodu B, 2002, J INTERN MED, V252, P398, DOI 10.1046/j.1365-2796.2002.01057.x; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P991, DOI 10.1080/00016480510043440; Schildt EB, 1998, INT J CANCER, V77, P341, DOI 10.1002/(SICI)1097-0215(19980729)77:3<341::AID-IJC6>3.0.CO;2-O; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schuller HM, 2002, NAT REV CANCER, V2, P455, DOI 10.1038/nrc824; Stegmayr B, 2005, SCAND J PUBLIC HEALT, V33, P321, DOI 10.1080/14034940510032301; WILLIAMS RR, 1977, JNCI-J NATL CANCER I, V58, P525, DOI 10.1093/jnci/58.3.525; Zheng W, 1993, CANCER CAUSE CONTROL, V4, P477	39	163	167	0	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					2015	2020		10.1016/S0140-6736(07)60678-3	http://dx.doi.org/10.1016/S0140-6736(07)60678-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17498797				2022-12-24	WOS:000247354400025
J	Grundy, SM				Grundy, Scott M.			Should women be offered cholesterol lowering drugs to prevent cardiovascular disease?	BRITISH MEDICAL JOURNAL			English	Article									Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Clin Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Grundy, SM (corresponding author), Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Clin Nutr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	scott.grundy@utsouthwestern.edu							0	18	18	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 12	2007	334	7601					982	983		10.1136/bmj.39202.399942.AD	http://dx.doi.org/10.1136/bmj.39202.399942.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170AI	17494017	Green Published			2022-12-24	WOS:000246632800027
J	Pessiglione, M; Schmidt, L; Draganski, B; Kalisch, R; Lau, H; Dolan, RJ; Frith, CD				Pessiglione, Mathias; Schmidt, Liane; Draganski, Bogdan; Kalisch, Raffael; Lau, Hakwan; Dolan, Ray J.; Frith, Chris D.			How the brain translates money into force: A neuroimaging study of subliminal motivation	SCIENCE			English	Article							BASAL GANGLIA; ORBITOFRONTAL CORTEX; REWARD; HUMANS; CIRCUITS; AMYGDALA; REPRESENTATION; STRIATUM; PARALLEL; BEHAVIOR	Unconscious motivation in humans is often inferred but rarely demonstrated empirically. We imaged motivational processes, implemented in a paradigm that varied the amount and reportability of monetary rewards for which subjects exerted physical effort. We show that, even when subjects cannot report how much money is at stake, they nevertheless deploy more force for higher amounts. Such a motivational effect is underpinned by engagement of a specific basal forebrain region. Our findings thus reveal this region as a key node in brain circuitry that enables expected rewards to energize behavior, without the need for the subjects' awareness.	UCL, Wellcome Trust, Ctr Neuroimaging, Inst Neurol, London WC1N 3BG, England; Univ Paris 06, INSERM, Unite 610,Grp Pitie Salpetriere, Ctr Neuroimagerie & Rech, F-75013 Paris, France	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pessiglione, M (corresponding author), UCL, Wellcome Trust, Ctr Neuroimaging, Inst Neurol, 12 Queen Sq, London WC1N 3BG, England.	pessigli@ccr.jussieu.fr	Pessiglione, Mathias/E-2141-2017; Draganski, Bogdan/C-3096-2016; Frith, Chris D/A-2171-2009; Kalisch, Raffael/A-9863-2018; Kalisch, Raffael/H-6624-2016	Pessiglione, Mathias/0000-0002-6992-3677; Draganski, Bogdan/0000-0002-5159-5919; Frith, Chris D/0000-0002-8665-0690; Schmidt, Liane/0000-0002-4159-9705; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [078865] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; DETIMERS C, 1995, J NEUROPHYSIOL, V74, P802; Elliott R, 2003, J NEUROSCI, V23, P303; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Friedman DP, 2002, J COMP NEUROL, V450, P345, DOI 10.1002/cne.10336; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Heimer L, 2006, NEUROSCI BIOBEHAV R, V30, P126, DOI 10.1016/j.neubiorev.2005.06.006; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; MCALONAN GM, 1993, NEUROSCIENCE, V52, P605, DOI 10.1016/0306-4522(93)90410-H; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; PANAGIS G, 1995, BEHAV BRAIN RES, V68, P165, DOI 10.1016/0166-4328(94)00169-G; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Tindell AJ, 2004, J NEUROSCI, V24, P1058, DOI 10.1523/JNEUROSCI.1437-03.2004; Vaillancourt DE, 2004, NEUROIMAGE, V23, P175, DOI 10.1016/j.neuroimage.2004.04.040; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026	30	417	428	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					904	906		10.1126/science.1140459	http://dx.doi.org/10.1126/science.1140459			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166HM	17431137	Green Accepted, Green Published			2022-12-24	WOS:000246369800042
J	Ren, M; Yoshimura, Y; Takada, N; Horibe, S; Komatsu, Y				Ren, Ming; Yoshimura, Yumiko; Takada, Naoki; Horibe, Shoko; Komatsu, Yukio			Specialized inhibitory synaptic actions between nearby neocortical pyramidal neurons	SCIENCE			English	Article							PRESYNAPTIC IONOTROPIC RECEPTORS; VESICULAR GLUTAMATE TRANSPORTERS; KAINATE RECEPTORS; HIPPOCAMPAL INTERNEURONS; TRANSMITTER RELEASE; CEREBRAL-CORTEX; RAT NEOCORTEX; AMPA RECEPTOR; GABA RELEASE; DESENSITIZATION	We found that, in the mouse visual cortex, action potentials generated in a single layer-2/3 pyramidal ( excitatory) neuron can reliably evoke large, constant-latency inhibitory postsynaptic currents in other nearby pyramidal cells. This effect is mediated by axo-axonic ionotropic glutamate receptor-mediated excitation of the nerve terminals of inhibitory interneurons, which connect to the target pyramidal cells. Therefore, individual cortical excitatory neurons can generate inhibition independently from the somatic firing of inhibitory interneurons.	Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan	Nagoya University	Komatsu, Y (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan.	komatsu@riem.nagoya-u.ac.jp		Yoshimura, Yumiko/0000-0002-7526-4153				Ali AB, 2001, J NEUROSCI, V21, P2992, DOI 10.1523/JNEUROSCI.21-09-02992.2001; Alonso-Nanclares L, 2004, NEUROSCIENCE, V123, P547, DOI 10.1016/j.neuroscience.2003.09.033; Braga MFM, 2003, J NEUROSCI, V23, P442, DOI 10.1523/JNEUROSCI.23-02-00442.2003; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Bureau I, 1999, J NEUROSCI, V19, P653; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DECAMILLI P, 2000, SYNAPSES, pCH2; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jiang L, 2001, NEURON, V30, P503, DOI 10.1016/S0896-6273(01)00298-7; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; More JCA, 2003, BRIT J PHARMACOL, V138, P1093, DOI 10.1038/sj.bjp.0705148; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Pelletier JC, 1996, J MED CHEM, V39, P343, DOI 10.1021/jm950740w; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Wilding TJ, 1997, J NEUROSCI, V17, P2713; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x	30	60	62	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					758	761		10.1126/science.1135468	http://dx.doi.org/10.1126/science.1135468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478724				2022-12-24	WOS:000246181400050
J	Peng, CH; Ouyang, H; Gao, Q; Jiang, Y; Zhang, F; Li, J; Yu, Q				Peng, Changhui; Ouyang, Hua; Gao, Qiong; Jiang, Yuan; Zhang, Feng; Li, Jun; Yu, Qiang			Environment - Building a "green" railway in China	SCIENCE			English	Editorial Material									Univ Quebec, Inst Environm Sci, Dept Biol Sci, Montreal, PQ H3C 3P8, Canada; Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China	University of Quebec; University of Quebec Montreal; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Beijing Normal University	Peng, CH (corresponding author), Univ Quebec, Inst Environm Sci, Dept Biol Sci, Montreal, PQ H3C 3P8, Canada.	peng.changhui@uqam.ca	Peng, Changhui/G-8248-2012; Yu, Qiang/D-3702-2009	Yu, Qiang/0000-0001-6950-1821				LI WH, 1998, ECOSYSTEM QINGHAI XI, P1; Liu J.Y., 2005, INTEGRATED ECOSYSTEM; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; National Research Council, 2003, TECHN DEV ARM UNM GR, P1; *QINGH TIB RAILW, ENV PROT; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; XI GJ, 2001, ECOLOGICAL ENV W CHI; ZHANG ZY, 2002, EXPLOITATION USAGE W; 2006, CHINA THROUGH LENS; PROTECTION ENDANGERE; RESTORING GRASSLAND; 2002, PEOPLES DAILY   1105	12	38	44	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					546	547		10.1126/science.1134134	http://dx.doi.org/10.1126/science.1134134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	160ZC	17463272				2022-12-24	WOS:000245983100026
J	Katona, G; Carpentier, P; Niviere, V; Amara, P; Adam, V; Ohana, J; Tsanov, N; Bourgeois, D				Katona, Gergely; Carpentier, Philippe; Niviere, Vincent; Amara, Patricia; Adam, Virgile; Ohana, Jereny; Tsanov, Nikolay; Bourgeois, Dominique			Raman-assisted crystallography reveals end-on peroxide intermediates in a nonheme iron enzyme	SCIENCE			English	Article							SUPEROXIDE REDUCTASE; ACTIVE-SITE; DESULFOARCULUS-BAARSII; ELECTRONIC-STRUCTURES; PYROCOCCUS-FURIOSUS; CATALYTIC PATHWAY; MECHANISM; DIOXYGEN; BINDING; IDENTIFICATION	Iron-peroxide intermediates are central in the reaction cycle of many iron-containing biomolecules. We trapped iron(III)-(hydro) peroxo species in crystals of superoxide reductase (SOR), a nonheme mononuclear iron enzyme that scavenges superoxide radicals. X-ray diffraction data at 1.95 angstrom resolution and Raman spectra recorded in crystallo revealed iron-(hydro) peroxo intermediates with the ( hydro) peroxo group bound end-on. The dynamic SOR active site promotes the formation of transient hydrogen bond networks, which presumably assist the cleavage of the iron- oxygen bond in order to release the reaction product, hydrogen peroxide.	Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France; Univ Grenoble 1, CNRS, CEA,Lab Chim & Biol Met, Inst Rech Technol & Sci Vivant, F-38054 Grenoble 9, France; European Synchrotron Radiat Facil, F-38043 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF)	Bourgeois, D (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	dominique.bourgeois@ibs.fr	, Bourgeois/AAI-2337-2020; Katona, Gergely/B-3491-2008; Carpentier, Philippe/AAF-5995-2019; Adam, Virgile/B-9359-2009	Katona, Gergely/0000-0002-2031-8716; Adam, Virgile/0000-0003-2209-7846; Amara, Patricia/0000-0001-9634-7305; Niviere, Vincent/0000-0002-5132-457X; Ohana, Jeremy/0000-0002-2772-7483				Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bourgeois D, 2005, CURR OPIN STRUC BIOL, V15, P538, DOI 10.1016/j.sbi.2005.08.002; Brines LM, 2007, EUR J INORG CHEM, P29, DOI 10.1002/ejic.200600461; Brunold TC, 1999, J AM CHEM SOC, V121, P8277, DOI 10.1021/ja990334s; Bukowski MR, 2005, ANGEW CHEM INT EDIT, V44, P584, DOI 10.1002/anie.200461527; Carey PR, 2004, BIOCHEMISTRY-US, V43, P8885, DOI 10.1021/bi049138a; Clay MD, 2006, BIOCHEMISTRY-US, V45, P427, DOI 10.1021/bi052034v; Clay MD, 2002, J AM CHEM SOC, V124, P788, DOI 10.1021/ja016889g; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emerson JP, 2002, BIOCHEMISTRY-US, V41, P4348, DOI 10.1021/bi0119159; Girerd JJ, 2000, STRUCT BOND, V97, P145; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kuhnel K, 2007, P NATL ACAD SCI USA, V104, P99, DOI 10.1073/pnas.0606285103; Loew GH, 2000, CHEM REV, V100, P407, DOI 10.1021/cr980389x; Lombard M, 2000, J BIOL CHEM, V275, P27021; Mathe C, 2006, BIOPHYS CHEM, V119, P38, DOI 10.1016/j.bpc.2005.06.013; Mathe C, 2005, J AM CHEM SOC, V127, P16436, DOI 10.1021/ja053808y; Mathe C, 2002, J AM CHEM SOC, V124, P4966, DOI 10.1021/ja025707v; Niviere V, 2004, BIOCHEMISTRY-US, V43, P808, DOI 10.1021/bi035698i; Rodrigues JV, 2006, BIOCHEMISTRY-US, V45, P9266, DOI 10.1021/bi052489k; Roelfes G, 2003, INORG CHEM, V42, P2639, DOI 10.1021/ic034065p; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Yeh AP, 2000, BIOCHEMISTRY-US, V39, P2499, DOI 10.1021/bi992428k	27	125	127	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					449	453		10.1126/science.1138885	http://dx.doi.org/10.1126/science.1138885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446401	Green Submitted, Green Accepted			2022-12-24	WOS:000245813400057
J	Kibar, Z; Torban, E; McDearmid, JR; Reynolds, A; Berghout, J; Mathieu, M; Kirillova, I; De Marco, P; Merello, E; Hayes, JM; Wallingford, JB; Drapeau, P; Capra, V; Gros, P				Kibar, Zoha; Torban, Elena; McDearmid, Jonathan R.; Reynolds, Annie; Berghout, Joanne; Mathieu, Melissa; Kirillova, Irena; De Marco, Patrizia; Merello, Elisa; Hayes, Julie M.; Wallingford, John B.; Drapeau, Pierre; Capra, Valeria; Gros, Philippe			Mutations in VANGL1 associated with neural-tube defects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLANAR CELL POLARITY; TISSUE POLARITY; GENE; STRABISMUS; GOGH	Neural-tube defects such as anencephaly and spina bifida constitute a group of common congenital malformations caused by complex genetic and environmental factors. We have identified three mutations in the VANGL1 gene in patients with familial types (V239I and R274Q) and a sporadic type (M328T) of the disease, including a spontaneous mutation (V239I) appearing in a familial setting. In a protein-protein interaction assay V239I abolished interaction of VANGL1 protein with its binding partners, disheveled-1, -2, and -3. These findings implicate VANGL1 as a risk factor in human neural-tube defects.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Ctr Hlth, Res Inst, Neurosci Res Ctr, Montreal, PQ, Canada; Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada; Inst Hereditary Dis, Minsk, BELARUS; Ist Giannina Gaslini, Unita Operat Neurochirurg, I-16148 Genoa, Italy; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	McGill University; McGill University; Universite de Montreal; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Texas System; University of Texas Austin	Gros, P (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler,Rm 907, Montreal, PQ H3G 1Y6, Canada.	philippe.gros@mcgill.ca	Berghout, Joanne/M-5493-2017; Valeria, Capra/AAB-1501-2019; De Marco, Patrizia/AAB-3172-2019; capra, valeria/N-4367-2013	Berghout, Joanne/0000-0002-9250-9159; De Marco, Patrizia/0000-0001-8498-3750; capra, valeria/0000-0002-3097-0388	NIGMS NIH HHS [R01 GM074104] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Doudney K, 2005, AM J MED GENET A, V136A, P90, DOI 10.1002/ajmg.a.30766; Doudney K, 2005, AM J MED GENET A, V138A, P415, DOI 10.1002/ajmg.a.30931; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; PANG D, 1993, NEUROSURGERY, V32, P755, DOI 10.1227/00006123-199305000-00009; STEIN KF, 1953, J HERED, V44, P59, DOI 10.1093/oxfordjournals.jhered.a106356; Strutt H, 2005, BIOESSAYS, V27, P1218, DOI 10.1002/bies.20318; Taylor J, 1998, GENETICS, V150, P199; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Tortori-Donati P, 2000, NEURORADIOLOGY, V42, P471, DOI 10.1007/s002340000325; van der Linden IJM, 2006, P NUTR SOC, V65, P204, DOI 10.1079/PNS2006495; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wolff T, 1998, DEVELOPMENT, V125, P1149	18	210	257	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1432	1437		10.1056/NEJMoa060651	http://dx.doi.org/10.1056/NEJMoa060651			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153GG	17409324	Bronze			2022-12-24	WOS:000245419600006
J	Colquhoun, D				Colquhoun, David			Science degrees without the science	NATURE			English	Editorial Material									UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Colquhoun, D (corresponding author), UCL, Dept Pharmacol, London WC1E 6BT, England.		Colquhoun, David/C-1664-2008	Colquhoun, David/0000-0002-4263-017X				Barry CA, 2006, SOC SCI MED, V62, P2646, DOI 10.1016/j.socscimed.2005.11.025; Desmond Adrian, 1992, POLITICS EVOLUTION M; GOLDACRE B, 2007, GUARDIAN        0217; HARRIS M, 2003, U NHS PARTNERS CARE; HOLMES OW, 1842, HOM ITS KINDR DEL; Lancet, 2005, LANCET, V336, P690; 2000, QAA OTHER SUBJECTS A	7	25	25	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					373	374		10.1038/446373a	http://dx.doi.org/10.1038/446373a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377563				2022-12-24	WOS:000245079500018
J	Chaves, SS; Gargiullo, P; Zhang, JX; Civen, R; Guris, D; Mascola, MPHL; Seward, JF				Chaves, Sandra S.; Gargiullo, Paul; Zhang, John X.; Civen, Rachel; Guris, Dalya; Mascola, M. P. H. Laurene; Seward, Jane F.			Loss of vaccine-induced immunity to varicella over time	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTBREAK; RESPONSES; POSTLICENSURE; CHILDREN; DECLINE; SAFETY; IMPACT	BACKGROUND: The introduction of universal varicella vaccination in 1995 has substantially reduced varicella-related morbidity and mortality in the United States. However, it remains unclear whether vaccine-induced immunity wanes over time, a condition that may result in increased susceptibility later in life, when the risk of serious complications may be greater than in childhood. METHODS: We examined 10 years (1995 to 2004) of active surveillance data from a sentinel population of 350,000 subjects to determine whether the severity and incidence of breakthrough varicella (with an onset of rash >42 days after vaccination) increased with the time since vaccination. We used multivariate logistic regression to adjust for the year of disease onset (calendar year) and the subject's age at both disease onset and vaccination. RESULTS: A total of 11,356 subjects were reported to have varicella during the surveillance period, of whom 1080 (9.5%) had breakthrough disease. Children between the ages of 8 and 12 years who had been vaccinated at least 5 years previously were significantly more likely to have moderate or severe disease than were those who had been vaccinated less than 5 years previously (risk ratio, 2.6; 95% confidence interval [CI], 1.2 to 5.8). The annual rate of breakthrough varicella significantly increased with the time since vaccination, from 1.6 cases per 1000 person-years (95% CI, 1.2 to 2.0) within 1 year after vaccination to 9.0 per 1000 person-years (95% CI, 6.9 to 11.7) at 5 years and 58.2 per 1000 person-years (95% CI, 36.0 to 94.0) at 9 years. CONCLUSIONS: A second dose of varicella vaccine, now recommended for all children, could improve protection from both primary vaccine failure and waning vaccine-induced immunity.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA	Chaves, SS (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop A-47, Atlanta, GA 30333 USA.	bev8@cdc.gov						Ampofo K, 2002, CLIN INFECT DIS, V34, P774, DOI 10.1086/338959; Arvin AM, 1996, INFECT DIS CLIN N AM, V10, P529, DOI 10.1016/S0891-5520(05)70312-3; Brisson M., 2003, Journal of Medical Virology, V70, pS31, DOI 10.1002/jmv.10317; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P389; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Davis MM, 2004, PEDIATRICS, V114, P786, DOI 10.1542/peds.2004-0012; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Haddad MB, 2005, PEDIATRICS, V115, P1488, DOI 10.1542/peds.2004-1826; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; Krause PR, 2001, ARCH VIR S, V17, P7; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; Lee BR, 2004, J INFECT DIS, V190, P477, DOI 10.1086/422041; Li S, 2002, PEDIATR INFECT DIS J, V21, P337, DOI 10.1097/00006454-200204000-00014; Lopez AS, 2006, PEDIATRICS, V117, pE1070, DOI 10.1542/peds.2005-2085; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mullooly JP, 2004, VACCINE, V22, P1480, DOI 10.1016/j.vaccine.2003.10.021; Ngai AL, 1996, PEDIATR INFECT DIS J, V15, P49, DOI 10.1097/00006454-199601000-00011; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Tugwell BD, 2004, PEDIATRICS, V113, P455, DOI 10.1542/peds.113.3.455; Vazquez M, 2004, JAMA-J AM MED ASSOC, V291, P851, DOI 10.1001/jama.291.7.851; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; Verstraeten T, 2003, PEDIATRICS, V112, P1039, DOI 10.1542/peds.112.2.e98; WATSON B, 1995, CLIN INFECT DIS, V20, P316, DOI 10.1093/clinids/20.2.316; WATSON B, 1995, J INFECT DIS, V172, P217, DOI 10.1093/infdis/172.1.217; Zhou FJ, 2005, JAMA-J AM MED ASSOC, V294, P797, DOI 10.1001/jama.294.7.797	26	215	241	2	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1121	1129		10.1056/NEJMoa064040	http://dx.doi.org/10.1056/NEJMoa064040			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360990				2022-12-24	WOS:000244877200005
J	Levenson, R				Levenson, Ros			A patient's journey - Whooping cough	BRITISH MEDICAL JOURNAL			English	Editorial Material												ros@roslevenson.demon.co.uk							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					532	533		10.1136/bmj.39120.556296.AE	http://dx.doi.org/10.1136/bmj.39120.556296.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347240	Bronze, Green Published			2022-12-24	WOS:000245106400045
J	Gordon, DM				Gordon, Deborah M.			Control without hierarchy	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Gordon, DM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							GORDON DM, 2000, ANTS WORK; Haraway Donna J., 1976, CRYSTALS FABRICS FIE; Lewontin R., 2000, TRIPLE HELIX GENE OR, DOI 10.5061/dryad.f7m0cfxx6	3	38	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					143	143		10.1038/446143a	http://dx.doi.org/10.1038/446143a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344838				2022-12-24	WOS:000244718100025
J	Chen, YMA; Kuo, SHS				Chen, Yi-Ming Arthur; Kuo, Steve Hsu-Sung			HIV-1 in Taiwan	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; INFECTIONS; CHINA; RECOMBINANT; STRAIN		Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan; Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; Ctr Dis Control, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Centers For Disease Control - Taiwan	Chen, YMA (corresponding author), Natl Yang Ming Univ, AIDS Prevent & Res Ctr, Taipei 112, Taiwan.	Arthur@ym.edu.tw						Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; *CDC, 2006, HIV AIDS DAT; Chen QF, 2005, CHINESE PHYS LETT, V22, P2005, DOI 10.1088/0256-307X/22/8/051; CHEN YM, 2002, J ACQ IMMUN DEF SYND, V26, P274; Chen YMA, 2006, EMERG INFECT DIS, V12, P703, DOI 10.3201/eid1204.050762; Cohen J, 2004, SCIENCE, V304, P1932, DOI 10.1126/science.304.5679.1932; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Hsieh SM, 1996, J FORMOS MED ASSOC, V95, P923; Hsueh PR, 2000, J INFECT DIS, V181, P1706, DOI 10.1086/315432; Hung CC, 2000, J ACQ IMMUN DEF SYND, V24, P378, DOI 10.1097/00126334-200008010-00013; Ko NY, 2006, SEX TRANSM DIS, V33, P467, DOI 10.1097/01.olq.0000204512.15297.5f; LAI SF, 2004, 15 INT AIDS C BANGK; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; Lim WL, 2004, AIDS RES HUM RETROV, V20, P259, DOI 10.1089/088922204322996473; LIN YT, IN PRESS J INFECT DI; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; *WHO JOINT UN PROG, 2005, 2005 UPD HIV AIDS EP	18	90	90	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					623	625		10.1016/S0140-6736(07)60291-8	http://dx.doi.org/10.1016/S0140-6736(07)60291-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141RO	17321295				2022-12-24	WOS:000244596600007
J	Patton, C				Patton, Cindy			Bullets, balance, or both: medicalisation in HIV treatment	LANCET			English	Article; Proceedings Paper	Meeting on Medicalisation in the 21st Century	JUN, 2005	New York, NY						Simon Fraser Univ, Hlth Res & Methods Training Facil, Vancouver, BC V6B 5K3, Canada	Simon Fraser University	Patton, C (corresponding author), Simon Fraser Univ, Hlth Res & Methods Training Facil, Vancouver, BC V6B 5K3, Canada.	healthlab@gmail.com						Epstein Steven., 1996, IMPURE SCI; Patton Cindy, 1990, INVENTING AIDS; Patton Cindy, 1996, FATAL ADVICE	3	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2007	369	9562					706	707		10.1016/S0140-6736(07)60322-5	http://dx.doi.org/10.1016/S0140-6736(07)60322-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	141RO	17321320				2022-12-24	WOS:000244596600036
J	Lake, JA				Lake, James A.			Disappearing act	NATURE			English	Editorial Material									Univ Calif Los Angeles, Dept MCD Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lake, JA (corresponding author), Univ Calif Los Angeles, Dept MCD Biol, 242 Boyer Hall, Los Angeles, CA 90095 USA.							Hey J., 2005, SYSTEMATICS ORIGIN S; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Martin W, 2004, NATURE, V431, P134, DOI 10.1038/431134a	3	9	9	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					983	983		10.1038/446983a	http://dx.doi.org/10.1038/446983a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	160NU	17460647	Bronze			2022-12-24	WOS:000245950400023
J	Grassly, NC; Wenger, J; Durrani, S; Bahl, S; Deshpande, JM; Sutter, RW; Heymann, DL; Aylward, RB				Grassly, Nicholas C.; Wenger, Jay; Durrani, Sunita; Bahl, Sunil; Deshpande, Jagadish M.; Sutter, Roland W.; Heymann, David L.; Aylward, R. Bruce			Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study	LANCET			English	Article							SURVEILLANCE; SENSITIVITY; VIRUS; INDIA	Background A high-potency monovalent oral type 1 poliovirus vaccine (mOPV1) was developed in 2005 to tackle persistent poliovirus transmission in the last remaining infected countries. Our aim was to assess the efficacy of this vaccine in India. Methods We estimated the efficacy of mOPVl used in supplementary immunisation activities from 2076 matched case-control pairs of confirmed cases of poliomyelitis caused by type 1 wild poliovirus and cases of non-polio acute flaccid paralysis in India. The effect of the introduction of mOPVl on population immunity was calculated on the basis of estimates of vaccination coverage from data for non-polio acute flaccid paralysis. Findings In areas of persistent poliovirus transmission in Uttar Pradesh, the protective efficacy of mOPVl was estimated to be 30% (95% CI 19-41) per dose against type 1 paralytic disease, compared with 11% (7-14) for the trivalent oral vaccine. 76-82% of children aged 0-23 months were estimated to be protected by vaccination against type 1 poliovirus at the end of 2006, compared with 59% at the end of 2004, before the introduction of mOPV1. Interpretation Under conditions where the efficacy of live-attenuated oral poliovirus vaccines is compromised by a high prevalence of diarrhoea and other infections, a dose of high-potency mOPVl is almost three times more effective against type 1 poliomyelitis disease than is trivalent vaccine. Achieving high coverage with this new vaccine in areas of persistent poliovirus transmission should substantially improve the probability of rapidly eliminating transmission of the disease.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; WHO, Natl Polio Surveillance Project, New Delhi, India; Enterovirus Res Ctr, Bombay, Maharashtra, India; WHO, Global Polio Eradicat Initiat, CH-1211 Geneva, Switzerland	Imperial College London; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre; World Health Organization	Grassly, NC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	n.grassly@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Deshpande, Jagadish/0000-0001-5194-0375				[Anonymous], 2004, Wkly Epidemiol Rec, V79, P121; [Anonymous], 1995, J Infect Dis, V171, P1097; Aylward RB, 2006, RISK ANAL, V26, P1441, DOI 10.1111/j.1539-6924.2006.00840.x; Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; Banerjee K, 2000, B WORLD HEALTH ORGAN, V78, P321; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; Gary HE, 1997, J INFECT DIS, V175, pS135, DOI 10.1093/infdis/175.Supplement_1.S135; GHENDON YZ, 1961, ACTA VIROL, V5, P265; Graf H, 2006, BIOLOGICALS, V34, P141, DOI 10.1016/j.biologicals.2006.03.011; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; HALSEY N, 1985, B WORLD HEALTH ORGAN, V63, P1151; HENRY JL, 1966, J HYG-CAMB, V64, P105, DOI 10.1017/S0022172400040389; Hills, 1993, STAT MODELS EPIDEMIO; Kohler KA, 2003, EPIDEMIOL INFECT, V131, P711, DOI 10.1017/S0950268803008562; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; ONORATO IM, 1991, J INFECT DIS, V163, P1, DOI 10.1093/infdis/163.1.1; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; Sutter R. W., 2004, VACCINES, P651; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P409; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P401; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P229; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P316	23	105	116	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1356	1362		10.1016/S0140-6736(07)60531-5	http://dx.doi.org/10.1016/S0140-6736(07)60531-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448821				2022-12-24	WOS:000245856100028
J	Wang, CC; Lee, JC; Luo, SY; Kulkarni, SS; Huang, YW; Lee, CC; Chang, KL; Hung, SC				Wang, Cheng-Chung; Lee, Jinq-Chyi; Luo, Shun-Yuan; Kulkarni, Suvarn S.; Huang, Yu-Wen; Lee, Chia-Chen; Chang, Ken-Lien; Hung, Shang-Cheng			Regioselective one-pot protection of carbohydrates	NATURE			English	Article							SOLID-PHASE SYNTHESIS; OLIGOSACCHARIDE SYNTHESIS; O-GLYCOSYLATION; EFFICIENT; HEMAGGLUTININ; STRATEGY; ETHERS	Carbohydrates are involved in a wide range of biological processes(1-4). These structurally diverse compounds are more complex than other biological polymers, and are often present as heterogeneous mixtures in nature. The chemical synthesis of carbohydrates is one way to obtain pure oligosaccharides, but it is hampered by difficulties associated with the regioselective protection of polyhydroxyls and challenges related to the stereoselective assembly of glycosidic linkages(5-14). Here we describe a combinatorial, and highly-regioselective, method that can be used to protect individual hydroxy groups of a monosaccharide. This approach can be used to install an orthogonal protecting group pattern in a single reaction vessel (a 'one-pot' reaction), which removes the need to carry out the time-consuming isolation and purification of intermediates. Hundreds of building blocks have been efficiently prepared starting from D-glucose, and the iterative coupling of these building blocks enabled us to assemble beta-1,6-glucans and a library of oligosaccharides based on the influenza-virus binding trisaccharide.	Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan; Acad Sinica, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 115, Taiwan; Acad Sinica, Inst Chem, Taipei 115, Taiwan; Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Hung, SC (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan.	hung@mx.nthu.edu.tw	Lee, Jinq-Chyi/C-1373-2010; Wang, Cheng-Chung/ABG-6014-2020; Wang, Cheng-Chung/D-8946-2015	Wang, Cheng-Chung/0000-0002-2562-0658; 				Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; DANISHEFSKY SJ, 1993, SCIENCE, V260, P1307, DOI 10.1126/science.8493573; De Meo C, 2005, TETRAHEDRON-ASYMMETR, V16, P303, DOI 10.1016/j.tetasy.2004.11.043; Demchenko AV, 2003, SYNLETT, P1225, DOI 10.1055/s-2003-40349; Douglas NL, 1998, J CHEM SOC PERK T 1, P51, DOI 10.1039/a705275h; Ernst B., 2000, CARBOHYDRATES CHEM B, V1-4; Flitsch SL, 2005, NATURE, V437, P201, DOI 10.1038/437201a; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; HATAKEYAMA S, 1994, TETRAHEDRON LETT, V35, P4367, DOI 10.1016/S0040-4039(00)73357-0; Huang XF, 2004, ANGEW CHEM INT EDIT, V43, P5221, DOI 10.1002/anie.200460176; Jobron L, 1999, J AM CHEM SOC, V121, P5835, DOI 10.1021/ja9836085; Kim JH, 2005, J AM CHEM SOC, V127, P12090, DOI 10.1021/ja052548h; Kocienski P. J, 2005, PROTECTING GROUPS; Lee JC, 2004, J AM CHEM SOC, V126, P476, DOI 10.1021/ja038244h; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Pellissier H, 2005, TETRAHEDRON, V61, P2947, DOI 10.1016/j.tet.2005.01.070; Plante OJ, 2000, J AM CHEM SOC, V122, P7148, DOI 10.1021/ja0008665; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899; Shie CR, 2005, ANGEW CHEM INT EDIT, V44, P1665, DOI 10.1002/anie.200462172; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; TSUNODA T, 1980, TETRAHEDRON LETT, V21, P1357, DOI 10.1016/S0040-4039(00)74575-8; Varki A., 1999, ESSENTIALS GLYCOBIOL; Wang CC, 2002, ANGEW CHEM INT EDIT, V41, P2360, DOI 10.1002/1521-3773(20020703)41:13<2360::AID-ANIE2360>3.0.CO;2-R; Wright JA, 2001, TETRAHEDRON LETT, V42, P4033, DOI 10.1016/S0040-4039(01)00563-9; Wuts P. G. M., 2007, GREENS PROTECTIVE GR; YAMADA H, 1994, TETRAHEDRON LETT, V35, P3979, DOI 10.1016/S0040-4039(00)76718-9; Zhang ZY, 1999, J AM CHEM SOC, V121, P734, DOI 10.1021/ja982232s	29	299	300	0	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					896	899		10.1038/nature05730	http://dx.doi.org/10.1038/nature05730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	158IR	17443183				2022-12-24	WOS:000245785700038
J	Whitehurst, AW; Bodemann, BO; Cardenas, J; Ferguson, D; Girard, L; Peyton, M; Minna, JD; Michnoff, C; Hao, WH; Roth, MG; Xie, XJ; White, MA				Whitehurst, Angelique W.; Bodemann, Brian O.; Cardenas, Jessica; Ferguson, Deborah; Girard, Luc; Peyton, Michael; Minna, John D.; Michnoff, Carolyn; Hao, Weihua; Roth, Michael G.; Xie, Xian-Jin; White, Michael A.			Synthetic lethal screen identification of chemosensitizer loci in cancer cells	NATURE			English	Article							SALICYLIHALAMIDE-A; V-ATPASE; CHECKPOINT; DISCOVERY; COMPLEXES; MITOSIS; DRUGS	Abundant evidence suggests that a unifying principle governing the molecular pathology of cancer is the co-dependent aberrant regulation of core machinery driving proliferation and suppressing apoptosis(1). Anomalous proteins engaged in support of this tumorigenic regulatory environment most probably represent optimal intervention targets in a heterogeneous population of cancer cells. The advent of RNA-mediated interference (RNAi)-based functional genomics provides the opportunity to derive unbiased comprehensive collections of validated gene targets supporting critical biological systems outside the framework of preconceived notions of mechanistic relationships. We have combined a high-throughput cell-based one-well/one-gene screening platform with a genome-wide synthetic library of chemically synthesized small interfering RNAs for systematic interrogation of the molecular underpinnings of cancer cell chemoresponsiveness. NCI-H1155, a human non-small-cell lung cancer line, was employed in a paclitaxel-dependent synthetic lethal screen designed to identify gene targets that specifically reduce cell viability in the presence of otherwise sublethal concentrations of paclitaxel. Using a stringent objective statistical algorithm to reduce false discovery rates below 5%, we isolated a panel of 87 genes that represent major focal points of the autonomous response of cancer cells to the abrogation of microtubule dynamics. Here we show that several of these targets sensitize lung cancer cells to paclitaxel concentrations 1,000-fold lower than otherwise required for a significant response, and we identify mechanistic relationships between cancer-associated aberrant gene expression programmes and the basic cellular machinery required for robust mitotic progression.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Simmons Canc Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Biostat & Clin Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	White, MA (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Peyton, Michael/A-8728-2008	Roth, Michael/0000-0002-9056-332X	NCI NIH HHS [P50 CA070907] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 1995, J R STAT SOC B, V57, P57, DOI DOI 10.2307/2346101; Boyd MR, 2001, J PHARMACOL EXP THER, V297, P114; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Davies KJA, 2005, HANDB ENVIRON CHEM, V2, P63, DOI 10.1007/b10146; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan MA, 1999, METHOD CELL BIOL, V61, P267; Kawasaki-Nishi S, 2003, FEBS LETT, V545, P76, DOI 10.1016/S0014-5793(03)00396-X; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wit E, 2003, BIOINFORMATICS, V19, P1055, DOI 10.1093/bioinformatics/btg003; Wu YS, 2002, J AM CHEM SOC, V124, P3245, DOI 10.1021/ja0177713; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200	21	385	408	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					815	819		10.1038/nature05697	http://dx.doi.org/10.1038/nature05697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429401				2022-12-24	WOS:000245626800045
J	Kott, A				Kott, Andrea			Steven's violin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1529	1530		10.1001/jama.297.14.1529	http://dx.doi.org/10.1001/jama.297.14.1529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426262				2022-12-24	WOS:000245589800001
J	Alonso, MC; Drummond, DR; Kain, S; Hoeng, J; Amos, L; Cross, RA				Alonso, Maria C.; Drummond, Douglas R.; Kain, Susan; Hoeng, Julia; Amos, Linda; Cross, Robert A.			An ATP gate controls tubulin binding by the tethered head of kinesin-1	SCIENCE			English	Article							HAND-OVER-HAND; NECK-LINKER; DIMERIC KINESIN; CATALYTIC CORE; MECHANISM; STEPS; HYDROLYSIS; MICROTUBULES; MOLECULES; MOTILITY	Kinesin-1 is a two-headed molecular motor that walks along microtubules, with each step gated by adenosine triphosphate (ATP) binding. Existing models for the gating mechanism propose a role for the microtubule lattice. We show that unpolymerized tubulin binds to kinesin-1, causing tubulin-activated release of adenosine diphosphate (ADP). With no added nucleotide, each kinesin-1 dimer binds one tubulin heterodimer. In adenylyl-imidodiphosphate (AMP-PNP), a nonhydrolyzable ATP analog, each kinesin-1 dimer binds two tubulin heterodimers. The data reveal an ATP gate that operates independently of the microtubule lattice, by ATP-dependent release of a steric or allosteric block on the tubulin binding site of the tethered kinesin-ADP head.	Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Cross, RA (corresponding author), Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England.	r.cross@mcri.ac.uk	Cross, Robert A/F-1798-2011	Cross, Robert A/0000-0002-0004-7832; Drummond, Douglas/0000-0003-4155-3747; Amos, Linda/0000-0001-8305-5346	Medical Research Council [MC_U105184313, G0200542(63814), G0200542, U.1051.04.002(78842)] Funding Source: Medline; MRC [G0200542, MC_U105184313] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Asenjo AB, 2006, NAT STRUCT MOL BIOL, V13, P648, DOI 10.1038/nsmb1109; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CURR OPIN CELL BIOL, V18, P61, DOI 10.1016/j.ceb.2005.12.009; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; Cross RA, 2000, PHILOS T ROY SOC B, V355, P459, DOI 10.1098/rstb.2000.0587; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hahlen K, 2006, J BIOL CHEM, V281, P18868, DOI 10.1074/jbc.M508019200; Hirose K, 1999, MOL BIOL CELL, V10, P2063, DOI 10.1091/mbc.10.6.2063; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mather WH, 2006, BIOPHYS J, V91, P2416, DOI 10.1529/biophysj.106.087049; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Sugata K, 2004, BIOCHEM BIOPH RES CO, V314, P447, DOI 10.1016/j.bbrc.2003.12.093; TORNISHIGE M, 2000, J CELL BIOL, V151, P1081; VILDIZ A, 2005, TRENDS CELL BIOL, V15, P112; Walczak CE, 2006, NAT CELL BIOL, V8, P903, DOI 10.1038/ncb0906-903; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	29	90	93	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					120	123		10.1126/science.1136985	http://dx.doi.org/10.1126/science.1136985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412962	Green Accepted			2022-12-24	WOS:000245470500046
J	Colf, LA; Bankovich, AJ; Hanick, NA; Bowerman, NA; Jones, LL; Kranz, DM; Garcia, KC				Colf, Leremy A.; Bankovich, Alexander J.; Hanick, Nicole A.; Bowerman, Natalie A.; Jones, Lindsay L.; Kranz, David M.; Garcia, K. Christopher			How a single T cell receptor recognizes both self and foreign MHC	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-MHC; NEGATIVE SELECTION; DEGENERATE RECOGNITION; ANTIGEN RECOGNITION; HELICAL RESIDUES; STRUCTURAL BASIS; TCR BINDING; ALLOREACTIVITY; SPECIFICITY	alpha beta T cell receptors (TCRs) can crossreact with both self- and foreign- major histocompatibility complex (MHC) proteins in an enigmatic phenomenon termed alloreactivity. Here we present the 2.35 angstrom structure of the 2C TCR complexed with its foreign ligand H-2L(d)-QL9. Surprisingly, we find that this TCR utilizes a different strategy to engage the foreign pMHC in comparison to the manner in which it recognizes a self ligand H-2K(b)-dEV8. 2C engages both shared and polymorphic residues on L-d and K-b, as well as the unrelated QL9 and dEV8 peptide antigens, in unique pair-wise contacts, resulting in greater structural complementarity with the L-d-QL9 complex. In the structure of an engineered, high-affinity 2C TCR variant bound to H-2L(d)- QL9, the "wild-type" TCR-MHC binding orientation persists despite modified TCR-CDR3 alpha interactions with peptide. Thus, a single TCR recognizes two globally similar, but distinct ligands by divergent mechanisms, indicating that receptor-ligand crossreactivity can occur in the absence of molecular mimicry.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Jones, Lindsay/0000-0003-4360-6451; Bankovich, Alexander/0000-0003-2368-4479	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540, T32AI007290, R56AI048540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007290, AI 48540] Funding Source: Medline; NIGMS NIH HHS [GM55767] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Chen JZ, 2003, MICROBES INFECT, V5, P233, DOI 10.1016/S1286-4579(03)00016-9; CONNOLLY JM, 1994, P NATL ACAD SCI USA, V91, P11482, DOI 10.1073/pnas.91.24.11482; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Ge Q, 2006, P NATL ACAD SCI USA, V103, P1822, DOI 10.1073/pnas.0510561103; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hansen T, 2000, IMMUNOL TODAY, V21, P83, DOI 10.1016/S0167-5699(98)01426-1; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Hornell TMC, 1999, J IMMUNOL, V163, P3217; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huseby E, 2004, EUR J IMMUNOL, V34, P1243, DOI 10.1002/eji.200425000; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; RODEWALD HR, 1989, J IMMUNOL, V143, P4238; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; SKYULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tallquist MD, 1998, J IMMUNOL, V160, P802; TJOA BA, 1994, MOL IMMUNOL, V31, P705, DOI 10.1016/0161-5890(94)90144-9; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Udaka K, 1996, J IMMUNOL, V157, P670; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	63	181	189	2	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					135	146		10.1016/j.cell.2007.01.048	http://dx.doi.org/10.1016/j.cell.2007.01.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418792	Bronze			2022-12-24	WOS:000245661100017
J	Chen, NJ; Mirtsos, C; Suh, D; Lu, YC; Lin, WJ; McKerlie, C; Lee, T; Baribault, H; Tian, H; Yeh, WC				Chen, Nien-Jung; Mirtsos, Christine; Suh, Daniel; Lu, Yong-Chen; Lin, Wen-Jye; McKerlie, Colin; Lee, Taeweon; Baribault, Helene; Tian, Hui; Yeh, Wen-Chen			C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a	NATURE			English	Article							CHEMOATTRACTANT RECEPTOR; COMPLEMENT; COMPONENT; NEUTROPHILS; ACTIVATION; PROTEIN; CLONING; REVEAL	Complement-derived anaphylatoxins regulate immune and inflammatory responses through G-protein-coupled receptor ( GPCR)mediated signalling(1-4). C5L2 ( also known as GPR77) is a relatively new GPCR thought to be a non-signalling receptor binding to C5a, on the basis of sequence information and experimental evidence(5-7). Here we show, using gene targeting, that C5L2 is required to facilitate C5a signalling in neutrophils, macrophages and fibroblasts in vitro. Deficiency of C5L2 results in reduced inflammatory cell infiltration, suggesting that C5L2 is critical for optimal C5a-mediated cell infiltration in certain in vivo settings. C5L2 is also involved in optimizing C3a-induced signals. Furthermore, like mice incapable of C3a/complement 3a receptor (C3aR) signalling(4,8,9), C5L2-deficient mice are hypersensitive to lipopolysaccharide (LPS)-induced septic shock, show reduced ovalbumin (OVA)-induced airway hyperresponsiveness and inflammation, and are mildly delayed in haematopoietic cell regeneration after gamma-irradiation. Our data indicate that C5L2 can function as a positive modulator for both C5a- and C3a-anaphylatoxin-induced responses.	Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Amgen San Francisco, San Francisco, CA 94080 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Amgen	Yeh, WC (corresponding author), Univ Toronto, Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada.	weny@amgen.com	Lu, Yong-Chen/G-4520-2014; Mohammed, Imran/J-8271-2012; Lin, Wen-Jye/D-1028-2016	Lu, Yong-Chen/0000-0002-0275-9825; Mohammed, Imran/0000-0002-8412-0768; McKerlie, Colin/0000-0002-2232-0967				BOKISCH VA, 1969, J EXP MED, V129, P1109, DOI 10.1084/jem.129.5.1109; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Duncan GS, 1999, J IMMUNOL, V162, P3022; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gavrilyuk V, 2005, J NEUROCHEM, V92, P1140, DOI 10.1111/j.1471-4159.2004.02942.x; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Guo RF, 2004, SHOCK, V21, P1, DOI 10.1097/01.shk.0000105502.75189.5e; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hsu MH, 1997, IMMUNOGENETICS, V47, P64, DOI 10.1007/s002510050327; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Kalant D, 2003, J BIOL CHEM, V278, P11123, DOI 10.1074/jbc.M206169200; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Perianayagam MC, 2002, KIDNEY INT, V61, P456, DOI 10.1046/j.1523-1755.2002.00139.x; PERRET JJ, 1992, BIOCHEM J, V288, P911, DOI 10.1042/bj2880911; Ratajczak MZ, 2004, LEUKEMIA, V18, P1482, DOI 10.1038/sj.leu.2403446; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SHIN HS, 1968, SCIENCE, V162, P361, DOI 10.1126/science.162.3851.361; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	24	184	196	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					203	207		10.1038/nature05559	http://dx.doi.org/10.1038/nature05559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17322907				2022-12-24	WOS:000244718100044
J	Berkowitz, SA; Gerstenblith, G; Anderson, GF				Berkowitz, Scott A.; Gerstenblith, Gary; Anderson, Gerard F.			Medicare prescription drug coverage gap - Navigating the "doughnut hole" with patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Anderson, GF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Hampton House 302, Baltimore, MD 21205 USA.	ganderso@jhsph.edu						Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Centers for Medicare and Medicaid Services, MED YOU; CUBANSKI J, 2006, HLTH AFF MILLWO 1121, pW1; *DEST RX, PART D OPT; *KAIS FAM FDN, 2006, PRESCR DRUG COV MED; *KAIS FAM FDN, 2006, KAIS DAIL HLTH POL R; Mitka M, 2006, JAMA-J AM MED ASSOC, V296, P1720; *PRICEWATERHOUSECO, 2006, SIGN COV GAP MED PAR; SIMON S, 2006, NATL PUBLIC RAD 1007; Tseng CW, 2004, JAMA-J AM MED ASSOC, V292, P952, DOI 10.1001/jama.292.8.952; *US DEP HHS, 2006, MEDICARE        1013; *US FDA, 2005, INF IMP DRUGS; *US FDA, OR BOOK	13	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					868	870		10.1001/jama.297.8.868	http://dx.doi.org/10.1001/jama.297.8.868			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140DS	17327528				2022-12-24	WOS:000244485000029
J	Dean, R; Bonsall, MB; Pizzari, T				Dean, Rebecca; Bonsall, Michael B.; Pizzari, Tommaso			Aging and sexual conflict	SCIENCE			English	Editorial Material							YOUNG SPERM; AGE		Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Oxford	Dean, R (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	tommaso.pizzari@zoo.ox.ac.uk		Bonsall, Michael/0000-0003-0250-0423	NERC [NE/D002788/1, NE/D003865/1] Funding Source: UKRI; Natural Environment Research Council [NE/D003865/1, NE/D002788/1, NE/C507196/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Chow V, 2006, J REPROD MED, V51, P149; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Lovlie H, 2005, CURR BIOL, V15, P1222, DOI 10.1016/j.cub.2005.05.060; Reinhardt K, 2005, AM NAT, V165, P718, DOI 10.1086/430010; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Wagner RH, 2004, P ROY SOC B-BIOL SCI, V271, pS134, DOI 10.1098/rsbl.2003.0142; White J, 2006, J ORNITHOL, V147, P88; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103	9	14	14	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					383	384		10.1126/science.1142201	http://dx.doi.org/10.1126/science.1142201			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158RY	17446381				2022-12-24	WOS:000245813400032
J	Evans, JT; Smith, EG; Banerjee, A; Smith, RMM; Dale, J; Innes, JA; Hunt, D; Tweddell, A; Wood, A; Anderson, C; Hewinson, RG; Smith, NH; Hawkey, PM; Sonnenberg, P				Evans, Jason T.; Smith, E. Grace; Banerjee, Ashis; Smith, Robert M. M.; Dale, James; Innes, John A.; Hunt, David; Tweddell, Alan; Wood, Annette; Anderson, Charlotte; Hewinson, R. Glyn; Smith, Noel H.; Hawkey, Peter M.; Sonnenberg, Pam			Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK	LANCET			English	Article							LENGTH-POLYMORPHISM ANALYSIS; VARIABLE NUMBERS; TANDEM REPEATS; INFECTION; PCR; DIFFERENTIATION; DISCRIMINATION; IDENTIFICATION; DIAGNOSIS; OUTBREAK	Background Despite a recent resurgence in the incidence of bovine tuberculosis in UK cattle herds, no associated rise in the number of cases in man has been noted. Disease due to human Mycobacterium bovis infection usually occurs in older patients, in whom drinking unpasteurised milk in the past is the probable source of infection. Person-to-person transmission is very rare. Methods After identification of two epidemiologically-linked cases of human M bovis infection through routine laboratory and surveillance activities, all patients identified with M bovis infection in the Midlands from 2001-05 (n=20) were assessed by DNA fingerprinting (MIRU-VNTR and spoligotyping), with additional interviews for patients with a clustered strain. Findings A cluster of six cases was identified. All clustered cases were young and UK-born; five patients had pulmonary disease, and one patient died due to M bovis meningitis, with four patients possessing factors predisposing to tuberculosis. All patients had common social links through visits to bars in two different areas. With the exception of the first case, there was an absence of zoonotic links or consumption of unpasteurised dairy products, suggesting that person-to-person transmission had occurred. Interpretation This report of several instances of M bovis transmission between people in a modem urban setting emphasises the need to maintain control measures for human and bovine tuberculosis. Transmission and subsequent disease was probably due to a combination of host and environmental factors. Prospective surveillance and DNA fingerprinting identified the cluster, enabling health protection teams to set up control measures and prevent further transmission.	Birmingham Heartlands Hosp, Hlth Protect Agcy, W Midlands Publ Hlth Lab, Reg Ctr Mycobacteriol, Birmingham B9 5SS, W Midlands, England; Natl Publ Hlth Serv Wales, Ctr Communicable Dis Surveillance, Zoonoses Surveillance Unit, Cardiff, Wales; Hlth Protect Agcy Ctr Infect, TB Sect, London, England; Vet Labs Agcy, TB Res Grp, Weybridge, Surrey, England; Heart England NHS Fdn Trust, Birmingham Chest Clin, Birmingham, W Midlands, England; Hlth Protect Agcy Reg Surveillance Unit W Midland, Birmingham, W Midlands, England; Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham, W Midlands, England; UCL, Dept Primary Care & Populat Sci, London, England	Health Protection Agency; Heart of England NHS Foundation Trust; University of Birmingham; Health Protection Agency; Veterinary Laboratories Agency; Heart of England NHS Foundation Trust; University of Birmingham; University of London; University College London	Evans, JT (corresponding author), Birmingham Heartlands Hosp, Hlth Protect Agcy, W Midlands Publ Hlth Lab, Reg Ctr Mycobacteriol, Birmingham B9 5SS, W Midlands, England.	jason.evans@heartofengland.nhs.uk	Smith, Noel H/C-6708-2011; Hewinson, Glyn/F-7077-2010; Hewinson, Glyn/J-1902-2014; Hewinson, Glyn/AAA-2364-2019	Sonnenberg, Pam/0000-0002-1067-1583; Hewinson, Glyn/0000-0002-5517-4281				Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cousins DV, 1998, INT J TUBERC LUNG D, V2, P471; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; DANKNER WM, 1993, MEDICINE, V72, P11, DOI 10.1097/00005792-199301000-00002; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; *DEEP HLTH, 2004, STOPP TUB ENGL ACT P; Delahay RJ, 2002, VET J, V164, P90, DOI 10.1053/tvjl.2001.0667; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; DUPON M, 1992, Q J MED, V85, P719; Evans JT, 2004, J CLIN MICROBIOL, V42, P4175, DOI 10.1128/JCM.42.9.4175-4180.2004; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; GENEWEIN A, 1993, LANCET, V342, P841, DOI 10.1016/0140-6736(93)92698-S; Gibson AL, 2004, J CLIN MICROBIOL, V42, P431, DOI 10.1128/JCM.42.1.431-434.2004; GOYAL M, 1994, J CLIN MICROBIOL, V32, P3070, DOI 10.1128/JCM.32.12.3070-3071.1994; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Gutierrez MC, 1998, LANCET, V351, P758, DOI 10.1016/S0140-6736(05)78537-8; Hawkey PM, 2003, J CLIN MICROBIOL, V41, P3514, DOI 10.1128/JCM.41.8.3514-3520.2003; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Hilty M, 2005, VET MICROBIOL, V109, P217, DOI 10.1016/j.vetmic.2005.05.017; *HLTH PROT AG, TUB MYC BOV; Jalava K, 2007, EPIDEMIOL INFECT, V135, P40, DOI 10.1017/S0950268806006509; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; LOBUE P, 2006, MYCOBACTERIUM BOVIS, P6; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Richter E, 2003, J CLIN MICROBIOL, V41, P2672, DOI 10.1128/JCM.41.6.2672-2675.2003; Rivero A, 2001, CLIN INFECT DIS, V32, P159, DOI 10.1086/317547; Roring S, 2002, J CLIN MICROBIOL, V40, P2126, DOI 10.1128/JCM.40.6.2126-2133.2002; Skuce RA, 2005, VET REC, V157, P501, DOI 10.1136/vr.157.17.501; Skuce RA, 2002, MICROBIOL-SGM, V148, P519, DOI 10.1099/00221287-148-2-519; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; Smith RMM, 2004, EMERG INFECT DIS, V10, P539, DOI 10.3201/eid1003.020819; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; [No title captured]	38	131	133	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1270	1276		10.1016/S0140-6736(07)60598-4	http://dx.doi.org/10.1016/S0140-6736(07)60598-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434402				2022-12-24	WOS:000246269700029
J	Luo, JL; Tan, W; Ricono, JM; Korchynskyi, O; Zhang, M; Gonias, SL; Cheresh, DA; Karin, M				Luo, Jun-Li; Tan, Wei; Ricono, Jill M.; Korchynskyi, Olexandr; Zhang, Ming; Gonias, Steven L.; Cheresh, David A.; Karin, Michael			Nuclear cytokine-activated IKK alpha controls prostate cancer metastasis by repressing Maspin	NATURE			English	Article							NF-KAPPA-B; MAMMARY-GLAND DEVELOPMENT; TRANSCRIPTION FACTOR; TRANSGENIC MOUSE; BONE METASTASIS; TUMOR-GROWTH; EXPRESSION; CELLS; INFLAMMATION; PROGRESSION	Inflammation enhances tumour promotion through NF-kappa B-dependent mechanisms(1). NF-kappa B was also proposed to promote metastatogenesis through epithelial - mesenchymal transition(2). Yet a mechanistic link between inflammation and metastasis is missing. We identified a role for I kappa B kinase alpha (IKK alpha), activated by receptor activator of NF-kappa B (RANK/TNFRSF11A), in mammary epithelial proliferation during pregnancy(3). Owing to similarities between mammary and prostate epithelia, we examined IKK alpha involvement in prostate cancer and its progression. Here we show that a mutation that prevents IKK alpha activation slows down CaP growth and inhibits metastatogenesis in TRAMP mice, which express SV40 T antigen in the prostate epithelium(4). Decreased metastasis correlated with elevated expression of the metastasis suppressor Maspin(5), the ablation of which restored metastatic activity. IKK alpha activation by RANK ligand (RANKL/TNFSF11) inhibits Maspin expression in prostate epithelial cells, whereas repression of Maspin transcription requires nuclear translocation of active IKK alpha. The amount of active nuclear IKK alpha in mouse and human prostate cancer correlates with metastatic progression, reduced Maspin expression and infiltration of prostate tumours with RANKL-expressing inflammatory cells. We propose that tumour-infiltrating RANKL-expressing cells lead to nuclear IKK alpha activation and inhibition of Maspin transcription, thereby promoting the metastatic phenotype.	Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Baylor College of Medicine	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008; Korchynskyi, Olexandr/ADA-6398-2022	Tan, Weihong/0000-0002-8066-1524; Luo, Jun-Li/0000-0002-7625-4766; Korchynskyi, Olexandr/0000-0002-4557-4003	NCI NIH HHS [R01 CA127923] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127923] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen EI, 2006, IUBMB LIFE, V58, P25, DOI 10.1080/15216540500531721; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Chuang CK, 2003, J FORMOS MED ASSOC, V102, P480; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lockett J, 2006, J CELL BIOCHEM, V97, P651, DOI 10.1002/jcb.20721; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Montironi R, 2006, BJU INT, V97, P485, DOI 10.1111/j.1464-410X.2005.05972.x; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Zhang M, 2000, ONCOGENE, V19, P6053, DOI 10.1038/sj.onc.1204006; Zhang M, 1999, DEV BIOL, V215, P278, DOI 10.1006/dbio.1999.9442; Zou ZQ, 2002, CLIN CANCER RES, V8, P1172; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	30	347	368	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					690	694		10.1038/nature05656	http://dx.doi.org/10.1038/nature05656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377533				2022-12-24	WOS:000245438300045
J	Fukami, T; Beaumont, HJE; Zhang, XX; Rainey, PB				Fukami, Tadashi; Beaumont, Hubertus J. E.; Zhang, Xue-Xian; Rainey, Paul B.			Immigration history controls diversification in experimental adaptive radiation	NATURE			English	Article							SPECIES-AREA RELATIONSHIP; PSEUDOMONAS-FLUORESCENS; SPECIATION; EVOLUTION; DETERMINISM; CONTINGENCY; ADAPTATION; DIVERGENCE; DIVERSITY; ISLANDS	Diversity in biological communities is a historical product of immigration, diversification and extinction(1-4), but the combined effect of these processes is poorly understood. Here we show that the order and timing of immigration controls the extent of diversification. When an ancestral bacterial genotype was introduced into a spatially structured habitat, it rapidly diversified into multiple niche-specialist types(5). However, diversification was suppressed when a niche-specialist type was introduced before, or shortly after, introduction of the ancestral genotype. In contrast, little suppression occurred when the same niche specialist was introduced relatively late. The negative impact of early arriving immigrants was attributable to the historically sensitive outcome of interactions involving neutral competition(3) and indirect facilitation. Ultimately, the entire boom-and-bust dynamics of adaptive radiation were altered. These results demonstrate that immigration and diversification are tightly linked processes, with small differences in immigration history greatly affecting the evolutionary emergence of diversity.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Hawaii System; University of Hawaii Manoa; University of Auckland	Fukami, T (corresponding author), Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA.	tfukami@hawaii.edu	Zhang, Xue-Xian/B-8143-2008; Zhang, Xue-Xian/AAP-1415-2020; Rainey, Paul/A-3207-2008; Fukami, Tadashi/A-2934-2010	Zhang, Xue-Xian/0000-0002-6536-3529; Rainey, Paul/0000-0003-0879-5795; Fukami, Tadashi/0000-0001-5654-4785				Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Cowie RH, 1995, EVOLUTION, V49, P1191, DOI 10.1111/j.1558-5646.1995.tb04446.x; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; Emerson BC, 2005, EVOLUTION, V59, P586; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Gavrilets S, 2005, P NATL ACAD SCI USA, V102, P18040, DOI 10.1073/pnas.0506330102; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; GILLESPIE RG, 1994, P NATL ACAD SCI USA, V91, P2290, DOI 10.1073/pnas.91.6.2290; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Hubbell Stephen P., 2001, V32, pi; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; MAC ARTHUR ROBERT H., 1967; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; RAINEY PB, 2005, INFLUENCE COOPERATIV, P83; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Taylor EB, 2000, P ROY SOC B-BIOL SCI, V267, P2375, DOI 10.1098/rspb.2000.1294; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E., 1999, ECOLOGICAL ASSEMBLY	30	171	172	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					436	439		10.1038/nature05629	http://dx.doi.org/10.1038/nature05629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377582				2022-12-24	WOS:000245079500039
J	Simon, A; Frisen, J				Simon, Andras; Frisen, Jonas			From stem cell to progenitor and back again	CELL			English	Editorial Material							REGENERATION	Under normal homeostatic conditions, tissue stem cells undergo long-term self renewal and produce progeny that differentiate into several different cell types. But what happens if the stem cells are lost? In a recent issue of Developmental Cell, Nakagawa et W. (2007) propose that the progeny of stem cells, called transit-amplifying progenitor cells, are able to replace lost stem cells.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se		Simon, Andras/0000-0002-1018-1891				Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X	5	13	13	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					825	826		10.1016/j.cell.2007.02.026	http://dx.doi.org/10.1016/j.cell.2007.02.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350567	Bronze			2022-12-24	WOS:000245073400005
J	Pettersson, A; Richiardi, L; Nordenskjold, A; Kaijser, M; Akre, O				Pettersson, Andreas; Richiardi, Lorenzo; Nordenskjold, Agneta; Kaijser, Magnus; Akre, Olof			Age at surgery for undescended testis and risk of testicular cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INGUINAL-HERNIA; CRYPTORCHIDISM; ORCHIDOPEXY; ABNORMALITIES; DESCENT; COHORT; BOYS; MEN	BACKGROUND: Undescended testis, which is a risk factor for testicular cancer, is usually treated surgically, but whether the age at treatment has any effect on the risk is unclear. We studied the relation between the age at treatment for undescended testis and the risk of testicular cancer. METHODS: We identified men who underwent orchiopexy for undescended testis in Sweden between 1964 and 1999. Cohort subjects were identified in the Swedish Hospital Discharge Register and followed for the occurrence of testicular cancer through the Swedish Cancer Registry. Vital statistics and data on migration status were taken from the Register of Population and Population Changes for the years 1965 through 2000. We estimated the relative risk of testicular cancer using Poisson regression of standardized incidence ratios, comparing the risk in the cohort with that in the general population. We also analyzed the data by means of Cox regression, using internal comparison groups. RESULTS: The cohort consisted of 16,983 men who were surgically treated for undescended testis and followed for a total of 209,984 person-years. We identified 56 cases of testicular cancer during follow-up. The relative risk of testicular cancer among those who underwent orchiopexy before reaching 13 years of age was 2.23 (95% confidence interval [CI], 1.58 to 3.06), as compared with the Swedish general population; for those treated at 13 years of age or older, the relative risk was 5.40 (95% CI, 3.20 to 8.53). The effect of age at orchiopexy on the risk of testicular cancer was similar in comparisons within the cohort. CONCLUSIONS: Treatment for undescended testis before puberty decreases the risk of testicular cancer.	Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; Karolinska Inst, Dept Women & Child Hlth, Div Pediat Surg, Stockholm, Sweden; Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; Karolinska Inst, Danderyds Hosp, Dept Clin Sci, Stockholm, Sweden; Univ Turin, Ctr Expt Res & Med Sci, Canc Epidemiol Unit, Turin, Italy; Univ Turin, Ctr Oncol Prevent, Turin, Italy	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; University of Turin; University of Turin	Pettersson, A (corresponding author), Karolinska Univ Hosp, Clin Epidemiol Unit, M9-01, SE-17176 Stockholm, Sweden.	andreas.h.pettersson@ki.se	Kaijser, Magnus/ABB-5970-2021; richiardi, lorenzo/J-3480-2018	Kaijser, Magnus/0000-0003-4064-0822; richiardi, lorenzo/0000-0003-0316-9402; Nordenskjold, Agneta/0000-0001-6638-4631				Bergstrom R, 1996, J NATL CANCER I, V88, P727, DOI 10.1093/jnci/88.11.727; BERKOWITZ GS, 1993, PEDIATRICS, V92, P44; Dieckmann KP, 2004, WORLD J UROL, V22, P2, DOI 10.1007/s00345-004-0398-8; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; Hack WWM, 2003, BJU INT, V92, P293, DOI 10.1046/j.1464-410X.2003.04317.x; Herrinton LJ, 2003, AM J EPIDEMIOL, V157, P602, DOI 10.1093/aje/kwg012; Hutson JM, 2005, CELL TISSUE RES, V322, P155, DOI 10.1007/s00441-005-1126-4; Hutson JM, 2005, J PEDIATR SURG, V40, P297, DOI 10.1016/j.jpedsurg.2004.10.033; Kass E, 1996, PEDIATRICS, V97, P590; Moller H, 1996, CANCER CAUSE CONTROL, V7, P264, DOI 10.1007/BF00051302; *NAT BOARD HLTH WE, 2005, CANC INC SWED 2004; *NAT BOARD HLTH WE, 2006, HLTH REG COV SWED IN; PIKE MC, 1986, LANCET, V1, P1246; PINCZOWSKI D, 1991, J UROLOGY, V146, P1291, DOI 10.1016/S0022-5347(17)38071-0; POTTERN LM, 1985, J NATL CANCER I, V74, P377; Prener A, 1996, EPIDEMIOLOGY, V7, P14, DOI 10.1097/00001648-199601000-00004; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; STRADER CH, 1988, AM J EPIDEMIOL, V127, P1013, DOI 10.1093/oxfordjournals.aje.a114877; Swerdlow AJ, 1997, BRIT MED J, V315, P1129; Swerdlow AJ, 1997, BRIT MED J, V314, P1507, DOI 10.1136/bmj.314.7093.1507; Toledano MB, 2003, ENVIRON HEALTH PERSP, V111, P129, DOI 10.1289/ehp.5446; Toppari J, 1999, HORM RES, V51, P261, DOI 10.1159/000023412	23	282	295	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1835	1841		10.1056/NEJMoa067588	http://dx.doi.org/10.1056/NEJMoa067588			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163CL	17476009	Green Published, Bronze			2022-12-24	WOS:000246136200005
J	Singleton, RJ; Hennessy, TW; Bulkow, LR; Hammitt, LL; Zulz, T; Hurlburt, DA; Butler, JC; Rudolph, K; Parkinson, A				Singleton, Rosalyn J.; Hennessy, Thomas W.; Bulkow, Lisa R.; Hammitt, Laura L.; Zulz, Tammy; Hurlburt, Debby A.; Butler, Jay C.; Rudolph, Karen; Parkinson, Alan			Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSUSCEPTIBLE STREPTOCOCCUS-PNEUMONIAE; FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; NASOPHARYNGEAL CARRIAGE; IMPACT; COLONIZATION; EPIDEMIOLOGY; IMMUNIZATION; POPULATION; PATTERNS	Context With routine childhood vaccination using heptavalent pneumococcal conjugate vaccine, one concern has been the potential for emergence and expansion of replacement disease caused by serotypes not contained in the heptavalent conjugate vaccine. Objective To determine whether replacement disease is associated with the overall decline in invasive pneumococcal disease among Alaska Native children. Design, Setting, and Patients Alaska statewide longitudinal population-based laboratory surveillance of invasive Streptococcus pneumoniae infections from January 1, 1995, through December 31, 2006. Main Outcome Measures Incidence and types of pneumococcal disease in children younger than 2 years. Results In the first 3 years after introduction of routine vaccination with heptavalent pneumococcal conjugate vaccine, overall invasive pneumococcal disease decreased 67% in Alaska Native children younger than 2 years (from 403.2 per 100 000 in 1995-2000 to 134.3 per 100 000 per year in 2001-2003, P < .001). However, between 2001-2003 and 2004-2006, there was an 82% increase in invasive disease in Alaska Native children younger than 2 years to 244.6/100 000 (P = .02). Since 2004, the invasive pneumococcal disease rate caused by nonvaccine serotypes has increased 140% compared with the prevaccine period (from 95.1 per 100 000 in 1995-2000 to 228.6 in 2004-2006, P = .001). During the same period, there was a 96% decrease in heptavalent vaccine serotype disease. Serotype 19A accounted for 28.3% of invasive pneumococcal disease among Alaska children younger than 2 years during 2004-2006. There was no significant increase in nonvaccine disease in non-Native Alaska children younger than 2 years. Conclusions Alaska Native children are experiencing replacement invasive pneumococcal disease with serotypes not covered by heptavalent pneumococcal conjugate vaccine. The demonstration of replacement invasive pneumococcal disease emphasizes the importance of ongoing surveillance and development of expanded valency vaccines.	Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Preparedness Detect & Control Infect Dis, Anchorage, AK 99508 USA; Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; Alaska Div Publ Hlth, Anchorage, AK USA	Centers for Disease Control & Prevention - USA; Alaska Native Tribal Health Consortium	Singleton, RJ (corresponding author), Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Preparedness Detect & Control Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	ris2@cdc.gov						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 5 INT S PNEUM PNEUM; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; BYLINGTON CL, 2006, PEDIATR INFECT DIS J, V25, P250; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; *CDCP, 2006, Q32003Q22004 CDCP NA; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dagan R, 1997, PEDIATR INFECT DIS J, V16, P1060, DOI 10.1097/00006454-199711000-00011; DAVIDSON M, 1994, J INFECT DIS, V170, P368, DOI 10.1093/infdis/170.2.368; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; HAMMITT LL, 2006, 5 INT S PNEUM PNEUM; Hennessy TW, 2005, VACCINE, V23, P5464, DOI 10.1016/j.vaccine.2005.08.100; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; McEllistrem MC, 2000, J CLIN MICROBIOL, V38, P351; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; National Committee for Clinical Laboratory Standards, 2003, METH DIL ANT SUSC TE; O'Brien KL, 2004, AM J EPIDEMIOL, V160, P270, DOI 10.1093/aje/kwh191; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; OBRIEN KL, 2006, 5 ANN INT S PNEUM PN; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Porat N, 2004, J INFECT DIS, V190, P2154, DOI 10.1086/425908; Ramani RR, 2004, AM J PUBLIC HEALTH, V94, P958, DOI 10.2105/AJPH.94.6.958; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rudolph KM, 2000, J INFECT DIS, V182, P490, DOI 10.1086/315716; Rudolph KM, 1998, J CLIN MICROBIOL, V36, P2703, DOI 10.1128/JCM.36.9.2703-2707.1998; RUDOLPH KM, 2006, 5 INT S PNEUM PNEUM; Salmon DA, 2006, EPIDEMIOL REV, V28, P27, DOI 10.1093/epirev/mxj001; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	43	499	520	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1784	1792		10.1001/jama.297.16.1784	http://dx.doi.org/10.1001/jama.297.16.1784			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456820				2022-12-24	WOS:000245922100024
J	Kaufmann, T; Tai, L; Ekert, PG; Huang, DCS; Norris, F; Lindemann, RK; Johnstone, RW; Dixit, VM; Strasser, A				Kaufmann, Thomas; Tai, Lin; Ekert, Paul G.; Huang, David C. S.; Norris, Fiona; Lindemann, Ralph K.; Johnstone, Ricky W.; Dixit, Vishva M.; Strasser, Andreas			The BH3-only protein bid is dispensable for DNA darnage- and replicative stress-induced apoptosis or cell-cycle arrest	CELL			English	Article							FAMILY-MEMBER BIM; BH3 DOMAINS; BCL-2; DEATH; MITOCHONDRIA; DELETION; DAMAGE; HOMEOSTASIS; RESPONSES; PUMA	Bid, a caspase-activated proapoptotic BH3 only protein, is essential for Fas-induced hepatocyte destruction. Recent studies published in Cell produced conflicting results, indicating that loss of Bid either protects or enhances apoptosis induced by DNA damage or replicative stress. To resolve this controversy, we generated novel Bid-deficient mice on an inbred C57BL/6 background and removed the drugselection cassette from the targeted locus. Nine distinct cell types from these Bid-deficient mice underwent cell-cycle arrest and apoptosis in a manner indistinguishable from control WT cells in response to DNA damage or replicative stress. Moreover, we found that even cells from the original Bid-deficient mice responded normally to these stimuli, indicating that differences in genetic background or the presence of a strong promoter within the targeted locus are unlikely to explain the differences between our results and those reported previously. We conclude that Bid has no role in DNA damage- or replicative stress-induced apoptosis or cellcycle arrest.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Childrens Canc Ctr, Parkville, Vic 3052, Australia; VCGS Pathol, Cytogenet Lab, Parkville, Vic 3052, Australia; Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia; Genentech Inc, San Francisco, CA 94080 USA	Walter & Eliza Hall Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Peter Maccallum Cancer Center; Roche Holding; Genentech	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	Ekert, Paul G/C-7247-2013; Strasser, Andreas/C-7581-2013; Huang, David C. S./C-7586-2013; Johnstone, Ricky w/H-3748-2014; Ekert, Paul/Q-1842-2015; dixit, vishva m/A-4496-2012	Ekert, Paul G/0000-0002-2976-8617; Strasser, Andreas/0000-0002-5020-4891; Huang, David C. S./0000-0002-3101-4873; Johnstone, Ricky w/0000-0001-7053-9237; Ekert, Paul/0000-0002-2976-8617; dixit, vishva m/0000-0001-6983-0326; Kaufmann, Thomas/0000-0001-9906-874X	NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER; NCI NIH HHS [CA 43540, CA 80188] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bai L, 2005, AM J PATHOL, V166, P1523, DOI 10.1016/S0002-9440(10)62368-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; KOYASU S, 1994, EMBO J, V13, P784, DOI 10.1002/j.1460-2075.1994.tb06321.x; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022; Zinkel SS, 2003, GENE DEV, V17, P229, DOI 10.1101/gad.1045603	34	161	165	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					423	433		10.1016/j.cell.2007.03.017	http://dx.doi.org/10.1016/j.cell.2007.03.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448999	Bronze			2022-12-24	WOS:000246474600027
J	Konstantinova, I; Nikolova, G; Ohara-Imaizumi, M; Meda, P; Kucera, T; Zarbalis, K; Wurst, W; Nagamatsu, S; Lammert, E				Konstantinova, Irena; Nikolova, Ganka; Ohara-Imaizumi, Mica; Meda, Paolo; Kucera, Tomas; Zarbalis, Konstantinos; Wurst, Wolfgang; Nagamatsu, Shinya; Lammert, Eckhard			EphA-ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets	CELL			English	Article							TYROSINE-PHOSPHATASE; SYNAPTIC FUNCTION; MEMBRANE DOMAINS; B-CELLS; RECEPTORS; CONTACT; GLUCOSE; ENDOCYTOSIS; EXPRESSION; REPULSION	Invertebrates, beta cells are aggregated in the form of pancreatic islets. Within these islets, communication between beta cells inhibits basal insulin secretion and enhances glucose-stimulated insulin secretion, thus contributing to glucose homeostasis during fasting and feeding. In the search for the underlying molecular mechanism, we have discovered that beta cells communicate via ephrin-As and EphAs. We provide evidence that ephrin-A5 is required for glucosestimulated insulin secretion. We further show that EphA-ephrin-A-mediated beta cell communication is bidirectional: EphA forward signaling inhibits insulin secretion, whereas ephrin-A reverse signaling stimulates insulin secretion. EphA forward signaling is downregulated in response to glucose, which indicates that, under basal conditions, beta cells use EphA forward signaling to suppress insulin secretion and that, under stimulatory conditions, they shift to ephrin-A reverse signaling to enhance insulin secretion. Thus, we explain how beta cell communication in pancreatic islets conversely affects basal and glucose-stimulated insulin secretion to improve glucose homeostasis.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Kyorin Univ, Sch Med, Tokyo 1818611, Japan; Univ Geneva, CH-1211 Geneva, Switzerland; Tech Univ Munich, GSF, Natl Res Ctr, Inst Dev Genet, D-85764 Munich, Germany	Max Planck Society; Kyorin University; University of Geneva; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Lammert, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	lammert@mpi-cbg.de	Kučera, Tomáš/C-7532-2017	Kučera, Tomáš/0000-0003-2134-4657; Wurst, Wolfgang/0000-0003-4422-7410				Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BOSCO D, 1989, EXP CELL RES, V184, P72, DOI 10.1016/0014-4827(89)90365-0; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Dahl U, 1996, DEVELOPMENT, V122, P2895; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Gogg S, 2001, BIOCHEM BIOPH RES CO, V280, P1161, DOI 10.1006/bbrc.2000.4239; Grapin-Botton A, 2000, TRENDS GENET, V16, P124, DOI 10.1016/S0168-9525(99)01957-5; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; Halban PA, 2004, NAT CELL BIOL, V6, P1021, DOI 10.1038/ncb1104-1021; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; HOPCROFT DW, 1985, ENDOCRINOLOGY, V117, P2073, DOI 10.1210/endo-117-5-2073; Knoll B, 2001, DEVELOPMENT, V128, P895; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Luther MJ, 2006, BIOCHEM BIOPH RES CO, V343, P99, DOI 10.1016/j.bbrc.2006.02.003; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; MAES E, 1984, ENDOCRINOLOGY, V114, P2205, DOI 10.1210/endo-114-6-2205; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; MEDA P, 1990, J CLIN INVEST, V86, P759, DOI 10.1172/JCI114772; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Yamagata K, 2002, DIABETES, V51, P114, DOI 10.2337/diabetes.51.1.114; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	49	237	267	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					359	370		10.1016/j.cell.2007.02.044	http://dx.doi.org/10.1016/j.cell.2007.02.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448994	Bronze			2022-12-24	WOS:000246474600022
J	Saulsbury, FT				Saulsbury, Frank T.			Clinical update: Henoch-Schonlein purpura	LANCET			English	Article							NEPHRITIS; CHILDREN; THERAPY; GLYCOSYLATION; PREDNISONE; CHILDHOOD		Univ Virginia Hlth Syst, Dept Pediat, Div Immunol & Rheumatol, Charlottesville, VA 22908 USA	University of Virginia	Saulsbury, FT (corresponding author), Univ Virginia Hlth Syst, Dept Pediat, Div Immunol & Rheumatol, Charlottesville, VA 22908 USA.	fts@virginia.edu						Allen AC, 1998, NEPHROL DIAL TRANSPL, V13, P930, DOI 10.1093/ndt/13.4.930; Calvino MC, 2001, MEDICINE, V80, P279, DOI 10.1097/00005792-200109000-00001; Davin JC, 2001, KIDNEY INT, V59, P823, DOI 10.1046/j.1523-1755.2001.059003823.x; Foster BJ, 2000, J PEDIATR-US, V136, P370, DOI 10.1067/mpd.2000.103448; Huber AM, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-7; KOSKIMIES O, 1981, ARCH DIS CHILD, V56, P482, DOI 10.1136/adc.56.6.482; LIJIMA K, 1998, PEDIATR NEPHROL, V12, P244; NARCHI H, 2005, ARCH DIS CHILD, V90, P16; Niaudet P, 1998, PEDIATR NEPHROL, V12, P238, DOI 10.1007/s004670050446; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Ronkainen J, 2003, CLIN NEPHROL, V60, P80; Ronkainen J, 2002, LANCET, V360, P666, DOI 10.1016/S0140-6736(02)09835-5; Ronkainen J, 2006, J PEDIATR-US, V149, P241, DOI 10.1016/j.jpeds.2006.03.024; ROSENBLUM ND, 1987, PEDIATRICS, V79, P1018; Saulsbury FT, 1999, MEDICINE, V78, P395, DOI 10.1097/00005792-199911000-00005; Saulsbury FT, 1997, J RHEUMATOL, V24, P2246; Saulsbury FT, 2001, CURR OPIN RHEUMATOL, V13, P35, DOI 10.1097/00002281-200101000-00006; Shin JI, 2005, SCAND J RHEUMATOL, V34, P392, DOI 10.1080/03009740510026544; Trapani S, 2005, SEMIN ARTHRITIS RHEU, V35, P143, DOI 10.1016/j.semarthrit.2005.08.007; YOSHIKAWA N, 1981, CLIN NEPHROL, V16, P223	20	182	208	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					976	978		10.1016/S0140-6736(07)60474-7	http://dx.doi.org/10.1016/S0140-6736(07)60474-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382810				2022-12-24	WOS:000245286500010
J	Brandvain, Y; Barker, MS; Wade, MJ				Brandvain, Yaniv; Barker, Michael S.; Wade, Michael J.			Gene co-inheritance and gene transfer	SCIENCE			English	Article							EVOLUTION; NUCLEUS; RATES		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Brandvain, Y (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ybrandva@indiana.edu	Barker, Mike/AAE-7891-2019; Barker, Michael/A-9645-2010	Barker, Mike/0000-0001-7173-1319; 	NIGMS NIH HHS [R01GM65414] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065414] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Blanchard JL, 2000, TRENDS GENET, V16, P315, DOI 10.1016/S0168-9525(00)02053-9; ESHEL I, 1970, Theoretical Population Biology, V1, P88, DOI 10.1016/0040-5809(70)90043-2; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Wade MJ, 2006, EVOLUTION, V60, P643	7	13	16	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1685	1685		10.1126/science.1134789	http://dx.doi.org/10.1126/science.1134789			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379800				2022-12-24	WOS:000245106900030
J	Steinbrook, R				Steinbrook, Robert			HIV in India - The challenge ahead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						LUCE E, 2007, SPITE GODS STRANGE R; Moses SA, 2006, AIDS S ASIA UNDERSTA; Steinbrook R, 2007, NEW ENGL J MED, V356, P1089, DOI 10.1056/NEJMp078009; *UN DEV PROGR, 2006, 2006 HUM DEV REP; World Health Organization, 2006, ANT THER HIV INF AD	5	45	45	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1197	+		10.1056/NEJMp078011	http://dx.doi.org/10.1056/NEJMp078011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148UP	17377154	Bronze			2022-12-24	WOS:000245101900001
J	Buzsaki, G				Buzsaki, Gyoergy			The structure of consciousness - Subjective awareness may depend on neural networks in the brain supporting complex wiring schemes and dynamic patterns of activity.	NATURE			English	Editorial Material									Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.			Buzsaki, Gyorgy/0000-0002-3100-4800				Buzsaki G., 2006, RHYTHMS BRAIN; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033	2	43	46	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					267	267		10.1038/446267a	http://dx.doi.org/10.1038/446267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145VC	17361165				2022-12-24	WOS:000244892900027
J	Roberts, I; Smith, R; Evans, S				Roberts, Ian; Smith, Richard; Evans, Stephen			Doubts over head injury studies	BRITISH MEDICAL JOURNAL			English	Editorial Material							HIGH-DOSE MANNITOL; RANDOMIZED-TRIAL					Ian.Roberts@Lshtm.ac.uk		Evans, Stephen/0000-0002-1474-2596				Couzin J, 2006, SCIENCE, V312, P38, DOI 10.1126/science.312.5770.38; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Marshall LF, 2004, J NEUROSURG, V100, P367, DOI 10.3171/jns.2004.100.3.0367; Wakai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub2	7	30	32	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					392	394		10.1136/bmj.39118.480023.BE	http://dx.doi.org/10.1136/bmj.39118.480023.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MQ	17322250	Green Published, Green Accepted			2022-12-24	WOS:000244654400023
J	Richards, T				Richards, Tessa			A better way to die - Why dying and death need to be "rehabilitated" back to a more central position in society	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 21	2007	334	7598					830	830		10.1136/bmj.39188.592940.59	http://dx.doi.org/10.1136/bmj.39188.592940.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446614	Green Published			2022-12-24	WOS:000246090800030
J	Lohman, DJ; Bickford, D; Sodhi, NS				Lohman, David J.; Bickford, David; Sodhi, Navjot S.			The burning issue	SCIENCE			English	Editorial Material							FOREST; SMOKE		Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore	Lohman, DJ (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	lohman@nus.edu.sg; dbsns@nus.edu.sg	Bickford, David P/A-5306-2011	Bickford, David P/0000-0003-1478-3387; Lohman, David/0000-0002-0689-2906				Barber C, 2000, TRIAL FIRE FOREST FI; Byron N, 2004, AGR ECOSYST ENVIRON, V104, P57, DOI 10.1016/j.agee.2004.01.006; FAO, 2007, FIR MAN GLOB ASS 200; Glover D., 1999, INDONESIAS FIRES HAZ; Jayachandran S, 2005, 95 BREAD; Kinnaird MF, 1998, CONSERV BIOL, V12, P954, DOI 10.1046/j.1523-1739.1998.012005954.x; Marten G. G., 1986, TRADITIONAL AGR SE A; Nichol J, 1998, ATMOS ENVIRON, V32, P3917; Nichol J, 1997, ATMOS ENVIRON, V31, P1209, DOI 10.1016/S1352-2310(96)00260-9; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Sastry N, 2002, DEMOGRAPHY, V39, P1, DOI 10.1353/dem.2002.0009; Tomich TP, 2004, AGR ECOSYST ENVIRON, V104, P229, DOI 10.1016/j.agee.2004.01.017; 2007, STRAITS TIMES   0106, P24	13	54	54	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					376	376		10.1126/science.1140278	http://dx.doi.org/10.1126/science.1140278			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446376				2022-12-24	WOS:000245813400026
J	Ohtake, F; Baba, A; Takada, I; Okada, M; Iwasaki, K; Miki, H; Takahashi, S; Kouzmenko, A; Nohara, K; Chiba, T; Fujii-Kuriyama, Y; Kato, S				Ohtake, Fumiaki; Baba, Atsushi; Takada, Ichiro; Okada, Maiko; Iwasaki, Kei; Miki, Hiromi; Takahashi, Sayuri; Kouzmenko, Alexander; Nohara, Keiko; Chiba, Tomoki; Fujii-Kuriyama, Yoshiaki; Kato, Shigeaki			Dioxin receptor is a ligand-dependent E3 ubiquitin ligase	NATURE			English	Article							ARYL-HYDROCARBON RECEPTOR; BOX PROTEIN TIR1; AUXIN RECEPTOR; AH-RECEPTOR; TRANSCRIPTION; ALPHA; PROTEOLYSIS; EXPRESSION; PROMOTERS; COMPLEX	Fat-soluble ligands, including sex steroid hormones and environmental toxins, activate ligand-dependent DNA-sequence-specific transcriptional factors that transduce signals through target-gene-selective transcriptional regulation(1). However, the mechanisms of cellular perception of fat-soluble ligand signals through other target-selective systems remain unclear. The ubiquitin-proteasome system regulates selective protein degradation, in which the E3 ubiquitin ligases determine target specificity(2-4). Here we characterize a fat-soluble ligand-dependent ubiquitin ligase complex in human cell lines, in which dioxin receptor ( AhR)(5-9) is integrated as a component of a novel cullin 4B ubiquitin ligase complex, CUL4B(AhR). Complex assembly and ubiquitin ligase activity of CUL4B(AhR) in vitro and in vivo are dependent on the AhR ligand. In the CUL4B(AhR) complex, ligand-activated AhR acts as a substrate-specific adaptor component that targets sex steroid receptors for degradation. Thus, our findings uncover a function for AhR as an atypical component of the ubiquitin ligase complex and demonstrate a non-genomic signalling pathway in which fat-soluble ligands regulate target-protein-selective degradation through a ubiquitin ligase complex.	Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo 1138655, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058577, Japan; Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan	Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; National Institute for Environmental Studies - Japan; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Japan Sci & Technol Agcy, ERATO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	uskato@mail.ecc.u-tokyo.ac.jp						Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Baba T, 2005, MOL CELL BIOL, V25, P10040, DOI 10.1128/MCB.25.22.10040-10051.2005; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Carlson DB, 2002, J BIOCHEM MOL TOXIC, V16, P317, DOI 10.1002/jbt.10051; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Lin TM, 2002, TOXICOL SCI, V68, P479, DOI 10.1093/toxsci/68.2.479; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Poellinger L, 2000, FOOD ADDIT CONTAM A, V17, P261, DOI 10.1080/026520300283333; Roberts BJ, 1999, J BIOL CHEM, V274, P36351, DOI 10.1074/jbc.274.51.36351; ROMKES M, 1987, TOXICOL APPL PHARM, V87, P306, DOI 10.1016/0041-008X(87)90292-4; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	30	402	421	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					562	566		10.1038/nature05683	http://dx.doi.org/10.1038/nature05683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392787				2022-12-24	WOS:000245242900054
J	Cawthorne, P; Ford, N; Limpananont, J; Tienudom, N; Purahong, W				Cawthorne, Paul; Ford, Nathan; Limpananont, Jiraporn; Tienudom, Nimit; Purahong, Wirat			WHO must defend patients' interests, not industry	LANCET			English	Editorial Material									Med Sans Frontieres, Bangkok 10240, Thailand; Chulalongkorn Univ, Fac Pharmaceut Sci, Bangkok, Thailand; AIDS Access Fdn, Bangkok, Thailand; Thai Network People Living HIV AIDS, Bangkok, Thailand	Chulalongkorn University	Cawthorne, P (corresponding author), Med Sans Frontieres, Bangkok 10240, Thailand.	msfb-bangkok@brussels.msf.org						*ABB, 2006, ABB REP STRONG 4 Q R; [Anonymous], 2001, DECL TRIPS AGR PUBL; *BRIST MYERS SQUIB, BRIST MYERS SQUIBB C; CHAN M, 2007, COMMUNICATION   0212; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; Pinheiro E, 2006, AIDS, V20, P1745, DOI 10.1097/01.aids.0000242821.67001.65; REVENGA A, 2006, EC EFF AIDS TREATM E; SCHWAB S, 2007, COMMUNICATION   0117; TREERUTKUARKUL A, 2007, BANGKOK POST    0213; TREERUTKUARKUL A, 2007, BANGKOK POST    0202; *WHO, 2005, EXT REV HLTH SECT RE; Wilson D, 1999, LANCET, V354, P1893, DOI 10.1016/S0140-6736(99)06114-0; ZAMISKA N, 2007, WALL STREET J   0314	13	12	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					974	975		10.1016/S0140-6736(07)60473-5	http://dx.doi.org/10.1016/S0140-6736(07)60473-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151JO	17382809				2022-12-24	WOS:000245286500009
J	Chang, JT; Palanivel, VR; Kinjyo, I; Schambach, F; Intlekofer, AM; Banerjee, A; Longworth, SA; Vinup, KE; Mrass, P; Oliaro, J; Killeen, N; Orange, JS; Russell, SM; Weninger, W; Reiner, SL				Chang, John T.; Palanivel, Vikram R.; Kinjyo, Ichiko; Schambach, Felix; Intlekofer, Andrew M.; Banerjee, Arnob; Longworth, Sarah A.; Vinup, Kristine E.; Mrass, Paul; Oliaro, Jane; Killeen, Nigel; Orange, Jordan S.; Russell, Sarah M.; Weninger, Wolfgang; Reiner, Steven L.			Asymmetric T lymphocyte division in the initiation of adaptive immune responses	SCIENCE			English	Article							DENDRITIC CELL-INTERACTIONS; ANTIGEN-PRESENTING CELLS; IN-VIVO; IMMUNOLOGICAL SYNAPSE; CUTTING EDGE; STEM-CELLS; DIFFERENTIATION; NODES; EFFECTOR; BET	A hallmark of mammalian immunity is the heterogeneity of cell fate that exists among pathogen-experienced lymphocytes. We show that a dividing T lymphocyte initially responding to a microbe exhibits unequal partitioning of proteins that mediate signaling, cell fate specification, and asymmetric cell division. Asymmetric segregation of determinants appears to be coordinated by prolonged interaction between the T cell and its antigen-presenting cell before division. Additionally, the first two daughter T cells displayed phenotypic and functional indicators of being differentially fated toward effector and memory lineages. These results suggest a mechanism by which a single lymphocyte can apportion diverse cell fates necessary for adaptive immunity.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Wistar Inst Anat & Biol, Program Immunol, Philadelphia, PA 19104 USA; Peter MacCallum Canc Inst, Immune Signalling Lab, Melbourne, Vic 2002, Australia; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Swinburne Univ Technol, Ctr Microphoton, Fac Engn & Ind Sci, Hawthorn, Vic 3122, Australia	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; The Wistar Institute; Peter Maccallum Cancer Center; University of California System; University of California San Francisco; University of Pennsylvania; Swinburne University of Technology	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu	Schambach, Felix/B-9055-2009; Orange, Jordan S/D-5239-2009; Russell, Sarah M/B-9341-2009	Russell, Sarah M/0000-0001-5826-9641; orange, jordan/0000-0001-7117-7725; Oliaro, Jane/0000-0002-2097-6428; Kinjyo, Ichiko/0000-0001-7051-3790; Intlekofer, Andrew/0000-0001-9046-6549; Chang, John/0000-0003-0873-6218	NATIONAL CANCER INSTITUTE [R25CA087812, R21CA114114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061699, T32AI007532, R01AI053827, R56AI069380, R01AI042370, T32AI055428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066] Funding Source: NIH RePORTER; NCI NIH HHS [CA114114, CA87812] Funding Source: Medline; NIAID NIH HHS [AI042370, R01 AI061699, AI007532, AI055428, AI061699, AI069380, T32 AI055428, AI053827] Funding Source: Medline; NIDDK NIH HHS [DK007066] Funding Source: Medline; NIGMS NIH HHS [GM007170] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; AMIGORENA S, COMMUNICATION; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Anderson AC, 2005, J IMMUNOL, V174, P890, DOI 10.4049/jimmunol.174.2.890; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lin J, 2005, J CELL BIOL, V170, P177, DOI 10.1083/jcb.200503032; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Martin P, 2005, P NATL ACAD SCI USA, V102, P9866, DOI 10.1073/pnas.0501202102; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004	40	623	638	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1687	1691		10.1126/science.1139393	http://dx.doi.org/10.1126/science.1139393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17332376				2022-12-24	WOS:000245106900032
J	Wharam, JF; Landon, BE; Galbraith, AA; Kleinman, KP; Soumerai, SB; Ross-Degnan, D				Wharam, J. Frank; Landon, Bruce E.; Galbraith, Alison A.; Kleinman, Ken P.; Soumerai, Stephen B.; Ross-Degnan, Dennis			Emergency department use and subsequent hospitalizations among members of a high-deductible health plan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC DISEASE SCORE; INSURANCE STATUS; CLAIMS DATA; CARE; COST; ASSOCIATION; MORTALITY; ADMISSION; COVERAGE; EVENTS	Context Patients evaluated at emergency departments often present with nonemergency conditions that can be treated in other clinical settings. High-deductible health plans have been promoted as a means of reducing overutilization but could also be related to worse outcomes if patients defer necessary care. Objectives To determine the relationship between transition to a high-deductible health plan and emergency department use for low- and high-severity conditions and to examine changes in subsequent hospitalizations. Design, Setting, and Participants Analysis of emergency department visits and subsequent hospitalizations among 8724 individuals for 1 year before and after their employers mandated a switch from a traditional health maintenance organization plan to a high-deductible health plan, compared with 59 557 contemporaneous controls who remained in the traditional plan. All persons were aged 1 to 64 years and insured by a Massachusetts health plan between March 1, 2001, and June 30, 2005. Main Outcome Measures Rates of first and repeat emergency department visits classified as low, indeterminate, or high severity during the baseline and follow-up periods, as well as rates of inpatient admission after emergency department visits. Results Between the baseline and follow-up periods, emergency department visits among members who switched to high-deductible coverage decreased from 197.5 to 178.1 per 1000 members, while visits among controls remained at approximately 220 per 1000(- 10.0% adjusted difference in difference; 95% confidence interval [CI],- 16.6% to- 2.8%; P=. 007). The high-deductible plan was not associated with a change in the rate of first visits occurring during the study period (- 4.1% adjusted difference in difference; 95% CI, - 11.8% to 4.3%). Repeat visits in the high-deductible group decreased from 334.6 to 255.3 visits per 1000 members and increased from 321.1 to 334.4 per 1000 members in controls(- 24.9% difference in difference; 95% CI, - 37.5% to - 9.7%; P=. 002). Low-severity repeat emergency department visits decreased in the high-deductible group from 142.5 to 92.1 per 1000 members and increased in controls from 128.0 to 132.5 visits per 1000 members(- 36.4% adjusted difference in difference; 95% CI, - 51.1% to - 17.2%; P <. 001), whereas a small decrease in high-severity visits in the high-deductible group could not be excluded. The percentage of patients admitted from the emergency department in the high-deductible group decreased from 11.8% to 10.9% and increased from 11.9% to 13.6% among controls (- 24.7% adjusted difference in difference; 95% CI, - 41.0% to - 3.9%; P=. 02). Conclusions Traditional health plan members who switched to high-deductible coverage visited the emergency department less frequently than controls, with reductions occurring primarily in repeat visits for conditions that were not classified as high severity, and had decreases in the rate of hospitalizations from the emergency department. Further research is needed to determine long-term health care utilization patterns under high-deductible coverage and to assess risks and benefits related to clinical outcomes.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Wharam, JF (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	jwharam@partners.org		Kleinman, Ken/0000-0002-5600-5834; Wharam, James/0000-0003-2053-0757	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011843] Funding Source: NIH RePORTER; AHRQ HHS [U 18 HS 11843] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Ash AS, 2003, HEALTH SERV RES, V38, P1253, DOI 10.1111/1475-6773.00175; BAKER LC, 1994, HEALTH AFFAIR, V13, P162, DOI 10.1377/hlthaff.13.5.162; Bamezai A, 2005, ANN EMERG MED, V45, P483, DOI 10.1016/j.annemergmed.2004.08.029; Billings J, 2000, Issue Brief (Commonw Fund), P1; BILLINGS J, 2000, ISSUE BRIEF COMMONW, V433, P1; BINDMAN AB, 1991, JAMA-J AM MED ASSOC, V266, P1091, DOI 10.1001/jama.266.8.1091; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; BUNTIN MB, 2006, HLTH AFF MILLWOOD, V25, pS516; BUSH GW, PRESIDENTS PROPOSAL; CANNON MF, HLTH SAVINGS ACCOUNT; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Cogan JF, 2005, HEALTH AFFAIR, V24, P1447, DOI 10.1377/hlthaff.24.6.1447; Cowen ME, 2002, MED CARE, V40, P650, DOI 10.1097/00005650-200208000-00004; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; *CTR MED MED SERV, FACT SHEET 2007 MED; Davis Karen, 2004, Issue Brief (Commonw Fund), P1; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Fishman PA, 1999, MED CARE, V37, P874, DOI 10.1097/00005650-199909000-00004; Ginsburg PB, 2004, NEW ENGL J MED, V351, P1591, DOI 10.1056/NEJMp048159; Herzlinger RE, 2002, HARVARD BUS REV, V80, P44; Hsu J, 2006, HEALTH SERV RES, V41, P1801, DOI 10.1111/j.1475-6773.2006.00562.x; *I MED COMM FUT EM, FUT EM CAR KEY FIND; JOHNSON RE, 1994, J CLIN EPIDEMIOL, V47, P1191, DOI 10.1016/0895-4356(94)90106-6; *KAIS FAM FDN HLTH, EMPL HLTH BEN 2006 A; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; LANDA AS, MEDICAID OFFER HSA P; Lee TH, 2005, NEW ENGL J MED, V353, P1202, DOI 10.1056/NEJMp058209; Magid DJ, 1997, NEW ENGL J MED, V336, P1722, DOI 10.1056/NEJM199706123362406; Newhouse JP, 1996, FREE ALL LESSONS RAN; OGRADY KF, 1985, NEW ENGL J MED, V313, P484, DOI 10.1056/NEJM198508223130806; Palmisano DJ, 2004, JAMA-J AM MED ASSOC, V291, P2237, DOI 10.1001/jama.291.18.2237; RASELL ME, 1995, NEW ENGL J MED, V332, P1164, DOI 10.1056/NEJM199504273321711; Richardson DB, 2006, MED J AUSTRALIA, V184, P213, DOI 10.5694/j.1326-5377.2006.tb00204.x; Roblin DW, 2005, MED CARE, V43, P951, DOI 10.1097/01.mlr.0000178216.23514.b7; Ruger JP, 2003, ACAD EMERG MED, V10, P1285, DOI 10.1197/S1069-6563(03)00500-1; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Selby JV, 1996, NEW ENGL J MED, V334, P635, DOI 10.1056/NEJM199603073341006; Shearer G, 2004, HEALTH SERV RES, V39, P1159, DOI 10.1111/j.1475-6773.2004.00280.x; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; Sox CM, 1998, AM J MED, V105, P506, DOI 10.1016/S0002-9343(98)00324-6; Sprivulis PC, 2006, MED J AUSTRALIA, V184, P208, DOI 10.5694/j.1326-5377.2006.tb00203.x; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Travers DA, 2003, ACAD EMERG MED, V10, P1337, DOI 10.1197/S1069-6563(03)00536-0; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; U.S. Bureau of Census, 1994, GEOGR AR REF MAN; WUERZ RC, 1992, ANN EMERG MED, V21, P669, DOI 10.1016/S0196-0644(05)82777-5; YOO H, JANUARY CENSUS SHOWS; Yu W, 2004, AM J MANAG CARE, V10, P909; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	51	124	127	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1093	1102		10.1001/jama.297.10.1093	http://dx.doi.org/10.1001/jama.297.10.1093			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356030	Bronze			2022-12-24	WOS:000244865200023
J	Coulibaly, F; Chiu, E; Ikeda, K; Gutmann, S; Haebel, PW; Schulze-Briese, C; Mori, H; Metcalf, P				Coulibaly, Fasseli; Chiu, Elaine; Ikeda, Keiko; Gutmann, Sascha; Haebel, Peter W.; Schulze-Briese, Clemens; Mori, Hajime; Metcalf, Peter			The molecular organization of cypovirus polyhedra	NATURE			English	Article							X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; PROTEIN; BODIES	Cypoviruses and baculoviruses are notoriously difficult to eradicate because the virus particles are embedded in micrometresized protein crystals called polyhedra(1,2). The remarkable stability of polyhedra means that, like bacterial spores, these insect viruses remain infectious for years in soil. The environmental persistence of polyhedra is the cause of significant losses in silkworm cocoon harvests but has also been exploited against pests in biological alternatives to chemical insecticides(3,4). Although polyhedra have been extensively characterized since the early 1900s(5), their atomic organization remains elusive(6). Here we describe the 2 angstrom crystal structure of both recombinant and infectious silkworm cypovirus polyhedra determined using crystals 5 - 12 micrometres in diameter purified from insect cells. These are the smallest crystals yet used for de novo X-ray protein structure determination(7). We found that polyhedra are made of trimers of the viral polyhedrin protein and contain nucleotides. Although the shape of these building blocks is reminiscent of some capsid trimers, polyhedrin has a new fold and has evolved to assemble in vivo into three-dimensional cubic crystals rather than icosahedral shells. The polyhedrin trimers are extensively cross-linked in polyhedra by non-covalent interactions and pack with an exquisite molecular complementarity similar to that of antigen - antibody complexes. The resulting ultrastable and sealed crystals shield the virus particles from environmental damage. The structure suggests that polyhedra can serve as the basis for the development of robust and versatile nanoparticles for biotechnological applications 8 such as microarrays(9) and biopesticides(4).	Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; Prot Crystal Corp, Osaka 5410053, Japan; Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; Altana Pharma AG, D-78467 Constance, Germany; Kyoto Inst Technol, Kyoto 6068585, Japan	University of Auckland; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Altana; Kyoto Institute of Technology	Metcalf, P (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand.	peter.metcalf@auckland.ac.nz	Metcalf, Peter/B-4598-2011	Gutmann, Sascha/0000-0002-4242-8510; Coulibaly, Fasseli/0000-0003-3380-2117; Mori, Hajime/0000-0001-9219-6140				Anduleit K, 2005, PROTEIN SCI, V14, P2741, DOI 10.1110/ps.051516405; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belloncik S, 1998, VIRUSES, P337; Chang JH, 2003, J INVERTEBR PATHOL, V84, P30, DOI 10.1016/S0022-2011(03)00121-6; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Doye JPK, 2006, CURR OPIN COLLOID IN, V11, P40, DOI 10.1016/j.cocis.2005.10.002; Fields B. N., 2001, FIELDS VIROLOGY, V4; FUJIWARA T, 1984, APPL ENTOMOL ZOOL, V19, P402, DOI 10.1303/aez.19.402; Glaser RW, 1916, BIOL BULL-US, V30, P367, DOI 10.2307/1536363; GRIMES J, 1995, NATURE, V373, P167, DOI 10.1038/373167a0; Hill CL, 1999, NAT STRUCT BIOL, V6, P565, DOI 10.1038/9347; Ikeda K, 2006, PROTEOMICS, V6, P54, DOI 10.1002/pmic.200500022; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Miller L.K., 1997, BACULOVIRUSES; MORI H, 1993, J GEN VIROL, V74, P99, DOI 10.1099/0022-1317-74-1-99; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; ROHRMANN GF, 1986, J GEN VIROL, V67, P1499, DOI 10.1099/0022-1317-67-8-1499; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Thorne RE, 2003, J APPL CRYSTALLOGR, V36, P1455, DOI 10.1107/S0021889803018375; Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9; Zhang H, 1999, J VIROL, V73, P1624, DOI 10.1128/JVI.73.2.1624-1629.1999	30	148	161	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					97	101		10.1038/nature05628	http://dx.doi.org/10.1038/nature05628			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330045				2022-12-24	WOS:000244525600045
J	Storici, F; Bebenek, K; Kunkel, TA; Gordenin, DA; Resnick, MA				Storici, Francesca; Bebenek, Katarzyna; Kunkel, Thomas A.; Gordenin, Dmitry A.; Resnick, Michael A.			RNA-templated DNA repair	NATURE			English	Article							DOUBLE-STRAND BREAKS; REVERSE-TRANSCRIPTASE; SACCHAROMYCES-CEREVISIAE; POLYMERASE-ETA; RECA PROTEIN; RECOMBINATION; RIBONUCLEOTIDES; REPLICATION; OLIGONUCLEOTIDES; RETROTRANSPOSONS	RNA can act as a template for DNA synthesis in the reverse transcription of retroviruses and retrotransposons(1) and in the elongation of telomeres(2). Despite its abundance in the nucleus, there has been no evidence for a direct role of RNA as a template in the repair of any chromosomal DNA lesions, including DNA double-strand breaks (DSBs), which are repaired in most organisms by homologous recombination or by non-homologous end joining(3). An indirect role for RNA in DNA repair, following reverse transcription and formation of a complementary DNA, has been observed in the non-homologous joining of DSB ends(4,5). In the yeast Saccharomyces cerevisiae, in which homologous recombination is efficient(3), RNA was shown to mediate recombination, but only indirectly through a cDNA intermediate(6,7) generated by the reverse transcriptase function of Ty retrotransposons in Ty particles in the cytoplasm(8). Although pairing between duplex DNA and single-strand (ss) RNA can occur in vitro(9,10) and in vivo(11), direct homologous exchange of genetic information between RNA and DNA molecules has not been observed. We show here that RNA can serve as a template for DNA synthesis during repair of a chromosomal DSB in yeast. The repair was accomplished with RNA oligonucleotides complementary to the broken ends. This and the observation that even yeast replicative DNA polymerases such as alpha and delta can copy short RNA template tracts in vitro demonstrate that RNA can transfer genetic information in vivo through direct homologous interaction with chromosomal DNA.	NIEHS, Mol Biol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Mol Biol Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA.	resnick@niehs.nih.gov	resnick, Michael/F-1668-2019; Dmitry, Gordenin/C-3907-2018; Kunkel, Thomas A./D-5088-2019	resnick, Michael/0000-0002-8473-7506; Dmitry, Gordenin/0000-0002-8399-1836; Kunkel, Thomas A./0000-0002-9900-1788	Intramural NIH HHS [Z01 ES065072-17] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065072, Z01ES065070] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; BALTIMORE D, 1985, CELL, V40, P481, DOI 10.1016/0092-8674(85)90190-4; BOEKE JD, 1986, MOL CELL BIOL, V6, P3575, DOI 10.1128/MCB.6.11.3575; DERR LK, 1993, NATURE, V361, P170, DOI 10.1038/361170a0; Franklin A, 2004, IMMUNOL CELL BIOL, V82, P219, DOI 10.1046/j.0818-9641.2004.01221.x; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Kasahara M, 2000, GENE DEV, V14, P360; Lesage P, 2005, CYTOGENET GENOME RES, V110, P70, DOI 10.1159/000084940; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200; NevoCaspi Y, 1997, CURR GENET, V32, P32, DOI 10.1007/s002940050245; Niimi A, 2004, MOL CELL BIOL, V24, P2734, DOI 10.1128/MCB.24.7.2734-2746.2004; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045; RICCHETTI M, 1993, EMBO J, V12, P387, DOI 10.1002/j.1460-2075.1993.tb05670.x; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Shcherbakova Polina V., 2006, V47, P391; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Vengrova S, 2006, EMBO REP, V7, P59, DOI 10.1038/sj.embor.7400576; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Zaitsev EN, 2000, GENE DEV, V14, P740	29	158	167	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					338	341		10.1038/nature05720	http://dx.doi.org/10.1038/nature05720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17429354	Green Accepted			2022-12-24	WOS:000246520300050
J	Visser, AW				Visser, Andre W.			Biomixing of the oceans?	SCIENCE			English	Editorial Material							GENERATED TURBULENCE; DIFFUSION; DISSIPATION; ENERGY		Tech Univ Denmark, Danish Inst Fisheries Res, Dept Marine Ecol & Aquaculture, DK-2920 Charlottenlund, Denmark	Technical University of Denmark	Visser, AW (corresponding author), Tech Univ Denmark, Danish Inst Fisheries Res, Dept Marine Ecol & Aquaculture, Kavalergaarden 6, DK-2920 Charlottenlund, Denmark.	awv@difres.dk	Visser, Andre/G-6317-2015	Visser, Andre/0000-0002-1604-7263				Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Britter R.E., 1985, TURBULENCE DIFFUSION, P3; Dengler M, 2002, J PHYS OCEANOGR, V32, P1165, DOI 10.1175/1520-0485(2002)032<1165:EDJAAM>2.0.CO;2; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Kunze E, 2006, SCIENCE, V313, P1768, DOI 10.1126/science.1129378; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; OAKEY NS, 1982, J PHYS OCEANOGR, V12, P256, DOI 10.1175/1520-0485(1982)012<0256:DOTROD>2.0.CO;2; OKUBO A, 1971, DEEP-SEA RES, V18, P789, DOI 10.1016/0011-7471(71)90046-5; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Rehmann CR, 2004, DYNAM ATMOS OCEANS, V37, P271, DOI 10.1016/j.dynatmoce.2003.09.001; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Thorpe S. A, 2005, TURBULENT OCEAN; Wunsch C, 2000, NATURE, V405, P743, DOI 10.1038/35015639; YOON KH, 1990, J FLUID MECH, V215, P601, DOI 10.1017/S0022112090002786	15	65	66	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					838	839		10.1126/science.1141272	http://dx.doi.org/10.1126/science.1141272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495157				2022-12-24	WOS:000246369800021
J	Mikkelsen, TS; Wakefield, MJ; Aken, B; Amemiya, CT; Chang, JL; Duke, S; Garber, M; Gentles, AJ; Goodstadt, L; Heger, A; Jurka, J; Kamal, M; Mauceli, E; Searle, SMJ; Sharpe, T; Baker, ML; Batzer, MA; Benos, PV; Belov, K; Clamp, M; Cook, A; Cuff, J; Das, R; Davidow, L; Deakin, JE; Fazzari, MJ; Glass, JL; Grabherr, M; Greally, JM; Gu, WJ; Hore, TA; Huttley, GA; Kleber, M; Jirtle, RL; Koina, E; Lee, JT; Mahony, S; Marra, MA; Miller, RD; Nicholls, RD; Oda, M; Papenfuss, AT; Parra, ZE; Pollock, DD; Ray, DA; Schein, JE; Speed, TP; Thompson, K; VandeBerg, JL; Wade, CM; Walker, JA; Waters, PD; Webber, C; Weidman, JR; Xie, XH; Zody, MC; Graves, JAM; Ponting, CP; Breen, M; Samollow, PB; Lander, ES; Lindblad-Toh, K				Mikkelsen, Tarjei S.; Wakefield, Matthew J.; Aken, Bronwen; Amemiya, Chris T.; Chang, Jean L.; Duke, Shannon; Garber, Manuel; Gentles, Andrew J.; Goodstadt, Leo; Heger, Andreas; Jurka, Jerzy; Kamal, Michael; Mauceli, Evan; Searle, Stephen M. J.; Sharpe, Ted; Baker, Michelle L.; Batzer, Mark A.; Benos, Panayiotis V.; Belov, Katherine; Clamp, Michele; Cook, April; Cuff, James; Das, Radhika; Davidow, Lance; Deakin, Janine E.; Fazzari, Melissa J.; Glass, Jacob L.; Grabherr, Manfred; Greally, John M.; Gu, Wanjun; Hore, Timothy A.; Huttley, Gavin A.; Kleber, Michael; Jirtle, Randy L.; Koina, Edda; Lee, Jeannie T.; Mahony, Shaun; Marra, Marco A.; Miller, Robert D.; Nicholls, Robert D.; Oda, Mayumi; Papenfuss, Anthony T.; Parra, Zuly E.; Pollock, David D.; Ray, David A.; Schein, Jacqueline E.; Speed, Terence P.; Thompson, Katherine; VandeBerg, John L.; Wade, Claire M.; Walker, Jerilyn A.; Waters, Paul D.; Webber, Caleb; Weidman, Jennifer R.; Xie, Xiaohui; Zody, Michael C.; Graves, Jennifer A. Marshall; Ponting, Chris P.; Breen, Matthew; Samollow, Paul B.; Lander, Eric S.; Lindblad-Toh, Kerstin		Broad Inst Genome Sequencing Platf; Broad Inst Whole Genome Assembly	Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences	NATURE			English	Review							X-CHROMOSOME INACTIVATION; SHORT-TAILED OPOSSUM; TRANSPOSABLE ELEMENTS; RECOMBINATION RATES; REGULATORY NETWORKS; MOBILE ELEMENTS; EVOLUTION; GENE; VERTEBRATE; MOUSE	We report a high-quality draft of the genome sequence of the grey, short-tailed opossum ( Monodelphis domestica). As the first metatherian ('marsupial') species to be sequenced, the opossum provides a unique perspective on the organization and evolution of mammalian genomes. Distinctive features of the opossum chromosomes provide support for recent theories about genome evolution and function, including a strong influence of biased gene conversion on nucleotide sequence composition, and a relationship between chromosomal characteristics and X chromosome inactivation. Comparison of opossum and eutherian genomes also reveals a sharp difference in evolutionary innovation between protein-coding and non-coding functional elements. True innovation in protein-coding genes seems to be relatively rare, with lineage-specific differences being largely due to diversification and rapid turnover in gene families involved in environmental interactions. In contrast, about 20% of eutherian conserved non-coding elements (CNEs) are recent inventions that postdate the divergence of Eutheria and Metatheria. A substantial proportion of these eutherian-specific CNEs arose from sequence inserted by transposable elements, pointing to transposons as a major creative force in the evolution of mammalian gene regulation.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Benaroya Res Inst Virginia Mason, Mol Genet Program, Seattle, WA 98101 USA; N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Genet Informat Res Inst, Mountain View, CA 94043 USA; Univ Oxford, MRC Funct Genet Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; Univ New Mexico, Ctr Evolutionary & Theoret Immunol, Dept Biol, Albuquerque, NM 87131 USA; Louisiana State Univ, Ctr Biomodular Multiscale Syst, Dept Biol Sci, Biol Computat & Visualizat Ctr, Baton Rouge, LA 70803 USA; Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15260 USA; Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Australian Natl Univ, Res Sch Biol Sci, ARC Ctr Kangaroo Genom, Canberra, ACT 2601, Australia; Yeshiva Univ Albert Einstein Coll Med, Dept Med Hematol & Mol Genet, Bronx, NY 10461 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z4S6, Canada; Childrens Hosp Pittsburgh, Res Ctr, Dept Pediat, Pittsburgh, PA 15213 USA; W Virginia Univ, Dept Biol, Morgantown, WV 26505 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; SW Fdn Biomed Res, SW Natl Primate Res Ctr, San Antonio, TX 78245 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27606 USA; Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Walter & Eliza Hall Institute; Wellcome Trust Sanger Institute; Benaroya Research Institute; Virginia Mason Medical Center; University of North Carolina; North Carolina State University; Stanford University; University of Oxford; University of New Mexico; Louisiana State University System; Louisiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Sydney; Duke University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Australian National University; Yeshiva University; Albert Einstein College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; Australian National University; John Curtin School of Medical Research; British Columbia Cancer Agency; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; West Virginia University; Texas Biomedical Research Institute; Texas Biomedical Research Institute; Harvard University; Massachusetts General Hospital; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindblad-Toh, K (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	tarjei@broad.mit.edu; lander@broad.mit.edu; kersli@broad.mit.edu	Pollock, David D/M-4740-2016; Gu, Wanjun/B-3998-2010; Ponting, Chris/AAV-2621-2021; Wakefield, Matthew J/A-7795-2008; Greally, John/AAF-9540-2019; Waters, Paul D/B-7871-2015; Graves, Jennifer A.M./A-1387-2008; Baker, Michelle/AAX-9171-2020; Oda, Mayumi/Z-2010-2019; Mahony, Shaun/C-5699-2014; Schein, Jacquie E/G-3674-2015; Papenfuss, Anthony T/C-6297-2008; Marra, Marco A/B-5987-2008; Wakefield, Matthew/X-7593-2019; Gu, Wanjun/P-5389-2019; Huttley, Gavin A/G-5169-2015; Deakin, Janine/A-1941-2008; Waters, Paul/D-1044-2009; Baker, Michelle L/C-9694-2013; Mikkelsen, Tarjei S/A-1306-2007; Speed, Terence P/B-8085-2009; Oda, Mayumi/AAU-4837-2020	Pollock, David D/0000-0002-7627-4214; Wakefield, Matthew J/0000-0001-6624-4698; Greally, John/0000-0001-6069-7960; Waters, Paul D/0000-0002-4689-8747; Baker, Michelle/0000-0002-7993-9971; Oda, Mayumi/0000-0001-5102-7076; Mahony, Shaun/0000-0002-2641-1807; Papenfuss, Anthony T/0000-0002-1102-8506; Marra, Marco A/0000-0001-7146-7175; Wakefield, Matthew/0000-0001-6624-4698; Gu, Wanjun/0000-0003-4501-0539; Huttley, Gavin A/0000-0001-7224-2074; Deakin, Janine/0000-0002-1259-3531; Baker, Michelle L/0000-0002-7993-9971; Mikkelsen, Tarjei S/0000-0002-8133-3135; Speed, Terence P/0000-0002-5403-7998; Falk, Jill/0000-0003-2910-9803; Heger, Andreas/0000-0001-7720-0447; Webber, Caleb/0000-0001-8063-7674; Grabherr, Manfred/0000-0001-8792-6508; Wade, Claire/0000-0003-3413-4771; Ray, David/0000-0002-3340-3987; Aken, Bronwen/0000-0002-3032-4095; Fazzari, Melissa/0000-0002-5674-3589; Xie, Xiaohui/0000-0002-5479-6345; Benos, Panayiotis/0000-0003-3172-3132; Belov, Katherine/0000-0002-9762-5554; Ponting, Chris/0000-0003-0202-7816; Cuff, James/0000-0003-0570-4106; Hore, Timothy/0000-0002-6735-225X; Nicol, Robert/0000-0003-1932-1392; Breen, Matthew/0000-0002-8901-4155; Graves, Jennifer/0000-0001-6480-7856; Miller, Robert/0000-0002-8479-8819	MRC [MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_U137761446] Funding Source: Medline; Wellcome Trust [062023] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey PJ, 2006, EXP CELL RES, V312, P3108, DOI 10.1016/j.yexcr.2006.06.017; Baker ML, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-50; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Belle EMS, 2004, J MOL EVOL, V58, P653, DOI 10.1007/s00239-004-2587-x; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; Belov K, 2007, GENOME RES, V17, P982, DOI 10.1101/gr.6121807; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Britten RJ, 1997, GENE, V205, P177, DOI 10.1016/S0378-1119(97)00399-5; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; CLAMP M, UNPUB NATURE; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper D.W., 1993, Seminars in Developmental Biology, V4, P117, DOI 10.1006/sedb.1993.1014; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Davidow LS, 2007, CHROMOSOME RES, V15, P137, DOI 10.1007/s10577-007-1121-6; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; Deakin JE, 2006, CYTOGENET GENOME RES, V114, p94H, DOI 10.1159/000091942; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Disteche CM, 2002, CYTOGENET GENOME RES, V99, P36, DOI 10.1159/000071572; Duke SE, 2007, CHROMOSOME RES, V15, P361, DOI 10.1007/s10577-007-1131-4; Dumas D, 2002, GENETICS, V162, P1355; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Duret L, 2006, GENE, V385, P71, DOI 10.1016/j.gene.2006.04.030; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goodstadt L, 2007, GENOME RES, V17, P969, DOI 10.1101/gr.6093907; Goodstadt L, 2006, PLOS COMPUT BIOL, V2, P1134, DOI 10.1371/journal.pcbi.0020133; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grus WE, 2005, P NATL ACAD SCI USA, V102, P5767, DOI 10.1073/pnas.0501589102; Gu W, 2007, GENE, V396, P46, DOI 10.1016/j.gene.2007.02.028; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HOLM P B, 1986, Tokai Journal of Experimental and Clinical Medicine, V11, P415; HOPE RM, 1993, GENETICA, V90, P165, DOI 10.1007/BF01435038; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KATO T, 1994, NUCLEIC ACIDS RES, V22, P4119, DOI 10.1093/nar/22.20.4119; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lyon MF, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/59746; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; MAHONY S, IN PRESS GENOME BIOL; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Marino-Ramirez L, 2005, CYTOGENET GENOME RES, V110, P333, DOI 10.1159/000084965; Michael MZ, 2003, MOL CANCER RES, V1, P882; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ovcharenko I, 2004, GENOMICS, V84, P890, DOI 10.1016/j.ygeno.2004.07.011; PARRA ZE, UNPUB P NATL ACAD SC; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Rens W, 2001, CHROMOSOME RES, V9, P301, DOI 10.1023/A:1016646629889; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Samollow PB, 2007, CHROMOSOME RES, V15, P269, DOI 10.1007/s10577-007-1123-4; Samollow PB, 2006, AUST J ZOOL, V54, P173, DOI 10.1071/ZO05059; Samollow PB, 2004, GENETICS, V166, P307, DOI 10.1534/genetics.166.1.307; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SHARP PJ, 1988, HEREDITY, V60, P77, DOI 10.1038/hdy.1988.12; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silva JC, 2003, GENET RES, V82, P1, DOI 10.1017/S0016672303006268; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; TYNDALEBISCOE H, 2005, LIFE MARSUPIALS, pNIL6; VANDEBERG JL, 1990, AUST J ZOOL, V37, P235, DOI 10.1071/ZO9890235; VANDEBERG JL, 1994, ARCH DERMATOL RES, V286, P12, DOI 10.1007/BF00375837; VANDEBERG JL, 1999, UFAW HDB MANAGEMENT, V1, P193; VandeBerg John L., 1997, ILAR J, V38, P4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wakefield MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-218; Wakefield MJ, 1997, P NATL ACAD SCI USA, V94, P9665, DOI 10.1073/pnas.94.18.9665; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Weidman JR, 2004, GENOME RES, V14, P1726, DOI 10.1101/gr.2774804; Wintzer M, 2004, J ANAT, V204, P3, DOI 10.1111/j.1469-7580.2004.00258.x; Wistow G, 2005, FEBS J, V272, P2276, DOI 10.1111/j.1742-4658.2005.04655.x; Wong Emily Sw, 2006, Immunome Res, V2, P4, DOI 10.1186/1745-7580-2-4; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xie XH, 2006, P NATL ACAD SCI USA, V103, P11659, DOI 10.1073/pnas.0604768103; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	109	539	558	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					167	U1		10.1038/nature05805	http://dx.doi.org/10.1038/nature05805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495919	Green Published, Bronze			2022-12-24	WOS:000246338700035
J	Auerbach, M; Ballard, H; Glaspy, J				Auerbach, Michael; Ballard, Harold; Glaspy, John			Clinical update: intravenous iron for anaemia	LANCET			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; DEXTRAN; INFUSION; HEPCIDIN; SUCROSE; SAFETY		Georgetown Univ, Sch Med, Baltimore, MD 21237 USA; NYU, Sch Med, New York Harbor Healthcare Syst, Dept Vet Affairs, New York, NY USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Georgetown University; New York University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Auerbach, M (corresponding author), Georgetown Univ, Sch Med, Baltimore, MD 21237 USA.	mauerbachmd@aol.com						Adamson JW, 1998, NEW ENGL J MED, V339, P625, DOI 10.1056/NEJM199808273390910; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Auerbach M, 2004, J CLIN ONCOL, V22, P1301, DOI 10.1200/JCO.2004.08.119; Auerbach M, 1998, AM J KIDNEY DIS, V31, P81, DOI 10.1053/ajkd.1998.v31.pm9428456; Auerbach M, 1998, J LAB CLIN MED, V131, P257, DOI 10.1016/S0022-2143(98)90098-1; AUERBACH M, 1988, J LAB CLIN MED, V111, P566; Chandler G, 2001, AM J KIDNEY DIS, V38, P988, DOI 10.1053/ajkd.2001.28587; Chertow GM, 2006, NEPHROL DIAL TRANSPL, V21, P378, DOI 10.1093/ndt/gfi253; Chertow GM, 2004, NEPHROL DIAL TRANSPL, V19, P1571, DOI 10.1093/ndt/gfh185; FISHBANE S, 1995, AM J KIDNEY DIS, V26, P41, DOI 10.1016/0272-6386(95)90151-5; Fishbane S, 1996, AM J KIDNEY DIS, V28, P529, DOI 10.1016/S0272-6386(96)90463-1; Fishbane S, 1999, KIDNEY INT, V55, pS67, DOI 10.1046/j.1523-1755.1999.055Suppl.69067.x; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; HAMSTRA RD, 1980, JAMA-J AM MED ASSOC, V243, P1726, DOI 10.1001/jama.243.17.1726; Hedenus M, 2007, LEUKEMIA, V21, P627, DOI 10.1038/sj.leu.2404562; Henry DH, 2007, ONCOLOGIST, V12, P231, DOI 10.1634/theoncologist.12-2-231; Kanakaraddi V P, 1973, J Assoc Physicians India, V21, P849; Macdougall IC, 2005, AM J KIDNEY DIS, V46, P283, DOI 10.1053/j.ajkd.2005.04.032; MACDOUGALL IC, 1992, BRIT MED J, V304, P225, DOI 10.1136/bmj.304.6821.225; Tessitore N, 2001, NEPHROL DIAL TRANSPL, V16, P1416, DOI 10.1093/ndt/16.7.1416	20	139	149	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1502	1504		10.1016/S0140-6736(07)60689-8	http://dx.doi.org/10.1016/S0140-6736(07)60689-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482969				2022-12-24	WOS:000246215800009
J	Lentink, D; Muller, UK; Stamhuis, EJ; de Kat, R; van Gestel, W; Veldhuis, LLM; Henningsson, P; Hedenstrom, A; Videler, JJ; van Leeuwen, JL				Lentink, D.; Muller, U. K.; Stamhuis, E. J.; de Kat, R.; van Gestel, W.; Veldhuis, L. L. M.; Henningsson, P.; Hedenstrom, A.; Videler, J. J.; van Leeuwen, J. L.			How swifts control their glide performance with morphing wings	NATURE			English	Article							BLACK VULTURE; APUS-APUS; FLIGHT; BIRDS; TUNNEL; AERODYNAMICS; ORIENTATION	Gliding birds continually change the shape and size of their wings(1-6), presumably to exploit the profound effect of wing morphology on aerodynamic performance(7-9). That birds should adjust wing sweep to suit glide speed has been predicted qualitatively by analytical glide models(2,10), which extrapolated the wing's performance envelope from aerodynamic theory. Here we describe the aerodynamic and structural performance of actual swift wings, as measured in a wind tunnel, and on this basis build a semiempirical glide model. By measuring inside and outside swifts' behavioural envelope, we show that choosing the most suitable sweep can halve sink speed or triple turning rate. Extended wings are superior for slow glides and turns; swept wings are superior for fast glides and turns. This superiority is due to better aerodynamic performance - with the exception of fast turns. Swept wings are less effective at generating lift while turning at high speeds, but can bear the extreme loads. Finally, our glide model predicts that cost-effective gliding occurs at speeds of 8 - 10 m s(-1), whereas agility-related figures of merit peak at 15 - 25 m s(-1). In fact, swifts spend the night ('roost') in flight at 8 - 10 m s(-1) ( ref. 11), thus our model can explain this choice for a resting behaviour(11,12). Morphing not only adjusts birds' wing performance to the task at hand, but could also control the flight of future aircraft(7).	Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands; Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands; Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden; Delft Univ Technol, Dept Aerosp Engn, NL-2629 HS Delft, Netherlands; Univ Groningen, Dept Marine Biol, NL-9750 AA Haren, Netherlands	Wageningen University & Research; Leiden University; Leiden University - Excl LUMC; Lund University; Delft University of Technology; University of Groningen	Lentink, D (corresponding author), Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	david.lentink@wur.nl	de Kat, Roeland/A-4874-2013; van Leeuwen, Johan L/B-7897-2011; Hedenström, Anders/F-5377-2010; van Leeuwen, Johan/N-3437-2019	de Kat, Roeland/0000-0002-6851-4409; Hedenström, Anders/0000-0002-1757-0945; van Leeuwen, Johan/0000-0002-4433-880X; Videler, John/0000-0003-1226-9528				Azuma A., 2006, BIOKINETICS FLYING S; Backman J, 2002, J EXP BIOL, V205, P905; Backman J, 2001, P ROY SOC B-BIOL SCI, V268, P1081, DOI 10.1098/rspb.2001.1622; Bird JD, 1969, D5045 NASA; BRUDERER B, 1972, Revue Suisse de Zoologie, V79, P1190; Glutz von Blozheim UN., 1980, HDB VOGEL MITTELEURO; Hedenstrom A, 2001, BEHAV ECOL, V12, P150, DOI 10.1093/beheco/12.2.150; Hoerner S.F, 1985, FLUID DYNAMIC LIFT; Lack D., 1956, SWIFTS TOWER; Muller UK, 2004, SCIENCE, V306, P1899, DOI 10.1126/science.1107070; NACHTIGALL W, 1979, Journal fuer Ornithologie, V120, P30, DOI 10.1007/BF01647339; NEWMAN BG, 1958, J EXP BIOL, V35, P280; PARROTT GC, 1970, J EXP BIOL, V53, P363; PENNYCUICK CJ, 1968, J EXP BIOL, V49, P509; PENNYCUICK CJ, 1987, J EXP BIOL, V128, P335; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; PENNYCUICK CJ, 1960, J EXP BIOL, V37, P330; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Rosen M, 2001, J EXP BIOL, V204, P1153; Ruijgrok G. J. J., 1994, ELEMENTS AIRPLANE PE; Schlichting H., 2017, BOUNDARY LAYER THEOR; Schmitz FW, 1942, AERODYNAMIK FLUGMODE; Thomas ALR, 1996, J THEOR BIOL, V183, P237, DOI 10.1006/jtbi.1996.0217; TUCKER VA, 1987, J EXP BIOL, V133, P33; TUCKER VA, 1970, J EXP BIOL, V52, P345; VELDHUIS LLM, 1993, 931 LSW DELFT U TECH; Videler JJ, 2004, SCIENCE, V306, P1960, DOI 10.1126/science.1104682; Vogel S, 1994, LIFE MOVING FLUIDS; Weiss P, 2003, SCI NEWS, V164, P359, DOI DOI 10.2307/4018925; WITHERS PC, 1981, J EXP BIOL, V90, P143	30	182	195	9	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1082	1085		10.1038/nature05733	http://dx.doi.org/10.1038/nature05733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460673				2022-12-24	WOS:000245950400050
J	Treasure, T; Utley, M; Hunt, I				Treasure, Tom; Utley, Martin; Hunt, Ian			When professional opinion is not enough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METASTASES		Guys Hosp, London SE1 9RT, England; UCL, Clin Operat Res Unit, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; University College London	Treasure, T (corresponding author), Guys Hosp, London SE1 9RT, England.			Utley, Martin/0000-0001-9928-1516				DIAMOND J, 2001, SNAKE OIL; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Inoue M, 2004, ANN THORAC SURG, V78, P238, DOI 10.1016/j.athoracsur.2004.02.017; National Institute for Clinical Excellence (NICE), 2004, IMPR OUTC COL CANC M; Nauenheim KS, 2007, DIFFICULT DECISIONS, P151; NICE, 2005, LUNG CANC DIAGN TREA; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Patel A, 2007, DIFFICULT DECISIONS, P158; Porter R., 1997, GREATEST BENEFIT MAN; Rena O, 2002, EUR J CARDIO-THORAC, V21, P906, DOI 10.1016/S1010-7940(02)00088-X; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	13	43	43	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2007	334	7598					831	832		10.1136/bmj.39161.403218.AD	http://dx.doi.org/10.1136/bmj.39161.403218.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446615	Green Published			2022-12-24	WOS:000246090800031
J	Kovaleva, EG; Lipscomb, JD				Kovaleva, Elena G.; Lipscomb, John D.			Crystal structures of Fe2+ dioxygenase superoxo, alkylperoxo, and bound product intermediates	SCIENCE			English	Article							ACTIVE-SITE FE-2+; CATECHOL 2,3-DIOXYGENASE; SUBSTRATE-BINDING; RING-CLEAVAGE; EXTRADIOL; ACTIVATION; MECHANISM; ENZYMES; COMPLEX	We report the structures of three intermediates in the O-2 activation and insertion reactions of an extradiol ring-cleaving dioxygenase. A crystal of Fe2+-containing homoprotocatechuate 2,3-dioxygenase was soaked in the slow substrate 4-nitrocatechol in a low O-2 atmosphere. The x-ray crystal structure shows that three different intermediates reside in different subunits of a single homotetrameric enzyme molecule. One of these is the key substrate-alkylperoxo-Fe2+ intermediate, which has been predicted, but not structurally characterized, in an oxygenase. The intermediates define the major chemical steps of the dioxygenase mechanism and point to a general mechanistic strategy for the diverse 2-His-1-carboxylate enzyme family.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lipscomb, JD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	lipsc001@umn.edu		Lipscomb, John/0000-0002-8158-5594	NIGMS NIH HHS [R01 GM024689-27, R01 GM024689, R37 GM024689, R37 GM024689-26, R01 GM024689-28, GM24689] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024689, R01GM024689] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCIERO DM, 1985, J BIOL CHEM, V260, P4035; ARCIERO DM, 1986, J BIOL CHEM, V261, P2170; Bugg TDH, 2001, CHEM COMMUN, P941, DOI 10.1039/b100484k; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Deeth RJ, 2003, J BIOL INORG CHEM, V8, P409, DOI 10.1007/s00775-002-0430-7; Groce SL, 2005, BIOCHEMISTRY-US, V44, P7175, DOI 10.1021/bi050180v; Groce SL, 2004, BIOCHEMISTRY-US, V43, P15141, DOI 10.1021/bi048690x; Hajdu J, 2000, NAT STRUCT BIOL, V7, P1006, DOI 10.1038/80911; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; HAYAISHI O, 1955, J AM CHEM SOC, V77, P5450, DOI 10.1021/ja01625a095; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Komatsuzaki H, 1998, INORG CHEM, V37, P6554, DOI 10.1021/ic980509j; LIPSCOMB JD, 1992, MET IONS BIOL SYST, V28, P243; Miller MA, 1996, J BIOL CHEM, V271, P5524, DOI 10.1074/jbc.271.10.5524; Sato N, 2002, J MOL BIOL, V321, P621, DOI 10.1016/S0022-2836(02)00673-3; Senda T, 1996, J MOL BIOL, V255, P735, DOI 10.1006/jmbi.1996.0060; SHU LJ, 1995, BIOCHEMISTRY-US, V34, P6649, DOI 10.1021/bi00020a010; Siegbahn PEM, 2004, J AM CHEM SOC, V126, P8919, DOI 10.1021/ja0493805; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200	24	287	290	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					453	457		10.1126/science.1134697	http://dx.doi.org/10.1126/science.1134697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446402	Green Accepted			2022-12-24	WOS:000245813400058
J	Hernandez, RD; Hubisz, MJ; Wheeler, DA; Smith, DG; Ferguson, B; Rogers, J; Nazareth, L; Indap, A; Bourquin, T; McPherson, J; Muzny, D; Gibbs, R; Nielsen, R; Bustamante, CD				Hernandez, Ryan D.; Hubisz, Melissa J.; Wheeler, David A.; Smith, David G.; Ferguson, Betsy; Rogers, Jeffrey; Nazareth, Lynne; Indap, Amit; Bourquin, Traci; McPherson, John; Muzny, Donna; Gibbs, Richard; Nielsen, Rasmus; Bustamante, Carlos D.			Demographic histories and patterns of linkage disequilibrium in Chinese and Indian rhesus macaques	SCIENCE			English	Article							MACACA-MULATTA; MITOCHONDRIAL-DNA; HUMAN GENOME; FREQUENCIES; ORIGIN; GENES; LOCI; MAP	To understand the demographic history of rhesus macaques ( Macaca mulatta) and document the extent of linkage disequilibrium (LD) in the genome, we partially resequenced five Encyclopedia of DNA Elements regions in 9 Chinese and 38 captive-born Indian rhesus macaques. Population genetic analyses of the 1467 single-nucleotide polymorphisms discovered suggest that the two populations separated about 162,000 years ago, with the Chinese population tripling in size since then and the Indian population eventually shrinking by a factor of four. Using coalescent simulations, we confirmed that these inferred demographic events explain a much faster decay of LD in Chinese (r(2) approximate to 0.15 at 10 kilobases) versus Indian (r(2) approximate to 0.52 at 10 kilobases) macaque populations.	Cornell Univ, Ithaca, NY 14850 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Dept Anthropol, Davis, CA USA; Calif Natl Primate Res Ctr, Davis, CA USA; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Genet Res & Informat Program, Beaverton, OR 97006 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; Univ Copenhagen, Dept Biol, Ctr Comparat Genom, DK-2100 Copenhagen O, Denmark	Cornell University; University of Chicago; Baylor College of Medicine; Oregon Health & Science University; Oregon National Primate Research Center; University of Washington; University of Washington Seattle; Texas Biomedical Research Institute; University of Copenhagen	Bustamante, CD (corresponding author), Cornell Univ, Ithaca, NY 14850 USA.	cdb28@cornell.edu	McPherson, John D/D-2633-2017; Nielsen, Rasmus/D-4405-2009; Wheeler, David A/M-9740-2018	McPherson, John D/0000-0001-8049-9347; Nielsen, Rasmus/0000-0003-0513-6591; Wheeler, David A/0000-0002-9056-6299; Bustamante, Carlos D./0000-0002-4187-7920; Indap, Amit/0000-0002-3322-4735; Hubisz, Melissa/0000-0002-9561-6830	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, R24RR015383, R24RR005090] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abegg C, 2002, BIOL J LINN SOC, V75, P555, DOI 10.1046/j.1095-8312.2002.00045.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; DEISON E, 1980, MACAQUES STUDIES ECO, P10; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Falush D, 2003, GENETICS, V164, P1567; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Fooden J., 1980, P1; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hayasaka K, 1996, MOL BIOL EVOL, V13, P1044, DOI 10.1093/oxfordjournals.molbev.a025655; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Morales JC, 1998, J HUM EVOL, V34, P1, DOI 10.1006/jhev.1997.0171; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raveendran M, 2006, GENOMICS, V88, P706, DOI 10.1016/j.ygeno.2006.08.009; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Smith DG, 2005, AM J PRIMATOL, V65, P1, DOI 10.1002/ajp.20094; Viray J, 2001, COMPARATIVE MED, V51, P555; Weiss RA, 2001, NATURE, V410, P1035, DOI 10.1038/35074222	19	133	136	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					240	243		10.1126/science.1140462	http://dx.doi.org/10.1126/science.1140462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431170				2022-12-24	WOS:000245654500040
J	Lo, JC; Wang, YG; Tumanov, AV; Bamji, M; Yao, ZM; Reardon, CA; Getz, GS; Fu, YX				Lo, James C.; Wang, Yugang; Tumanov, Alexei V.; Bamji, Michelle; Yao, Zemin; Reardon, Catherine A.; Getz, Godfrey S.; Fu, Yang-Xin			Lymphotoxin beta receptor-dependent control of lipid homeostasis	SCIENCE			English	Article							HEPATIC LIPASE; LIPOPROTEIN METABOLISM; ATHEROSCLEROSIS; INFLAMMATION; LIGHT; MICE; MECHANISMS; DISEASE; ALPHA; TNF	Hyperlipidemia, one of the most important risk factors for coronary heart disease, is often associated with inflammation. We identified lymphotoxin ( LT) and LIGHT, tumor necrosis factor cytokine family members that are primarily expressed on lymphocytes, as critical regulators of key enzymes that control lipid metabolism. Dysregulation of LIGHT expression on T cells resulted in hypertriglyceridemia and hypercholesterolemia. In low-density lipoprotein receptor-deficient mice, which lack the ability to control lipid levels in the blood, inhibition of LT and LIGHT signaling with a soluble lymphotoxin beta receptor decoy protein attenuated the dyslipidemia. These results suggest that the immune system directly influences lipid metabolism and that LT modulating agents may represent a novel therapeutic route for the treatment of dyslipidemia.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Ottawa, Inst Heart, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Chicago; University of Chicago; University of Ottawa; University of Ottawa Heart Institute	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	getz@bsd.uchicago.edu; yfu@uchicago.edu	Tumanov, Alexei/AAR-1607-2021; Lo, James/GYR-1149-2022	Tumanov, Alexei/0000-0001-6042-0152; Lo, James/0000-0003-0244-1670; fu, yang-xin/0000-0001-8441-6617	NATIONAL CANCER INSTITUTE [P01CA097296] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Barcat D, 2006, ATHEROSCLEROSIS, V188, P347, DOI 10.1016/j.atherosclerosis.2005.11.022; Dichek HL, 2001, J LIPID RES, V42, P201; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Reardon CA, 2003, ARTERIOSCL THROM VAS, V23, P1449, DOI 10.1161/01.ATV.0000079793.58054.2E; Reardon CA, 2001, CURR OPIN LIPIDOL, V12, P167, DOI 10.1097/00041433-200104000-00010; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; Shaikh RB, 2001, J IMMUNOL, V167, P6330, DOI 10.4049/jimmunol.167.11.6330; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719	18	113	119	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					285	288		10.1126/science.1137221	http://dx.doi.org/10.1126/science.1137221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431181				2022-12-24	WOS:000245654500053
J	Bennett, J				Bennett, Jean			Retinal progenitor cells - Timing is everything	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION		Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Bennett, J (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.							Humayun MS, 2000, INVEST OPHTH VIS SCI, V41, P3100; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; O'Brien KMB, 2003, MOL VIS, V9, P401; 2006, US ADULTS DIABETES F	5	12	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1577	1579		10.1056/NEJMcibr070209	http://dx.doi.org/10.1056/NEJMcibr070209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429090				2022-12-24	WOS:000245624400014
J	Cui, RT; Widlund, HR; Feige, E; Lin, JY; Wilensky, DL; Igras, VE; D'Orazio, J; Fung, CY; Schanbacher, CF; Granter, SR; Fisher, DE				Cui, Rutao; Widlund, Hans R.; Feige, Erez; Lin, Jennifer Y.; Wilensky, Dara L.; Igras, Viven E.; D'Orazio, John; Fung, Claire Y.; Schanbacher, Carl F.; Granter, Scott R.; Fisher, David E.			Central role of p53 in the suntan response and pathologic hyperpigmentation	CELL			English	Article							PROOPIOMELANOCORTIN GENE-EXPRESSION; MICROPHTHALMIA TRANSCRIPTION FACTOR; SQUAMOUS-CELL CARCINOMA; PLASMA BETA-ENDORPHIN; SKIN-CANCER; DNA-DAMAGE; MELANOCORTIN-1 RECEPTOR; ULTRAVIOLET-B; HUMAN MELANOCYTES; SV40-TRANSFORMED CELLS	UV-induced Pigmentation (suntanning) requires induction of a-melanocyte-stimulating hormone (alpha-MSH) secretion by keratinocytes- alpha-MSH and other bioactive pepticles are cleavage products Of pro-opiomelanocortin (POMC). Here we Provide biochemical and genetic evidence demonstrating that UV induction of POMC/MSH in skin is directly controlled by p53. Whereas p53 potently stimulates the POMC promoter in response to UV, the absence of p53, as in knockout mice, is associated with absence of the UV-tanning response. The same pathway produces beta-endorphin, another POMC derivative, which potentially contributes to sun-seeking behaviors. Furthermore, several instances of UV-independent pathologic Pigmentation are shown to involve p53 "mimicking" the tanning response. P53 thus functions as a sensor/effector for UV Pigmentation, which is a nearly constant environmental exposure. Moreover, this pathway is activated in numerous conditions of pathologic pigmentation and thus mimics the tanning response.	Harvard Univ, Sch Med, Melanoma Program Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat Hematol Oncol, Dana Farber Canc Inst,Childrens Hosp Boston, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fisher, DE (corresponding author), Harvard Univ, Sch Med, Melanoma Program Med Oncol, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	david_fisher@dfci.harvard.edu	Schanbacher, Carl/AAF-7641-2019	Widlund, Hans/0000-0002-7506-2447; Cui, Rutao/0000-0002-4377-9988				Abdel-Malek Z, 2000, PIGM CELL RES, V13, P156, DOI 10.1034/j.1600-0749.13.s8.28.x; Ananthaswamy HN, 1997, NAT MED, V3, P510, DOI 10.1038/nm0597-510; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; Barsh G, 2000, PIGM CELL RES, V13, P48, DOI 10.1034/j.1600-0749.13.s8.10.x; Bayerl C, 1995, PHOTODERMATOL PHOTO, V11, P149, DOI 10.1111/j.1600-0781.1995.tb00157.x; BLEEHEN SS, 1975, BRIT J DERMATOL, V93, P361, DOI 10.1111/j.1365-2133.1975.tb06509.x; BOUTILLIER AL, 1991, MOL ENDOCRINOL, V5, P1301, DOI 10.1210/mend-5-9-1301; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Bykov VJ, 2000, J INVEST DERMATOL, V114, P40, DOI 10.1046/j.1523-1747.2000.00821.x; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Commission Internationale de l'Eclairage (CIE), 1998, 007E1998 CIE S; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Cui RT, 2005, J BIOL CHEM, V280, P39152, DOI 10.1074/jbc.M504655200; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Diffey BL, 1997, PHOTODERMATOL PHOTO, V13, P64, DOI 10.1111/j.1600-0781.1997.tb00110.x; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dunham WR, 1996, J INVEST DERMATOL, V107, P332, DOI 10.1111/1523-1747.ep12363174; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELLER MS, 1994, NATURE, V372, P413, DOI 10.1038/372413a0; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FITZPATRICK TB, 1985, NEW ENGL J MED, V313, P818, DOI 10.1056/NEJM198509263131310; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; FRIEDMANN PS, 1987, J CELL PHYSIOL, V133, P88, DOI 10.1002/jcp.1041330111; Gambichler T, 2002, BRIT J DERMATOL, V147, P1207, DOI 10.1046/j.1365-2133.2002.04859.x; Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x; Gottifredi V, 2000, COLD SPRING HARB SYM, V65, P483, DOI 10.1101/sqb.2000.65.483; Goukassian DA, 1999, J INVEST DERMATOL, V112, P25, DOI 10.1046/j.1523-1747.1999.00468.x; Granter SR, 2002, APPL IMMUNOHISTO M M, V10, P47, DOI 10.1097/00022744-200203000-00008; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Holick MF, 2001, LANCET, V357, P4, DOI 10.1016/S0140-6736(00)03560-1; Horikawa T, 1996, PIGM CELL RES, V9, P58, DOI 10.1111/j.1600-0749.1996.tb00089.x; Im SB, 1998, CANCER RES, V58, P47; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; IYENGAR B, 1994, MELANOMA RES, V4, P293; Kadekaro AL, 2003, ANN NY ACAD SCI, V994, P359, DOI 10.1111/j.1749-6632.2003.tb03200.x; Karalis KP, 2004, J BIOL CHEM, V279, P10837, DOI 10.1074/jbc.M313063200; KASTAN MB, 1991, CANCER RES, V51, P6304; Kaur M, 2006, J AM ACAD DERMATOL, V54, P919, DOI 10.1016/j.jaad.2006.01.062; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Khlgatian MK, 2002, J INVEST DERMATOL, V118, P126, DOI 10.1046/j.0022-202x.2001.01667.x; Kichina J, 1996, PIGM CELL RES, V9, P85, DOI 10.1111/j.1600-0749.1996.tb00094.x; King R, 1999, AM J PATHOL, V155, P731, DOI 10.1016/S0002-9440(10)65172-3; Kippenberger S, 1996, PIGM CELL RES, V9, P179, DOI 10.1111/j.1600-0749.1996.tb00107.x; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; LEVINS PC, 1983, LANCET, V2, P166; Li G, 1998, J INVEST DERMATOL, V110, P72, DOI 10.1046/j.1523-1747.1998.00090.x; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LUBBE J, 1994, J INVEST DERMATOL, V102, P819, DOI 10.1111/1523-1747.ep12381544; LUNEC J, 1990, PATHOBIOLOGY, V58, P193, DOI 10.1159/000163583; MARCELO CL, 1978, J CELL BIOL, V79, P356, DOI 10.1083/jcb.79.2.356; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Newell-Price J, 2003, J ENDOCRINOL, V177, P365, DOI 10.1677/joe.0.1770365; NORDLUND JJ, 1986, J INVEST DERMATOL, V86, P433, DOI 10.1111/1523-1747.ep12285717; PATHAK MA, 1983, J AM ACAD DERMATOL, V9, P724, DOI 10.1016/S0190-9622(83)70186-6; *PDR STAFF, 2005, PHYS DESK REF, P3267; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Picon A, 1999, ONCOGENE, V18, P2627, DOI 10.1038/sj.onc.1202635; PICON A, 1995, J MOL ENDOCRINOL, V15, P187, DOI 10.1677/jme.0.0150187; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Sturm RA, 1998, MUTAT RES-FUND MOL M, V422, P69, DOI 10.1016/S0027-5107(98)00176-6; Suzuki I, 1999, J INVEST DERM SYMP P, V4, P29, DOI 10.1038/sj.jidsp.5640177; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wintzen M, 1996, J INVEST DERMATOL, V106, P673, DOI 10.1111/1523-1747.ep12345496; Wintzen M, 2001, EXP DERMATOL, V10, P305, DOI 10.1034/j.1600-0625.2001.100502.x; Zanello SB, 1999, ANN NY ACAD SCI, V885, P85; Zhang H, 2001, AM J PATHOL, V158, P381, DOI 10.1016/S0002-9440(10)63980-6; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	85	421	438	6	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					853	864		10.1016/j.cell.2006.12.045	http://dx.doi.org/10.1016/j.cell.2006.12.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350573	Bronze			2022-12-24	WOS:000245073400011
J	Piccart, M; Goldhirsch, A				Piccart, Martine; Goldhirsch, Aron			Keeping faith with trial volunteers	NATURE			English	Editorial Material							POSTMENOPAUSAL WOMEN; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; LETROZOLE		European Breast Canc Coalit, Milan, Italy; Int Breast Canc Study Grp, Bern, Switzerland	International Breast Cancer Study Group								Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; ANGELL M, 2006, NEW YORK REV BOOKS, V53; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Drazen JM, 2002, NEW ENGL J MED, V347, P1362, DOI 10.1056/NEJMe020122; GILPIN K, 2004, NY TIMES        0602; Giordano SH, 2006, J CLIN ONCOL, V24, P2750, DOI 10.1200/JCO.2005.02.3028; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Mello MM, 2005, NEW ENGL J MED, V352, P2202, DOI 10.1056/NEJMsa044115; *NIH, 2000, ADJ THER BREAST CANC; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Regan MM, 2005, BREAST, V14, P582, DOI 10.1016/j.breast.2005.08.021; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; World Medical Association, DECL HELS	13	19	21	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					137	138		10.1038/446137a	http://dx.doi.org/10.1038/446137a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143JS	17344833				2022-12-24	WOS:000244718100021
J	Thermann, R; Hentze, MW				Thermann, Rolf; Hentze, Matthias W.			Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation	NATURE			English	Article							MESSENGER-RNA DEGRADATION; HUMAN-CELLS; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS; MICRORNA TARGETS; IDENTIFICATION; MECHANISM; REPRESS; BODIES; GENES	MicroRNAs (miRs) inhibit protein synthesis by mechanisms that are as yet unresolved(1-11). We developed a cell-free system from Drosophila melanogaster embryos that faithfully recapitulates miR2-mediated translational control by means of the 39 untranslated region of the D. melanogaster reaper messenger RNA. Here we show that miR2 inhibits translation initiation without affecting mRNA stability. Surprisingly, miR2 induces the formation of dense ( heavier than 80S) miRNPs ('pseudo-polysomes') even when polyribosome formation and 60S ribosomal subunit joining are blocked. An mRNA bearing an ApppG instead of anm(7) GpppG cap structure escapes the miR2-mediated translational block. These results directly show the inhibition of m(7) GpppG cap-mediated translation initiation as the mechanism of miR2 function, and uncover pseudo-polysomal messenger ribonucleoprotein assemblies that may help to explain earlier findings.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de	Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; HERSHEY JWB, 1966, J MOL BIOL, V18, P68, DOI 10.1016/S0022-2836(66)80077-3; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	29	239	248	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					875	878		10.1038/nature05878	http://dx.doi.org/10.1038/nature05878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17507927				2022-12-24	WOS:000247207500048
J	Serrano, M				Serrano, Manuel			Cancer regression by senescence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							P53 RESTORATION		Spanish Natl Canc Res Ctr, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr, Madrid, Spain.		Serrano, Manuel/H-2634-2015	Serrano, Manuel/0000-0001-7177-9312				Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	4	35	35	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1996	1997		10.1056/NEJMcibr071461	http://dx.doi.org/10.1056/NEJMcibr071461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494935				2022-12-24	WOS:000246305500015
J	Mant, D; Mayon-White, R				Mant, David; Mayon-White, Richard			Tuberculosis: think globally and act locally	LANCET			English	Editorial Material									Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; Directorate Publ Hlth & Hlth Policy, Oxford, England	University of Oxford; University of Oxford	Mant, D (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	David.mant@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009					Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; *HLTH PROT AG, 2005, ANN REP TUB CAS REP; *HLTH PROT AG, 2006, FOC TUB ANN SURV REP; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; *NAT STAT, FOC PEOPL MIGR; *NIH CLIN EXC, 2006, TUB CLIN DIAGN MAN T; Ormerod P, 2000, THORAX, V55, P887; WHO, 2006, WHO REP 2006 GLOB TU; WOODBRIDGE J, SIZING UNAUTHORISED	10	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1493	1494		10.1016/S0140-6736(07)60684-9	http://dx.doi.org/10.1016/S0140-6736(07)60684-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164EI	17482964				2022-12-24	WOS:000246215800004
J	Purohit, P; Mitra, A; Auerbach, A				Purohit, Prasad; Mitra, Ananya; Auerbach, Anthony			A stepwise mechanism for acetylcholine receptor channel gating	NATURE			English	Article							CYS-LOOP RECEPTOR; GATED ION-CHANNEL; TRANSITION-STATE; ALPHA-SUBUNIT; M2 SEGMENT; TRANSMEMBRANE SEGMENT; NICOTINIC RECEPTORS; PORE; DYNAMICS; RESIDUES	Muscle contraction is triggered by the opening of acetylcholine receptors at the vertebrate nerve - muscle synapse(1-4). The M2 helix of this allosteric membrane protein lines the channel, and contains a 'gate' that regulates the flow of ions through the pore. We used single-molecule kinetic analysis to probe the transition state of the gating conformational change and estimate the relative timing of M2 motions in the alpha-subunit of the murine acetylcholine receptor(5). This analysis produces a 'Phi-value' for a given residue that reflects its open-like versus closed-like character at the transition state. Here we show that most of the residues throughout the length of M2 have a Phi-value of similar to 0.64 but that some near the middle have lower Phi-values of 0.52 or 0.31, suggesting that alpha M2 moves in three discrete steps. The core of the channel serves both as a gate that regulates ion flow and as a hub that directs the propagation of the gating isomerization through the membrane domain of the acetylcholine receptor.	SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Auerbach, A (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	auerbach@buffalo.edu						AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; BALI M, IN PRESS J GEN PHYSL; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; CADUGAN DJ, IN PRESS BIOPHYS J; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Edelstein SJ, 1998, ADV PROTEIN CHEM, V51, P121; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Leffler J. E., 1963, RATES EQUILIBRIA ORG; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	29	119	121	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					930	933		10.1038/nature05721	http://dx.doi.org/10.1038/nature05721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443187				2022-12-24	WOS:000245785700046
J	Lerdau, M				Lerdau, Manuel			A positive feedback with negative consequences	SCIENCE			English	Editorial Material							ORGANIC-COMPOUND EMISSIONS; ISOPRENE EMISSION; BIOGENIC ISOPRENE; FOREST; LEAVES; PLANTS; PATHWAY		Univ Virginia, Dept Environm Sci, Blandy Expt Farm, Charlottesville, VA 22904 USA	University of Virginia	Lerdau, M (corresponding author), Univ Virginia, Dept Environm Sci, Blandy Expt Farm, Charlottesville, VA 22904 USA.	mlerdau@virginia.edu	Lerdau, Manuel/E-7320-2011	Lerdau, Manuel/0000-0003-1864-0834				Fiore AM, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005485; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; Geron C, 2002, ATMOS ENVIRON, V36, P3793, DOI 10.1016/S1352-2310(02)00301-1; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Horowitz LW, 1999, J GEOPHYS RES-ATMOS, V104, P23823, DOI 10.1029/1999JD900205; Keller M, 1999, GLOBAL BIOGEOCHEM CY, V13, P19, DOI 10.1029/1998GB900007; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Loreto F, 2007, PLANT PHYSIOL, V143, P1096, DOI 10.1104/pp.106.091892; MONSON RK, 1995, ATMOS ENVIRON, V29, P2989, DOI 10.1016/1352-2310(94)00360-W; RASMUSSEN RA, 1970, ENVIRON SCI TECHNOL, V4, P667, DOI 10.1021/es60043a008; Sanadze GA, 2004, RUSS J PLANT PHYSL+, V51, P729, DOI 10.1023/B:RUPP.0000047821.63354.a4; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; SHARKEY TD, 1995, NATURE, V374, P769, DOI 10.1038/374769a0; Velikova V, 2005, PLANT CELL ENVIRON, V28, P318, DOI 10.1111/j.1365-3040.2004.01314.x; Wiedinmyer C, 2006, EARTH INTERACT, V10, DOI 10.1175/EI174.1	17	48	52	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					212	213		10.1126/science.1141486	http://dx.doi.org/10.1126/science.1141486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156MV	17431162				2022-12-24	WOS:000245654500032
J	Schweitzer, MH; Suo, Z; Avci, R; Asara, JM; Allen, MA; Arce, FT; Horner, JR				Schweitzer, Mary Higby; Suo, Zhiyong; Avci, Recep; Asara, John M.; Allen, Mark A.; Arce, Fernando Teran; Horner, John R.			Analyses of soft tissue from Tyrannosaurus rex suggest the presence of protein	SCIENCE			English	Article							FOSSIL BONES; CELLULAR PRESERVATION; ANCIENT DNA; COLLAGEN; STABILIZATION; EXTRACTION; MATRIX; IRON	We performed multiple analyses of Tyrannosaurus rex ( specimen MOR 1125) fibrous cortical and medullary tissues remaining after demineralization. The results indicate that collagen I, the main organic component of bone, has been preserved in low concentrations in these tissues. The findings were independently confirmed by mass spectrometry. We propose a possible chemical pathway that may contribute to this preservation. The presence of endogenous protein in dinosaur bone may validate hypotheses about evolutionary relationships, rates, and patterns of molecular change and degradation, as well as the chemical stability of molecules over time.	N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; N Carolina Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; Montana State Univ, Image & Chem Anal Lab Facil, Dept Phys, Bozeman, MT 59717 USA; Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; Univ Chicago, Ctr Nanomed Pulm & Crit Care Med, Dept Med, Chicago, IL 60637 USA	University of North Carolina; North Carolina State University; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Montana State University System; Montana State University Bozeman; University of Chicago	Schweitzer, MH (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Box 8208, Raleigh, NC 27695 USA.	schweitzer@ncsu.edu	schweitzer, mary h/A-6756-2010; Schweitzer, Mary/V-8143-2019; Teran Arce, Fernando/I-7835-2018; Allen, Mark/K-8070-2018	schweitzer, mary h/0000-0002-0427-3829; Teran Arce, Fernando/0000-0002-6518-8695; Allen, Mark/0000-0002-1825-0118				Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Avci R, 2005, LANGMUIR, V21, P3584, DOI 10.1021/la047682e; Bada JL, 1999, PHILOS T ROY SOC B, V354, P77, DOI 10.1098/rstb.1999.0361; Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200; Berna F, 2004, J ARCHAEOL SCI, V31, P867, DOI 10.1016/j.jas.2003.12.003; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 2000, PALEOBIOLOGY, V26, P169, DOI 10.1666/0094-8373(2000)26[169:TBPOCF]2.0.CO;2; DENIRO MJ, 1988, GEOCHIM COSMOCHIM AC, V52, P2415, DOI 10.1016/0016-7037(88)90298-0; EGLINTON G, 1991, PHILOS T ROY SOC B, V333, P315, DOI 10.1098/rstb.1991.0081; GLIMCHER MJ, 1990, PALEOBIOLOGY, V16, P219, DOI 10.1017/S0094837300009891; Gotliv BA, 2006, J STRUCT BIOL, V156, P320, DOI 10.1016/j.jsb.2006.02.005; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; Holtz Thomas R. Jr, 2000, Gaia (Lisboa), V15, P5; Hoss M, 2000, NATURE, V404, P453, DOI 10.1038/35006551; HUGHES JM, 1989, AM MINERAL, V74, P870; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; LINDAHL T, 1993, NATURE, V365, P700, DOI 10.1038/365700a0; MINDENKA P, 2006, FREE RADICAL RES, V40, P263; MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X; NEMETHY G, 1986, BIOCHEMISTRY-US, V25, P3184, DOI 10.1021/bi00359a016; Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Schafer FQ, 2000, CELL MOL BIOL, V46, P657; Schmidt-Schultz TH, 2004, AM J PHYS ANTHROPOL, V123, P30, DOI 10.1002/ajpa.10308; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; SEMAL P, 1995, J ARCHAEOL SCI, V22, P463, DOI 10.1006/jasc.1995.0045; Stankiewicz BA, 2000, GEOLOGY, V28, P559, DOI 10.1130/0091-7613(2000)28<559:AOOAPI>2.0.CO;2; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; TUROSS N, 1993, METHOD ENZYMOL, V224, P121, DOI 10.1016/0076-6879(93)24010-R; VANDERREST M, 1991, BONE BONE MATRIX BON, V3, P187; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Zylberberg L, 2004, CR PALEVOL, V3, P591, DOI 10.1016/j.crpv.2004.07.012	36	126	132	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					277	280		10.1126/science.1138709	http://dx.doi.org/10.1126/science.1138709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431179				2022-12-24	WOS:000245654500051
J	Benito-Leon, J; Louis, ED				Benito-Leon, Julian; Louis, Elan D.			Clinical update: diagnosis and treatment of essential tremor	LANCET			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PROPRANOLOL; PRIMIDONE; STIMULATION		Univ Hosp 12 Octubre, Dept Neurol, E-28041 Madrid, Spain; Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Hospital Universitario 12 de Octubre; Columbia University; Columbia University	Benito-Leon, J (corresponding author), Univ Hosp 12 Octubre, Dept Neurol, E-28041 Madrid, Spain.	jbenitol@meditex.es	Benito-León, Julián/AAA-1331-2019	Benito-León, Julián/0000-0002-1769-4809				Benito-Leon J, 2006, NEUROLOGY, V66, P69, DOI 10.1212/01.wnl.0000192393.05850.ec; Benito-Leon J, 2006, NAT CLIN PRACT NEURO, V2, P666, DOI 10.1038/ncpneuro0347; Brin MF, 2001, NEUROLOGY, V56, P1523, DOI 10.1212/WNL.56.11.1523; CLEEVES L, 1988, J NEUROL NEUROSUR PS, V51, P379, DOI 10.1136/jnnp.51.3.379; FINDLEY LJ, 1985, J NEUROL NEUROSUR PS, V48, P911, DOI 10.1136/jnnp.48.9.911; GORMAN WP, 1986, J NEUROL NEUROSUR PS, V49, P64, DOI 10.1136/jnnp.49.1.64; HUBER SJ, 1988, NEUROLOGY, V38, P241, DOI 10.1212/WNL.38.2.241; Jain S, 2006, ARCH NEUROL-CHICAGO, V63, P1100, DOI 10.1001/archneur.63.8.1100; KOLLER WC, 1989, NEUROLOGY, V39, P1587, DOI 10.1212/WNL.39.12.1587; LEIGH PN, 1983, J NEUROL NEUROSUR PS, V46, P710, DOI 10.1136/jnnp.46.8.710; Lorenz D, 2006, MOVEMENT DISORD, V21, P1114, DOI 10.1002/mds.20884; Ondo W, 2000, MOVEMENT DISORD, V15, P678, DOI 10.1002/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0; Ondo WG, 2006, NEUROLOGY, V66, P672, DOI 10.1212/01.wnl.0000200779.03748.0f; Pahwa R, 2006, J NEUROSURG, V104, P506, DOI 10.3171/jns.2006.104.4.506; Putzke JD, 2006, J NEUROL NEUROSUR PS, V77, P1235, DOI 10.1136/jnnp.2006.086579; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Shahed J, 2007, PARKINSONISM RELAT D, V13, P67, DOI 10.1016/j.parkreldis.2006.05.033; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD	18	83	85	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1152	1154		10.1016/S0140-6736(07)60544-3	http://dx.doi.org/10.1016/S0140-6736(07)60544-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416247				2022-12-24	WOS:000245595100010
J	Bianchi, DW; Fisk, NM				Bianchi, Diana W.; Fisk, Nicholas M.			Fetomaternal cell trafficking and the stem cell debate - Gender matters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONINVASIVE PRENATAL-DIAGNOSIS; FETAL MICROCHIMERISM; PROGENITOR CELLS; MATERNAL BLOOD; BONE-MARROW; PREGNANCY; WOMEN; LONG; TRANSPLANTATION; POSTPARTUM		Tufts Univ New England Med Ctr, Dept Pediat, Div Genet, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Obstet, Div Genet, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Gynecol, Div Genet, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; Queen Charlottes & Chelsea Hosp, London W6 0XG, England	Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Tufts University; Imperial College London; Imperial College London	Bianchi, DW (corresponding author), Tufts Univ New England Med Ctr, Dept Pediat, Div Genet, 750 Washington St,Box 394, Boston, MA 02111 USA.	Dbianchi@tufts-nemc.org	Fisk, Nicholas M/B-2126-2009	Fisk, Nicholas M/0000-0003-0031-7975	Medical Research Council [G0300340] Funding Source: Medline; NICHD NIH HHS [R01HD49469] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049469] Funding Source: NIH RePORTER; MRC [G0300340] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams KM, 2003, BLOOD, V102, P3845, DOI 10.1182/blood-2003-05-1570; Bianchi DW, 2001, AM J OBSTET GYNECOL, V184, P703, DOI 10.1067/mob.2001.111072; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Christner PJ, 2000, ARTHRITIS RHEUM, V43, P2598, DOI 10.1002/1529-0131(200011)43:11<2598::AID-ANR30>3.0.CO;2-8; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Guetta E, 2003, BLOOD CELL MOL DIS, V30, P13, DOI 10.1016/S1079-9796(03)00008-1; Imaizumi M, 2002, ENDOCRINOLOGY, V143, P247, DOI 10.1210/en.143.1.247; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnson KL, 2001, ARTHRITIS RHEUM, V44, P2107, DOI 10.1002/1529-0131(200109)44:9<2107::AID-ART361>3.0.CO;2-9; Johnson KL, 2002, HEPATOLOGY, V36, P1295, DOI 10.1053/jhep.2002.35622; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Khosrotehrani K, 2003, ARTHRITIS RHEUM, V48, P3237, DOI 10.1002/art.11324; Klintschar M, 2006, EUR J ENDOCRINOL, V154, P237, DOI 10.1530/eje.1.02080; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; LIEGEOIS A, 1977, TRANSPLANT P, V9, P273; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; O'Donoghue K, 2003, MOL HUM REPROD, V9, P497, DOI 10.1093/molehr/gag063; Ohtsuka T, 2001, ARCH DERMATOL RES, V293, P387, DOI 10.1007/s004030100245; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Stevens AM, 2004, LAB INVEST, V84, P1603, DOI 10.1038/labinvest.3700193; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Tokita K, 2001, LANCET, V358, P2047, DOI 10.1016/S0140-6736(01)07140-9; Wang Y, 2004, BIOCHEM BIOPH RES CO, V325, P961, DOI 10.1016/j.bbrc.2004.10.105; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037	25	25	26	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1489	1491		10.1001/jama.297.13.1489	http://dx.doi.org/10.1001/jama.297.13.1489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405974				2022-12-24	WOS:000245404100025
J	Hsieh, MM; Everhart, JE; Byrd-Holt, DD; Tisdale, JF; Rodgers, GP				Hsieh, Matthew M.; Everhart, James E.; Byrd-Holt, Danita D.; Tisdale, John F.; Rodgers, Griffin P.			Prevalence of neutropenia in the US population: Age, sex, smoking status, and ethnic differences	ANNALS OF INTERNAL MEDICINE			English	Article							BENIGN IDIOPATHIC NEUTROPENIA; FAMILIAL LEUKOPENIA; LEUKOCYTE COUNTS; INFECTION; MARROW; WHITE; BLACK; NEGROES; CELL	Background: Benign reductions in neutrophil counts may be more common at certain ages and in certain ethnic groups and may be affected by sex and smoking status. Objective: To determine differences in neutrophil counts in the U.S. population according to ethnicity, age, sex, and smoking status. Design: Population-based, cross-sectional study. Setting: Various locations in the United States. Participants: 25 222 participants in the 1999 to 2004 National Health and Nutrition Examination Survey who were 1 year of age or older. Measurements: Complete blood counts and comparison of means and the proportion of participants with neutropenia. Results: Relative to white participants, black participants had lower leukocyte counts (mean difference, 0.89 x 10(9) cells/L; P < 0.001), lower neutrophil counts (0.83 x 10(9) cells/L; P < 0.001), and similar lymphocyte counts (0.022 x 10(9) cells/L; P = 0.36), whereas Mexican-American participants had slightly higher mean leukocyte counts (0.16 x 10(9) cells/L; P = 0.014), higher neutrophil counts (0.11 x 10(9) cells/L; P = 0.026), and higher lymphocyte counts (0.095 x 10(9) cells/L; P < 0.001). The prevalence of neutropenia (neutrophil count < 1.5 x 10(9) cells/L) was 4.5% among black participants, 0.79% among white participants, and 0.38% among Mexican-American participants. The prevalence of neutropenia was higher among males and children younger than 5 years of age. Neutrophil counts less than 1.0 x 10(9) cells/L were observed in fewer than 1% of the overall sample (0.57% in black participants, 0.11% in white participants, and 0.08% in Mexican-American participants). Smoking was associated with higher leukocyte and neutrophil counts but had a smaller effect among black and Mexican-American participants than among white participants. Limitation: Because estimates are based on single measures, fluctuations over time could not be determined. Conclusions: In the United States, neutrophil counts are lower in black persons than in white persons and neutropenia is more prevalent in black persons. Neutrophil counts are slightly higher in Mexican -American persons than in white persons, and neutropenia is uncommon in both groups. The clinical implications of these findings are unclear, but they suggest that when determining the need for a diagnostic evaluation for neutropenia, clinicians should consider the patient's age, sex, ethnicity, and smoking status.	NIDDKD, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA; Social & Sci Syst Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Social & Scientific Systems	Rodgers, GP (corresponding author), NIDDKD, Mol & Clin Hematol Branch, NIH, 9000 Rockville Pike,Bldg 10,9N 119, Bethesda, MD 20892 USA.	gr5n@nih.gov			Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AGHAJI MAC, 1990, CENT AFR J MED, V36, P273; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BAIN BJ, 1975, BRIT MED J, V1, P306, DOI 10.1136/bmj.1.5953.306; Bain BJ, 2000, BRIT J HAEMATOL, V108, P483, DOI 10.1046/j.1365-2141.2000.01922.x; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; BROUN GO, 1966, NEW ENGL J MED, V275, P1410, DOI 10.1056/NEJM196612222752504; Cancer Therapy Evaluation Program, 2003, CANC THER EV PROGR C; CARAMIHAI E, 1975, J PEDIATR-US, V86, P252, DOI 10.1016/S0022-3476(75)80483-5; *CDCP NAT CTR HLTH, 2005, VITAL HLTH STAT, V11, P1; DANCEY JT, 1980, AM J MED, V68, P251, DOI 10.1016/0002-9343(80)90362-9; Ezeilo G C, 1972, East Afr Med J, V49, P94; Ezeilo G C, 1974, East Afr Med J, V51, P936; EZEILO GC, 1972, LANCET, V2, P1003; Forbes WH, 1941, AM J MED SCI, V201, P407, DOI 10.1097/00000441-194103000-00013; Freedman DS, 1997, INT J EPIDEMIOL, V26, P757, DOI 10.1093/ije/26.4.757; JUMEAN HG, 1983, ACTA HAEMATOL-BASEL, V69, P59, DOI 10.1159/000206841; KARAYALCIN G, 1972, LANCET, V1, P387; MANT MJ, 1987, CLIN LAB HAEMATOL, V9, P281, DOI 10.1111/j.1365-2257.1987.tb00092.x; MASON BA, 1979, AM J MED, V67, P201, DOI 10.1016/0002-9343(79)90391-7; McGrath C R, 1982, Vital Health Stat 11, P1; National Center for Health Statistics, 2007, NAT HLTH NUTR EX SUR; Neser M L, 1968, S Afr Med J, V42, P444; RANA SR, 1985, ANN CLIN LAB SCI, V15, P51; REED WW, 1991, ARCH INTERN MED, V151, P501, DOI 10.1001/archinte.151.3.501; RIPPEY JJ, 1967, LANCET, V2, P44; Shah BV, 1996, SUDAAN USERS MANUAL; SHAPER AG, 1971, LANCET, V2, P1021; SHOENFELD Y, 1985, BIOMED PHARMACOTHER, V39, P23; SHOENFELD Y, 1982, ARCH INTERN MED, V142, P797, DOI 10.1001/archinte.142.4.797; SHOENFELD Y, 1988, EUR J HAEMATOL, V41, P273; Watson HG, 2001, BRIT J HAEMATOL, V112, P826; WEINGARTEN MA, 1992, ACTA HAEMATOL-BASEL, V87, P126; WEINGARTEN MA, 1993, ISRAEL J MED SCI, V29, P297; Wright DG, 2006, CLIN HEMATOLOGY, P192; 1982, VITAL HLTH STAT, V11, pR1	35	233	239	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					486	492		10.7326/0003-4819-146-7-200704030-00004	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153VB	17404350				2022-12-24	WOS:000245463200002
J	Hattendorf, DA; Andreeva, A; Gangar, A; Brennwald, PJ; Weis, WI				Hattendorf, Douglas A.; Andreeva, Anna; Gangar, Akanksha; Brennwald, Patrick J.; Weis, William I.			Structure of the yeast polarity protein Sro7 reveals a SNARE regulatory mechanism	NATURE			English	Article							LETHAL-GIANT-LARVAE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; EXOCYTOSIS; TOMOSYN; COMPLEX; PHOSPHORYLATION; RESIDUES; VESICLES; EFFECTOR	Polarized exocytosis requires coordination between the actin cytoskeleton and the exocytic machinery responsible for fusion of secretory vesicles at specific sites on the plasma membrane(1). Fusion requires formation of a complex between a vesicle-bound R-SNARE and plasma membrane Qa, Qb and Qc SNARE proteins(2). Proteins in the lethal giant larvae protein family, including lethal giant larvae and tomosyn in metazoans and Sro7 in yeast, interact with Q-SNAREs and are emerging as key regulators of polarized exocytosis(3). The crystal structure of Sro7 reveals two seven-bladed WD40 beta-propellers followed by a 60-residue- long 'tail', which is bound to the surface of the amino-terminal propeller. Deletion of the Sro7 tail enables binding to the Qbc SNARE region of Sec9 and this interaction inhibits SNARE complex assembly. The N-terminal domain of Sec9 provides a second, high-affinity Sro7 interaction that is unaffected by the tail. The results suggest that Sro7 acts as an allosteric regulator of exocytosis through interactions with factors that control the tail. Sequence alignments indicate that lethal giant larvae and tomosyn have a two-beta-propeller fold similar to that of Sro7, but only tomosyn appears to retain the regulatory tail.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Stanford University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr W, Stanford, CA 94305 USA.	pjbrennw@med.unc.edu; bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150	NIGMS NIH HHS [R01 GM054712] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054712] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kagami M, 1998, GENETICS, V149, P1717; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Vasioukhin V, 2006, DEV NEUROSCI-BASEL, V28, P13, DOI 10.1159/000090749; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; Zhang XY, 2005, J CELL BIOL, V170, P273, DOI 10.1083/jcb.200502055	27	70	74	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					567	571		10.1038/nature05635	http://dx.doi.org/10.1038/nature05635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392788				2022-12-24	WOS:000245242900055
J	Simon, MD; Chu, FX; Racki, LR; de la Cruz, CC; Burlingame, AL; Panning, B; Narlikar, GJ; Shokat, KM				Simon, Matthew D.; Chu, Feixia; Racki, Lisa R.; de la Cruz, Cecile C.; Burlingame, Alma L.; Panning, Barbara; Narlikar, Geeta J.; Shokat, Kevan M.			The site-specific installation of methyl-lysine analogs into recombinant histones	CELL			English	Article							NUCLEOSOME MOBILITY; CHROMATIN-STRUCTURE; EPIGENETIC CONTROL; MOLECULAR-BASIS; PHD FINGER; H3; PROTEINS; LIGATION; BINDING; NURF	Histone lysine residues can be mono-, di-, or trimethylated. These posttranslational modifications regulate the affinity of effector proteins and may also impact chromatin structure independent of their role as adaptors. In order to study histone lysine methylation, particularly in the context of chromatin, we have developed a chemical approach to install analogs of methyl lysine into recombinant proteins. This approach allows for the rapid generation of large quantities of histones in which the site and degree of methylation can be specified. We demonstrate that these methyl-lysine analogs (MLAs) are functionally similar to their natural counterparts. These methylated histones, were used to examine the influence of specific lysine methylation on the binding of effecter proteins and the rates of nucleosme remodeling. This simple method of introducing site-specific and degree-specific methylation into recombinant histones provides a powerful tool to investigate the biochemical mechanisms by which lysine methylation influences chromatin structure and function.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	shokat@cmp.ucsf.edu	Simon, Matthew/ABF-9127-2020	Simon, Matthew/0000-0001-7423-5265	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR019934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085186] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [RR 001614, S10 RR019934, P41 RR001614, RR 019934] Funding Source: Medline; NIGMS NIH HHS [R01 GM085186] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chu FX, 2006, MOL CELL PROTEOMICS, V5, P194, DOI 10.1074/mcp.M500285-MCP200; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; GLOSS LM, 1995, BIOCHEMISTRY-US, V34, P3990, DOI 10.1021/bi00012a017; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Hopkins CE, 2005, ARCH BIOCHEM BIOPHYS, V443, P1, DOI 10.1016/j.abb.2005.08.020; ITANO HA, 1972, J BIOL CHEM, V247, P4819; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kenyon G L, 1977, Methods Enzymol, V47, P407; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; RAFTERY MA, 1966, J BIOL CHEM, V241, P3457; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zubarev RA, 1998, J AM CHEM SOC, V120, P3265, DOI 10.1021/ja973478k	45	342	351	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					1003	1012		10.1016/j.cell.2006.12.041	http://dx.doi.org/10.1016/j.cell.2006.12.041			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350582	Green Accepted, Bronze			2022-12-24	WOS:000245073400022
J	Kouzarides, T				Kouzarides, Tony			SnapShot: Histone-modifying enzymes	CELL			English	Editorial Material							LYSINE METHYLATION; GENE-EXPRESSION; CODE; H3		Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.			Kouzarides, Tony/0000-0002-8918-4162				Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	12	65	69	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2007	128	4					802	+		10.1016/j.cell.2007.02.018	http://dx.doi.org/10.1016/j.cell.2007.02.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320515	Bronze			2022-12-24	WOS:000245098600020
J	Osborne, AR; Rapoport, TA				Osborne, Andrew R.; Rapoport, Tom A.			Protein translocation is mediated by oligomers of the SecY complex with one SecY copy forming the channel	CELL			English	Article							ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; CONDUCTING CHANNEL; ATPASE SECA; CRYSTAL-STRUCTURE; DISULFIDE BRIDGE; MEMBRANE-PROTEIN; CROSS-LINKING; ER MEMBRANE; BINDING	Many proteins are translocated across the bacterial plasma membrane by the interplay of the cytoplasmic ATPase SecA with a protein-conducting channel, formed from the evolutionarily conserved heterotrimeric SecY complex. Here, we have used purified E. coli components to address the mechanism of translocation. Disulfide bridge crosslinking demonstrates that SecA transfers both the signal sequence and the mature region of a secreted substrate into a single SecY molecule. However, protein translocation involves oligomers of the SecY complex, because a SecY molecule defective in translocation can be rescued by linking it covalently with a wild-type SecY copy. SecA interacts through one of its domains with a nontranslocating SecY copy and moves the polypeptide chain through a neighboring SecY copy. Oligomeric channels with only one active pore likely mediate protein translocation in all organisms.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_raoport@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM052586] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Dapic V, 2000, J BIOL CHEM, V275, P25000, DOI 10.1074/jbc.M001100200; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 2004, TRENDS BIOCHEM SCI, V29, P221, DOI 10.1016/j.tibs.2004.03.001; Gumbart J, 2006, BIOPHYS J, V90, P2356, DOI 10.1529/biophysj.105.075291; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Ismail N, 2006, J CELL SCI, V119, P2826, DOI 10.1242/jcs.03018; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Scheuring J, 2005, J MOL BIOL, V354, P258, DOI 10.1016/j.jmb.2005.09.058; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; TANI K, 1990, J BIOL CHEM, V265, P17341; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023	32	120	125	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					97	110		10.1016/j.cell.2007.02.036	http://dx.doi.org/10.1016/j.cell.2007.02.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418789	Bronze			2022-12-24	WOS:000245661100014
J	Dy, S; Lynn, J				Dy, Sydney; Lynn, Joanne			Getting services right for those sick enough to die	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; PROGRAM		Johns Hopkins Univ, Baltimore, MD 21205 USA; RAND Corp, Arlington, VA 22202 USA	Johns Hopkins University; RAND Corporation	Dy, S (corresponding author), Johns Hopkins Univ, Baltimore, MD 21205 USA.	sdy@jhsph.edu						Aiken LS, 2006, J PALLIAT MED, V9, P111, DOI 10.1089/jpm.2006.9.111; American Academy of Hospice and Palliative Medicine Center to Advance Palliative Care Hospice and Palliative Nurses Association Last Acts Partnership National Hospice and Palliative Care Organization, 2004, J PALLIAT MED, V7, P611; *CMS, 2004, MED BEN POL MAN; Federal Interagency Foram on Aging-Related Statistics, 2006, OLD AM UPD 2006 KEY; FORD PE, 2003, J PALLIAT MED, V6, P645; GYSELS M, 2003, IMPROVING SUPPORTIVE; *HAST CTR, 1987, GUID TERM LIF SUST T; King N, 2005, PALLIATIVE MED, V19, P619, DOI 10.1191/0269216305pm1084oa; Kodner DL, 2006, HEALTH SOC CARE COMM, V14, P384, DOI 10.1111/j.1365-2524.2006.00655.x; Lorenz K, 2004, END OF LIFE CARE OUT; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; LYNN J, 2004, SICK DEATH NOT GOING; *MEDPAC, 2006, REP C INCR VAL MED W, P59; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; *NAT I HLTH STAT O, 2005, J PALLIAT MED S, V8; *ONS, 2004, NAT POP PROJ; Temkin-Greener H, 2002, J AM GERIATR SOC, V50, P125, DOI 10.1046/j.1532-5415.2002.50018.x	17	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					511	513		10.1136/bmj.39127.653704.80	http://dx.doi.org/10.1136/bmj.39127.653704.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148VV	17347238	Green Published			2022-12-24	WOS:000245106400039
J	Co, C; Wong, DT; Gierke, S; Chang, V; Taunton, J				Co, Carl; Wong, Derek T.; Gierke, Sarah; Chang, Vicky; Taunton, Jack			Mechanism of actin network attachment to moving membranes: Barbed end capture by N-WASP WH2 domains	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; LISTERIA-MONOCYTOGENES; FORCE GENERATION; DENDRITIC ORGANIZATION; N-WASP-ARP2/3 COMPLEX; FILAMENT ELONGATION; ENA/VASP PROTEINS; ATP HYDROLYSIS; LIPID VESICLES	Actin filament networks exert protrusive and attachment forces on membranes and thereby drive membrane deformation and movement. Here, we show that N-WASP WH2 domains play a previously unanticipated role in vesicle movement by transiently attaching actin filament barbed ends to the membrane. To dissect the attachment mechanism, we reconstituted the propulsive motility of lipid-coated glass beads, using purified soluble proteins. N-WASP WH2 mutants assembled actin comet tails and initiated movement, but the comet tails catastrophically detached from the membrane. When presented on the surface of a lipid-coated bead, WH2 domains were sufficient to maintain comet tail attachment. In v-Src-transformed fibroblasts, N-WASP WH2 mutants were severely defective in the formation of circular podosome arrays. In addition to creating an attachment force, interactions between WH2 domains and barbed ends may locally amplify signals for dendritic actin nucleation.	Univ Calif San Francisco, UCB Cell Prop Lab, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Biol Sci, UCB Cell Prop Lab, San Francisco, CA 94158 USA; Univ Calif Berkeley, Joint Grad Grp Bioengn, Berkeley, CA 94720 USA; Univ Calif San Francisco, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Taunton, J (corresponding author), Univ Calif San Francisco, UCB Cell Prop Lab, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	taunton@cmp.ucsf.edu			NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066229] Funding Source: NIH RePORTER; NEI NIH HHS [PN2 EY 016546, PN2 EY016546] Funding Source: Medline; NIGMS NIH HHS [R01 GM066229, R01 GM066229-05, GM 066229] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts JB, 2004, PLOS BIOL, V2, P2054, DOI 10.1371/journal.pbio.0020412; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bernheim-Groswasser A, 2002, NATURE, V417, P308, DOI 10.1038/417308a; Boukellal H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061906; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Dickinson RB, 2002, BIOPHYS J, V82, P605, DOI 10.1016/S0006-3495(02)75425-8; Dutartre H, 1996, J CELL SCI, V109, P367; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Gerbal F, 2000, EUR BIOPHYS J BIOPHY, V29, P134, DOI 10.1007/s002490050258; Giardini PA, 2003, P NATL ACAD SCI USA, V100, P6493, DOI 10.1073/pnas.1031670100; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; HOFFMAN GR, 2004, CELL, V110, P345; Hufner K, 2001, J BIOL CHEM, V276, P35761, DOI 10.1074/jbc.M106520200; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2000, J CELL SCI, V113, P4421; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Kuo SC, 2000, NATURE, V407, P1026, DOI 10.1038/35039544; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Mizutani K, 2002, CANCER RES, V62, P669; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Olbris DJ, 2000, BBA-MOL CELL RES, V1495, P140, DOI 10.1016/S0167-4889(99)00156-1; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Soo FS, 2005, P NATL ACAD SCI USA, V102, P16233, DOI 10.1073/pnas.0507022102; Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Upadhyaya A, 2003, CURR BIOL, V13, pR734, DOI 10.1016/j.cub.2003.08.051; Upadhyaya A, 2003, P NATL ACAD SCI USA, V100, P4521, DOI 10.1073/pnas.0837027100; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; van der Gucht J, 2005, P NATL ACAD SCI USA, V102, P7847, DOI 10.1073/pnas.0502121102; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Wiesner S, 2003, J CELL BIOL, V160, P387, DOI 10.1083/jcb.200207148; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494	64	140	142	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					901	913		10.1016/j.cell.2006.12.049	http://dx.doi.org/10.1016/j.cell.2006.12.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350575	Green Accepted, Bronze			2022-12-24	WOS:000245073400015
J	Coovadia, HM; Rollins, NC; Bland, RM; Little, K; Coutsoudis, A; Bennish, ML; Newell, ML				Coovadia, Hoosen M.; Rollins, Nigel C.; Bland, Ruth M.; Little, Kirsty; Coutsoudis, Anna; Bennish, Michael L.; Newell, Marie-Louise			Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POSTNATAL TRANSMISSION; SOUTH-AFRICA; PREVENT; ZIDOVUDINE; EFFICACY; INFANTS; WOMEN; POPULATIONS; NEVIRAPINE	Background Exclusive breastfeeding, though better than other forms of infant feeding and associated with improved child survival, is uncommon. We assessed the HIV-1 transmission risks and survival associated with exclusive breastfeeding and other types of infant feeding. Methods 2722 HIV-infected and uninfected pregnant women attending antenatal clinics in KwaZulu Natal, South Africa (seven rural, one semiurban, and one urban), were enrolled into a non-randomised intervention cohort study. Infant feeding data were obtained every week from mothers, and blood samples from infants were taken monthly at clinics to establish HIV infection status. Kaplan-Meier analyses conditional on exclusive breastfeeding were used to estimate transmission risks at 6 weeks and 22 weeks of age, and Cox's proportional hazard was used to quantify associations with maternal and infant factors. Findings 1132 of 1372 (83%) infants born to HIV-infected mothers initiated exclusive breastfeeding from birth. of 1276 infants with complete feeding data, median duration of cumulative exclusive breastfeeding was 159 days (first quartile [Q1] to third quartile [Q3], 122-174 days). 14.1% (95% Cl 12.0-16.4) of exclusively breastfed infants were infected with HIV-1 by age 6 weeks and 19.5% (17.0-22.4) by 6 months; risk was significantly associated with maternal CD4-cell counts below 200 cells per mu L (adjusted hazard ratio [HR] 3.79; 2.35-6.12) and birthweight less than 2500 g (1.81, 1.07-3.06). Kaplan-Meier estimated risk of acquisition of infection at 6 months of age was 4.04% (2.29-5.76). Breastfed infants who also received solids were significantly more likely to acquire infection than were exclusively breastfed children (HR 10.87, 1.51-78.00, p=0.018), as were infants who at 12 weeks received both breastmilk and formula milk (1.82, 0.98-3.36, p=0.057). Cumulative 3-month mortality in exclusively breastfed infants was 6.1% (4.74-7.92) versus 15.1% (7.63-28.73) in infants given replacement feeds (HR 2.06, 1.00-4.27; p=0.051). Interpretation The association between mixed breastfeeding and increased HIV transmission risk, together with evidence that exclusive breastfeeding can be successfully supported in HIV-infected women, warrant revision of the present UNICEF, WHO, and UNAIDS infant feeding guidelines.	Univ Kwazulu Natal, Dept Paediat & Child Hlth, Nelson Mandela Sch Med, ZA-4013 Congella, South Africa; Univ Kwazulu Natal, Africa Ctr Hlth & Populat Studies, ZA-4013 Congella, South Africa; Univ Kwazulu Natal, Ctr HIV AIDS Networking, ZA-4013 Congella, South Africa; UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London, England; Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of London; University College London; University of Oxford	Rollins, NC (corresponding author), Univ Kwazulu Natal, Dept Paediat & Child Hlth, Nelson Mandela Sch Med, Private Bag 7, ZA-4013 Congella, South Africa.	rollins@ukzn.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268				Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Alioum A, 2001, STAT MED, V20, P3539, DOI 10.1002/sim.1076; Becquet R, 2006, 16 INT AIDS C TOR CA; Blackard JT, 2001, VIROLOGY, V287, P261, DOI 10.1006/viro.2001.1059; Bland RM, 2003, ARCH DIS CHILD, V88, P778, DOI 10.1136/adc.88.9.778; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; Coovadia H, 2004, NEW ENGL J MED, V351, P289, DOI 10.1056/NEJMe048128; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2002, HEALTH POLICY PLANN, V17, P154, DOI 10.1093/heapol/17.2.154; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Cox D. R., 1984, ANAL SURVIVAL DATA; Creek T, 2006, 2006 HIV AIDS IMPL M; Dabis F, 2005, AIDS, V19, P309; Doherty T, 2006, B WORLD HEALTH ORGAN, V84, P90, DOI 10.2471/BLT.04.019448; Fawzi W, 2002, JAIDS-J ACQ IMM DEF, V31, P331, DOI 10.1097/00126334-200211010-00010; Hilderbrand K, 2003, SAMJ S AFR MED J, V93, P779; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KwaZulu Natal Provincial Department of Health, 2003, PROT PHAS IMPL COMPR; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 2003, AIDS, V17, P1493, DOI 10.1097/00002030-200307040-00010; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34; Renjifo B, 2001, J HUMAN VIROL, V4, P16; Rollins N, 2004, JAIDS-J ACQ IMM DEF, V35, P188, DOI 10.1097/00126334-200402010-00014; Smith MM, 2000, NUTR REV, V58, P333, DOI 10.1111/j.1753-4887.2000.tb01830.x; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thorne Claire, 2005, Curr Opin Investig Drugs, V6, P804; *UNAIDS WHO, 2005, AIDS EP UPD; WHO, 2006, ANT DRUGS TREAT PREG; *WHO, 2001, WHORHR0112WHOCAH0121; WHO, 2001, NEW DAT PREV MOTH CH; *WHO UNICEF UNAIDS, 1998, WHOFRHNUTCHD98LED; *WHO UNICEF UNAIDS, 2000, WHOSCHCAH004; World Health Organization, 1991, WHOCDDSER9114; [No title captured]	42	445	453	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1107	1116		10.1016/S0140-6736(07)60283-9	http://dx.doi.org/10.1016/S0140-6736(07)60283-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398310				2022-12-24	WOS:000245323700031
J	Juliano, R				Juliano, Rudy			Clinical implications of basic research: Bugging tumors to put drugs on target	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; Univ N Carolina, Sch Med, Carolina Ctr Canc Nanotechnol Excellence, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Juliano, R (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.							Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Cheong I, 2006, SCIENCE, V314, P1308, DOI 10.1126/science.1130651; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c	4	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					954	955		10.1056/NEJMcibr067638	http://dx.doi.org/10.1056/NEJMcibr067638			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329705				2022-12-24	WOS:000244496400014
J	Thery, M; Jimenez-Dalmaroni, A; Racine, V; Bornens, M; Julicher, F				Thery, Manuel; Jimenez-Dalmaroni, Andrea; Racine, Victor; Bornens, Michel; Juelicher, Frank			Experimental and theoretical study of mitotic spindle orientation	NATURE			English	Article							CELL-DIVISION AXIS; FORCE GENERATORS; CENTROSOME; CUES; PINS	The architecture and adhesiveness of a cell microenvironment is a critical factor for the regulation of spindle orientation in vivo(1,2). Using a combination of theory and experiments, we have investigated spindle orientation in HeLa ( human) cells. Here we show that spindle orientation can be understood as the result of the action of cortical force generators, which interact with spindle microtubules and are activated by cortical cues. We develop a simple physical description of this spindle mechanics, which allows us to calculate angular profiles of the torque acting on the spindle, as well as the angular distribution of spindle orientations. Our model accounts for the preferred spindle orientation and the shape of the full angular distribution of spindle orientations observed in a large variety of different cellular microenvironment geometries. It also correctly describes asymmetric spindle orientations, which are observed for certain distributions of cortical cues. We conclude that, on the basis of a few simple assumptions, we can provide a quantitative description of the spindle orientation of adherent cells.	Inst Curie, CNRS, UMR 144, F-75248 Paris, France; Comm Energie Atom, DSV, iRTSV, Lab Biopuces, F-38054 Grenoble, France; Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; CEA; Max Planck Society	Bornens, M (corresponding author), Inst Curie, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris, France.	michel.bornens@curie.fr; julicher@pks.mpg.de	Julicher, Frank/B-1828-2009; Racine, Victor/I-4576-2014	Julicher, Frank/0000-0003-4731-9185; Racine, Victor/0000-0002-1486-8973				Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cuvelier D, 2003, EUR BIOPHYS J BIOPHY, V32, P342, DOI 10.1007/s00249-003-0282-2; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	18	308	313	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					493	U6		10.1038/nature05786	http://dx.doi.org/10.1038/nature05786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17495931				2022-12-24	WOS:000246693100051
J	Lehmann, J				Lehmann, Johannes			A handful of carbon	NATURE			English	Editorial Material									Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA	Cornell University	Lehmann, J (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.		Lehmann, Johannes/H-2682-2014	Lehmann, Johannes/0000-0002-4701-2936				Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; *EIA, 2006, DOEEIA0573; Gaunt J., 2007, POW GEN REN EN FUELS; IPCC, 2007, IPCC CLIM CHANG 2007; Jackson RB, 2004, P NATL ACAD SCI USA, V101, P15827, DOI 10.1073/pnas.0403631101; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; LEHMANN J, IN PRESS FRONTIERS E; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; McCarl BA, 2001, SCIENCE, V294, P2481, DOI 10.1126/science.1064193; Stern Nicholas, 2006, STERN REV EC CLIMATE	11	1579	1857	91	1190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					143	144		10.1038/447143a	http://dx.doi.org/10.1038/447143a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495905				2022-12-24	WOS:000246338700019
J	Check, E				Check, Erika			Patenting the obvious?	NATURE			English	News Item																		Wadman M, 2005, NATURE, V435, P272, DOI 10.1038/435272a	1	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					16	17		10.1038/447016a	http://dx.doi.org/10.1038/447016a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476235				2022-12-24	WOS:000246149300013
J	Buesseler, KO; Lamborg, CH; Boyd, PW; Lam, PJ; Trull, TW; Bidigare, RR; Bishop, JKB; Casciotti, KL; Dehairs, F; Elskens, M; Honda, M; Karl, DM; Siegel, DA; Silver, MW; Steinberg, DK; Valdes, J; Van Mooy, B; Wilson, S				Buesseler, Ken O.; Lamborg, Carl H.; Boyd, Philip W.; Lam, Phoebe J.; Trull, Thomas W.; Bidigare, Robert R.; Bishop, James K. B.; Casciotti, Karen L.; Dehairs, Frank; Elskens, Marc; Honda, Makio; Karl, David M.; Siegel, David A.; Silver, Mary W.; Steinberg, Deborah K.; Valdes, Jim; Van Mooy, Benjamin; Wilson, Stephanie			Revisiting carbon flux through the ocean's twilight zone	SCIENCE			English	Article							ORGANIC-MATTER; TRANSPORT; PUMP	The oceanic biological pump drives sequestration of carbon dioxide in the deep sea via sinking particles. Rapid biological consumption and remineralization of carbon in the "twilight zone" ( depths between the euphotic zone and 1000 meters) reduce the efficiency of sequestration. By using neutrally buoyant sediment traps to sample this chronically understudied realm, we measured a transfer efficiency of sinking particulate organic carbon between 150 and 500 meters of 20 and 50% at two contrasting sites. This large variability in transfer efficiency is poorly represented in biogeochemical models. If applied globally, this is equivalent to a difference in carbon sequestration of more than 3 petagrams of carbon per year.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Otago, Natl Inst Water, Dunedin, New Zealand; Univ Otago, Atmospher Res Ctr Phys & Chem Oceanog, Dept Chem, Dunedin, New Zealand; Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7001, Australia; CSIRO, Marine & Atmospher Res, Hobart, Tas 7001, Australia; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Free Univ Brussels, B-1050 Brussels, Belgium; Mutsu Inst Oceanog, JAMSTEC, Kanagawa 2370061, Japan; Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; University of Otago; University of Otago; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Hawaii System; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz; William & Mary; Virginia Institute of Marine Science; Woods Hole Oceanographic Institution	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu	Boyd, Philip W/J-7624-2014; Lam, Phoebe/GQQ-7325-2022; Trull, Tom W/B-7028-2014; Karl, David/AFP-3837-2022; Siegel, David A/C-5587-2008	Boyd, Philip W/0000-0001-7850-1911; Bishop, James/0000-0002-8036-3017; Casciotti, Karen/0000-0002-5286-7795; Lam, Phoebe J./0000-0001-6609-698X; Wilson, Stephanie/0000-0002-1280-5506; Karl, David/0000-0002-6660-6721				Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; BISHOP JKB, 1989, LIFE SCI R, V44, P117; Bopp L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023653; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Buesseler KO, 2000, DEEP-SEA RES PT I, V47, P277, DOI 10.1016/S0967-0637(99)00056-4; BUESSELER KO, 1991, NATURE, V353, P420, DOI 10.1038/353420a0; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; Honda MC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026466; Honda MC, 2003, J OCEANOGR, V59, P671, DOI 10.1023/B:JOCE.0000009596.57705.0c; HONJO S, 1982, DEEP-SEA RES, V29, P609, DOI 10.1016/0198-0149(82)90079-6; Howard MT, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002499; Ito T, 2005, J MAR RES, V63, P813, DOI 10.1357/0022240054663231; Karl DM, 1996, DEEP-SEA RES PT II, V43, P539, DOI 10.1016/0967-0645(96)00002-1; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Najjar RG, 1992, GLOBAL BIOGEOCHEM CY, V6, P45, DOI 10.1029/91GB02718; PEINERT R, 1989, LIFE SCI R, V44, P35; Schlitzer R, 2002, DEEP-SEA RES PT II, V49, P1623, DOI 10.1016/S0967-0645(02)00004-8; TRULL T, 2006, ASLO TOS AGU OC SCI; VOLK T, 1985, GEOPHYS MONOGR AM GE, V32; Yamanaka Y, 1996, GLOBAL BIOGEOCHEM CY, V10, P361, DOI 10.1029/96GB00634	26	432	440	6	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					567	570		10.1126/science.1137959	http://dx.doi.org/10.1126/science.1137959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463282				2022-12-24	WOS:000245983100036
J	Nishiyama, T; Ohsumi, K; Kishimoto, T				Nishiyama, Tomoko; Ohsumi, Keita; Kishimoto, Takeo			Phosphorylation of Erp1 by p90rsk is required for cytostatic factor arrest in Xenopus laevis eggs	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; METAPHASE ARREST; MEIOTIC MATURATION; CELL-CYCLE; VERTEBRATE EGGS; MAP KINASE; INHIBITOR; EXIT; DEGRADATION; INDUCTION	Until fertilization, the meiotic cell cycle of vertebrate eggs is arrested at metaphase of meiosis II by a cytoplasmic activity termed cytostatic factor (CSF)(1), which causes inhibition of the anaphase-promoting complex/cyclosome (APC/C), a ubiquitin ligase that targets mitotic cyclins - regulatory proteins of meiosis and mitosis - for degradation(2,3). Recent studies indicate that Erp1/ Emi2, an inhibitor protein for the APC/C, has an essential role in establishing and maintaining CSF arrest(4-6), but its relationship to Mos, a mitogen-activated protein kinase ( MAPK) kinase kinase that also has an essential role in establishing CSF arrest 7 through activation of p90 ribosomal S6 kinase (p90rsk)(8,9), is unclear. Here we report that in Xenopus eggs Erp1 is a substrate of p90rsk, and that Mos-dependent phosphorylation of Erp1 by p90rsk at Thr 336, Ser 342 and Ser 344 is crucial for both stabilizing Erp1 and establishing CSF arrest in meiosis II oocytes. Semi-quantitative analysis with CSF-arrested egg extracts reveals that the Mos-dependent phosphorylation of Erp1 enhances, but does not generate, the activity of Erp1 that maintains metaphase arrest. Our results also suggest that Erp1 inhibits cyclin B degradation by binding the APC/C at its carboxy-terminal destruction box(10), and this binding is also enhanced by the Mos-dependent phosphorylation. Thus, Mos and Erp1 collaboratively establish and maintain metaphase II arrest in Xenopus eggs. The link between Mos and Erp1 provides a molecular explanation for the integral mechanism of CSF arrest in unfertilized vertebrate eggs.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Ohsumi, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	kohsumi@bio.titech.ac.jp						Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; GOTOH Y, 1994, ONCOGENE, V9, P1891; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025	29	91	92	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1096	1099		10.1038/nature05696	http://dx.doi.org/10.1038/nature05696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17410129				2022-12-24	WOS:000245950400053
J	Pulendran, B				Pulendran, Bali			Tolls and beyond - Many roads to vaccine immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.		Pulendran, Bali/AAW-9550-2021					Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720	3	15	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1776	1778		10.1056/NEJMcibr070454	http://dx.doi.org/10.1056/NEJMcibr070454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160LQ	17460233				2022-12-24	WOS:000245942600017
J	Doyle, J; Csete, M				Doyle, John; Csete, Marie			Rules of engagement - Complex engineered and biological systems share protocol-based architectures that make them robust and evolvable, but with hidden fragilities to rare perturbations.	NATURE			English	Editorial Material									CALTECH, Pasadena, CA 91125 USA; Emory Univ, Atlanta, GA 30322 USA	California Institute of Technology; Emory University	Doyle, J (corresponding author), CALTECH, Pasadena, CA 91125 USA.							Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Moritz MA, 2005, P NATL ACAD SCI USA, V102, P17912, DOI 10.1073/pnas.0508985102	2	37	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					860	860		10.1038/446860a	http://dx.doi.org/10.1038/446860a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443168	Bronze			2022-12-24	WOS:000245785700023
J	Reay, D; Sabine, C; Smith, P; Hymus, G				Reay, Dave; Sabine, Christopher; Smith, Pete; Hymus, Graham			Spring-time for sinks	NATURE			English	Editorial Material									Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JN, Midlothian, Scotland; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Aberdeen, Aberdeen AB9 1FX, Scotland; No Arizona Univ, Flagstaff, AZ 86011 USA	University of Edinburgh; National Oceanic Atmospheric Admin (NOAA) - USA; University of Aberdeen; Northern Arizona University	Reay, D (corresponding author), Univ Edinburgh, Sch Geosci, W Mains Rd, Edinburgh EH9 3JN, Midlothian, Scotland.	David.Reay@ed.ac.uk	Smith, Pete/G-1041-2010; Reay, David/F-4054-2010; Masselink, Gerd/B-6743-2015; Blenkinsopp, Chris/AFF-8523-2022; Turner, Ian L/H-7122-2014; Alecha, Maria/B-4717-2016	Smith, Pete/0000-0002-3784-1124; Masselink, Gerd/0000-0001-6079-7611; Blenkinsopp, Chris/0000-0001-5784-2805; Turner, Ian L/0000-0001-9884-6917; Reay, Dave/0000-0001-5829-9007; Alecha, Maria/0000-0003-1540-1870	Natural Environment Research Council [NE/C51755X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; RAUPACH MR, 2004, GLOBAL CARBON CYCLE, P526; ROSE S, 2007, ENERGY MODELING FORU; Tans P.P., 2007, TRENDS ATMOSPHERIC C; Watson AJ, 2003, GLO CH IGBP, P123; Watson RT, 2000, IPCC SPECIAL REPORT	7	34	36	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					727	728		10.1038/446727a	http://dx.doi.org/10.1038/446727a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429376				2022-12-24	WOS:000245626800017
J	Plaut, JJ; Picardi, G; Safaeinili, A; Ivanov, AB; Milkovich, SM; Cicchetti, A; Kofman, W; Mouginot, J; Farrell, WM; Phillips, RJ; Clifford, SM; Frigeri, A; Orosei, R; Federico, C; Williams, IP; Gurnett, DA; Nielsen, E; Hagfors, T; Heggy, E; Stofan, ER; Plettemeier, D; Watters, TR; Leuschen, CJ; Edenhofer, P				Plaut, Jeffrey J.; Picardi, Giovanni; Safaeinili, Ali; Ivanov, Anton B.; Milkovich, Sarah M.; Cicchetti, Andrea; Kofman, Wlodek; Mouginot, Jeremie; Farrell, William M.; Phillips, Roger J.; Clifford, Stephen M.; Frigeri, Alessandro; Orosei, Roberto; Federico, Costanzo; Williams, Iwan P.; Gurnett, Donald A.; Nielsen, Erling; Haegfors, Tor; Heggy, Essam; Stofan, Ellen R.; Plettemeier, Dirk; Watters, Thomas R.; Leuschen, Carlton J.; Edenhofer, Peter			Subsurface radar sounding of the south polar layered deposits of Mars	SCIENCE			English	Article							CAP; REGION	The ice-rich south polar layered deposits of Mars were probed with the Mars Advanced Radar for Subsurface and Ionospheric Sounding on the Mars Express orbiter. The radar signals penetrate deep into the deposits (more than 3.7 kilometers). For most of the area, a reflection is detected at a time delay that is consistent with an interface between the deposits and the substrate. The reflected power from this interface indicates minimal attenuation of the signal, suggesting a composition of nearly pure water ice. Maps were generated of the topography of the basal interface and the thickness of the layered deposits. A set of buried depressions is seen within 300 kilometers of the pole. The thickness map shows an asymmetric distribution of the deposits and regions of anomalous thickness. The total volume is estimated to be 1.6 x 10(6) cubic kilometers, which is equivalent to a global water layer approximately 11 meters thick.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Roma La Sapienza, Infocom Dept, I-00184 Rome, Italy; Lab Planetol Grenoble, F-38041 Grenoble, France; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Lunar & Planetary Inst, Houston, TX 77058 USA; Univ Perugia, Dipartimento Sci Terra, I-06123 Perugia, Italy; Ist Nazl Astrofis, Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Queen Mary Univ London, Sch Math Sci, Astron Unit, London E1 4NS, England; Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; Max Planck Inst Solar Syst Res, D-37191 Katlenburg Lindau, Germany; Proxemy Res, Laytonville, MD 20882 USA; Tech Univ Dresden, Fak Elekrtotech & Informat Tech, D-01062 Dresden, Germany; Smithsonian Inst, Ctr Earth & Planetary Studies, Natl Air & Space Museum, Washington, DC 20560 USA; Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; Ruhr Univ Bochum, Fak Elektrotech & Informat Tech, D-44780 Bochum, Germany	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Sapienza University Rome; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Washington University (WUSTL); University of Perugia; Istituto Nazionale Astrofisica (INAF); University of London; Queen Mary University London; University of Iowa; Max Planck Society; Technische Universitat Dresden; Smithsonian Institution; University of Kansas; Ruhr University Bochum	Plaut, JJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.		Farrell, William/I-4865-2013; Mouginot, Jeremie/G-7045-2015; Heggy, Essam/E-8250-2013; Frigeri, Alessandro/F-2151-2010; Kofman, Wlodek/C-4556-2008; Heggy, Essam/AAL-8124-2020; Ivanov, Anton B/C-8944-2014	Mouginot, Jeremie/0000-0001-9155-5455; Heggy, Essam/0000-0001-7476-2735; Frigeri, Alessandro/0000-0002-9140-3977; Kofman, Wlodek/0000-0002-6744-8796; Heggy, Essam/0000-0001-7476-2735; Ivanov, Anton B/0000-0001-8376-8581; CICCHETTI, ANDREA/0000-0002-9588-6531; Williams, Iwan Prys/0000-0002-8069-1344				Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; BLASIUS RK, 1982, ICARUS, V50, P140; Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; CLIFFORD SM, 1987, J GEOPHYS RES-SOLID, V92, P9135, DOI 10.1029/JB092iB09p09135; CUTTS JA, 1973, J GEOPHYS RES, V78, P4231, DOI 10.1029/JB078i020p04231; DAVIES C, 2004, EOS S, V85; HEGGY E, 2006, 4 INT C MARS POL SCI; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; KIEFFER HH, 1990, J GEOPHYS RES-SOLID, V95, P1481, DOI 10.1029/JB095iB02p01481; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MURRAY BC, 1972, ICARUS, V17, P328, DOI 10.1016/0019-1035(72)90004-8; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Picardi G., 2004, EUROPEAN SPACE AGENC, P51; Schenk PM, 2000, J GEOPHYS RES-PLANET, V105, P24529, DOI 10.1029/1999JE001054; Sibson R., 1981, BRIEF DESCRIPTION NA, P21, DOI DOI 10.1002/ADVS.201700552; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; TANAKA K, 2005, 20051271 US GEOL SUR; Thomas P., 1992, MARS, P767; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X	19	228	232	5	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					92	95		10.1126/science.1139672	http://dx.doi.org/10.1126/science.1139672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17363628				2022-12-24	WOS:000245470500038
J	Alon, U				Alon, Uri			Simplicity in biology	NATURE			English	Editorial Material									Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.							Alon U., 2006, INTRO SYSTEMS BIOL D; PTASHNE M, 2002, GENES SIGNALS; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Simon HA, 1996, ARCHITECTURE COMPLEX	4	52	54	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					497	497		10.1038/446497a	http://dx.doi.org/10.1038/446497a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392770				2022-12-24	WOS:000245242900032
J	Hijiya, N; Hudson, MM; Lensing, S; Zacher, M; Onciu, M; Behm, FG; Razzouk, BI; Ribeiro, RC; Rubnitz, JE; Sandlund, JT; Rivera, GK; Evans, WE; Relling, MV; Pui, CH				Hijiya, Nobuko; Hudson, Melissa M.; Lensing, Shelly; Zacher, Margie; Onciu, Mihaela; Behm, Fred G.; Razzouk, Bassem I.; Ribeiro, Raul C.; Rubnitz, Jeffrey E.; Sandlund, John T.; Rivera, Gaston K.; Evans, William E.; Relling, Mary V.; Pui, Ching-Hon			Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER SURVIVOR; TOTAL-THERAPY; BRAIN-TUMORS; CRANIAL RADIOTHERAPY; MYELOID-LEUKEMIA; ADVERSE EVENTS; COMPETING RISK; 2ND NEOPLASMS; CHILDREN; CHEMOTHERAPY	Context Little is known about the incidence of secondary neoplasms after 15 to 20 years in children and adolescents who were treated for acute lymphoblastic leukemia. Objectives To investigate the cumulative incidence of secondary neoplasms in pediatric patients treated for acute lymphoblastic leukemia over 30 years and to characterize late-occurring tumors. Design, Setting, and Patients Retrospective study of 2169 patients with acute lymphoblastic leukemia treated between 1962 and 1998 at St Jude Children's Research Hospital, Memphis, Tenn, who achieved complete remission and had a median follow-up time of 18.7 years (range, 2.4-41.3 years). Main Outcome Measures Cumulative incidences of secondary neoplasms in first remission and standard incidence ratios of observed rates compared with rates of cancer development in the general US population. Results Secondary neoplasms developed as the first event in 123 patients and comprised 46 myeloid malignancies, 3 lymphomas, 14 basal cell carcinomas, 16 other carcinomas, 6 sarcomas, 16 meningiomas, and 22 other brain tumors. The cumulative incidence of secondary neoplasm was 4.17% (SE, 0.46%) at 15 years and increased substantially after 20 years, reaching 10.85% (SE, 1.27%) at 30 years. When meningiomas and basal cell carcinomas were excluded, the overall cumulative incidence was 3.99% (SE, 0.44%) at 15 years and 6.27% (SE, 0.83%) at 30 years, representing a 13.5-fold increase in overall risk compared with the general population. The cumulative incidence of each tumor type at 30 years was 2.19% (SE, 0.32%) for myeloid malignancy, 0.17% (SE, 0.10%) for lymphoma, 3.00% (SE, 0.59%) for brain tumor, 4.91% (SE, 1.04%) for carcinoma, and 0.57% (SE, 0.37%) for sarcoma. Conclusions The cumulative incidence of secondary neoplasms increases steadily over 30 years after treatment of acute lymphoblastic leukemia. Although the majority of the late-occurring secondary neoplasms are low-grade tumors, the increase in incidence of more aggressive malignant neoplasms is significantly higher than expected in the general population. These results suggest that lifelong follow-up of acute lymphoblastic leukemia survivors is needed to ascertain the full impact of treatment and other leukemia-related factors on secondary neoplasm development.	St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pediat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci & Pharm, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Ctr Pediat Pharmacokinet & Therapeut, Memphis, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Hijiya, N (corresponding author), St Jude Childrens Hosp, Dept Oncol, MS 260,332 N Lauderdale St, Memphis, TN 38105 USA.	nobuko.hijiya@stjude.org	Rubnitz, Jeffrey E/N-2619-2018; Pui, Ching-Hon/N-8076-2018; Relling, Mary/N-5032-2018; Hudson, Melissa M/N-4441-2018; Evans, William E./C-2069-2012	Rubnitz, Jeffrey E/0000-0001-9885-3527; Pui, Ching-Hon/0000-0003-0303-5658; Hudson, Melissa M/0000-0001-6984-2407; Evans, William E./0000-0002-9333-5322; Razzouk, Bassem/0000-0003-0536-6135	NATIONAL CANCER INSTITUTE [R01CA036401, R01CA060419, R37CA036401, P30CA021765, P01CA071907, U01CA060419, R29CA051001, R01CA078224, R01CA051001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER; NCI NIH HHS [CA-71907, CA-78224, CA-21765, CA-36401, CA-51001, CA-60419] Funding Source: Medline; NIGMS NIH HHS [GM-61393] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bassal M, 2006, J CLIN ONCOL, V24, P476, DOI 10.1200/JCO.2005.02.7235; Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Bogni A, 2006, LEUKEMIA, V20, P239, DOI 10.1038/sj.leu.2404059; Breslow N E, 1987, IARC Sci Publ, P1; Dalton VMK, 1998, J CLIN ONCOL, V16, P2848, DOI 10.1200/JCO.1998.16.8.2848; Edick MJ, 2005, GENE CHROMOSOME CANC, V42, P107, DOI 10.1002/gcc.20121; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gaynon PS, 2000, LEUKEMIA, V14, P2223, DOI 10.1038/sj.leu.2401939; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Kalbfleisch JD, 2002, STAT ANAL FAILURE TI, P247; Loning L, 2000, BLOOD, V95, P2770, DOI 10.1182/blood.V95.9.2770.009k16_2770_2775; *NCI DCCPS, 2004, SEER STAT DAT INC SE; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Perkins JL, 2005, J CLIN ONCOL, V23, P3733, DOI 10.1200/JCO.2005.06.237; Pui CH, 2005, J CLIN ONCOL, V23, P7936, DOI 10.1200/JCO.2004.01.0033; PUI CH, 1995, LEUKEMIA, V9, P1680; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; PUI CH, 1991, J CLIN ONCOL, V9, P1341, DOI 10.1200/JCO.1991.9.8.1341; PUI CH, 1991, NEW ENGL J MED, V325, P1682, DOI 10.1056/NEJM199112123252402; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; Relling MV, 2003, BLOOD, V101, P3862, DOI 10.1182/blood-2002-08-2405; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; Schrappe M, 2000, BLOOD, V95, P3310; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; SIMONE J, 1972, CANCER-AM CANCER SOC, V30, P1488, DOI 10.1002/1097-0142(197212)30:6<1488::AID-CNCR2820300612>3.0.CO;2-D; Strojan P, 2000, INT J RADIAT ONCOL, V48, P65, DOI 10.1016/S0360-3016(00)00609-X; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; Zwerdling T, 2002, J PEDIAT HEMATOL ONC, V24, P199, DOI 10.1097/00043426-200203000-00008	33	203	211	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1207	1215		10.1001/jama.297.11.1207	http://dx.doi.org/10.1001/jama.297.11.1207			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	147XO	17374815	Bronze			2022-12-24	WOS:000245039300024
J	Franck, L; Chantler, C; Dixon, M				Franck, Linda; Chantler, Cyril; Dixon, Michael			Should NICE evaluate complementary and alternative medicine?	BRITISH MEDICAL JOURNAL			English	Article									UCL, Inst Child Hlth, London WC1N 1EH, England; Kings Fund, London W1G OAN, England; NHS Alliance, Nottingham DN22 6JD, England	University of London; University College London	Franck, L (corresponding author), UCL, Inst Child Hlth, London WC1N 1EH, England.	l.franck@ich.ucl.ac.uk	; Colquhoun, David/C-1664-2008	Franck, Linda/0000-0003-4291-9181; Colquhoun, David/0000-0002-4263-017X					0	15	15	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					506	506		10.1136/bmj.39122.512211.BE	http://dx.doi.org/10.1136/bmj.39122.512211.BE			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17347233	Green Submitted, Green Published			2022-12-24	WOS:000245106400034
J	Cai, L; Marshall, TW; Uetrecht, AC; Schafer, DA; Bear, JE				Cai, Liang; Marshall, Thomas W.; Uetrecht, Andrea C.; Schafer, Dorothy A.; Bear, James E.			Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge	CELL			English	Article							ACTIN-DEPOLYMERIZING FACTOR; LIM-KINASE; ENA/VASP PROTEINS; CROSS-LINKING; POLYMERIZATION; SLINGSHOT; PHOSPHATASES; PROMOTES; FAMILY; CELLS	Actin filament formation and turnover within the treadmilling actin filament array at the leading edge of migrating cells are interdependent and coupled, but the mechanisms coordinating these two activities are not understood. We report that Coronin 1B interacts simultaneously with Arp2/3 complex and Slingshot (SSH1L) phosphatase, two regulators of actin filament formation and turnover, respectively. Coronin 1B inhibits filament nucleation by Arp2/3 complex and this inhibition is attenuated by phosphorylation of Coronin 1B at Serine 2, a site targeted by SSH1L. Coronin 1B also directs SSH1L to lamellipodia where SSH1L likely regulates Cofilin activity via dephosphorylation. Accordingly, depleting Coronin 1B increases phospho-Cofilin levels, and alters lamellipodial dynamics and actin filament architecture at the leading edge. We conclude that Coronin 1B's coordination of filament formation by Arp2/3 complex and filament turnover by Cofilin is required for effective lamellipodial protrusion and cell migration.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Dev Biol, Sch Med, Chapel Hill, NC 27599 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Virginia; University of Virginia	Bear, JE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jbear@email.unc.edu			NCI NIH HHS [P30 CA016086, 1U54 CA 119343, CA 16086] Funding Source: Medline; NIGMS NIH HHS [R01 GM067222, R01 GM083035, GM 067222, R01 GM083035-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016086, U54CA119343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067222, R01GM083035] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; BRYAN J, 1985, J CELL BIOL, V101, P1236, DOI 10.1083/jcb.101.4.1236; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Cohen PTW, 2002, J CELL SCI, V115, P241; CONDEELIS J, 1988, CELL MOTIL CYTOSKEL, V10, P77, DOI 10.1002/cm.970100113; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; DesMarais V, 2004, J CELL SCI, V117, P3499, DOI 10.1242/jcs.01211; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; DINUBILE MJ, 1995, MOL BIOL CELL, V6, P1659, DOI 10.1091/mbc.6.12.1659; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Mishima M, 1999, J CELL SCI, V112, P2833; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shao D, 2006, CELL MOTIL CYTOSKEL, V63, P395, DOI 10.1002/cm.20131; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Soosairajah J, 2005, EMBO J, V24, P473, DOI 10.1038/sj.emboj.7600543; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stanyon CA, 1999, INT J BIOCHEM CELL B, V31, P389, DOI 10.1016/S1357-2725(98)00116-2; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; SVITKINA TM, 2005, J CELLS, V3, P277; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	49	171	176	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					915	929		10.1016/j.cell.2007.01.031	http://dx.doi.org/10.1016/j.cell.2007.01.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350576	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000245073400016
J	Qu, XP; Zou, ZJ; Sun, QH; Luby-Phelps, K; Cheng, PF; Hogan, RN; Gilpin, C; Levine, B				Qu, Xueping; Zou, Zhongju; Sun, Qihua; Luby-Phelps, Kate; Cheng, Pengfei; Hogan, Robert N.; Gilpin, Christopher; Levine, Beth			Autophagy gene-dependent clearance of apoptotic cells during embryonic development	CELL			English	Article							DEATH; PHOSPHATIDYLSERINE; DIFFERENTIATION; ENGULFMENT; SURVIVAL; SIGNALS; REDISTRIBUTION; INHIBITION; CAVITATION; MECHANISMS	Autophagy is commonly observed in metazoan organisms during programmed cell death (PCD), but its function in dying cells has been unclear. We studied the role of autophagy in embryonic cavitation, the earliest PCD process in mammalian development. Embryoid bodies (EBs) derived from cells lacking the autophagy genes, atg5 or beclin 1, fail to cavitate. This defect is due to persistence of cell corpses, rather than impairment of PCD. Dying cells in autophagy gene null EBs fail to express the "eat-me" signal, phosphaticlylserine exposure, and secrete lower levels of the "come-get-me" signal, lysophosphatidylcholine. These defects are associated with low levels of cellular ATIP and are reversed by treatment with the metabolic substrate, methylpyruvate. Moreover, mice lacking atg5 display a defect in apoptotic corpse engulfment during embryonic development. We conclude that autophagy contributes to dead-cell clearance during PCD by a mechanism that likely involves the generation of energy-dependent engulfment signals.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Ophthalmol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Levine, B (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409	NATIONAL CANCER INSTITUTE [R01CA109618, R01CA084254, R56CA109618] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA109618, CA 109618, R01 CA 084254] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Marguet D, 1999, NAT CELL BIOL, V1, P454, DOI 10.1038/15690; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Murray P, 2001, DIFFERENTIATION, V68, P227, DOI 10.1046/j.1432-0436.2001.680410.x; Ng YS, 2004, LAB INVEST, V84, P1209, DOI 10.1038/labinvest.3700150; POIRIER F, 1991, DEVELOPMENT, V113, P1105; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	37	500	522	0	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					931	946		10.1016/j.cell.2006.12.044	http://dx.doi.org/10.1016/j.cell.2006.12.044			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350577	Bronze			2022-12-24	WOS:000245073400017
J	Robinson, AL; Donahue, NM; Shrivastava, MK; Weitkamp, EA; Sage, AM; Grieshop, AP; Lane, TE; Pierce, JR; Pandis, SN				Robinson, Allen L.; Donahue, Neil M.; Shrivastava, Manish K.; Weitkamp, Emily A.; Sage, Amy M.; Grieshop, Andrew P.; Lane, Timothy E.; Pierce, Jeffrey R.; Pandis, Spyros N.			Rethinking organic aerosols: Semivolatile emissions and photochemical aging	SCIENCE			English	Article							AIR-POLLUTION SOURCES; SOURCE APPORTIONMENT; SECONDARY; DILUTION; MASS; OH; TROPOSPHERE; COMBUSTION; TRACERS; PM2.5	Most primary organic-particulate emissions are semivolatile; thus, they partially evaporate with atmospheric dilution, creating substantial amounts of low-volatility gas-phase material. Laboratory experiments show that photo-oxidation of diesel emissions rapidly generates organic aerosol, greatly exceeding the contribution from known secondary organic-aerosol precursors. We attribute this unexplained secondary organic-aerosol production to the oxidation of low-volatility gas-phase species. Accounting for partitioning and photochemical processing of primary emissions creates a more regionally distributed aerosol and brings model predictions into better agreement with observations. Controlling organic particulate-matter concentrations will require substantial changes in the approaches that are currently used to measure and regulate emissions.	Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; Univ Patras, Dept Chem Engn, Patras 26500, Greece	Carnegie Mellon University; University of Patras	Robinson, AL (corresponding author), Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA.	alr@andrew.cmu.edu; nmd@andrew.cmu.edu	Pandis, Spyros/AAW-3089-2021; Donahue, Neil M/A-2329-2008; Studies, Center for Atmospheric Particle/AAR-6731-2020; Worsnop, Douglas R/D-2817-2009; Pierce, Jeffrey R/E-4681-2013; Grieshop, Andrew/AAL-1174-2020; Robinson, Allen L/M-3046-2014; Pandis, Spyros/D-3680-2013; Robinson, Allen/I-5713-2012	Pandis, Spyros/0000-0001-8085-9795; Donahue, Neil M/0000-0003-3054-2364; Worsnop, Douglas R/0000-0002-8928-8017; Pierce, Jeffrey R/0000-0002-4241-838X; Grieshop, Andrew/0000-0002-6470-9946; Robinson, Allen L/0000-0002-1819-083X; Robinson, Allen/0000-0003-1053-7090				Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; Bahreini R, 2005, ENVIRON SCI TECHNOL, V39, P5674, DOI 10.1021/es048061a; Bloss WJ, 2005, FARADAY DISCUSS, V130, P425, DOI 10.1039/b419090d; Cabada JC, 2004, AEROSOL SCI TECH, V38, P140, DOI 10.1080/02786820390229084; Chung MY, 2003, ATMOS ENVIRON, V37, pS159, DOI 10.1016/S1352-2310(03)00388-1; de Gouw JA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005623; Donahue NM, 2006, ENVIRON SCI TECHNOL, V40, P2635, DOI 10.1021/es052297c; Heald CL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023831; Heard DE, 2003, CHEM REV, V103, P5163, DOI 10.1021/cr020522s; HILDEMANN LM, 1989, AEROSOL SCI TECH, V10, P193, DOI 10.1080/02786828908959234; Johnson D, 2006, ATMOS CHEM PHYS, V6, P403, DOI 10.5194/acp-6-403-2006; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; Koo BY, 2003, ATMOS ENVIRON, V37, P4757, DOI 10.1016/j.atmosenv.2003.08.016; Lim YB, 2005, ENVIRON SCI TECHNOL, V39, P9229, DOI 10.1021/es051447g; Lipsky EM, 2006, ENVIRON SCI TECHNOL, V40, P155, DOI 10.1021/es050319p; Odum JR, 1996, ENVIRON SCI TECHNOL, V30, P2580, DOI 10.1021/es950943+; Pun BK, 2003, ENVIRON SCI TECHNOL, V37, P3647, DOI 10.1021/es0341541; Schauer JJ, 1999, ENVIRON SCI TECHNOL, V33, P1578, DOI 10.1021/es980081n; Schauer JJ, 2002, ENVIRON SCI TECHNOL, V36, P1169, DOI 10.1021/es0108077; Schauer JJ, 2001, ENVIRON SCI TECHNOL, V35, P1716, DOI 10.1021/es001331e; Schauer JJ, 1996, ATMOS ENVIRON, V30, P3837, DOI 10.1016/1352-2310(96)00085-4; Shrivastava MK, 2006, ENVIRON SCI TECHNOL, V40, P2671, DOI 10.1021/es0522231; TURPIN BJ, 1995, ATMOS ENVIRON, V29, P3527, DOI 10.1016/1352-2310(94)00276-Q; Volkamer R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026899; VULUKURU S, 2006, J GEOPHYS RES, V111, pS1012; Zhang Q, 2005, ATMOS CHEM PHYS, V5, P3289, DOI 10.5194/acp-5-3289-2005; Zheng M, 2002, ENVIRON SCI TECHNOL, V36, P2361, DOI 10.1021/es011275x	27	1290	1320	43	918	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1259	1262		10.1126/science.1133061	http://dx.doi.org/10.1126/science.1133061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332409				2022-12-24	WOS:000244564700045
J	Panowski, SH; Wolff, S; Aguilaniu, H; Durieux, J; Dillin, A				Panowski, Siler H.; Wolff, Suzanne; Aguilaniu, Hugo; Durieux, Jenni; Dillin, Andrew			PHA-4/Foxa mediates diet-restriction-induced longevity of C-elegans	NATURE			English	Article							SUPEROXIDE-DISMUTASE GENE; NUCLEAR FACTOR 3-GAMMA; LIFE-SPAN; CAENORHABDITIS-ELEGANS; INSULIN-RECEPTOR; GLUCOSE-HOMEOSTASIS; OXIDATIVE STRESS; DAF-16; EXPRESSION; HEPATOCYTE	Reduced food intake as a result of dietary restriction increases the lifespan of a wide variety of metazoans and delays the onset of multiple age-related pathologies. Dietary restriction elicits a genetically programmed response to nutrient availability that cannot be explained by a simple reduction in metabolism or slower growth of the organism. In the nematode worm Caenorhabditis elegans, the transcription factor PHA-4 has an essential role in the embryonic development of the foregut and is orthologous to genes encoding the mammalian family of Foxa transcription factors, Foxa1, Foxa2 and Foxa3. Foxa family members have important roles during development, but also act later in life to regulate glucagon production and glucose homeostasis, particularly in response to fasting. Here we describe a newly discovered, adult-specific function for PHA-4 in the regulation of diet-restriction-mediated longevity in C. elegans. The role of PHA-4 in lifespan determination is specific for dietary restriction, because it is not required for the increased longevity caused by other genetic pathways that regulate ageing.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu						Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; AVERY L, 1993, GENETICS, V133, P897; Azzaria M, 1996, DEV BIOL, V178, P289, DOI 10.1006/dbio.1996.0219; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fujii M, 1998, DNA Res, V5, P25, DOI 10.1093/dnares/5.1.25; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GIGLIO AM, 1994, BIOCHEM MOL BIOL INT, V33, P41; GIGLIO MP, 1994, BIOCHEM MOL BIOL INT, V33, P37; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOPE IA, 1999, C ELEGANS PRACTICAL, P88; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MANGO SE, 1994, DEVELOPMENT, V120, P3019; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Suzuki N, 1996, DNA Res, V3, P171, DOI 10.1093/dnares/3.3.171; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	50	406	446	7	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					550	+		10.1038/nature05837	http://dx.doi.org/10.1038/nature05837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17476212				2022-12-24	WOS:000246842000039
J	Chen, CH; Huang, HX; Ward, CM; Su, JT; Schaeffer, LV; Guo, M; Hay, BA				Chen, Chun-Hong; Huang, Haixia; Ward, Catherine M.; Su, Jessica T.; Schaeffer, Lorian V.; Guo, Ming; Hay, Bruce A.			A synthetic maternal-effect selfish genetic element drives population replacement in Drosophila	SCIENCE			English	Article							ANOPHELES-GAMBIAE; RESISTANCE; MOSQUITOS; DYNAMICS; SYSTEMS	One proposed strategy for controlling the transmission of insect-borne pathogens uses a drive mechanism to ensure the rapid spread of transgenes conferring disease refractoriness throughout wild populations. Here, we report the creation of maternal-effect selfish genetic elements in Drosophila that drive population replacement and are resistant to recombination-mediated dissociation of drive and disease refractoriness functions. These selfish elements use microRNA-mediated silencing of a maternally expressed gene essential for embryogenesis, which is coupled with early zygotic expression of a rescuing transgene.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Pharmacol, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hay, BA (corresponding author), CALTECH, Div Biol, Mail Code 156-29, Pasadena, CA 91125 USA.	haybruce@caltech.edu	anand, amit/A-7222-2009; Chung, Sun-Lin/F-9574-2015; Mockler, Todd C/L-2609-2013; Albers, Pieter/I-2563-2017; Chen, Chun-Hong/E-3990-2010	Mockler, Todd C/0000-0002-0462-5775; CHEN, CHUN-HONG/0000-0002-3028-5508	NIGMS NIH HHS [GM057422, GM70956] Funding Source: Medline; NINDS NIH HHS [NS048396, NS042580] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070956, R01GM057422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS042580, R01NS048396] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060; Beeman RW, 1999, HEREDITY, V82, P529, DOI 10.1038/sj.hdy.6885150; Boete Christopher, 2002, Malaria Journal, V1, pUnpaginated; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; GEER BW, 1962, AM NAT, V96, P175, DOI 10.1086/282220; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; Kambris Z, 2003, EMBO REP, V4, P64, DOI 10.1038/sj.embor.embor714; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P10, DOI 10.1093/jmedent/31.1.10; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Smith NGC, 1998, J THEOR BIOL, V191, P173, DOI 10.1006/jtbi.1997.0579; Vernick KD, 2005, CURR TOP MICROBIOL, V295, P383; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; WADE MJ, 1994, GENETICS, V138, P1309	23	239	249	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					597	600		10.1126/science.1138595	http://dx.doi.org/10.1126/science.1138595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17395794				2022-12-24	WOS:000245983100045
J	Leibundgut, M; Jenni, S; Frick, C; Ban, N				Leibundgut, Marc; Jenni, Simon; Frick, Christian; Ban, Nenad			Structural basis for substrate delivery by acyl carrier protein in the yeast fatty acid synthase	SCIENCE			English	Article							BINDING-SITES; BIOSYNTHESIS; SYNTHETASE; IDENTIFICATION; ARCHITECTURE; RESOLUTION; REDUCTASE; PEPTIDE; ENZYMES; BIOLOGY	In the multifunctional fungal fatty acid synthase (FAS), the acyl carrier protein (ACP) domain shuttles reaction intermediates covalently attached to its prosthetic phosphopantetheine group between the different enzymatic centers of the reaction cycle. Here, we report the structure of the Saccharomyces cerevisiae FAS determined at 3.1 angstrom resolution with its ACP stalled at the active site of ketoacyl synthase. The ACP contacts the base of the reaction chamber through conserved, charge-complementary surfaces, which optimally position the ACP toward the catalytic cleft of ketoacyl synthase. The conformation of the prosthetic group suggests a switchblade mechanism for acyl chain delivery to the active site of the enzyme.	ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mol.biol.ethz.ch						Bhaumik P, 2005, CURR OPIN STRUC BIOL, V15, P621, DOI 10.1016/j.sbi.2005.10.010; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; HOLAK TA, 1988, EUR J BIOCHEM, V175, P9, DOI 10.1111/j.1432-1033.1988.tb14159.x; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; KRESZE GB, 1977, EUR J BIOCHEM, V79, P181, DOI 10.1111/j.1432-1033.1977.tb11796.x; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; MOHAMED AH, 1988, J BIOL CHEM, V263, P12315; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SCHRECKENBACH T, 1977, EUR J BIOCHEM, V80, P13, DOI 10.1111/j.1432-1033.1977.tb11850.x; SCHUSTER H, 1995, EUR J BIOCHEM, V228, P417; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; von Wettstein-Knowles P, 2006, FEBS J, V273, P695, DOI 10.1111/j.1742-4658.2005.05101.x; Weissman KJ, 2004, PHILOS T R SOC A, V362, P2671, DOI 10.1098/rsta.2004.1470; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	29	147	157	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					288	290		10.1126/science.1138249	http://dx.doi.org/10.1126/science.1138249			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431182				2022-12-24	WOS:000245654500054
J	Check, E				Check, Erika			The hard copy	NATURE			English	News Item							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; PROGENITOR CELLS; FUSION; BRAIN											Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Giles J, 2006, NATURE, V442, P344, DOI 10.1038/442344a; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Serafini M, 2007, J EXP MED, V204, P129, DOI 10.1084/jem.20061115; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	10	21	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					485	486		10.1038/446485a	http://dx.doi.org/10.1038/446485a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392761				2022-12-24	WOS:000245242900022
J	Liu, XG; Yue, YL; Li, B; Nie, YL; Li, W; Wu, WH; Ma, LG				Liu, Xigang; Yue, Yanling; Li, Bin; Nie, Yanli; Li, Wei; Wu, Wei-Hua; Ma, Ligeng			A G protein-coupled receptor is a plasma membrane receptor for the plant hormone abscisic acid	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; GAMMA-SUBUNIT; ION CHANNELS; GENE; SYSTEM; GPA1; GCR1	The plant hormone abscisic acid (ABA) regulates many physiological and developmental processes in plants. The mechanism of ABA perception at the cell surface is not understood. Here, we report that a G protein-coupled receptor genetically and physically interacts with the G protein a subunit GPA1 to mediate all known ABA responses in Arabidopsis. Overexpressing this receptor results in an ABA-hypersensitive phenotype. This receptor binds ABA with high affinity at physiological concentration with expected kinetics and stereospecificity. The binding of ABA to the receptor leads to the dissociation of the receptor-GPA1 complex in yeast. Our results demonstrate that this G protein-coupled receptor is a plasma membrane ABA receptor.	Natl Inst Biol Sci, Beijing 102206, Peoples R China; Hebei Normal Univ, Mol & Cellular Biol Lab, Shiziazhuang 050016, Hebei, Peoples R China; China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Beijing 100094, Peoples R China	National Institute of Biological Sciences, Beijing; Hebei Normal University; China Agricultural University	Ma, LG (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	maligeng@nibs.ac.cn						ANDERSON BE, 1994, PLANT PHYSIOL, V104, P1177, DOI 10.1104/pp.104.4.1177; Assmann SM, 2005, SCIENCE, V310, P71, DOI 10.1126/science.1118580; Colucci G, 2002, P NATL ACAD SCI USA, V99, P4736, DOI 10.1073/pnas.072087699; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; GILROY S, 1992, P NATL ACAD SCI USA, V89, P3591, DOI 10.1073/pnas.89.8.3591; Jeannette E, 1999, PLANT J, V18, P13, DOI 10.1046/j.1365-313X.1999.00423.x; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Plakidou-Dymock S, 1998, CURR BIOL, V8, P315, DOI 10.1016/S0960-9822(98)70131-9; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; WARD JM, 1995, PLANT CELL, V7, P833, DOI 10.1105/tpc.7.7.833; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	25	151	187	5	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1712	1716		10.1126/science.1135882	http://dx.doi.org/10.1126/science.1135882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17347412				2022-12-24	WOS:000245106900040
J	Hovi, P; Andersson, S; Eriksson, JG; Jarvenpaa, A; Strang-Karlsson, S; Makitie, O; Kajantie, E				Hovi, Petteri; Andersson, Sture; Eriksson, Johan G.; Jarvenpaa, Anna-Liisa; Strang-Karlsson, Sonja; Makitie, Outi; Kajantie, Eero			Glucose regulation in young adults with very low birth weight	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; GESTATIONAL-AGE; BLOOD-PRESSURE; PRETERM INFANTS; PLASMA-GLUCOSE; GROWTH; CHILDREN; SENSITIVITY; BORN	Background: The association between small size at birth and impaired glucose regulation later in life is well established in persons born at term. Preterm birth with very low birth weight (< 1500 g) is also associated with insulin resistance in childhood. If insulin resistance persists into adulthood, preterm birth with very low birth weight also may be associated with an increased risk of disease in adulthood. We assessed glucose tolerance and insulin sensitivity and measured serum lipid levels and blood pressure in young adults with very low birth weight. Methods: We performed a standard 75-g oral glucose-tolerance test, measuring insulin and glucose concentrations at baseline and at 120 minutes in 163 young adults (age range, 18 to 27 years) with very low birth weight and in 169 subjects who had been born at term and were not small for gestational age. The two groups were similar with regard to age, sex, and birth hospital. We measured blood pressure and serum lipid levels, and in 150 very-low-birth-weight subjects and 136 subjects born at term, we also measured body composition by means of dual-energy x-ray absorptiometry. Results: As compared with the subjects born at term, the very-low-birth-weight subjects had a 6.7% increase in the 2-hour glucose concentration (95% confidence interval [CI], 0.8 to 12.9), a 16.7% increase in the fasting insulin concentration (95% CI, 4.6 to 30.2), a 40.0% increase in the 2-hour insulin concentration (95% CI, 17.5 to 66.8), an 18.9% increase in the insulin-resistance index determined by homeostatic model assessment (95% CI, 5.7 to 33.7), and an increase of 4.8 mm Hg in systolic blood pressure (95% CI, 2.1 to 7.4). Adjustment for the lower lean body mass in the very-low-birth-weight subjects did not attenuate these relationships. Conclusions: Young adults with a very low birth weight have higher indexes of insulin resistance and glucose intolerance and higher blood pressure than those born at term.	Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FI-00300 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, Inst Clin Med, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki	Hovi, P (corresponding author), Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Mannerheimintie 166, FI-00300 Helsinki, Finland.	petteri.hovi@helsinki.fi		Eriksson, Johan/0000-0002-2516-2060; Makitie, Outi/0000-0002-4547-001X				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Arends NJT, 2005, CLIN ENDOCRINOL, V62, P44, DOI 10.1111/j.1365-2265.2004.02171.x; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bazaes RA, 2004, J CLIN ENDOCR METAB, V89, P1267, DOI 10.1210/jc.2003-031239; Bloomfield FH, 2003, SCIENCE, V300, P606, DOI 10.1126/science.1080803; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Fewtrell MS, 2000, DIABETOLOGIA, V43, P714, DOI 10.1007/s001250051368; Finken MJJ, 2006, DIABETOLOGIA, V49, P478, DOI 10.1007/s00125-005-0118-y; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Gluckman PD, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P33, DOI 10.1017/CBO9780511544699.004; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; HACK M, 1989, NEW ENGL J MED, V321, P1642, DOI 10.1056/NEJM198912143212405; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hofman PL, 2004, NEW ENGL J MED, V351, P2888; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; Hu G., 2004, DIABETOLOGIA, V47, P1245; Irving RJ, 2000, LANCET, V356, P514; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; JARVENPAA AL, 1991, ANN MED, V23, P699, DOI 10.3109/07853899109148106; Keijzer-Veen MG, 2005, PEDIATRICS, V116, P725, DOI 10.1542/peds.2005-0309; Keller H, 2000, MED SCI SPORT EXER, V32, P278, DOI 10.1097/00005768-200002000-00005; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Leger J, 1997, BRIT MED J, V315, P341; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Nijpels G, 1998, EUR J CLIN INVEST, V28, P8; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Philip AGS, 2005, PEDIATR RES, V58, P799, DOI 10.1203/01.PDR.0000151693.46655.66; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Pihkala J, 1989, Duodecim, V105, P1540; Pyorala M, 2000, DIABETES CARE, V23, P1097, DOI 10.2337/diacare.23.8.1097; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; Regan FM, 2006, PEDIATRICS, V118, P1943, DOI 10.1542/peds.2006-0733; ROBINSON S, 1992, DIABETOLOGIA, V35, P444, DOI 10.1007/BF02342441; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Stevenson CJ, 2001, ARCH DIS CHILD-FETAL, V84, pF18, DOI 10.1136/fn.84.1.F18; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; TOIVONEN E, 1986, CLIN CHEM, V32, P637	44	377	388	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2053	2063		10.1056/NEJMoa067187	http://dx.doi.org/10.1056/NEJMoa067187			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507704	Bronze			2022-12-24	WOS:000246490500006
J	Bruey, JM; Bruey-Sedano, N; Luciano, F; Zhai, DY; Balpai, R; Xu, CY; Kress, CL; Bailly-Maitre, B; Li, XQ; Osterman, A; Matsuzawa, SI; Terskikh, AV; Faustin, B; Reed, JC				Bruey, Jean-Marie; Bruey-Sedano, Nathalie; Luciano, Frederic; Zhai, Dayong; Balpai, Ruchi; Xu, Chunyan; Kress, Christina L.; Bailly-Maitre, Beatrice; Li, Xiaoqing; Osterman, Andrei; Matsuzawa, Shu-ichi; Terskikh, Alexey V.; Faustin, Benjamin; Reed, John C.			Bcl-2 and Bcl-X-L regulate proinf lammatory caspase-1 activation by interaction with NALP1	CELL			English	Article							BACTERIAL MURAMYL DIPEPTIDE; PROGRAMMED CELL-DEATH; INFLAMMATORY CASPASES; IMMUNE-SYSTEM; CYTOCHROME-C; APOPTOSIS; INNATE; IDENTIFICATION; IPAF; BAX	Caspases are intracellular proteases that cleave substrates involved in apoptosis or inflammation. In C. elegans, a paradigm for caspase regulation exists in which caspase CED-3 is activated by In ucleotide-binding protein CED-4, which is suppressed by Bcl-2-family protein CED-9. We have identified a mammalian analog of this caspase-regulatory system in the NLR-family protein NALP1, a nucleotide-dependent activator of cytokine-processing protease caspase-1, which responds to bacterial ligand muramyl-dipeptide (MDP). Antiapoptotic proteins Bcl-2 and Bcl-X-L bind and suppress NALP1, reducing caspase-1 activation and interleukin-1 beta (IL-1 beta) production. When exposed to MDP, Bcl-2-deficient macrophages exhibit more caspase-1 processing and IL-1 beta production, whereas Bcl-2-overexpressing macrophages demonstrate less caspase-1 processing and IL-1 beta production. The findings reveal an interaction of host defense and apoptosis machinery.	Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	reedoffice@burnham.org	luciano, frederic/P-6264-2016; Terskikh, Alexey/U-8407-2019	luciano, frederic/0000-0001-9253-4998; Bailly-Maitre, Beatrice/0000-0002-8389-8498				Adams JM, 2002, CURR OPIN CELL BIOL, V14, P715, DOI 10.1016/S0955-0674(02)00381-2; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Stehlik C, 2004, J EXP MED, V200, P551, DOI 10.1084/jem.20032234; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Wang SJ, 2005, DEV BIOL, V279, P205, DOI 10.1016/j.ydbio.2004.12.017; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; ZHAI D, 2006, IN PRESS CELL DEATH; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	32	248	267	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					45	56		10.1016/j.cell.2007.01.045	http://dx.doi.org/10.1016/j.cell.2007.01.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418785	Bronze			2022-12-24	WOS:000245661100010
J	Stoleru, D; Nawathean, P; Fernandez, MDLP; Menet, JS; Ceriani, MF; Rosbash, M				Stoleru, Dan; Nawathean, Pipat; Fernandez, Maria de la Paz; Menet, Jerome S.; Ceriani, M. Fernanda; Rosbash, Michael			The Drosophila circadian network is a seasonal timer	CELL			English	Article							NEGATIVE FEEDBACK LOOP; CLOCK-GENE; TRANSCRIPTIONAL REPRESSOR; FUNCTIONAL-ANALYSIS; BEHAVIORAL RHYTHMS; PACEMAKER NEURONS; LIGHT RESPONSE; PERIOD PROTEIN; CRYPTOCHROME; MELANOGASTER	Previous work in Drosophila has defined two populations of circadian brain neurons, morning cells (M-cells) and evening cells (E-cells), both of which keep circadian time and regulate morning and evening activity, respectively. It has long been speculated that a multiple oscillator circadian network in animals underlies the behavioral and physiological pattern variability caused by seasonal fluctuations of photoperiod. We have manipulated separately the circadian photoentrainment pathway within E- and M-cells and show that E-cells process light information and function as master clocks in the presence of light. M-cells in contrast need darkness to cycle autonomously and dominate the network. The results indicate that the network switches control between these two centers as a function of photoperiod. Together with the different entraining properties of the two clock centers, the results suggest that the functional organization of the network underlies the behavioral adjustment to variations in daylength and season.	Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA; Fdn Inst Leloir, Lab Genet Comportamiento, RA-1405 Buenos Aires, DF, Argentina	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Leloir Institute	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA.	rosbash@brandeis.edu	de la Paz Fernandez, Maria/ABC-5366-2020; Menet, Jerome/B-7054-2015	de la Paz Fernandez, Maria/0000-0002-9261-6114; Menet, Jerome/0000-0002-7682-0967; Ceriani, Maria/0000-0001-8945-3070	NIGMS NIH HHS [GM66778] Funding Source: Medline; NINDS NIH HHS [T32 NS007292, NS44232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292, P01NS044232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Magnusson A, 2003, CHRONOBIOL INT, V20, P189, DOI 10.1081/CBI-120019310; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Nawathean P, 2005, METHOD ENZYMOL, V393, P610, DOI 10.1016/S0076-6879(05)93032-2; Papadopoulou D, 2004, MOL CELL BIOL, V24, P4909, DOI 10.1128/MCB.24.11.4909-4919.2004; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Qiu J, 1996, MOL CELL BIOL, V16, P4182; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Ruel L, 1999, J BIOL CHEM, V274, P21790, DOI 10.1074/jbc.274.31.21790; Rush BL, 2006, J BIOL RHYTHM, V21, P272, DOI 10.1177/0748730406290416; Rutila JE, 1998, J BIOL RHYTHM, V13, P380, DOI 10.1177/074873098129000200; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Shafer OT, 2004, CURR BIOL, V14, P424, DOI 10.1016/j.cub.2004.02.038; Shafer OT, 2002, J NEUROSCI, V22, P5946; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	55	183	188	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					207	219		10.1016/j.cell.2007.02.038	http://dx.doi.org/10.1016/j.cell.2007.02.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418796	Bronze			2022-12-24	WOS:000245661100022
J	Suel, GM; Kulkarni, RP; Dworkin, J; Garcia-Ojalvo, J; Elowitz, MB				Sueel, Guerol M.; Kulkarni, Rajan P.; Dworkin, Jonathan; Garcia-Ojalvo, Jordi; Elowitz, Michael B.			Tunability and noise dependence in differentiation dynamics	SCIENCE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; SUBTILIS K-STATE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GENETIC COMPETENCE; COMK; EXPRESSION; NETWORKS; BISTABILITY; BACTERIA	The dynamic process of differentiation depends on the architecture, quantitative parameters, and noise of underlying genetic circuits. However, it remains unclear how these elements combine to control cellular behavior. We analyzed the probabilistic and transient differentiation of Bacillus subtilis cells into the state of competence. A few key parameters independently tuned the frequency of initiation and the duration of competence episodes and allowed the circuit to access different dynamic regimes, including oscillation. Altering circuit architecture showed that the duration of competence events can be made more precise. We used an experimental method to reduce global cellular noise and showed that noise levels are correlated with frequency of differentiation events. Together, the data reveal a noise-dependent circuit that is remarkably resilient and tunable in terms of its dynamic behavior.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, Green Ctr Div Syst Biol, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Dept Pharmacol, SW Med Ctr, Dallas, TX 75390 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Univ Politecn Catalunya, Dept Fis & Engn Nucl, E-08222 Terrassa, Spain	California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; California Institute of Technology; Columbia University; Universitat Politecnica de Catalunya	Elowitz, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, P50GM068763] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM068763, GM079771] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon U., 2006, MATH COMPUTATIONAL B, V10; [Anonymous], [No title captured]; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; ISHINO F, 1989, J BACTERIOL, V171, P5523, DOI 10.1128/jb.171.10.5523-5530.1989; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Maki N, 2000, J BACTERIOL, V182, P4337, DOI 10.1128/JB.182.15.4337-4342.2000; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ogura M, 1999, MOL MICROBIOL, V32, P799, DOI 10.1046/j.1365-2958.1999.01399.x; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; TETART F, 1992, MOL MICROBIOL, V6, P621, DOI 10.1111/j.1365-2958.1992.tb01509.x; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Turgay K, 1998, EMBO J, V17, P6730; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455	23	349	363	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1716	1719		10.1126/science.1137455	http://dx.doi.org/10.1126/science.1137455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379809				2022-12-24	WOS:000245106900041
J	Stone, MD; Mihalusova, M; O'Connor, CM; Prathapam, R; Collins, K; Zhuang, XW				Stone, Michael D.; Mihalusova, Mariana; O'Connor, Catherine M.; Prathapam, Ramadevi; Collins, Kathleen; Zhuang, Xiaowei			Stepwise protein-mediated RNA folding directs assembly of telomerase ribonucleoprotein	NATURE			English	Article							STEM-LOOP IV; REVERSE-TRANSCRIPTASE; ENERGY-TRANSFER; HOLOENZYME; SUBUNIT; PROCESSIVITY; COMPONENT; DISEASE	Telomerase is an essential cellular ribonucleoprotein (RNP) that solves the end replication problem and maintains chromosome stability by adding telomeric DNA to the termini of linear chromosomes(1-3). Genetic mutations that abrogate the normal assembly of telomerase RNP cause human disease(4). It is therefore of fundamental and medical importance to decipher cellular strategies for telomerase biogenesis, which will require new insights into how specific interactions occur in a precise order along the RNP assembly pathway. Here we use a single-molecule approach to dissect the individual assembly steps of telomerase. Direct observation of complex formation in real time revealed two sequential steps of protein-induced RNA folding, establishing a hierarchical RNP assembly mechanism: interaction with the telomerase holoenzyme protein p65 induces structural rearrangement of telomerase RNA, which in turn directs the binding of the telomerase reverse transcriptase to form the functional ternary complex. This hierarchical assembly process is facilitated by an evolutionarily conserved structural motif within the RNA. These results identify the RNA folding pathway during telomerase biogenesis and define the mechanism of action for an essential telomerase holoenzyme protein.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198, R01GM068518] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068518-05, R01 GM068518-01A2, R01 GM054198, R01 GM068518] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adilakshmi T, 2005, J MOL BIOL, V351, P508, DOI 10.1016/j.jmb.2005.06.020; Aigner S, 2003, BIOCHEMISTRY-US, V42, P5736, DOI 10.1021/bi034121y; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chen Y, 2006, EMBO J, V25, P3156, DOI 10.1038/sj.emboj.7601195; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Cunningham DD, 2005, MOL CELL BIOL, V25, P4442, DOI 10.1128/MCB.25.11.4442-4454.2005; Greider Carol W., 2004, Cell, VS116, pS83, DOI 10.1016/S0092-8674(04)00053-4; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Harrington L, 2003, CANCER LETT, V194, P139, DOI 10.1016/S0304-3835(02)00701-2; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Lai CK, 2003, MOL CELL, V11, P1673, DOI 10.1016/S1097-2765(03)00232-6; Mason DX, 2003, MOL CELL BIOL, V23, P5606, DOI 10.1128/MCB.23.16.5606-5613.2003; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moore MJ, 2000, METHOD ENZYMOL, V317, P109; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Prathapam R, 2005, NAT STRUCT MOL BIOL, V12, P252, DOI 10.1038/nsmb900; Richards RJ, 2006, RNA, V12, P1475, DOI 10.1261/rna.112306; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Sperger JM, 2001, BIOCHEMISTRY-US, V40, P7005, DOI 10.1021/bi0103359; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Ye AJ, 2002, INT J SYST EVOL MICR, V52, P2297, DOI 10.1099/00207713-52-6-2297; Zhuang XW, 2005, ANNU REV BIOPH BIOM, V34, P399, DOI 10.1146/annurev.biophys.34.040204.144641	26	147	150	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					458	461		10.1038/nature05600	http://dx.doi.org/10.1038/nature05600			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17322903	Green Accepted			2022-12-24	WOS:000245079500044
J	[Anonymous]				[Anonymous]			Tuberculosis and HIV in India	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		INDIA TB, 2006, 2006 RNTCP STATUS RE; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; World Health Organization, 2006, WHOHTMTB2006362	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1198	1199						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148UP	17377155				2022-12-24	WOS:000245101900002
J	Gartner, CE; Hall, WD; Vos, T; Bertram, MY; Wallace, AL; Lim, SS				Gartner, Coral E.; Hall, Wayne D.; Vos, Theo; Bertram, Melanie Y.; Wallace, Angela L.; Lim, Stephen S.			Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study	LANCET			English	Article							CIGARETTE-SMOKING; UNITED-STATES; CESSATION; PRODUCT; DEATHS; ADULTS; HEALTH; PANEL	Background Swedish snus is a smokeless tobacco product that has been suggested as a tobacco harm reduction product. Our aim was to assess the potential population health effects of snus. Methods We assessed the potential population health effects of snus in Australia with multistate life tables to estimate the difference in health-adjusted life expectancy between people who have never been smokers and various trajectories of tobacco use, including switching from smoking to snus use; and the potential for net population-level harm given different rates of snus uptake by current smokers, ex-smokers, and people who have never smoked. Findings There was little difference in health-adjusted life expectancy between smokers who quit all tobacco and smokers who switch to snus (difference of 0.1-0.3 years for men and 0.1-0.4 years for women). For net harm to occur, 14-25 ex-smokers would have to start using snus to offset the health gain from every smoker who switched to snus rather than continuing to smoke. Likewise, 14-25 people who have never smoked would need to start using snus to offset the health gain from every new tobacco user who used snus rather than smoking. Interpretation Current smokers who switch to using snus rather than continuing to smoke can realise substantial health gains. Snus could produce a net benefit to health at the population level if it is adopted in sufficient numbers by inveterate smokers. Relaxing current restrictions on the sale of snus is more likely to produce a net benefit than harm, with the size of the benefit dependent on how many inveterate smokers switch to snus.	Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of Queensland	Hall, WD (corresponding author), Univ Queensland, Sch Populat Hlth, Publ Hlth Bldg,Herston Rd, Herston, Qld 4006, Australia.	w.hall@sph.uq.edu.au	Gartner, Coral/F-7306-2010; Lim, Stephen S/B-4055-2012; Vos, Theo/F-3324-2010; Hall, Wayne D/A-3283-2008	Gartner, Coral/0000-0002-6651-8035; Hall, Wayne D/0000-0003-1984-0096				Accortt NA, 2002, AM J EPIDEMIOL, V156, P730, DOI 10.1093/aje/kwf106; AIHW, 2004, AIHW DRUG STAT SER, V16; *AM CANC SOC, 1998, CANC PREV STUD, V2; BEGG S, 2004, BURDEN DIS INJURY AU; BERTRAM MY, IN PRESS TOB CONTROL; Bondurant, 2001, CLEARING SMOKE ASSES; CHAPMAN S, 2007, PUBLIC HLTH ADVOCACY, pCH4; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Gray N, 2006, LANCET, V368, P899, DOI 10.1016/S0140-6736(06)69349-5; Hall WD, 2005, INT J DRUG POLICY, V16, P139, DOI 10.1016/j.drugpo.2005.04.002; Hill DJ, 1998, MED J AUSTRALIA, V168, P209, DOI 10.5694/j.1326-5377.1998.tb140132.x; Jamrozik K, 2005, BRIT MED J, V330, P812, DOI 10.1136/bmj.38370.496632.8F; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kozlowski LT, 2001, TOB CONTROL, V10, P201, DOI 10.1136/tc.10.3.201; Kozlowski LT, 1998, AM J PREV MED, V15, P9, DOI 10.1016/S0749-3797(98)00004-X; Levy DT, 2006, ADDICT BEHAV, V31, P1190, DOI 10.1016/j.addbeh.2005.09.010; Levy DT, 2004, CANCER EPIDEM BIOMAR, V13, P2035; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; O'Connor RJ, 2005, ADDICT BEHAV, V30, P325, DOI 10.1016/j.addbeh.2004.05.020; PETO R, 2000, CRITICAL ISSUES GLOB; Ramstrom LM, 2006, TOB CONTROL, V15, P210, DOI 10.1136/tc.2005.014969; RODU B, 1994, AM J MED SCI, V308, P32, DOI 10.1097/00000441-199407000-00007; Rodu Brad, 2006, Harm Reduct J, V3, P37, DOI 10.1186/1477-7517-3-37; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; TREWIN D, 2003, 13010 ABS; WOOLACOTT NF, 2002, HLTH TECHNOL ASSESS, V6	30	114	117	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					2010	2014		10.1016/S0140-6736(07)60677-1	http://dx.doi.org/10.1016/S0140-6736(07)60677-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17498798				2022-12-24	WOS:000247354400024
J	Charo, RA				Charo, R. Alta			Politics, parents, and prophylaxis - Mandating HPV vaccination in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				Bleakley A, 2006, ARCH PEDIAT ADOL MED, V160, P1151, DOI 10.1001/archpedi.160.11.1151; Dailard C, 2006, GUTTMACHER POLICY RE, V9, P12; Hodge James G, 2001, KY Law J, V90, P831; National Foundation for Infectious Diseases, 2005, AD VACC BRIDG STRONG	4	83	85	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1905	1908		10.1056/NEJMp078054	http://dx.doi.org/10.1056/NEJMp078054			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	165KX	17494922				2022-12-24	WOS:000246305500001
J	Weitzer, S; Martinez, J				Weitzer, Stefan; Martinez, Javier			The human RNA kinase hClp1 is active on 3 ' transfer RNA exons and short interfering RNAs	NATURE			English	Article							PROMOTES TRANSCRIPTION TERMINATION; POLYMERASE-II; CLEAVAGE; YEAST; COMPLEX; CELLS; REQUIREMENTS; PURIFICATION; RIBONUCLEASE; PROTEIN	RNA interference allows the analysis of gene function by introducing synthetic, short interfering RNAs (siRNAs) into cells(1). In contrast to siRNA and microRNA duplexes generated endogenously by the RNaseIII endonuclease Dicer(2), synthetic siRNAs display a 5' OH group. However, to become incorporated into the RNA-induced silencing complex (RISC) and mediate target RNA cleavage, the guide strand of an siRNA needs to display a phosphate group at the 5' end(3-5). The identity of the responsible kinase has so far remained elusive. Monitoring siRNA phosphorylation, we applied a chromatographic approach that resulted in the identification of the protein hClp1 ( human Clp1), a known component of both transfer RNA splicing(6) and messenger RNA 3'-end formation(7) machineries. Here we report that the kinase hClp1 phosphorylates and licenses synthetic siRNAs to become assembled into RISC for subsequent target RNA cleavage. More importantly, we reveal the physiological role of hClp1 as the RNA kinase that phosphorylates the 5' end of the 3' exon during human tRNA splicing(8), allowing the subsequent ligation of both exon halves by an unknown tRNA ligase. The investigation of this novel enzymatic activity of hClp1 in the context of mRNA 3'-end formation, where no RNA phosphorylation event has hitherto been predicted, remains a challenge for the future.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Martinez, J (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at		Martinez, Javier/0000-0001-9152-7323				Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pellino JL, 2005, RNA, V11, P1719, DOI 10.1261/rna.2102805; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; SHUMAN S, 1979, J BIOL CHEM, V254, P396; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Tanabe S, 1996, BLOOD, V88, P3535; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang LK, 2001, J BIOL CHEM, V276, P26868, DOI 10.1074/jbc.M103663200; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137; WINICOV I, 1982, MOL CELL BIOL, V2, P241, DOI 10.1128/MCB.2.3.241; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410; ZILLMANN M, 1992, J BIOL CHEM, V267, P10289	27	158	170	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					222	U8		10.1038/nature05777	http://dx.doi.org/10.1038/nature05777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495927				2022-12-24	WOS:000246338700047
J	Bielas, SL; Serneo, FF; Chechlacz, M; Deerinck, TJ; Perkins, GA; Allen, PB; Ellisman, MH; Gleeson, JG				Bielas, Stephanie L.; Serneo, Finley F.; Chechlacz, Magdalena; Deerinck, Thomas J.; Perkins, Guy A.; Allen, Patrick B.; Ellisman, Mark H.; Gleeson, Joseph G.			Spinophilin facilitates dephosphorylation of doublecortin by PP1 to mediate microtubule bundling at the axonal wrist	CELL			English	Article							NEURONAL MIGRATION; PROTEIN PHOSPHATASE-1; NEURABIN-II; GROWTH CONE; DENDRITIC SPINES; ACTIN-FILAMENTS; BINDING-PROTEIN; KINASE; CDK5; MICE	The axonal shafts of neurons contain bundled microtubules, whereas extending growth cones contain unbundled microtubule filaments, suggesting that localized activation of microtubule-associated proteins (MAP) at the transition zone may bundle these filaments during axonal growth. Dephosphorylation is thought to lead to MAP activation, but specific molecular pathways have remained elusive. We find that Spinophilin, a Protein-phosphatase 1 (PP1) targeting protein, is responsible for the dephosphorylation of the MAP Doublecortin (Dcx) Ser 297 selectively at the "wrist" of growing axons, leading to activation. Loss of activity at the "wrist" is evident as an impaired microtubule cytoskeleton along the shaft. These findings suggest that spatially restricted adaptor-specific MAP reactivation through dephosphorylation is important in organization of the neuronal cytoskeleton.	Univ Calif San Diego, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Yale University	Gleeson, JG (corresponding author), Univ Calif San Diego, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Chechlacz, Magdalena/ABB-6360-2021	Chechlacz, Magdalena/0000-0003-1811-3946; Bielas, Stephanie/0000-0003-0567-5632; Perkins, Guy/0000-0002-1834-6646	NCRR NIH HHS [P41 RR004050, P41 RR04050] Funding Source: Medline; NINDS NIH HHS [K02 NS042749, R01 NS041537-05, R01 NS041537, P30 NS047101, R01 NS14718, P30 NS047101-04, K02 NS042749-05, P30 NS047101-03S1, R01 NS014718] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537, R01NS014718, K02NS042749, P30NS047101] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; CAJAL SRY, 1988, CAJAL CEREBRAL CORTE; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Corbo JC, 2002, J NEUROSCI, V22, P7548; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; des Portes V, 1998, CELL, V92, P51; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Rothenberg ME, 2003, NEURON, V39, P779, DOI 10.1016/S0896-6273(03)00508-7; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Szebenyi G, 1998, J NEUROSCI, V18, P7930; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tsukada M, 2006, BIOCHEM BIOPH RES CO, V343, P839, DOI 10.1016/j.bbrc.2006.03.045; Tsukada M, 2005, J BIOL CHEM, V280, P11361, DOI 10.1074/jbc.M405525200; Tsukada M, 2003, MECH DEVELOP, V120, P1033, DOI 10.1016/S0925-4773(03)00177-1; Wahlsten D, 2006, GENES BRAIN BEHAV, V5, P170, DOI 10.1111/j.1601-183X.2005.00153.x; YU WQ, 1994, J NEUROSCI, V14, P2818; Zaman K, 1999, J NEUROSCI, V19, P9821	38	110	114	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					579	591		10.1016/j.cell.2007.03.023	http://dx.doi.org/10.1016/j.cell.2007.03.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482550	Green Accepted, Bronze			2022-12-24	WOS:000246373600023
J	Fukao, T; Fukuda, Y; Kiga, K; Sharif, J; Hino, K; Enomoto, Y; Kawamura, A; Nakamura, K; Takeuchi, T; Tanabe, M				Fukao, Taro; Fukuda, Yoko; Kiga, Kotaro; Sharif, Jafar; Hino, Kimihiro; Enomoto, Yutaka; Kawamura, Aya; Nakamura, Kaito; Takeuchi, Tsutomu; Tanabe, Masanobu			An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling	CELL			English	Editorial Material							TRANSCRIPTIONAL REGULATION; DIFFERENTIATION; IDENTIFICATION; C/EBP; BIOGENESIS; GENOMICS	Many microRNAs (miRNAs) are evolutionarily conserved and have intriguing expression patterns. Tissue and/or time-specific expressions of some miRNAs are presumably controlled by unique cis-acting regulatory elements that coevolved with the miRNA sequences. Exploiting bioinformatics, we identified several miRNAs whose primary transcripts could be regulated by conserved genomic elements proximal to their transcription start sites. Such miRNAs include microRNA-223 (miR-223), which is reportedly controlled by a unique regulatory mechanism during granulopoiesis. Here, we define a mechanism distinct from that previously proposed to regulate miR-223 expression. We find that the mir-223 gene resembles a "myeloid gene" and might be driven by the myeloid transcription factors, PU.1 and C/EBPs. This mechanism is specified by the conserved proximal cis-regulatory element and might be common among different species. Hence, it needs to be considered that two distinct mechanisms that would play critical roles in myeloid functions and differentiation are actually concerned with the regulation of miR-223.	Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Dept Neurol, Grad Sch Med, Bunkyo Ku, Tokyo 1138656, Japan; Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo 1608582, Japan	University of Tokyo; University of Tokyo; Keio University	Fukao, T (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	tarofukao@2002.jukuin.keio.ac.jp	Fukao, Taro/I-3246-2014; Nakamura, Kaito/AFS-6165-2022; Nakamura, Kaito/AAY-7547-2021	Nakamura, Kaito/0000-0002-1009-240X; Nakamura, Kaito/0000-0002-1009-240X; Hino, Kimihiro/0000-0003-0617-8232; Fukuda-Yuzawa, Yoko/0000-0002-9887-9820; Enomoto, Yutaka/0000-0002-6346-9362				Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Mueller BU, 2006, BLOOD, V107, P3330, DOI 10.1182/blood-2005-07-3068; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Venkatesh B, 2005, BIOESSAYS, V27, P100, DOI 10.1002/bies.20134; YAMANAKA I, 2001, NATURE, V409, P685; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	38	260	279	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					617	631		10.1016/j.cell.2007.02.048	http://dx.doi.org/10.1016/j.cell.2007.02.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482553	Bronze			2022-12-24	WOS:000246373600026
J	Whalen, EJ; Foster, MW; Matsumoto, A; Ozawa, K; Violin, JD; Que, LG; Nelson, CD; Benhar, M; Keys, JR; Rockman, HA; Koch, WJ; Daaka, Y; Lefkowitz, RJ; Stamler, JS				Whalen, Erin J.; Foster, Matthew W.; Matsumoto, Akio; Ozawa, Kentaro; Violin, Jonathan D.; Que, Loretta G.; Nelson, Chris D.; Benhar, Moran; Keys, Janelle R.; Rockman, Howard A.; Koch, Walter J.; Daaka, Yehia; Lefkowitz, Robert J.; Stamler, Jonathan S.			Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2	CELL			English	Article							NITRIC-OXIDE SYNTHASE; HEART-FAILURE; BETA-2-ADRENERGIC RECEPTOR; SMOOTH-MUSCLE; PHOSPHORYLATION; ACTIVATION; DESENSITIZATION; TRANSLOCATION; NITROSOTHIOLS; EXPRESSION	beta-adrenergic receptors (beta-ARs), prototypic G-protein-coupled receptors (GPCRs), play a critical role in regulating numerous physiological processes. The GPCR kinases (GRKs) curtail G-protein signaling and target receptors for internalization. Nitric oxide (NO) and/or S-nitrosothiols (SNOs) can prevent the loss of beta-AR signaling in vivo, but the molecular details are unknown. Here we show in mice that SNOs increase beta-AR expression and prevent agonist-stimulated receptor downregulation; and in cells, SNOs decrease GRK2-mediated beta-AR phosphorylation and subsequent recruitment of beta-arrestin to the receptor, resulting in the attenuation of receptor desensitization and internalization. In both cells and tissues, GRK2 is S-nitrosylated by SNOs as well as by NO synthases, and GRK2 S-nitrosylation increases following stimulation of multiple GPCRs with agonists. Cys340 of GRK2 is identified as a principal locus of inhibition by S-nitrosylation. Our studies thus reveal a central molecular mechanism through which GPCR signaling is regulated.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Mol Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; Jefferson University; University System of Georgia; Augusta University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu; staml001@mc.duke.edu	Benhar, Moran/AAV-5764-2020; Lefkowitz, Robert/AAW-2649-2021	Benhar, Moran/0000-0002-7094-3456; Stamler, Jonathan/0000-0002-6866-1572; Matsumoto, Akio/0000-0002-3402-6992	NHLBI NIH HHS [P01-HL075443, R01 HL16037, R01 HL61690, R01 HL70631] Funding Source: Medline; NIEHS NIH HHS [U19-ES012496] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, P01HL075443, R01HL016037, R01HL061690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES012496] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adam L, 1999, J BIOL CHEM, V274, P26337, DOI 10.1074/jbc.274.37.26337; ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Currie GP, 2006, DRUG SAFETY, V29, P647, DOI 10.2165/00002018-200629080-00002; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferro A, 1999, BRIT J PHARMACOL, V126, P1872, DOI 10.1038/sj.bjp.0702512; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; GOSINK EC, 1993, AM J PHYSIOL, V265, pC1620, DOI 10.1152/ajpcell.1993.265.6.C1620; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hansen JL, 2006, TRENDS CARDIOVAS MED, V16, P169, DOI 10.1016/j.tcm.2006.03.004; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Ju H, 1998, J BIOL CHEM, V273, P24025, DOI 10.1074/jbc.273.37.24025; Kaiser RA, 2002, CIRC RES, V91, P292, DOI 10.1161/01.RES.0000030711.21521.AC; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Kokkola T, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-21; Leclerc PC, 2006, BRIT J PHARMACOL, V148, P306, DOI 10.1038/sj.bjp.0706725; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Ostrovidov S, 2004, BIOMED MICRODEVICES, V6, P279, DOI 10.1023/B:BMMD.0000048560.96140.ca; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Tilley Douglas G, 2006, Expert Rev Cardiovasc Ther, V4, P417, DOI 10.1586/14779072.4.3.417; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Whalen EJ, 2000, HYPERTENSION, V36, P376, DOI 10.1161/01.HYP.36.3.376; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; ZHAO MM, 1993, CIRC RES, V73, P943, DOI 10.1161/01.RES.73.5.943	67	236	245	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					511	522		10.1016/j.cell.2007.02.046	http://dx.doi.org/10.1016/j.cell.2007.02.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482545	Bronze			2022-12-24	WOS:000246373600018
J	McCurry, J				McCurry, Justin			Japan unveils 5-year plan to boost clinical research	LANCET			English	Editorial Material																			0	11	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1333	1336		10.1016/S0140-6736(07)60615-1	http://dx.doi.org/10.1016/S0140-6736(07)60615-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17455378				2022-12-24	WOS:000245856100011
J	Duarte, CM; Marba, N; Holmer, M				Duarte, Carlos M.; Marba, Nuria; Holmer, Marianne			Rapid domestication of marine species	SCIENCE			English	Editorial Material							AQUACULTURE		UIB, CSIC, IMEDEA, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Mallorca, Spain; Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Southern Denmark	Duarte, CM (corresponding author), UIB, CSIC, IMEDEA, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Mallorca, Spain.	carlosduarte@imedea.uib.es	Marbà, Nuria/N-8143-2019; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Duarte, Carlos M/A-7670-2013; Marba, Nuria/H-8136-2015; Holmer, Marianne/M-6989-2014	Marbà, Nuria/0000-0002-8048-6789; Duarte, Carlos M/0000-0002-1213-1361; Marba, Nuria/0000-0002-8048-6789; Holmer, Marianne/0000-0002-6095-5488				Diamond JM, 2001, NATURE, V411, P755, DOI 10.1038/35081231; *FAO, 2006, FAOSTAT AGR; *FAO, 2006, 500 FAO UN FAO; FAO, 2006, FAO FISH INF DAT STA; GROOMBRIDGE B, 2000, GLOBAL BIODIVERSITY; Hale E. B., 1969, BEHAV DOMESTIC ANIMA, P22; Mannion AM, 1999, PROG PHYS GEOG, V23, P37, DOI 10.1191/030913399677315626; Naylor RL, 1998, SCIENCE, V282, P883, DOI 10.1126/science.282.5390.883; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Normile D, 1997, SCIENCE, V275, P309, DOI 10.1126/science.275.5298.309; Olive PJW, 1999, HYDROBIOLOGIA, V402, P175, DOI 10.1023/A:1003744610012; Pullin R.S.V., 1996, P409; Sorgeloos, 1999, WORLD AQUACULTURE, V30, P11; Woods LC, 2001, AQUACULTURE, V202, P343, DOI 10.1016/S0044-8486(01)00783-9	14	170	172	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					382	383		10.1126/science.1138042	http://dx.doi.org/10.1126/science.1138042			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446380				2022-12-24	WOS:000245813400031
J	Sano, M; Minamino, T; Toko, H; Miyauchi, H; Orimo, M; Qin, YJ; Akazawa, H; Tateno, K; Kayama, Y; Harada, M; Shimizu, I; Asahara, T; Hamada, H; Tomita, S; Molkentin, JD; Zou, YZ; Komuro, I				Sano, Masanori; Minamino, Tohru; Toko, Haruhiro; Miyauchi, Hideyuki; Orimo, Masayuki; Qin, Yingjie; Akazawa, Hiroshi; Tateno, Kaoru; Kayama, Yosuke; Harada, Mutsuo; Shimizu, Ippei; Asahara, Takayuki; Hamada, Hirofumi; Tomita, Shuhei; Molkentin, Jeffrey D.; Zou, Yunzeng; Komuro, Issei			p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; HYPOXIA; ANGIOGENESIS; HYPERTROPHY; P53; EXPRESSION; HEART; GENE; MICE	Cardiac hypertrophy occurs as an adaptive response to increased workload to maintain cardiac function(1). However, prolonged cardiac hypertrophy causes heart failure(2), and its mechanisms are largely unknown. Here we show that cardiac angiogenesis is crucially involved in the adaptive mechanism of cardiac hypertrophy and that p53 accumulation is essential for the transition from cardiac hypertrophy to heart failure. Pressure overload initially promoted vascular growth in the heart by hypoxia-inducible factor-1 (Hif-1)-dependent induction of angiogenic factors, and inhibition of angiogenesis prevented the development of cardiac hypertrophy and induced systolic dysfunction. Sustained pressure overload induced an accumulation of p53 that inhibited Hif-1 activity and thereby impaired cardiac angiogenesis and systolic function. Conversely, promoting cardiac angiogenesis by introducing angiogenic factors or by inhibiting p53 accumulation developed hypertrophy further and restored cardiac dysfunction under chronic pressure overload. These results indicate that the anti-angiogenic property of p53 may have a crucial function in the transition from cardiac hypertrophy to heart failure.	Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, Chiba 2608670, Japan; RIKEN, Ctr Dev Biol, Kobe Inst Biomed Res & Innovat, Stem Cell Translat Res,Chuo Ku, Kobe, Hyogo 6500047, Japan; Sapporo Med Univ, Dept Mol Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan; Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China; Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Chiba University; Institute for Biomedical Research & Innovation (IBRI); RIKEN; Sapporo Medical University; Tokushima University; Cincinnati Children's Hospital Medical Center; Fudan University; Fudan University	Komuro, I (corresponding author), Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	komuro-tky@umin.ac.jp	Minamino, Tohru/P-8145-2018	Minamino, Tohru/0000-0003-1627-6151; Akazawa, Hiroshi/0000-0002-3574-9607; Molkentin, Jeffery/0000-0002-3558-6529; Shimizu, Ippei/0000-0003-3333-8131				Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; MARCUS ML, 1983, AM J MED, V75, P62, DOI 10.1016/0002-9343(83)90120-1; Morani A, 2006, P NATL ACAD SCI USA, V103, P7165, DOI 10.1073/pnas.0602194103; Patel TH, 2005, CARDIOVASC RES, V68, P144, DOI 10.1016/j.cardiores.2005.05.002; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ravi R, 2000, GENE DEV, V14, P34; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Shyu KG, 2005, J BIOMED SCI, V12, P409, DOI 10.1007/s11373-005-3008-x; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Takimoto E, 2002, FASEB J, V16, DOI 10.1096/fj.01-0735com; TOMANEK RJ, 1990, J AM COLL CARDIOL, V15, P528, DOI 10.1016/0735-1097(90)90620-5; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36	24	681	704	6	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					444	448		10.1038/nature05602	http://dx.doi.org/10.1038/nature05602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17334357				2022-12-24	WOS:000245079500041
J	Robertson, MP; Scott, WG				Robertson, Michael P.; Scott, William G.			The structural basis of ribozyme-catalyzed RNA assembly	SCIENCE			English	Article							IN-VITRO SELECTION; INTERVENING SEQUENCE; HAMMERHEAD RIBOZYME; LIGASE; POLYMERIZATION; OPTIMIZATION; TETRAHYMENA; CLEAVAGE; COMPLEX; ENZYME	Life originated, according to the RNA World hypothesis, from self-replicating ribozymes that catalyzed ligation of RNA fragments. We have solved the 2.6 angstrom crystal structure of a ligase ribozyme that catalyzes regiospecific formation of a 5' to 3' phosphodiester bond between the 5'-triphosphate and the 3'-hydroxyl termini of two RNA fragments. Invariant residues form tertiary contacts that stabilize a flexible stem of the ribozyme at the ligation site, where an essential magnesium ion coordinates three phosphates. The structure of the active site permits us to suggest how transition-state stabilization and a general base may catalyze the ligation reaction required for prebiotic RNA assembly.	Univ Calif Santa Cruz, Ctr Mol Biol RNA, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Chem & Biochem, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Scott, WG (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA.	wgscott@chemistry.ucsc.edu		Scott, William/0000-0002-9273-3564	NIGMS NIH HHS [R01 GM087721] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bandyopadhyay D, 2003, J BIOMOL STRUCT DYN, V21, P447, DOI 10.1080/07391102.2003.10506939; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Doudna JA, 2002, NATURE, V418, P222, DOI 10.1038/418222a; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; GERRIERTAKADA C, 1983, CELL, V35, P849; GESTELAND RF, 1993, RNA WORLD; Ikawa Y, 2004, P NATL ACAD SCI USA, V101, P13750, DOI 10.1073/pnas.0405886101; Jaeger L, 1999, P NATL ACAD SCI USA, V96, P14712, DOI 10.1073/pnas.96.26.14712; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Landweber LF, 1999, P NATL ACAD SCI USA, V96, P173, DOI 10.1073/pnas.96.1.173; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Lawrence MS, 2003, BIOCHEMISTRY-US, V42, P8748, DOI 10.1021/bi034228l; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; McGinness KE, 2003, CHEM BIOL, V10, P5, DOI 10.1016/S1074-5521(03)00003-6; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; Robertson MP, 2000, NUCLEIC ACIDS RES, V28, P1751, DOI 10.1093/nar/28.8.1751; Robertson MP, 2004, RNA, V10, P114, DOI 10.1261/rna.5900204; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; Robertson MP, 2001, NAT BIOTECHNOL, V19, P650, DOI 10.1038/90256; Robertson MP, 2001, RNA, V7, P513, DOI 10.1017/S1355838201002199; Rogers J, 1999, NATURE, V402, P323, DOI 10.1038/46335; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911	24	73	78	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1549	1553		10.1126/science.1136231	http://dx.doi.org/10.1126/science.1136231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363667	Green Submitted			2022-12-24	WOS:000244934800044
J	Saarela, JM; Rai, HS; Doyle, JA; Endress, PK; Mathews, S; Marchant, AD; Briggs, BG; Graham, SW				Saarela, Jeffery M.; Rai, Hardeep S.; Doyle, James A.; Endress, Peter K.; Mathews, Sarah; Marchant, Adam D.; Briggs, Barbara G.; Graham, Sean W.			Hydatellaceae identified as a new branch near the base of the angiosperm phylogenetic tree	NATURE			English	Article							EARLY EVOLUTION; GENES; MITOCHONDRIAL; FAMILIES; GENOME	Although the relationship of angiosperms to other seed plants remains controversial 1, great progress has been made in identifying the earliest extant splits in flowering-plant phylogeny, with the discovery that the New Caledonian shrub Amborella trichopoda, the water lilies (Nymphaeales), and the woody Austrobaileyales constitute a basal grade of lines that diverged before the main radiation in the clade(2-8). By focusing attention on these ancient lines, this finding has re-written our understanding of angiosperm structural and reproductive biology, physiology, ecology and taxonomy(9-12). The discovery of a new basal lineage would lead to further re-evaluation of the initial angiosperm radiation, but would also be unexpected, as nearly all of the 460 flowering-plant families have been surveyed in molecular studies(10). Here we show that Hydatellaceae, a small family of dwarf aquatics that were formerly interpreted as monocots, are instead a highly modified and previously unrecognized ancient lineage of angiosperms. Molecular phylogenetic analyses of multiple plastid genes and associated noncoding regions from the two genera of Hydatellaceae identify this overlooked family as the sister group of Nymphaeales. This surprising result is further corroborated by evidence from the nuclear gene phytochrome C (PHYC), and by numerous morphological characters. This indicates that water lilies are part of a larger lineage that evolved more extreme and diverse modifications for life in an aquatic habitat than previously recognized.	Univ British Columbia, Fac Land & Food Syst, Ctr Biodivers Res, Plant Res Ctr, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, UBC Bot Garden, Vancouver, BC V6T 1Z4, Canada; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Zurich, Inst Systemat Bot, CH-8008 Zurich, Switzerland; Harvard Univ, Arnold Arboretum, Cambridge, MA 02138 USA; Royal Bot Gardens, Sydney, NSW 2000, Australia	University of British Columbia; University of British Columbia; University of California System; University of California Davis; University of Zurich; Harvard University	Graham, SW (corresponding author), Univ British Columbia, Fac Land & Food Syst, Ctr Biodivers Res, Plant Res Ctr, 2357 Main Mall, Vancouver, BC V6T 1Z4, Canada.	swgraham@interchange.ubc.ca	Graham, Sean W/L-3944-2014; Mathews, Sarah/A-6513-2015	Graham, Sean W/0000-0001-8209-5231; Mathews, Sarah/0000-0002-5518-7541; Saarela, Jeffery/0000-0003-1790-4332				APPEL O, 1998, FAMILIES GENERA VASC, V4, P208; Borsch T, 2003, J EVOLUTION BIOL, V16, P558, DOI 10.1046/j.1420-9101.2003.00577.x; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Burleigh JG, 2004, AM J BOT, V91, P1599, DOI 10.3732/ajb.91.10.1599; Chase Mark W., 2006, Aliso, V22, P63; COOKE DA, 1998, FAMILIES GENERA VASC, V4, P106; Dahlgren R.M.T., 1985, FAMILIES MONOCOTYLED, P520, DOI [10.1007/978-3-642-61663-1, DOI 10.1007/978-3-642-61663-1]; Doyle JA, 2005, GRANA, V44, P227, DOI 10.1080/00173130500424557; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Feild TS, 2004, PALEOBIOLOGY, V30, P82, DOI 10.1666/0094-8373(2004)030<0082:DADANI>2.0.CO;2; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999; GRAHAM SW, 2006, MONOCOTS COMP BIOL E, P3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAMANN U, 1976, New Zealand Journal of Botany, V14, P193; HAMANN U, 1975, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V96, P154; Hamann U., 1998, FAMILIES GENERA VASC, V4, P231, DOI [DOI 10.1007/978-3-662-03531-3_23, 10.1007/978-3-662-03531-3_23]; Harden GJ., 1993, FLORA NEW S WALES VO, V4; Kim S, 2004, MOL PHYLOGENET EVOL, V31, P16, DOI 10.1016/j.ympev.2003.07.017; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Mathews S, 2000, INT J PLANT SCI, V161, pS41, DOI 10.1086/317582; Michelangeli FA, 2003, AM J BOT, V90, P93, DOI 10.3732/ajb.90.1.93; Morrison D. A., 2000, MONOCOTS SYSTEMATICS; Qiu YL, 2005, INT J PLANT SCI, V166, P815, DOI 10.1086/431800; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Williams JH, 2004, AM J BOT, V91, P332, DOI 10.3732/ajb.91.3.332; Zanis MJ, 2002, P NATL ACAD SCI USA, V99, P6848, DOI 10.1073/pnas.092136399	31	183	199	0	54	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					312	315		10.1038/nature05612	http://dx.doi.org/10.1038/nature05612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361182	Green Published			2022-12-24	WOS:000244892900044
J	Maga, G; Villani, G; Crespan, E; Wimmer, U; Ferrari, E; Bertocci, B; Hubscher, U				Maga, Giovanni; Villani, Giuseppe; Crespan, Emmanuele; Wimmer, Ursula; Ferrari, Elena; Bertocci, Barbara; Huebscher, Ulrich			8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins	NATURE			English	Article							CELL NUCLEAR ANTIGEN; IN-VITRO; REPLICATION; LAMBDA; BETA; ETA; ALPHA; IOTA; PCNA; MU	Specialized DNA polymerases (DNA pols) are required for lesion bypass in human cells(1). Auxiliary factors have an important, but so far poorly understood, role. Here we analyse the effects of human proliferating cell nuclear antigen (PCNA) and replication protein A (RP-A) on six different human DNA pols - belonging to the B, Y and X classes - during in vitro bypass of different lesions. The mutagenic lesion 8-oxo-guanine (8-oxo-G) has high miscoding potential(2-4). A major and specific effect was found for 8-oxo-G bypass with DNA pols lambda and eta. PCNA and RP-A allowed correct incorporation of dCTP opposite a 8-oxo-G template 1,200-fold more efficiently than the incorrect dATP by DNA pol lambda, and 68-fold by DNA pol eta, respectively. Experiments with DNA-pol-lambda-null cell extracts suggested an important role for DNA pol lambda. On the other hand, DNA pol iota, together with DNA pols a, delta and beta, showed a much lower correct bypass efficiency. Our findings show the existence of an accurate mechanism to reduce the deleterious consequences of oxidative damage and, in addition, point to an important role for PCNA and RP-A in determining a functional hierarchy among different DNA pols in lesion bypass.	CNR, Inst Mol Genet IGM, I-27100 Pavia, Italy; CNRS, IPBS, F-31077 Toulouse, France; Univ Paris 05, Fac Med Rene Descartes, Inst Natl Francais Rech Med, F-75730 Paris, France; Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Zurich	Maga, G (corresponding author), CNR, Inst Mol Genet IGM, Via Abbiategrasso 207, I-27100 Pavia, Italy.	maga@igm.cnr.it	Crespan, Emmanuele/F-3899-2018; Bertocci, Barbara/L-9115-2018; Maga, Giovanni/C-5409-2009	Crespan, Emmanuele/0000-0003-0597-6929; Maga, Giovanni/0000-0001-8092-1552				Bassett E, 2002, DNA REPAIR, V1, P1003, DOI 10.1016/S1568-7864(02)00150-7; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; HOFFMANN JS, 1995, P NATL ACAD SCI USA, V92, P5356, DOI 10.1073/pnas.92.12.5356; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Maga G, 2006, NUCLEIC ACIDS RES, V34, P1405, DOI 10.1093/nar/gkl032; Maga G, 2005, J BIOL CHEM, V280, P1971, DOI 10.1074/jbc.M411650200; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Maga G, 2001, J BIOL CHEM, V276, P18235, DOI 10.1074/jbc.M009599200; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vaisman A, 2001, EMBO J, V20, P6520, DOI 10.1093/emboj/20.22.6520; WEISER T, 1991, J BIOL CHEM, V266, P10420; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200	19	186	196	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					606	+		10.1038/nature05843	http://dx.doi.org/10.1038/nature05843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17507928				2022-12-24	WOS:000246842000052
J	Aelony, Y				Aelony, Yossef			Talc pleurodesis and acute respiratory distress syndrome	LANCET			English	Editorial Material							MALIGNANT PLEURAL EFFUSION; POUDRAGE; SLURRY		Harbor UCLA Med Ctr, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Aelony, Y (corresponding author), Harbor UCLA Med Ctr, Torrance, CA 90502 USA.	y.aelony@cox.net						Aelony Y, 2004, AM J RESP CRIT CARE, V169, P1075; Aelony Y, 1998, CHEST, V113, P1007, DOI 10.1378/chest.113.4.1007; AELONY Y, 2002, CHEST, V165, pA35; BOUTIN C, 1991, PRACTICAL THORACOSCO, P68; Dresler CM, 2005, CHEST, V127, P909, DOI 10.1378/chest.127.3.909; Ferrer J, 2001, CHEST, V119, P1901, DOI 10.1378/chest.119.6.1901; Janssen JP, 2007, LANCET, V369, P1535, DOI 10.1016/S0140-6736(07)60708-9; Manes Nuria, 2000, Chest, V118, p131S; Montes JF, 2003, AM J RESP CRIT CARE, V168, P348, DOI 10.1164/rccm.200207-767OC; Rehse DH, 1999, AM J SURG, V177, P437, DOI 10.1016/S0002-9610(99)00075-6; RINALDO JE, 1983, J THORAC CARDIOV SUR, V85, P523; SANCHEZARMENGOL A, 1993, CHEST, V104, P1482, DOI 10.1378/chest.104.5.1482; Tremblay A, 2006, CHEST, V129, P362, DOI 10.1378/chest.129.2.362; Viallat JR, 1996, CHEST, V110, P1387, DOI 10.1378/chest.110.6.1387; Yim APC, 1996, ANN THORAC SURG, V62, P1655, DOI 10.1016/S0003-4975(96)00808-9	15	11	11	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1494	1496		10.1016/S0140-6736(07)60685-0	http://dx.doi.org/10.1016/S0140-6736(07)60685-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482965				2022-12-24	WOS:000246215800005
J	Smith, CE; Llorente, B; Symington, LS				Smith, Catherine E.; Llorente, Bertrand; Symington, Lorraine S.			Template switching during break-induced replication	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; GENE CONVERSION; REPAIR; DNA; MODEL; GAPS; DUPLICATION; DROSOPHILA	DNA double-strand breaks (DSBs) are potentially lethal lesions that arise spontaneously during normal cellular metabolism, as a consequence of environmental genotoxins or radiation, or during programmed recombination processes. Repair of DSBs by homologous recombination generally occurs by gene conversion resulting from transfer of information from an intact donor duplex to both ends of the break site of the broken chromosome(1). In mitotic cells, gene conversion is rarely associated with reciprocal exchange and thus limits loss of heterozygosity for markers downstream of the site of repair and restricts potentially deleterious chromosome rearrangements(2-5). DSBs that arise by replication fork collapse or by erosion of uncapped telomeres have only one free end and are thought to repair by strand invasion into a homologous duplex DNA followed by replication to the chromosome end (break-induced replication, BIR)(6). BIR from one of the two ends of a DSB would result in loss of heterozygosity, suggesting that BIR is suppressed when DSBs have two ends so that repair occurs by the more conservative gene conversion mechanism. Here we show that BIR can occur by several rounds of strand invasion, DNA synthesis and dissociation. We further show that chromosome rearrangements can occur during BIR if dissociation and reinvasion occur within dispersed repeated sequences. This dynamic process could function to promote gene conversion by capture of the displaced invading strand at two-ended DSBs to prevent BIR.	Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Paris 06, Inst Pasteur, UFR 927, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 2171, Unite Genet Mol Levures, F-75724 Paris 15, France	Columbia University; Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Symington, LS (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, 701 W 169th St, New York, NY 10032 USA.	lss5@columbia.edu	llorente, bertrand/M-3501-2016	Smith, Catherine/0000-0001-6779-8035; Llorente, Bertrand/0000-0002-6291-5797	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041784-19, R01 GM041784, R01 GM041784-18] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Aguilera A, 2001, TRENDS GENET, V17, P318, DOI 10.1016/S0168-9525(01)02309-5; Bartsch S, 2000, MOL CELL BIOL, V20, P1194, DOI 10.1128/MCB.20.4.1194-1205.2000; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Ferguson DO, 1996, P NATL ACAD SCI USA, V93, P5419, DOI 10.1073/pnas.93.11.5419; JINKSROBERTSON S, 1986, GENETICS, V114, P731; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; McVey M, 2004, GENETICS, V167, P699, DOI 10.1534/genetics.103.025411; Merker JD, 2003, GENETICS, V165, P47; Morrow DM, 1997, GENETICS, V147, P371; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Nickoloff JA, 1999, GENETICS, V153, P665; RAY A, 1989, P NATL ACAD SCI USA, V86, P6225, DOI 10.1073/pnas.86.16.6225; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Stark JM, 2003, MOL CELL BIOL, V23, P733, DOI 10.1128/MCB.23.2.733-743.2003; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; WHITE MA, 1994, CURR GENET, V26, P21, DOI 10.1007/BF00326300	26	256	259	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					102	105		10.1038/nature05723	http://dx.doi.org/10.1038/nature05723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17410126				2022-12-24	WOS:000246149300052
J	Fine, PEM; Griffiths, UK				Fine, Paul E. M.; Griffiths, Ulla Kou			Global poliomyelitis eradication: status and implications	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Fine, PEM (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Paul.fine@lshtm.ac.uk						Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; Dowdle W, 2006, RISK ANAL, V26, P1449, DOI 10.1111/j.1539-6924.2006.00844.x; Fine P E, 2001, Dev Biol (Basel), V105, P129; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; *GAVI, 2006, GAVI ROADM; GRASSLY NC, 2007, LANCET; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; Thomsen C, 2001, ANN PHYS-BERLIN, V10, P7; WHO, 2006, WKLY EPIDEMIOL REC, V81, P453; WHO, 2006, WKLY EPIDEMIOL REC, V81, P465	12	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1321	1322		10.1016/S0140-6736(07)60533-9	http://dx.doi.org/10.1016/S0140-6736(07)60533-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448799				2022-12-24	WOS:000245856100004
J	Odling-Smee, L				Odling-Smee, Lucy			Biofuels bandwagon hits a rut	NATURE			English	News Item																			0	12	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					483	483		10.1038/446483a	http://dx.doi.org/10.1038/446483a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392760	Bronze			2022-12-24	WOS:000245242900021
J	Veiga-Fernandes, H; Coles, MC; Foster, KE; Patel, A; Williams, A; Natarajan, D; Barlow, A; Pachnis, V; Kioussis, D				Veiga-Fernandes, Henrique; Coles, Mark C.; Foster, Katie E.; Patel, Amisha; Williams, Adam; Natarajan, Dipa; Barlow, Amanda; Pachnis, Vassilis; Kioussis, Dimitris			Tyrosine kinase receptor RET is a key regulator of Peyer's Patch organogenesis	NATURE			English	Article							PERIPHERAL LYMPHOID ORGANS; BETA-DEFICIENT MICE; ABNORMAL-DEVELOPMENT; LYMPHOTOXIN-ALPHA; NERVOUS-SYSTEM; LACKING GDNF; T-CELLS; EXPRESSION; DEFECTS; TISSUES	Normal organogenesis requires co-ordinate development and interaction of multiple cell types, and is seemingly governed by tissue specific factors. Lymphoid organogenesis during embryonic life is dependent on molecules the temporal expression of which is tightly regulated. During this process, haematopoietic 'inducer' cells interact with stromal 'organizer' cells, giving rise to the lymphoid organ primordia(1). Here we show that the haematopoietic cells in the gut exhibit a random pattern of motility before aggregation into the primordia of Peyer's patches, a major component of the gut-associated lymphoid tissue. We further show that a CD45(+)CD4(-)CD3(-)Il7R alpha(-) c-Kit(+) CD11c(+) haematopoietic population expressing lymphotoxin has an important role in the formation of Peyer's patches. A subset of these cells expresses the receptor tyrosine kinase RET, which is essential for mammalian enteric nervous system formation(2). We demonstrate that RET signalling is also crucial for Peyer's patch formation. Functional genetic analysis revealed that Gfra3-deficiency results in impairment of Peyer's patch development, suggesting that the signalling axis RET/GFR alpha 3/ARTN is involved in this process. To support this hypothesis, we show that the RET ligand ARTN is a strong attractant of gut haematopoietic cells, inducing the formation of ectopic Peyer's patch-like structures. Our work strongly suggests that the RET signalling pathway, by regulating the development of both the nervous and lymphoid system in the gut, has a key role in the molecular mechanisms that orchestrate intestine organogenesis.	Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Kioussis, D (corresponding author), Natl Inst Med Res, MRC, Div Mol Immunol, Ridgeway Mill Hill, London NW7 1AA, England.	dkiouss@nimr.mrc.ac.uk		Veiga-Fernandes, Henrique/0000-0001-6216-1836; Pachnis, Vassilis/0000-0001-9733-7686	Medical Research Council [MC_U117537087, MC_U117512796, G0601156] Funding Source: Medline; MRC [MC_U117537087, G0601156, MC_U117512796] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BANKS TA, 1995, J IMMUNOL, V155, P1685; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Coles MC, 2006, P NATL ACAD SCI USA, V103, P13457, DOI 10.1073/pnas.0604183103; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Vargas-Leal V, 2005, J IMMUNOL, V175, P2301, DOI 10.4049/jimmunol.175.4.2301; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	33	202	209	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					547	551		10.1038/nature05597	http://dx.doi.org/10.1038/nature05597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17322904				2022-12-24	WOS:000245242900051
J	Baran, PS; Maimone, TJ; Richter, JM				Baran, Phil S.; Maimone, Thomas J.; Richter, Jeremy M.			Total synthesis of marine natural products without using protecting groups	NATURE			English	Article							ENANTIOSELECTIVE SYNTHESIS; HAPALOSIPHON-FONTINALIS; CARBONYL-COMPOUNDS; ORGANIC-SYNTHESIS; ALKALOIDS; HAPALINDOLES; PALLADIUM; INDOLES; CYCLIZATION; DISCOVERY	The field of organic synthesis has made phenomenal advances in the past fifty years, yet chemists still struggle to design synthetic routes that will enable them to obtain sufficient quantities of complex molecules for biological and medical studies. Total synthesis is therefore increasingly focused on preparing natural products in the most efficient manner possible. Here we describe the preparative-scale, enantioselective, total syntheses of members of the hapalindole, fischerindole, welwitindolinone and ambiguine families, each constructed without the need for protecting groups - the use of such groups adds considerably to the cost and complexity of syntheses. As a consequence, molecules that have previously required twenty or more steps to synthesize racemically in milligram amounts can now be obtained as single enantiomers in significant quantities in ten steps or less. Through the extension of the general principles demonstrated here, it should be possible to access other complex molecular architectures without using protecting groups.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu						Baran PS, 2006, J AM CHEM SOC, V128, P14028, DOI 10.1021/ja0659673; Baran PS, 2005, J AM CHEM SOC, V127, P15394, DOI 10.1021/ja056171r; Baran PS, 2005, ANGEW CHEM INT EDIT, V44, P609, DOI 10.1002/anie.200462048; Baran PS, 2004, J AM CHEM SOC, V126, P7450, DOI 10.1021/ja047874w; BERTZ SH, 1982, J AM CHEM SOC, V104, P5801, DOI 10.1021/ja00385a049; BURNS B, 1988, TETRAHEDRON LETT, V29, P4329, DOI 10.1016/S0040-4039(00)80489-X; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; D?rwald F.Z., 2005, SIDE REACTIONS ORGAN; ESCHENMOSER A, 1988, ANGEW CHEM INT EDIT, V27, P5, DOI 10.1002/anie.198800051; EVANS DA, 2004, SYNTHESIS DESIGN OXI; Faber K, 2018, BIOTRANSFORMATIONS O, P134, DOI 10.1007/978-3-319-61590-5; Green T. W., 1999, PROTECTIVE GROUPS OR, V3rd; HEATHCOCK CH, 1992, ANGEW CHEM INT EDIT, V31, P665, DOI 10.1002/anie.199206653; HENDRICKSON JB, 1975, J AM CHEM SOC, V97, P5784, DOI 10.1021/ja00853a023; HERRMANN WA, 1995, ANGEW CHEM INT EDIT, V34, P1844, DOI 10.1002/anie.199518441; Hoffmann RW, 2006, SYNTHESIS-STUTTGART, P3531, DOI 10.1055/s-2006-950311; HOVEYDA AH, 1993, CHEM REV, V93, P1307, DOI 10.1021/cr00020a002; Hudlicky T, 1996, CHEM REV, V96, P3, DOI 10.1021/cr950012g; Kocienski P. J, 2005, PROTECTING GROUPS; LAROCK RC, 1987, TETRAHEDRON LETT, V28, P5291, DOI 10.1016/S0040-4039(00)96710-8; MEHTA G, 1994, J CHEM SOC CHEM COMM, P2759, DOI 10.1039/c39940002759; MOORE RE, 1984, J AM CHEM SOC, V106, P6456, DOI 10.1021/ja00333a079; MOORE RE, 1987, J ORG CHEM, V52, P1036, DOI 10.1021/jo00382a012; MURATAKE H, 1990, TETRAHEDRON, V46, P6351, DOI 10.1016/S0040-4020(01)96007-7; Nicolaou K., 2003, CLASSICS TOTAL SYNTH, VII; Nicolaou KC, 2006, ANGEW CHEM INT EDIT, V45, P7134, DOI 10.1002/anie.200601872; Nicolaou K. C., 1996, CLASSICS TOTAL SYNTH; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4442, DOI 10.1002/anie.200500368; Nicolaou KC, 2004, P NATL ACAD SCI USA, V101, P11929, DOI 10.1073/pnas.0403799101; OIKAWA Y, 1977, J ORG CHEM, V42, P1213, DOI 10.1021/jo00427a024; Raveh A, 2007, J NAT PROD, V70, P196, DOI 10.1021/np060495r; Reisman SE, 2006, J AM CHEM SOC, V128, P1448, DOI 10.1021/ja057640s; Schkeryantz JM, 1999, J AM CHEM SOC, V121, P11964, DOI 10.1021/ja9925249; Scholz U, 2000, NAT PROD REP, V17, P349, DOI 10.1039/a902278c; SEEBACH D, 1990, ANGEW CHEM INT EDIT, V29, P1320, DOI 10.1002/anie.199013201; Service RF, 1999, SCIENCE, V285, P184, DOI 10.1126/science.285.5425.184; SHELLHAMER DF, 1991, J CHEM SOC PERK T 2, P401, DOI 10.1039/p29910000401; Sierra M. A., 2004, DEAD ENDS DETOURS DI; SMITKA TA, 1992, J ORG CHEM, V57, P857, DOI 10.1021/jo00029a014; STRATMANN K, 1994, J AM CHEM SOC, V116, P9935, DOI 10.1021/ja00101a015; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; Turro N. J., 1991, MODERN MOL PHOTOCHEM; Vanderwal CD, 2003, J AM CHEM SOC, V125, P5393, DOI 10.1021/ja021472b; Wender P. A., 1993, ORGANIC SYNTHESIS TH, P27; Wender PA, 1996, CHEM REV, V96, P1, DOI 10.1021/cr9500803; Wilson RM, 2006, J ORG CHEM, V71, P8329, DOI 10.1021/jo0610053; Wohler F., 1828, ANN PHYS CHEM, V88, P253, DOI DOI 10.1002/ANDP.18280880206	48	377	391	6	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					404	408		10.1038/nature05569	http://dx.doi.org/10.1038/nature05569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	148MO	17377577				2022-12-24	WOS:000245079500032
J	Mayr, C; Hemann, MT; Bartel, DP				Mayr, Christine; Hemann, Michael T.; Bartel, David P.			Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation	SCIENCE			English	Article							MESSENGER-RNAS; PROTEIN GENE; C GENE; MICRORNAS; EXPRESSION; SEQUENCE; LIPOMAS; ADENOMA; FUSION; FAMILY	MicroRNAs ( miRNAs) are similar to 22-nucleotide RNAs that can pair to sites within messenger RNAs to specify posttranscriptional repression of these messages. Aberrant miRNA expression can contribute to tumorigenesis, but which of the many miRNA-target relationships are relevant to this process has been unclear. Here, we report that chromosomal translocations previously associated with human tumors disrupt repression of High Mobility Group A2 (Hmga2) by let-7 miRNA. This disrupted repression promotes anchorage-independent growth, a characteristic of oncogenic transformation. Thus, losing miRNA-directed repression of an oncogene provides a mechanism for tumorigenesis, and disrupting a single miRNA-target interaction can produce an observable phenotype in mammalian cells.	MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068348] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIDDK NIH HHS [R01 DK068348, R01 DK068348-03, R01 DK068348-01, R01 DK068348-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baldassarre G, 2001, P NATL ACAD SCI USA, V98, P7970, DOI 10.1073/pnas.141224998; Battista S, 1999, CANCER RES, V59, P4793; Borrmann L, 2001, ONCOGENE, V20, P4537, DOI 10.1038/sj.onc.1204577; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fedele M, 1998, ONCOGENE, V17, P413, DOI 10.1038/sj.onc.1201952; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; Geurts JMW, 1997, CANCER RES, V57, P13; Geurts JMW, 1997, CANCER GENET CYTOGEN, V95, P198, DOI 10.1016/S0165-4608(96)00411-6; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Inoue N, 2006, BLOOD, V108, P4232, DOI 10.1182/blood-2006-05-025148; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mine N, 2001, JPN J CANCER RES, V92, P135, DOI 10.1111/j.1349-7006.2001.tb01075.x; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; Schoenmakers EFPM, 1999, CANCER RES, V59, P19; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Sgarra R, 2004, FEBS LETT, V574, P1, DOI 10.1016/j.febslet.2004.08.013; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	27	897	971	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1576	1579		10.1126/science.1137999	http://dx.doi.org/10.1126/science.1137999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17322030	Green Accepted			2022-12-24	WOS:000244934800053
J	Friedman, RA; Leon, AC				Friedman, Richard A.; Leon, Andrew C.			Expanding the black box - Depression, antidepressants, and the risk of suicide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Weil Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA		Friedman, RA (corresponding author), Weil Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA.							*AM PSYCH ASS, 2003, AM J PSYCHIAT S11, V160; Gibbons RD, 2006, AM J PSYCHIAT, V163, P1898, DOI 10.1176/appi.ajp.163.11.1898; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Harris G., 2004, NEW YORK TIMES, pC1; Leon AC, 2006, J AM ACAD CHILD PSY, V45, P1054, DOI 10.1097/01.chi.0000227875.12286.a2	5	100	104	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2343	2346		10.1056/NEJMp078015	http://dx.doi.org/10.1056/NEJMp078015			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175QY	17485726				2022-12-24	WOS:000247029300002
J	Martin, S; Nishimune, A; Mellor, JR; Henley, JM				Martin, Stephane; Nishimune, Atsushi; Mellor, Jack R.; Henley, Jeremy M.			SUMOylation regulates kainate-receptor-mediated synaptic transmission	NATURE			English	Article							DIFFERENTIAL REGULATION; SUMO; AMPA; PROTEINS	The small ubiquitin-like modifier protein (SUMO) regulates transcriptional activity and the translocation of proteins across the nuclear membrane(1). The identification of SUMO substrates outside the nucleus is progressing(2) but little is yet known about the wider cellular role of protein SUMOylation. Here we report that in rat hippocampal neurons multiple SUMOylation targets are present at synapses and we show that the kainate receptor subunit GluR6 is a SUMO substrate. SUMOylation of GluR6 regulates endocytosis of the kainate receptor and modifies synaptic transmission. GluR6 exhibits low levels of SUMOylation under resting conditions and is rapidly SUMOylated in response to a kainate but not an N-methyl-D-aspartate ( NMDA) treatment. Reducing GluR6 SUMOylation using the SUMO-specific isopeptidase SENP1 prevents kainate-evoked endocytosis of the kainate receptor. Furthermore, a mutated non-SUMOylatable form of GluR6 is not endocytosed in response to kainate in COS-7 cells. Consistent with this, electrophysiological recordings in hippocampal slices demonstrate that kainate-receptor-mediated excitatory postsynaptic currents are decreased by SUMOylation and enhanced by deSUMOylation. These data reveal a previously unsuspected role for SUMO in the regulation of synaptic function.	Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Bristol BS8 1TD, Avon, England	University of Bristol	Henley, JM (corresponding author), Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Univ Walk, Bristol BS8 1TD, Avon, England.	j.m.henley@bris.ac.uk	Martin, Stéphane/G-5954-2012; Henley, Jeremy M/A-2776-2009; MELLOR, Jack/B-4548-2019	Martin, Stéphane/0000-0001-6771-7645; MELLOR, Jack/0000-0002-7706-8105; Henley, Jeremy/0000-0003-3589-8335	Medical Research Council [G120/838, G0601810, G0601810(80974)] Funding Source: Medline; Wellcome Trust [059917] Funding Source: Medline; MRC [G120/838] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NISHIOKA N S, 1987, Lasers in Medical Science, V2, P21, DOI 10.1007/BF02594126; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WILSON VG, 2005, SCI STKE, pPE32, DOI DOI 10.1126/STKE.2902005PE32; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859	22	219	235	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					321	U6		10.1038/nature05736	http://dx.doi.org/10.1038/nature05736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17486098	Green Accepted			2022-12-24	WOS:000246520300046
J	Agosti, JM; Goldie, SJ				Agosti, Jan M.; Goldie, Sue J.			Introducing HPV vaccine in developing countries - Key challenges and issues	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Bill & Melinda Gates Foundation; Harvard University; Harvard T.H. Chan School of Public Health	Agosti, JM (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA.							Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009	5	215	220	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1908	1910		10.1056/NEJMp078053	http://dx.doi.org/10.1056/NEJMp078053			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	165KX	17494923	Bronze			2022-12-24	WOS:000246305500002
J	Wang, HY; Lin, S; Allen, JP; Williams, JC; Blankert, S; Laser, C; Woodbury, NW				Wang, Haiyu; Lin, Su; Allen, James P.; Williams, JoAnn C.; Blankert, Sean; Laser, Christa; Woodbury, Neal W.			Protein dynamics control the kinetics of initial electron transfer in photosynthesis	SCIENCE			English	Article							SPHAEROIDES REACTION-CENTER; BACTERIAL REACTION CENTERS; MUTANT REACTION CENTERS; RHODOBACTER-SPHAEROIDES; CHARGE SEPARATION; WILD-TYPE; STATE; DEPENDENCE; BACTERIOCHLOROPHYLL; TEMPERATURE	The initial electron transfer dynamics during photosynthesis have been studied in Rhodobacter sphaeroides reaction centers from wild type and 14 mutants in which the driving force and the kinetics of charge separation vary over a broad range. Surprisingly, the protein relaxation kinetics, as measured by tryptophan absorbance changes, are invariant in these mutants. By applying a reaction-diffusion model, we can fit the complex electron transfer kinetics of each mutant quantitatively, varying only the driving force. These results indicate that initial photosynthetic charge separation is limited by protein dynamics rather than by a static electron transfer barrier.	Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Woodbury, NW (corresponding author), Arizona State Univ, Biodesign Inst, 1001 S McAllister Ave, Tempe, AZ 85287 USA.	Nwoodbury@asu.edu						Ando K, 1998, J PHYS CHEM B, V102, P10991, DOI 10.1021/jp982659l; BAGCHI B, 1983, J CHEM PHYS, V78, P7375, DOI 10.1063/1.444729; CHO MH, 1995, J CHEM PHYS, V103, P595, DOI 10.1063/1.470094; Deisenhofer J., 1993, PHOTOSYNTHETIC REACT, VII, P49; DU M, 1992, P NATL ACAD SCI USA, V89, P8517, DOI 10.1073/pnas.89.18.8517; GEHLEN JN, 1994, SCIENCE, V263, P499, DOI 10.1126/science.263.5146.499; Haffa ALM, 2002, J PHYS CHEM B, V106, P7376, DOI 10.1021/jp0257552; HAMM P, 1993, BIOCHIM BIOPHYS ACTA, V1142, P99, DOI 10.1016/0005-2728(93)90090-3; Huppman P, 2002, BIOPHYS J, V82, P3186, DOI 10.1016/S0006-3495(02)75661-0; JIA YW, 1993, J PHYS CHEM-US, V97, P13180, DOI 10.1021/j100152a024; Katilius E, 2004, PHOTOSYNTH RES, V81, P165, DOI 10.1023/B:PRES.0000035048.10358.90; KIRMAIER C, 1990, P NATL ACAD SCI USA, V87, P3552, DOI 10.1073/pnas.87.9.3552; Laible PD, 1997, BIOCHEMISTRY-US, V36, P8677, DOI 10.1021/bi970672a; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; LIN X, 1994, P NATL ACAD SCI USA, V91, P10265, DOI 10.1073/pnas.91.22.10265; McMahon BH, 1998, BIOPHYS J, V74, P2567, DOI 10.1016/S0006-3495(98)77964-0; Parson WW, 2004, J PHYS CHEM B, V108, P10474, DOI 10.1021/jp0495904; Potter JA, 2005, J BIOL CHEM, V280, P27155, DOI 10.1074/jbc.M501961200; Schenkl S, 2005, SCIENCE, V309, P917, DOI 10.1126/science.1111482; SUMI H, 1986, J CHEM PHYS, V84, P4272, DOI 10.1063/1.450804; TOMINAGA K, 1991, J PHYS CHEM-US, V95, P10485, DOI 10.1021/j100178a040; WARSHEL A, 1989, SCIENCE, V246, P112, DOI 10.1126/science.2675313; WILLAERT K, 1992, BIOCHEMISTRY-US, V31, P711, DOI 10.1021/bi00118a011; Williams JC, 2001, BIOCHEMISTRY-US, V40, P15403, DOI 10.1021/bi011574z; WOODBURY NW, 1995, CHEM PHYS, V197, P405, DOI 10.1016/0301-0104(95)00170-S; WOODBURY NW, 1995, ADV PHOTOSYNTH, V2, P527; ZINTH W, 1993, PHOTOSYNTHETIC REACT, P71	27	200	208	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					747	750		10.1126/science.1140030	http://dx.doi.org/10.1126/science.1140030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478721				2022-12-24	WOS:000246181400047
J	Ogo, S; Kabe, R; Uehara, K; Kure, B; Nishimura, T; Menon, SC; Harada, R; Fukuzumi, S; Higuchi, Y; Ohhara, T; Tamada, T; Kuroki, R				Ogo, Seiji; Kabe, Ryota; Uehara, Keiji; Kure, Bunsho; Nishimura, Takashi; Menon, Saija C.; Harada, Ryosuke; Fukuzumi, Shunichi; Higuchi, Yoshiki; Ohhara, Takashi; Tamada, Taro; Kuroki, Ryota			A dinuclear Ni(mu-H)Ru complex derived from H-2	SCIENCE			English	Article							HYDROGENASE ACTIVE-SITE; NICKEL HYDROGENASES; NIFE HYDROGENASE; X-RAY; NEUTRON-DIFFRACTION; DESULFOVIBRIO-GIGAS; CRYSTAL-STRUCTURE; IRON; ACTIVATION; DIHYDROGEN	Models of the active site in [NiFe] hydrogenase enzymes have proven challenging to prepare. We isolated a paramagnetic dinuclear nickel-ruthenium complex with a bridging hydrido ligand from the heterolytic cleavage of H-2 by a dinuclear NiRu aqua complex in water under ambient conditions (20 degrees C and 1 atmosphere pressure). The structure of the hexacoordinate Ni(mu-H) Ru complex was unequivocally determined by neutron diffraction analysis, and it comes closest to an effective analog for the core structure of the proposed active form of the enzyme.	Kyushu Univ, Ctr Future Chem, Fukuoka 8190395, Japan; Osaka Univ, JST,Solut Oriented Res Sci & Technol, Dept Mat & Life Sci, Div Adv Sci & Biotechnol, Suita, Osaka 5650871, Japan; Univ Hyogo, Grad Sch Life sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; Japan Atom Energy Agcy, Res Grp Mol Struct Biol, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan	Kyushu University; Japan Science & Technology Agency (JST); Osaka University; University of Hyogo; Japan Atomic Energy Agency	Ogo, S (corresponding author), Kyushu Univ, Ctr Future Chem, Fukuoka 8190395, Japan.	ogo-tcm@mbox.nc.kyushu-u.ac.jp	Kabe, Ryota/B-4130-2018; Fukuzumi, Shunichi/E-4728-2010	Kabe, Ryota/0000-0002-3647-4262; Tamada, Taro/0000-0003-1419-8022; Ohhara, Takashi/0000-0002-1215-6032				Albinati A, 1997, INORG CHIM ACTA, V259, P351, DOI 10.1016/S0020-1693(97)05521-7; ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Alvarez HM, 2001, INORG CHEM, V40, P5736, DOI 10.1021/ic0155838; Bouwman E, 2005, COORDIN CHEM REV, V249, P1555, DOI 10.1016/j.ccr.2004.10.010; Brecht M, 2003, J AM CHEM SOC, V125, P13075, DOI 10.1021/ja036624x; Cammack R., 2001, HYDROGEN FUEL LEARNI; Cammi R, 2003, INORG CHEM, V42, P1769, DOI 10.1021/ic025870r; Carepo M, 2002, J AM CHEM SOC, V124, P281, DOI 10.1021/ja010204v; COLPAS GJ, 1990, INORG CHEM, V29, P4779, DOI 10.1021/ic00348a037; Darensbourg MY, 2000, COORDIN CHEM REV, V206, P533, DOI 10.1016/S0010-8545(00)00268-X; Drabnis MH, 1998, EUR J INORG CHEM, P851; Evans DJ, 2003, CHEM SOC REV, V32, P268, DOI 10.1039/b201317g; Foerster S, 2003, J AM CHEM SOC, V125, P83, DOI 10.1021/ja027522u; Frey M, 1998, STRUCT BOND, V90, P97; Gu ZJ, 1996, J AM CHEM SOC, V118, P11155, DOI 10.1021/ja962429p; Jahncke M, 1997, ORGANOMETALLICS, V16, P1137, DOI 10.1021/om960840f; Justice AK, 2004, J AM CHEM SOC, V126, P13214, DOI 10.1021/ja0455594; Li ZL, 2005, J AM CHEM SOC, V127, P8950, DOI 10.1021/ja051590+; Linck RC, 2001, J AM CHEM SOC, V123, P8856, DOI 10.1021/ja010603q; MARKS TJ, 1977, CHEM REV, V77, P263, DOI 10.1021/cr60306a004; Marr AC, 2001, COORDIN CHEM REV, V219, P1055, DOI 10.1016/S0010-8545(01)00396-4; Ogo S, 2002, J AM CHEM SOC, V124, P597, DOI 10.1021/ja011846l; Ontko AC, 1998, ORGANOMETALLICS, V17, P5467, DOI 10.1021/om980711u; PERUZZINI M, 2001, RECENT ADV HYDRIDE C, P139; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pickett CJ, 2005, COORDIN CHEM REV, V249, P1517, DOI 10.1016/j.ccr.2005.04.011; Reynolds MA, 2003, ORGANOMETALLICS, V22, P1619, DOI 10.1021/om020724e; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Wang YL, 2005, POLYHEDRON, V24, P585, DOI 10.1016/j.poly.2004.12.019; Zhu WF, 2005, P NATL ACAD SCI USA, V102, P18280, DOI 10.1073/pnas.0505779102	31	220	222	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					585	587		10.1126/science.1138751	http://dx.doi.org/10.1126/science.1138751			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463285				2022-12-24	WOS:000245983100041
J	Francis, PT				Francis, Paul T.			Surveillance of acute flaccid paralysis in India	LANCET			English	Editorial Material									Amrita Sch Med, Cochin 682026, Kerala, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi	Francis, PT (corresponding author), Amrita Sch Med, Cochin 682026, Kerala, India.	paultfrancis@gmail.com						Kohler KA, 2003, B WORLD HEALTH ORGAN, V81, P2; *WHO, IMM VACC DEV VPD SUR; 2005, FIELD GUIDE SURVEILL	3	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1322	1323		10.1016/S0140-6736(07)60610-2	http://dx.doi.org/10.1016/S0140-6736(07)60610-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448800				2022-12-24	WOS:000245856100005
J	Hankey, GJ				Hankey, Graeme J.			Clinical update: management of stroke	LANCET			English	Article							CLOPIDOGREL; PREVENTION; ASPIRIN; DIPYRIDAMOLE; TRIAL; RISK		Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia	Royal Perth Hospital; University of Western Australia	Hankey, GJ (corresponding author), Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia.	gjhankey@cyllene.uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Amarenco P, 2006, NEW ENGL J MED, V355, P549; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; de Bruijn SFTM, 2006, STROKE, V37, P2531, DOI 10.1161/01.STR.0000241064.46659.69; Diener HC, 2007, CEREBROVASC DIS, V23, P368, DOI 10.1159/000100105; Halkes PHA, 2007, LANCET NEUROL, V6, P115, DOI 10.1016/S1474-4422(06)70685-8; Halkes PHA, 2006, LANCET, V367, P1665; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; HANKEY GJ, 2005, STROKE TREATMENT PRE; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Rothwell PM, 2005, LANCET, V365, P256; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; STEYER R, 2007, STREET COM      0226; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4	19	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1330	1332		10.1016/S0140-6736(07)60614-X	http://dx.doi.org/10.1016/S0140-6736(07)60614-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448805				2022-12-24	WOS:000245856100010
J	Nachega, JB; Hislop, M; Dowdy, DW; Chaisson, RE; Regensberg, L; Maartens, G				Nachega, Jean B.; Hislop, Michael; Dowdy, David W.; Chaisson, Richard E.; Regensberg, Leon; Maartens, Gary			Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	13th Conference on Retroviruses and Opportunistic Infections	FEB 05-09, 2006	Denver, CO				ACTIVE ANTIRETROVIRAL THERAPY; TRIPLE-COMBINATION THERAPY; DRUG-RESISTANCE MUTATIONS; SOCIETY-USA PANEL; PROTEASE INHIBITORS; VIRAL SUPPRESSION; TREATMENT FAILURE; PHARMACY RECORDS; INFECTED ADULTS; EFAVIRENZ	Background: Adherence of 95% or more to unboosted protease regimens is required for optimal virologic suppression in HIV-1 infected patients. Whether the same is true for nonnucleoside reverse transcriptase inhibitor (NNRTI)-based therapy is unclear. Objective: To assess the relationship between adherence to NNRTI-based therapy and viral load in treatment-naive patients. Design: Observational cohort study. Setting: Private-sector HIV and AIDS disease management program in South Africa. Patients: 2821 adults infected with HIV who began NNRTI-based therapy between January 1998 and March 2003 (2764 patients [98%] were enrolled after December 2000). Measurements: Adherence was assessed by monthly pharmacy claims. The primary end point was sustained viral load suppression (< 400 copies/mL) in 100% of recorded viral load measurements throughout follow-up. Secondary end points included time to initial viral load suppression and time to subsequent virologic failure (< 400 copies/mL). Results: The median follow-up period was 2.2 years (interquartile range, 1.7 to 2.7 years). The proportion of patients with sustained viral load suppression ranged from 13% (41 of 325 patients) in patients who filled less than 50% of antiretroviral drug prescriptions to 73% (725 of 997 patients) in those who filled 100% of antiretroviral drug prescriptions. Each 10% increase in pharmacy claim adherence greater than 50% was associated with a mean absolute increase of 0.10 in the proportion of patients with sustained virologic suppression (P < 0.001). Predictors for shorter time to virologic failure after initial suppression in multivariable Cox regression included CD4(+) T-cell counts of 0.50 x 10(9) cells/L or less (hazard ratio, 1.60 [95% CI, 1.22 to 2.10] vs. CD4(+) T-cell counts > 0.20 x 10(9) cells/L), baseline viral load greater than 10(5) copies/mL (hazard ratio, 1.39 [CI 1.14 to 1.70]), nevirapine-based regimen (hazard ratio, 1.43 [CI 1.16 to 1.75]), and low pharmacy claim adherence (hazard ratio, 1.58 [CI 1.48 to 1.69], per 10% decrease in adherence to 50%). Limitations: Observational study with adherence stratification at study end and lack of standardized timing for outcome measurement. Conclusion: Virologic outcomes improve in a linear dose-response manner as adherence to NNRTI-based regimens increases beyond 50%.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Baltimore, MD USA; Univ Cape Town, Groote Schuur Hosp, ZA-7700 Rondebosch, South Africa; Aid AIDS Dis Management Programme Pty Ltd, Cape Town, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Cape Town	Nachega, JB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Suite W5031, Baltimore, MD 21205 USA.	jnachega@jhsph.edu	Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Nachega, Jean/0000-0002-2862-4443	NIAID NIH HHS [R01 AI 5535901, R01 AI 016137, K23 AI068582-01] Funding Source: Medline; PHS HHS [5 T32 GMO7309] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI068582, R01AI055359, R01AI016137] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bacheler LT, 2000, ANTIMICROB AGENTS CH, V44, P2475, DOI 10.1128/AAC.44.9.2475-2484.2000; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Benatar SR, 2004, NEW ENGL J MED, V351, P81, DOI 10.1056/NEJMhpr033471; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Dezii C M, 2001, Manag Care, V10, P42; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Egger M, 2006, J INFECT DIS, V194, P612, DOI 10.1086/506362; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Miller V, 1999, J INFECT DIS, V180, P530, DOI 10.1086/314890; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Siddique MA, 2006, J INFECT DIS, V194, P661, DOI 10.1086/505913; Smith PF, 2005, ANTIMICROB AGENTS CH, V49, P3558, DOI 10.1128/AAC.49.8.3558-3561.2005; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Wong MD, 2004, J GEN INTERN MED, V19, P366, DOI 10.1111/j.1525-1497.2004.30429.x; Wood E, 2006, AIDS, V20, P1117, DOI 10.1097/01.aids.0000226951.49353.ed; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	37	272	280	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2007	146	8					564	U16		10.7326/0003-4819-146-8-200704170-00007	http://dx.doi.org/10.7326/0003-4819-146-8-200704170-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	158FV	17438315				2022-12-24	WOS:000245778000003
J	Brent, AE; Yucel, G; Small, S; Desplan, C				Brent, Ava E.; Yucel, Gozde; Small, Stephen; Desplan, Claude			Permissive and instructive anterior patterning rely on mRNA localization in the wasp embryo	SCIENCE			English	Article							DROSOPHILA EMBRYO; GRADIENT; NASONIA; PROTEIN; GIANT; HUNCHBACK; KRUPPEL; LONG; SEGMENTATION; EXPRESSION	The long-germ mode of embryogenesis, in which segments arise simultaneously along the anterior-posterior axis, has evolved several times in different lineages of the holometabolous, or fully metamorphosing, insects. Drosophila's long-germ fate map is established largely by the activity of the dipteran-specific Bicoid (Bcd) morphogen gradient, which operates both instructively and permissively to accomplish anterior patterning. By contrast, all nondipteran long-germ insects must achieve anterior patterning independently of bcd. We show that bcd's permissive function is mimicked in the wasp by a maternal repression system in which anterior localization of the wasp ortholog of giant represses anterior expression of the trunk gap genes so that head and thorax can properly form.	NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, 100 Washington Sq E, New York, NY 10003 USA.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051946, R01GM064864, R55GM051946] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM64864, GM51946] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bucher G, 2005, EVOL DEV, V7, P142, DOI 10.1111/j.1525-142X.2005.05016.x; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Hewitt GF, 1999, DEVELOPMENT, V126, P1201; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; KRAUT R, 1991, DEVELOPMENT, V111, P601; KRAUT R, 1991, DEVELOPMENT, V111, P611; Lynch J, 2003, CURR BIOL, V13, pR557, DOI 10.1016/S0960-9822(03)00472-X; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Lynch JA, 2006, DEV GENES EVOL, V216, P493, DOI 10.1007/s00427-006-0076-5; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Olesnicky EC, 2006, DEVELOPMENT, V133, P3973, DOI 10.1242/dev.02576; PREISS A, 1985, NATURE, V313, P27, DOI 10.1038/313027a0; Pultz MA, 2005, DEVELOPMENT, V132, P3705, DOI 10.1242/dev.01939; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schroder R, 2000, P NATL ACAD SCI USA, V97, P6591, DOI 10.1073/pnas.100005497; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; Wu XL, 1998, DEVELOPMENT, V125, P3765	20	47	47	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1841	1843		10.1126/science.1137528	http://dx.doi.org/10.1126/science.1137528			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395827				2022-12-24	WOS:000245280100042
J	Ruan, DK; He, Q; Ding, Y; Hou, LS; Li, JY; Luk, KDK				Ruan, Dike; He, Qin; Ding, Yu; Hou, Lisheng; Li, Jingyun; Luk, Keith D. K.			Intervertebral disc transplantation in the treatment of degenerative spine disease: a preliminary study	LANCET			English	Article							FOLLOW-UP; ARTIFICIAL DISC; PROSTHESIS; REPLACEMENT	Background Spinal fusion can be complicated by accelerated degeneration of the adjacent segments. Artificial disc replacements have been developed, but results are variable. Successful transplantations of intervertebral disc autografts, fresh allografts, and fresh-frozen allografts-ie, a non-fusion strategy-in which the mobility and stability of the spinal segment were preserved have been done in a primate model. Our aim was to determine the feasibility, safety, and long-term clinical results of disc transplantation in human beings. Methods Five patients, average age 47 years, with cervical disc herniation underwent transplantation of fresh-frozen composite disc allografts after disc excision. Serial MRI and static and dynamic radiographs were used to monitor the status of the grafts and the sagittal stability and mobility of the segment. Findings Good union of the graft endplates was seen by the end of 3 months after surgery in all patients. At a minimum follow-up of 5 years, the neurological symptoms of all patients had improved from before surgery levels. No immunoreaction was encountered. There was no olisthesis and only mild degenerative changes of the transplanted discs. All except one of the discs showed preservation of 7.0-11.3 degrees of sagittal motion at the final follow-up. MRI at 5 years showed preservation of hydration in at least two discs. Interpretation Despite signs of mild disc degeneration, the motion and stability of the spinal unit was preserved after transplantation of fresh-frozen allogenic intervertebral discs in our patients. With further refinements, such transplantations could be an effective treatment for degenerative disc disease.	Univ Hong Kong, Dept Orthoped & Traumatol, Hong Kong, Peoples R China; Navy Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China	University of Hong Kong; Sixth Medical Center of Chinese PLA General Hospital	Luk, KDK (corresponding author), Univ Hong Kong, Dept Orthoped & Traumatol, Pokfulam Rd, Hong Kong, Peoples R China.	hrmoldk@hku.hk	ding, yy/HHS-9589-2022					BABA H, 1993, SPINE, V18, P2167, DOI 10.1097/00007632-199311000-00004; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; CLEMENTS DH, 1990, SPINE, V15, P1023, DOI 10.1097/00007632-199015100-00008; DVORAK J, 1991, J ORTHOPAED RES, V9, P828, DOI 10.1002/jor.1100090608; FRICK SL, 1994, SPINE, V19, P1826, DOI 10.1097/00007632-199408150-00006; Gillet P, 2003, J SPINAL DISORD TECH, V16, P338, DOI 10.1097/00024720-200308000-00005; Goffin J, 2003, SPINE, V28, P2673, DOI 10.1097/01.BRS.0000099392.90849.AA; GRIFFITH SL, 1994, SPINE, V19, P1842, DOI 10.1097/00007632-199408150-00009; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; LEHMANN TR, 1987, SPINE, V12, P97, DOI 10.1097/00007632-198703000-00004; Leivseth G, 2006, SPINE, V31, P1726, DOI 10.1097/01.brs.0000224213.45330.68; Lemaire JP, 2005, J SPINAL DISORD TECH, V18, P353, DOI 10.1097/01.bsd.0000172361.07479.6b; LUK KD, 1997, CLIN ORTHOP RELAT R, V337, P13; Luk KDK, 2003, SPINE, V28, P864, DOI 10.1097/00007632-200305010-00005; Matsunaga S, 1999, SPINE, V24, P670, DOI 10.1097/00007632-199904010-00011; OLSON EJ, 1991, SPINE, V16, P1081, DOI 10.1097/00007632-199109000-00013; PENTA M, 1995, SPINE, V20, P743, DOI 10.1097/00007632-199503150-00018; Putzier M, 2006, EUR SPINE J, V15, P183, DOI 10.1007/s00586-005-1022-3; SCHNEIDERMAN G, 1987, SPINE, V12, P276, DOI 10.1097/00007632-198704000-00016; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Zeegers WS, 1999, EUR SPINE J, V8, P210, DOI 10.1007/s005860050160	22	80	101	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					993	999		10.1016/S0140-6736(07)60496-6	http://dx.doi.org/10.1016/S0140-6736(07)60496-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382826				2022-12-24	WOS:000245286500028
J	Sato, M; Toda, T				Sato, Masamitsu; Toda, Takashi			Alp7/TACC is a crucial target in Ran-GTPase-dependent spindle formation in fission yeast	NATURE			English	Article							XENOPUS EGG EXTRACTS; SCHIZOSACCHAROMYCES-POMBE; IMPORTIN-BETA; CELL-DIVISION; MICROTUBULES; PROTEIN; KINETOCHORE; CHECKPOINT; ALPHA; CYCLE	Microtubules are essential intracellular structures involved in several cellular phenomena, including polarity establishment and chromosome segregation(1). Because the nuclear envelope persists during mitosis ( closed mitosis) in fission yeast ( Schizosaccharomyces pombe), cytoplasmic microtubules must be reorganized into the spindle in the compartmentalized nucleus on mitotic entry(2). An ideal mechanism might be to take advantage of an evolutionarily conserved microtubule formation system that uses the Ran-GTPase nuclear transport machinery(3-5), but no targets of Ran for spindle formation have been identified in yeast. Here we show that a microtubule-associated protein, Alp7, which forms a complex with Alp14, is a target of Ran in yeast for spindle formation. The Ran-deficient pim1 mutant (pim1-F201S) failed to show mitosis-specific nuclear accumulation of Alp7. Moreover, this mutant exhibited compromised spindle formation and early mitotic delay. Importantly, these defects were suppressed by Alp7 that was artificially targeted to the nucleus by a Ran-independent and importin-alpha-mediated system. Thus, Ran targets Alp7 - Alp14 to achieve nuclear spindle formation, and might differentiate its targets depending on whether the organism undergoes closed or open mitosis.	Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Lab Cell Regulat, London WC2A 3PX, England	Cancer Research UK	Sato, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	masasato@biochem.s.u-tokyo.ac.jp; Takashi.Toda@cancer.org.uk						Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Brittle AL, 2005, CURR BIOL, V15, pR880, DOI 10.1016/j.cub.2005.10.022; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Fleig U, 2000, J CELL BIOL, V151, P1101, DOI 10.1083/jcb.151.5.1101; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; HAGAN IM, 1988, J CELL SCI, V89, P343; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hirose E, 2006, GENES CELLS, V11, P29, DOI 10.1111/j.1365-2443.2005.00919.x; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; MATSUMOTO T, 1991, CELL, V66, P347, DOI 10.1016/0092-8674(91)90624-8; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; Oliferenko S, 2002, NAT CELL BIOL, V4, P816, DOI 10.1038/ncb861; Salus SS, 2002, MOL CELL BIOL, V22, P8491, DOI 10.1128/MCB.22.24.8491-8505.2002; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Sato M, 2003, NAT CELL BIOL, V5, P764, DOI 10.1038/ncb0903-764; SAZER S, 1994, EMBO J, V13, P606, DOI 10.1002/j.1460-2075.1994.tb06298.x; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Umeda M, 2005, GENETICS, V171, P7, DOI 10.1534/genetics.105.042598; Usui T, 2003, EMBO J, V22, P4779, DOI 10.1093/emboj/cdg459; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zheng YX, 2004, ANNU REV CELL DEV BI, V20, P867, DOI 10.1146/annurev.cellbio.20.012103.094648	33	57	58	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					334	U9		10.1038/nature05773	http://dx.doi.org/10.1038/nature05773			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17476213				2022-12-24	WOS:000246520300049
J	Liu, J; Fan, DM				Liu, Jie; Fan, Daiming			Hepatitis B in China	LANCET			English	Editorial Material									Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Liu, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China.	jieliu@fmmu.edu.cn						Cui FQ, 2006, CHIN J VACCINES IMMU, V12, P206; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Jia Ji-dong, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P698; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Liang Xiao-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P655; Lok AS, 2005, NEW ENGL J MED, V352, P2743, DOI 10.1056/NEJMe058119; Si CW, 2006, CLIN MED J, V4, P1; Sung JJY, 2005, GASTROENTEROLOGY, V128, P1890, DOI 10.1053/j.gastro.2005.03.009; Wang X.J., 2004, DIS SURVEILLANCE, V19, P290; Zhuang H, 2005, CHIN J INFECT DIS S, V23, P2; 刘耕陶, 2002, [中华医学杂志, National Medical Journal of China], V82, P74	11	198	215	1	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1582	1583		10.1016/S0140-6736(07)60723-5	http://dx.doi.org/10.1016/S0140-6736(07)60723-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167YO	17499584				2022-12-24	WOS:000246488800007
J	Gill, B; Okie, S				Gill, Bates; Okie, Susan			China and HIV - A window of opportunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Strateg & Int Studies, Washington, DC 20006 USA	Centre for Strategic & International Studies	Gill, B (corresponding author), Ctr Strateg & Int Studies, Washington, DC 20006 USA.			Gill, Bates/0000-0002-9425-5623				*WHO PEOPL REP CHI, 2006, 2005 UPD HIV AIDS EP; 2006, GENEVA GLOBAL FUND F; 2005, CHINA DAILY BEI 1028; 2005, CHINA DAILY BEI 1228; 2006, CHINA DAILY BEI 0405	5	49	49	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1801	1805		10.1056/NEJMp078010	http://dx.doi.org/10.1056/NEJMp078010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163CL	17476005				2022-12-24	WOS:000246136200001
J	Berner, RA; VandenBrooks, JM; Ward, PD				Berner, Robert A.; VandenBrooks, John M.; Ward, Peter D.			Evolution - Oxygen and evolution	SCIENCE			English	Editorial Material							ATMOSPHERIC OXYGEN; RESPONSES; HYPEROXIA; INSECTS; HYPOXIA; OCEAN; RISE		Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA	Yale University; Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle	Berner, RA (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	robert.berner@yale.edu						Berner R.A., 2004, PHANEROZOIC CARBON C; Berner RA, 2005, GEOCHIM COSMOCHIM AC, V69, P3211, DOI 10.1016/j.gca.2005.03.021; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Dabrowski K, 2004, AQUACULTURE, V233, P383, DOI 10.1016/j.aquaculture.2003.09.047; Dudley R, 1998, J EXP BIOL, V201, P1043; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FARZIN M, 2007, ANN M SOC INT COMP B; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Henry JR, 2004, J EXP BIOL, V207, P3559, DOI 10.1242/jeb.01189; Jammes Y, 1975, Poumon Coeur, V31, P165; KAISER A, 2006, COMP PHYS M INT DIV; Kump LR, 2005, GEOLOGY, V33, P397, DOI 10.1130/G21295.1; MCALESTER A L, 1970, Journal of Paleontology, V44, P405; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; VANDENBROOKS JM, 2007, THESIS YALE U; WARD PD, 2006, OUT THIN AIR; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; Warkentin KM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P155, DOI 10.1086/339214	23	236	256	7	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					557	558		10.1126/science.1140273	http://dx.doi.org/10.1126/science.1140273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463279				2022-12-24	WOS:000245983100033
J	Shuchman, M				Shuchman, Miriam			Approving the vagus-nerve stimulator for depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; Rush AJ, 2005, BIOL PSYCHIAT, V58, P347, DOI 10.1016/j.biopsych.2005.05.025; US Senate Committee on Finance, 2006, REV FDAS APPR PROC V	3	34	34	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1604	1607		10.1056/NEJMp078035	http://dx.doi.org/10.1056/NEJMp078035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442903				2022-12-24	WOS:000245762000002
J	Bianchi, A; Shore, D				Bianchi, Alessandro; Shore, David			Early replication of short telomeres in budding yeast	CELL			English	Article							ORIGIN ACTIVATION; LENGTH REGULATION; DNA; PROTEIN; SEQUENCES; TIME; COMPLEX; CENTROMERES; DYNAMICS; REQUIRES	The maintenance of an appropriate number of telomere repeats by telomerase is essential for proper chromosome protection. The action of telomerase at the telomere terminus is regulated by opposing activities that either recruit/activate the enzyme at shorter telomeres or inhibit it at longer ones, thus achieving a stable average telomere length. To elucidate the mechanistic details of telomerase regulation we engineered specific chromosome ends in yeast so that a single telomere could be suddenly shortened and, as a consequence of its reduced length, elongated by telomerase. We show that shortened telomeres replicate early in S phase, unlike normal-length telomeres, due to the early firing of origins of DNA replication in subtelomeric regions. Early telomere replication correlates with increased telomere length and telomerase activity. These data reveal an epigenetic effect of telomere length on the activity of nearby replication origins and an unanticipated link between telomere replication timing and telomerase action.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, NCCR, Frontiers Genet Program, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Bianchi, A (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	alessandro.bianchi@molbio.unige.ch	Shore, David/F-6240-2015	Shore, David/0000-0002-9859-143X; Bianchi, Alessandro/0000-0001-6583-1671				Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cosgrove AJ, 2002, GENE DEV, V16, P2485, DOI 10.1101/gad.231602; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dionne I, 1998, NUCLEIC ACIDS RES, V26, P5365, DOI 10.1093/nar/26.23.5365; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Grossi S, 2001, MOL CELL BIOL, V21, P8117, DOI 10.1128/MCB.21.23.8117-8128.2001; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hultdin M, 2001, EXP CELL RES, V271, P223, DOI 10.1006/excr.2001.5391; Kim SM, 2003, GENE DEV, V17, P330, DOI 10.1101/gad.1046203; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Louis EJ, 2005, BIOESSAYS, V27, P685, DOI 10.1002/bies.20259; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; Ofir R, 1999, P NATL ACAD SCI USA, V96, P11434, DOI 10.1073/pnas.96.20.11434; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tanaka S, 1996, YEAST, V12, P101, DOI 10.1002/(SICI)1097-0061(199602)12:2<101::AID-YEA885>3.0.CO;2-2; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; WELLINGER RJ, 1993, MOL CELL BIOL, V13, P4057, DOI 10.1128/MCB.13.7.4057; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Zappulla DC, 2002, CURR BIOL, V12, P869, DOI 10.1016/S0960-9822(02)00871-0; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101	47	67	68	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1051	1062		10.1016/j.cell.2007.01.041	http://dx.doi.org/10.1016/j.cell.2007.01.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382879	Bronze			2022-12-24	WOS:000245396200013
J	Lin, HH; Lai, JSY; Chin, AL; Chen, YC; Chiang, AS				Lin, Hui-Hao; Lai, Jason Sih-Yu; Chin, An-Lun; Chen, Yung-Chang; Chiang, Ann-Shyn			A map of olfactory representation in the Drosophila mushroom body	CELL			English	Article							SHORT-TERM-MEMORY; NEURONS; BODIES; ORGANIZATION; RECEPTORS; NEUROTRANSMISSION; LOCALIZATION; ABLATION; SLEEP; BRAIN	Neural coding for olfactory sensory stimuli has been mapped near completion in the Drosophila first-order center, but little is known in the higher brain centers. Here, we report that the antenna lobe (AL) spatial map is transformed further in the calyx of the mushroom body (MB), an essential olfactory associated learning center, by stereotypic connections with projection neurons (PNs). We found that Kenyon cell (KC) dendrites are segregated into 17 complementary domains according to their neuroblast clonal origins and birth orders. Aligning the PN axonal map with the KC dendritic map and ultrastructural observation suggest a positional ordering such that inputs from the different AL glomeruli have distinct representations in the MB calyx, and these representations might synapse on functionally distinct KCs. Our data suggest that olfactory coding at the AL is decoded in the MB and then transferred via distinct lobes to separate higher brain centers.	Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Dept Elect Engn, Engn & Syst Sci Grp, Hsinchu 30013, Taiwan; Natl Cent Univ, Dept Life Sci, Tao Yuan 32001, Taiwan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Central University; Cold Spring Harbor Laboratory	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw		Chiang, Ann-Shyn/0000-0001-9668-7115				Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Chiang AS, 2001, J COMP NEUROL, V440, P1, DOI 10.1002/cne.1365; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Ito K, 1998, LEARN MEMORY, V5, P52; Ito K, 1997, DEVELOPMENT, V124, P761; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stopfer M, 2005, CURR BIOL, V15, pR996, DOI 10.1016/j.cub.2005.11.052; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	50	158	164	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1205	1217		10.1016/j.cell.2007.03.006	http://dx.doi.org/10.1016/j.cell.2007.03.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382887	Bronze			2022-12-24	WOS:000245396200024
J	Oliveri, P; Davidson, EH				Oliveri, Paola; Davidson, Eric H.			Built to run, not fail	SCIENCE			English	Editorial Material							GENE REGULATORY NETWORKS		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Oliveri, P (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	poliveri@caltech.edu; davidson@caltech.edu		Oliveri, Paola/0000-0002-3477-8529	NICHD NIH HHS [HD-37105] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Davidson E. H., 2001, DEV EVOLUTION; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2006, REG GEN GEN REG; Kiefer JC, 2007, DEV BIOL, V303, P611, DOI 10.1016/j.ydbio.2006.11.042; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Minokawa T, 2004, GENE EXPR PATTERNS, V4, P449, DOI 10.1016/j.modgep.2004.01.009; Oliveri P, 2006, DEVELOPMENT, V133, P4173, DOI 10.1242/dev.02577	8	38	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1510	1511		10.1126/science.1140979	http://dx.doi.org/10.1126/science.1140979			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363653				2022-12-24	WOS:000244934800029
J	Wilker, EW; van Vugt, MATM; Artim, SA; Huang, PH; Petersen, CP; Reinhardt, HC; Feng, Y; Sharp, PA; Sonenberg, N; White, FM; Yaffe, MB				Wilker, Erik W.; van Vugt, Marcel A. T. M.; Artim, Steven A.; Huang, Paul H.; Petersen, Christian P.; Reinhardt, H. Christian; Feng, Yun; Sharp, Phillip A.; Sonenberg, Nahum; White, Forest M.; Yaffe, Michael B.			14-3-3 sigma controls mitotic translation to facilitate cytokinesis	NATURE			English	Article							RIBOSOME ENTRY SITE; BREAST-CANCER; CELL-CYCLE; MAMMALIAN-CELLS; EARLY EVENT; SIGMA GENE; HYPERMETHYLATION; PROTEIN; EXPRESSION; INITIATION	14-3-3 proteins are crucial in a wide variety of cellular responses including cell cycle progression, DNA damage checkpoints and apoptosis. One particular 14-3-3 isoform, sigma, is a p53-responsive gene, the function of which is frequently lost in human tumours, including breast and prostate cancers as a result of either hypermethylation of the 14-3-3 sigma promoter or induction of an oestrogen-responsive ubiquitin ligase that specifically targets 14-3-3 sigma for proteasomal degradation(1-9). Loss of 14-3-3 sigma protein occurs not only within the tumours themselves but also in the surrounding pre-dysplastic tissue (so-called field cancerization), indicating that 14-3-3 sigma might have an important tumour suppressor function that becomes lost early in the process of tumour evolution(3,9). The molecular basis for the tumour suppressor function of 14-3-3 sigma is unknown. Here we report a previously unknown function for 14-3-3 sigma as a regulator of mitotic translation through its direct mitosis-specific binding to a variety of translation/ initiation factors, including eukaryotic initiation factor 4B in a stoichiometric manner. Cells lacking 14-3-3 sigma, in marked contrast to normal cells, cannot suppress cap-dependent translation and do not stimulate cap-independent translation during and immediately after mitosis. This defective switch in the mechanism of translation results in reduced mitotic-specific expression of the endogenous internal ribosomal entry site (IRES)-dependent form of the cyclin-dependent kinase Cdk11 (p58 PITSLRE), leading to impaired cytokinesis, loss of Polo-like kinase-1 at the midbody, and the accumulation of binucleate cells. The aberrant mitotic phenotype of 14-3-3 sigma-depleted cells can be rescued by forced expression of p58 PITSLRE or by extinguishing cap-dependent translation and increasing cap-independent translation during mitosis by using rapamycin. Our findings show how aberrant mitotic translation in the absence of 14-3-3 sigma impairs mitotic exit to generate binucleate cells and provides a potential explanation of how 14-3-3 sigma-deficient cells may progress on the path to aneuploidy and tumorigenesis.	MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; McGill Univ, McGill Canc Ctr, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Massachusetts Institute of Technology (MIT); McGill University	Yaffe, MB (corresponding author), MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA.	myaffe@mit.edu	Petersen, Christian P./GZG-4541-2022; Huang, Paul H./H-8591-2015	Petersen, Christian P./0000-0001-7552-6865; Huang, Paul H./0000-0003-3972-5087; White, Forest/0000-0002-1545-1651; /0000-0003-4503-9024				Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gasco M, 2002, ONCOGENE, V21, P1876, DOI 10.1038/sj.onc.1205256; HERSHEY JWB, 1994, BIOCHIMIE, V76, P847, DOI 10.1016/0300-9084(94)90186-4; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Suzuki H, 2000, CANCER RES, V60, P4353; Umbricht CB, 2001, ONCOGENE, V20, P3348, DOI 10.1038/sj.onc.1204438; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Vercoutter-Edouart AS, 2001, CANCER RES, V61, P76; Villaret DB, 2000, LARYNGOSCOPE, V110, P374, DOI 10.1097/00005537-200003000-00008; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200	30	172	184	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					329	332		10.1038/nature05584	http://dx.doi.org/10.1038/nature05584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361185				2022-12-24	WOS:000244892900048
J	Fisher, RD; Chung, HY; Zhai, QT; Robinson, H; Sundquist, WI; Hill, CP				Fisher, Robert D.; Chung, Hyo-Young; Zhai, Qianting; Robinson, Howard; Sundquist, Wesley I.; Hill, Christopher P.			Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding	CELL			English	Article							BINDING PARTNER; HUMAN HOMOLOG; PROTEIN; ALIX; TSG101; DOMAIN; PATHWAY; BRO1; GAG; P6	ALIX/AIP1 functions in enveloped virus budding, endosomal protein sorting, and many other cellular processes. Retroviruses, including HIV-1, SIV, and EIAV, bind and recruit ALIX through YPXnL late-domain motifs (X = any residue; In = 1-3). Crystal structures reveal that human ALIX is composed of an N-terminal Bro1 domain and a central domain that is composed of two extended three-helix bundles that form elongated arms that fold back into a "V." The structures also reveal conformational flexibility in the arms that suggests that the V domain may act as a flexible hinge in response to ligand binding. YPXnL late domains bind in a conserved hydrophobic pocket on the second arm near the apex of the V, whereas CHMP4/ ESCRT-III proteins bind a conserved hydrophobic patch on the Bro1 domain, and both interactions are required for virus budding. ALIX therefore serves as a flexible, extended scaffold that connects retroviral Gag proteins to ESCRT-III and other cellular-budding machinery.	Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu	zhai, qianting/G-1301-2013		NIAID NIH HHS [AI 051174, R01 AI051174] Funding Source: Medline; NIGMS NIH HHS [GM 066521, P50 GM082545] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, P01GM066521] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Bibollet-Ruche F, 2004, J VIROL, V78, P7748, DOI 10.1128/JVI.78.14.7748-7762.2004; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Chatellard-Causse C, 2002, J BIOL CHEM, V277, P29108, DOI 10.1074/jbc.M204019200; Chen CP, 2005, J BIOL CHEM, V280, P40474, DOI 10.1074/jbc.M509317200; DEJOURNETT RE, 2006, BIOCHEM J, V401, P521; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.0167.x; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ichioka F, 2005, BIOSCI BIOTECH BIOCH, V69, P861, DOI 10.1271/bbb.69.861; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Olsen JC, 1998, GENE THER, V5, P1481, DOI 10.1038/sj.gt.3300768; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Sadoul R, 2006, BIOL CELL, V98, P69, DOI 10.1042/BC20050007; Schmidt MHH, 2003, J CELL SCI, V116, P2845, DOI 10.1242/jcs.00522; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Schmidt MHH, 2005, J BIOL CHEM, V280, P3414, DOI 10.1074/jbc.M409839200; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Tsuda M, 2006, FEBS LETT, V580, P3296, DOI 10.1016/j.febslet.2006.05.005; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang Margaret Q, 2003, J Biol, V3, P4, DOI 10.1186/1475-4924-3-4	43	250	259	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					841	852		10.1016/j.cell.2007.01.035	http://dx.doi.org/10.1016/j.cell.2007.01.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350572	Bronze			2022-12-24	WOS:000245073400010
J	Sheen, J; He, P				Sheen, Jen; He, Ping			Nuclear actions in innate immune signaling	CELL			English	Editorial Material							RESISTANCE PROTEIN	Innate immunity in plants and animals is mediated through pattern recognition receptors, which were thought to initiate signaling in the cytoplasm to activate defense pathways. Shen et al. (2006) and Burch-Smith et al. (2007) now provide compelling evidence that certain plant disease resistance proteins, which detect specific pathogenic effectors, act in the nucleus to trigger downstream signaling and defense pathways.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu		He, Ping/0000-0002-5926-8349				Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; SHEN QH, 2006, SCIENCE         1221; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523	10	7	8	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					821	823		10.1016/j.cell.2007.02.019	http://dx.doi.org/10.1016/j.cell.2007.02.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350565	Bronze			2022-12-24	WOS:000245073400003
J	Fitzpatrick, MJ; Feder, E; Rowe, L; Sokolowski, MB				Fitzpatrick, Mark J.; Feder, Elah; Rowe, Locke; Sokolowski, Marla B.			Maintaining a behaviour polymorphism by frequency-dependent selection on a single gene	NATURE			English	Article							PROTEIN-KINASE PKG; DROSOPHILA-MELANOGASTER; BALANCING SELECTION; LARVAL COMPETITION; LOCUS	Accounting for the abundance of genetic variation in the face of natural selection remains a central problem of evolutionary biology(1,2). Genetic polymorphisms are constantly arising through mutation, and although most are promptly eliminated(3), polymorphisms in functionally important traits are common. One mechanism that can maintain polymorphisms is negative frequency-dependent selection on alternative alleles, whereby the fitness of each decreases as its frequency increases(4,5). Examples of frequency-dependent selection are rare, especially when attempting to describe the genetic basis of the phenotype under selection. Here we show frequency-dependent selection in a well-known natural genetic polymorphism affecting fruitfly foraging behaviour. When raised in low nutrient conditions, both of the naturally occurring alleles of the foraging gene (for(s) and for(R)) have their highest fitness when rare - the hallmark of negative frequency-dependent selection. This effect disappears at higher resources levels, demonstrating the role of larval competition. We are able to confirm the involvement of the foraging gene by showing that a sitter-like mutant allele on a rover background has similar frequency-dependent fitness as the natural sitter allele. Our study represents a clear demonstration of frequency-dependent selection, and we are able to attribute this effect to a single, naturally polymorphic gene known to affect behaviour.	Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3G5, Canada	University of Toronto; University Toronto Mississauga; University of Toronto	Sokolowski, MB (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	msokolow@utm.utoronto.ca	Allen, John A/B-5510-2008; Fitzpatrick, Mark J/A-3414-2008	Sokolowski, Marla/0000-0002-7462-8007; Fitzpatrick, Mark/0000-0003-3484-4327				Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; ATKINSON WD, 1979, J ANIM ECOL, V48, P91, DOI 10.2307/4102; AYALA FJ, 1974, ANNU REV ECOL SYST, V5, P1115; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; DAWOOD MM, 1969, GENETICS, V63, P213; DEBELLE JS, 1987, HEREDITY, V59, P73, DOI 10.1038/hdy.1987.98; DEBELLE JS, 1993, GENOME, V36, P94, DOI 10.1139/g93-013; Fitzpatrick MJ, 2004, INTEGR COMP BIOL, V44, P28, DOI 10.1093/icb/44.1.28; Foley PA, 2001, EVOLUTION, V55, P2493, DOI 10.1111/j.0014-3820.2001.tb00764.x; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Houle D, 2003, AM NAT, V161, P50, DOI 10.1086/345480; HUANG SL, 1971, GENETICS, V68, P97; KALDERON D, 1989, J BIOL CHEM, V264, P10738; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; LEWONTIN RC, 1958, GENETICS, V43, P420; MILLER RS, 1964, ECOLOGY, V45, P132, DOI 10.2307/1937114; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; RODRIGUEZ L, 1990, CAN J ZOOL, V68, P2616, DOI 10.1139/z90-364; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; SNYDER TP, 1979, GENETICS, V92, P995; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Subramaniam B, 2000, EVOLUTION, V54, P691, DOI 10.1111/j.0014-3820.2000.tb00070.x; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8	29	144	149	0	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					210	U5		10.1038/nature05764	http://dx.doi.org/10.1038/nature05764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495926				2022-12-24	WOS:000246338700044
J	Shelly, M; Cancedda, L; Heilshorn, S; Sumbre, G; Poo, MM				Shelly, Maya; Cancedda, Laura; Heilshorn, Sarah; Sumbre, German; Poo, Mu-ming			LKB1/STRAD promotes axon initiation during neuronal polarization	CELL			English	Article							SAD KINASES; LKB1; CAMP; ESTABLISHMENT; POLARITY; GROWTH; PHOSPHORYLATION; ACTIVATION; SIGNALS; COMPLEX	Axon/dendrite differentiation is a critical step in neuronal development. In cultured hippocampal neurons, the accumulation of LKB1 and STRAD, two interacting proteins critical for establishing epithelial polarity, in an undifferentiated neurite correlates with its subsequent axon differentiation. Downregulation of either LKB1 or STRAD by siRNAs prevented axon differentiation, and overexpression of these proteins led to multiple axon formation. Furthermore, interaction of STRAD with LKB1 promoted LKB1 phosphorylation at a PKA site S431 and elevated the LKB1 level, and overexpressing LKB1 with a serine-to-alanine mutation at S431 (LKB1 S431 A) prevented axon differentiation. In developing cortical neurons in vivo, downregulation of LKB1 or overexpression of LKB1 S431 A also abolished axon formation. Finally, local exposure of the undifferentiated neurite to brain-derived neurotrophic factor or dibutyryl-cAMP promoted axon differentiation in a manner that depended on PKA-depenclent LKB1 phosphorylation. Thus local LKB1/STRAD accumulation and PKA-dependent LKB1 phosphorylation represents an early signal for axon initiation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu	Sumbre, German/K-7538-2017	Sumbre, German/0000-0003-4436-6840; Cancedda, Laura/0000-0003-0566-057X; Heilshorn, Sarah/0000-0002-9801-6304; shelly, maya/0000-0002-2211-1751	NINDS NIH HHS [NS-22764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Gao Y, 2003, J NEUROSCI, V23, P11770; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Martone ME, 2003, NEUROINFORMATICS, V1, P379, DOI 10.1385/NI:1:4:379; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; STERNBERGER LA, 1982, P NATL ACAD SCI-BIOL, V79, P1326, DOI 10.1073/pnas.79.4.1326; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	33	276	282	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					565	577		10.1016/j.cell.2007.04.012	http://dx.doi.org/10.1016/j.cell.2007.04.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482549	Bronze			2022-12-24	WOS:000246373600022
J	Inoue, D; Ohe, M; Kanemori, Y; Nobui, T; Sagata, N				Inoue, Daigo; Ohe, Munemichi; Kanemori, Yoshinori; Nobui, Toshiya; Sagata, Noriyuki			A direct link of the Mos-MAPK pathway to Erp1/Emi2 in meiotic arrest of Xenopus laevis eggs	NATURE			English	Article							CYTOSTATIC FACTOR ARREST; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; MEIOSIS-II; METAPHASE ARREST; VERTEBRATE EGGS; CELL-CYCLE; KINASE; OOCYTES; INHIBITOR; EMI2	In vertebrates, unfertilized eggs ( or mature oocytes) are arrested at metaphase of meiosis II by a cytoplasmic activity called cytostatic factor (CSF)(1). The classical Mos - MAPK pathway has long been implicated in CSF arrest of vertebrate eggs, but exactly how it exerts CSF activity remains unclear(2-4). Recently, Erp1 ( also called Emi2), an inhibitor of the anaphase-promoting complex/cyclosome (APC/C) required for degradation of the mitotic regulator cyclin B (ref. 5), has also been shown to be a component of CSF in both Xenopus and mice(6-8). Erp1 is destroyed on fertilization or egg activation(9,10), like Mos(11). However, despite these similarities the Mos-MAPK (mitogen-activated protein kinase) pathway and Erp1 are thought to act rather independently in CSF arrest(3,6,8). Here, we show that p90rsk, the kinase immediately downstream from Mos MAPK, directly targets Erp1 for CSF arrest in Xenopus oocytes. Erp1 is synthesized immediately after meiosis I, and the Mos MAPK pathway or p90rsk is essential for CSF arrest by Erp1. p90rsk can directly phosphorylate Erp1 on Ser 335/Thr 336 both in vivo and in vitro, and upregulates both Erp1 stability and activity. Erp1 is also present in early embryos, but has little CSF activity owing, at least in part, to the absence of p90rsk activity. These results clarify the direct link of the classical Mos - MAPK pathway to Erp1 in meiotic arrest of vertebrate oocytes.	Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Sagata, N (corresponding author), Kyushu Univ, Grad Sch Sci, Dept Biol, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	nsagascb@mbox.nc.kyushu-u.ac.jp						Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; Furuno N, 1997, EMBO J, V16, P3860, DOI 10.1093/emboj/16.13.3860; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Inoue D, 2005, EMBO J, V24, P1057, DOI 10.1038/sj.emboj.7600567; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Liu JJ, 2006, J BIOL CHEM, V281, P34736, DOI 10.1074/jbc.M606607200; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Murakami MS, 1999, GENE DEV, V13, P620, DOI 10.1101/gad.13.5.620; Ohe M, 2007, DEV BIOL, V303, P157, DOI 10.1016/j.ydbio.2006.10.044; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sagata N, 1996, TRENDS CELL BIOL, V6, P22, DOI 10.1016/0962-8924(96)81034-8; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Smith JA, 2005, CANCER RES, V65, P1027; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; WATANABE N, 1991, NATURE, V352, P247, DOI 10.1038/352247a0; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025	29	98	100	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1100	1104		10.1038/nature05688	http://dx.doi.org/10.1038/nature05688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17410130				2022-12-24	WOS:000245950400054
J	Stegmeier, F; Rape, M; Draviam, VM; Nalepa, G; Sowa, ME; Ang, XLL; McDonald, ER; Li, MZ; Hannon, GJ; Sorger, PK; Kirschner, MW; Harper, JW; Elledge, SJ				Stegmeier, Frank; Rape, Michael; Draviam, Viji M.; Nalepa, Grzegorz; Sowa, Mathew E.; Ang, Xiaolu L.; McDonald, E. Robert, III; Li, Mamie Z.; Hannon, Gregory J.; Sorger, Peter K.; Kirschner, Marc W.; Harper, J. Wade; Elledge, Stephen J.			Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities	NATURE			English	Article							SPINDLE CHECKPOINT; MITOTIC CHECKPOINT; PROMOTING COMPLEX/CYCLOSOME; CYCLIN-A; MITOSIS; BISTABILITY; ANEUPLOIDY; P31(COMET); PROTEIN; CANCER	The spindle checkpoint prevents chromosome mis-segregation by delaying sister chromatid separation until all chromosomes have achieved bipolar attachment to the mitotic spindle. Its operation is essential for accurate chromosome segregation, whereas its dysregulation can contribute to birth defects and tumorigenesis. The target of the spindle checkpoint is the anaphase-promoting complex (APC), a ubiquitin ligase that promotes sister chromatid separation and progression to anaphase. Using a short hairpin RNA screen targeting components of the ubiquitin-proteasome pathway in human cells, we identified the deubiquitinating enzyme USP44 (ubiquitin-specific protease 44) as a critical regulator of the spindle checkpoint. USP44 is not required for the initial recognition of unattached kinetochores and the subsequent recruitment of checkpoint components. Instead, it prevents the premature activation of the APC by stabilizing the APC-inhibitory Mad2 - Cdc20 complex. USP44 deubiquitinates the APC coactivator Cdc20 both in vitro and in vivo, and thereby directly counteracts the APC-driven disassembly of Mad2 - Cdc20 complexes ( discussed in an accompanying paper). Our findings suggest that a dynamic balance of ubiquitination by the APC and deubiquitination by USP44 contributes to the generation of the switch-like transition controlling anaphase entry, analogous to the way that phosphorylation and dephosphorylation of Cdk1 by Wee1 and Cdc25 controls entry into mitosis.	Harvard Univ, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst, Dept Genet,Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory	Elledge, SJ (corresponding author), Harvard Univ, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst, Dept Genet,Sch Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	marc@hms.harvard.edu; wade_harper@hms.harvard.edu; selledge@genetics.med.harvard.edu	Cambronne, Xiaolu Ang/GRY-7149-2022; Hannon, Gregory/AAB-3568-2019; 高, 雨莉/HGU-8187-2022	Cambronne, Xiaolu Ang/0000-0002-3547-448X; Lab, Nalepa/0000-0002-7560-1906; Rape, Michael/0000-0003-4849-6343; Nalepa, Grzegorz/0000-0002-5779-9103; Sorger, Peter/0000-0002-3364-1838; Draviam, Viji/0000-0001-8295-3689; Harper, Jeffrey/0000-0002-6944-7236	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG011085] Funding Source: Medline; NINDS NIH HHS [F31 NS054507-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322	25	292	302	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					876	881		10.1038/nature05694	http://dx.doi.org/10.1038/nature05694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443180				2022-12-24	WOS:000245785700034
J	Thulasiram, HV; Erickson, HK; Poulter, CD				Thulasiram, Hirekodathakallu V.; Erickson, Hans K.; Poulter, C. Dale			Chimeras of two isoprenoid synthases catalyze all four coupling reactions in isoprenoid biosynthesis	SCIENCE			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; ABSOLUTE-CONFIGURATION; RECOMBINANT SQUALENE; CRYSTAL-STRUCTURE; SEX-PHEROMONE; PRESQUALENE; MONOTERPENES; MECHANISM; MEALYBUG; GENE	The carbon skeletons of over 55,000 naturally occurring isoprenoid compounds are constructed from four fundamental coupling reactions: chain elongation, cyclopropanation, branching, and cyclobutanation. Enzymes that catalyze chain elongation and cyclopropanation are well studied, whereas those that catalyze branching and cyclobutanation are unknown. We have catalyzed the four reactions with chimeric proteins generated by replacing segments of a chain-elongation enzyme with corresponding sequences from a cyclopropanation enzyme. Stereochemical and mechanistic considerations suggest that the four coupling enzymes could have evolved from a common ancestor through relatively small changes in the catalytic site.	Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Thulasiram, HV (corresponding author), Univ Utah, Dept Chem, 315 S 1400 E,Room 2020, Salt Lake City, UT 84112 USA.	poulter@chemistry.utah.edu			NIGMS NIH HHS [GM 21328] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM021328, R37GM021328, R01GM021328] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER K, 1975, J ORG CHEM, V40, P2576, DOI 10.1021/jo00905a053; ALTMAN LF, 1972, J AM CHEM SOC, V94, P3257, DOI 10.1021/ja00764a073; ALTMAN LJ, 1978, J AM CHEM SOC, V100, P6174, DOI 10.1021/ja00487a037; BIERLLEONHARDT BA, 1981, TETRAHEDRON LETT, V22, P389, DOI 10.1016/0040-4039(81)80107-4; Blagg BSJ, 2002, J AM CHEM SOC, V124, P8846, DOI 10.1021/ja020411a; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; DOLENCE JM, 1999, COMPREHENSIVE NATURA, V5, P18473; Erickson HK, 2003, J AM CHEM SOC, V125, P6886, DOI 10.1021/ja034520g; Giner JL, 2000, J NAT PROD, V63, P267, DOI 10.1021/np990081g; Gunawardena K, 2002, PHYTOCHEMISTRY, V59, P197, DOI 10.1016/S0031-9422(01)00438-1; HEATHCOCK CH, 1985, SCIENCE, V229, P862, DOI 10.1126/science.3927485; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Iwata-Reuyl D, 2003, BIOCHEMISTRY-US, V42, P3359, DOI 10.1021/bi0206614; Jarstfer MB, 2002, J AM CHEM SOC, V124, P8834, DOI 10.1021/ja020410i; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; POPJAK G, 1973, J AM CHEM SOC, V95, P2713, DOI 10.1021/ja00789a066; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; RILLING HC, 1969, J AM CHEM SOC, V91, P1041, DOI 10.1021/ja01032a052; Rivera SB, 2001, P NATL ACAD SCI USA, V98, P4373, DOI 10.1073/pnas.071543598; SOUCEK M, 1959, COLLECT CZECH CHEM C, V24, P3802; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Thulasiram HV, 2006, J AM CHEM SOC, V128, P15819, DOI 10.1021/ja065573b; Zhang AJ, 2004, P NATL ACAD SCI USA, V101, P9601, DOI 10.1073/pnas.0401298101	23	134	141	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					73	76		10.1126/science.1137786	http://dx.doi.org/10.1126/science.1137786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	153XD	17412950				2022-12-24	WOS:000245470500033
J	Zhou, Y; Atkins, JB; Rompani, SB; Bancescu, DL; Petersen, PH; Tang, HY; Zou, KY; Stewart, SB; Zhong, WM				Zhou, Yan; Atkins, Joshua B.; Rompani, Santiago B.; Bancescu, Daria L.; Petersen, Petur H.; Tang, Haiyan; Zou, Kaiyong; Stewart, Sinead B.; Zhong, Weimin			The mammalian golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosis	CELL			English	Article							PROGENITOR CELLS; MOUSE NUMB; STEM-CELLS; PROTEIN; ORIENTATION; MEMBRANE; DOMAIN; FATES; IDENTIFICATION; FRAGMENTATION	Mammalian neural progenitor cells divide asymmetrically to self-renew and produce a neuron by segregating cytosolic Numb proteins primarily to one daughter cell. Numb signaling specifies progenitor over neuronal fates but, paradoxically, also promotes neuronal differentiation. Here we report that ACBD3 is a Numb partner in cell-fate specification. ACBD3 and Numb proteins interact through an essential Numb domain, and the respective loss- and gain-of-function mutant mice share phenotypic similarities. Interestingly, ACBD3 associates with the Golgi apparatus in neurons and interphase progenitor cells but becomes cytosolic after Golgi fragmentation during mitosis, when Numb activity is needed to distinguish the two daughter cells. Accordingly, cytosolic ACBD3 can act synergistically with Numb to specify cell fates, and its continuing presence during the progenitor cell cycle inhibits neuron production. We propose that Golgi fragmentation and reconstitution during cell cycle differentially regulate Numb signaling through changes in ACBD3 subcellular distribution and represent a mechanism for coupling cell-fate specification and cell-cycle progression.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University	Zhong, WM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	weimin.zhong@yale.edu	Zhou, Yan/AAM-3591-2021; , PeturHenry/H-1506-2011	Zhou, Yan/0000-0002-2713-4442; Rompani, Santiago/0000-0002-3994-3052	NINDS NIH HHS [R01 NS042048] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BANG AG, 1991, DEVELOPMENT, V111, P89; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2006, DEV NEUROSCI-BASEL, V28, P156, DOI 10.1159/000090761; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Prokopenko SN, 2005, SEMIN CELL DEV BIOL, V16, P423, DOI 10.1016/j.semcdb.2005.02.005; Qian XM, 1998, DEVELOPMENT, V125, P3143; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Tang HY, 2005, MOL CELL BIOL, V25, P2899, DOI 10.1128/MCB.25.8.2899-2909.2005; Yaich L, 1998, J BIOL CHEM, V273, P10381, DOI 10.1074/jbc.273.17.10381; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9	39	89	97	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					163	178		10.1016/j.cell.2007.02.037	http://dx.doi.org/10.1016/j.cell.2007.02.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418793	Bronze			2022-12-24	WOS:000245661100019
J	Hadley, J				Hadley, Jack			Insurance coverage, medical care use, and short-term health changes following an unintentional injury or the onset of a chronic condition	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELF-RATED HEALTH; PREMIUM INCREASES; MORTALITY; DECLINE; ADULTS; RISK; TRAUMA; OLDER	Context Given the large and increasing number of uninsured US individuals, identifying the health consequences of being uninsured has assumed increased importance. Objective To compare medical care use and short-term health changes among US uninsured individuals and insured nonelderly individuals following a health shock caused by either an unintentional injury or the onset of a chronic condition. Design, Setting, and Participants Multivariate logistic regression analysis of longitudinal data from Medical Expenditure Panel Surveys (1997-2004) limited to nonelderly individuals whose insurance status was established for 2 months prior to 1 or more unintentional injuries ( 20 783 cases among 15 866 individuals) and onset of 1 or more chronic conditions ( 10 485 cases among 7954 individuals). Main Outcome Measures Self-reported medical care use and change in short-term general health status following the health shock. Results After experiencing a health shock, uninsured individuals were less likely to obtain any medical care ( unintentional injury [UI] group: 78.8% uninsured vs 88.7% insured [ adjusted odds ratio {AOR}, 0.47; 95% confidence interval {CI}, 0.43-0.51]; new chronic condition [NCC] group: 81.7% uninsured vs 91.5% insured [ AOR, 0.45; 95% CI, 0.40-0.50]) and more likely not to have received any recommended follow-up care ( UI group: 19.3% uninsured vs 9.2% insured [ AOR, 2.59; 95% CI, 2.15-3.11]; NCC group: 9.4% uninsured vs 4.4% insured [ AOR, 1.65; 95% CI, 1.32-2.06]). Based on the AORs, uninsured individuals with UIs had fewer outpatient visits (6.1% uninsured vs 9.0% insured; AOR, 0.71 [ 95% CI, 0.63-0.80]), office-based visits (41.8% uninsured vs 57.3% insured; AOR, 0.59 [ 95% CI, 0.56-0.62]), and prescription medicines (35.5% uninsured vs 35.6% insured; AOR, 0.71 [ 95% CI, 0.67-0.75]). Uninsured individuals with an NCC had fewer office-based visits (58.9% uninsured vs 68.3% insured; AOR, 0.77 [ 95% CI, 0.72-0.82]) and prescription medicines (52.7% uninsured vs 61.7% insured; AOR, 0.66 [ 95% CI, 0.57-0.76]). Higher proportions of uninsured individuals reported a decrease in health status ( classified as much worse) approximately 3.5 months after the health shock ( UI group: 9.8% uninsured vs 6.7% insured; AOR, 0.86 [ 95% CI, 0.75-0.98]; NCC group: 12.3% uninsured vs 10.1% insured; AOR, 0.74 [ 95% CI, 0.68-0.80]). Uninsured individuals with UIs were more likely to report not being fully recovered and no longer receiving treatment. At approximately 7 months after the health shock, uninsured individuals with NCCs still reported worse health status. Conclusions Among individuals who experienced a health shock caused by an unintentional injury or a new chronic condition, uninsured individuals reported receiving less medical care and poorer short-term changes in health than those with insurance.	Urban Inst, Washington, DC 20037 USA	Urban Institute	Hadley, J (corresponding author), Urban Inst, 2100 M St NW, Washington, DC 20037 USA.	jhadley@ui.urban.org	Shadmi, Efrat/A-3954-2016					*AG HEALTHC RES QU, DET INF MED EXP PAN; *AG HEALTHC RES QU, MED EXP PAN SURV HC; [Anonymous], MEPS HC RESP RAT PAN; Baker DW, 2006, MED CARE, V44, P277, DOI 10.1097/01.mlr.0000199696.41480.45; Baker DW, 2002, MED CARE, V40, P1126, DOI 10.1097/00005650-200211000-00013; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Diehr P, 2001, J AM GERIATR SOC, V49, P36, DOI 10.1046/j.1532-5415.2001.49007.x; Dor A, 2006, HEALTH SERV RES, V41, P759, DOI 10.1111/j.1475-6773.2006.00513.x; Doyle JJ, 2005, REV ECON STAT, V87, P256, DOI 10.1162/0034653053970348; ENGLE RF, 1983, ECONOMETRICA, V51, P277, DOI 10.2307/1911990; ERICSON P, 1995, 7 NAT CTR HLTH STAT; *FAM US, 2001, GETT LESS CAR UN CHR; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Gabel J, 2005, HEALTH AFFAIR, V24, P1273, DOI 10.1377/hlthaff.24.5.1273; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Hadley J, 2006, HEALTH SERV RES, V41, P429, DOI 10.1111/j.1475-6773.2005.00491.x; Hadley J, 2006, MED CARE RES REV, V63, P447, DOI 10.1177/1077558706288841; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; *I MED, 2002, CAR COV; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; KREIDER B, 2006, INF POL HLTH CAR COS; LEVY H, 2005, HLTH POLICY UNINSURE; LICHTENBERG FR, 2002, FRONTIERS HLTH POLIC, V5; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; NEWHOUSE J, 1993, FREE ALL RAND HLTH I; Schoen C, 1998, J URBAN HEALTH, V75, P30, DOI 10.1007/BF02344923; Schoen C, 2000, HEALTH SERV RES, V35, P187; SORLIE PD, 1994, ARCH INTERN MED, V154, P2409, DOI 10.1001/archinte.154.21.2409; STAGNITTI M, 2000, MED CARE TREATMENT C; *STATACORP, BIN COUNT LTD DEP VA; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; 2003, MED CARE RES REV S, V60, pS3	34	142	142	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2007	297	10					1073	1084		10.1001/jama.297.10.1073	http://dx.doi.org/10.1001/jama.297.10.1073			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145KZ	17356028	Bronze			2022-12-24	WOS:000244865200021
J	Holden, C				Holden, Constance			Stem cells - Data on adult stem cells questioned	SCIENCE			English	News Item																			0	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1207	1207		10.1126/science.315.5816.1207a	http://dx.doi.org/10.1126/science.315.5816.1207a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332385				2022-12-24	WOS:000244564700007
J	Kawahara, Y; Zinshteyn, B; Sethupathy, P; Iizasa, H; Hatzigeorgiou, AG; Nishikura, K				Kawahara, Yukio; Zinshteyn, Boris; Sethupathy, Praveen; Iizasa, Hisashi; Hatzigeorgiou, Artemis G.; Nishikura, Kazuko			Redirection of silencing targets by adenosine-to-inosine editing of miRNAs	SCIENCE			English	Article							RNA; MICRORNA; BIOGENESIS; GENE; DEAMINASES; MUTATION; ADAR1	Primary transcripts of certain microRNA ( miRNA) genes are subject to RNA editing that converts adenosine to inosine. However, the importance of miRNA editing remains largely undetermined. Here we report that tissue-specific adenosine-to-inosine editing of miR-376 cluster transcripts leads to predominant expression of edited miR-376 isoform RNAs. One highly edited site is positioned in the middle of the 5'-proximal half "seed" region critical for the hybridization of miRNAs to targets. We provide evidence that the edited miR-376 RNA silences specifically a different set of genes. Repression of phosphoribosyl pyrophosphate synthetase 1, a target of the edited miR-376 RNA and an enzyme involved in the uric-acid synthesis pathway, contributes to tight and tissue-specific regulation of uric-acid levels, revealing a previously unknown role for RNA editing in miRNA-mediated gene silencing.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Engn & Appl Sci, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania	Kawahara, Y (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	ykawahara@wistar.org; kazuko@wistar.org	Hatzigeorgiou, Artemis/Z-1976-2019; Iizasa, Hisashi/A-9821-2012	Zinshteyn, Boris/0000-0003-0103-3501	NATIONAL CANCER INSTITUTE [P01CA072765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA072765-050002, P01 CA072765] Funding Source: Medline; NHLBI NIH HHS [R01 HL070045, R01 HL070045-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM040536-16, R01 GM040536] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed M, 1999, J BIOL CHEM, V274, P7482, DOI 10.1074/jbc.274.11.7482; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Reenan RA, 2001, TRENDS GENET, V17, P53, DOI 10.1016/S0168-9525(00)02169-7; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	19	580	619	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1137	1140		10.1126/science.1138050	http://dx.doi.org/10.1126/science.1138050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322061	Green Accepted			2022-12-24	WOS:000244387600040
J	Bandfield, JL				Bandfield, Joshua L.			High-resolution subsurface water-ice distributions on Mars	NATURE			English	Article							MARTIAN GROUND-ICE; NEAR-SURFACE; STABILITY; BEHAVIOR	Theoretical models indicate that water ice is stable in the shallow subsurface ( depths of < 1 - 2 m) of Mars at high latitudes(1-7). These models have been mainly supported by the observed presence of large concentrations of hydrogen detected by the Gamma Ray Spectrometer suite of instruments on the Mars Odyssey spacecraft(8-10). The models and measurements are consistent with a water-ice table that steadily increases in depth with decreasing latitude. More detailed modelling has predicted that the depth at which water ice is stable can be highly variable, owing to local surface heterogeneities such as rocks and slopes, and the thermal inertia of the ground cover(11-13). Measurements have, however, been limited to the footprint ( several hundred kilometres) of the Gamma Ray Spectrometer suite, preventing the observations from documenting more detailed water-ice distributions. Here I show that by observing the seasonal temperature response of the martian surface with the Thermal Emission Imaging System on the Mars Odyssey spacecraft(14), it is possible to observe such heterogeneities at subkilometre scale. These observations show significant regional and local water-ice depth variability, and, in some cases, support distributions in the subsurface predicted by atmospheric exchange and vapour diffusion models. The presence of water ice where it follows the depth of stability under current climatic conditions implies an active martian water cycle that responds to orbit-driven climate cycles(15-17). Several regions also have apparent deviations from the theoretical stability level, indicating that additional factors influence the ice-table depth. The high-resolution measurements show that the depth to the water-ice table is highly variable within the potential Phoenix spacecraft landing ellipses, and is likely to be variable at scales that may be sampled by the spacecraft.	Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Bandfield, JL (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	joshband@asu.edu		Bandfield, Joshua/0000-0003-3571-3716				Aharonson O, 2006, J GEOPHYS RES-PLANET, V111, DOI [10.1029/2005JE002636, 10.1029/2005JE002636.]; Armstrong JC, 2005, ICARUS, V174, P360, DOI 10.1016/j.icarus.2004.10.032; ARVIDSON RE, 2006, LUNAR PLANET SCI C, V37; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002289; BETTS BH, 1995, J GEOPHYS RES-PLANET, V100, P5285, DOI 10.1029/95JE00226; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; EDWARDS CS, 2005, EOS, V158; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; HABERLE RM, 1990, J GEOPHYS RES-SOLID, V95, P1423, DOI 10.1029/JB095iB02p01423; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Jakosky BM, 1997, ICARUS, V130, P87, DOI 10.1006/icar.1997.5799; Jakosky BM, 2005, ICARUS, V175, P58, DOI 10.1016/j.icarus.2004.11.014; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Mitrofanov IG, 2004, SOLAR SYST RES+, V38, P253, DOI 10.1023/B:SOLS.0000037461.70809.45; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25959, DOI 10.1029/93JE03428; Schorghofer N, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002350; Sizemore HG, 2006, ICARUS, V185, P358, DOI 10.1016/j.icarus.2006.07.018; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497; TITUS TN, 2006, LUNAR PLANET SCI C, V37; ZENT AP, 1986, ICARUS, V67, P19, DOI 10.1016/0019-1035(86)90171-5	29	78	79	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					64	U1		10.1038/nature05781	http://dx.doi.org/10.1038/nature05781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476262				2022-12-24	WOS:000246149300043
J	Perrier, E				Perrier, Emilie			A patient's journey - Intensive care	BMJ-BRITISH MEDICAL JOURNAL			English	Article												azanome@hotmail.com							0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2007	334	7597					796	797		10.1136/bmj.39157.723090.BE	http://dx.doi.org/10.1136/bmj.39157.723090.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161SX	17431267	Green Published, Bronze			2022-12-24	WOS:000246037300032
J	Hadler, NM; Tait, RC; Chibnall, JT				Hadler, Nortin M.; Tait, Raymond C.; Chibnall, John T.			Back pain in the Workplace	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTORS; PSYCHOSOCIAL FACTORS; SICKNESS ABSENCE; FOLLOW-UP; WORKERS; PREDICTORS; DISORDERS; DURATION; INJURIES; SURGERY		Univ N Carolina, Sch Med, Dept Med, Div Rheumatol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; St Louis Univ, Sch Med, Dept Psychiat, St Louis, MO USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Saint Louis University	Hadler, NM (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Rheumatol, 3300 Thurston Bldg CB 7280, Chapel Hill, NC 27599 USA.	nmh@med.unc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013087] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS-013087-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Battie MC, 2004, SPINE, V29, P2679, DOI 10.1097/01.brs.0000146457.83240.eb; Blum F., 2006, WORKERS COMPENSATION, V6, P3; Carragee E, 2006, SPINE, V31, P2942, DOI 10.1097/01.brs.0000248429.10963.13; Cassidy JD, 2005, SPINE, V30, P2817, DOI 10.1097/01.brs.0000190448.69091.53; Chibnall JT, 2006, SPINE, V31, P1272, DOI 10.1097/01.brs.0000217584.79528.9b; HADLER NM, 1978, ANN INTERN MED, V89, P992; HADLER NM, 1986, NEW ENGL J MED, V315, P1090, DOI 10.1056/NEJM198610233151711; Hadler NM, 1997, NEW ENGL J MED, V337, P341, DOI 10.1056/NEJM199707313370511; Hadler NM, 2003, JAMA-J AM MED ASSOC, V289, P2863, DOI 10.1001/jama.289.21.2863; Hadler NM., 2005, OCCUPATIONAL MUSCULO; Harkness EF, 2003, RHEUMATOLOGY, V42, P959, DOI 10.1093/rheumatology/keg265; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Hashemi L, 1998, J OCCUP ENVIRON MED, V40, P1110; Head J, 2006, J EPIDEMIOL COMMUN H, V60, P55, DOI 10.1136/jech.2005.038752; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Kaila-Kangas L, 2004, SPINE, V29, P1823, DOI 10.1097/01.BRS.0000134572.46151.0A; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Lotters F, 2006, OCCUP ENVIRON MED, V63, P794, DOI 10.1136/oem.2005.020420; Mixter WJ, 1935, NEW ENGL J MED, V213, P385, DOI 10.1056/NEJM193508292130901; Nielsen ML, 2006, J OCCUP ENVIRON MED, V48, P591, DOI 10.1097/01.jom.0000201567.70084.3a; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Tait RC, 2006, J PAIN, V7, P951, DOI 10.1016/j.jpain.2006.05.007; Tait RC, 2004, PAIN, V112, P389, DOI 10.1016/j.pain.2004.09.027; Volinn E, 2005, SPINE, V30, P697, DOI 10.1097/01.brs.0000155404.32725.f8; Waddell G, 2002, BACK PAIN INCAPACITY	25	22	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1594	1596		10.1001/jama.297.14.1594	http://dx.doi.org/10.1001/jama.297.14.1594			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426279				2022-12-24	WOS:000245589800028
J	Affara, NI; Coussens, LM				Affara, Nesrine I.; Coussens, Lisa M.			IKK alpha at the crossroads of inflammation and metastasis	CELL			English	Editorial Material							CANCER DEVELOPMENT; MASPIN; BONE	The development of solid tumors is regulated by dynamic interactions between evolving neoplastic cells and their microenvironment. Luo et al. (2007) recently demonstrated that tumor-infiltrating immune cells expressing RANKL induce activation and nuclear localization of IKK alpha in prostatic epithelial tumor cells. This leads to repression of maspin, a critical suppressor of metastasis, and thus commits malignant prostatic epithelial cells to a metastatic fate.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Coussens, LM (corresponding author), Univ Calif San Francisco, Dept Pathol, 2340 Sutter St, San Francisco, CA 94143 USA.	coussens@cc.ucsf.edu	Coussens, Lisa/ABH-9834-2020					Clezardin P, 2005, CANCER RES, V65, P4971, DOI 10.1158/0008-5472.CAN-05-0264; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; LUO JL, 2007, NATURE; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; Sheng SJ, 2004, FRONT BIOSCI-LANDMRK, V9, P2733, DOI 10.2741/1432; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	8	38	43	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					25	26		10.1016/j.cell.2007.03.029	http://dx.doi.org/10.1016/j.cell.2007.03.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418780	Bronze			2022-12-24	WOS:000245661100005
J	Lee, YS; Mulugu, S; York, JD; O'Shea, EK				Lee, Young-Sam; Mulugu, Sashidhar; York, John D.; O'Shea, Erin K.			Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TELOMERE LENGTH; PROTEIN-KINASES; YEAST; PHO80-PHO85; HEXAKISPHOSPHATE; PHOSPHORYLATION; POLYPHOSPHATES; DICTYOSTELIUM; ENZYMES	In budding yeast, phosphate starvation triggers inhibition of the Pho80-Pho85 cyclin-cyclin-dependent kinase (CDK) complex by the CDK inhibitor Pho81, leading to expression of genes involved in nutrient homeostasis. We isolated myo-D-inositol heptakisphosphate (IP7) as a cellular component that stimulates Pho81-dependent inhibition of Pho80-Pho85. IP7 is necessary for Pho81- dependent inhibition of Pho80-Pho85 in vitro. Moreover, intracellular concentrations of IP7 increased upon phosphate starvation, and yeast mutants defective in IP7 production failed to inhibit Pho80-Pho85 in response to phosphate starvation. These observations reveal regulation of a cyclin-CDK complex by a metabolite and suggest that a complex metabolic network mediates signaling of phosphate availability.	Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Harvard University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Lee, Young-Sam/A-2499-2013		NHLBI NIH HHS [HL055672] Funding Source: Medline; NIDDK NIH HHS [DK070272] Funding Source: Medline; NIGMS NIH HHS [R01 GM051377, R01 GM051377-15] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051377] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; Flick JS, 1998, GENETICS, V148, P33; Huang SD, 2005, GENETICS, V169, P1859, DOI 10.1534/genetics.104.038695; Huang SD, 2001, MOL CELL BIOL, V21, P6695, DOI 10.1128/MCB.21.19.6695-6705.2001; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; MAYR GW, 1992, CARBOHYD RES, V234, P247, DOI 10.1016/0008-6215(92)85052-2; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	25	214	222	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					109	112		10.1126/science.1139080	http://dx.doi.org/10.1126/science.1139080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412959	Green Accepted			2022-12-24	WOS:000245470500043
J	Ota, KG; Kuraku, S; Kuratani, S				Ota, Kinya G.; Kuraku, Shigehiro; Kuratani, Shigeru			Hagfish embryology with reference to the evolution of the neural crest	NATURE			English	Article							VERTEBRATE EVOLUTION; HEAD; MIGRATION; SEQUENCES; ORIGIN; SLUG	Hagfish, which lack both jaws and vertebrae, have long been the subject of intense interest owing to their position at a crucial point in the evolutionary transition to a truly vertebrate body plan(1-4). However, unlike the comparatively well characterized vertebrate agnathan lamprey, little is known about hagfish development. The inability to analyse hagfish at early embryonic stages has frustrated attempts to resolve questions with important phylogenetic implications, including fundamental ones relating to the emergence of the neural crest(1,5,6). Here we report the obtainment of multiple pharyngula-stage embryos of the hagfish species Eptatretus burgeri and our preliminary analyses of their early development. We present histological evidence of putative neural crest cells, which appear as delaminated cells that migrate along pathways corresponding to neural crest cells in fish and amphibians(2,7-11). Molecular cloning studies further revealed the expression of several regulatory genes, including cognates of Pax6, Pax3/7, SoxEa and Sox9, suggesting that the hagfish neural crest is specified by molecular mechanisms that are general to vertebrates. We propose that the neural crest emerged as a population of de-epithelialized migratory cells in a common vertebrate ancestor, and suggest that the possibility of classical and molecular embryology in hagfish opens up new approaches to clarifying the evolutionary history of vertebrates.	RIKEN, Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan	RIKEN	Kuratani, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Kuraku, Shigehiro/B-2801-2009; Kuratani, Shigeru/J-4146-2014	Kuraku, Shigehiro/0000-0003-1464-8388; Kuratani, Shigeru/0000-0001-9717-7221				BRONNERFRASER M, 1993, J NEUROBIOL, V24, P233, DOI 10.1002/neu.480240209; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; COLLAZO A, 1993, DEVELOPMENT, V118, P363; Conel JL, 1942, J COMP NEUROL, V76, P191, DOI 10.1002/cne.900760202; Dean B., 1899, EMBRYOLOGY BDELLOSTO, P220; EISEN JS, 1993, DEV BIOL, V159, P50, DOI 10.1006/dbio.1993.1220; Furlong RF, 2002, ZOOL SCI, V19, P593, DOI 10.2108/zsj.19.593; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; Gorbman A, 1997, ZOOL SCI, V14, P375, DOI 10.2108/zsj.14.375; GORBMAN A, 1985, EVOLUTIONARY BIOL PR, P165; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Hall BK, 1999, NEURAL CREST DEV EVO; Holmgren N., 1946, ACTA ZOOLOGICA, V27, P1, DOI [10.1111/j.1463-6395.1946.tb00019.x, DOI 10.1111/J.1463-6395.1946.TB00019.X]; Janvier P., 1996, EARLY VERTEBRATES; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Le Douarin NM, 1999, NEURAL CREST, V2; Locascio A, 2002, P NATL ACAD SCI USA, V99, P16841, DOI 10.1073/pnas.262525399; Lovtrup S., 1977, PHYLOGENY VERTEBRATA; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Ota KG, 2006, ZOOL SCI, V23, P403, DOI 10.2108/zsj.23.403; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; WICHT H, 1995, PHILOS T ROY SOC B, V349, P119, DOI 10.1098/rstb.1995.0098; Wicht H, 1998, BIOLOGY OF HAGFISHES, P431	30	156	163	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					672	675		10.1038/nature05633	http://dx.doi.org/10.1038/nature05633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377535				2022-12-24	WOS:000245438300041
J	Mason, KD; Carpinelli, MR; Fletcher, JI; Collinge, JE; Hilton, AA; Ellis, S; Kelly, PN; Ekert, PG; Metcalf, D; Roberts, AW; Huang, DCS; Kile, BT				Mason, Kylie D.; Carpinelli, Marina R.; Fletcher, Jamie I.; Collinge, Janelle E.; Hilton, Adrienne A.; Ellis, Sarah; Kelly, Priscilla N.; Ekert, Paul G.; Metcalf, Donald; Roberts, Andrew W.; Huang, David C. S.; Kile, Benjamin T.			Programmed anuclear cell death delimits platelet life span	CELL			English	Article							BCL-X; IN-VIVO; APOPTOSIS; SURVIVAL; BAX; PROTEINS; INHIBITION; ACTIVATION; PATHWAYS; EXPOSURE	Platelets are anuclear cytoplasmic fragments essential for blood clotting and wound healing. Despite much speculation, the factors determining their life span in the circulation are unknown. We show here that an intrinsic program for apoptosis, controls platelet survival and dictates their life span. Pro-survival Bcl-X-L constrains the pro-apoptotic activity of Bak to maintain platelet survival, but as Bcl-X-L degrades, aged platelets are primed for cell death. Genetic ablation or pharmacological inactivation of Bcl-X-L reduces platelet half-life and causes thrombocytopenia in a dose-dependent manner. Deletion of Bak corrects these defects, and platelets from Bak-deficient mice live longer than normal. Thus, platelets are, by default, genetically programmed to die by apoptosis. The antagonistic balance between Bcl-X-L and Bak constitutes a molecular clock that determines platelet life span: this represents an important paradigm for cellular homeostasis, and has profound implications for the diagnosis and treatment of disorders that affect platelet number and function.	Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Div Mol Med, Melbourne, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Canc & Hematol Div, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia; Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Royal Children's Hospital Melbourne	Huang, DCS (corresponding author), Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic 3050, Australia.	huang_d@wehi.edu.au; kile@wehi.edu.au	Ekert, Paul/Q-1842-2015; Ekert, Paul G/C-7247-2013; Kile, Benjamin T/F-6593-2011; Kile, Benjamin/GNP-3246-2022; Fletcher, Jamie/V-4667-2019; Roberts, Andrew W./C-6736-2012; Huang, David C. S./C-7586-2013	Ekert, Paul/0000-0002-2976-8617; Ekert, Paul G/0000-0002-2976-8617; Kile, Benjamin T/0000-0002-8836-8947; Kile, Benjamin/0000-0002-8836-8947; Roberts, Andrew W./0000-0002-7341-5720; Huang, David C. S./0000-0002-3101-4873; Mason, Kylie/0000-0002-6238-4092; Ellis, Sarah/0000-0002-5772-6051; Carpinelli, Marina/0000-0001-5115-7831; Fletcher, Jamie/0000-0003-2949-9469				Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; AULT KA, 1995, EXP HEMATOL, V23, P996; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; Cohen Z, 2004, THROMB RES, V113, P387, DOI 10.1016/j.thromres.2004.03.020; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; George JN, 1998, ANN INTERN MED, V129, P886, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00009; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; Kaluzhny Y, 2002, BLOOD, V100, P1670, DOI 10.1182/blood-2001-12-0263; Kasai S, 2003, DEV BIOL, V264, P202, DOI 10.1016/S0012-1606(03)00400-7; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; KIENAST J, 1990, BLOOD, V75, P116; LEEKSMA CHW, 1955, NATURE, V175, P552, DOI 10.1038/175552b0; Li JZ, 2000, TRANSFUSION, V40, P1320, DOI 10.1046/j.1537-2995.2000.40111320.x; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Methot N, 2004, J EXP MED, V199, P199, DOI 10.1084/jem.20031791; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; MUSTARD JF, 1966, BRIT J HAEMATOL, V12, P1, DOI 10.1111/j.1365-2141.1966.tb00121.x; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Pereira J, 2002, THROMB HAEMOSTASIS, V87, P905; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rand ML, 2004, J THROMB HAEMOST, V2, P651, DOI 10.1111/j.1538-7836.2004.00670.x; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Rudin CM, 1997, ANNU REV MED, V48, P267; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; ZHANG H, 2007, IN PRESS CELL DEATH; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	44	731	768	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1173	1186		10.1016/j.cell.2007.01.037	http://dx.doi.org/10.1016/j.cell.2007.01.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382885	Bronze			2022-12-24	WOS:000245396200022
J	Abbott, A				Abbott, Alison			A place in the sun	NATURE			English	News Item								Novartis has declared it's intention to become he world leader in vaccines since it took over Chiron and continued with it's vaccine research. Now Novartis aims to double last years sales by 2011. The business today has half-a-dozen vaccines in late-stage clinical trials for diseases such as meningitis and influenza.											0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					124	125		10.1038/446124a	http://dx.doi.org/10.1038/446124a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344823	Bronze			2022-12-24	WOS:000244718100010
J	Nowack, MK; Shirzadi, R; Dissmeyer, N; Dolf, A; Endl, E; Grini, PE; Schnittger, A				Nowack, Moritz K.; Shirzadi, Reza; Dissmeyer, Nico; Dolf, Andreas; Endl, Elmar; Grini, Paul E.; Schnittger, Arp			Bypassing genomic imprinting allows seed development	NATURE			English	Article							POLYCOMB GROUP-COMPLEXES; ENDOSPERM DEVELOPMENT; ARABIDOPSIS-THALIANA; GROUP GENE; MEDEA; FERTILIZATION; EXPRESSION; PLANTS; EMBRYOGENESIS; MAIZE	In developing progeny of mammals the two parental genomes are differentially expressed according to imprinting marks, and embryos with only a uniparental genetic contribution die(1-3). Gene expression that is dependent on the parent of origin has also been observed in the offspring of flowering plants, and mutations in the imprinting machinery lead to embryonic lethality, primarily affecting the development of the endosperm - a structure in the seed that nourishes the embryo, analogous to the function of the mammalian placenta(4). Here we have generated Arabidopsis thaliana seeds in which the endosperm is of uniparental, that is, maternal, origin. We demonstrate that imprinting in developing seeds can be bypassed and viable albeit smaller seedlings can develop from seeds lacking a paternal contribution to the endosperm. Bypassing is only possible if the mother is mutant for any of the FIS-class genes, which encode Polycomb group chromatin-modifying factors. Thus, these data provide functional evidence that the action of the FIS complex balances the contribution of the paternal genome. As flowering plants have evolved a special reproduction system with a parallel fusion of two female with two male gametes, our findings support the hypothesis that only with the evolution of double fertilization did the action of the FIS genes become a requirement for seed development. Furthermore, our data argue for a gametophytic origin of endosperm in flowering plants, thereby supporting a hypothesis raised in 1900 by Eduard Strasburger.	Univ Cologne, Dept Bot 3, Max Delbruck Lab, Max Planck Inst Plant Breeding Res,Univ Grp, D-50829 Cologne, Germany; Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; Inst Mol Med & Expt Immunol, D-53105 Bonn, Germany	Max Planck Society; University of Cologne; University of Oslo; University of Bonn	Schnittger, A (corresponding author), Univ Cologne, Dept Bot 3, Max Delbruck Lab, Max Planck Inst Plant Breeding Res,Univ Grp, Carl von Linne Weg 10, D-50829 Cologne, Germany.	schnitt@mpiz-koeln.mpg.de	Dissmeyer, Nico/HII-8298-2022; Grini, Paul/H-9471-2016; dissmeyer, nico/A-4738-2015; Schnittger, Arp/F-8989-2010; Schnittger, Arp/AAO-6920-2020; Grini, Paul/N-5948-2019	Grini, Paul/0000-0003-3898-6277; dissmeyer, nico/0000-0002-4156-3761; Schnittger, Arp/0000-0001-7067-0091; Schnittger, Arp/0000-0001-7067-0091; Grini, Paul/0000-0003-3898-6277; Nowack, Moritz/0000-0001-8918-7577				Autran D, 2005, CURR OPIN PLANT BIOL, V8, P19, DOI 10.1016/j.pbi.2004.11.011; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Berger F, 2004, SCIENCE, V303, P483, DOI 10.1126/science.1094375; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; FAURE JE, 1993, PLANT CELL, V5, P747, DOI 10.1105/tpc.5.7.747; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Grini PE, 2002, GENETICS, V162, P1911; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Ingouff M, 2005, PLANT J, V42, P663, DOI 10.1111/j.1365-313X.2005.02404.x; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2005, PROG MOLEC, V38, P237; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; LIN BY, 1982, GENETICS, V100, P475; LIN BY, 1984, GENETICS, V107, P103; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; MAHESHWARI P, 1967, BIOL REV, V42, P88, DOI 10.1111/j.1469-185X.1967.tb01341.x; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sargant E, 1900, ANN BOT-LONDON, V14, P689, DOI 10.1093/oxfordjournals.aob.a088799; Scott RJ, 2006, CYTOGENET GENOME RES, V113, P53, DOI 10.1159/000090815; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; STRASBURGER E, 1900, BOT Z, V58, P294; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171	34	83	86	4	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					312	U3		10.1038/nature05770	http://dx.doi.org/10.1038/nature05770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17468744				2022-12-24	WOS:000246520300044
J	Mok, KH; Kuhn, LT; Goez, M; Day, IJ; Lin, JC; Andersen, NH; Hore, PJ				Mok, K. Hun; Kuhn, Lars T.; Goez, Martin; Day, Iain J.; Lin, Jasper C.; Andersen, Niels H.; Hore, P. J.			A pre-existing hydrophobic collapse in the unfolded state of an ultrafast folding protein	NATURE			English	Article							TRP-CAGE; PHOTO-CIDNP; RESIDUAL STRUCTURE; DENATURED STATE; NMR; INTERMEDIATE; SIMULATIONS; MINIPROTEIN; RESOLUTION; BEHAVIOR	Insights into the conformational passage of a polypeptide chain across its free energy landscape have come from the judicious combination of experimental studies and computer simulations(1,2). Even though some unfolded and partially folded proteins are now known to possess biological function(3) or to be involved in aggregation phenomena associated with disease states(1,4), experimentally derived atomic-level information on these structures remains sparse as a result of conformational heterogeneity and dynamics. Here we present a technique that can provide such information. Using a 'Trp-cage' miniprotein known as TC5b ( ref. 5), we report photochemically induced dynamic nuclear polarization NMR6 pulse-labelling experiments that involve rapid in situ protein refolding(7,8). These experiments allow dipolar cross-relaxation with hyperpolarized aromatic side chain nuclei in the unfolded state to be identified and quantified in the resulting folded-state spectrum. We find that there is residual structure due to hydrophobic collapse in the unfolded state of this small protein, with strong inter-residue contacts between side chains that are relatively distant from one another in the native state. Prior structuring, even with the formation of non-native rather than native contacts, may be a feature associated with fast folding events in proteins.	Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, Oxford OX1 3QZ, England; Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; Univ Halle Wittenberg, Fachbereich Chem, D-06120 Halle, Germany; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Oxford; Trinity College Dublin; Martin Luther University Halle Wittenberg; University of Massachusetts System; University of Massachusetts Worcester; University of Washington; University of Washington Seattle	Mok, KH (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, S Parks Rd, Oxford OX1 3QZ, England.	mok1@tcd.ie; peter.hore@chem.ox.ac.uk	Kuhn, Lars Thorsten/J-5451-2015; Hore, Peter/R-1923-2017; Mok, K. Hun/C-2607-2009	Kuhn, Lars Thorsten/0000-0002-3701-580X; Hore, Peter/0000-0002-8863-570X; Mok, K Hun/0000-0003-3663-2002; Day, Iain/0000-0002-2311-6837	NIGMS NIH HHS [R01 GM059658] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059658] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed Z, 2005, J AM CHEM SOC, V127, P10943, DOI 10.1021/ja050664e; Balbach J, 1997, P NATL ACAD SCI USA, V94, P7182, DOI 10.1073/pnas.94.14.7182; Bunagan MR, 2006, J PHYS CHEM B, V110, P3759, DOI 10.1021/jp055288z; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chowdhury S, 2003, J MOL BIOL, V327, P711, DOI 10.1016/S0022-2836(03)00177-3; Crowhurst KA, 2003, BIOCHEMISTRY-US, V42, P8687, DOI 10.1021/bi034601p; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; HORE PJ, 1982, J MAGN RESON, V49, P122, DOI 10.1016/0022-2364(82)90302-X; KAPTEIN R, 1982, BIOL MAGN RESON, V4, P145; Khan F, 2006, J AM CHEM SOC, V128, P10729, DOI 10.1021/ja060618u; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Lyon CE, 1999, J AM CHEM SOC, V121, P6505, DOI 10.1021/ja9907663; Mok KH, 2005, P NATL ACAD SCI USA, V102, P8899, DOI 10.1073/pnas.0500661102; Mok KH, 2004, METHODS, V34, P75, DOI 10.1016/j.ymeth.2004.03.006; Mok KH, 2003, J AM CHEM SOC, V125, P12484, DOI 10.1021/ja036357v; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Neuweiler H, 2005, P NATL ACAD SCI USA, V102, P16650, DOI 10.1073/pnas.0507351102; Pitera JW, 2003, P NATL ACAD SCI USA, V100, P7587, DOI 10.1073/pnas.1330954100; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; SHORT PF, 1989, J HEALTH ECON, V8, P293, DOI 10.1016/0167-6296(89)90023-4; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Snow CD, 2002, J AM CHEM SOC, V124, P14548, DOI 10.1021/ja028604l; Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100	30	136	139	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					106	109		10.1038/nature05728	http://dx.doi.org/10.1038/nature05728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17429353	Green Accepted			2022-12-24	WOS:000246149300053
J	Burgdorf, S; Kautz, A; Bohnert, V; Knolle, PA; Kurts, C				Burgdorf, Sven; Kautz, Andreas; Boehnert, Volker; Knolle, Percy A.; Kurts, Christian			Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation	SCIENCE			English	Article							DENDRITIC CELLS; CROSS-PRESENTATION; IN-VIVO; MANNOSE RECEPTOR; CROSSPRESENTATION; COMPARTMENT; ENDOCYTOSIS; MEMORY; ER	The mechanisms that allow antigen-presenting cells (APCs) to selectively present extracellular antigen to CD8(+) effector T cells (cross-presentation) or to CD4(+) T helper cells are not fully resolved. We demonstrated that APCs use distinct endocytosis mechanisms to simultaneously introduce soluble antigen into separate intracellular compartments, which were dedicated to presentation to CD8(+) or CD4(+) T cells. Specifically, the mannose receptor supplied an early endosomal compartment distinct from lysosomes, which was committed to cross-presentation. These findings imply that antigen does not require intracellular diversion to access the cross-presentation pathway, because it can enter the pathway already during endocytosis.	Univ Bonn, Inst Mol Med & Expt Immunol, D-5300 Bonn, Germany	University of Bonn	Burgdorf, S (corresponding author), Univ Bonn, Inst Mol Med & Expt Immunol, D-5300 Bonn, Germany.	sven.burgdorf@ukb.uni-bonn.de; ckurts@web.de	Eckhardt, Erik/G-1567-2010	Bohnert, Volker/0000-0002-3205-827X; Knolle, Percy A./0000-0003-2983-0414				Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Palecanda Aiyappa, 2001, Current Molecular Medicine (Hilversum), V1, P589, DOI 10.2174/1566524013363384; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zinkernagel RM, 2002, EUR J IMMUNOL, V32, P2385, DOI 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V	32	469	484	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					612	616		10.1126/science.1137971	http://dx.doi.org/10.1126/science.1137971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463291				2022-12-24	WOS:000245983100049
J	Lindsey, JB; Hillis, LD				Lindsey, Jason B.; Hillis, L. David			Clinical update: atrial septal defect in adults	LANCET			English	Article							SURGICAL-TREATMENT; FOLLOW-UP; TRANSCATHETER CLOSURE; DEVICE; EXPERIENCE; OCCLUDER; COMPLICATIONS; CHILDREN; TRIAL		Univ Texas, SW Med Ctr, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hillis, LD (corresponding author), Univ Texas, SW Med Ctr, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA.	dhilli@parknet.pmh.org						Amin Z, 2004, CATHETER CARDIO INTE, V63, P496, DOI 10.1002/ccd.20211; Attie F, 2001, J AM COLL CARDIOL, V38, P2035, DOI 10.1016/S0735-1097(01)01635-7; Butera G, 2006, AM HEART J, V151, P228, DOI 10.1016/j.ahj.2005.02.051; Carminati M, 2000, CARDIOL YOUNG, V10, P519; Divekar A, 2005, J AM COLL CARDIOL, V45, P1213, DOI 10.1016/j.jacc.2004.12.072; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4; Fischer G, 2003, HEART, V89, P199, DOI 10.1136/heart.89.2.199; Giamberti A, 2006, ANN THORAC SURG, V82, P1327, DOI 10.1016/j.athoracsur.2006.05.010; Hausdorf G, 1996, HEART, V75, P83, DOI 10.1136/hrt.75.1.83; HORVATH KA, 1992, J AM COLL CARDIOL, V20, P1156, DOI 10.1016/0735-1097(92)90372-T; KONSTANTINIDES S, 1995, NEW ENGL J MED, V333, P469, DOI 10.1056/NEJM199508243330801; Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066; Mills NL, 2003, AM J CARDIOL, V92, P353, DOI 10.1016/S0002-9149(03)00647-7; MURPHY JG, 1990, NEW ENGL J MED, V323, P1645, DOI 10.1056/NEJM199012133232401; Podnar T, 2001, CATHETER CARDIO INTE, V53, P386, DOI 10.1002/ccd.1187; SHAH D, 1994, BRIT HEART J, V71, P224; Sharafuddin MJA, 1997, CIRCULATION, V95, P2162, DOI 10.1161/01.CIR.95.8.2162; SUTTON MGS, 1981, CIRCULATION, V64, P402, DOI 10.1161/01.CIR.64.2.402; Thanopoulos BD, 1998, J AM COLL CARDIOL, V31, P1110, DOI 10.1016/S0735-1097(98)00039-4; Theodoro DA, 1998, ANN THORAC SURG, V65, P149, DOI 10.1016/S0003-4975(97)01193-4	20	46	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1244	1246		10.1016/S0140-6736(07)60576-5	http://dx.doi.org/10.1016/S0140-6736(07)60576-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434386				2022-12-24	WOS:000246269700010
J	Han, K; Konkel, MK; Xing, J; Wang, H; Lee, J; Meyer, TJ; Huang, CT; Sandifer, E; Hebert, K; Barnes, EW; Hubley, R; Miller, W; Smit, AFA; Ullmer, B; Batzer, MA				Han, Kyudong; Konkel, Miriam K.; Xing, Jinchuan; Wang, Hui; Lee, Jungnam; Meyer, Thomas J.; Huang, Charles T.; Sandifer, Erin; Hebert, Kristi; Barnes, Erin W.; Hubley, Robert; Miller, Webb; Smit, Arian F. A.; Ullmer, Brygg; Batzer, Mark A.			Mobile DNA in old world monkeys: A glimpse through the rhesus macaque genome	SCIENCE			English	Article							LYON REPEAT HYPOTHESIS; INTERSPERSED REPEATS; LINE-1 ELEMENTS; ALU ELEMENTS; RETROTRANSPOSITION; EVOLUTION; PRIMATES; INACTIVATION; DIVERSITY; LINEAGES	The completion of the draft sequence of the rhesus macaque genome allowed us to study the genomic composition and evolution of transposable elements in this representative of the Old World monkey lineage, a group of diverse primates closely related to humans. The L1 family of long interspersed elements appears to have evolved as a single lineage, and Alu elements have evolved into four currently active lineages. We also found evidence of elevated horizontal transmissions of retroviruses and the absence of DNA transposon activity in the Old World monkey lineage. In addition, similar to 100 precursors of composite SVA ( short interspersed element, variable number of tandem repeat, and Alu) elements were identified, with the majority being shared by the common ancestor of humans and rhesus macaques. Mobile elements compose roughly 50% of primate genomes, and our findings illustrate their diversity and strong influence on genome evolution between closely related species.	Louisiana State Univ, Dept Biol Sci, Biol Computat & Visualizat Ctr, Ctr Biomodular Multiscale Syst, Baton Rouge, LA 70803 USA; Inst Syst Biol, Seattle, WA 98103 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Louisiana State Univ, Dept Comp Sci, Ctr Computat Technol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Institute for Systems Biology (ISB); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Louisiana State University System; Louisiana State University	Batzer, MA (corresponding author), Louisiana State Univ, Dept Biol Sci, Biol Computat & Visualizat Ctr, Ctr Biomodular Multiscale Syst, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu	Xing, Jinchuan/A-2489-2012; Han, Kyudong/AAF-1788-2019	Han, Kyudong/0000-0001-6791-2408; Barnes, Erin W./0000-0002-9930-7664	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Callinan P, 2006, GENOME DYN, V1, P104, DOI 10.1159/000092503; Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054; Chen JM, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/56182; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mills RE, 2006, AM J HUM GENET, V78, P671, DOI 10.1086/501028; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Ray DA, 2006, SYSTEMATIC BIOL, V55, P928, DOI 10.1080/10635150600865419; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shedlock AM, 2004, TRENDS ECOL EVOL, V19, P545, DOI 10.1016/j.tree.2004.08.002; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Xing J, 2006, P NATL ACAD SCI USA, V103, P17608, DOI 10.1073/pnas.0603224103	27	78	81	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					238	240		10.1126/science.1139462	http://dx.doi.org/10.1126/science.1139462			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431169	Green Submitted			2022-12-24	WOS:000245654500039
J	Anderson, KB; Chunsuttiwat, S; Nisalak, A; Mammen, MP; Libraty, DH; Rothman, AL; Green, S; Vaughn, DW; Ennis, FA; Endy, TP				Anderson, Katie B.; Chunsuttiwat, Supamit; Nisalak, Ananda; Mammen, Mammen P.; Libraty, Daniel H.; Rothman, Alan L.; Green, Sharone; Vaughn, David W.; Ennis, Francis A.; Endy, Timothy P.			Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study	LANCET			English	Article							FEVER/DENGUE HEMORRHAGIC-FEVER; ADJUSTED LIFE YEARS; ECONOMIC-IMPACT; KAMPHAENG PHET; HEALTH PROBLEM; EMERGENCE; AMERICA	Background Dengue viruses are a major cause of morbidity and mortality in tropical and subtropical areas. Our aim was to assess prospectively the burden of dengue-related illness in children in Thailand. Methods We did a prospective study in a cohort of children at primary school in northern Thailand from 1998 to 2002. We assessed the burden of dengue illness as disability-adjusted life years (DALYs) and patient costs per illness. Findings Dengue accounted for 328 (11%) of the 3056 febrile cases identified in 2114 children during the study period. The mean burden of dengue was 465.3 (SD 358.0; range 76.5-954.0) DALYs per million population per year accounting for about 15% of DALYs lost to all febrile illnesses (3213.1 [SD 2624.2] DALYs per million per year). Non-hospitalised patients with dengue illnesses represented a substantial proportion of the overall burden of disease, with 44-73% of the total DALYs lost to dengue each year due to such illness. The infecting dengue serotype was an important determinant of DALYs lost: DEN4 was responsible for 1% of total DALYs lost, DEN1 for 9%, DEN2 for 30%, and DEN3 for 29%. Interpretation Use of prospective data to estimate the burden of disease shows that most DALYs lost to dengue illness were the result of non-hospitalised illnesses of long duration. Thus, inclusion of non-hospitalised cases is critical to accurately assess the total burden of dengue illness.	Walter Reed Army Inst Res, Div Communicable Dis & Immunol, Silver Spring, MD USA; Minist Publ Hlth, Nonthaburi, Thailand; Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; Univ Massachusetts, Sch Med, Ctr Infect Dis & Vaccine Res, Worcester, MA USA; Mil Infect Dis Res Program, Ft Detrick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Ministry of Public Health - Thailand; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of Massachusetts System; University of Massachusetts Worcester	Endy, TP (corresponding author), SUNY, Upstate Med Univ, Dept Med, Div Infect Dis, Syracuse, NY 13210 USA.	endyt@upstate.edu			NIAID NIH HHS [AI34533, P01 AI034533] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI034533] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almond Jeffrey, 2002, Vaccine, V20, P3043, DOI 10.1016/S0264-410X(02)00246-3; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; DeRoeck D, 2003, VACCINE, V22, P121, DOI 10.1016/S0264-410X(03)00533-4; Dietz V, 1996, P R Health Sci J, V15, P201; Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5; GUBLER DJ, 1993, INFECT AGENT DIS, V2, P383; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003; Halstead Scott B., 1997, P23; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; *NAT STAT OFF THAI, 2003, HOUS SOC SURV 2003; Nimmannitya Suchitra, 1997, P133; Okanurak K, 1997, Southeast Asian J Trop Med Public Health, V28, P711; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; World Bank, 1993, WORLD DEV REP INV HL; World Health Organization, 2004, WORLD HLTH REP 2003; [No title captured]	25	137	140	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1452	1459		10.1016/S0140-6736(07)60671-0	http://dx.doi.org/10.1016/S0140-6736(07)60671-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161LW	17467515				2022-12-24	WOS:000246017700031
J	Webb, DJ; Walker, A				Webb, David J.; Walker, Andrew			Value-based pricing of drugs in the UK	LANCET			English	Editorial Material									Queens Med Res Inst, Clin Pharmacol Unit, Edinburgh EH16 4TJ, Midlothian, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Webb, DJ (corresponding author), Queens Med Res Inst, Clin Pharmacol Unit, Edinburgh EH16 4TJ, Midlothian, Scotland.	d.j.webb@ed.ac.uk						*ASS BRIT PHARM IN, 2007, OFT STUD UK MED PRIC; Cooksey D., 2006, REV UK HLTH RES FUND; UK Department of Health, PHARM PRIC REG SCHEM; UK Office of Fair Trading, 2007, PHARM PRIC REG SCHEM	4	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1415	1416		10.1016/S0140-6736(07)60648-5	http://dx.doi.org/10.1016/S0140-6736(07)60648-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467498				2022-12-24	WOS:000246017700010
J	van Swinderen, B				van Swinderen, Bruno			Attention-like processes in Drosophila require short-term memory genes	SCIENCE			English	Article							MELANOGASTER; MUTANTS; BRAIN; DUNCE; CONTEXT; SYSTEM	Although there is much behavioral evidence for complex brain functions in insects, it is not known whether insects have selective attention. In humans, selective attention is a dynamic process restricting perception to a succession of salient stimuli, while less relevant competing stimuli are suppressed. Local field potential recordings in the brains of flies responding to visual novelty revealed attention-like processes with stereotypical temporal properties. These processes were modulated by genes involved in short-term memory formation, namely dunce and rutabaga. Attention defects in these mutants were associated with distinct optomotor effects in behavioral assays.	Inst Neurosci, San Diego, CA 92121 USA		van Swinderen, B (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	van@nsi.edu		van Swinderen, Bruno/0000-0001-6552-7418				Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Brembs B, 2006, LEARN MEMORY, V13, P618, DOI 10.1101/lm.318606; DAUWALDER B, 1995, J NEUROSCI, V15, P3490; DAVIS RL, 1995, MOL CELL BIOCHEM, V149, P271, DOI 10.1007/BF01076588; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Engel JE, 1996, J NEUROSCI, V16, P3486; FOLKERS E, 1982, J INSECT PHYSIOL, V28, P535, DOI 10.1016/0022-1910(82)90034-8; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gong ZF, 1998, J INSECT PHYSIOL, V44, P1149, DOI 10.1016/S0022-1910(98)00076-6; Guo FZ, 2005, SCIENCE, V309, P307, DOI 10.1126/science.1111280; HEISENBERG M, 1948, STUDIES BRAIN FUNCTI; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; van Swinderen B, 2005, BIOESSAYS, V27, P321, DOI 10.1002/bies.20195; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300; VANSWINDEREN B, 2006, J NEUROBIOL     1207, DOI DOI 10.1002/NEU.20334; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749	24	75	76	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1590	1593		10.1126/science.1137931	http://dx.doi.org/10.1126/science.1137931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363675				2022-12-24	WOS:000244934800057
J	Tenoever, BR; Ng, SL; Chua, MA; McWhirter, SM; Garcia-Sastre, A; Maniatis, T				tenOever, Benjamin R.; ng, Sze-Li Ng; Chua, Mark A.; McWhirter, Sarah M.; Garcia-Sastre, Adolfo; Maniatis, Tom			Multiple functions of the IKK-related kinase IKK epsilon in interferon-mediated antiviral immunity	SCIENCE			English	Article							STAT1; LIPOPOLYSACCHARIDE; INFECTION	IKK epsilon is an IKK ( inhibitor of nuclear factor kappa B kinase)-related kinase implicated in virus induction of interferon-beta (IFN beta). We report that, although mice lacking IKK epsilon produce normal amounts of IFN beta, they are hypersusceptible to viral infection because of a defect in the IFN signaling pathway. Specifically, a subset of type I IFN-stimulated genes are not activated in the absence of IKK epsilon because the interferon-stimulated gene factor 3 complex (ISGF3) does not bind to promoter elements of the affected genes. We demonstrate that IKK epsilon is activated by IFN beta and that IKK epsilon directly phosphorylates signal transducer and activator of transcription 1 (STAT1), a component of ISGF3. We conclude that IKK epsilon plays a critical role in the IFN-inducible antiviral transcriptional response.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; Mt Sinai Sch Med, Microbiol Grad Sch Training Program, New York, NY 10029 USA; Mt Sinai Sch Med, Emerging Pathogens Inst, New York, NY 10029 USA	Harvard University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Maniatis, T (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	maniatis@mcb.harvard.edu		Garcia-Sastre, Adolfo/0000-0002-6551-1827	NIAID NIH HHS [R01AI46954, P01AI058113, F31 AI056678, U19AI62623] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062623, F31AI056678, P01AI058113, R01AI046954] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; QURESHI SA, 1995, P NATL ACAD SCI USA, V92, P3829, DOI 10.1073/pnas.92.9.3829; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Sweeney SE, 2006, ANN RHEUM DIS, V65, pA32; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9	19	271	284	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1274	1278		10.1126/science.1136567	http://dx.doi.org/10.1126/science.1136567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332413				2022-12-24	WOS:000244564700049
J	Von Drygalski, A; Curtis, BR; Bougie, DW; McFarland, JG; Ahl, S; Limbu, I; Baker, KR; Aster, RH				Von Drygalski, Annette; Curtis, Brian R.; Bougie, Daniel W.; McFarland, Janice G.; Ahl, Scott; Limbu, Indra; Baker, Kelty R.; Aster, Richard H.			Vancomycin-induced immune thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; DEPENDENT ANTIBODIES; NEUTROPENIA	BACKGROUND: Vancomycin has only rarely been implicated as a cause of thrombocytopenia, and there is only limited evidence that this complication is caused by immune mechanisms. We conducted a study to determine whether thrombocytopenia is caused by vancomycin-dependent antibodies in patients being treated with vancomycin. METHODS: We identified and characterized vancomycin-dependent, platelet-reactive antibodies in patients who had been referred for testing during a 5-year period because of a clinical suspicion of vancomycin-induced thrombocytopenia. We obtained clinical information about the patients from their referring physicians. RESULTS: Drug-dependent, platelet-reactive antibodies of the IgG class, the IgM class, or both were identified in 34 patients, and clinical follow-up information was obtained from 29 of these patients. The mean nadir platelet count in these patients was 13,600 per cubic millimeter, and severe bleeding occurred in 10 patients (34%). Platelet levels returned to baseline in all 26 surviving patients after vancomycin was stopped. In 15 patients, the drug was continued for 1 to 14 days while other possible causes of thrombocytopenia were investigated. Vancomycin-dependent antibodies were not found in 25 patients who had been given vancomycin and in whom thrombocytopenia did not develop. CONCLUSIONS: Severe bleeding can occur in patients with vancomycin-induced immune thrombocytopenia. The detection of vancomycin-dependent antiplatelet antibodies in patients receiving the antibiotic in whom thrombocytopenia develops, and the absence of antibodies in patients given the drug in whom platelet counts remain stable, indicate that these antibodies are the cause of the thrombocytopenia.	Blood Ctr Wisonsin, Blood Res Inst, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin; Baylor College of Medicine	Aster, RH (corresponding author), Blood Ctr Wisonsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	richard.aster@bcw.edu	Curtis, Brian R/AAT-7861-2020		NHLBI NIH HHS [R01 HL013629, HL-13629] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL013629, R01HL013629, R56HL013629] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aster RH, 2005, TOXICOLOGY, V209, P149, DOI 10.1016/j.tox.2004.12.031; Bougie DW, 2006, BLOOD, V108, P922, DOI 10.1182/blood-2006-01-009803; Bougie DW, 2002, BLOOD, V100, P2071, DOI 10.1182/blood.V100.6.2071.h81802002071_2071_2076; CHRISTIE DJ, 1990, BLOOD, V75, P518; Crowther MA, 2005, J CRIT CARE, V20, P348, DOI 10.1016/j.jcrc.2005.09.008; CURTIS BR, 1994, BLOOD, V84, P176, DOI 10.1182/blood.V84.1.176.bloodjournal841176; Curtis BR, 2002, BLOOD, V99, P2054, DOI 10.1182/blood.V99.6.2054; Davoren A, 2006, AM J HEMATOL, V81, P36, DOI 10.1002/ajh.20490; DeLoughery TG, 2005, CRIT CARE CLIN, V21, P531, DOI 10.1016/j.ccc.2005.05.003; Garner SF, 2005, BRIT J HAEMATOL, V129, P279, DOI 10.1111/j.1365-2141.2005.05430.x; George JN, 1998, ANN INTERN MED, V129, P886, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00009; Kojouri K, 2000, J Okla State Med Assoc, V93, P519; Kuruppu JC, 1999, AM J HEMATOL, V60, P249, DOI 10.1002/(SICI)1096-8652(199903)60:3<249::AID-AJH20>3.3.CO;2-8; Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Marraffa J, 2003, PHARMACOTHERAPY, V23, P1195, DOI 10.1592/phco.23.10.1195.32765; Michelson A., 2002, PLATELETS, P593; MILSTEEN S, 1987, AM J MED SCI, V294, P110, DOI 10.1097/00000441-198708000-00010; Mizon P, 1997, VOX SANG, V73, P49, DOI 10.1046/j.1423-0410.1997.7310049.x; MORRIS A, 1991, J INFECTION, V22, P217, DOI 10.1016/S0163-4453(05)80002-7; PARKER CW, 1981, ARTHRITIS RHEUM, V24, P1024, DOI 10.1002/art.1780240808; Peterson JA, 2005, TRANSFUSION, V45, P1487, DOI 10.1111/j.1537-2995.2005.00561.x; Reddy JC, 2004, ARCH INTERN MED, V164, P218, DOI 10.1001/archinte.164.2.218; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712; Segarra-Newnham M, 2004, ANN PHARMACOTHER, V38, P1855, DOI 10.1345/aph.1E187; Shulman N. Raphael, 1993, Transfusion Medicine Reviews, V7, P215; VISENTIN GP, 1991, BLOOD, V77, P2668; Warkentin TE, 2004, SEMIN THROMB HEMOST, V30, P273, DOI 10.1055/s-2004-831039	28	111	114	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					904	910		10.1056/NEJMoa065066	http://dx.doi.org/10.1056/NEJMoa065066			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329697				2022-12-24	WOS:000244496400005
J	Kraft, M; Israel, E; O'Connor, GT				Kraft, Monica; Israel, Elliot; O'Connor, George T.			Treatment of mild persistent asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ORAL MONTELUKAST; CORTICOSTEROIDS; BECLOMETHASONE; SALMETEROL		Duke Med Ctr, Div Pulm, Durham, NC 27710 USA; Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA	Duke University; Harvard University; Brigham & Women's Hospital; Boston University	Kraft, M (corresponding author), Duke Med Ctr, Div Pulm, Durham, NC 27710 USA.			O'Connor, George/0000-0002-6476-3926				Boulet LP, 2004, CURR OPIN PULM MED, V10, P15, DOI 10.1097/00063198-200401000-00004; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Breekvedt-Postma NS, 2004, RESP MED, V98, P752, DOI 10.1016/j.rmed.2004.01.014; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; CHROININ MN, 2005, COCHRANE DB SYST REV, V4; Edelman JM, 2000, ANN INTERN MED, V132, P97, DOI 10.7326/0003-4819-132-2-200001180-00002; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; Israel E, 2001, NEW ENGL J MED, V345, P941, DOI 10.1056/NEJMoa002304; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; National Asthma Education and Prevention Program, 2002, NAT HEART LUNG BLOOD, V02-5075; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Tattersfield Anne E, 2004, Proc Am Thorac Soc, V1, P171, DOI 10.1513/pats.200402-016MS; Zeiger RS, 2005, AM J MED, V118, P649, DOI 10.1016/j.amjmed.2005.03.003	15	8	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2096	2100						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167ZD	17507711				2022-12-24	WOS:000246490500014
J	McMichael, AJ; Bambrick, HJ				McMichael, Anthony J.; Bambrick, Hilary J.			Greenhouse-gas costs of clinical trials	LANCET			English	Editorial Material									Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au		Bambrick, Hilary/0000-0001-5361-950X				Burnett J, 2007, BMJ-BRIT MED J, V334, P671; McMichael AJ, 2006, EUR J PUBLIC HEALTH, V16, P579, DOI 10.1093/eurpub/ckl102; Stern Nicholas, 2006, STERN REV EC CLIMATE	3	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1584	1585		10.1016/S0140-6736(07)60725-9	http://dx.doi.org/10.1016/S0140-6736(07)60725-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499586				2022-12-24	WOS:000246488800009
J	Maeda, T; Merghoub, T; Hobbs, RM; Dong, L; Maeda, M; Zakrzewski, J; van den Brink, MRM; Zelent, A; Shigematsu, H; Akashi, K; Teruya-Feldstein, J; Cattoretti, G; Pandolfi, PP				Maeda, Takahiro; Merghoub, Taha; Hobbs, Robin M.; Dong, Lin; Maeda, Manami; Zakrzewski, Johannes; van den Brink, Marcel R. M.; Zelent, Arthur; Shigematsu, Hirokazu; Akashi, Koichi; Teruya-Feldstein, Julie; Cattoretti, Giorgio; Pandolfi, Pier Paolo			Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; ZINC-FINGER PROTEIN; MOUSE BONE-MARROW; DIFFERENTIATION; NOTCH1; MICE; MAINTENANCE; PROGENITORS; APOPTOSIS	Hematopoietic stem cells in the bone marrow give rise to lymphoid progenitors, which subsequently differentiate into B and T lymphocytes. Here we show that the proto-oncogene LRF plays an essential role in the B versus T lymphoid cell-fate decision. We demonstrate that LRF is key for instructing early lymphoid progenitors in mice to develop into B lineage cells by repressing T cell-instructive signals produced by the cell-fate signal protein, Notch. We propose a new model for lymphoid lineage commitment, in which LRF acts as a master regulator of the cell's determination of B versus T lineage.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Inst Canc Res, Leukemia Res Fund Ctr, Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Dana-Farber Cancer Institute; Columbia University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Zelent, Arthur/B-3532-2009; Maeda, Takahiro/AAC-4563-2019; van den Brink, Marcel R. M./HGB-9434-2022; Cattoretti, Giorgio/H-2340-2011; Hobbs, Robin/I-2577-2014	Maeda, Takahiro/0000-0003-4530-6460; Cattoretti, Giorgio/0000-0003-3799-3221; Hobbs, Robin/0000-0002-3853-2614; Zelent, Arthur/0000-0002-7968-9888	NCI NIH HHS [R01 CA102142-06A1, CA-102142, R01 CA102142] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Harman BC, 2003, SEMIN IMMUNOL, V15, P91, DOI 10.1016/S1044-5323(03)00005-8; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Piazza F, 2004, MOL CELL BIOL, V24, P10456, DOI 10.1128/MCB.24.23.10456-10469.2004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Vieira Paulo, 2004, Methods Mol Biol, V271, P67; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	27	170	176	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					860	866		10.1126/science.1140881	http://dx.doi.org/10.1126/science.1140881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495164	Green Accepted			2022-12-24	WOS:000246369800030
J	van der Heide, A; Onwuteaka-Philipsen, BD; Rurup, ML; Buiting, HM; van Delden, JJM; Hanssen-de Wolf, JE; Janssen, AGJM; Pasman, HRW; Rietjens, JAC; Prins, CJM; Deerenberg, IM; Gevers, JKM; van der Maas, PJ; van der Wal, G				van der Heide, Agnes; Onwuteaka-Philipsen, Bregje D.; Rurup, Mette L.; Buiting, Hilde M.; van Delden, Johannes J. M.; Hanssen-de Wolf, Johanna E.; Janssen, Anke G. J. M.; Pasman, H. Roeline W.; Rietjens, Judith A. C.; Prins, Cornelis J. M.; Deerenberg, Ingeborg M.; Gevers, Joseph K. M.; van der Maas, Paul J.; van der Wal, Gerrit			End-of-life practices in the Netherlands under The Euthanasia Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERMINAL SEDATION; DECISION-MAKING; DEATH; EXPERIENCES; BELGIUM; OPIOIDS; CARE	BACKGROUND: In 2002, an act regulating the ending of life by a physician at the request of a patient with unbearable suffering came into effect in the Netherlands. In 2005, we performed a follow-up study of euthanasia, physician-assisted suicide, and other end-of-life practices. METHODS: We mailed questionnaires to physicians attending 6860 deaths that were identified from death certificates. The response rate was 77.8%. RESULTS: In 2005, of all deaths in the Netherlands, 1.7% were the result of euthanasia and 0.1% were the result of physician-assisted suicide. These percentages were significantly lower than those in 2001, when 2.6% of all deaths resulted from euthanasia and 0.2% from assisted suicide. Of all deaths, 0.4% were the result of the ending of life without an explicit request by the patient. Continuous deep sedation was used in conjunction with possible hastening of death in 7.1% of all deaths in 2005, significantly increased from 5.6% in 2001. In 73.9% of all cases of euthanasia or assisted suicide in 2005, life was ended with the use of neuromuscular relaxants or barbiturates; opioids were used in 16.2% of cases. In 2005, 80.2% of all cases of euthanasia or assisted suicide were reported. Physicians were most likely to report their end-of-life practices if they considered them to be an act of euthanasia or assisted suicide, which was rarely true when opioids were used. CONCLUSIONS: The Dutch Euthanasia Act was followed by a modest decrease in the rates of euthanasia and physician-assisted suicide. The decrease may have resulted from the increased application of other end-of-life care interventions, such as palliative sedation.	Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; Univ Med Ctr, Utrecht, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Stat Netherlands, Voorburg, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	van der Heide, A (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.vanderheide@erasmusmc.nl						[Anonymous], 1993, HIST PUBLIC HLTH; Bercovitch M, 2004, CANCER-AM CANCER SOC, V101, P1473, DOI 10.1002/cncr.20485; Blank RH, 2005, END OF LIFE DECISION; Deliens L, 2003, LANCET, V362, P1239, DOI 10.1016/S0140-6736(03)14520-5; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; den Hartogh G, 2003, MED CONTACT, V58, P1063; Drazen JM, 2003, NEW ENGL J MED, V349, P1109, DOI 10.1056/NEJMp038146; FOLEYY K, 2002, CASE ASSISTED SUICID; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 2002, NEW ENGL J MED, V347, P582, DOI 10.1056/NEJMsa020562; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Onwuteaka-Philipsen BD, 2005, BMJ-BRIT MED J, V331, P1065; Onwuteaka-Philipsen BD, 2003, LANCET, V362, P395, DOI 10.1016/S0140-6736(03)14029-9; Quill T.E., 2004, PHYS ASSISTED DYING; Quill TE, 2004, NEW ENGL J MED, V350, P2029, DOI 10.1056/NEJMp038216; Rietjens JAC, 2006, ARCH INTERN MED, V166, P749, DOI 10.1001/archinte.166.7.749; Rietjens JAC, 2004, ANN INTERN MED, V141, P178, DOI 10.7326/0003-4819-141-3-200408030-00006; Rurup M L, 2006, Ned Tijdschr Geneeskd, V150, P618; *STAT COMM EUTH, 1985, REP EUTH; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Thorns A, 2000, LANCET, V356, P398, DOI 10.1016/S0140-6736(00)02534-4; Tolle SW, 2004, J CLIN ETHIC, V15, P111; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vanderWal G, 1996, NEW ENGL J MED, V335, P1706	28	274	280	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1957	1965		10.1056/NEJMsa071143	http://dx.doi.org/10.1056/NEJMsa071143			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494928				2022-12-24	WOS:000246305500007
J	Amunts, A; Drory, O; Nelson, N				Amunts, Alexey; Drory, Omri; Nelson, Nathan			The structure of a plant photosystem I supercomplex at 3.4 angstrom resolution	NATURE			English	Article							LIGHT-HARVESTING-COMPLEX; STATE TRANSITIONS; ARABIDOPSIS-THALIANA; TRANSFER DYNAMICS; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; 14 KDA; PSI-G; SUBUNIT; EVOLUTION	All higher organisms on Earth receive energy directly or indirectly from oxygenic photosynthesis performed by plants, green algae and cyanobacteria. Photosystem I ( PSI) is a supercomplex of a reaction centre and light-harvesting complexes. It generates the most negative redox potential in nature, and thus largely determines the global amount of enthalpy in living systems. We report the structure of plant PSI at 3.4 angstrom resolution, revealing 17 protein subunits. PsaN was identified in the luminal side of the supercomplex, and most of the amino acids in the reaction centre were traced. The crystal structure of PSI provides a picture at near atomic detail of 11 out of 12 protein subunits of the reaction centre. At this level, 168 chlorophylls ( 65 assigned with orientations for Q(x) and Q(y) transition dipole moments), 2 phylloquinones, 3 Fe4S4 clusters and 5 carotenoids are described. This structural information extends the understanding of the most efficient nano-photochemical machine in nature.	Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Nelson, N (corresponding author), Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel.	nelson@post.tau.ac.il	Amunts, A./AAZ-2279-2020	Amunts, A./0000-0002-5302-1740; Nelson, Nathan/0000-0003-3588-7265				Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Amunts A, 2005, PHOTOCH PHOTOBIO SCI, V4, P1011, DOI 10.1039/b506132f; Anderson J M, 1995, Photosynth Res, V46, P129, DOI 10.1007/BF00020423; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Barber J, 2004, PHOTOSYNTH RES, V80, P137, DOI 10.1023/B:PRES.0000030662.04618.27; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Ben-Shem A, 2004, PHOTOSYNTH RES, V81, P239, DOI 10.1023/B:PRES.0000036881.23512.42; Ben-Shem A, 2003, ACTA CRYSTALLOGR D, V59, P1824, DOI 10.1107/S0907444903016056; Ben-Shem A, 2004, FEBS LETT, V564, P274, DOI 10.1016/S0014-5793(04)00360-6; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Consoli E, 2005, EMBO REP, V6, P782, DOI 10.1038/sj.embor.7400464; Dashdorj N, 2005, BIOPHYS J, V88, P1238, DOI 10.1529/biophysj.104.050963; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Ganeteg U, 2001, PLANT PHYSIOL, V127, P150, DOI 10.1104/pp.127.1.150; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; HE WZ, 1992, FEBS LETT, V308, P298, DOI 10.1016/0014-5793(92)81297-Y; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; IKEUCHI M, 1991, FEBS LETT, V280, P332, DOI 10.1016/0014-5793(91)80324-V; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Jensen PE, 2004, J BIOL CHEM, V279, P24212, DOI 10.1074/jbc.M403147200; Joliot P, 1999, BIOCHEMISTRY-US, V38, P11130, DOI 10.1021/bi990857c; Jolley C, 2005, J BIOL CHEM, V280, P33627, DOI 10.1074/jbc.M500937200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; KNOETZEL J, 1993, PLANT MOL BIOL, V22, P337, DOI 10.1007/BF00014940; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; KYLE DJ, 1983, ARCH BIOCHEM BIOPHYS, V222, P527, DOI 10.1016/0003-9861(83)90551-9; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lucinski R, 2006, FEBS LETT, V580, P6485, DOI 10.1016/j.febslet.2006.10.063; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schmid VHR, 2002, BIOCHEMISTRY-US, V41, P9126, DOI 10.1021/bi016042x; Sener MK, 2005, BIOPHYS J, V89, P1630, DOI 10.1529/biophysj.105.066464; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B; Zygadlo A, 2006, J BIOL CHEM, V281, P10548, DOI 10.1074/jbc.M512687200	49	368	387	6	144	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					58	63		10.1038/nature05687	http://dx.doi.org/10.1038/nature05687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476261	Green Accepted			2022-12-24	WOS:000246149300042
J	Blackman, T				Blackman, Tim			Statins, saving lives, and shibbloleths	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Durham, Durham DH1 3HP, England	Durham University	Blackman, T (corresponding author), Univ Durham, Durham DH1 3HP, England.	tim.blackman@dur.ac.uk							0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					902	902		10.1136/bmj.39163.563519.55	http://dx.doi.org/10.1136/bmj.39163.563519.55			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463464	Green Published			2022-12-24	WOS:000246217800034
J	Nenci, A; Becker, C; Wullaert, A; Gareus, R; van Loo, G; Danese, S; Huth, M; Nikolaev, A; Neufert, C; Madison, B; Gumucio, D; Neurath, MF; Pasparakis, M				Nenci, Arianna; Becker, Christoph; Wullaert, Andy; Gareus, Ralph; van Loo, Geert; Danese, Silvio; Huth, Marion; Nikolaev, Alexei; Neufert, Clemens; Madison, Blair; Gumucio, Deborah; Neurath, Markus F.; Pasparakis, Manolis			Epithelial NEMO links innate immunity to chronic intestinal inflammation	NATURE			English	Article							NF-KAPPA-B; DEFICIENT MICE; CANCER DEVELOPMENT; COLON-CANCER; DISEASE; GAMMA; ACTIVATION; EXPRESSION; DELETION; COLITIS	Deregulation of intestinal immune responses seems to have a principal function in the pathogenesis of inflammatory bowel disease(1-4). The gut epithelium is critically involved in the maintenance of intestinal immune homeostasis-acting as a physical barrier separating luminal bacteria and immune cells, and also expressing antimicrobial peptides(3,5,6). However, the molecular mechanisms that control this function of gut epithelial cells are poorly understood. Here we show that the transcription factor NF kappa B, a master regulator of pro-inflammatory responses(7,8), functions in gut epithelial cells to control epithelial integrity and the interaction between the mucosal immune system and gut microflora. Intestinal epithelial-cell-specific inhibition of NF-kappa B through conditional ablation of NEMO ( also called I kappa B kinase-gamma ( IKK gamma)) or both IKK1 ( IKK alpha) and IKK2 ( IKK beta)-IKK subunits essential for NF-kappa B activation(7-9)-spontaneously caused severe chronic intestinal inflammation in mice. NF-kappa B deficiency led to apoptosis of colonic epithelial cells, impaired expression of antimicrobial peptides and translocation of bacteria into the mucosa. Concurrently, this epithelial defect triggered a chronic inflammatory response in the colon, initially dominated by innate immune cells but later also involving T lymphocytes. Deficiency of the gene encoding the adaptor protein MyD88 prevented the development of intestinal inflammation, demonstrating that Toll-like receptor activation by intestinal bacteria is essential for disease pathogenesis in this mouse model. Furthermore, NEMO deficiency sensitized epithelial cells to tumour-necrosis factor ( TNF)-induced apoptosis, whereas TNF receptor-1 inactivation inhibited intestinal inflammation, demonstrating that TNF receptor-1 signalling is crucial for disease induction. These findings demonstrate that a primary NF-kappa B signalling defect in intestinal epithelial cells disrupts immune homeostasis in the gastrointestinal tract, causing an inflammatory-bowel-disease-like phenotype. Our results identify NF-kappa B signalling in the gut epithelium as a critical regulator of epithelial integrity and intestinal immune homeostasis, and have important implications for understanding the mechanisms controlling the pathogenesis of human inflammatory bowel disease.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; EMBL, Mouse Biol Unit, I-00016 Monterotondo, Italy; Johannes Gutenberg Univ Mainz, Dept Med, Lab Clin Immunol 1, D-55131 Mainz, Germany; IRCCS Gastroenterol, Ist Clin Humanitas, Div Gastroenterol, I-20089 Milan, Italy; Univ Michigan, Dept Cell & Dev Biol, Ctr Organogenesis, Ann Arbor, MI 48109 USA	University of Cologne; European Molecular Biology Laboratory (EMBL); Johannes Gutenberg University of Mainz; IRCCS Humanitas Research Hospital; University of Michigan System; University of Michigan	Pasparakis, M (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	pasparakis@uni-koeln.de	Danese, Silvio/ABH-9571-2020; , van Loo Geert/AAD-1220-2019; Becker, Christoph/L-2996-2016; Pasparakis, Manolis/H-9292-2017; Wullaert, Andy/D-2975-2018; Pasparakis, Manolis/N-4350-2019; Eckhardt, Erik/G-1567-2010; Becker, Christoph/A-6694-2008; van Loo, Geert/C-1505-2009; Wullaert, Andy/R-1924-2019	Danese, Silvio/0000-0001-7341-1351; , van Loo Geert/0000-0002-8427-4775; Pasparakis, Manolis/0000-0002-9870-0966; Wullaert, Andy/0000-0001-5012-654X; Pasparakis, Manolis/0000-0002-9870-0966; Becker, Christoph/0000-0002-1388-1041; Wullaert, Andy/0000-0001-5012-654X				Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Darmoul D, 1996, AM J PHYSIOL-GASTR L, V271, pG68, DOI 10.1152/ajpgi.1996.271.1.G68; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; GAREUS R, IN PRESS NATURE CELL; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lan JG, 2005, WORLD J GASTROENTERO, V11, P3375, DOI 10.3748/wjg.v11.i22.3375; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rudolph D, 2000, GENE DEV, V14, P854; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Wehkamp J, 2005, NAT CLIN PRACT GASTR, V2, P406, DOI 10.1038/ncpgasthep0265	29	794	828	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					557	561		10.1038/nature05698	http://dx.doi.org/10.1038/nature05698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17361131	Green Published			2022-12-24	WOS:000245242900053
J	Morrish, TA; Garcia-Perez, JL; Stamato, TD; Taccioli, GE; Sekiguchi, J; Moran, JV				Morrish, Tammy A.; Garcia-Perez, Jose Luis; Stamato, Thomas D.; Taccioli, Guillermo E.; Sekiguchi, JoAnn; Moran, John V.			Endonuclease-independent LINE-1 retrotransposition at mammalian telomeres	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; CULTURED HUMAN-CELLS; CATALYTIC SUBUNIT; DNA-REPAIR; SCID MOUSE; CHROMOSOMES; MECHANISM; MUTATION; FUSIONS; PKCS	Long interspersed element-1 (LINE-1 or L1) elements are abundant, non-long-terminal-repeat (non-LTR) retrotransposons that comprise 17% of human DNA(1). The average human genome contains similar to 80-100 retrotransposition- competent L1s (ref. 2), and they mobilize by a process that uses both the L1 endonuclease and reverse transcriptase, termed target-site primed reverse transcription(3-5). We have previously reported an efficient, endonuclease-independent L1 retrotransposition pathway (ENi) in certain Chinese hamster ovary (CHO) cell lines that are defective in the non-homologous end-joining (NHEJ) pathway of DNA double-strand-break repair(6). Here we have characterized ENi retrotransposition events generated in V3 CHO cells, which are deficient in DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity and have both dysfunctional telomeres and an NHEJ defect. Notably, similar to 30% of ENi retrotransposition events insert in an orientation-specific manner adjacent to a perfect telomere repeat (5'-TTAGGG-3'). Similar insertions were not detected among ENi retrotransposition events generated in controls or in XR-1 CHO cells deficient for XRCC4, an NHEJ factor that is required for DNA ligation but has no known function in telomere maintenance. Furthermore, transient expression of a dominant-negative allele of human TRF2 ( also called TERF2) in XRCC4-deficient XR-1 cells, which disrupts telomere capping, enables telomere-associated ENi retrotransposition events. These data indicate that L1s containing a disabled endonuclease can use dysfunctional telomeres as an integration substrate. The findings highlight similarities between the mechanism of ENi retrotransposition and the action of telomerase, because both processes can use a 3' OH for priming reverse transcription at either internal DNA lesions or chromosome ends(7,8). Thus, we propose that ENi retrotransposition is an ancestral mechanism of RNA-mediated DNA repair associated with non-LTR retrotransposons that may have been used before the acquisition of an endonuclease domain.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Lankenau Inst Med Res, Wynnewood, PA 19096 USA; Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Lankenau Medical Center; Lankenau Institute for Medical Research; Boston University	Moran, JV (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	morrisht@jhmi.edu; moranj@umich.edu		Morrish, Tammy/0000-0002-6725-0253; Garcia-Perez, Jose Luis/0000-0002-8132-9849; Sekiguchi, JoAnn/0000-0002-7178-4258				Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Beamish HJ, 2000, NUCLEIC ACIDS RES, V28, P1506, DOI 10.1093/nar/28.7.1506; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Faravelli M, 2002, GENE, V283, P11, DOI 10.1016/S0378-1119(01)00877-0; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Hao LY, 2004, J BIOL CHEM, V279, P45148, DOI 10.1074/jbc.M403924200; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881	30	125	130	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					208	212		10.1038/nature05560	http://dx.doi.org/10.1038/nature05560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344853	Green Published			2022-12-24	WOS:000244718100045
J	Tessier, PM; Lindquist, S				Tessier, Peter M.; Lindquist, Susan			Prion recognition elements govern nucleation, strain specificity and species barriers	NATURE			English	Article							GENETIC-VARIATION; PROTEIN; TRANSMISSION; SCRAPIE; SUP35; MICE; REPLICATION; PROPAGATION; PRINCIPLES; MECHANISM	Prions are proteins that can switch to self-perpetuating, infectious conformations. The abilities of prions to replicate, form structurally distinct strains, and establish and overcome transmission barriers between species are poorly understood. We exploit surface-bound peptides to overcome complexities of investigating such problems in solution. For the yeast prion Sup35, we find that the switch to the prion state is controlled with exquisite specificity by small elements of primary sequence. Strikingly, these same sequence elements govern the formation of distinct self-perpetuating conformations ( prion strains) and determine species-specific seeding activities. A Sup35 chimaera that traverses the transmission barrier between two yeast species possesses the critical sequence elements from both. Using this chimaera, we show that the influence of environment and mutations on the formation of species-specific strains is driven by selective recognition of either sequence element. Thus, critical aspects of prion conversion are enciphered by subtle differences between small, highly specific recognition elements.	Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Tessier, Peter/GPP-3396-2022; Tessier, Peter/I-5730-2013	Tessier, Peter/0000-0002-3220-007X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM025874, R37 GM025874-27, R01 GM025874] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1996, GENETICS, V144, P1375; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Resende C, 2002, MICROBIOL-SGM, V148, P1049, DOI 10.1099/00221287-148-4-1049; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1996, CURR TOP MICROBIOL, V207, P147; Zhao ZG, 1999, BIOCONJUGATE CHEM, V10, P424, DOI 10.1021/bc980120k	51	118	120	0	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					556	+		10.1038/nature05848	http://dx.doi.org/10.1038/nature05848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17495929	Green Accepted			2022-12-24	WOS:000246842000040
J	Mitchell, B; Jacobs, R; Li, J; Chien, S; Kintner, C				Mitchell, Brian; Jacobs, Richard; Li, Julie; Chien, Shu; Kintner, Chris			A positive feedback mechanism governs the polarity and motion of motile cilia	NATURE			English	Article							MALE-INFERTILITY; MICE DEFICIENT; FLOW; DIAGNOSIS	Ciliated epithelia produce fluid flow in many organ systems, ranging from the respiratory tract where it clears mucus(1) to the ventricles of the brain where it transports cerebrospinal fluid(2). Human diseases that disable ciliary flow, such as primary ciliary dyskinesia, can compromise organ function or the ability to resist pathogens, resulting in recurring respiratory infections, otitis, hydrocephaly and infertility(3). To create a ciliary flow, the cilia within each cell need to be polarized coordinately along the planar axis of the epithelium, but how polarity is established in any ciliated epithelia is not known. Here we analyse the developmental mechanisms that polarize cilia, using the ciliated cells in the developing Xenopus larval skin as a model system(4). We show that cilia acquire polarity through a sequence of events, beginning with a polar bias set by tissue patterning, followed by a refinement phase. Our results indicate that during refinement, fluid flow is both necessary and sufficient in determining cilia polarity. These findings reveal a novel mechanism in which tissue patterning coupled with fluid flow act in a positive feedback loop to direct the planar polarity of cilia.	Salk Inst Biol Studies, San Diego, CA 92186 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Whitehead Inst Biomed Engn, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California San Diego	Kintner, C (corresponding author), Salk Inst Biol Studies, San Diego, CA 92186 USA.	kintner@salk.edu		Mitchell, Brian/0000-0001-6281-1536				Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; ASSHETON R, 1896, Q J MICROSC SCI, V38, P465; Bush A, 1998, EUR RESPIR J, V12, P982, DOI 10.1183/09031936.98.12040982; CHIEN S, 1975, RED BLOOD CELL, P1031; Davidson LA, 2002, DEV BIOL, V242, P109, DOI 10.1006/dbio.2002.0537; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Hsu PP, 2001, BIOCHEM BIOPH RES CO, V285, P751, DOI 10.1006/bbrc.2001.5221; KONIG G, 1993, DEV BIOL, V160, P355, DOI 10.1006/dbio.1993.1312; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Roomans GM, 2006, UPSALA J MED SCI, V111, P155, DOI 10.3109/2000-1967-010; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sive HL, 1998, EARLY DEV XENOPUS LA; Tanaka H, 2004, MOL CELL BIOL, V24, P7958, DOI 10.1128/MCB.24.18.7958-7964.2004; Tung Ti-Chow, 1940, ARCH BIOL, V51, P203; Twitty VC, 1928, J EXP ZOOL, V50, P319, DOI 10.1002/jez.1400500302; Witzgall R, 2005, CURR MOL MED, V5, P455, DOI 10.2174/1566524054553496; Woerdeman MW, 1925, ROUX ARCH DEV BIOL, V106, P41; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	21	200	202	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					97	U8		10.1038/nature05771	http://dx.doi.org/10.1038/nature05771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17450123				2022-12-24	WOS:000246149300051
J	Ross, DB				Ross, David B.			The FDA and the case of Ketek	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TELITHROMYCIN		George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA	George Washington University	Ross, DB (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.							Clay KD, 2006, ANN INTERN MED, V144, P415, DOI 10.7326/0003-4819-144-6-200503210-00121; *FOOD DRUG ADM, 2004, NDA21144 FOOD DRUG A; Graham DJ, 2006, NEW ENGL J MED, V355, P2260, DOI 10.1056/NEJMc066372; GRASSLEY CE, 2006, COMMUNICATION   1213; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011	5	91	94	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1601	1604		10.1056/NEJMp078032	http://dx.doi.org/10.1056/NEJMp078032			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442902				2022-12-24	WOS:000245762000001
J	Wang, RN; He, GG; Nelman-Gonzalez, M; Ashorn, CL; Gallick, GE; Stukenberg, PT; Kirschner, MW; Kuang, J				Wang, Ruoning; He, Guangan; Nelman-Gonzalez, Mayra; Ashorn, Cheryl L.; Gallick, Gary E.; Stukenberg, P. Todd; Kirschner, Marc W.; Kuang, Jian			Regulation of Cdc25C by ERK-MAP kinases during the G(2)/M transition	CELL			English	Article							ACTIVATED PROTEIN-KINASE; XENOPUS-OOCYTE MATURATION; CELL-CYCLE; M-PHASE; MEIOTIC MATURATION; MPF ACTIVATION; EGG EXTRACTS; OKADAIC ACID; POLO KINASE; PHOSPHORYLATION	Induction of G(2)/M phase transition in mitotic and meiotic cell cycles requires activation by phosphorylation of the protein phosphatase Cdc25. Although Cdc2/cyclin B and polo-like kinase (PLK) can phosphorylate and activate Cdc25 in vitro, phosphorylation by these two kinases is insufficient to account for Cdc25 activation during M phase induction. Here we demonstrate that p42 MAP kinase (MAPK), the Xenopus ortholog of ERK2, is a major Cdc25 phosphorylating kinase in extracts of M phase-arrested Xenopus eggs. In Xenopus oocytes, p42 MAPK interacts with hypophosphorylated Cdc25 before meiotic induction. During meiotic induction, p42 MAPK phosphorylates Cdc25 at T48, T138, and S205, increasing Cdc25's phosphatase activity. In a mammalian cell line, ERK1/2 interacts with Cdc25C in interphase and phosphorylates Cdc25C at T48 in mitosis. Inhibition of ERK activation partially inhibits T48 phosphorylation, Cdc25C activation, and mitotic induction. These findings demonstrate that ERK-MAP kinases; are directly involved in activating Cdc25 during the G2/M transition.	Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Virginia; Harvard University; Harvard Medical School	Kuang, J (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jkuang@mdanderson.org	Wang, Ruoning/C-1683-2014	Ashorn, Cheryl/0000-0003-1207-7323; Stukenberg, Todd/0000-0002-6788-2111	NATIONAL CANCER INSTITUTE [P30CA016672, R01CA093941] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA93941, CA-16672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Castro A, 2001, MOL BIOL CELL, V12, P2660, DOI 10.1091/mbc.12.9.2660; Che SL, 1999, J BIOL CHEM, V274, P5522, DOI 10.1074/jbc.274.9.5522; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Fisher DL, 1999, DEVELOPMENT, V126, P4537; Foijer F, 2005, CANCER CELL, V8, P455, DOI 10.1016/j.ccr.2005.10.021; Gavin AC, 1999, MOL BIOL CELL, V10, P2971, DOI 10.1091/mbc.10.9.2971; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; GORIS J, 1989, FEBS LETT, V245, P91, DOI 10.1016/0014-5793(89)80198-X; Gotoh Y, 1995, Prog Cell Cycle Res, V1, P287; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Gottlin EB, 1996, J BIOL CHEM, V271, P27445, DOI 10.1074/jbc.271.44.27445; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; HSIAO KM, 1994, P NATL ACAD SCI USA, V91, P5480, DOI 10.1073/pnas.91.12.5480; Huang CYF, 1996, EMBO J, V15, P2169, DOI 10.1002/j.1460-2075.1996.tb00570.x; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; Karaiskou A, 1999, J CELL SCI, V112, P3747; Karaiskou A, 1998, EXP CELL RES, V244, P491, DOI 10.1006/excr.1998.4220; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; KUANG J, 1993, J CELL BIOL, V123, P859, DOI 10.1083/jcb.123.4.859; KUANG J, 1991, DEV BIOL, V144, P54, DOI 10.1016/0012-1606(91)90478-L; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; LEWIS T, 1995, J CELL SCI, V108, P2885; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; Okano-Uchida T, 2003, EMBO J, V22, P5633, DOI 10.1093/emboj/cdg535; Palmer A, 2000, Prog Cell Cycle Res, V4, P131; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perdiguero E, 2004, CELL CYCLE, V3, P733; RIME H, 1990, CELL DIFFER DEV, V29, P47, DOI 10.1016/0922-3371(90)90023-P; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; SHIBUYA EK, 1992, P NATL ACAD SCI USA, V89, P9831, DOI 10.1073/pnas.89.20.9831; Sillje HHW, 2003, SCIENCE, V299, P1190; Sohaskey ML, 2002, MOL BIOL CELL, V13, P454, DOI 10.1091/mbc.01-11-0553; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; WU M, 1980, DEV BIOL, V79, P455; Wu Y, 2001, DIFFERENTIATION, V67, P139, DOI 10.1046/j.1432-0436.2001.670406.x; Yue JB, 2004, CURR BIOL, V14, P1581, DOI 10.1016/j.cub.2004.08.056	56	101	106	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1119	1132		10.1016/j.cell.2006.11.053	http://dx.doi.org/10.1016/j.cell.2006.11.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382881	Green Submitted, Bronze			2022-12-24	WOS:000245396200018
J	Uemura, S; Dorywalska, M; Lee, TH; Kim, HD; Puglisi, JD; Chu, S				Uemura, Sotaro; Dorywalska, Magdalena; Lee, Tae-Hee; Kim, Harold D.; Puglisi, Joseph D.; Chu, Steven			Peptide bond formation destabilizes Shine-Dalgarno interaction on the ribosome	NATURE			English	Article							TRANSFER-RNA; MESSENGER-RNA; A-SITES; P-SITES; TRANSLOCATION; SPECTROSCOPY; TRANSLATION; ELONGATION	The ribosome is a molecular machine that translates the genetic code contained in the messenger RNA into an amino acid sequence through repetitive cycles of transfer RNA selection, peptide bond formation and translocation(1-3). Here we demonstrate an optical tweezer assay to measure the rupture force between a single ribosome complex and mRNA. The rupture force was compared between ribosome complexes assembled on an mRNA with and without a strong Shine-Dalgarno (SD) sequence - a sequence found just upstream of the coding region of bacterial mRNAs, involved in translation initiation(4,5). The removal of the SD sequence significantly reduced the rupture force in complexes carrying an aminoacyl tRNA, Phe-tRNA(Phe), in the A site, indicating that the SD interactions contribute significantly to the stability of the ribosomal complex on the mRNA before peptide bond formation. In contrast, the presence of a peptidyl tRNA analogue, N-acetyl-Phe-tRNA(Phe), in the A site, which mimicked the post-peptidyl transfer state, weakened the rupture force as compared to the complex with Phe-tRNA(Phe), and the resultant force was the same for both the SD-containing and SD-deficient mRNAs. These results suggest that formation of the first peptide bond destabilizes the SD interaction, resulting in the weakening of the force with which the ribosome grips an mRNA. This might be an important requirement to facilitate movement of the ribosome along mRNA during the first translocation step.	Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Puglisi, JD (corresponding author), Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA.	puglisi@stanford.edu; schu@lbl.gov	Lee, Tae-Hee/A-1266-2010					Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; van Dijk MA, 2004, J PHYS CHEM B, V108, P6479, DOI 10.1021/jp049805+; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	16	82	83	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 22	2007	446	7134					454	457		10.1038/nature05625	http://dx.doi.org/10.1038/nature05625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377584				2022-12-24	WOS:000245079500043
J	Hollenstein, K; Frei, DC; Locher, KP				Hollenstein, Kaspar; Frei, Dominik C.; Locher, Kaspar P.			Structure of an ABC transporter in complex with its binding protein	NATURE			English	Article							ATP-BINDING; AZOTOBACTER-VINELANDII; CASSETTE TRANSPORTER; MOLYBDATE TRANSPORT; MALTOSE TRANSPORT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; P-GLYCOPROTEIN; MECHANISM; HYDROLYSIS	ATP-binding cassette (ABC) transporter proteins carry diverse substrates across cell membranes(1). Whereas clinically relevant ABC exporters are implicated in various diseases or cause multidrug resistance of cancer cells(2,3), bacterial ABC importers are essential for the uptake of nutrients(4), including rare elements such as molybdenum. A detailed understanding of their mechanisms requires direct visualization at high resolution and in distinct conformations. Our recent structure of the multidrug ABC exporter Sav1866 has revealed an outward-facing conformation of the transmembrane domains coupled to a closed conformation of the nucleotide-binding domains, reflecting the ATP-bound state(5). Here we present the 3.1 angstrom crystal structure of a putative molybdate transporter (ModB(2)C(2)) from Archaeoglobus fulgidus in complex with its binding protein ( ModA). Twelve transmembrane helices of the ModB subunits provide an inward-facing conformation, with a closed gate near the external membrane boundary. The ATP-hydrolysing ModC subunits reveal a nucleotide-free, open conformation, whereas the attached binding protein aligns the substrate-binding cleft with the entrance to the presumed translocation pathway. Structural comparison of ModB(2)C(2)A with Sav1866 suggests a common alternating access and release mechanism, with binding of ATP promoting an outward-facing conformation and dissociation of the hydrolysis products promoting an inward-facing conformation.	ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	kaspar.locher@mol.biol.ethz.ch		Hollenstein, Kaspar/0000-0001-7606-4105				Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland I. B., 2003, ABC PROTEINS BACTERI; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hu YL, 1997, NAT STRUCT BIOL, V4, P703, DOI 10.1038/nsb0997-703; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Lawson DM, 1998, STRUCTURE, V6, P1529, DOI 10.1016/S0969-2126(98)00151-8; Liu CE, 1999, J BIOL CHEM, V274, P739, DOI 10.1074/jbc.274.2.739; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Mannering DE, 2001, J BIOL CHEM, V276, P12362, DOI 10.1074/jbc.M011686200; MOUNCEY NJ, 1995, J BACTERIOL, V177, P5294, DOI 10.1128/jb.177.18.5294-5302.1995; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Nikaido H, 1998, METHOD ENZYMOL, V292, P3; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; PROSSNITZ E, 1991, J BIOL CHEM, V266, P9673; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RECH S, 1995, J BACTERIOL, V177, P1023, DOI 10.1128/jb.177.4.1023-1029.1995; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Self WT, 2001, RES MICROBIOL, V152, P311, DOI 10.1016/S0923-2508(01)01202-5; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2	30	378	396	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					213	216		10.1038/nature05626	http://dx.doi.org/10.1038/nature05626			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17322901				2022-12-24	WOS:000244718100046
J	Daemen, J; Wenaweser, P; Tsuchida, K; Abrecht, L; Sophia, V; Morger, C; Kukreja, N; Juni, P; Sianos, G; Hellige, G; Domburg, RT; Hess, OM; Boersma, E; Meier, B; Windecker, S; Serruys, PW				Daemen, Joost; Wenaweser, Peter; Tsuchida, Keiichi; Abrecht, Linda; Sophia, Vaina; Morger, Cyrill; Kukreja, Neville; Jueni, Peter; Sianos, Georgios; Hellige, Gerrit; van Domburg, Ron T.; Hess, Otto M.; Boersma, Eric; Meier, Bernhard; Windecker, Stephan; Serruys, Patrick W.			Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study	LANCET			English	Article							BARE-METAL STENT; HOSPITAL RESEARCH REGISTRY; LATE ANGIOGRAPHIC STENT; ARTERY-DISEASE; DIABETIC-PATIENTS; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; CIGARETTE-SMOKING; STANDARD STENT; REAL-WORLD	Background Stent thrombosis is a safety concern associated with use of drug-eluting stents. Little is known about occurrence of stent thrombosis more than 1 year after implantation of such stents. Methods Between April, 2002, and Dec, 2005, 8146 patients underwent percutaneous coronary intervention with sirolimus-eluting stents (SES; n=3823) or paclitaxel-eluting stents (PES; n=4323) at two academic hospitals. We assessed data from this group to ascertain the incidence, time course, and correlates of stent thrombosis, and the differences between early (0-30 days) and late (>30 days) stent thrombosis and between SES and PES. Findings Angiographically documented stent thrombosis occurred in 152 patients (incidence density 1.3 per 100 person-years; cumulative incidence at 3 years 2.9%). Early stent thrombosis was noted in 91 (60%) patients, and late stent thrombosis in 61 (40%) patients. Late stent thrombosis occurred steadily at a constant rate of 0.6% per year up to 3 years after stent implantation. incidence of early stent thrombosis was similar for SES (1.1%) and PES (1.3%), but late stent thrombosis was more frequent with PES (1.8%) than with SES (1.4%; p=0.031). At the time of stent thrombosis, dual antiplatelet therapy was being taken by 87% (early) and 23% (late) of patients (p<0.0001). Independent predictors of overall stent thrombosis were acute coronary syndrome at presentation (hazard ratio 2.28, 95% CI 1.29-4.03) and diabetes (2.03, 1.07-3.83). Interpretation Late stent thrombosis was encountered steadily with no evidence of diminution up to 3 years of follow-up. Early and late stent thrombosis were observed with SES and with PES. Acute coronary syndrome at presentation and diabetes were independent predictors of stent thrombosis.	Erasmus MC, Dept Cardiol, Thoraxctr, NL-3015 GD Rotterdam, Netherlands; Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; Univ Bern, Div Epidemiol & Biostat, Dept Social & Prevent Med, Bern, Switzerland	Erasmus University Rotterdam; Erasmus MC; University of Bern; University Hospital of Bern; University of Bern	Serruys, PW (corresponding author), Erasmus MC, Dept Cardiol, Thoraxctr, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl	Juni, Peter/Q-8700-2016; Wenaweser, Peter/AAN-7009-2021	Juni, Peter/0000-0002-5985-0670; 				Aronson D, 1996, J AM COLL CARDIOL, V27, P528, DOI 10.1016/0735-1097(95)00496-3; BARBASH GI, 1993, CIRCULATION, V87, P53, DOI 10.1161/01.CIR.87.1.53; Bavry AA, 2005, J AM COLL CARDIOL, V45, P941, DOI 10.1016/j.jacc.2004.11.064; Blais L, 1996, AM J EPIDEMIOL, V144, P1161; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; Granados JAT, 1997, J CLIN EPIDEMIOL, V50, P891, DOI 10.1016/S0895-4356(97)00105-4; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Honda Y, 2003, CIRCULATION, V108, P2, DOI 10.1161/01.CIR.0000075929.79964.D8; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Kaluza GL, 2000, J AM COLL CARDIOL, V35, P1288, DOI 10.1016/S0735-1097(00)00521-0; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lee CH, 2006, HEART, V92, P551, DOI 10.1136/hrt.2005.073619; Lemos PA, 2004, CIRCULATION, V109, P190, DOI 10.1161/01.CIR.0000109138.84579.FA; Lemos PA, 2003, J AM COLL CARDIOL, V41, P2093, DOI 10.1016/S0735-1097(03)00429-7; LEON M, 2006, J AM COLL CARDIOL SB, V47; Levin AD, 2004, P NATL ACAD SCI USA, V101, P9463, DOI 10.1073/pnas.0400918101; Lincoff AM, 2003, CIRCULATION, V107, P1556, DOI 10.1161/01.CIR.0000055653.52489.E9; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Niles NW, 2001, J AM COLL CARDIOL, V37, P1008, DOI 10.1016/S0735-1097(00)01205-5; Nilsen DWT, 2006, INT J CARDIOL, V109, P398, DOI 10.1016/j.ijcard.2005.05.029; Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Ong ATL, 2005, J AM COLL CARDIOL, V45, P1135, DOI 10.1016/j.jacc.2005.01.008; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Perimenis P, 2005, EXPERT OPIN PHARMACO, V6, P1, DOI 10.1517/14656566.6.1.1; Rodriguez Alfredo E, 2006, EuroIntervention, V2, P53; Rogers Campbell D K, 2005, Rev Cardiovasc Med, V6 Suppl 1, pS3; Roiron C, 2006, HEART, V92, P641, DOI 10.1136/hrt.2005.061622; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421; STONE G, 2006, INDEPENDENT PHYS LED; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; Violaris AG, 2000, HEART, V84, P299, DOI 10.1136/heart.84.3.299; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Wenaweser P, 2005, J AM COLL CARDIOL, V45, P1748, DOI 10.1016/j.jacc.2005.01.058; Wenaweser P, 2005, EUR HEART J, V26, P1180, DOI 10.1093/eurheartj/ehi135; West NEJ, 2004, CIRCULATION, V109, P867, DOI 10.1161/01.CIR.0000116750.63158.94; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094	56	1373	1457	2	78	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					667	678		10.1016/S0140-6736(07)60314-6	http://dx.doi.org/10.1016/S0140-6736(07)60314-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141RO	17321312				2022-12-24	WOS:000244596600028
J	Chendrimada, TP; Finn, KJ; Ji, XJ; Baillat, D; Gregory, RI; Liebhaber, SA; Pasquinelli, AE; Shiekhattar, R				Chendrimada, Thimmaiah P.; Finn, Kenneth J.; Ji, Xinjun; Baillat, David; Gregory, Richard I.; Liebhaber, Stephen A.; Pasquinelli, Amy E.; Shiekhattar, Ramin			MicroRNA silencing through RISC recruitment of eIF6	NATURE			English	Article							EUKARYOTIC INITIATION FACTOR-6; MESSENGER-RNA DEGRADATION; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; C-ELEGANS; LIN-4 RNA; GENE; PROTEIN; BIOGENESIS; ASSOCIATION	MicroRNAs ( miRNAs) are a class of small RNAs that act post-transcriptionally to regulate messenger RNA stability and translation. To elucidate how miRNAs mediate their repressive effects, we performed biochemical and functional assays to identify new factors in the miRNA pathway. Here we show that human RISC ( RNA-induced silencing complex) associates with a multiprotein complex containing MOV10 - which is the homologue of Drosophila translational repressor Armitage and proteins of the 60S ribosome subunit. Notably, this complex contains the anti-association factor eIF6 ( also called ITGB4BP or p27BBP), a ribosome inhibitory protein known to prevent productive assembly of the 80S ribosome. Depletion of eIF6 in human cells specifically abrogates miRNA-mediated regulation of target protein and mRNA levels. Similarly, depletion of eIF6 in Caenorhabditis elegans diminishes lin-4 miRNA-mediated repression of the endogenous LIN-14 and LIN-28 target protein and mRNA levels. These results uncover an evolutionarily conserved function of the ribosome anti-association factor eIF6 in miRNA-mediated post-transcriptional silencing.	Univ Penn, Sch Med, Dept Genet & Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Wistar Inst, Philadelphia, PA 19104 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of Pennsylvania; The Wistar Institute; University of Pennsylvania; University of California System; University of California San Diego	Pasquinelli, AE (corresponding author), Ctr Regulacio Genom, Dr Aiguader 88, Barcelona 08003, Spain.	apasquin@ucsd.edu; ramin.shiekhattar@crg.es			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071654] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Ji XJ, 2003, MOL CELL BIOL, V23, P899, DOI 10.1128/MCB.23.3.899-907.2003; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; RAYCHAUDHURI P, 1984, J BIOL CHEM, V259, P1930; Reinhard J, 2001, J INSECT BEHAV, V14, P157, DOI 10.1023/A:1007881510237; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Si K, 1999, MOL CELL BIOL, V19, P1416; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005	36	363	408	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					823	U1		10.1038/nature05841	http://dx.doi.org/10.1038/nature05841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17507929				2022-12-24	WOS:000247207500036
J	Hudson, KL				Hudson, Kathy L.			Prohibiting genetic discrimination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLORECTAL-CANCER		Johns Hopkins Genet & Publ Policy Ctr, Washington, DC USA; Johns Hopkins Univ, Berman Bioeth Inst, Baltimore, MD USA; Johns Hopkins Univ, Inst Med Genet, Baltimore, MD USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Hudson, KL (corresponding author), Johns Hopkins Genet & Publ Policy Ctr, Washington, DC USA.							Apse KA, 2004, GENET MED, V6, P510, DOI 10.1097/01.GIM.0000144013.96456.6C; Hadley DW, 2003, ARCH INTERN MED, V163, P573, DOI 10.1001/archinte.163.5.573; LANMAN RB, 2005, ANAL ADEQUACY CURREN; Matloff ET, 2000, J CLIN ONCOL, V18, P2484, DOI 10.1200/JCO.2000.18.12.2484	4	40	40	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2021	2023		10.1056/NEJMp078033	http://dx.doi.org/10.1056/NEJMp078033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507700				2022-12-24	WOS:000246490500002
J	Medeiros, RB; Burbach, BJ; Mueller, KL; Srivastava, R; Moon, JJ; Highfill, S; Peterson, EJ; Shimizu, Y				Medeiros, Ricardo B.; Burbach, Brandon J.; Mueller, Kristen L.; Srivastava, Rupa; Moon, James J.; Highfill, Sarah; Peterson, Erik J.; Shimizu, Yoji			Regulation of NF-kappa B activation in T cells via association of the adapter proteins ADAP and CARMA1	SCIENCE			English	Article							EXTENDED SH3 DOMAIN; KINASE-C-THETA; ANTIGEN-RECEPTOR; MAGUK FAMILY; SCAFFOLDING PROTEINS; INTEGRIN ACTIVATION; PLASMA-MEMBRANE; MALT LYMPHOMA; ADHESION; BCL10	The adapter protein ADAP regulates T lymphocyte adhesion and activation. We present evidence for a previously unrecognized function for ADAP in regulating T cell receptor (TCR)-mediated activation of the transcription factor NF-kappa B. Stimulation of ADAP-deficient mouse T cells with antibodies to CD3 and CD28 resulted in impaired nuclear translocation of NF-kappa B, a reduced DNA binding, and delayed degradation and decreased phosphorylation of I kappa B ( inhibitor of NF-kappa B). TCR-stimulated assembly of the CARMA1-BCL-10-MALT1 complex was substantially impaired in the absence of ADAP. We further identified a region of ADAP that is required for association with the CARMA1 adapter and NF-kappa B activation but is not required for ADAP-dependent regulation of adhesion. These findings provide new insights into ADAP function and the mechanism by which CARMA1 regulates NF-kappa B activation in T cells.	Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Canc, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Med, Ctr Immunol,Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Medeiros, RB (corresponding author), Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Canc, Minneapolis, MN 55455 USA.	shimi002@umn.edu	Peterson, Erik/M-9365-2013; moon, james/F-1031-2014	moon, james/0000-0001-8071-1491; Shimizu, Yoji/0000-0001-9760-0288; Burbach, Brandon/0000-0003-0922-7722	NIAID NIH HHS [F32AI063793, R01AI056016, F32 AI063793-01A1, R01AI038474, F32 AI063793] Funding Source: Medline; NIDCR NIH HHS [T32DE007288] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038474, F32AI063793, R01AI056016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; CHEN CC, 1995, AGENT ACTION SUPPL, V47, P135; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Heuer K, 2005, J MOL BIOL, V348, P1025, DOI 10.1016/j.jmb.2005.02.069; Heuer K, 2004, STRUCTURE, V12, P603, DOI 10.1016/j.str.2004.02.021; Heuer K, 2006, J MOL BIOL, V361, P94, DOI 10.1016/j.jmb.2006.06.004; Hurez Vincent, 2002, BMC Immunol, V3, P4, DOI 10.1186/1471-2172-3-4; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Wu JN, 2006, J IMMUNOL, V176, P6681, DOI 10.4049/jimmunol.176.11.6681	30	80	85	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					754	758		10.1126/science.1137895	http://dx.doi.org/10.1126/science.1137895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478723				2022-12-24	WOS:000246181400049
J	McNally, LM; Jeena, PM; Gajee, K; Thula, SA; Sturm, AW; Cassol, S; Tomkins, AM; Coovadia, HM; Goldblatt, D				McNally, Lisa M.; Jeena, Prakash M.; Gajee, Kovitha; Thula, Stanley A.; Sturm, A. Willem; Cassol, Sharon; Tomkins, Andrew M.; Coovadia, Hoosen M.; Goldblatt, David			Effect of age, polymicrobial disease,, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESPIRATORY-TRACT INFECTIONS; PNEUMOCYSTIS-CARINII-PNEUMONIA; BRONCHOALVEOLAR LAVAGE; GAMBIAN CHILDREN; ETIOLOGY; MORTALITY; COMMUNITY; CYTOMEGALOVIRUS; INFANTS	Background HIV-related pneumonia is the main cause of paediatric hospital admissions in southern Africa. We aimed to measure predictors of treatment failure and the cause of non-responsive pneumonia in children admitted to hospital with severe pneumonia in Durban, South Africa. Methods We investigated 358 children aged 1-59 months who presented with WHO-defined severe or very severe pneumonia. Children were recruited irrespective of HIV status and started on a standard antimicrobial regimen of benzylpenicillin and gentamicin. All infants also received high-dose trimethoprim-sulfamethoxazole. The primary outcome measure was treatment failure at 48 h. Findings 242 (68%) children were HIV infected, 41 (12%) HIV exposed, unindected, and 75 (21%) HIV uninfected. Failure to respond by 48 h was predicted by age under 1 year (adjusted odds ratio 6.38, 95% CI 2.72-14.91, p < 0.0001), very severe disease (2.47, 1.17-5.24, p=0.0181), HIV status (HIV infected 10.3, 3.26-32.51; HIV exposed, uninfected 6.02, 1.55-23.38; p=0.0003), and polymicrobial disease (one organism 2.06, 1.05-4.05; two organisms 10.75, 4.38-26.36; p < 0.0001) on logistic regression analysis. All children with three organisms failed treatment. 72/110 treatment failures had at least two organisms isolated. Three of nine HIV-exposed, uninfected infants, 29/74 HIV-infected, but no HIV-uninfected infants who failed study therapy had Pneumocystis jirovecii pneumonia. Interpretation For children younger than 1 year, the WHO guidelines are inadequate and need to be revised since both HIV-infected and HIV-exposed, uninfected infants had more treatment failures than did HIV-uninfected infants. Polymicrobial disease is an important reason for treatment failure, and we need to identify rapid low-cost diagnostic methods to assist clinicians.	UCL, Inst Child Hlth, Ctr Int Child Hlth & Dev, London WC1N 1EH, England; UCL, Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Paediat & Child Hlth, Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Med Microbiol, Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Durban, South Africa; Univ Pretoria, Fac Hlth Sci, Dept Immunol, MRC,Unit Inflammat & Immun, ZA-0002 Pretoria, South Africa	University of London; University College London; University of London; University College London; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of Pretoria	McNally, LM (corresponding author), GlaxoSmithKline Biol, B43,Rue Inst 89, B-1330 Rixensart, Belgium.	lisa.m.mc-nally@gskbio.com	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242	Wellcome Trust [GR056609MA] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; AMAROGALVEZ R, 1991, PEDIATR INFECT DIS J, V10, P473, DOI 10.1097/00006454-199106000-00015; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Burmester M, 2001, INTENS CARE MED, V27, P716, DOI 10.1007/s001340100904; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Delport SD, 2002, SAMJ S AFR MED J, V92, P907; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; FORGIE IM, 1992, PEDIATR INFECT DIS J, V11, P466, DOI 10.1097/00006454-199206000-00009; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P33, DOI 10.1097/00006454-199101000-00008; Gilks CF, 1997, T ROY SOC TROP MED H, V91, P627, DOI 10.1016/S0035-9203(97)90498-3; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Heresi GP, 1997, CLIN INFECT DIS, V25, P739, DOI 10.1086/516938; Jeena PM, 1996, ANN TROP PAEDIATR, V16, P361, DOI 10.1080/02724936.1996.11747852; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Lucas SB, 1996, E AFR MED J, V73, pS7; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Mann M, 1997, AM J RESP CRIT CARE, V155, P1723, DOI 10.1164/ajrccm.155.5.9154883; Martin M, 2004, PEDIATR INFECT DIS J, V23, P842, DOI 10.1097/01.inf.0000137575.82874.0c; McNally LM, 2005, AIDS, V19, P1548, DOI 10.1097/01.aids.0000183941.67730.3a; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; NATHOO KJ, 1993, ANN TROP PAEDIATR, V13, P253, DOI 10.1080/02724936.1993.11747655; Nesheim S, 2003, JAIDS-J ACQ IMM DEF, V32, P192, DOI 10.1097/00126334-200302010-00011; Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398; Pillay T, 2004, LANCET INFECT DIS, V4, P155, DOI 10.1016/S1473-3099(04)00939-9; PRINSLOO JG, 1974, S AFR MED J, V48, P597; *S AFR NAT DEP HLT, 2002, ANT SYPH HIV SER DAT; SCHINDLER MB, 1994, ANAESTH INTENS CARE, V22, P66, DOI 10.1177/0310057X9402200111; Shann F, 2001, LANCET, V357, P2070, DOI 10.1016/S0140-6736(00)05226-0; Sherman GG, 2005, PEDIATR INFECT DIS J, V24, P993, DOI 10.1097/01.inf.0000187036.73539.8d; Smyth A, 1997, ARCH DIS CHILD, V77, P227, DOI 10.1136/adc.77.3.227; Statistics South Africa, 2001, NAT CENS; *WHO, 1990, 5 WHO PROGR CONTR AC; *WHO BOST U, 2004, MAN CHILDR PNEUM HIV; Williams AJ, 2001, AIDS, V15, P335, DOI 10.1097/00002030-200102160-00006; Woolfson A, 1997, B WORLD HEALTH ORGAN, V75, P453; Zar Heather J., 2001, Pediatr Crit Care Med, V2, P108, DOI 10.1097/00130478-200104000-00003; Zar HJ, 2001, ACTA PAEDIATR, V90, P119, DOI 10.1080/080352501300049163; Zwi K, 2000, ARCH DIS CHILD, V83, P227, DOI 10.1136/adc.83.3.227	43	205	207	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2007	369	9571					1440	1451		10.1016/S0140-6736(07)60670-9	http://dx.doi.org/10.1016/S0140-6736(07)60670-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161LW	17467514				2022-12-24	WOS:000246017700030
J	Huikeshoven, M; Koster, PHL; de Borgie, CAJM; Beek, JF; van Gemert, MJC; van der Horst, CMAM				Huikeshoven, Menno; Koster, Petra H. L.; de Borgie, Corianne A. J. M.; Beek, Johan F.; van Gemert, Martin J. C.; van der Horst, Chantal M. A. M.			Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EFFICACY	Background: Although pulsed-dye-laser therapy is currently the gold standard for the treatment of port-wine stains, few objective data are available on its long-term efficacy. Using objective color measurements, we performed a 10-year follow-up of a previously conducted prospective clinical study of the treatment of port-wine stains with a pulsed-dye laser. Methods: We invited the patients to undergo repeated color measurements performed by the same procedures as in the previous study. The results at long-term follow-up were compared with color measurements obtained before treatment and after completion of an average of five laser treatments of the complete port-wine stain. A questionnaire was used to investigate patients' satisfaction with the treatment and their perception of long-term changes in the stain. Results: Of the 89 patients from whom color measurements were obtained in the previous study, 51 were included in this study. The patients had received a median of seven additional treatment sessions since the last color measurement, which had been made after an average of five treatments. The median length of follow-up was 9.5 years. On average, the stain when measured at follow-up was significantly darker than it was when measured after the last of the initial five laser treatments (P=0.001), but it was still significantly lighter than it was when measured before treatment (P<0.001). Fifty-nine percent of patients were satisfied with the overall treatment result. Six percent of patients reported that the stain had become lighter since their last treatment, 59% that it was unchanged, and 35% that it had become darker. Conclusions: Using objective color measurements, we observed significant redarkening of port-wine stains at long-term follow-up after pulsed-dye-laser therapy. Patients should be informed about the possibility of redarkening before beginning treatment.	Univ Amsterdam, Acad Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Ctr Laser, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Huikeshoven, M (corresponding author), Univ Amsterdam, Acad Med Ctr G4 226, Dept Plast Reconstruct & Hand Surg, Meibergdreeef 9, NL-1105 AZ Amsterdam, Netherlands.	m.huikeshoven@amc.uva.nl		van der Horst, chantal/0000-0002-4937-3786				BARSKY SH, 1980, J INVEST DERMATOL, V74, P154, DOI 10.1111/1523-1747.ep12535052; BRAINARD DH, 1995, HDB OPTICS, V1; Breugem CC, 2005, PLAST RECONSTR SURG, V115, P578, DOI 10.1097/01.PRS.0000150150.69479.70; Hansen K, 2003, DERMATOL SURG, V29, P49, DOI 10.1046/j.1524-4725.2003.29010.x; Heger M, 2005, THROMB HAEMOSTASIS, V93, P242, DOI 10.1160/TH04-05-0291; Ho WS, 2002, LASER SURG MED, V30, P44, DOI 10.1002/lsm.10003; Koster PHL, 1998, PLAST RECONSTR SURG, V102, P1210, DOI 10.1097/00006534-199809040-00047; Michel S, 2000, BRIT J DERMATOL, V143, P1230, DOI 10.1046/j.1365-2133.2000.03893.x; MORK NJ, 1998, J EUR ACAD DERMATOL, V11, pS142; Orten SS, 1996, ARCH OTOLARYNGOL, V122, P1174; Ozluer SM, 2001, CLIN EXP DERMATOL, V26, P37, DOI 10.1046/j.1365-2230.2001.00756.x; ROSEN S, 1987, J AM ACAD DERMATOL, V17, P164, DOI 10.1016/S0190-9622(87)70186-8; TAN OT, 1989, NEW ENGL J MED, V320, P416, DOI 10.1056/NEJM198902163200702; TAN OT, 1992, MANAGEMENT TREATMENT, P83; Troilius A, 2000, DERMATOL SURG, V26, P190, DOI 10.1046/j.1524-4725.2000.09204.x; van der Horst CMAM, 1998, NEW ENGL J MED, V338, P1028, DOI 10.1056/NEJM199804093381504	16	92	98	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1235	1240		10.1056/NEJMoa064329	http://dx.doi.org/10.1056/NEJMoa064329			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377161				2022-12-24	WOS:000245101900008
J	Mani, A; Radhakrishnan, J; Wang, H; Mani, A; Mani, MA; Nelson-Williams, C; Carew, KS; Mane, S; Najmabadi, H; Wu, D; Lifton, RP				Mani, Arya; Radhakrishnan, Jayaram; Wang, He; Mani, Alaleh; Mani, Mohammad-Ali; Nelson-Williams, Carol; Carew, Khary S.; Mane, Shrikant; Najmabadi, Hossein; Wu, Dan; Lifton, Richard P.			LRP6 mutation in a family with early coronary disease and metabolic risk factors	SCIENCE			English	Article							RECEPTOR-RELATED PROTEIN-5; HEART-DISEASE; DENSITY; GENE; MORTALITY	Coronary artery disease ( CAD) is the leading cause of death worldwide and is commonly caused by a constellation of risk factors called the metabolic syndrome. We characterized a family with autosomal dominant early CAD, features of the metabolic syndrome (hyperlipidemia, hypertension, and diabetes), and osteoporosis. These traits showed genetic linkage to a short segment of chromosome 12p, in which we identified a missense mutation in LRP6, which encodes a co-receptor in the Wnt signaling pathway. The mutation, which substitutes cysteine for arginine at a highly conserved residue of an epidermal growth factor-like domain, impairs Wnt signaling in vitro. These results link a single gene defect in Wnt signaling to CAD and multiple cardiovascular risk factors.	Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA; Howard Hughes Med Inst, Dept Genet & Mol Biophys, New Haven, CT 06510 USA; Howard Hughes Med Inst, Dept Biochem, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; Amirkabir Univ Technol, Dept Mat Sci, Tehran 15875 4413, Iran; Azad Univ Tehran, Dept Human Sci, Tehran 13185 786, Iran; Social Welf & Rehab Sci Univ, Ctr Gene Res, Tehran 19875 383, Iran	Howard Hughes Medical Institute; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Yale University; Amirkabir University of Technology; Islamic Azad University	Mani, A (corresponding author), Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA.	arya.mani@yale.edu; richard.lifton@yale.edu	Najmabadi, Hossein/P-8182-2017	Najmabadi, Hossein/0000-0002-6084-7778	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD041481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK068229] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL55007] Funding Source: Medline; NIAMS NIH HHS [R01 AR051476, R01 AR051476-03, R01 AR051476-04, R01 AR051476-02, R01 AR051476-01A1] Funding Source: Medline; NICHD NIH HHS [K08 HD041481-01, K08 HD041481] Funding Source: Medline; NIDDK NIH HHS [P01DK68229] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Johansson J, 2002, J INTERN MED, V252, P551, DOI 10.1046/j.1365-2796.2002.01068.x; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Marcovitz PA, 2005, AM J CARDIOL, V96, P1059, DOI 10.1016/j.amjcard.2005.06.034; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Poulsen P, 2001, DIABETOLOGIA, V44, P537, DOI 10.1007/s001250051659; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; ZAVARONI I, 1991, DIABETES METAB, V17, P109	26	452	518	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1278	1282		10.1126/science.1136370	http://dx.doi.org/10.1126/science.1136370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332414	Green Accepted			2022-12-24	WOS:000244564700050
J	Sokolov, S; Scheuer, T; Catterall, WA				Sokolov, Stanislav; Scheuer, Todd; Catterall, William A.			Gating pore current in an inherited ion channelopathy	NATURE			English	Article							HYPOKALEMIC PERIODIC PARALYSIS; SODIUM-CHANNEL; VOLTAGE-SENSOR; SKELETAL-MUSCLE; ENHANCED INACTIVATION; FUNCTIONAL EXPRESSION; MUTATIONS; BRAIN; PERSPECTIVE; MODELS	Ion channelopathies are inherited diseases in which alterations in control of ion conductance through the central pore of ion channels impair cell function, leading to periodic paralysis, cardiac arrhythmia, renal failure, epilepsy, migraine and ataxia(1). Here we show that, in contrast with this well-established paradigm, three mutations in gating-charge-carrying arginine residues in an S4 segment that cause hypokalaemic periodic paralysis(2) induce a hyperpolarization- activated cationic leak through the voltage sensor of the skeletal muscle Na(V)1.4 channel. This 'gating pore current' is active at the resting membrane potential and closed by depolarizations that activate the voltage sensor. It has similar permeability to Na+, K+ and Cs+, but the organic monovalent cations tetraethylammonium and N-methyl-D-glucamine are much less permeant. The inorganic divalent cations Ba2+, Ca2+ and Zn2+ are not detectably permeant and block the gating pore at millimolar concentrations. Our results reveal gating pore current in naturally occurring disease mutations of an ion channel and show a clear correlation between mutations that cause gating pore current and hypokalaemic periodic paralysis. This gain-of-function gating pore current would contribute in an important way to the dominantly inherited membrane depolarization, action potential failure, flaccid paralysis and cytopathology that are characteristic of hypokalaemic periodic paralysis. A survey of other ion channelopathies reveals numerous examples of mutations that would be expected to cause gating pore current, raising the possibility of a broader impact of gating pore current in ion channelopathies.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu						ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; BARCHI RL, 1983, J NEUROCHEM, V36, P1377; Bendahhou S, 2001, ANN NEUROL, V50, P417, DOI 10.1002/ana.1144; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Cannon SC, 2006, ANNU REV NEUROSCI, V29, P387, DOI 10.1146/annurev.neuro.29.051605.112815; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; Kuzmenkin A, 2002, BRAIN, V125, P835, DOI 10.1093/brain/awf071; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Struyk AF, 2000, J NEUROSCI, V20, P8610; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	24	210	215	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					76	78		10.1038/nature05598	http://dx.doi.org/10.1038/nature05598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330043				2022-12-24	WOS:000244525600040
J	Schwartz, D; Collins, F				Schwartz, David; Collins, Francis			Medicine - Environmental biology and human disease	SCIENCE			English	Editorial Material							MACULAR DEGENERATION; VARIANT; GENOME; RISK								NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101946] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; GROOPMAN JD, 1992, CANCER RES, V52, P45; Kandimalla VB, 2004, ANAL BIOANAL CHEM, V380, P587, DOI 10.1007/s00216-004-2793-9; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Martinez FD, 2005, IMMUNOL ALLERGY CLIN, V25, P709, DOI 10.1016/j.iac.2005.09.001; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	13	68	73	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					695	696		10.1126/science.1141331	http://dx.doi.org/10.1126/science.1141331			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163RR	17478705				2022-12-24	WOS:000246181400027
J	van Kasteren, SI; Kramer, HB; Jensen, HH; Campbell, SJ; Kirkpatrick, J; Oldham, NJ; Anthony, DC; Davis, BG				van Kasteren, Sander I.; Kramer, Holger B.; Jensen, Henrik H.; Campbell, Sandra J.; Kirkpatrick, Joanna; Oldham, Neil J.; Anthony, Daniel C.; Davis, Benjamin G.			Expanding the diversity of chemical protein modification allows post-translational mimicry	NATURE			English	Article							BLOOD-BRAIN-BARRIER; O-GLCNAC; P-SELECTIN; TERMINAL ALKYNES; IN-VIVO; EXPRESSION; MALARIA; AZIDES; GLYCOSYLATION; GLYCOPROTEIN	One of the most important current scientific paradoxes is the economy with which nature uses genes. In all higher animals studied, we have found many fewer genes than we would have previously expected. The functional outputs of the eventual products of genes seem to be far more complex than the more restricted blueprint. In higher organisms, the functions of many proteins are modulated by post-translational modifications (PTMs)(1). These alterations of amino-acid side chains lead to higher structural and functional protein diversity and are, therefore, a leading contender for an explanation for this seeming incongruity. Natural protein production methods typically produce PTM mixtures within which function is difficult to dissect or control. Until now it has not been possible to access pure mimics of complex PTMs. Here we report a chemical tagging approach that enables the attachment of multiple modifications to bacterially expressed ( bare) protein scaffolds: this approach allows reconstitution of functionally effective mimics of higher organism PTMs. By attaching appropriate modifications at suitable distances in the widely-used LacZ reporter enzyme scaffold, we created protein probes that included sensitive systems for detection of mammalian brain inflammation and disease. Through target synthesis of the desired modification, chemistry provides a structural precision and an ability to retool with a chosen PTM in a manner not available to other approaches. In this way, combining chemical control of PTM with readily available protein scaffolds provides a systematic platform for creating probes of protein PTM interactions. We therefore anticipate that this ability to build model systems 2 will allow some of this gene product complexity to be dissected, with the aim of eventually being able to completely duplicate the patterns of a particular protein's PTMs from an in vivo assay into an in vitro system.	Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford; University of Oxford	Davis, BG (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	Ben.Davis@chem.ox.ac.uk	Anthony, Daniel/F-7765-2010; Davis, Benjamin G/C-5281-2011; Kramer, Holger/AAL-4433-2020	Anthony, Daniel/0000-0003-1380-6655; Davis, Benjamin G/0000-0002-5056-407X; Kramer, Holger/0000-0002-6400-0945; Oldham, Neil/0000-0001-8024-4563	Biotechnology and Biological Sciences Research Council [EGA17763, BB/E004350/1] Funding Source: Medline; Medical Research Council [G0500853] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/C510824/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/D023327/1, EP/E000614/1, EP/D023343/1, GR/T26542/01, EP/D023335/1] Funding Source: researchfish; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/E000614/1] Funding Source: UKRI; MRC [G0500853] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barkalow FJ, 1996, BLOOD, V88, P4585, DOI 10.1182/blood.V88.12.4585.bloodjournal88124585; Bernardes-Silva M, 2001, J CEREBR BLOOD F MET, V21, P1115, DOI 10.1097/00004647-200109000-00009; Campbell SJ, 1996, J CELL SCI, V109, P2619; CUBELLIS MV, 1990, GENE, V94, P89, DOI 10.1016/0378-1119(90)90472-4; Davis BG, 1998, J ORG CHEM, V63, P9614, DOI 10.1021/jo9816461; Davis BG, 2002, CHEM REV, V102, P579, DOI 10.1021/cr0004310; Davis BG, 2004, SCIENCE, V303, P480, DOI 10.1126/science.1093449; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Easton RL, 2000, J BIOL CHEM, V275, P21928, DOI 10.1074/jbc.M001534200; ELLIOT SP, 1993, J NEUROSCI, V13, P2424, DOI 10.1523/JNEUROSCI.13-06-02424.1993; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Fodje MN, 2002, PROTEIN ENG, V15, P353, DOI 10.1093/protein/15.5.353; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Lefebvre T, 2005, EXPERT REV PROTEOMIC, V2, P265, DOI 10.1586/14789450.2.2.265; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; NELSON RM, 1993, J CLIN INVEST, V91, P1157, DOI 10.1172/JCI116275; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Sibson NR, 2004, MAGN RESON MED, V51, P248, DOI 10.1002/mrm.10723; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sun G, 2003, INFECT IMMUN, V71, P6553, DOI 10.1128/IAI.71.11.6553-6561.2003; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; WOLD F, 1981, ANNU REV BIOCHEM, V50, P783, DOI 10.1146/annurev.bi.50.070181.004031	30	255	264	2	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1105	1109		10.1038/nature05757	http://dx.doi.org/10.1038/nature05757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460675				2022-12-24	WOS:000245950400055
J	Cohen, SB; Graham, ME; Lovrecz, GO; Bache, N; Robinson, PJ; Reddel, RR				Cohen, Scott B.; Graham, Mark E.; Lovrecz, George O.; Bache, Nicolai; Robinson, Phillip J.; Reddel, Roger R.			Protein composition of catalytically active human telomerase from immortal cells	SCIENCE			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; RNA COMPONENT; PURIFICATION; SUBUNIT	Telomerase is a ribonucleoprotein enzyme complex that adds 5'-TTAGGG-3' repeats onto the ends of human chromosomes, providing a telomere maintenance mechanism for similar to 90% of human cancers. We have purified human telomerase similar to 10(8)-fold, with the final elution dependent on the enzyme's ability to catalyze nucleotide addition onto a DNA oligonucleotide of telomeric sequence, thereby providing specificity for catalytically active telomerase. Mass spectrometric sequencing of the protein components and molecular size determination indicated an enzyme composition of two molecules each of telomerase reverse transcriptase, telomerase RNA, and dyskerin.	Childrens Med Res Inst, Canc Res Unit, Westmead, NSW 2145, Australia; Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia; CSIRO, Mol & Hlth Technol, Fermentat Lab, Parkville, Vic 3052, Australia; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Children's Medical Research Institute - Australia; Children's Medical Research Institute - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Southern Denmark	Reddel, RR (corresponding author), Childrens Med Res Inst, Canc Res Unit, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia.	rreddel@cmri.usyd.edu.au	Lovrecz, George/H-8602-2013; Reddel, Roger R/A-6635-2014; Graham, Mark E/A-6480-2014; Robinson, Phillip J/G-4008-2011	Reddel, Roger R/0000-0002-6302-6107; Graham, Mark E/0000-0002-7290-1217; Robinson, Phillip J/0000-0002-7878-0313				Arai K, 2002, J BIOL CHEM, V277, P8538, DOI 10.1074/jbc.M111068200; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Lingner J, 1996, P NATL ACAD SCI USA, V93, P10712, DOI 10.1073/pnas.93.20.10712; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Wallweber G, 2003, BIOCHEMISTRY-US, V42, P589, DOI 10.1021/bi026914a; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526	19	495	521	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1850	1853		10.1126/science.1138596	http://dx.doi.org/10.1126/science.1138596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395830				2022-12-24	WOS:000245280100045
J	Smith, BD				Smith, Bruce D.			The ultimate ecosystem engineers	SCIENCE			English	Editorial Material									Smithsonian Inst, Natl Museum Nat Hist, Archaeobiol Program, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Smith, BD (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Archaeobiol Program, Washington, DC 20560 USA.	smithb@si.edu						Anderson M., 2005, TENDING WILD; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Odling-Smee F., 2003, NICHE CONSTRUCTION; Weiss E, 2006, SCIENCE, V312, P1608, DOI 10.1126/science.1127235; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101	6	86	92	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1797	1798		10.1126/science.1137740	http://dx.doi.org/10.1126/science.1137740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395815				2022-12-24	WOS:000245280100025
J	Steinbrook, R				Steinbrook, Robert			HIV in India - A complex epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV/AIDS					rsteinbrook@attglobal.net						Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-31; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; O'Neil J, 2004, SOC SCI MED, V59, P851, DOI 10.1016/j.socscimed.2003.11.032; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335	5	83	85	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1089	1093		10.1056/NEJMp078009	http://dx.doi.org/10.1056/NEJMp078009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	145PO	17360986	Bronze			2022-12-24	WOS:000244877200001
J	Rocco, B; Djavan, B				Rocco, Bernardo; Djavan, Bob			Robotic prostatectomy: facts or fiction?	LANCET			English	Editorial Material							LAPAROSCOPIC RADICAL PROSTATECTOMY; OUTCOMES; CANCER		European Inst Oncol, Dept Urol, I-20141 Milan, Italy; Univ Vienna, Dept Urol, Vienna, Austria	IRCCS European Institute of Oncology (IEO); University of Vienna	Rocco, B (corresponding author), European Inst Oncol, Dept Urol, I-20141 Milan, Italy.	bernardo.rocco@ieo.it	Rocco, Bernardo/R-4041-2016	Rocco, Bernardo/0000-0002-9135-0035				Ahlering TE, 2004, UROLOGY, V63, P819, DOI 10.1016/j.urology.2004.01.038; Ahlering TE, 2003, J UROLOGY, V170, P1738, DOI 10.1097/01.ju.0000092881.24608.5e; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Burgess SV, 2006, J ENDOUROL, V20, P827, DOI 10.1089/end.2006.20.827; Descazeaud A, 2007, EUR UROL, V51, P9, DOI 10.1016/j.eururo.2006.10.007; Ficarra V, 2007, EUR UROL, V51, P45, DOI 10.1016/j.eururo.2006.06.017; Han M, 2004, J UROLOGY, V171, P23, DOI 10.1097/01.ju.0000098604.09395.27; Lepor Herbert, 2005, Rev Urol, V7 Suppl 2, pS11; Lotan Y, 2004, J UROLOGY, V172, P1431, DOI 10.1097/01.ju.0000139714.09832.47; Menon M, 2005, UROLOGY, V66, P101, DOI 10.1016/j.urology.2005.06.008; Menon M, 2007, EUR UROL, V51, P648, DOI 10.1016/j.eururo.2006.10.055; Penson DF, 2005, J UROLOGY, V173, P1701, DOI 10.1097/01.ju.0000154637.38262.3a; Rassweiler J, 2006, EUR UROL, V49, P612, DOI 10.1016/j.eururo.2005.12.054; Smith JA, 2005, J CLIN ONCOL, V23, P8170, DOI 10.1200/JCO.2005.03.1963; Tewari Ashutosh, 2003, Rev Urol, V5 Suppl 6, pS33; *UK OFF NAT STAT, CANC INC MORT UK 200; *US NAT CANC I, SURV EP END RES CAND	17	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					723	724		10.1016/S0140-6736(07)60336-5	http://dx.doi.org/10.1016/S0140-6736(07)60336-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336632				2022-12-24	WOS:000244726700008
J	Pearse, RM; Young, JD				Pearse, Rupert M.; Young, J. Duncan			Steroids to prevent postextubation laryngeal oedema	LANCET			English	Editorial Material							MECHANICAL VENTILATION; DOUBLE-BLIND; DEXAMETHASONE; EXTUBATION; STRIDOR; ADULTS		Royal London Hosp, Barts & London Sch Med & Dent, London E1 1BB, England; John Radcliffe Hosp, Adult Intens Care Unit, Oxford OX3 9DU, England	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Oxford	Pearse, RM (corresponding author), Royal London Hosp, Barts & London Sch Med & Dent, London E1 1BB, England.	rupert.pearse@bartsandthelondon.nhs.uk	Pearse, Rupert/H-5426-2011; Young, John D/M-9756-2016	Pearse, Rupert/0000-0002-4373-5934; Young, John Duncan/0000-0002-6838-4835				Anene O, 1996, CRIT CARE MED, V24, P1666, DOI 10.1097/00003246-199610000-00011; Cheng KC, 2006, CRIT CARE MED, V34, P1345, DOI 10.1097/01.CCM.0000214678.92134.BD; DARMON JY, 1992, ANESTHESIOLOGY, V77, P245, DOI 10.1097/00000542-199208000-00004; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Esteban A, 1998, INTENS CARE MED, V24, P999, DOI 10.1007/s001340050708; Ferrara T B, 1989, J Perinatol, V9, P287; Francois B, 2007, LANCET, V369, P1083, DOI 10.1016/S0140-6736(07)60526-1; Ho LI, 1996, INTENS CARE MED, V22, P933; TELLEZ DW, 1991, J PEDIATR-US, V118, P289, DOI 10.1016/S0022-3476(05)80505-0	9	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1060	1061		10.1016/S0140-6736(07)60503-0	http://dx.doi.org/10.1016/S0140-6736(07)60503-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398289				2022-12-24	WOS:000245323700006
J	Coombes, R				Coombes, Rebecca			Medicine and the media - Having the last laugh at big pharma - How campaigners are creating humorous videos to hit back at the drug industry	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					396	397		10.1136/bmj.39133.480880.59	http://dx.doi.org/10.1136/bmj.39133.480880.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MQ	17322252	Green Published			2022-12-24	WOS:000244654400025
J	Gullison, RE; Frumhoff, PC; Canadell, JG; Field, CB; Nepstad, DC; Hayhoe, K; Avissar, R; Curran, LM; Friedlingstein, P; Jones, CD; Nobre, C				Gullison, Raymond E.; Frumhoff, Peter C.; Canadell, Josep G.; Field, Christopher B.; Nepstad, Daniel C.; Hayhoe, Katharine; Avissar, Roni; Curran, Lisa M.; Friedlingstein, Pierre; Jones, Chris D.; Nobre, Carlos			Tropical forests and climate policy	SCIENCE			English	Editorial Material									Union Concerned Sci, Cambridge, MA 02238 USA; Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; CSIRO Marine & Atmospher Res, Global Carbon Project, Canberra, ACT 2601, Australia; Carnegie Inst, Dept Global Ecol, Stanford, CA 94305 USA; Woods Hole Res Ctr, Woods Hole, MA 02543 USA; Texas Tech Univ, Dept Geosci, Lubbock, TX 79409 USA; Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; YAle Sch Forestry & Environm Studies, Trop Resources Inst, New Haven, CT 06511 USA; CEA, CNRS, Unite Mixte Rech 1572, Lab Sci Climate & Environm IPSL LSCE, F-91191 Gif Sur Yvette, France; Hadley Ctr Climate Predict & Res, Met Off, Exeter EX1 3PB, Devon, England; CPTEC, Cachoeira Paulista, SP, Brazil	University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Carnegie Institution for Science; Woods Hole Research Center; Texas Tech University System; Texas Tech University; Duke University; Yale University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Met Office - UK; Hadley Centre; Instituto Nacional de Pesquisas Espaciais (INPE)	Gullison, RE (corresponding author), Union Concerned Sci, Cambridge, MA 02238 USA.		Canadell, Pep/E-9419-2010; Jones, Chris/I-2983-2014; Friedlingstein, Pierre/H-2700-2014	Canadell, Pep/0000-0002-8788-3218; Jones, Chris/0000-0002-7141-9285; Friedlingstein, Pierre/0000-0003-3309-4739				CHOMITZ K, 2006, LOGGERHEADS AGR EXPA; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Gitz V, 2004, CLIMATIC CHANGE, V67, P161, DOI 10.1007/s10584-004-0065-5; Houghton R.A., 2005, TROPICAL DEFORESTATI, P13; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Laurance WF, 2007, BIOTROPICA, V39, P20, DOI 10.1111/j.1744-7429.2006.00229.x; Moutinho P., 2005, TROPICAL DEFORESTATI; NABUURS GJ, IN PRESS CLIMATE CHA, pCH9; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Sabine CL, 2004, SCOPE SER, V62, P17; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Stern N., 2006, EC CLIMATE CHANGE ST; UNFCCC, 2007, 2 WORKSH RED EM DEF; *UNFCCC, 2005, C PART MONTR 28 NOV; UNFCCC, 2006, 1A UNFCCC; UNFCCC, 2007, SUBS BOD SCI TECHN A; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753	18	318	326	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					985	986		10.1126/science.1136163	http://dx.doi.org/10.1126/science.1136163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17495140				2022-12-24	WOS:000246554000029
J	Coombes, R				Coombes, Rebecca			Bad blood	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					879	880		10.1136/bmj.39195.621528.59	http://dx.doi.org/10.1136/bmj.39195.621528.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463458	Green Published			2022-12-24	WOS:000246217800026
J	Obot, IS				Obot, Isidore S.			Limits of substance-use interventions in developing countries	LANCET			English	Editorial Material									Morgan State Univ, Sch Publ Hlth & Policy, Dept Behav Hlth Sci, Baltimore, MD 21251 USA	Morgan State University	Obot, IS (corresponding author), Morgan State Univ, Sch Publ Hlth & Policy, Dept Behav Hlth Sci, Baltimore, MD 21251 USA.	isobot@moac.morgan.edu	Obot, Isidore/AAZ-8477-2020	Obot, Isidore/0000-0002-7207-0652				Babor TF, 2003, ALCOHOL NO ORDINARY; Obot I. S., 2005, Substance use among young people in urban environments, P203; Obot IS, 2005, ADDICTION, V100, P1210, DOI 10.1111/j.1360-0443.2005.01156.x; Obot IS, 2004, SUBST USE MISUSE, V39, P1287, DOI 10.1081/JA-120038687; PARRY C.D.H., 2006, AFR J DRUG ALCOHOL S, V5, P41; TOURNBOUROU JW, 2007, LANCET; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	7	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1323	1325		10.1016/S0140-6736(07)60373-0	http://dx.doi.org/10.1016/S0140-6736(07)60373-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448801				2022-12-24	WOS:000245856100006
J	Sykes, NP				Sykes, Nigel P.			Morphine kills the pain, not the patient	LANCET			English	Editorial Material							OPIOID USE; LIFE; END; CANCER		St Christophers Hospice, London SE26 6DZ, England		Sykes, NP (corresponding author), St Christophers Hospice, London SE26 6DZ, England.	n.sykes@stchristophers.org.uk						BILLINGS A, 2007, BBC THOUGHT DAY; *INT NARC CONTR BO, 2006, NARC DRUGS EST WORLD, P109; MORGAN J P, 1985, Advances in Alcohol and Substance Abuse, V5, P163; Morita Tatsuya, 2003, J Palliat Med, V6, P557, DOI 10.1089/109662103768253669; Pargeon KL, 1999, J PAIN SYMPTOM MANAG, V18, P358, DOI 10.1016/S0885-3924(99)00097-4; Portenoy RK, 2006, J PAIN SYMPTOM MANAG, V32, P532, DOI 10.1016/j.jpainsymman.2006.08.003; PORTER J, 1980, NEW ENGL J MED, V302, P123; Regnard C, 2003, PALLIATIVE MED, V17, P714, DOI 10.1191/0269216303pm838cr; Seale C, 2006, PALLIATIVE MED, V20, P3, DOI 10.1191/0269216306pm1094oa; Stjernsward J, 2004, OXFORD TXB PALLIATIV, P1199; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Thorns A, 2000, LANCET, V356, P398, DOI 10.1016/S0140-6736(00)02534-4; WALSH TD, 1984, RECENT RESULTS CANC, V89, P115; *WHO, 1987, CANC PAIN REL	14	15	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1325	1326		10.1016/S0140-6736(07)60611-4	http://dx.doi.org/10.1016/S0140-6736(07)60611-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448802				2022-12-24	WOS:000245856100007
J	Koenigs, M; Young, L; Adolphs, R; Tranel, D; Cushman, F; Hauser, M; Damasio, A				Koenigs, Michael; Young, Liane; Adolphs, Ralph; Tranel, Daniel; Cushman, Fiery; Hauser, Marc; Damasio, Antonio			Damage to the prefrontal cortex increases utilitarian moral judgements	NATURE			English	Article							NETWORKS; EMOTION; FMRI	The psychological and neurobiological processes underlying moral judgement have been the focus of many recent empirical studies(1-11). Of central interest is whether emotions play a causal role in moral judgement, and, in parallel, how emotion-related areas of the brain contribute to moral judgement. Here we show that six patients with focal bilateral damage to the ventromedial prefrontal cortex (VMPC), a brain region necessary for the normal generation of emotions and, in particular, social emotions(12-14), produce an abnormally 'utilitarian' pattern of judgements on moral dilemmas that pit compelling considerations of aggregate welfare against highly emotionally aversive behaviours ( for example, having to sacrifice one person's life to save a number of other lives)(7,8). In contrast, the VMPC patients' judgements were normal in other classes of moral dilemmas. These findings indicate that, for a selective set of moral dilemmas, the VMPC is critical for normal judgements of right and wrong. The findings support a necessary role for emotion in the generation of those judgements.	Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; Univ So Calif, Dornsife Ctr Cognit Neuroimaging, Los Angeles, CA 90089 USA	University of Iowa; Harvard University; California Institute of Technology; California Institute of Technology; University of Southern California; University of Southern California	Adolphs, R (corresponding author), Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA.	radolphs@hss.caltech.edu	Damasio, Antonio/AAD-1342-2019	Tranel, Daniel/0000-0002-1338-1389; Cushman, Fiery/0000-0002-6929-9982; Koenigs, Michael/0000-0002-5799-4881	NIDA NIH HHS [R01 DA022549-02, R01 DA022549] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022549] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson S. W., 1993, IOWA RATING SCALES P; Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 2003, LOOKING SPINOZA JOY; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hauser M.D., 2006, MORAL MINDS; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kohlberg L, 1981, ESSAYS MORAL DEV, VI; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; MIKHAIL JM, 2000, THESIS CORNELL U; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Valdesolo P, 2006, PSYCHOL SCI, V17, P476, DOI 10.1111/j.1467-9280.2006.01731.x; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x	29	959	993	13	292	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					908	911		10.1038/nature05631	http://dx.doi.org/10.1038/nature05631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IR	17377536	Green Accepted, Green Published			2022-12-24	WOS:000245785700041
J	Reddy, SK; Rape, M; Margansky, WA; Kirschner, MW				Reddy, S. K.; Rape, M.; Margansky, W. A.; Kirschner, M. W.			Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation	NATURE			English	Article							ASSEMBLY CHECKPOINT; MITOTIC CHECKPOINT; PROTEIN BUBR1; MAD2; ACTIVATION; BINDING; UBCH10; OVEREXPRESSION; INHIBITION; CARCINOMAS	Eukaryotic cells rely on a surveillance mechanism known as the spindle checkpoint to ensure accurate chromosome segregation. The spindle checkpoint prevents sister chromatids from separating until all kinetochores achieve bipolar attachments to the mitotic spindle(1-3). Checkpoint proteins tightly inhibit the anaphase-promoting complex (APC), a ubiquitin ligase required for chromosome segregation and progression to anaphase. Unattached kinetochores promote the binding of checkpoint proteins Mad2 and BubR1 to the APC-activator Cdc20, rendering it unable to activate APC. Once all kinetochores are properly attached, however, cells inactivate the checkpoint within minutes, allowing for the rapid and synchronous segregation of chromosomes(4). How cells switch from strong APC inhibition before kinetochore attachment to rapid APC activation once attachment is complete remains a mystery. Here we show that checkpoint inactivation is an energy-consuming process involving APC-dependent multi-ubiquitination. Multi-ubiquitination by APC leads to the dissociation of Mad2 and BubR1 from Cdc20, a process that is reversed by a Cdc20-directed de-ubiquitinating enzyme(5). The mutual regulation between checkpoint proteins and APC leaves the cell poised for rapid checkpoint inactivation and ensures that chromosome segregation promptly follows the completion of kinetochore attachment. In addition, our results suggest a mechanistic basis for how cancer cells can have a compromised spindle checkpoint without corresponding mutations in checkpoint genes(6).	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu	高, 雨莉/HGU-8187-2022	Rape, Michael/0000-0003-4849-6343				Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Okamoto Y, 2003, CANCER RES, V63, P4167; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; STEGMEIER F, IN PRESS NATURE; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	22	273	283	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					921	925		10.1038/nature05734	http://dx.doi.org/10.1038/nature05734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443186				2022-12-24	WOS:000245785700044
J	Gupta, GP; Nguyen, DX; Chiang, AC; Bos, PD; Kim, JY; Nadal, C; Gomis, RR; Manova-Todorova, K; Massague, J				Gupta, Gaorav P.; Nguyen, Don X.; Chiang, Anne C.; Bos, Paula D.; Kim, Juliet Y.; Nadal, Cristina; Gomis, Roger R.; Manova-Todorova, Katia; Massague, Joan			Mediators of vascular remodelling co-opted for sequential steps in lung metastasis	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER METASTASIS; TUMOR; ANGIOGENESIS; CYCLOOXYGENASE-2; GENES; INHIBITOR; CELECOXIB; SURVIVAL; EFFICACY	Metastasis entails numerous biological functions that collectively enable cancerous cells from a primary site to disseminate and overtake distant organs. Using genetic and pharmacological approaches, we show that the epidermal growth factor receptor ligand epiregulin, the cyclooxygenase COX2, and the matrix metalloproteinases 1 and 2, when expressed in human breast cancer cells, collectively facilitate the assembly of new tumour blood vessels, the release of tumour cells into the circulation, and the breaching of lung capillaries by circulating tumour cells to seed pulmonary metastasis. These findings reveal how aggressive primary tumorigenic functions can be mechanistically coupled to greater lung metastatic potential, and how such biological activities may be therapeutically targeted with specific drug combinations.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Gupta, Gaorav/AAL-4472-2021; Gomis, Roger R/E-9788-2016	Gomis, Roger R/0000-0001-6473-2858; Massague, Joan/0000-0001-9324-8408				Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Dannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; Giordano SH, 2004, CANCER, V100, P44, DOI 10.1002/cncr.11859; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Jacoby RF, 2000, CANCER RES, V60, P5040; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karashima T, 2002, CLIN CANCER RES, V8, P1253; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; Luo FR, 2005, CANCER CHEMOTH PHARM, V56, P455, DOI 10.1007/s00280-005-1022-3; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Niederberger E, 2001, FASEB J, V15, P1622, DOI 10.1096/fj.00-0716fje; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Solomayer EF, 2000, BREAST CANCER RES TR, V59, P271, DOI 10.1023/A:1006308619659; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wary Kishore K, 2003, Mol Cancer, V2, P25, DOI 10.1186/1476-4598-2-25; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233	37	541	565	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					765	U2		10.1038/nature05760	http://dx.doi.org/10.1038/nature05760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429393				2022-12-24	WOS:000245626800033
J	Koh, HK; Joossens, LX; Connolly, GN				Koh, Howard K.; Joossens, Luk X.; Connolly, Gregory N.			Making smoking history worldwide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Assoc European Canc Leagues, Brussels, Belgium	Harvard University; Harvard T.H. Chan School of Public Health	Koh, HK (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Fong GT, 2006, TOB CONTROL, V15, P51, DOI 10.1136/tc.2005.013649; HHS (Department of Health and Human Services), 2006, HLTH CONS INV EXP TO; Mackay J, 2006, TOBACCO ATLAS; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13	5	68	72	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1496	1498		10.1056/NEJMp068279	http://dx.doi.org/10.1056/NEJMp068279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	156CA	17429081	Bronze			2022-12-24	WOS:000245624400002
J	Jung, J; Bonini, N				Jung, Joonil; Bonini, Nancy			CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease	SCIENCE			English	Article							MACHADO-JOSEPH-DISEASE; CAG REPEATS; DNA-REPAIR; POLYGLUTAMINE DISEASE; GENETIC INSTABILITY; LENGTH; TRANSCRIPTION; MECHANISMS; HUNTINGTIN; EXPANSION	Although expansion of trinucleotide repeats accounts for over 30 human diseases, mechanisms of repeat instability remain poorly understood. We show that a Drosophila model for the CAG/polyglutamine (polyQ) disease spinocerebellar ataxia type 3 recapitulates key features of human CAG-repeat instability, including large repeat changes and strong expansion bias. Instability is dramatically enhanced by transcription and modulated by nuclear excision repair and a regulator of DNA repair adenosine 3',5'- monophosphate (cAMP) response element-binding protein (CREB)-binding protein-a histone acetyltransferase (HAT) whose decreased activity contributes to polyQ disease. Pharmacological treatment to normalize acetylation suppressed instability. Thus, toxic consequences of pathogenic polyQ protein may include enhancing repeat instability.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Bonini, N (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu						Bodai L, 2003, CURR MED CHEM, V10, P2577, DOI 10.2174/0929867033456530; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hasan S, 2002, J MOL MED, V80, P463, DOI 10.1007/s00109-002-0341-7; Jackson SM, 2005, GENE, V347, P35, DOI 10.1016/j.gene.2004.12.008; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kaytor MD, 1997, HUM MOL GENET, V6, P2135, DOI 10.1093/hmg/6.12.2135; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Maciel P, 1999, EUR J HUM GENET, V7, P147, DOI 10.1038/sj.ejhg.5200264; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marx J, 2005, SCIENCE, V310, P43, DOI 10.1126/science.310.5745.43; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Sato T, 1999, HUM MOL GENET, V8, P99, DOI 10.1093/hmg/8.1.99; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; Tanaka F, 1999, AM J HUM GENET, V65, P966, DOI 10.1086/302578; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Zhang Y, 2002, HUM MOL GENET, V11, P791, DOI 10.1093/hmg/11.7.791	30	110	110	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1857	1859		10.1126/science.1139517	http://dx.doi.org/10.1126/science.1139517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17332375				2022-12-24	WOS:000245280100047
J	Spar, D				Spar, Debora			The egg trade - Making sense of the market for human oocytes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Spar, D (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							*BBC, 2005, BBC NEWS ONL; GALPERN E, 2006, WOMENS HLTH ACTI MAY; Guidice L., 2007, ASSESSING MED RISKS; ORTIZ, 2006, 1260 SB; Practice Committe of the American Society for Reproductive Medicine, 2003, Fertil Steril, V80, P1309	5	30	30	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1289	1291		10.1056/NEJMp078012	http://dx.doi.org/10.1056/NEJMp078012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392298				2022-12-24	WOS:000245221000001
J	Pelletier, F; Clutton-Brock, T; Pemberton, J; Tuljapurkar, S; Coulson, T				Pelletier, Fanie; Clutton-Brock, Tim; Pemberton, Josephine; Tuljapurkar, Shripad; Coulson, Tim			The evolutionary demography of ecological change: Linking trait variation and population growth	SCIENCE			English	Article							NATURAL-SELECTION; RAPID EVOLUTION; NEONATAL TRAITS; SOAY SHEEP; DENSITY; TIME	Population dynamics and evolutionary change are linked by the fundamental biological processes of birth and death. This means that population growth may correlate with the strength of selection, whereas evolutionary change can leave an ecological signature. We decompose population growth in an age-structured population into contributions from variation in a quantitative trait. We report that the distribution of body sizes within a population of Soay sheep can markedly influence population dynamics, accounting for up to one-fifth of observed population growth. Our results suggest that there is substantial opportunity for evolutionary dynamics to leave an ecological signature and visa versa.	Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Div Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, NERC, Ascot SL5 7PY, Berks, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Cambridge; University of Edinburgh; Stanford University	Coulson, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Div Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	t.coulson@imperial.ac.uk	Pemberton, Josephine M/F-3100-2010; Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003; Tuljapurkar, Shripad/0000-0001-5549-4245	NIA NIH HHS [P01 AG022500-04, P01 AG 22500, P01 AG022500] Funding Source: Medline; NERC [cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001, NER/A/S/2003/00461] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI 10.1111/j.1558-5646.1984.tb00344.x; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; CLUTTONELROCK TH, 2004, SOAY SHEEP DYNAMICS; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson T, 2003, EVOLUTION, V57, P2879, DOI 10.1111/j.0014-3820.2003.tb01528.x; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fisher R.A., 1930, GENETICAL THEORY NAT; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hanski I, 2006, PLOS BIOL, V4, P719, DOI 10.1371/journal.pbio.0040129; JORGENSON JT, 1993, CAN J ZOOL, V71, P2509, DOI 10.1139/z93-344; LANDE R, 1982, ECOLOGY, V63, P607, DOI 10.2307/1936778; Overall ADJ, 2005, MOL ECOL, V14, P3383, DOI 10.1111/j.1365-294X.2005.02682.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; SLOBODKIN LAWRENCE B., 1961; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216; WILSON AJ, 2004, J EVOLUTION BIOL, DOI DOI 10.1007/S10682-006-9106-Z	22	185	185	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1571	1574		10.1126/science.1139024	http://dx.doi.org/10.1126/science.1139024			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363672				2022-12-24	WOS:000244934800051
J	Bao, ZH; Weatherspoon, MR; Shian, S; Cai, Y; Graham, PD; Allan, SM; Ahmad, G; Dickerson, MB; Church, BC; Kang, ZT; Abernathy, HW; Summers, CJ; Liu, ML; Sandhage, KH				Bao, Zhihao; Weatherspoon, Michael R.; Shian, Samuel; Cai, Ye; Graham, Phillip D.; Allan, Shawn M.; Ahmad, Gul; Dickerson, Matthew B.; Church, Benjamin C.; Kang, Zhitao; Abernathy, Harry W., III; Summers, Christopher J.; Liu, Meilin; Sandhage, Kenneth H.			Chemical reduction of three-dimensional silica micro-assemblies into microporous silicon replicas	NATURE			English	Article							POROUS SILICON; GAS SENSOR; VAPOR; EMISSION; DIOXIDE; WATER	The carbothermal reduction of silica into silicon requires the use of temperatures well above the silicon melting point (>= 2,000 degrees C)(1). Solid silicon has recently been generated directly from silica at much lower temperatures (<= 850 degrees C) via electrochemical reduction in molten salts(2,3). However, the silicon products of such electrochemical reduction did not retain the microscale morphology of the starting silica reactants(2,3). Here we demonstrate a low-temperature ( 650 degrees C) magnesiothermic reduction process for converting three-dimensional nanostructured silica micro-assemblies into microporous nanocrystalline silicon replicas. The intricate nanostructured silica microshells (frustules) of diatoms ( unicellular algae) were converted into co-continuous, nanocrystalline mixtures of silicon and magnesia by reaction with magnesium gas. Selective magnesia dissolution then yielded an interconnected network of silicon nanocrystals that retained the starting three-dimensional frustule morphology. The silicon replicas possessed a high specific surface area (>500 m(2) g(-1)), and contained a significant population of micropores (<= 20 angstrom). The silicon replicas were photoluminescent, and exhibited rapid changes in impedance upon exposure to gaseous nitric oxide ( suggesting a possible application in microscale gas sensing). This process enables the syntheses of microporous nanocrystalline silicon microassemblies with multifarious three-dimensional shapes inherited from biological(4-6) or synthetic silica templates(7-9) for sensor, electronic, optical or biomedical applications(10-13).	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Sandhage, KH (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	ken.sandhage@mse.gatech.edu	Liu, Meilin/E-5782-2010; Shao, Zongping/AAY-8177-2020; Shian, Samuel/H-3168-2013; Ahmad, Gul/GZL-7770-2022	Liu, Meilin/0000-0002-6188-2372; Bao, Zhihao/0000-0002-8708-7510; Kang, Zhitao/0000-0001-6736-7809				Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Balagurov LA, 1996, J APPL PHYS, V79, P7143, DOI 10.1063/1.361484; BANERJEE HD, 1982, MATER SCI ENG, V52, P173, DOI 10.1016/0025-5416(82)90046-5; Baratto C, 2001, THIN SOLID FILMS, V391, P261, DOI 10.1016/S0040-6090(01)00992-0; Barin I., 1995, THERMOCHEMICAL DATA, P994; BARRET EP, 1951, J AM CHEM SOC, V73, P380; Bengtsson M, 2000, PHYS STATUS SOLIDI A, V182, P495, DOI 10.1002/1521-396X(200011)182:1<495::AID-PSSA495>3.0.CO;2-4; Blaaderen A, 1997, NATURE, V385, P321; Boarino L, 2000, MAT SCI ENG B-SOLID, V69, P210, DOI 10.1016/S0921-5107(99)00267-6; BOUVARD D, 1991, ACTA METALL MATER, V39, P3083, DOI 10.1016/0956-7151(91)90041-X; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; CULLIS AG, 1991, NATURE, V353, P335, DOI 10.1038/353335a0; Cullity B. D., 1978, ELEMENTS XRAY DIFFRA, P101; Fan HY, 2000, NATURE, V405, P56, DOI 10.1038/35011026; Gelloz B, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2001136; Hall SR, 2003, CHEM COMMUN, P2784, DOI 10.1039/b309877j; International Centre for Diffraction Data, POWD DIFFR FIL; Li XG, 2003, LANGMUIR, V19, P8490, DOI 10.1021/la034487b; Miron AS, 1999, J BIOTECHNOL, V70, P249; NAGAMORI M, 1986, METALL TRANS B, V17, P503, DOI 10.1007/BF02670216; Nohira T, 2003, NAT MATER, V2, P397, DOI 10.1038/nmat900; Round F. E, 2000, DIATOMS BIOL MORPHOL; Sandhage KH, 2002, ADV MATER, V14, P429, DOI 10.1002/1521-4095(20020318)14:6<429::AID-ADMA429>3.3.CO;2-3; SCHMID AM, 1981, CELL BIOL MONOGR, V8, P63; Seals L, 2002, J APPL PHYS, V91, P2519, DOI 10.1063/1.1436556; Shin HC, 2005, J POWER SOURCES, V139, P314, DOI 10.1016/j.jpowsour.2004.06.073; Watanabe K, 1996, SENSOR ACTUAT B-CHEM, V33, P194, DOI 10.1016/0925-4005(96)80097-9; WYNNYCKYJ JR, 1976, HIGH TEMP SCI, V8, P203; Yasuda K, 2005, J ELECTROCHEM SOC, V152, pD232, DOI 10.1149/1.2103947	29	632	680	17	738	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					172	175		10.1038/nature05570	http://dx.doi.org/10.1038/nature05570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344850				2022-12-24	WOS:000244718100037
J	Balague, F; Mannion, AF; Pellise, F; Cedraschi, C				Balague, Federico; Mannion, Anne F.; Pellise, Ferran; Cedraschi, Christine			Clinical update: low back pain	LANCET			English	Article							EUROPEAN GUIDELINES; PRIMARY-CARE; PREDICTION; MANAGEMENT; DISABILITY; DISORDERS		Cantonal Hosp, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland; Schulthess Klin, Spine Unit, Zurich, Switzerland; Hosp Univ Vall Hebron, Spine Unit, Barcelona, Spain; Univ Hosp Geneva, Ctr Multidisciplinary Pain, Serv Clin Pharmacol & Toxicol, Geneva, Switzerland; Univ Hosp Geneva, Ctr Multidisciplinary Pain, Div Gen Med Rehabil, Geneva, Switzerland	Schulthess Clinic; Hospital Universitari Vall d'Hebron; University of Geneva; University of Geneva	Balague, F (corresponding author), Cantonal Hosp, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland.	balaguef@hopcantfr.ch	Mannion, Anne F./AAN-5908-2020; Mannion, Anne F./C-6615-2009; Pellise, Ferran/D-4488-2016	Mannion, Anne F./0000-0002-1203-1096; Mannion, Anne F./0000-0002-1203-1096; Pellise, Ferran/0000-0002-0644-7757				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Balague F, 2006, JOINT BONE SPINE, V73, P508, DOI 10.1016/j.jbspin.2006.01.005; Bombardier C, 2000, SPINE, V25, P3100, DOI 10.1097/00007632-200012150-00003; Brennan GP, 2006, SPINE, V31, P623, DOI 10.1097/01.brs.0000202807.72292.a8; Burton AK, 2006, EUR SPINE J, V15, pS136, DOI 10.1007/s00586-006-1070-3; Cassidy JD, 2005, SPINE, V30, P2817, DOI 10.1097/01.brs.0000190448.69091.53; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; Dunn KM, 2006, PAIN, V126, P10, DOI 10.1016/j.pain.2006.06.005; Ferrer M, 2006, SPINE, V31, P1372, DOI 10.1097/01.brs.0000218477.53318.bc; Hicks GE, 2005, ARCH PHYS MED REHAB, V86, P1753, DOI 10.1016/j.apmr.2005.03.033; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Laerum E, 2006, J REHABIL MED, V38, P255, DOI 10.1080/16501970600613461; Mannion AF, 2005, EUR SPINE J, V14, P1014, DOI 10.1007/s00586-005-0911-9; Mannion AF, 2001, SPINE, V26, P920, DOI 10.1097/00007632-200104150-00015; Modic MT, 2005, RADIOLOGY, V237, P597, DOI 10.1148/radiol.2372041509; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Walsh TL, 2003, SPINE, V28, P607, DOI 10.1097/00007632-200303150-00017; Watkins E, 2006, MAYO CLIN PROC, V81, P167, DOI 10.4065/81.2.167	20	87	88	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					726	728		10.1016/S0140-6736(07)60340-7	http://dx.doi.org/10.1016/S0140-6736(07)60340-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336636				2022-12-24	WOS:000244726700012
J	Metzl, JM				Metzl, Jonathan M.			If direct-to-consumer advertisements come to Europe: lessons from the USA	LANCET			English	Article; Proceedings Paper	Meeting on Medicalisation in the 21st Century	JUN, 2005	New York, NY				ANTIDEPRESSANTS		Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Womens Studies Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Metzl, JM (corresponding author), Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.	jmetzl@umich.edu			NICHD NIH HHS [K12HD001438] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001438] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aikin K. J., 2003, DIRECT TO CONSUMER A; Alexander-Banys Bambi, 2002, J Pediatr Health Care, V16, P49, DOI 10.1016/S0891-5245(02)96294-2; ANGELL M, 2004, TRUTH DRUG CO THEY D, P83; AUTON F, 2004, INT J ADVER, V23, P1; Hollon MF, 2005, JAMA-J AM MED ASSOC, V293, P2030, DOI 10.1001/jama.293.16.2030; HONE F, 2004, PHARM EXEC, V24, P96; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Metzl JM, 2004, SOC SCI MED, V58, P577, DOI 10.1016/S0277-9536(03)00369-1; Metzl Jonathan, 2003, PROZAC COUCH PRESCRI; Weissman JS, 2003, HEALTH AFFAIR, V22, pW82, DOI 10.1377/hlthaff.w3.82	10	12	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					704	706		10.1016/S0140-6736(07)60321-3	http://dx.doi.org/10.1016/S0140-6736(07)60321-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	141RO	17321319				2022-12-24	WOS:000244596600035
J	Gatfield, D; Schibler, U				Gatfield, David; Schibler, Ueli			Proteasomes keep the circadian clock ticking	SCIENCE			English	Editorial Material							CLONING; LIMB; GENE		Univ Geneva, Dept Biol Mol, CH-1211 Geneva, Switzerland; Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Gatfield, D (corresponding author), Univ Geneva, Dept Biol Mol, CH-1211 Geneva, Switzerland.	david.gatfield@molbio.unige.ch; ueli.schibler@molbio.unige.ch	Gatfield, David/C-2354-2011	Gatfield, David/0000-0001-5114-2824				Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SIEPKA SM, 2007, CELL            0425	10	30	32	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1135	1136		10.1126/science.1144165	http://dx.doi.org/10.1126/science.1144165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17495136				2022-12-24	WOS:000246724300026
J	Peter, ME; Budd, RC; Desbarats, J; Hedrick, SM; Hueber, AO; Newell, MK; Owen, LB; Tschopp, J; Wajant, H; Wallach, D; Wiltrout, RH; Zornig, M; Lynch, DH				Peter, Marcus E.; Budd, Ralph C.; Desbarats, Julie; Hedrick, Stephen M.; Hueber, Anne-Odile; Newell, M. Karen; Owen, Laurie B.; Tschopp, Juerg; Wajant, Harald; Wallach, David; Wiltrout, Robert H.; Zornig, Martin; Lynch, David H.			The CD95 receptor: Apoptosis revisited	CELL			English	Article							HEMATOPOIETIC PROGENITOR CELLS; FAS LIGAND; DEATH; ACTIVATION; PROLIFERATION; CASPASE-8; SIGNALS; INJURY; LEADS; FADD	CD95 is the quintessential death receptor and, when it is bound by ligand, cells undergo apoptosis. Recent evidence suggests, however, that CD95 mediates not only apoptosis but also diverse nonapoptotic functions depending on the tissue and the conditions.	Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; McGill Univ, Dept Physiol, Montreal, PQ, Canada; Univ Calif San Diego, La Jolla, CA 92093 USA; CNRS, UMR 6543, Inst Signaling Dev Biol & Canc Res, F-06189 Nice, France; Univ Colorado, Inst Bioenerget, Colorado Springs, CO 80907 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Univ Wurzburg, Dept Mol Internal Med, Med Clin & Polyclin 2, D-97070 Wurzburg, Germany; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; NCI, Ctr Canc Res, Expt Immunol Lab, Ft Detrick, MD 21702 USA; Bainbridge Biopharma Consulting, Bainbridge Is, WA 98110 USA	University of Chicago; University of Vermont; McGill University; University of California System; University of California San Diego; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Colorado System; University of Colorado at Colorado Springs; University of California System; University of California Riverside; Northwestern University; Feinberg School of Medicine; University of Lausanne; University of Wurzburg; Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peter, ME (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	mpeter@uchicago.edu	Anne-Odile, Hueber/P-9860-2019; Wajant, Harald/A-3020-2017; Hedrick, Stephen M/E-9171-2010; Anne-Odile, Hueber/G-4352-2013	Anne-Odile, Hueber/0000-0003-3816-2446; Wajant, Harald/0000-0002-2005-3949; Anne-Odile, Hueber/0000-0003-3816-2446; Hedrick, Stephen/0000-0002-6345-8751; Peter, Marcus Ernst/0000-0003-3216-036X; Desbarats, Julie/0000-0002-2495-7152; Pope, Richard M./0000-0003-2416-8660	NATIONAL CANCER INSTITUTE [ZIABC009262, ZIABC009322, Z01BC009262, Z01BC009322] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Apostolou I, 2003, J EXP MED, V198, P1103, DOI 10.1084/jem.20030698; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Diehl AM, 2000, IMMUNOL REV, V174, P160, DOI 10.1034/j.1600-0528.2002.017411.x; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Josefsen D, 1999, EXP HEMATOL, V27, P1451, DOI 10.1016/S0301-472X(99)00073-9; Lee JK, 2003, APOPTOSIS, V8, P151, DOI 10.1023/A:1022918625509; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Matsumoto N, 2007, FEBS J, V274, P2376, DOI 10.1111/j.1742-4658.2007.05772.x; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mitsiades CS, 2006, CLIN CANCER RES, V12, P3705, DOI 10.1158/1078-0432.CCR-05-2493; Muschen M, 2000, J MOL MED-JMM, V78, P312, DOI 10.1007/s001090000112; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Pellegrini M, 2005, BLOOD, V106, P1581, DOI 10.1182/blood-2005-01-0284; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Schuchmann M, 2005, WORLD J GASTROENTERO, V11, P7248, DOI 10.3748/wjg.v11.i46.7248; Sun MY, 2006, J IMMUNOL, V177, P1481, DOI 10.4049/jimmunol.177.3.1481; Tamm C, 2004, EUR J NEUROSCI, V19, P2613, DOI 10.1111/j.0953-816X.2004.03391.x; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	31	315	325	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					447	450		10.1016/j.cell.2007.04.031	http://dx.doi.org/10.1016/j.cell.2007.04.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482535	Bronze			2022-12-24	WOS:000246373600007
J	Smogorzewska, A; Matsuoka, S; Vinciguerra, P; McDonald, ER; Hurov, KE; Luo, J; Ballif, BA; Gygi, SP; Hofmann, K; D'Andrea, AD; Elledge, SJ				Smogorzewska, Agata; Matsuoka, Shuhei; Vinciguerra, Patrizia; McDonald, E. Robert, III; Hurov, Kristen E.; Luo, Ji; Ballif, Bryan A.; Gygi, Steven P.; Hofmann, Kay; D'Andrea, Alan D.; Elledge, Stephen J.			Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair	CELL			English	Article							HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; ANEMIA PATHWAY; COMPLEX; CHROMATIN; CANCER; BRCA2; PALB2; PHOSPHORYLATION; EXPRESSION	Fanconi anemia (FA) is a developmental and cancer-predisposition syndrome caused by mutations in genes controlling DNA interstrand crosslink repair. Several FA proteins form a ubiquitin ligase that controls monoubiquitination of the FANCD2 protein in an ATR-dependent manner. Here we describe the FA protein FANCI, identified as an ATM/ATR kinase substrate required for resistance to mitomycin C. FANCI shares sequence similarity with FANCD2, likely evolving from a common ancestral gene. The FANCI protein associates with FANCD2 and, together, as the FANCI-FANCD2 (ID) complex, localize to chromatin in response to DNA damage. Like FANCD2, FANCI is monoubiquitinated and unexpectedly, ubiquitination of each protein is important for the maintenance of ubiquitin on the other, indicating the existence of a dual ubiquitin-locking mechanism required for ID complex function. Mutation in FANCI is responsible for loss of a functional FA pathway in a patient with Fanconi anemia complementation group I.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst,Ctr Genet & Genom,Dept Gen, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA; Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; Miltenyi Biotec GmbH, D-50829 Cologne, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Miltenyi Biotec	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst,Ctr Genet & Genom,Dept Gen, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	高, 雨莉/HGU-8187-2022; Hofmann, Kay/D-6714-2011; Smogorzewska, Agata/B-8891-2011	Hofmann, Kay/0000-0002-2289-9083; Smogorzewska, Agata/0000-0001-6285-1562	NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32CA09216, T32 CA009216] Funding Source: Medline; NHLBI NIH HHS [R37 HL052725] Funding Source: Medline; NIAID NIH HHS [U19 AI067751-01, U19 AI067751-020002, U19 AI067751] Funding Source: Medline; NIGMS NIH HHS [R37 GM044664-18, R37 GM044664, R37 GM044664-19] Funding Source: Medline; PHS HHS [1U19A1067751] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Addison CL, 1997, J GEN VIROL, V78, P1653, DOI 10.1099/0022-1317-78-7-1653; Alter BP, 2003, BLOOD, V101, P2072, DOI 10.1182/blood-2002-11-3597; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gurtan AM, 2006, DNA REPAIR, V5, P1119, DOI 10.1016/j.dnarep.2006.05.009; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; JAKOBS PM, 1996, CELL MOL GENET, V22, P151; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2004, CELL CYCLE, V3, P179; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SCHMID W, 1978, CYTOGENET CELL GENET, V20, P141, DOI 10.1159/000130845; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	38	528	543	1	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					289	301		10.1016/j.cell.2007.03.009	http://dx.doi.org/10.1016/j.cell.2007.03.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17412408	Bronze, Green Accepted			2022-12-24	WOS:000246474600017
J	Zhao, Y; Ransom, JF; Li, A; Vedantham, V; von Drehle, M; Muth, AN; Tsuchihashi, T; McManus, MT; Schwartz, RJ; Srivastava, D				Zhao, Yong; Ransom, Joshua F.; Li, Ankang; Vedantham, Vasanth; von Drehle, Morgan; Muth, Alecia N.; Tsuchihashi, Takatoshi; McManus, Michael T.; Schwartz, Robert J.; Srivastava, Deepak			Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2	CELL			English	Article							BHLH TRANSCRIPTION FACTOR; MUSCLE-SPECIFIC MICRORNA; C-ELEGANS; CARDIOVASCULAR DEVELOPMENT; CAENORHABDITIS-ELEGANS; HEART-DISEASE; DIFFERENTIATION; MORPHOGENESIS; RNA; HYPERTROPHY	MicroRNAs (miRNAs) are genomically encoded small RNAs used by organisms to regulate the expression of proteins generated from messenger RNA transcripts. The in vivo requirement of specific miRNAs in mammals through targeted deletion remains unknown, and reliable prediction of mRNA targets is still problematic. Here, we show that miRNA biogenesis in the mouse heart is essential for cardiogenesis. Furthermore, targeted deletion of the muscle-specific miRNA, miR-1-2, revealed numerous functions in the heart, including regulation of cardiac morphogenesis, electrical conduction, and cellcycle control. Analyses of miR-1 complementary sequences in mRNAs upregulated upon miR-1-2 deletion revealed an enrichment of miR-1 '' seed matches '' and a strong tendency for potential miR-1 binding sites to be located in physically accessible regions. These findings indicate that subtle alteration of miRNA dosage can have profound consequences in mammals and demonstrate the utility of mammalian lossof-function models in revealing physiologic miRNA targets.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pediat Cardiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Internal Med Cardiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Cardiovasc Sci, Houston, TX 77030 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Vedantham, Vasanth/0000-0003-1032-700X; Ransom, Joshua/0000-0002-3591-0288	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR018928] Funding Source: Medline; NHLBI NIH HHS [T32HL007731] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng CF, 2003, TRENDS MOL MED, V9, P59, DOI 10.1016/S1471-4914(03)00004-2; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Desai AD, 2006, AM J MED, V119, P600, DOI 10.1016/j.amjmed.2005.08.028; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Gourdie RG, 1999, TRENDS CARDIOVAS MED, V9, P18, DOI 10.1016/S1050-1738(98)00035-8; HAFE BD, 2005, P NATL ACAD SCI USA, V102, P10898; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mendez-Ferrer S, 2006, NAT CLIN PRACT CARD, V3, pS8; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; RAO PK, 2006, IN PRESS P NATL ACAD; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; ZHAO Y, 2007, IN PRESS TRENDS BIOC; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	69	1069	1182	1	82	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					303	317		10.1016/j.cell.2007.03.030	http://dx.doi.org/10.1016/j.cell.2007.03.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17397913	Bronze			2022-12-24	WOS:000246474600018
J	Rodriguez, RA; Sen, S; Mehta, K; Moody-Ayers, S; Bacchetti, P; O'Hare, AM				Rodriguez, Rudolph A.; Sen, Saunak; Mehta, Kala; Moody-Ayers, Sandra; Bacchetti, Peter; O'Hare, Ann M.			Geography matters: Relationships among urban residential segregation, dialysis facilities, and patient outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; PAY-FOR-PERFORMANCE; HEMODIALYSIS-PATIENTS; REPLACEMENT THERAPY; RACIAL DISPARITIES; SURVIVAL ANALYSIS; HEALTH-CARE; TRANSPLANTATION; MORTALITY; QUALITY	Background: End-stage renal disease disproportionately affects black Americans. However, the impact of residential segregation by race-a prominent feature of many U.S. cities-on outcomes of patients receiving dialysis and on facility performance has not been evaluated. Objective: To examine the relationship among racial composition of ZIP codes in metropolitan areas, outcomes of patients receiving dialysis, and characteristics of dialysis facilities. Design: Retrospective cohort study of patients receiving dialysis and cross-sectional study of dialysis facilities. Setting: U.S. metropolitan ZIP codes with differing percentages of black residents. Patients: Black and non-Hispanic white patients who initiated long-term dialysis between 1 January 1995 and 31 December 2002 (n = 399 424) and dialysis facilities in operation in December 2004 (n = 3244). Measurements: Mortality and time to transplantation among patients receiving dialysis, and performance of dialysis facilities on the basis of quality indicators (anemia management, dialysis adequacy, and facility-level mortality rates). Results: Most black patients (50.3%) but few white patients (5%) lived in the 3% (n = 769) of ZIP codes in which most residents were black. in analyses adjusted for patient and ZIP code characteristics, mortality rates were higher among white patients but not among black patients living in areas with a higher percentage of black residents (adjusted hazard ratio for ZIP codes with 75% black residents vs. < 10% black residents, 1.14 [95% Cl, 1.07 to 1.21] for white patients and 1.02 [Cl, 0.99 to 1.06] for black patients). Time to transplantation was longer among both black and white patients (adjusted hazard ratio for ZIP codes with >= 75% black residents vs. < 10% black residents, 0.84 [Cl, 0.78 to 0.92] and 0.63 [Cl, 0.57 to 0.71] for black patients and white patients, respectively). Dialysis facilities located in areas with a higher percentage of black residents were more likely to have higher-than-expected mortality rates and were less likely to meet performance targets. Limitations: Patient-level analyses were restricted to black and non-Hispanic white patients. Patient-level and facility-level analyses focused only on the percentage of black residents in each ZIP code. Conclusions: The racial composition of urban residential areas is associated with time to transplantation and dialysis facility performance on standard quality measures. Closer scrutiny of care provided to patients receiving dialysis who live in predominantly black residential areas and to dialysis facilities operating in these areas may be warranted.	Univ Calif San Francisco, San Francisco Gen Hosp, Vet Affairs Med Ctr, San Francisco, CA 94110 USA; Vet Affairs San Francisco Res Enhancement Award P, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Rodriguez, RA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Vet Affairs Med Ctr, Renal Ctr Bldg 100,Room 350,Box 1341, San Francisco, CA 94110 USA.	rrodriguez@medsfgh.ucsf.edu			NIA NIH HHS [K23 AG 028980-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG028980] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; Alexander GC, 2002, AM J KIDNEY DIS, V40, P824, DOI 10.1053/ajkd.2002.35695; [Anonymous], 2004, DIABETES EDUCATOR, V30, P196, DOI 10.1177/014572170403000209; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Bleyer AJ, 1996, AM J KIDNEY DIS, V28, P72, DOI 10.1016/S0272-6386(96)90133-X; BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231; Brown WW, 2003, KIDNEY INT S, V83, pS50; COWIE CC, 1994, DIABETES CARE, V17, P681, DOI 10.2337/diacare.17.7.681; *CTR MED MED SERV, 2003, NEPHROL DIAL TRANSPL, V18, P147; EGGERS PW, 1990, AM J KIDNEY DIS, V15, P414, DOI 10.1016/S0272-6386(12)70359-1; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; Epstein AM, 2004, NEW ENGL J MED, V351, P603, DOI 10.1056/NEJMe048181; Fang L, 2003, AM J MED, V115, P448, DOI 10.1016/S0002-9343(03)00446-7; Ford B.L., 1983, INCOMPLETE DATA SAMP, P185; Frankenfield DL, 1999, AM J KIDNEY DIS, V34, P721, DOI 10.1016/S0272-6386(99)70399-9; Frederick PR, 2002, HEALTH CARE FINANC R, V23, P37; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; HELD PJ, 1987, JAMA-J AM MED ASSOC, V257, P645, DOI 10.1001/jama.257.5.645; Himmelfarb J, 2004, J AM SOC NEPHROL, V15, P3263, DOI 10.1097/01.ASN.0000145893.61791.7B; Hirth RA, 1996, JAMA-J AM MED ASSOC, V276, P1303; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Longenecker JC, 2000, J AM SOC NEPHROL, V11, P520, DOI 10.1681/ASN.V113520; McGill JB, 2004, DIABETES ED, V30, P200; McGill JB, 2004, DIABETES ED, V30, P206; *MED PAYM ADV COMM, 2006, REP C MED PAYM POL; Milgate K, 2006, HEALTH AFFAIR, V25, P413, DOI 10.1377/hlthaff.25.2.413; *NAT ESRD CPM WORK, 2002, J AM SOC NEPHROL, V13, P2117; O'Riordan E, 2003, QJM-INT J MED, V96, P739, DOI 10.1093/qjmed/hcg127; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; Pei YPC, 2000, KIDNEY INT, V58, P1293, DOI 10.1046/j.1523-1755.2000.00285.x; Powe NR, 2003, KIDNEY INT, V64, P763, DOI 10.1046/j.1523-1755.2003.00138.x; PUGH JA, 1994, AM J KIDNEY DIS, V23, P803; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sehgal AR, 2000, AM J KIDNEY DIS, V35, pS148, DOI 10.1016/S0272-6386(00)70242-3; Sehgal AR, 2003, JAMA-J AM MED ASSOC, V289, P996, DOI 10.1001/jama.289.8.996; Stack AG, 2002, J AM SOC NEPHROL, V13, P1279, DOI 10.1681/ASN.V1351279; Tanna MM, 2000, AM J KIDNEY DIS, V36, P1175, DOI 10.1053/ajkd.2000.19832; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; WHITEIS DG, 1992, PUBLIC HEALTH REP, V107, P409; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7	47	146	151	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					493	501		10.7326/0003-4819-146-7-200704030-00005	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153VB	17404351				2022-12-24	WOS:000245463200003
J	Stobbart, L; Murtagh, MJ; Rapley, T; Ford, GA; Louw, SJ; Rodgers, H				Stobbart, L.; Murtagh, M. J.; Rapley, T.; Ford, G. A.; Louw, S. J.; Rodgers, H.			"We saw human guinea pigs explode"	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Dept Hlth Res Capac Dev, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Royal Victoria Infirm, Stroke Res Grp, Inst Ageing & Hlth, Clin Res Facil, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Freeman Rd Hosp, Newcastle upon Tyne Hosp NHS Fdn Trust, Dept Hen Internal Med, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Murtagh, MJ (corresponding author), Univ Newcastle, Dept Hlth Res Capac Dev, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	m.j.murtagh@newcastle.ac.uk	Ford, Gary/AAY-6405-2020; Ford, Gary A/A-6353-2012	Ford, Gary/0000-0001-8719-4968; 	Department of Health [RDA/01/05/091] Funding Source: Medline	Department of Health			0	7	8	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 17	2007	334	7593					566	567		10.1136/bmj.39150.488264.47	http://dx.doi.org/10.1136/bmj.39150.488264.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AP	17363826	Green Published			2022-12-24	WOS:000245404400031
J	Garner, EC; Campbell, CS; Weibel, DB; Mullins, RD				Garner, Ethan C.; Campbell, Christopher S.; Weibel, Douglas B.; Mullins, R. Dyche			Reconstitution of DNA segregation driven by assembly of a prokaryotic actin homolog	SCIENCE			English	Article							DYNAMIC INSTABILITY; PLASMID; MREB	Multiple unrelated polymer systems have evolved to partition DNA molecules between daughter cells at division. To better understand polymer-driven DNA segregation, we reconstituted the three-component segregation system of the R1 plasmid from purified components. We found that the ParR/parC complex can construct a simple bipolar spindle by binding the ends of ParM filaments, inhibiting dynamic instability, and acting as a ratchet permitting incorporation of new monomers and riding on the elongating filament ends. Under steady-state conditions, the dynamic instability of unattached ParM filaments provides the energy required to drive DNA segregation.	Univ Calif San Francisco, UCB Nanomed Dev Ctr, San Francisco, CA 94158 USA; Marine Biol Lab, Physiol Course, Woods Hole, MA 02543 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of California System; University of California San Francisco; Marine Biological Laboratory - Woods Hole; University of Wisconsin System; University of Wisconsin Madison	Mullins, RD (corresponding author), Univ Calif San Francisco, UCB Nanomed Dev Ctr, San Francisco, CA 94158 USA.	dyche@mullinslab.ucsf.edu	Garner, Ethan/J-4025-2014	Garner, Ethan/0000-0003-0141-3555; Campbell, Christopher/0000-0002-3927-344X	NIGMS NIH HHS [R01GM61010, R01 GM061010-07, R01 GM061010, R01GM675287] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061010] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; INOUE S, 1967, J GEN PHYSIOL, V50, P259, DOI 10.1085/jgp.50.6.259; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Theriot JA, 2000, TRAFFIC, V1, P19, DOI 10.1034/j.1600-0854.2000.010104.x; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5	15	169	172	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1270	1274		10.1126/science.1138527	http://dx.doi.org/10.1126/science.1138527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332412	Green Accepted			2022-12-24	WOS:000244564700048
J	Burns, B; Watkins, L; Goadsby, PJ				Burns, Brian; Watkins, Laurence; Goadsby, Peter J.			Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients	LANCET			English	Article							PERIPHERAL NEUROSTIMULATION; HYPOTHALAMIC-STIMULATION; SURGICAL-TREATMENT; INJECTION; EFFICACY; ACTIVATION; MANAGEMENT; NEURALGIA; BLOCKADE; SECTION	Background Cluster headache is a form of primary headache that features repeated attacks of excruciatingly severe headache usually occurring several times a day. Patients with chronic cluster headache have unremitting illness that necessitates daily preventive medical treatment for years. When medically intractable, the condition has previously been treatable only with cranially invasive or neurally destructive methods. Methods Eight patients with medically intractable chronic cluster headache were implanted in the suboccipital region with electrodes for occipital nerve stimulation. Other than the first patient, who was initially stimulated unilaterally before being stimulated bilaterally, all patients were stimulated bilaterally during treatment. Findings At a median follow-up of 20 months (range 6-27 months for bilateral stimulation), six of eight patients reported responses that were sufficiently meaningful for them to recommend the treatment to similarly affected patients with chronic cluster headache. Two patients noticed a substantial improvement (90% and 95%) in their attacks; three patients noticed a moderate improvement (40%, 60%, and 20-80%) and one reported mild improvement (25%). Improvements occurred in both frequency and severity of attacks. These changes took place over weeks or months, although attacks returned in days when the device malfunctioned (eg, with battery depletion). Adverse events of concern were lead migrations in one patient and battery depletion requiring replacement in four. Interpretation Occipital nerve stimulation in cluster headache seems to offer a safe, effective treatment option that could begin a new era of neurostimulation therapy for primary headache syndromes.	UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Div Neurosurg, London WC1N 3BG, England; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of California System; University of California San Francisco	Goadsby, PJ (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, London WC1N 3BG, England.	peterg@ion.ucl.ac.uk	Goadsby, Peter J/B-2267-2009; Goadsby, Peter J/Z-1970-2019; Watkins, Laurence/AAH-6973-2021	Goadsby, Peter J/0000-0003-3260-5904; Watkins, Laurence/0000-0003-0678-3774				Afridi SK, 2006, PAIN, V122, P126, DOI 10.1016/j.pain.2006.01.016; Ambrosini A, 2005, PAIN, V118, P92, DOI 10.1016/j.pain.2005.07.015; Anthony m, 1985, MIGRAINE CLIN RES AD, P169; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bartsch T, 2002, BRAIN, V125, P1496, DOI 10.1093/brain/awf166; Bartsch T, 2003, BRAIN, V126, P1801, DOI 10.1093/brain/awg190; Bartsch T, 2005, HEADACHE CURRENTS, V2, P42, DOI DOI 10.1111/J.1743-5013.2005.20201.X; Dodick D, 2003, CEPHALALGIA, V23, P701; Donnet A, 2005, J NEUROL NEUROSUR PS, V76, P218, DOI 10.1136/jnnp.2004.041202; EKBOM K, 1987, CEPHALALGIA, V7, P21, DOI 10.1046/j.1468-2982.1987.0701021.x; Felisati G, 2006, LARYNGOSCOPE, V116, P1447, DOI 10.1097/01.mlg.0000227997.48020.44; Franzini A, 2003, NEUROSURGERY, V52, P1095, DOI 10.1227/01.NEU.0000057698.29634.D6; Goadsby PJ, 2006, CEPHALALGIA, V26, P1168, DOI 10.1111/j.1468-2982.2006.01173.x; Goadsby PJ, 2002, LANCET NEUROL, V1, P251, DOI 10.1016/S1474-4422(02)00104-7; Green MW, 2003, HEADACHE, V43, P479, DOI 10.1046/j.1526-4610.2003.03093.x; Jarrar RG, 2003, NEUROLOGY, V60, P1360, DOI 10.1212/01.WNL.0000055902.23139.16; Johnstone CSH, 2006, NEUROMODULATION, V9, P41, DOI 10.1111/j.1525-1403.2006.00041.x; Kapural L, 2005, ANESTH ANALG, V101, P171, DOI 10.1213/01.ANE.0000156207.73396.8E; KIRKPATRICK PJ, 1993, BRIT J NEUROSURG, V7, P483, DOI 10.3109/02688699308995070; Lance JW, 2005, MECH MANAGEMENT HEAD; Leone M, 2004, CEPHALALGIA, V24, P934, DOI 10.1111/j.1468-2982.2004.00742.x; Leone M, 2006, NEUROLOGY, V67, P150, DOI 10.1212/01.wnl.0000223319.56699.8a; Lovely TJ, 1998, HEADACHE, V38, P590, DOI 10.1046/j.1526-4610.1998.3808590.x; Magis D, 2006, CEPHALALGIA, V26, P1398; Magis D, 2005, CEPHALALGIA, V25, P1197; Matharu Manjit S, 2004, Expert Rev Neurother, V4, P895, DOI 10.1586/14737175.4.5.895; Matharu MS, 2006, ANN NEUROL, V59, P535, DOI 10.1002/ana.20763; Matharu MS, 2004, BRAIN, V127, P220, DOI 10.1093/brain/awh022; Matharu MS, 2003, DRUGS, V63, P1637, DOI 10.2165/00003495-200363160-00002; Matharu MS, 2002, BRAIN, V125, P976, DOI 10.1093/brain/awf118; MATHEW NT, 1988, HEADACHE, V28, P328, DOI 10.1111/j.1526-4610.1988.hed2805328.x; May A, 2005, LANCET, V366, P843, DOI 10.1016/S0140-6736(05)67217-0; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; MORGENLANDER JC, 1990, J NEUROSURG, V72, P866, DOI 10.3171/jns.1990.72.6.0866; Peres MFP, 2002, CEPHALALGIA, V22, P520, DOI 10.1046/j.1468-2982.2002.00410.x; Piovesan EJ, 2001, CEPHALALGIA, V21, P107, DOI 10.1046/j.1468-2982.2001.00166.x; Popeney CA, 2003, HEADACHE, V43, P369, DOI 10.1046/j.1526-4610.2003.03072.x; Remahl AIMN, 2003, CEPHALALGIA, V23, P504, DOI 10.1046/j.1468-2982.2003.00531.x; ROWED DW, 1990, HEADACHE, V30, P401, DOI 10.1111/j.1526-4610.1990.hed3007401.x; Sanders M, 1997, J NEUROSURG, V87, P876, DOI 10.3171/jns.1997.87.6.0876; Schoenen J, 2005, BRAIN, V128, P940, DOI 10.1093/brain/awh411; Schwedt TJ, 2006, CEPHALALGIA, V26, P1025, DOI 10.1111/j.1468-2982.2006.01142.x; Shields KG, 2004, NEUROLOGY, V63, P2193, DOI 10.1212/01.WNL.0000145832.26051.3C; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sjaastad O, 2003, CEPHALALGIA, V23, P528, DOI 10.1046/j.1468-2982.2003.00585.x; Slavin KV, 2006, NEUROSURGERY, V58, P112, DOI 10.1227/01.NEU.0000192163.55428.62; SOLOMON S, 1986, ARCH NEUROL-CHICAGO, V43, P479, DOI 10.1001/archneur.1986.00520050055022; Stojanovic M P, 2001, Curr Pain Headache Rep, V5, P130, DOI 10.1007/s11916-001-0081-3; SWEET WH, 1988, HEADACHE, V28, P669, DOI 10.1111/j.1526-4610.1988.hed2810669.x; Weiner RL, 2006, PAIN MED, V7, pS137, DOI 10.1111/j.1526-4637.2006.00129.x; Weiner RL, 1999, NEUROMODULATION, V2, P217, DOI 10.1046/j.1525-1403.1999.00217.x	52	222	231	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1099	1106		10.1016/S0140-6736(07)60328-6	http://dx.doi.org/10.1016/S0140-6736(07)60328-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398309				2022-12-24	WOS:000245323700030
J	Rainey, PB				Rainey, Paul B.			Unity from conflict	NATURE			English	Editorial Material									Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland	Rainey, PB (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1, New Zealand.		Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795				Michod Richard E., 1999, DARWINIAN DYNAMICS E; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Szathmary E, 1995, MAJOR TRANSITIONS EV	4	29	31	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					616	616		10.1038/446616a	http://dx.doi.org/10.1038/446616a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410161	Bronze			2022-12-24	WOS:000245438300022
J	Smith, GCS; Fleming, KM; White, IR				Smith, Gordon C. S.; Fleming, Kate M.; White, Ian R.			Birth order of twins and risk of perinatal death related to delivery in England, Northern Ireland, and Wales, 1994-2003: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							2ND TWIN; MORBIDITY; MORTALITY; MODE; OUTCOMES; WEIGHT; FETAL; TERM	Objective To determine the effect of birth order on the risk of perinatal death in twin pregnancies. Design Retrospective cohort study. Setting England, Northern Ireland, and Wales, 1994-2003. Participants 1377 twin pregnancies with one intrapartum stillbirth or neonatal death from causes other than congenital abnormality and one surviving infant. Main outcome measures The risk of perinatal death in the first and second twin estimated with conditional logistic regression. Results There was no association between birth order and, the risk of death overall (odds ratio 1.0, 95% confidence interval 0.9 to 1.1). However, there was a highly significant interaction with gestational age (P < 0.001). There was no association between birth order and the risk of death among infants born before 36 weeks' gestation but there was an increased risk of death among second twins born at term (2.3, 1.7 to 3.2, P < 0.001), which was stronger for deaths caused by intrapartum anoxia or trauma (3.4, 2.2 to 5.3). Among term births, there was a trend (P=0.1) towards a greater risk of the second twin dying from anoxia among those delivered vaginally (4.1, 1.8 to 9.5) compared with those delivered by caesarean section (1.8, 0.9 to 3.6). Conclusions In this cohort, compared with first twins, second twins born at term were at increased risk of perinatal death related to delivery. Vaginally delivered second twins had a fourfold risk of death caused by intrapartum anoxia.	Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2QQ, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England	University of Cambridge; MRC Biostatistics Unit; University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Box223, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Fleming, Kate M/A-6475-2010; Smith, Gordon/A-8070-2008	Fleming, Kate M/0000-0002-6572-5016; Smith, Gordon/0000-0003-2124-0997; White, Ian/0000-0002-6718-7661	Medical Research Council [MC_U105260558] Funding Source: Medline; MRC [MC_U105260558] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Armson BA, 2006, OBSTET GYNECOL, V108, P556, DOI 10.1097/01.AOG.0000227747.37184.0a; Cahill AG, 2006, AM J OBSTET GYNECOL, V194, P909, DOI 10.1016/j.ajog.2006.02.031; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Hartley RS, 2005, J MATERN-FETAL NEO M, V17, P375, DOI 10.1080/147670505000132484; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; Lydon-Rochelle MT, 2005, AM J PUBLIC HEALTH, V95, P1948, DOI 10.2105/AJPH.2004.044305; Sheay W, 2004, OBSTET GYNECOL, V103, P63, DOI 10.1097/01.AOG.0000101291.14773.F0; Smith GCS, 2005, BJOG-INT J OBSTET GY, V112, P1139, DOI 10.1111/j.1471-0528.2005.00631.x; Smith GCS, 2005, AM J OBSTET GYNECOL, V192, P17, DOI 10.1016/j.ajog.2004.08.014; Smith GCS, 2002, BRIT MED J, V325, P1004, DOI 10.1136/bmj.325.7371.1004; Thorngren-Jerneck K, 2001, OBSTET GYNECOL, V98, P65, DOI 10.1016/S0029-7844(01)01370-9; Yang Q, 2006, J PERINATOL, V26, P3, DOI 10.1038/sj.jp.7211408; Yang QY, 2006, AM J PERINAT, V23, P381, DOI 10.1055/s-2006-951286; Yang QY, 2005, AM J OBSTET GYNECOL, V192, P840, DOI 10.1016/j.ajog.2004.09.132	14	85	89	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2007	334	7593					576	578A		10.1136/bmj.39118.483819.55	http://dx.doi.org/10.1136/bmj.39118.483819.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AP	17337456	Green Published, Bronze			2022-12-24	WOS:000245404400036
J	Tang, RH; Han, SC; Zheng, HL; Cook, CW; Choi, CS; Woerner, TE; Jackson, RB; Pei, ZM				Tang, Ru-Hang; Han, Shengcheng; Zheng, Hailei; Cook, Charles W.; Choi, Christopher S.; Woerner, Todd E.; Jackson, Robert B.; Pei, Zhen-Ming			Coupling diurnal cytosolic Ca2+ oscillations to the CAS-IP3 pathway in Arabidopsis	SCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; CALCIUM; DYNAMICS; PHYSIOLOGY	Various signaling pathways rely on changes in cytosolic calcium ion concentration ([Ca2+](i)). In plants, resting [Ca2+](i) oscillates diurnally. We show that in Arabidopsis thaliana, [Ca2+](i) oscillations are synchronized to extracellular Ca2+ concentration ([Ca2+](o)) oscillations largely through the Ca2+- sensing receptor CAS. CAS regulates concentrations of inositol 1,4,5- trisphosphate (IP3), which in turn directs release of Ca2+ from internal stores. The oscillating amplitudes of [Ca2+](o) and [Ca2+](i) are controlled by soil Ca2+ concentrations and transpiration rates. The phase and period of oscillations are likely determined by stomatal conductance. Thus, the internal concentration of Ca2+ in plant cells is constantly being actively revised.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Xiamen Univ, Dept Biol, Xiamen 361005, Fujian, Peoples R China; Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Fujian, Peoples R China; Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Xiamen University; Xiamen University; Duke University	Pei, ZM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	zpei@duke.edu	Zheng, Hai-Lei/G-3432-2010	Zheng, Hai-Lei/0000-0001-8588-1529; Jackson, Robert/0000-0001-8846-7147; Han, Shengcheng/0000-0002-4039-7589; Tang, Ruhang/0000-0003-4918-3525; Pei, Zhen-Ming/0000-0003-1473-696X				Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; Dodd AN, 2005, TRENDS PLANT SCI, V10, P15, DOI 10.1016/j.tplants.2004.12.001; Gao DJ, 2004, PLANT PHYSIOL, V134, P898, DOI 10.1104/pp.103.032508; Han SC, 2003, NATURE, V425, P196, DOI 10.1038/nature01932; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; McLaughlin SB, 1999, NEW PHYTOL, V142, P373, DOI 10.1046/j.1469-8137.1999.00420.x; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Mueller-Roeber B, 2002, PLANT PHYSIOL, V130, P22, DOI 10.1104/pp.004770; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Webb AAR, 2003, NEW PHYTOL, V160, P281, DOI 10.1046/j.1469-8137.2003.00895.x; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164	26	120	137	5	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1423	1426		10.1126/science.1134457	http://dx.doi.org/10.1126/science.1134457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347443				2022-12-24	WOS:000244752200037
J	Torres-Rosell, J; De Piccoli, G; Cordon-Preciado, V; Farmer, S; Jamuz, A; Machin, F; Pasero, P; Lisby, M; Haber, JE; Aragon, L				Torres-Rosell, Jordi; De Piccoli, Giacomo; Cordon-Preciado, Violeta; Farmer, Sarah; Jamuz, Adam; Machin, Felix; Pasero, Philippe; Lisby, Michael; Haber, James E.; Aragon, Luis			Anaphase onset before complete DNA replication with intact checkpoint responses	SCIENCE			English	Article							COMMON FRAGILE SITE; S-PHASE; BUDDING YEAST; ACTIVATION; ORIGINS; DAMAGE; GENES	Cellular checkpoints prevent mitosis in the presence of stalled replication forks. Whether checkpoints also ensure the completion of DNA replication before mitosis is unknown. Here, we show that in yeast smc5-smc6 mutants, which are related to cohesin and condensin, replication is delayed, most significantly at natural replication-impeding loci like the ribosomal DNA gene cluster. In the absence of Smc5-Smc6, chromosome nondisjunction occurs as a consequence of mitotic entry with unfinished replication despite intact checkpoint responses. Eliminating processes that obstruct replication fork progression restores the temporal uncoupling between replication and segregation in smc5-smc6 mutants. We propose that the completion of replication is not under the surveillance of known checkpoints.	Imperial Coll London, Fac Med, Ctr Clin Sci, MRC,Cell Cycle Grp, London W12 0NN, England; Inst Human Genet, CNRS, Unite Propre Rech 1142, F-34396 Montpellier, France; Univ Copenhagen, Inst Mol Biol & Physiol, Dept Genet, DK-1353 Copenhagen, Denmark; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA	Imperial College London; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Copenhagen; Brandeis University	Aragon, L (corresponding author), Imperial Coll London, Fac Med, Ctr Clin Sci, MRC,Cell Cycle Grp, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	luis.aragon@csc.mrc.ac.uk	Pasero, Philippe/O-2340-2018; Machín, Félix/K-6569-2017; Torres-Rosell, Jordi/A-4213-2010; Lisby, Michael/K-9814-2014	Pasero, Philippe/0000-0001-5891-0822; Machín, Félix/0000-0003-4559-7798; Torres-Rosell, Jordi/0000-0003-1308-6926; Lisby, Michael/0000-0002-4830-5247; Haber, James/0000-0002-1878-0610	MRC [MC_U120074328] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061766, R01GM020056, R37GM020056] Funding Source: NIH RePORTER; Medical Research Council [MC_U120074328] Funding Source: Medline; NIGMS NIH HHS [R01 GM061766, GM 20056, R01 GM061766-08, R01 GM061766-07] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; LINSKENS MHK, 1988, MOL CELL BIOL, V8, P4927, DOI 10.1128/MCB.8.11.4927; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; Palakodeti A, 2004, GENE CHROMOSOME CANC, V39, P71, DOI 10.1002/gcc.10290; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	21	103	105	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1411	1415		10.1126/science.1134025	http://dx.doi.org/10.1126/science.1134025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347440				2022-12-24	WOS:000244752200034
J	Bach, PB; Jett, JR; Pastorino, U; Tockman, MS; Swensen, SJ; Begg, CB				Bach, Peter B.; Jett, James R.; Pastorino, Ugo; Tockman, Melvyn S.; Swensen, Stephen J.; Begg, Colin B.			Computed tomography screening and lung cancer outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; MORTALITY; CT; NODULES; OVERDIAGNOSIS; COLONOSCOPY; CARCINOMA; RESECTION; SURVIVAL; PROJECT	Context Current and former smokers are currently being screened for lung cancer with computed tomography (CT), although there are limited data on the effect screening has on lung cancer outcomes. Randomized controlled trials assessing CT screening are currently under way. Objective To assess whether screening may increase the frequency of lung cancer diagnosis and lung cancer resection or may reduce the risk of a diagnosis of advanced lung cancer or death from lung cancer. Design, Setting, and Participants Longitudinal analysis of 3246 asymptomatic current or former smokers screened for lung cancer beginning in 1998 either at 1 of 2 academic medical centers in the United States or an academic medical center in Italy with follow-up for a median of 3.9 years. Intervention Annual CT scans with comprehensive evaluation and treatment of detected nodules. Main Outcome Measures Comparison of predicted with observed number of new lung cancer cases, lung cancer resections, advanced lung cancer cases, and deaths from lung cancer. Results There were 144 individuals diagnosed with lung cancer compared with 44.5 expected cases ( relative risk [RR], 3.2; 95% confidence interval [CI], 2.7-3.8; P <. 001). There were 109 individuals who had a lung resection compared with 10.9 expected cases ( RR, 10.0; 95% CI, 8.2-11.9; P <. 001). There was no evidence of a decline in the number of diagnoses of advanced lung cancers ( 42 individuals compared with 33.4 expected cases) or deaths from lung cancer ( 38 deaths due to lung cancer observed and 38.8 expected; RR, 1.0; 95% CI, 0.7- 1.3; P=. 90). Conclusions Screening for lung cancer with low-dose CT may increase the rate of lung cancer diagnosis and treatment, but may not meaningfully reduce the risk of advanced lung cancer or death from lung cancer. Until more conclusive data are available, asymptomatic individuals should not be screened outside of clinical research studies that have a reasonable likelihood of further clarifying the potential benefits and risks.	Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Mayo Clin, Dept Radiol, Rochester, MN USA; Mayo Clin, Div Pulm Med & Oncol, Rochester, MN USA; Ist Tumori, Div Thorac Surg, Milan, Italy; H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Prevent & Control, Tampa, FL USA	Memorial Sloan Kettering Cancer Center; Mayo Clinic; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Box 221, New York, NY 10021 USA.		Peng, Bo/A-6920-2009; Pastorino, Ugo/C-2712-2017	Peng, Bo/0000-0001-8225-2284; Pastorino, Ugo/0000-0001-9974-7902	NCI NIH HHS [R01CA79935, UO1CA94973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA094973, R01CA079935] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach PB, 2004, CHEST, V126, P1742, DOI 10.1378/chest.126.6.1742; Bach PB, 2003, CHEST, V123, p72S, DOI 10.1378/chest.123.1_suppl.72S; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; BACH PB, 2005, CHEST           0318; BACH PB, 2000, J NATL CANCER I, V95, P470; Cronin KA, 2006, JNCI-J NATL CANCER I, V98, P637, DOI 10.1093/jnci/djj163; Dammas S, 2001, LUNG CANCER, V33, P11, DOI 10.1016/S0169-5002(01)00190-8; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; Gibson L, 1997, J Med Screen, V4, P44; GOLDBERG KB, 2002, NCI LUNG CANC SCREEN; HAKAMA M, 1985, BRIT J CANCER, V52, P669, DOI 10.1038/bjc.1985.241; Harpole DH, 1999, J THORAC CARDIOV SUR, V117, P969, DOI 10.1016/S0022-5223(99)70378-8; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.2311030634; Henschke CI, 2001, ONCOLOGIST, V6, P147, DOI 10.1634/theoncologist.6-2-147; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; KJELLGREN O, 1986, GYNECOL OBSTET INVES, V22, P57, DOI 10.1159/000298892; KUBIK A, 1986, CANCER-AM CANCER SOC, V57, P2427, DOI 10.1002/1097-0142(19860615)57:12<2427::AID-CNCR2820571230>3.0.CO;2-M; Kubik AK, 2000, CANCER, V89, P2363, DOI 10.1002/1097-0142(20001201)89:11+<2363::AID-CNCR9>3.0.CO;2-W; LANGE P, 1990, THORAX, V45, P579, DOI 10.1136/thx.45.8.579; Lee TH, 2002, NEW ENGL J MED, V346, P529, DOI 10.1056/NEJM200202143460715; LEVIN ML, 1982, RECENT RES CANCER, V82, P138; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lindell RM, 2007, RADIOLOGY, V242, P555, DOI 10.1148/radiol.2422052090; Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; Melamed MR, 2000, CANCER, V89, P2356, DOI 10.1002/1097-0142(20001201)89:11+<2356::AID-CNCR8>3.3.CO;2-Q; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Pinsky PF, 2005, CANCER-AM CANCER SOC, V103, P157, DOI 10.1002/cncr.20746; Schilling FH, 2002, NEW ENGL J MED, V346, P1047, DOI 10.1056/NEJMoa012277; Silvestri GA, 1998, CHEST, V114, P675, DOI 10.1378/chest.114.3.675; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Stephan F, 2000, CHEST, V118, P1263, DOI 10.1378/chest.118.5.1263; STITIK FP, 1978, RADIOL CLIN N AM, V16, P347; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; TOCKMAN MS, 2003, 10 INT C LUNG CANC A; *WHO, 2002, NUMB RAT REG DEATHS, V92, P1280; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Yankelevitz DF, 2003, CANCER, V97, P1271, DOI 10.1002/cncr.11185; Zhukov TA, 2003, LUNG CANCER, V40, P267, DOI 10.1016/S0169-5002(03)00082-5; FOCUS LUNG CANC SCRE	46	428	447	2	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 7	2007	297	9					953	961		10.1001/jama.297.9.953	http://dx.doi.org/10.1001/jama.297.9.953			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143CP	17341709				2022-12-24	WOS:000244697900024
J	Shea, K				Shea, Katriona			How the wood moves	SCIENCE			English	Editorial Material							DISPERSAL		Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Penn State Univ, Intercoll Grad Degree Program Ecol, Mueller Lab 208, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Shea, K (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	k-shea@psu.edu	Shea, Katriona/B-7954-2008	Shea, Katriona/0000-0002-7607-8248				Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; SHAKESPEARE W, 1969, MACBETH; Sugden A, 2006, SCIENCE, V313, P775, DOI 10.1126/science.313.5788.775; Tolkien J.R.R., 1966, 2 TOWERS BEING 2 PAR, V2nd; Wyndham J., 1951, DOUBLEDAY	8	12	13	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1231	1232		10.1126/science.1136096	http://dx.doi.org/10.1126/science.1136096			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332401				2022-12-24	WOS:000244564700036
J	Fox, GC; Shafiq, M; Briggs, DC; Knowles, PP; Collister, M; Didmon, MJ; Makrantoni, V; Dickinson, RJ; Hanrahan, S; Totty, N; Stark, MJR; Keyse, SM; McDonald, NQ				Fox, G. C.; Shafiq, M.; Briggs, D. C.; Knowles, P. P.; Collister, M.; Didmon, M. J.; Makrantoni, V.; Dickinson, R. J.; Hanrahan, S.; Totty, N.; Stark, M. J. R.; Keyse, S. M.; McDonald, N. Q.			Redox-mediated substrate recognition by Sdp1 defines a new group of tyrosine phosphatases	NATURE			English	Article							SPECIFICITY PROTEIN PHOSPHATASE; MAP KINASE; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; YEAST; ACTIVATION; PATHWAY; PYST1; ERK2	Reactive oxygen species trigger cellular responses by activation of stress-responsive mitogen-activated protein kinase ( MAPK) signalling pathways(1,2). Reversal of MAPK activation requires the transcriptional induction of specialized cysteine-based phosphatases that mediate MAPK dephosphorylation(3). Paradoxically, oxidative stresses generally inactivate cysteine-based phosphatases by thiol modification and thus could lead to sustained or uncontrolled MAPK activation(4,5). Here we describe how the stress-inducible MAPK phosphatase, Sdp1, presents an unusual solution to this apparent paradox by acquiring enhanced catalytic activity under oxidative conditions. Structural and biochemical evidence reveals that Sdp1 employs an intramolecular disulphide bridge and an invariant histidine side chain to selectively recognize a tyrosine-phosphorylated MAPK substrate. Optimal activity critically requires the disulphide bridge, and thus, to the best of our knowledge, Sdp1 is the first example of a cysteine-dependent phosphatase that couples oxidative stress with substrate recognition. We show that Sdp1, and its paralogue Msg5, have similar properties and belong to a new group of phosphatases unique to yeast and fungal taxa.	Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3PX, England; Canc Res UK, Prot Anal Lab, London Res Inst, London WC2A 3PX, England; Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; Ninewells Hosp, Canc Res UK, Stress Response Lab, Ctr Biomed Res, Dundee DD1 9SY, Scotland; Univ Dundee, Div Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland	Cancer Research UK; Cancer Research UK; University of London; Birkbeck University London; Cancer Research UK; University of Dundee; University of Dundee	McDonald, NQ (corresponding author), Canc Res UK, Struct Biol Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.	neil.mcdonald@cancer.org.uk	Keyse, Stephen M./B-9575-2009; Stark, Michael J. R./B-2815-2014; Briggs, David/F-1199-2010	Keyse, Stephen M./0000-0002-5150-8221; Stark, Michael J. R./0000-0001-9086-191X; Makrantoni, Vasso/0000-0003-0668-6157; Briggs, David/0000-0002-9793-7339	Biotechnology and Biological Sciences Research Council [BB/C007077/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alic N, 2003, J BIOL CHEM, V278, P41849, DOI 10.1074/jbc.M307760200; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Collister M, 2002, FEBS LETT, V527, P186, DOI 10.1016/S0014-5793(02)03220-9; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Krasley E, 2006, GENETICS, V172, P1477, DOI 10.1534/genetics.105.052266; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Mattison CP, 1999, MOL CELL BIOL, V19, P7651; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Rhee S G, 2000, Sci STKE, V2000, ppe1; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Staleva L, 2004, MOL BIOL CELL, V15, P5574, DOI 10.1091/mbc.E04-02-0142; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200	30	35	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					487	492		10.1038/nature05804	http://dx.doi.org/10.1038/nature05804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17495930				2022-12-24	WOS:000246693100050
J	Taubenberger, JK; Morens, DM; Fauci, AS				Taubenberger, Jeffery K.; Morens, David M.; Fauci, Anthony S.			The next influenza pandemic - Can it be predicted?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							H5N1 INFLUENZA; A VIRUSES; TRANSMISSION; ASIA; VIRULENCE; EVOLUTION; IMMUNE; HUMANS; GENE		NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), Bldg 31,Room 7A-10,31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA.	dmorens@niaid.nih.gov	Taubenberger, Jeffery/AAQ-1407-2021		Intramural NIH HHS [Z01 AI000995-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000995, Z01AI000986] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER DJ, 2006, VACCINE; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; SUBBARAO EK, 1993, J VIROL, V67, P7223, DOI 10.1128/JVI.67.12.7223-7228.1993; Taubenberger JK, 2006, FUTURE VIROL, V1, P415, DOI 10.2217/17460794.1.4.415; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; World Health Organization, WHO GLOB INFL PROGR	24	83	86	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					2025	2027		10.1001/jama.297.18.2025	http://dx.doi.org/10.1001/jama.297.18.2025			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488968	Green Accepted			2022-12-24	WOS:000246301800025
J	Kurotaki, Y; Hatta, K; Nakao, K; Nabeshima, Y; Fujimori, T				Kurotaki, Yoko; Hatta, Kohei; Nakao, Kazuki; Nabeshima, Yo-ichi; Fujimori, Toshihiko			Blastocyst axis is specified independently of early cell lineage but aligns with the ZP shape	SCIENCE			English	Article							1ST 2 BLASTOMERES; MOUSE BLASTOCYST; BILATERAL SYMMETRY; CLEAVAGE; TROPHECTODERM; EMBRYO; PROTEIN; ZYGOTE; STAGE; DIFFERENTIATION	The mechanisms controlling the establishment of the embryonic-abembryonic (E-Ab) axis of the mammalian blastocyst are controversial. We used in vitro time-lapse imaging and in vivo lineage labeling to provide evidence that the E-Ab axis of the mouse blastocyst is generated independently of early cell lineage. Rather, both the boundary between two-cell blastomeres and the E-Ab axis of the blastocyst align relative to the ellipsoidal shape of the zona pellucida (ZP), an extraembryonic structure. Lack of correlation between cell lineage and the E-Ab axis can be explained by the rotation of the embryo within the ZP.	Kyoto Univ, Grad Sch Sci, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; JST, CREST, Kawaguchi, Saitama 3320012, Japan; RIKEN, Ctr Dev Biol, Vertebrate Body Plan Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan; Riken Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Japan Science & Technology Agency (JST); RIKEN; RIKEN	Fujimori, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Pathol & Tumor Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fujimori@lmls.med.kyoto-u.ac.jp	Fujimori, Toshihiko/L-7711-2016	Fujimori, Toshihiko/0000-0001-5200-4634; zhong wei, he gui/0000-0002-3066-3564				Alarcon VB, 2005, MOL REPROD DEV, V72, P354, DOI 10.1002/mrd.20353; Alarcon VB, 2003, BIOL REPROD, V69, P1208, DOI 10.1095/biolreprod.103.018283; Chroscicka A, 2004, MOL REPROD DEV, V68, P308, DOI 10.1002/mrd.20081; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Gardner RL, 2007, HUM REPROD, V22, P798, DOI 10.1093/humrep/del424; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2006, HUM REPROD, V21, P492, DOI 10.1093/humrep/dei318; Gardner RL, 2001, DEVELOPMENT, V128, P839; Gardner RL, 2002, HUM REPROD, V17, P1839, DOI 10.1093/humrep/17.7.1839; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; HANDYSIDE AH, 1978, J EMBRYOL EXP MORPH, V45, P37; Hatta K, 2006, NAT PROTOC, V1, P960, DOI 10.1038/nprot.2006.96; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KESSLER DS, 1995, DEVELOPMENT, V121, P2155; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Waksmundzka M, 2006, BIOL REPROD, V75, P582, DOI 10.1095/biolreprod.106.053165	27	149	155	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					719	723		10.1126/science.1138591	http://dx.doi.org/10.1126/science.1138591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17446354				2022-12-24	WOS:000246181400038
J	Alonso-Alonso, M; Pascual-Leone, A				Alonso-Alonso, Miguel; Pascual-Leone, Alvaro			The right brain hypothesis for obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DECISION-MAKING; SELF; EXERCISE; DEFICITS		Beth Israel Deaconess Med Ctr, Dept Neurol, Behav Neurol Unit, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Pascual-Leone, A (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Behav Neurol Unit, Berenson Allen Ctr Noninvas Brain Stimulat, 330 Brookline Ave,KS 452, Boston, MA 02215 USA.	apleone@bidmc.harvard.edu	Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382; Alonso-Alonso, Miguel/0000-0003-3372-9933	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; NCRR NIH HHS [K24 RR018875] Funding Source: Medline; NIDDK NIH HHS [P30 DK46200] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anthony K, 2006, DIABETES, V55, P2986, DOI 10.2337/db06-0376; Arias M, 2002, REV NEUROLOGIA, V35, P531, DOI 10.33588/rn.3506.2002264; Berridge CW, 2003, ASYMMETRICAL BRAIN, P69; Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6; Cameron O.G., 2002, VISCERAL SENSORY NEU; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Davis C, 2004, OBES RES, V12, P929, DOI 10.1038/oby.2004.113; de Garine I, 1995, SOCIAL ASPECTS OBESI; DelParigi A, 2007, INT J OBESITY, V31, P440, DOI 10.1038/sj.ijo.0803431; Freeman W., 1950, PSYCHOSURGERY TREATM; JALKANEN L, 1987, SCAND J SOC MED, V15, P191, DOI 10.1177/140349488701500311; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Martins JM, 2001, INT J OBESITY, V25, P24, DOI 10.1038/sj.ijo.0801500; Matochik JA, 2005, J CLIN ENDOCR METAB, V90, P2851, DOI 10.1210/jc.2004-1979; Mikheev M, 2002, NEUROPSYCHOLOGIA, V40, P1209, DOI 10.1016/S0028-3932(01)00227-5; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Regard M, 1997, NEUROLOGY, V48, P1185, DOI 10.1212/WNL.48.5.1185; Short RA, 2005, ARCH NEUROL-CHICAGO, V62, P1106, DOI 10.1001/archneur.62.7.1106; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Uher R, 2005, J NEUROL NEUROSUR PS, V76, P852, DOI 10.1136/jnnp.2004.048819; Zhu KM, 2006, PREV MED, V42, P381, DOI 10.1016/j.ypmed.2006.01.020	25	133	133	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1819	1822		10.1001/jama.297.16.1819	http://dx.doi.org/10.1001/jama.297.16.1819			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160DW	17456824				2022-12-24	WOS:000245922100028
J	Soulard, A; Hall, MN				Soulard, Alexandre; Hall, Michael N.			SnapShot: mTOR signaling	CELL			English	Editorial Material							TRANSDUCTION PATHWAYS; KINASE-ACTIVITY; GROWTH; INSULIN; RICTOR; PHOSPHORYLATION; PROLIFERATION; REVEALS; GTPASE; PRAS40		Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Soulard, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.			Soulard, Alexandre/0000-0003-3556-1994; Hall, Michael N/0000-0002-2998-0757				Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	15	43	48	4	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					434	U14	E1	10.1016/j.cell.2007.04.010	http://dx.doi.org/10.1016/j.cell.2007.04.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17449000	Bronze			2022-12-24	WOS:000246474600028
J	Jacobs, GH; Williams, GA; Cahill, H; Nathans, J				Jacobs, Gerald H.; Williams, Gary A.; Cahill, Hugh; Nathans, Jeremy			Emergence of novel color vision in mice engineered to express a human cone photopigment	SCIENCE			English	Article							PRIMATE; COEXPRESSION; RECEPTORS; RESPONSES; EVOLUTION; RETINA; MOUSE	Changes in the genes encoding sensory receptor proteins are an essential step in the evolution of new sensory capacities. In primates, trichromatic color vision evolved after changes in X chromosome-linked photopigment genes. To model this process, we studied knock-in mice that expressed a human long-wavelength-sensitive (L) cone photopigment in the form of an X-linked polymorphism. Behavioral tests demonstrated that heterozygous females, whose retinas contained both native mouse pigments and human L pigment, showed enhanced long-wavelength sensitivity and acquired a new capacity for chromatic discrimination. An inherent plasticity in the mammalian visual system thus permits the emergence of a new dimension of sensory experience based solely on gene-driven changes in receptor organization.	Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; Johns Hopkins Med Sch, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Dept Ophthalmol, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Jacobs, GH (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	jacobs@psych.ucsb.edu		Nathans, Jeremy/0000-0001-8106-5460	NEI NIH HHS [EY002052] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002052] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALPERN M, 1953, J PHYSL, V335, P655; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hunt DM, 1998, VISION RES, V38, P3299, DOI 10.1016/S0042-6989(97)00443-4; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; Jacobs GH, 1996, J OPT SOC AM A, V13, P641, DOI 10.1364/JOSAA.13.000641; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Jacobs GH, 1999, J NEUROSCI, V19, P3258; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; JACOBS GH, 1987, P NATL ACAD SCI USA, V84, P2545, DOI 10.1073/pnas.84.8.2545; Lee Barry B, 2004, Clin Exp Optom, V87, P239; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Migeon BR, 2002, CYTOGENET GENOME RES, V99, P8, DOI 10.1159/000071568; MOLLON JD, 1989, J EXP BIOL, V146, P21; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Onishi A, 2005, ZOOL SCI, V22, P1145, DOI 10.2108/zsj.22.1145; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; Smallwood PM, 2002, P NATL ACAD SCI USA, V99, P1008, DOI 10.1073/pnas.022629799; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	27	143	149	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1723	1725		10.1126/science.1138838	http://dx.doi.org/10.1126/science.1138838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379811				2022-12-24	WOS:000245106900043
J	Biskup, C; Kusch, J; Schulz, E; Nache, V; Schwede, F; Lehmann, F; Hagen, V; Benndorf, K				Biskup, Christoph; Kusch, Jana; Schulz, Eckhard; Nache, Vasilica; Schwede, Frank; Lehmann, Frank; Hagen, Volker; Benndorf, Klaus			Relating ligand binding to activation gating in CNGA2 channels	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; FUNCTIONAL EXPRESSION; STRUCTURAL BASIS; MECHANISM; EFFICACY; STOICHIOMETRY	Cyclic nucleotide-gated (CNG) ion channels mediate sensory signal transduction in photoreceptors and olfactory cells. Structurally, CNG channels are heterotetramers composed of either two or three homologue subunits(1-4). Although it is well established that activation is a cooperative process of these subunits(5), it remains unknown whether the cooperativity is generated by the ligand binding, the gating, or both, and how the subunits interact. In this study, the action of homotetrameric olfactory-type CNGA2 channels(6) was studied in inside-out membrane patches by simultaneously determining channel activation and ligand binding, using the fluorescent cGMP analogue 8-DY547-cGMP as the ligand. At concentrations of 8-DY547-cGMP <1 mu M, steady-state binding was larger than steady-state activation, whereas at higher concentrations it was smaller, generating a crossover of the steady-state relationships. Global analysis of these relationships together with multiple activation time courses following cGMP jumps(7) showed that four ligands bind to the channels and that there is significant interaction between the binding sites. Among the binding steps, the second is most critical for channel opening: its association constant is three orders of magnitude smaller than the others and it triggers a switch from a mostly closed to a maximally open state. These results contribute to unravelling the role of the subunits in the cooperative mechanism of CNGA2 channel activation and could be of general relevance for the action of other ion channels and receptors.	Univ Jena, Inst Physiol 2, D-07740 Jena, Germany; Fachhsch Schmalkalden, Fachbereich Elektrotech, D-98574 Schmalkalden, Germany; BIOLOG Life Sci Inst, D-28199 Bremen, Germany; Dyomics GmbH, D-07745 Jena, Germany; Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Friedrich Schiller University of Jena; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Benndorf, K (corresponding author), Univ Jena, Inst Physiol 2, D-07740 Jena, Germany.	klaus.benndorf@mti.uni-jena.de	Horstmann, Britta/C-2154-2008; Kusch, Jana/ABC-9738-2020	Kusch, Jana/0000-0001-7206-8133; Benndorf, Klaus/0000-0002-0707-4083				Beato M, 2004, J NEUROSCI, V24, P895, DOI 10.1523/JNEUROSCI.4420-03.2004; Bonigk W, 1999, J NEUROSCI, V19, P5332; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Burzomato V, 2004, J NEUROSCI, V24, P10924, DOI 10.1523/JNEUROSCI.3424-04.2004; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D, 2006, BRIT J PHARMACOL, V147, pS17, DOI 10.1038/sj.bjp.0706502; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Edsall J. T., 1958, BIOPHYSICAL CHEM; GOULDING EH, 1994, NATURE, V372, P369, DOI 10.1038/372369a0; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Li J, 1999, MOL PHARMACOL, V55, P883; Li J, 1997, Q REV BIOPHYS, V30, P177, DOI 10.1017/S0033583597003326; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nache V, 2005, J PHYSIOL-LONDON, V569, P91, DOI 10.1113/jphysiol.2005.092304; PICONES A, 1995, J PHYSIOL-LONDON, V485, P699, DOI 10.1113/jphysiol.1995.sp020763; Ruiz M, 1999, J GEN PHYSIOL, V113, P873, DOI 10.1085/jgp.113.6.873; Ruiz M, 1997, NATURE, V389, P389, DOI 10.1038/38744; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Wyman J, 1990, BINDING LINKAGE FUNC; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng Jie, 2003, Sci STKE, V2003, pPL7, DOI 10.1126/stke.2003.176.pl7; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	30	90	91	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					440	443		10.1038/nature05596	http://dx.doi.org/10.1038/nature05596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17322905				2022-12-24	WOS:000245079500040
J	Collman, JP; Devaraj, NK; Decreau, RA; Yang, Y; Yan, YL; Ebina, W; Eberspacher, TA; Chidsey, CED				Collman, James P.; Devaraj, Neal K.; Decreau, Richard A.; Yang, Ying; Yan, Yi-Long; Ebina, Wataru; Eberspacher, Todd A.; Chidsey, Christopher E. D.			A cytochrome c oxidase model catalyzes oxygen to water reduction under rate-limiting electron flux	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; GOLD ELECTRODES; DIOXYGEN REDUCTION; TERMINAL ALKYNES; SITE; O-2; SURFACES; ANALOGS; BINDING; METALLOPORPHYRINS	We studied the selectivity of a functional model of cytochrome c oxidase's active site that mimics the coordination environment and relative locations of Fe-a3, Cu-B, and Tyr(244). To control electron flux, we covalently attached this model and analogs lacking copper and phenol onto self-assembled monolayer-coated gold electrodes. When the electron transfer rate was made rate limiting, both copper and phenol were required to enhance selective reduction of oxygen to water. This finding supports the hypothesis that, during steady-state turnover, the primary role of these redox centers is to rapidly provide all the electrons needed to reduce oxygen by four electrons, thus preventing the release of toxic partially reduced oxygen species.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Collman, JP (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	jpc@stanford.edu; chidsey@stanford.edu	DECREAU, Richard/I-4568-2012; Devaraj, Neal/B-4712-2014	DECREAU, Richard/0000-0003-4205-0092; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017880, R37GM017880] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-17880-35, R01 GM017880, R01 GM017880-35] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alleman KS, 1996, J PHYS CHEM-US, V100, P17050, DOI 10.1021/jp962193b; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Boulatov R, 2002, J AM CHEM SOC, V124, P11923, DOI 10.1021/ja026179q; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Cha SK, 2004, B KOREAN CHEM SOC, V25, P786; CHAZOTTE B, 1989, J BIOL CHEM, V264, P4978; CHIDSEY CED, 1991, SCIENCE, V251, P919, DOI 10.1126/science.251.4996.919; Collman JP, 2004, J ORG CHEM, V69, P3546, DOI 10.1021/jo0499625; Collman JP, 2006, LANGMUIR, V22, P2457, DOI 10.1021/la052947q; Collman JP, 2005, INORG CHEM, V44, P9628, DOI 10.1021/ic0516717; Collman JP, 2004, LANGMUIR, V20, P1051, DOI 10.1021/la0362977; Collman JP, 2002, INORG CHEM, V41, P2282, DOI 10.1021/ic011191p; Collman JP, 2002, ANGEW CHEM INT EDIT, V41, P3487, DOI 10.1002/1521-3773(20020916)41:18<3487::AID-ANIE3487>3.0.CO;2-Y; Collman JP, 1997, SCIENCE, V275, P949, DOI 10.1126/science.275.5302.949; COLLMAN JP, 1994, J AM CHEM SOC, V116, P9783, DOI 10.1021/ja00100a067; Collman JP, 1999, J AM CHEM SOC, V121, P1387, DOI 10.1021/ja983351a; Creager S, 1999, J AM CHEM SOC, V121, P1059, DOI 10.1021/ja983204c; CREAGER SE, 1993, LANGMUIR, V9, P2330, DOI 10.1021/la00033a014; Das TK, 1998, BIOCHEMISTRY-US, V37, P14471, DOI 10.1021/bi981500w; Degefa TH, 2004, J ELECTROANAL CHEM, V574, P49, DOI 10.1016/j.jelechem.2004.07.026; Devaraj NK, 2006, J PHYS CHEM B, V110, P15955, DOI 10.1021/jp057416p; FINKLEA HO, 1992, J AM CHEM SOC, V114, P3173, DOI 10.1021/ja00035a001; GUPTE SS, 1988, J BIOL CHEM, V263, P5248; Haas AS, 2001, J PHYS CHEM B, V105, P11351, DOI 10.1021/jp011834m; HUTCHISON JE, 1993, LANGMUIR, V9, P3277, DOI 10.1021/la00035a084; KATZ E, 1994, J ELECTROANAL CHEM, V368, P87, DOI 10.1016/0022-0728(93)03039-R; Lee JK, 2004, LANGMUIR, V20, P3844, DOI 10.1021/la049748b; MOGI T, 1995, FEBS LETT, V370, P259; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; Offord DA, 1998, J AM CHEM SOC, V120, P4478, DOI 10.1021/ja973528l; Pfitzner U, 1998, J BIOENERG BIOMEMBR, V30, P89, DOI 10.1023/A:1020515713103; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Sigal GB, 1997, LANGMUIR, V13, P2749, DOI 10.1021/la961024f; Sigman JA, 2000, J AM CHEM SOC, V122, P8192, DOI 10.1021/ja0015343; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; ZAK J, 1993, LANGMUIR, V9, P2772, DOI 10.1021/la00035a006; Zou SZ, 2002, LANGMUIR, V18, P3241, DOI 10.1021/la011444r	41	412	414	5	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1565	1568		10.1126/science.1135844	http://dx.doi.org/10.1126/science.1135844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363671	Green Accepted			2022-12-24	WOS:000244934800049
J	Kendall, M; Harris, F; Boyd, K; Sheikh, A; Murray, SA; Brown, D; Mallinson, I; Kearney, N; Worth, A				Kendall, Marilyn; Harris, Fiona; Boyd, Kirsty; Sheikh, Aziz; Murray, Scott A.; Brown, Duncan; Mallinson, Ian; Kearney, Nora; Worth, Allison			Key challenges and ways forward in researching the "good death": qualitative in-depth interview and focus group study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE; CANCER; VIEWS; NEED	Objective To understand key challenges in researching end of life issues and identify ways of overcoming these. Design Qualitative study involving in-depth interviews with researchers and focus groups with people affected by cancer. Participants An international sample of 32 researchers; seven patients with experience of cancer; and four carers in south east Scotland. Results Researchers highlighted the difficulty of defining, the end of life, overprotective gatekeeping by ethics committees and clinical staff, the need to factor in high attrition rates associated with deterioration or death, and managing the emotions of participants and research staff. People affected by cancer and researchers suggested that many people nearing the end of life do want to be offered the chance to participate in research, provided it is conducted sensitively. Although such research can be demanding, most researchers believed it to be no more problematic than many other areas of research and that the challenges identified can be overcome. Conclusions The continuing taboos around death and dying act as barriers to the commissioning and conduct of end of life research. Some people facing death, however, may want to participate in research and should be allowed to do so. Ethics committees and clinical staff must balance understandable concern about non-maleficence with the right of people with advanced illness to participate in research. Despite the inherent difficulties, end of life research can be conducted with ethical and methodological rigour. Adequate psychological support must be provided for participants, researchers, and transcribers.	Univ Edinburgh, Primary Palliat Care Res Grp, Div Community Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland; St Columbas Hosp, Edinburgh EH5 3RW, Midlothian, Scotland; Univ Stirling, Canc Care Res Ctr, Dept Nursing & Midwifery, Stirling FK9 4LA, Scotland	University of Edinburgh; University of Edinburgh; University of Stirling	Kendall, M (corresponding author), Univ Edinburgh, Primary Palliat Care Res Grp, Div Community Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	Marilyn.Kendall@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Harris, Fiona/B-5633-2008	Sheikh, Aziz/0000-0001-7022-3056; Harris, Fiona/0000-0003-3258-5624; Boyd, Kirsty/0000-0002-5526-1078				Addington-Hall J, 2002, EUR J CANCER CARE, V11, P220, DOI 10.1046/j.1365-2354.2002.00343.x; *ASS SOC ANTHR, ETH GUID GOOD RES PR; Beaver K., 1999, INT J PALLIAT NURS, V5, P13, DOI [10.12968/ijpn.1999.5.1.9926, DOI 10.12968/IJPN.1999.5.1.9926]; Bowling A, 2000, BRIT MED J, V320, P1205; *BRIT SOC ASS, STAT ETH PRACT; Clark J, 2003, BRIT MED J, V327, P174, DOI 10.1136/bmj.327.7408.174; Cook AM, 2002, PALLIATIVE MED, V16, P163, DOI 10.1191/0269216302pm551xx; Entwistle V, 2002, EUR J CANCER CARE, V11, P232, DOI 10.1046/j.1365-2354.2002.00344.x; Gray RE, 2003, QUAL INQ, V9, P254, DOI 10.1177/1077800402250957; Gray Ross, 2000, Health Expect, V3, P137, DOI 10.1046/j.1369-6513.2000.00071.x; Harris FM, 2005, WHAT ARE BEST WAYS S; Krishnasamy M, 2000, PALLIATIVE MED, V14, P410, DOI 10.1191/026921600701536246; Lawton J, 2001, QUAL HEALTH RES, V11, P693, DOI 10.1177/104973201129119389; Lee R.M., 1993, DOING RES SENSITIVE; Riley J, 2005, LANCET, V365, P735; Rose K, 1998, QUAL HEALTH RES, V8, P556, DOI 10.1177/104973239800800409; ROWLING L, 1999, MORTALITY, V14, P167; Seale C, 1998, CONSTRUCTING DEATH S; Seamark DA, 2000, PALLIATIVE MED, V14, P55, DOI 10.1191/026921600674088597; Seymour J, 2002, EUR J CANCER CARE, V11, P215, DOI 10.1046/j.1365-2354.2002.00342.x; Seymour J, 2005, INT J PALLIAT NURS, V11, P240, DOI 10.12968/ijpn.2005.11.5.240; Woods S, 2000, NURS ETHICS, V7, P314, DOI 10.1191/096973300676700359	22	80	80	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					521	524		10.1136/bmj.39097.582639.55	http://dx.doi.org/10.1136/bmj.39097.582639.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148VV	17329313	Bronze, Green Published			2022-12-24	WOS:000245106400042
J	Mito, Y; Henikoff, JG; Henikoff, S				Mito, Yoshiko; Henikoff, Jorja G.; Henikoff, Steven			Histone replacement marks the boundaries of cis-regulatory domains	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; BITHORAX COMPLEX; GENE-EXPRESSION; CHROMATIN; PROTEINS; H3.3; DISPLACEMENT; TRANSCRIPTION; MAINTENANCE; PATTERNS	Cellular memory is maintained at homeotic genes by cis-regulatory elements whose mechanism of action is unknown. We have examined chromatin at Drosophila homeotic gene clusters by measuring, at high resolution, levels of histone replacement and nucleosome occupancy. Homeotic gene clusters display conspicuous peaks of histone replacement at boundaries of cis-regulatory domains superimposed over broad regions of low replacement. Peaks of histone replacement closely correspond to nuclease-hypersensitive sites, binding sites for Polycomb and trithorax group proteins, and sites of nucleosome depletion. Our results suggest the existence of a continuous process that disrupts nucleosomes and maintains accessibility of cis-regulatory elements.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Cell & Mol Biol Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685				Barges S, 2000, DEVELOPMENT, V127, P779; BISISIC D, 2006, EMBO J, V25, P798; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brock HW, 2005, DEV DYNAM, V232, P633, DOI 10.1002/dvdy.20298; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; KARCH F, 1994, NUCLEIC ACIDS RES, V22, P3138, DOI 10.1093/nar/22.15.3138; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Platero JS, 1998, J CELL BIOL, V140, P1297; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Schwartz YB, 2005, MOL CELL BIOL, V25, P432, DOI 10.1128/MCB.25.1.432-439.2005; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sun FL, 2004, MOL CELL BIOL, V24, P8210, DOI 10.1128/MCB.24.18.8210-8220.2004; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	25	219	227	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1408	1411		10.1126/science.1134004	http://dx.doi.org/10.1126/science.1134004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347439				2022-12-24	WOS:000244752200033
J	Wang, LD; Liu, JJ; Chin, DP				Wang, Longde; Liu, Jianjun; Chin, Daniel P.			Progress in tuberculosis control and the evolving public-health system in China	LANCET			English	Article								China has the world's second largest tuberculosis epidemic, but progress in tuberculosis control was slow during the 1990s. Detection of tuberculosis had stagnated at around 30% of the estimated total of new cases, and multidrug-resistant tuberculosis was a major problem. These signs of inadequate tuberculosis control can be linked to a malfunctioning health system. The spread of severe acute respiratory syndrome (SARS) in 2003, brought to light substantial weaknesses in the country's public-health system. After the SARS epidemic was brought under control, the government increased its commitment and leadership to tackle public-health problems and, among other efforts, increased public-health funding, revised laws that concerned the control of infectious diseases, implemented the world's largest internet-based disease reporting system, and started a programme to rebuild local public-health facilities. These measures contributed to acceleration in efforts to control tuberculosis. By 2005, the detection of cases of tuberculosis had increased to 80% of the estimated total new cases, permitting China to achieve the 2005 global tuberculosis control targets. At the same time, specific efforts to improve tuberculosis control also contributed to strengthening of the public-health system. We examine how the strengthening of a disease control programme and the public-health system worked together to achieve a desired health outcome.	Minist Hlth, Beijing, Peoples R China; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; WHO, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; World Health Organization	Chin, DP (corresponding author), Room 401,23 Dongzhimenwai Dajie, Beijing 100600, Peoples R China.	chind@chn.wpro.who.int						Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Cai J, 2003, MODEL TUBERCULOSIS C; China National Health Development Research Center, 2020, CHIN NAT HLTH ACC RE; *DEV RES CTR PROJ, 2005, CHINA DEV REV, V7, P1; LEI H, 2005, CHINA DEV REV, V7, P81; Ma J. Q., 2006, DIS SURVEILLANCE, V21, P1; *MIN HLTH PUBL INF, 2005, MIN HLTH REP STAT NA; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Ministry of Health of the People's Republic of China, 2002, REP NAT RAND SURV EP; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; *STAT COUNC PEOPL, 200175 GEN OFF STAT, P75; *STAT COUNC PEOPL, CHIN AIDS PREV CONTR; *STAT COUNC PEOPL, 2003, CHIN PREV MED S, V4, P1; *STOP TB PARTN, 2 STOP TB PARTN FOR; *UN HLTH PARTN GRO, 2005, HLTH SIT ASS PEOPL R; *UN STAT DIV, MILL IND DAT; WEN J, 10 NAT PEOPL C CHIN; *WHO, 2000, WHOCDSTB2000278 IUAT; *WHO, 2004, WHOHTMTB2004343 IUAT; *WHO REG COMM W PA, WPRRC51R4 WHO REG CO; *WHO STOP TB PARTN, 2006, WHOHTMSTB200635; *WHO UNAIDS MIN HL, 2006, 2005 UPD HIV AIDS EP; World Health Organization, 2006, WHOHTMTB2006362; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; GEN OFFICE MINISTRY	25	184	194	3	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2007	369	9562					691	696		10.1016/S0140-6736(07)60316-X	http://dx.doi.org/10.1016/S0140-6736(07)60316-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141RO	17321314	Bronze, Green Published			2022-12-24	WOS:000244596600030
J	Kaiser, BK; Yim, D; Chow, IT; Gonzalez, S; Dai, Z; Mann, HH; Strong, RK; Groh, V; Spies, T				Kaiser, Brett K.; Yim, Daesong; Chow, I-Ting; Gonzalez, Segundo; Dai, Zhenpeng; Mann, Henning H.; Strong, Roland K.; Groh, Veronika; Spies, Thomas			Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands	NATURE			English	Article							T-CELLS; IN-VIVO; RECEPTOR; MHC; EXPRESSION; MICA; CYTOTOXICITY; IMMUNITY; ACTIVATION; EXCHANGE	Tumour-associated ligands of the activating NKG2D ( natural killer group 2, member D; also called KLRK1) receptor - which are induced by genotoxic or cellular stress - trigger activation of natural killer cells and co-stimulation of effector T cells, and may thus promote resistance to cancer(1-6). However, many progressing tumours in humans counter this anti-tumour activity by shedding the soluble major histocompatibility complex class-I-related ligand MICA, which induces internalization and degradation of NKG2D and stimulates population expansions of normally rare NKG2D(+) CD4(+) T cells with negative regulatory functions(7-9). Here we show that on the surface of tumour cells, MICA associates with endoplasmic reticulum protein 5 (ERp5; also called PDIA6 or P5), which, similar to protein disulphide isomerase, usually assists in the folding of nascent proteins inside cells(10). Pharmacological inhibition of thioreductase activity and ERp5 gene silencing revealed that cell-surface ERp5 function is required for MICA shedding. ERp5 and membrane-anchored MICA form transitory mixed disulphide complexes from which soluble MICA is released after proteolytic cleavage near the cell membrane. Reduction of the seemingly inaccessible disulphide bond in the membrane-proximal alpha 3 domain of MICA must involve a large conformational change that enables proteolytic cleavage. These results uncover a molecular mechanism whereby domain-specific deconstruction regulates MICA protein shedding, thereby promoting tumour immune evasion, and identify surface ERp5 as a strategic target for therapeutic intervention.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Chow, IT (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.		Gonzalez, Segundo/AAK-8719-2021	Gonzalez, Segundo/0000-0003-4631-9255				Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Kikuchi M, 2002, J BIOCHEM, V132, P451, DOI 10.1093/oxfordjournals.jbchem.a003242; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172	28	283	305	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					482	U5		10.1038/nature05768	http://dx.doi.org/10.1038/nature05768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17495932				2022-12-24	WOS:000246693100049
J	Hemelaar, J				Hemelaar, Joris			Minimising risk in first-in-man trials	LANCET			English	Editorial Material							TGN1412		Univ Oxford Magdalen Coll, Oxford OX1 4AU, England	University of Oxford	Hemelaar, J (corresponding author), Univ Oxford Magdalen Coll, Oxford OX1 4AU, England.	joris.hemelaar@trinity.oxon.org		Hemelaar, Joris/0000-0003-3523-7457				Beyersdorf N, 2006, AUTOIMMUN REV, V5, P40, DOI 10.1016/j.autrev.2005.06.001; Department of Health, 2006, EXP SCI GROUP PHAS O; European Medicines Agency, 2007, GUID REQ 1 MAN CLIN; Kenter MJH, 2006, LANCET, V368, P1387, DOI 10.1016/S0140-6736(06)69562-7; Medicines and Healthcare Products Regulatory Agency, 2006, INV ADV INC CLIN TRI; Royal Statistical Society, 2007, REP WORK PART STAT I; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842	7	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1496	1497		10.1016/S0140-6736(07)60686-2	http://dx.doi.org/10.1016/S0140-6736(07)60686-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482966				2022-12-24	WOS:000246215800006
J	Fuyuno, I				Fuyuno, Ichiko			Plastic promises	NATURE			English	News Item																			0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					715	715		10.1038/446715a	http://dx.doi.org/10.1038/446715a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429369	Bronze			2022-12-24	WOS:000245626800010
J	Modlin, JF				Modlin, John F.			Focus on research: Enterovirus deja vu	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dartmouth Coll Sch Med, Dept Pediat, Lebanon, NH 03766 USA	Dartmouth College	Modlin, JF (corresponding author), Dartmouth Coll Sch Med, Dept Pediat, Lebanon, NH 03766 USA.							Paul JR, 1971, HIST POLIOMYELITIS; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304	2	23	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1204	1205		10.1056/NEJMp078016	http://dx.doi.org/10.1056/NEJMp078016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377157				2022-12-24	WOS:000245101900004
J	Shann, F				Shann, Frank			Suckling and sugar reduce pain in babies	LANCET			English	Editorial Material							ORALLY-ADMINISTERED GLUCOSE; RANDOMIZED CONTROLLED-TRIAL; SUCROSE ANALGESIA; NEONATAL PAIN; INFANTS; NEWBORNS; YOUNGER; RELIEF; AGE		Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.	frank.shann@rch.org.au	Shann, Frank/C-9510-2011					ANAND KJS, 1992, NEW ENGL J MED, V326, P1, DOI 10.1056/NEJM199201023260101; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; Bilgen H, 2001, J PAIN, V2, P301, DOI 10.1054/jpai.2001.23140; Bucher HU, 2000, EARLY HUM DEV, V59, P51, DOI 10.1016/S0378-3782(00)00085-2; Carbajal R, 1999, BRIT MED J, V319, P1393, DOI 10.1136/bmj.319.7222.1393; Carbajal R, 2003, BMJ-BRIT MED J, V326, P13, DOI 10.1136/bmj.326.7379.13; Eriksson M, 2004, ACTA PAEDIATR, V93, P246, DOI 10.1080/08035250310008041; Gradin M, 2005, PEDIATRICS, V115, P1004, DOI 10.1542/peds.2004-1189; Gradin M, 2004, EARLY HUM DEV, V77, P57, DOI 10.1016/j.earlhumdev.2004.01.003; Guala A, 2001, Minerva Pediatr, V53, P271; Isik U, 2000, J PAIN, V1, P275, DOI 10.1054/jpai.2000.8919; Johnston CC, 2002, PEDIATRICS, V110, P523, DOI 10.1542/peds.110.3.523; Lewindon PJ, 1998, ARCH DIS CHILD, V78, P453, DOI 10.1136/adc.78.5.453; Lidow MS, 2002, PAIN, V99, P377, DOI 10.1016/S0304-3959(02)00258-0; Rogers AJ, 2006, ACAD EMERG MED, V13, P617, DOI 10.1197/j.aem.2006.01.026; Shah PS, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004950.PUB2; STEVENS B, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001069.P1B2; WILLIS DM, 1977, PEDIATRICS, V60, P535	18	9	9	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 3	2007	369	9563					721	723		10.1016/S0140-6736(07)60335-3	http://dx.doi.org/10.1016/S0140-6736(07)60335-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143MP	17336631				2022-12-24	WOS:000244726700007
J	Warkentin, TE				Warkentin, Theodore E.			Focus on research: Drug-induced immune-mediated thrombocytopenia - from purpura to thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada	McMaster University	Warkentin, TE (corresponding author), McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada.							ACKROYD JF, 1949, CLIN SCI, V7, P249; Aster RH, 2006, J THROMB HAEMOST, V4, P678, DOI 10.1111/j.1538-7836.2006.01829.x; RHODES GR, 1973, SURG GYNECOL OBSTET, V136, P409; Tinmouth AT, 2006, TRANSFUS MED REV, V20, P294, DOI 10.1016/j.tmrv.2006.05.008; WARKENTIN TE, 2005, HEMATOLOGY BASIC PRI, P2305	5	67	71	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2007	356	9					891	893		10.1056/NEJMp068309	http://dx.doi.org/10.1056/NEJMp068309			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140HV	17329695				2022-12-24	WOS:000244496400003
J	Kovtun, IV; Liu, Y; Bjoras, M; Klungland, A; Wilson, SH; McMurray, CT				Kovtun, Irina V.; Liu, Yuan; Bjoras, Magnar; Klungland, Arne; Wilson, Samuel H.; McMurray, Cynthia T.			OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells	NATURE			English	Article							BASE-EXCISION-REPAIR; CAG/CTG TRIPLET REPEATS; HUNTINGTON-DISEASE; SUBSTRATE-SPECIFICITY; HUMAN DNA; INSTABILITY; MICE; MECHANISM; GLYCOSYLASE; TOXICITY	Although oxidative damage has long been associated with ageing and neurological disease, mechanistic connections of oxidation to these phenotypes have remained elusive. Here we show that the age-dependent somatic mutation associated with Huntington's disease occurs in the process of removing oxidized base lesions, and is remarkably dependent on a single base excision repair enzyme, 7,8-dihydro-8-oxoguanine-DNA glycosylase (OGG1). Both in vivo and in vitro results support a 'toxic oxidation' model in which OGG1 initiates an escalating oxidation - excision cycle that leads to progressive age-dependent expansion. Age-dependent CAG expansion provides a direct molecular link between oxidative damage and toxicity in post-mitotic neurons through a DNA damage response, and error-prone repair of single-strand breaks.	Mayo Clin & Mayo Fdn, Dept Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Program Neurosci, Rochester, MN 55905 USA; Univ Oslo, Ctr Mol Biol & Neurosci, Rikshosp Radiumhosp HF, N-0027 Oslo, Norway; Univ Oslo, Inst Med Microbiol, Rikshosp Radiumhosp HF, N-0027 Oslo, Norway; NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Oslo; University of Oslo; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	McMurray, CT (corresponding author), Mayo Clin & Mayo Fdn, Dept Pharmacol & Expt Therapeut, 200 1st St SW, Rochester, MN 55905 USA.	mcmurray.cynthia@mayo.edu	Kovtun, Irina/ABA-8484-2020; Klungland, Arne/X-1233-2019; Wilson, Samuel H/E-6644-2019; Bjørås, Magnar/N-9286-2017	Wilson, Samuel H/0000-0002-1702-5293; Klungland, Arne/0000-0001-7274-3661	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, Z01ES050159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040738] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES050158-11] Funding Source: Medline; NIGMS NIH HHS [R01 GM066359-05A1, R01 GM066359] Funding Source: Medline; NINDS NIH HHS [R01 NS040738-05, R01 NS040738] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; BOITEUX S, 1984, NUCLEIC ACIDS RES, V12, P5429, DOI 10.1093/nar/12.13.5429; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Chauhan C, 2002, J BIOMOL STRUCT DYN, V20, P253, DOI 10.1080/07391102.2002.10506841; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Dizdaroglu M, 1999, BIOCHEMISTRY-US, V38, P243, DOI 10.1021/bi9819071; Dizdaroglu M, 2003, MUTAT RES-FUND MOL M, V531, P109, DOI 10.1016/j.mrfmmm.2003.07.003; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; Goellner GM, 1997, AM J HUM GENET, V60, P879; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Hartenstine MJ, 2000, J BIOL CHEM, V275, P18382, DOI 10.1074/jbc.275.24.18382; Hartenstine MJ, 2002, J BIOL CHEM, V277, P41379, DOI 10.1074/jbc.M207013200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Kabbarah O, 2003, MOL CARCINOGEN, V38, P155, DOI 10.1002/mc.10157; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Kovtun IV, 2001, BIOCHEM CELL BIOL, V79, P325, DOI 10.1139/bcb-79-3-325; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; KOVTUN IV, 2006, GENETIC INSTABILITIE, P679; KREMER B, 1995, AM J HUM GENET, V57, P343; Lyons-Darden T, 1999, J BIOL CHEM, V274, P25975, DOI 10.1074/jbc.274.37.25975; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wilson SH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P693; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	44	345	353	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					447	U2		10.1038/nature05778	http://dx.doi.org/10.1038/nature05778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17450122	Green Accepted			2022-12-24	WOS:000246693100041
J	Rodrigues-Martins, A; Riparbelli, M; Callaini, G; Glover, DM; Bettencourt-Dias, M				Rodrigues-Martins, A.; Riparbelli, M.; Callaini, G.; Glover, D. M.; Bettencourt-Dias, M.			Revisiting the role of the mother centriole in centriole biogenesis	SCIENCE			English	Article							C-ELEGANS; CENTROSOME DUPLICATION; MICROTUBULE ORGANIZATION; POLO KINASE; PROTEIN; SAS-4	Centrioles duplicate once in each cell division cycle through so-called templated or canonical duplication. SAK, also called PLK4 ( SAK/PLK4), a kinase implicated in tumor development, is an upstream regulator of canonical biogenesis necessary for centriole formation. We found that overexpression of SAK/PLK4 could induce amplification of centrioles in Drosophila embryos and their de novo formation in unfertilized eggs. Both processes required the activity of DSAS-6 and DSAS-4, two molecules required for canonical duplication. Thus, centriole biogenesis is a template-free self-assembly process triggered and regulated by molecules that ordinarily associate with the existing centriole. The mother centriole is not a bona fide template but a platform for a set of regulatory molecules that catalyzes and regulates daughter centriole assembly.	Univ Cambridge, Dept Genet, Canc Res UK, Cell Cycle Genet Res Grp, Cambridge CB2 3EH, England; Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy; Gulbenkian Inst Sci, Cell Cycle Regulat Lab, P-2780156 Oeiras, Portugal	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Siena	Glover, DM (corresponding author), Univ Cambridge, Dept Genet, Canc Res UK, Cell Cycle Genet Res Grp, Downing St, Cambridge CB2 3EH, England.	dmg25@hermes.cam.ac.uk; mdias@igc.gulbenkian.pt	Bettencourt-Dias, Monica/B-5176-2015; Callaini, Giuliano/T-6353-2018	Bettencourt-Dias, Monica/0000-0003-1987-5598; Callaini, Giuliano/0000-0003-2252-0309; Glover, David/0000-0003-0956-0103				Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Belecz I, 2001, CURR BIOL, V11, P136, DOI 10.1016/S0960-9822(01)00025-2; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Foe Victoria E., 1993, P149; FREEMAN M, 1987, GENE DEV, V1, P924, DOI 10.1101/gad.1.9.924; GAIL J, 2004, CENTROSOMES DEV DIS; Gonzalez C, 1998, J CELL SCI, V111, P2697; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Januschke J, 2006, DEVELOPMENT, V133, P129, DOI 10.1242/dev.02179; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; MAHOWALD AP, 1970, J CELL BIOL, V45, P306, DOI 10.1083/jcb.45.2.306; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Riparbelli MG, 2003, DEV BIOL, V260, P298, DOI 10.1016/S0012-1606(03)00243-4; SHAMANSKI FL, 1991, CELL, V66, P1289, DOI 10.1016/0092-8674(91)90050-9; YAMAGUCHI M, 1991, J CELL SCI, V100, P729	31	190	193	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1046	1050		10.1126/science.1142950	http://dx.doi.org/10.1126/science.1142950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17463247	Green Submitted			2022-12-24	WOS:000246554000052
J	Huang, YH; Grasis, JA; Miller, AT; Xu, R; Soonthornvacharin, S; Andreotti, AH; Tsoukas, CD; Cooke, MP; Sauer, K				Huang, Yina H.; Grasis, Juris A.; Miller, Andrew T.; Xu, Ruo; Soonthornvacharin, Stephen; Andreotti, Amy H.; Tsoukas, Constantine D.; Cooke, Michael P.; Sauer, Karsten			Positive regulation of ltk PH domain function by soluble IP4	SCIENCE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; T-LYMPHOCYTE DEVELOPMENT; INOSITOL 1,3,4,5-TETRAKISPHOSPHATE; GAP1 FAMILY; PROTEIN; KINASE; CELLS; ACTIVATION; SELECTION	Pleckstrin homology (PH) domain-mediated protein recruitment to cellular membranes is of paramount importance for signal transduction. The recruitment of many PH domains is controlled through production and turnover of their membrane ligand, phosphatidylinositol 3,4,5-trisphosphate (PIP3). We show that phosphorylation of the second messenger inositol 1,4,5-trisphosphate (IP3) into inositol 1,3,4,5-tetrakisphosphate (IP4) establishes another mode of PH domain regulation through a soluble ligand. At physiological concentrations, IP4 promoted PH domain binding to PIP3. In primary mouse CD4(+)CD8(+) thymocytes, this was required for full activation of the protein tyrosine kinase Itk after T cell receptor engagement. Our data suggest that IP4 establishes a feedback loop of phospholipase C-gamma 1 activation through Itk that is essential for T cell development.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Ctr Microbial Studies, San Diego, CA 92182 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Iowa State Univ Sci & Technol, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Scripps Research Institute; California State University System; San Diego State University; California State University System; San Diego State University; Novartis; Iowa State University	Sauer, K (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ksauer@scripps.edu	Grasis, Juris A./K-2568-2012	Grasis, Juris A./0000-0002-3945-0135; Huang, Yina/0000-0002-0125-9351	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048848] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR048848] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Ching KA, 1999, J IMMUNOL, V163, P6006; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Fukuda M, 1996, J BIOL CHEM, V271, P18838, DOI 10.1074/jbc.271.31.18838; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; GUSE AH, 1993, J BIOL CHEM, V268, P7129; Kojima T, 1997, BIOCHEM BIOPH RES CO, V236, P333, DOI 10.1006/bbrc.1997.6947; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Serrano CJ, 2005, J IMMUNOL, V174, P6233, DOI 10.4049/jimmunol.174.10.6233; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stricker R, 1999, EUR J BIOCHEM, V265, P815, DOI 10.1046/j.1432-1327.1999.00795.x; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846	17	68	68	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					886	889		10.1126/science.1138684	http://dx.doi.org/10.1126/science.1138684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17412921				2022-12-24	WOS:000246369800037
J	Gupta, R; Hong, DL; Iborra, F; Sarno, S; Enver, T				Gupta, Rajeev; Hong, Dengli; Iborra, Francisco; Sarno, Samantha; Enver, Tariq			NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells	SCIENCE			English	Article							REPOPULATING CELLS; CORD BLOOD; SELF-RENEWAL; IN-VITRO; TRANSDUCTION; MICE; DIFFERENTIATION; EXPRESSION; EFFICIENCY; EXPANSION	Clinically successful hematopoietic cell transplantation is dependent on hematopoietic stem and progenitor cells. Here we identify the matricellular protein Nephroblastoma Overexpressed (Nov, CCN3) as being essential for their functional integrity. Nov expression is restricted to the primitive (CD34) compartments of umbilical vein cord blood, and its knockdown in these cells by lentivirus-mediated RNA interference abrogates their function in vitro and in vivo. Conversely, forced expression of Nov and addition of recombinant Nov protein both enhance primitive stem and/or progenitor activity. Taken together, our results identify Nov ( CCN3) as a regulator of human hematopoietic stem or progenitor cells.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Headington OX3 9DS, England	University of Oxford	Enver, T (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Headington OX3 9DS, England.	tenver@gwmail.jr2.ox.ac.uk	Iborra, Francisco J/A-2943-2009; iborra, francisco j/K-9313-2015	iborra, francisco j/0000-0002-0692-3696; Gupta, Rajeev/0000-0001-9573-0505	MRC [MC_U137973816, MC_U137961143, MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137973817, MC_U137961143, MC_U137973816] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Attar EC, 2004, LEUKEMIA, V18, P1760, DOI 10.1038/sj.leu.2403515; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Broxmeyer HE, 2005, CYTOTHERAPY, V7, P209, DOI 10.1080/14653240510027190; Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Cho RH, 2000, EXP HEMATOL, V28, P1080, DOI 10.1016/S0301-472X(00)00507-5; DEHAAN G, COMMUNICATION; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Denning-Kendall PA, 2002, BRIT J HAEMATOL, V116, P218, DOI 10.1046/j.1365-2141.2002.03254.x; Dick JE, 2001, ANN NY ACAD SCI, V938, P184; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; LU L, 1993, J EXP MED, V178, P2089, DOI 10.1084/jem.178.6.2089; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173	31	93	98	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					590	593		10.1126/science.1136031	http://dx.doi.org/10.1126/science.1136031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463287				2022-12-24	WOS:000245983100043
J	Wijeysundera, DN; Karkouti, K; Dupuis, JY; Rao, V; Chan, CT; Granton, JT; Beattie, WS				Wijeysundera, Duminda N.; Karkouti, Keyvan; Dupuis, Jean-Yves; Rao, Vivek; Chan, Christopher T.; Granton, John T.; Beattie, W. Scott			Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTIMATED CREATININE CLEARANCE; GLOMERULAR-FILTRATION-RATE; RISK INDEX; FAILURE; BYPASS; DYSFUNCTION; MORTALITY; ASSOCIATION; ADULT; OUTCOMES	Context A predictive index for renal replacement therapy (RRT; hemodialysis or continuous venovenous hemodiafiltration) after cardiac surgery may improve clinical decision making and research design. Objectives To develop a predictive index for RRT using preoperative information. Design, Setting, and Participants Retrospective cohort of 20 131 cardiac surgery patients at 2 hospitals in Ontario, Canada. The derivation cohort consisted of 10 751 patients at Toronto General Hospital (1999-2004). The validation cohorts consisted of 2566 patients at Toronto General Hospital (2004-2005) and 6814 patients at Ottawa Heart Institute (1999-2003). Main Outcome Measure Postoperative RRT. Results RRT rates in the derivation, Toronto validation, and Ottawa validation cohorts were 1.3%, 1.8%, and 2.2%, respectively. Multivariable predictors of RRT were preoperative estimated glomerular filtration rate, diabetes mellitus requiring medication, left ventricular ejection fraction, previous cardiac surgery, procedure, urgency of surgery, and preoperative intra-aortic balloon pump. The predictive index was scored from 0 to 8 points. An estimated glomerular filtration rate less than or equal to 30 mL/min was assigned 2 points; other components were assigned 1 point each: estimated glomerular filtration rate 31 to 60 mL/min, diabetes mellitus, ejection fraction less than or equal to 40%, previous cardiac surgery, procedure other than coronary artery bypass grafting, intra-aortic balloon pump, and nonelective case. Among the 53% of patients with low risk scores (<= 1), the risk of RRT was 0.4%; by comparison, this risk was 10% among the 6% of patients with high-risk scores (>= 4). The predictive index had areas under the receiver operating characteristic curve in the derivation, Toronto validation, and Ottawa validation cohorts of 0.81, 0.78, and 0.78, respectively. When these cohorts were stratified based on index scores, likelihood ratios for RRT were more concordant than observed RRT rates. Conclusions RRT after cardiac surgery is predicted by readily available preoperative information. A simple predictive index based on this information discriminated well between low- and high-risk patients in derivation and validation cohorts. The index had improved generalizability when used to predict likelihood ratios for RRT.	Toronto Gen Hosp, Dept Anesthesia, Toronto, ON M5G 2C4, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Ottawa, Inst Heart, Dept Anesthesia, Ottawa, ON, Canada; Toronto Gen Hosp, Div Cardiac Surg, Toronto, ON M5G 2C4, Canada; Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; Univ Hlth Network, Div Respirol & Crit Care Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Ottawa; University of Ottawa Heart Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wijeysundera, DN (corresponding author), Toronto Gen Hosp, Dept Anesthesia, EN 3-450 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	duminda.wijeysundera@uhn.on.ca	Wijeysundera, Duminda/L-3350-2018; Beattie, William Scott/A-4352-2008	Wijeysundera, Duminda/0000-0002-5897-8605; Karkouti, Keyvan/0000-0001-8776-5660				Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Austin PC, 2020, STAT MED, V39, P103, DOI 10.1002/sim.8399; Burns KEA, 2005, JAMA-J AM MED ASSOC, V294, P342, DOI 10.1001/jama.294.3.342; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Chertow GM, 1997, CIRCULATION, V95, P878; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; Coresh J, 2002, J AM SOC NEPHROL, V13, P2811, DOI 10.1097/01.ASN.0000037420.89149.C9; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; DETSKY AS, 1986, J GEN INTERN MED, V1, P211, DOI 10.1007/BF02596184; Dupuis JY, 2001, ANESTHESIOLOGY, V94, P194, DOI 10.1097/00000542-200102000-00006; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HARRELL FE, DESIGN S FUNCTIONS B; Harrell FE, 2001, REGRESSION MODELING; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Hix JK, 2006, CRIT CARE MED, V34, P2979, DOI 10.1097/01.CCM.0000248905.67352.BA; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ivanov J, 1999, CIRCULATION, V99, P2098, DOI 10.1161/01.CIR.99.16.2098; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Karkouti K, 2005, J THORAC CARDIOV SUR, V129, P391, DOI 10.1016/j.jtcvs.2004.06.028; Landoni G, 2007, AM J KIDNEY DIS, V49, P56, DOI 10.1053/j.ajkd.2006.10.013; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Noyez L, 2006, EUR J CARDIO-THORAC, V29, P461, DOI 10.1016/j.ejcts.2006.01.024; PIERPONT GL, 1985, J THORAC CARDIOV SUR, V89, P673; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Taher T, 2002, J GEN INTERN MED, V17, P933, DOI 10.1046/j.1525-1497.2002.11230.x; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Wang F, 2003, CHEST, V124, P1852, DOI 10.1378/chest.124.5.1852; Wijeysundera DN, 2006, ANESTHESIOLOGY, V104, P65, DOI 10.1097/00000542-200601000-00012; Yap CH, 2006, EUR J CARDIO-THORAC, V29, P441, DOI 10.1016/j.ejcts.2005.12.046	48	282	329	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1801	1809		10.1001/jama.297.16.1801	http://dx.doi.org/10.1001/jama.297.16.1801			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456822	Bronze			2022-12-24	WOS:000245922100026
J	Galan-Caridad, JM; Harel, S; Arenzana, TL; Hou, ZE; Doetsch, FK; Mirny, LA; Reizis, B				Galan-Caridad, Jose M.; Harel, Sivan; Arenzana, Teresita L.; Hou, Z. Esther; Doetsch, Fiona K.; Mirny, Leonid A.; Reizis, Boris			Zfx controls the self-renewal of embryonic and hematopoietic stem cells	CELL			English	Article							GENE; MICE; BMI-1; NICHE; DIFFERENTIATION; PROLIFERATION; PLURIPOTENCY; MAINTENANCE; NETWORKS; BIOLOGY	Stem cells (SC) exhibit a unique capacity for self-renewal in an undifferentiated state. It is unclear whether the self-renewal of pluripotent embryonic SC (ESC) and of tissue-specific adult SC such as hernatopoietic SC (HSC) is controlled by common mechanisms. The deletion of transcription factor Zfx impaired the selfrenewal but not the differentiation capacity of murine ESC; conversely, Zfx overexpression facilitated ESC self-renewal by opposing differentiation. Furthermore, Zfx deletion abolished the maintenance of adult HSC but did not affect erythromyeloid progenitors or fetal HSC. Zfxdeficient ESC and HSC showed increased apoptosis and SC-specific upregulation of stressinducible genes. Zfx directly activated common target genes in ESC and HSC, as well as ESCspecific target genes including ESC selfrenewal regulators Tbx3 and Tcl1. These studies identify Zfx as a shared transcriptional regulator of ESC and HSC, suggesting a common genetic basis of self-renewal in embryonic and adult SC.	Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Columbia University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT)	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA.	bvr2101@columbia.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Reizis, Boris/0000-0003-1140-7853	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007525, R01AI072571, F31AI066459, R21AI085439] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL084353, R01 HL084353-01, R01 HL084353] Funding Source: Medline; NIAID NIH HHS [AI007525, R01 AI072571, T32 AI007525-10, R21 AI085439, F31 AI066459, AI066459, T32 AI007525, F31 AI066459-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Fortunel NO, 2003, SCIENCE, V302, P393; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Luoh SW, 1997, DEVELOPMENT, V124, P2275; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Sakaguchi T, 2006, MOL CELL BIOL, V26, P6557, DOI 10.1128/MCB.00729-06; SCHNEIDERGADICKE A, 1989, NATURE, V342, P708, DOI 10.1038/342708a0; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	186	203	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					345	357		10.1016/j.cell.2007.03.014	http://dx.doi.org/10.1016/j.cell.2007.03.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448993	Bronze, Green Accepted			2022-12-24	WOS:000246474600021
J	Hodge, JG; Gostin, LO; Vernick, JS				Hodge, James G., Jr.; Gostin, Lawrence O.; Vernick, Jon S.			The pandemic and all-hazards preparedness act - Improving public health emergency response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROFESSIONALS		Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Law & Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Washington, DC USA; Johns Hopkins Univ, Baltimore, MD USA; Oneill Inst Natl & Global Hlth Law, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Hodge, JG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Law & Publ Hlth, 624 N Broadway,Hampton House Room 588, Baltimore, MD 21205 USA.	jhodge@jhsph.edu						Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; GOSTIN LO, IN PRESS PUBLIC HLTH; *HLTH RES SERV AG, 2006, EM SYST ADV REG VOL; Hodge JG, 2006, PUBLIC HEALTH REP, V121, P205, DOI 10.1177/003335490612100217; Hodge JG, 2005, BIOSECUR BIOTERROR, V3, P216, DOI 10.1089/bsp.2005.3.216; Hodge JG, 2004, J LAW MED ETHICS, V32, P670, DOI 10.1111/j.1748-720X.2004.tb01972.x; Institute of Medicine, 2002, FUT PUBL HLTH 21 CEN; THOMPSON AK, 2006, BMC MED ETHICS, V7, P1; *U NC SCH PUBL HLT, PUBL PRIV LEG PREP I; *US CDCP, BIOSENSE; US Department of Health and Human Services, HHS PAND INFL PLAN; *WHIT HOUS, 2006, FED RESP HURR KATR L, V58; *WHO DEP COMM DIS, 2005, WHO GLOB INFL PREP P; NATL RESPONSE PLAN	14	33	33	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2007	297	15					1708	1711		10.1001/jama.297.15.1708	http://dx.doi.org/10.1001/jama.297.15.1708			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	157UR	17440147				2022-12-24	WOS:000245747400024
J	Mukherjee, R; Eastman, N; Turk, J; Hollins, S				Mukherjee, Raja; Eastman, Nigel; Turk, Jeremy; Hollins, Sheila			Fetal alcohol syndrome: law and ethics	LANCET			English	Editorial Material									Bracketts Resource Ctr, Surrey Border Partnership Trust, Surrey RH8 0QA, England; Univ London, St Georges, Div Mental Hlth, London SW17 0RE, England; Univ London, St Georges, Div Clin Dev Sci, London SW17 0RE, England	St Georges University London; University of London; St Georges University London; University of London	Mukherjee, R (corresponding author), Bracketts Resource Ctr, Surrey Border Partnership Trust, Surrey RH8 0QA, England.	rmukherj@sgul.ac.uk		Mukherjee, Raja/0000-0002-2171-928X				ABEL EL, 1988, NEUROTOXICOL TERATOL, V10, P1, DOI 10.1016/0892-0362(88)90060-8; Armstrong EM, 1998, SOC SCI MED, V47, P2025, DOI 10.1016/S0277-9536(98)00308-6; GOVARGUE S, 1998, MED LAW REV, V6, P265; Kesmodel U, 2002, ALCOHOL CLIN EXP RES, V26, P1553, DOI 10.1097/01.ALC.0000034702.14322.25; May PA, 2007, DRUG ALCOHOL DEPEN, V88, P259, DOI 10.1016/j.drugalcdep.2006.11.007; NANSON JL, 1995, CAN MED ASSOC J, V152, P1071; *PRIM MIN STRAT GR, 2004, ALC HARM RED STRAT E; Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840; SMITH JC, 2002, HOGAN CRIMINAL LAW	9	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1149	1150		10.1016/S0140-6736(07)60542-X	http://dx.doi.org/10.1016/S0140-6736(07)60542-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	155RH	17416245				2022-12-24	WOS:000245595100008
J	Sims, EJ; Mugford, M; Clark, A; Aitken, D; McCormick, J; Mehta, G; Mehta, A				Sims, Erika J.; Mugford, Miranda; Clark, Allan; Aitken, David; McCormick, Jonathan; Mehta, Gita; Mehta, Anil		UK Cystic Fibrosis Database	Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study	LANCET			English	Article							CONTROLLED-TRIAL; DORNASE-ALPHA; LUNG-FUNCTION; DIAGNOSIS; BENEFITS; OUTCOMES	Background Newborn screening for cystic fibrosis might not be introduced if implementation and running costs are perceived as prohibitive. Compared with clinical diagnosis, newborn screening is associated with clinical benefit and reduced treatment needs. We estimate the potential savings in treatment costs attributable to newborn screening. Methods Using the UK Cystic Fibrosis Database, we used a prevalence strategy to undertake a cost of illness retrospective snapshot cohort study. We estimated yearly costs of long-term therapies and intravenous antibiotics for 184 patients who were diagnosed as a result of screening as newborn babies, and 950 patients who were clinically diagnosed aged 1-9 years in 2002. Costs of adding cystic fibrosis screening to an established newborn screening service in Scotland were adjusted to 2002 prices and applied to the UK as a whole. Costs were recalculated in US$. Findings Cost of therapy for patients diagnosed by newborn screening was significantly lower than equivalent therapies for clinically diagnosed patients: mean ($7228 vs $12008, 95% CI of difference -6736 to -2028, p < 0.0001) and median ($352 vs $2442, -1916 to -180, p < 0.0001). When we limited the clinically diagnosed group to only those diagnosable with a 31 cystic fibrosis transmembrane regulator mutation assay and assumed similar disease progression in the clinically diagnosed group as in the newborn screening group, we showed that mean ($3397 344) or median ($947 032) drug cost savings could have offset the estimated cost of adding cystic fibrosis to a UK national newborn screening service ($2 971551). Interpretation Including indirect costs savings, newborn screening for cystic fibrosis might have even greater financial benefits to society than our estimate shows. Clinical, social, and now economic evidence suggests that universal newborn screening programmes for cystic fibrosis should be adopted internationally.	Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Sch Med, Norwich NR4 7TJ, Norfolk, England; Univ Dundee, UK Cyst Fibrosis Database, Div Maternal Child Hlth Sci, Ninewells Hosp, Dundee, Scotland; Univ Dundee, Sch Med, Dundee, Scotland; Univ E Anglia, Populat Hlth Grp, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Inst Med Genet, Scottish Newborn Screening Lab, Glasgow, Lanark, Scotland; Royal Hosp Sick Children, Resp Unit, Yorkhill NHS Trust, Glasgow G3 8SJ, Lanark, Scotland	University of East Anglia; University of Dundee; University of Dundee; University of East Anglia; University of East Anglia; University of Glasgow; University of Glasgow	Sims, EJ (corresponding author), Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Sch Med, Norwich NR4 7TJ, Norfolk, England.	e.sims@uea.ac.uk		Clark, Allan/0000-0003-2965-8941				[Anonymous], 1997, MMWR Recomm Rep, V46, P1; *BRIT MED ASS, 2002, BRIT NAT FORM; Farrell PM, 2003, AM J RESP CRIT CARE, V168, P1100, DOI 10.1164/rccm.200303-434OC; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; FARRELL PM, 1997, PEDIATRICS, V100, P2; HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; Lee DS, 2003, J PEDIATR-US, V142, P617, DOI 10.1067/mpd.2003.209; LITTLEWOOD J, 2002, ANTIBIOTIC TREATMENT; Mastella G, 2001, PANCREATOLOGY, V1, P531, DOI 10.1159/000055856; McCabe ERB, 1999, ACTA PAEDIATR, V88, P58, DOI 10.1080/080352599750029402; McCormick J, 2002, EUR J HUM GENET, V10, P583, DOI 10.1038/sj.ejhg.5200850; McCormick Jonathan, 2005, J Cyst Fibros, V4, P53, DOI 10.1016/j.jcf.2004.11.003; Mehta A, 2001, LANCET, V358, P1546, DOI 10.1016/S0140-6736(01)06593-X; Mehta G, 2004, J ROY SOC MED, V97, P60; *NO IR STAT RES AG, 2002, 81 ANN NO IR STAT RE; *OFF NAT STAT, BIRTH STAT 2002; *ORG EC COOP DEV, PURCH POW PAR OECD C; *ORG EC COOP DEV, CONS PRIC IND IND HL; Paul K, 2004, AM J RESP CRIT CARE, V169, P719, DOI 10.1164/rccm.200307-959OC; POLLITT RJ, 1997, HEALTH TECHNOL ASSES, V1, pI202; Quan JM, 2001, J PEDIATR-US, V139, P813, DOI 10.1067/mpd.2001.118570; RANDALL J, SCOTLANDS POPULATION; Rosenberg MA, 2005, J PEDIATR-US, V147, pS101, DOI 10.1016/j.jpeds.2005.08.018; Simpson Neil, 2005, Cost Eff Resour Alloc, V3, P8, DOI 10.1186/1478-7547-3-8; Sims EJ, 2005, J PEDIATR-US, V147, pS42, DOI 10.1016/j.jpeds.2005.08.002; Sims EJ, 2005, J PEDIATR-US, V147, P306, DOI 10.1016/j.jpeds.2005.05.034; Sims EJ, 2005, DIABETES CARE, V28, P1581, DOI 10.2337/diacare.28.7.1581; Sims EJ, 2007, PEDIATRICS, V119, P19, DOI 10.1542/peds.2006-1498; Siret D, 2003, PEDIATR PULM, V35, P342, DOI 10.1002/ppul.10259; Smyth A, 2005, LANCET, V365, P573, DOI 10.1016/S0140-6736(05)17906-9; *UK NAT STAT, 2005, CONS PRIC IND IND 06; *US C OFF TECHN AS, 1992, CYST FIBR DNA TESTS; Waters DL, 1999, ARCH DIS CHILD-FETAL, V80, pF1, DOI 10.1136/fn.80.1.F1; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	36	70	71	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2007	369	9568					1187	1195		10.1016/S0140-6736(07)60565-0	http://dx.doi.org/10.1016/S0140-6736(07)60565-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416263				2022-12-24	WOS:000245595100030
J	Chang, L; Huang, L; Gau, SS; Wu, Y; Hsia, S; Fan, T; Lin, K; Huang, Y; Lu, C; Lin, T				Chang, Luan-Yin; Huang, Li-Min; Gau, Susan Shur-Fen; Wu, Yu-Yu; Hsia, Shao-Hsuan; Fan, Tsui-Yen; Lin, Kuang-Lin; Huang, Yhu-Chering; Lu, Chun-Yi; Lin, Tzou-Yien			Neurodevelopment and cognition in children after enterovirus 71 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLUENZAE MENINGITIS; BACTERIAL-MENINGITIS; MOUTH-DISEASE; EPIDEMIC; OUTBREAK; TAIWAN; OUTCOMES; ENCEPHALOMYELITIS; ENCEPHALITIS; MANAGEMENT	Background: Enterovirus 71 is a common cause of hand, foot, and mouth disease and encephalitis in Asia and elsewhere. The long-term neurologic and psychiatric effects of this viral infection on the central nervous system (CNS) are not well understood. Methods: We conducted long-term follow-up of 142 children after enterovirus 71 infection with CNS involvement - 61 who had aseptic meningitis, 53 who had severe CNS involvement, and 28 who had cardiopulmonary failure after CNS involvement. At a median follow-up of 2.9 years (range, 1.0 to 7.4) after infection, the children received physical and neurologic examinations. We administered the Denver Developmental Screening Test (DDST II) to children 6 years of age or younger and the Wechsler intelligence test to children 4 years of age or older. Results: Nine of the 16 patients with a poliomyelitis-like syndrome (56%) and 1 of the 5 patients with encephalomyelitis (20%) had sequelae involving limb weakness and atrophy. Eighteen of the 28 patients with cardiopulmonary failure after CNS involvement (64%) had limb weakness and atrophy, 17 (61%) required tube feeding, and 16 (57%) required ventilator support. Among patients who underwent DDST II assessment, delayed neurodevelopment was found in only 1 of 20 patients (5%) with severe CNS involvement and in 21 of 28 patients (75%) with cardiopulmonary failure (P<0.001 for the overall comparison). Children with cardiopulmonary failure after CNS involvement scored lower on intelligence tests than did children with CNS involvement alone (P=0.003). Conclusions: Enterovirus 71 infection with CNS involvement and cardiopulmonary failure may be associated with neurologic sequelae, delayed neurodevelopment, and reduced cognitive functioning. Children with CNS involvement without cardiopulmonary failure did well on neurodevelopment tests. (ClinicalTrials. gov number, NCT00172393.)	Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, Taipei, Taiwan; Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Psychiat, Taipei, Taiwan; Chang Gung Univ, Chang Gung Childrens Hosp, Dept Child Psychiat, Tao Yuan, Taiwan; Chang Gung Univ, Chang Gung Childrens Hosp, Dept Pediat, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chang, L (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pediat, 7 Chung Shan S Rd, Taipei, Taiwan.	ly7077@tpts6.seed.net.tw	Gau, Susan Shur-Fen/P-4726-2017	Gau, Susan Shur-Fen/0000-0002-2718-8221; LU, CHUN-YI/0000-0002-5240-2808; CHANG, LUAN-YIN/0000-0003-2632-1956; HUANG, LI-MIN/0000-0002-9291-260X				ALLEN SR, 1995, J CLIN PSYCHOL, V51, P648, DOI 10.1002/1097-4679(199509)51:5<648::AID-JCLP2270510510>3.0.CO;2-R; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Baruah H C, 2002, Indian Pediatr, V39, P1143; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 2004, PEDIATR INFECT DIS J, V23, P327, DOI 10.1097/00006454-200404000-00010; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Dolin R, 1999, NEW ENGL J MED, V341, P984, DOI 10.1056/NEJM199909233411309; EMMETT M, 1980, AUST PAEDIATR J, V16, P90; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Kari K, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-8; Lahat E, 1999, ARCH DIS CHILD, V80, P69, DOI 10.1136/adc.80.1.69; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Mekan Sabeen F., 2005, JPMA Journal of the Pakistan Medical Association, V55, P146; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Shen WC, 1999, AM J NEURORADIOL, V20, P1889; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Taylor HG, 2000, NEUROPSYCHOLOGY, V14, P509, DOI 10.1037/0894-4105.14.4.509; Wong KT, 2000, NEUROPATH APPL NEURO, V26, P313, DOI 10.1046/j.1365-2990.2000.00256.x	22	258	318	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1226	1234		10.1056/NEJMoa065954	http://dx.doi.org/10.1056/NEJMoa065954			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377160				2022-12-24	WOS:000245101900007
J	Kales, SN; Soteriades, ES; Christophi, CA; Christiani, DC				Kales, Stefanos N.; Soteriades, Elpidoforos S.; Christophi, Costas A.; Christiani, David C.			Emergency duties and deaths from heart disease among firefighters in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR-DISEASE; HEALTH; RESPONSES; FITNESS; PROFILE; TIME; ECG	Background: Heart disease causes 45% of the deaths that occur among U.S. firefighters while they are on duty. We examined duty-specific risks of death from coronary heart disease among on-duty U.S. firefighters from 1994 to 2004. Methods: We reviewed summaries provided by the Federal Emergency Management Agency of the deaths of all on-duty firefighters between 1994 and 2004, except for deaths associated with the September 11, 2001, terrorist attacks. Estimates of the proportions of time spent by firefighters each year performing various duties were obtained from a municipal fire department, from 17 large metropolitan fire departments, and from a national database. Odds ratios and 95% confidence intervals for death from coronary heart disease during specific duties were calculated from the ratios of the observed odds to the expected odds, with nonemergency duties as the reference category. Results: Deaths from coronary heart disease were associated with suppressing a fire (32.1% of all such deaths), responding to an alarm (13.4%), returning from an alarm (17.4%), engaging in physical training (12.5%), responding to nonfire emergencies (9.4%), and performing nonemergency duties (15.4%). As compared with the odds of death from coronary heart disease during nonemergency duties, the odds were 12.1 to 136 times as high during fire suppression, 2.8 to 14.1 times as high during alarm response, 2.2 to 10.5 times as high during alarm return, and 2.9 to 6.6 times as high during physical training. These odds were based on three estimates of the time that firefighters spend on their duties. Conclusions: Certain emergency firefighting duties were associated with a risk of death from coronary heart disease that was markedly higher than the risk associated with nonemergency duties. Fire suppression was associated with the highest risk, which was approximately 10 to 100 times as high as that for nonemergency duties.	Harvard Univ, Sch Med, Cambridge Hlth Alliance, Employee Hlth & Ind Med, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; Kindred Hosp NE, Ctr Occupat & Environm Med, Braintree, MA USA; Harvard Univ, Sch Publ Hlth, Cyprus Inst Inst Environm & Publ Hlth, Nicosia, Cyprus	Harvard University; Cambridge Health Alliance; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Kales, SN (corresponding author), Harvard Univ, Sch Med, Cambridge Hlth Alliance, Employee Hlth & Ind Med, Lee B Macht Bldg,Rm 427,1493 Cambridge St, Cambridge, MA 02139 USA.	skales@challiance.org			PHS HHS [T42/CCT122961-02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Austin CC, 2001, AM J IND MED, V40, P683, DOI 10.1002/ajim.10023; BARNARD RJ, 1975, J OCCUP ENVIRON MED, V17, P247; Burgess JL, 2001, J OCCUP ENVIRON MED, V43, P467, DOI 10.1097/00043764-200105000-00007; Clark S, 2002, J OCCUP ENVIRON MED, V44, P940, DOI 10.1097/00043764-200210000-00013; Cohen, 1998, AM J CARDIOL, V81, P260; Cohen MC, 1997, AM J CARDIOL, V79, P1512, DOI 10.1016/S0002-9149(97)00181-1; Fahy RF., 2005, ANAL NFPA FIRE ANAL; Fisher Nicholas G, 2005, J R Nav Med Serv, V91, P112; FRANKE WD, 1994, J OCCUP ENVIRON MED, V36, P1127, DOI 10.1097/00043764-199410000-00016; Franklin BA, 1996, AM J CARDIOL, V77, P855, DOI 10.1016/S0002-9149(97)89181-3; FRIEL JK, 1992, AM J PUBLIC HEALTH, V82, P1175, DOI 10.2105/AJPH.82.8.1175-a; Glueck CJ, 1996, AM J IND MED, V30, P331, DOI 10.1002/ajim.4700300313; Guidotti TL, 1995, J OCCUP ENVIRON MED, V37, P1348, DOI 10.1097/00043764-199512000-00004; GUIDOTTI TL, 1992, INT ARCH OCC ENV HEA, V64, P1, DOI 10.1007/BF00625945; Haas NS, 2003, INT J OCCUP ENV HEAL, V9, P95, DOI 10.1179/oeh.2003.9.2.95; Holder JD, 2006, J OCCUP ENVIRON MED, V48, P1047, DOI 10.1097/01.jom.0000235909.31632.46; Ide CW, 2000, SCOT MED J, V45, P79, DOI 10.1177/003693300004500307; *INT ASS FIR FIGHT, PRES LEG; Johnstone MT, 1996, AM J HYPERTENS, V9, pS22, DOI 10.1016/0895-7061(95)00403-3; Kales SN, 1999, J OCCUP ENVIRON MED, V41, P589, DOI 10.1097/00043764-199907000-00007; Kales SN, 2000, J OCCUP ENVIRON MED, V42, P467, DOI 10.1097/00043764-200005000-00001; Kales Stefanos N, 2003, Environ Health, V2, P14, DOI 10.1186/1476-069X-2-14; KARTER MJ, 2001, US FIR DEP PROF 2000; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; KUORINKA I, 1981, J OCCUP ENVIRON MED, V23, P762, DOI 10.1097/00043764-198111000-00010; LEMON PWR, 1977, J OCCUP ENVIRON MED, V19, P337; Maguire BJ, 2002, ANN EMERG MED, V40, P625, DOI 10.1067/mem.2002.128681; Melius J, 2001, OCCUP MED-STATE ART, V16, P101; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; *NAT FIR PROT ASS, FIR STAT; Roberts MA, 2002, J STRENGTH COND RES, V16, P271; Smith DL, 2001, ERGONOMICS, V44, P244, DOI 10.1080/00140130010000910; Soteriades ES, 2005, OBES RES, V13, P1756, DOI 10.1038/oby.2005.214; Soteriades ES, 2002, J OCCUP ENVIRON MED, V44, P840, DOI 10.1097/00043764-200209000-00006; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Steenland K, 1996, AM J IND MED, V30, P495, DOI 10.1002/(SICI)1097-0274(199610)30:4<495::AID-AJIM16>3.3.CO;2-I; TriData Corporation, 2002, FIR FAT RETR STUD; *US FIR ADM, FIR FAT; Willich SN, 1998, EUR HEART J, V19, pC12	39	338	342	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1207	1215		10.1056/NEJMoa060357	http://dx.doi.org/10.1056/NEJMoa060357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377158	Green Published, Bronze			2022-12-24	WOS:000245101900005
J	Engelman, JA; Zejnullahu, K; Mitsudomi, T; Song, YC; Hyland, C; Park, JO; Lindeman, N; Gale, CM; Zhao, XJ; Christensen, J; Kosaka, T; Holmes, AJ; Rogers, AM; Cappuzzo, F; Mok, T; Lee, C; Johnson, BE; Cantley, LC; Janne, PA				Engelman, Jeffrey A.; Zejnullahu, Kreshnik; Mitsudomi, Tetsuya; Song, Youngchul; Hyland, Courtney; Park, Joon Oh; Lindeman, Neal; Gale, Christopher-Michael; Zhao, Xiaojun; Christensen, James; Kosaka, Takayuki; Holmes, Alison J.; Rogers, Andrew M.; Cappuzzo, Federico; Mok, Tony; Lee, Charles; Johnson, Bruce E.; Cantley, Lewis C.; Janne, Pasi A.			MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling	SCIENCE			English	Article							GROWTH-FACTOR-RECEPTOR; GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE; ACQUIRED-RESISTANCE; IMATINIB MESYLATE; INHIBITOR; MUTATIONS; THERAPY; GENE; ADENOCARCINOMA	The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance. Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance to gefitinib as a result of focal amplification of the MET proto-oncogene. inhibition of MET signaling in these cells restored their sensitivity to gefitinib. MET amplification was detected in 4 of 18 (22%) lung cancer specimens that had developed resistance to gefitinib or erlotinib. We find that amplification of MET causes gefitinib resistance by driving ERBB3 (HER3)-dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors. Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.	Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Signal Transduct, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 4648681, Japan; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Pfizer Global Res & Dev, Dept Res Pharmacol, San Diego, CA 92121 USA; Ist Clin Humanitas, Dept Hematol Oncol, I-20089 Rozzano, Italy; Chinese Univ Hong Kong, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Aichi Cancer Center; Harvard University; Brigham & Women's Hospital; Pfizer; IRCCS Humanitas Research Hospital; Chinese University of Hong Kong	Janne, PA (corresponding author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA.	pjanne@partners.org	Mok, Tony Shu Kam/B-2310-2019; Cappuzzo, federico/R-2827-2016; Cantley, Lewis C/D-1800-2014	Mok, Tony Shu Kam/0000-0002-8251-0551; Cappuzzo, federico/0000-0002-6295-6767; Cantley, Lewis C/0000-0002-1298-7653; Mitsudomi, Tetsuya/0000-0001-9860-8505	NCI NIH HHS [R01-CA111560, P01 CA089021, P20CA90578-02, 1K12CA87723-01, K08CA120060-01, R01CA114465-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM041890, GM41890] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA120060, K12CA087723, R01CA111560, R01CA114465, P01CA089021, P20CA090578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041890, R01GM041890] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Christensen JG, 2003, CANCER RES, V63, P7345; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miller CT, 2006, ONCOGENE, V25, P409, DOI 10.1038/sj.onc.1209057; Mukohara T, 2005, CLIN CANCER RES, V11, P8122, DOI 10.1158/1078-0432.CCR-05-1191; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Yakes FM, 2002, CANCER RES, V62, P4132	22	3606	3832	7	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1039	1043		10.1126/science.1141478	http://dx.doi.org/10.1126/science.1141478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17463250				2022-12-24	WOS:000246554000050
J	Blain, S; Queguiner, B; Armand, L; Belviso, S; Bombled, B; Bopp, L; Bowie, A; Brunet, C; Brussaard, C; Carlotti, F; Christaki, U; Corbiere, A; Durand, I; Ebersbach, F; Fuda, JL; Garcia, N; Gerringa, L; Griffiths, B; Guigue, C; Guillerm, C; Jacquet, S; Jeandel, C; Laan, P; Lefevre, D; Lo Monaco, C; Malits, A; Mosseri, J; Obernosterer, I; Park, YH; Picheral, M; Pondaven, P; Remenyi, T; Sandroni, V; Sarthou, G; Savoye, N; Scouarnec, L; Souhaut, M; Thuiller, D; Timmermans, K; Trull, T; Uitz, J; van Beek, P; Veldhuis, M; Vincent, D; Viollier, E; Vong, L; Wagener, T				Blain, Stephane; Queguiner, Bernard; Armand, Leanne; Belviso, Sauveur; Bombled, Bruno; Bopp, Laurent; Bowie, Andrew; Brunet, Christian; Brussaard, Corina; Carlotti, Francois; Christaki, Urania; Corbiere, Antoine; Durand, Isabelle; Ebersbach, Frederike; Fuda, Jean-Luc; Garcia, Nicole; Gerringa, Loes; Griffiths, Brian; Guigue, Catherine; Guillerm, Christophe; Jacquet, Stephanie; Jeandel, Catherine; Laan, Patrick; Lefevre, Dominique; Lo Monaco, Claire; Malits, Andrea; Mosseri, Julie; Obernosterer, Ingrid; Park, Young-Hyang; Picheral, Marc; Pondaven, Philippe; Remenyi, Thomas; Sandroni, Valerie; Sarthou, Geraldine; Savoye, Nicolas; Scouarnec, Lionel; Souhaut, Marc; Thuiller, Doris; Timmermans, Klaas; Trull, Thomas; Uitz, Julia; van Beek, Pieter; Veldhuis, Marcel; Vincent, Dorothee; Viollier, Eric; Vong, Lilita; Wagener, Thibaut			Effect of natural iron fertilization on carbon sequestration in the Southern Ocean	NATURE			English	Article							ATMOSPHERIC CO2; SEA; CLIMATE; ATLANTIC; EXCHANGE; SEAWATER; SAMPLES; WATERS; BLOOM; RATES	The availability of iron limits primary productivity and the associated uptake of carbon over large areas of the ocean. Iron thus plays an important role in the carbon cycle, and changes in its supply to the surface ocean may have had a significant effect on atmospheric carbon dioxide concentrations over glacial - interglacial cycles(1-5). To date, the role of iron in carbon cycling has largely been assessed using short-term iron-addition experiments(6,7). It is difficult, however, to reliably assess the magnitude of carbon export to the ocean interior using such methods, and the short observational periods preclude extrapolation of the results to longer timescales(8). Here we report observations of a phytoplankton bloom induced by natural iron fertilization - an approach that offers the opportunity to overcome some of the limitations of short-term experiments. We found that a large phytoplankton bloom over the Kerguelen plateau in the Southern Ocean was sustained by the supply of iron and major nutrients to surface waters from iron-rich deep water below. The efficiency of fertilization, defined as the ratio of the carbon export to the amount of iron supplied, was at least ten times higher than previous estimates from short-term blooms induced by iron-addition experiments(7). This result sheds new light on the effect of long-term fertilization by iron and macronutrients on carbon sequestration, suggesting that changes in iron supply from below - as invoked in some palaeoclimatic(9,10) and future climate change scenarios(11) - may have a more significant effect on atmospheric carbon dioxide concentrations than previously thought.	Univ Aix Marseille 2, Ctr Oceanol Marseille, Lab Oceanog & Biogeochim, F-13288 Marseille 09, France; CEN Saclay, IPSL, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Antarct Climate & Ecosyst CRC, Hobart, Tas 7001, Australia; Univ Tasmania, Sch Chem, ACROSS, Hobart, Tas 7001, Australia; Univ Paris 06, CNRS, UMR 7159, LOCEAN IPSL, F-75252 Paris 5, France; Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Texel, Netherlands; Univ Littoral Cote dOpale, FRE ELICO, MREN, F-62930 Wimereux, France; Museum Natl Hist Nat, USM402 LOCEAN, Dept Milieux & Peuplements Marins, F-75231 Paris 05, France; Fac Sci Luminy, Ctr Oceanol Marseille, F-13288 Marseille 09, France; CSIRO, Div Marine & Atmospher Res, Hobart, Tas 7001, Australia; CNRS, UMR 617, LMGEM, F-13288 Marseille 09, France; Technopole Brest Iroise, DT INSU CNRS, F-29280 Plouzane, France; Free Univ Brussels, Dept Analyt & Environm Chem, B-1050 Brussels, Belgium; Observ Midi Pyrenees, LEGOS, CNRS CNES IRD UPS, F-31400 Toulouse, France; Lab Oceanog Villefranche, F-06238 Villefranche Sur Mer, France; Univ Paris 06, CNRS, UMR7621, F-66650 Banyuls sur Mer, France; Technopole Brest Iroise, UMR 6539 LEMAR IUEM, F-29280 Plouzane, France; Univ Arcachon, Observ Aquitain Sci, UMR CNRS 5805 EPOC, Stn Marine Arcachon, F-33120 Arcachon, France; Univ Paris 07, UMP IPGP 7154, Lab Geochim Eaux, F-75251 Paris 05, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Tasmania; University of Tasmania; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universite du Littoral-Cote-d'Opale; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Aix-Marseille Universite; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Blain, S (corresponding author), Univ Aix Marseille 2, Ctr Oceanol Marseille, Lab Oceanog & Biogeochim, Campus Luminy,Case 901, F-13288 Marseille 09, France.	stephane.blain@univmed.fr	Bowie, Andrew/C-8677-2013; Quéguiner, Bernard/B-4060-2008; Lefevre, Dominique/AAN-8201-2021; Obernosterer, Ingrid/A-5434-2011; Trull, Tom W/B-7028-2014; blain, stéphane/F-6917-2010; Lo Monaco, Claire/E-1696-2012; jacquet, stéphanie/K-8678-2016; Jeandel, Catherine/P-3789-2014; UITZ, Julia/Q-7487-2018; Armand, Leanne/C-9004-2009; Vincent, Dorothee/I-8109-2013; bopp, laurent/ABF-5302-2020; Malits, Andrea/U-6869-2018	Bowie, Andrew/0000-0002-5144-7799; Quéguiner, Bernard/0000-0001-5020-8297; Lefevre, Dominique/0000-0003-1694-3807; Obernosterer, Ingrid/0000-0002-2530-8111; blain, stéphane/0000-0002-5234-2446; Jeandel, Catherine/0000-0002-4915-4719; UITZ, Julia/0000-0001-5461-0216; Armand, Leanne/0000-0003-3995-308X; bopp, laurent/0000-0003-4732-4953; timmermans, klaas/0000-0002-3214-4354; Christaki, Urania/0000-0002-2061-5278; VINCENT, Dorothee/0000-0003-0931-3014; Remenyi, Tomas/0000-0002-4145-9323; Pondaven, Philippe/0000-0002-3427-7767; Sarthou, Geraldine/0000-0001-6560-6669; Viollier, Eric/0000-0002-8863-4563; wagener, thibaut/0000-0002-3968-0678; Lo Monaco, Claire/0000-0002-5653-5018				Blain S, 2001, DEEP-SEA RES PT I, V48, P163, DOI 10.1016/S0967-0637(00)00047-9; BOPP L, 2003, PALEOCEANOGRAPHY, V18; Bowie AR, 2001, DEEP-SEA RES PT II, V48, P2703, DOI 10.1016/S0967-0645(01)00015-7; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014210; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BOYD PW, 2005, GLOB BIOCH CYCLES, V19; BRZEZINSKY MA, 2002, GEOPHYS RES LETT, V29; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Chisholm SW, 2001, SCIENCE, V294, P309, DOI 10.1126/science.1065349; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Croot PL, 2000, ELECTROANAL, V12, P565, DOI 10.1002/(SICI)1521-4109(200005)12:8<565::AID-ELAN565>3.0.CO;2-L; Cullen JT, 1999, MAR CHEM, V67, P233, DOI 10.1016/S0304-4203(99)00060-2; DEBAAR HJW, 2005, J GEOPHYS RES, V110; DILLON TM, 1982, J GEOPHYS RES-OCEANS, V87, P9601, DOI 10.1029/JC087iC12p09601; FERNANDEZ C, 2005, J GEOPHYS RES, V110; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; GNANADESIKAN A, 2003, GLOB BIOCH CYCLES, V17; Hartman O., 1942, Bulletin of the Bingham Oceanographic Collection, V8, P1; JABAUD A, 2004, GLOB BIOCH CYCLES, V18; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; JOHNSON KS, 2006, EOS T AGU S, V87; Latimer JC, 2001, PALEOCEANOGRAPHY, V16, P627, DOI 10.1029/2000PA000586; LAW C, 2003, J GEOPHYS RES, V108; Marinov I, 2006, NATURE, V441, P964, DOI 10.1038/nature04883; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Measures CI, 2001, DEEP-SEA RES PT II, V48, P3913, DOI 10.1016/S0967-0645(01)00074-1; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Pike SM, 2005, J RADIOANAL NUCL CH, V263, P355, DOI 10.1007/s10967-005-0062-9; Ridgwell AJ, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000729; Robinson C, 1999, DEEP-SEA RES PT II, V46, P745, DOI 10.1016/S0967-0645(98)00126-X; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sarthou G, 2003, DEEP-SEA RES PT I, V50, P1339, DOI 10.1016/S0967-0637(03)00126-2; Savoye N, 2006, MAR CHEM, V100, P234, DOI 10.1016/j.marchem.2005.10.014; SIGMAN DM, 2000, SCIENCE, V407, P859; SULLIVAN CW, 1993, SCIENCE, V262, P1832, DOI 10.1126/science.262.5141.1832; Timmermans KR, 2001, LIMNOL OCEANOGR, V46, P260, DOI 10.4319/lo.2001.46.2.0260; TYRELL T, 2005, J GEOPHYS RES, V110; van der Loeff MMR, 2002, DEEP-SEA RES PT II, V49, P3849; Wanninkhof R, 1999, GEOPHYS RES LETT, V26, P1889, DOI 10.1029/1999GL900363; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	44	559	565	3	404	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1070	U1		10.1038/nature05700	http://dx.doi.org/10.1038/nature05700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460670	Green Submitted			2022-12-24	WOS:000245950400047
J	Koizumi, S; Shigemoto-Mogami, Y; Nasu-Tada, K; Shinozaki, Y; Ohsawa, K; Tsuda, M; Joshi, BV; Jacobson, KA; Kohsaka, S; Inoue, K				Koizumi, Schuichi; Shigemoto-Mogami, Yukari; Nasu-Tada, Kaoru; Shinozaki, Yoichi; Ohsawa, Keiko; Tsuda, Makoto; Joshi, Bhalchandra V.; Jacobson, Kenneth A.; Kohsaka, Shinichi; Inoue, Kazuhide			UDP acting at P2Y(6) receptors is a mediator of microglial phagocytosis	NATURE			English	Article							NUCLEOTIDE RECEPTOR; APOPTOTIC CELLS; IN-VIVO; RELEASE; ATP; INVOLVEMENT; CHEMOTAXIS; ACTIVATION; MIGRATION; CLONING	Microglia, brain immune cells, engage in the clearance of dead cells or dangerous debris, which is crucial to the maintenance of brain functions. When a neighbouring cell is injured, microglia move rapidly towards it or extend a process to engulf the injured cell. Because cells release or leak ATP when they are stimulated(1,2) or injured(3,4), extracellular nucleotides are thought to be involved in these events. In fact, ATP triggers a dynamic change in the motility of microglia in vitro(5,6) and in vivo(3,4), a previously unrecognized mechanism underlying microglial chemotaxis(5,6); in contrast, microglial phagocytosis has received only limited attention. Here we show that microglia express the metabotropic P2Y(6) receptor whose activation by endogenous agonist UDP triggers microglial phagocytosis. UDP facilitated the uptake of microspheres in a P2Y(6)-receptor-dependent manner, which was mimicked by the leakage of endogenous UDP when hippocampal neurons were damaged by kainic acid in vivo and in vitro. In addition, systemic administration of kainic acid in rats resulted in neuronal cell death in the hippocampal CA1 and CA3 regions, where increases in messenger RNA encoding P2Y(6) receptors that colocalized with activated microglia were observed. Thus, the P2Y(6) receptor is upregulated when neurons are damaged, and could function as a sensor for phagocytosis by sensing diffusible UDP signals, which is a previously unknown pathophysiological function of P2 receptors in microglia.	Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 8128582, Japan; Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan; Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pharmacol, Yamanashi 4093893, Japan; Natl Inst Neurosci, Dept Neurochem, Tokyo 1878502, Japan; NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	Kyushu University; National Institute of Health Sciences - Japan; University of Yamanashi; National Center for Neurology & Psychiatry - Japan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Inoue, K (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	inoue@phar.kyushu-u.ac.jp	Jacobson, Kenneth Alan/A-1530-2009; Shinozaki, Youichi/AAC-9431-2019; Shinozaki, Youichi/E-8594-2010; Tsuda, Makoto/AAE-7256-2020; Koizumi, Schuichi/E-8568-2010	Jacobson, Kenneth Alan/0000-0001-8104-1493; Shinozaki, Youichi/0000-0002-6448-1304; Shinozaki, Youichi/0000-0002-6448-1304; Koizumi, Schuichi/0000-0001-6184-3106	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031116] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK031116-20] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; CHANG KG, 1995, J BIOL CHEM, V270, P26152, DOI 10.1074/jbc.270.44.26152; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Erlinge D, 2005, INT J CARDIOL, V100, P427, DOI 10.1016/j.ijcard.2004.10.005; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; GREENBERG S, 1995, TRENDS CELL BIOL, V5, P93, DOI 10.1016/S0962-8924(00)88957-6; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lazarowski ER, 2003, MOL PHARMACOL, V63, P1190, DOI 10.1124/mol.63.5.1190; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Mamedova LK, 2004, BIOCHEM PHARMACOL, V67, P1763, DOI 10.1016/j.bcp.2004.01.011; Mellor EA, 2001, P NATL ACAD SCI USA, V98, P7964, DOI 10.1073/pnas.141221498; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Nicholas RA, 1996, J AUTON PHARMACOL, V16, P319, DOI 10.1111/j.1474-8673.1996.tb00044.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohsawa K, 2000, J CELL SCI, V113, P3073; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786	28	570	601	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1091	1095		10.1038/nature05704	http://dx.doi.org/10.1038/nature05704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17410128	Green Accepted			2022-12-24	WOS:000245950400052
J	Ijspeert, AJ; Crespi, A; Ryczko, D; Cabelguen, JM				Ijspeert, Auke Jan; Crespi, Alessandro; Ryczko, Dimitri; Cabelguen, Jean-Marie			From swimming to walking with a salamander robot driven by a spinal cord model	SCIENCE			English	Article							CENTRAL PATTERN GENERATOR; COUPLED NONLINEAR OSCILLATORS; NEURAL-NETWORKS; LOCOMOTION; TERRESTRIAL; LAMPREY; COORDINATION; GAITS; NEWT	The transition from aquatic to terrestrial locomotion was a key development in vertebrate evolution. We present a spinal cord model and its implementation in an amphibious salamander robot that demonstrates how a primitive neural circuit for swimming can be extended by phylogenetically more recent limb oscillatory centers to explain the ability of salamanders to switch between swimming and walking. The model suggests neural mechanisms for modulation of velocity, direction, and type of gait that are relevant for all tetrapods. It predicts that limb oscillatory centers have lower intrinsic frequencies than body oscillatory centers, and we present biological data supporting this.	Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Stn 14, CH-1015 Lausanne, Switzerland; Univ Bordeaux 2, F-33077 Bordeaux, France; INSERM, U862, F-33077 Bordeaux, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Ijspeert, AJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Stn 14, CH-1015 Lausanne, Switzerland.	auke.ijspeert@epfl.ch	Crespi, Alessandro/M-6777-2014	Ryczko, Dimitri/0000-0003-3948-7728; Ijspeert, Auke/0000-0003-1417-9980; Crespi, Alessandro/0000-0001-9863-5220				Ashley-Ross MA, 2004, J EXP BIOL, V207, P461, DOI 10.1242/jeb.00769; Bem T, 2003, BIOL CYBERN, V88, P79, DOI 10.1007/s00422-002-0340-3; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; Cheng JG, 1998, J NEUROSCI, V18, P4295; COHEN AH, 1980, EXP BRAIN RES, V41, P11; Cohen AH., 1988, NEURAL CONTROL RHYTH, P129; COLLINS JJ, 1994, BIOL CYBERN, V71, P375, DOI 10.1007/BF00198915; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Delvolve I, 1997, J NEUROPHYSIOL, V78, P638, DOI 10.1152/jn.1997.78.2.638; Delvolve I, 1999, J NEUROPHYSIOL, V82, P1074, DOI 10.1152/jn.1999.82.2.1074; ERMENTROUT GB, 1994, SIAM J APPL MATH, V54, P478, DOI 10.1137/S0036139992231964; FROLICH LM, 1992, J EXP BIOL, V162, P107; Gao KQ, 2001, NATURE, V410, P574, DOI 10.1038/35069051; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; Grillner S., 1997, NEURONS NETWORKS MOT, P3; Ijspeert AJ, 2005, NEUROINFORMATICS, V3, P171, DOI 10.1385/NI:3:3:171; Ijspeert AJ, 2001, BIOL CYBERN, V84, P331, DOI 10.1007/s004220000211; Roos P. R., 1964, Proceedings Akademie van Wetenschappen Amsterdam, V67C, P223; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Szekely G., 1976, P765; TUNSTALL MJ, 1994, J PHYSIOL-LONDON, V474, P393, DOI 10.1113/jphysiol.1994.sp020031; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a; WHEATLEY M, 1994, J NEUROPHYSIOL, V71, P2025, DOI 10.1152/jn.1994.71.6.2025; WILLIAMS TL, 1990, J NEUROPHYSIOL, V64, P862, DOI 10.1152/jn.1990.64.3.862	26	696	744	22	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1416	1420		10.1126/science.1138353	http://dx.doi.org/10.1126/science.1138353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347441	Green Submitted			2022-12-24	WOS:000244752200035
J	McPherson, R; Pertsemlidis, A; Kavaslar, N; Stewart, AFR; Roberts, R; Cox, DR; Hinds, DA; Pennacchio, LA; Tybjaerg-Hansen, A; Folsom, AR; Boerwinkle, E; Hobbs, HH; Cohen, JC				McPherson, Ruth; Pertsemlidis, Alexander; Kavaslar, Nihan; Stewart, Alexandre F. R.; Roberts, Robert; Cox, David R.; Hinds, David A.; Pennacchio, Len A.; Tybjaerg-Hansen, Anne; Folsom, Aaron R.; Boerwinkle, Eric; Hobbs, Helen H.; Cohen, Jonathan C.			A common allele on chromosome 9 associated with coronary heart disease	SCIENCE			English	Article							GLOBAL MORTALITY; BURDEN	Coronary heart disease ( CHD) is a major cause of death in Western countries. We used genome-wide association scanning to identify a 58-kilobase interval on chromosome 9p21 that was consistently associated with CHD in six independent samples ( more than 23,000 participants) from four Caucasian populations. This interval, which is located near the CDKN2A and CDKN2B genes, contains no annotated genes and is not associated with established CHD risk factors such as plasma lipoproteins, hypertension, or diabetes. Homozygotes for the risk allele make up 20 to 25% of Caucasians and have a similar to 30 to 40% increased risk of CHD.	Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada; Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Perlegen Sci, Mountain View, CA 94043 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Copenhagen Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA	University of Ottawa; University of Ottawa Heart Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Rigshospitalet; University of Copenhagen; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada.	rmcpherson@ottawaheart.ca; jonathan.cohen@utsouthwestern.edu	Wang, Weili/D-1546-2011; Stewart, Alexandre F.R./A-5677-2011; Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372; Pennacchio, Len/0000-0002-8748-3732; Hinds, David/0000-0002-4911-803X; Stewart, Alexandre/0000-0003-2673-9164	NHLBI NIH HHS [R01 HL082896, HL-082896, HL-066681, R01 HL082896-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681, R01HL082896] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; PASMANT E, 2007, CANCER RES, V67, P1; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	12	1363	1430	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1488	1491		10.1126/science.1142447	http://dx.doi.org/10.1126/science.1142447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17478681	Green Accepted, Green Submitted			2022-12-24	WOS:000247066400046
J	Roberson, ED; Scearce-Levie, K; Palop, JJ; Yan, FR; Cheng, IH; Wu, T; Gerstein, H; Yu, GQ; Mucke, L				Roberson, Erik D.; Scearce-Levie, Kimberly; Palop, Jorge J.; Yan, Fengrong; Cheng, Irene H.; Wu, Tiffany; Gerstein, Hilary; Yu, Gui-Qiu; Mucke, Lennart			Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model	SCIENCE			English	Article							TRANSGENIC MICE; PROTEIN; EXPRESSION; NEURODEGENERATION; SYNAPTOTOXICITY; PERSPECTIVE; INHIBITION; HYPOTHESIS; CLEARANCE; NEURONS	Many potential treatments for Alzheimer's disease target amyloid-beta peptides (A beta), which are widely presumed to cause the disease. The microtubule-associated protein tau is also involved in the disease, but it is unclear whether treatments aimed at tau could block A beta-induced cognitive impairments. Here, we found that reducing endogenous tau levels prevented behavioral deficits in transgenic mice expressing human amyloid precursor protein, without altering their high A beta levels. Tau reduction also protected both transgenic and nontransgenic mice against excitotoxicity. Thus, tau reduction can block A beta- and excitotoxin-induced neuronal dysfunction and may represent an effective strategy for treating Alzheimer's disease and related conditions.	Gladstone Inst Neurol Sci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Roberson, ED (corresponding author), Gladstone Inst Neurol Sci, San Francisco, CA 94158 USA.	eroberson@gladstone.ucsf.edu; lmucke@gladstone.ucsf.edu	Roberson, Erik/A-5718-2009; Palop, Jorge J./D-8128-2011; Gerstein, Hertzel C/B-1235-2013; Palop, Jorge/AAH-9014-2020	Roberson, Erik/0000-0002-1810-9763; Gerstein, Hertzel C/0000-0001-8072-2836; Palop, Jorge/0000-0001-6086-1070; Wu, Tiffany/0000-0002-9273-0574	NCRR NIH HHS [RR18928-01] Funding Source: Medline; NIA NIH HHS [AG011385, AG022074] Funding Source: Medline; NIMH NIH HHS [MH070588] Funding Source: Medline; NINDS NIH HHS [K08 NS054811-02, NS054811, K08 NS054811] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH070588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS054811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, R37AG011385, R01AG011385] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Dawson HN, 2001, J CELL SCI, V114, P1179; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; GEDDES JW, 1985, SCIENCE, V230, P1179, DOI 10.1126/science.4071042; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Holsboer Florian, 2003, Curr Opin Investig Drugs, V4, P46; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu TB, 2004, J NEUROCHEM, V88, P554, DOI 10.1046/j.1471-4159.2003.02196.x; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Olney JW, 1997, ARCH NEUROL-CHICAGO, V54, P1234, DOI 10.1001/archneur.1997.00550220042012; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; STEWARD O, 1977, BRAIN RES BULL, V2, P41, DOI 10.1016/0361-9230(77)90023-5; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008	31	1426	1499	1	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					750	754		10.1126/science.1141736	http://dx.doi.org/10.1126/science.1141736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478722				2022-12-24	WOS:000246181400048
J	Wang, JX; Scully, K; Zhu, X; Cai, L; Zhang, J; Prefontaine, GG; Krones, A; Ohgi, KA; Zhu, P; Garcia-Bassets, I; Liu, F; Taylor, H; Lozach, J; Jayes, FL; Korach, KS; Glass, CK; Fu, XD; Rosenfeld, MG				Wang, Jianxun; Scully, Kathleen; Zhu, Xiaoyan; Cai, Ling; Zhang, Jie; Prefontaine, Gratien G.; Krones, Anna; Ohgi, Kenneth A.; Zhu, Ping; Garcia-Bassets, Ivan; Liu, Forrest; Taylor, Havilah; Lozach, Jean; Jayes, Friederike L.; Korach, Kenneth S.; Glass, Christopher K.; Fu, Xiang-Dong; Rosenfeld, Michael G.			Opposing LSD1 complexes function in developmental gene activation and repression programmes	NATURE			English	Article							POLYCOMB PROTEIN; PITUITARY-GLAND; HISTONE; RECEPTOR; EXPRESSION; ESTROGEN; MICE; PIT-1; IDENTIFICATION; TRANSCRIPTION	Precise control of transcriptional programmes underlying metazoan development is modulated by enzymatically active co-regulatory complexes, coupled with epigenetic strategies. One thing that remains unclear is how specific members of histone modification enzyme families, such as histone methyltransferases and demethylases, are used in vivo to simultaneously orchestrate distinct developmental gene activation and repression programmes. Here, we report that the histone lysine demethylase, LSD1 - a component of the CoREST-CtBP co- repressor complex - is required for late cell-lineage determination and differentiation during pituitary organogenesis. LSD1 seems to act primarily on target gene activation programmes, as well as in gene repression programmes, on the basis of recruitment of distinct LSD1-containing co- activator or co- repressor complexes. LSD1-dependent gene repression programmes can be extended late in development with the induced expression of ZEB1, a Kruppel-like repressor that can act as a molecular beacon for recruitment of the LSD1-containing CoREST-CtBP co- repressor complex, causing repression of an additional cohort of genes, such as Gh, which previously required LSD1 for activation. These findings suggest that temporal patterns of expression of specific components of LSD1 complexes modulate gene regulatory programmes in many mammalian organs.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Sch Med, La Jolla, CA 92093 USA; Natl Inst Environm Hlth Sci, Res Triangle Pk, NC 27709 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Garcia-Bassets, Ivan/F-5075-2010; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Korach, Kenneth/0000-0002-7765-418X; Jayes, Friederike/0000-0001-8862-9345; Garcia-Bassets, Ivan/0000-0002-6941-9585	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070065, ZIAES070065] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; Botz J, 1996, MOL CELL BIOL, V16, P3401; Chamberlain EM, 1999, MOL CELL BIOL, V19, P3600; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DAY RN, 1990, MOL ENDOCRINOL, V4, P1964, DOI 10.1210/mend-4-12-1964; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Gage PJ, 1996, DEVELOPMENT, V122, P151; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; HU NP, 1994, ONCOGENE, V9, P1021; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Keegan CE, 2003, GENE DEV, V17, P677, DOI 10.1101/gad.1085903; KORACH KS, 1994, SCIENCE, V266, P1524, DOI 10.1126/science.7985022; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; LIEBERMAN ME, 1983, J STEROID BIOCHEM, V19, P275, DOI 10.1016/S0022-4731(83)80037-5; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Ooi GT, 2004, MOL CELL ENDOCRINOL, V228, P1, DOI 10.1016/j.mce.2004.07.018; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ward RD, 2005, MOL ENDOCRINOL, V19, P698, DOI 10.1210/me.2004-0341; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhu XY, 2006, GENE DEV, V20, P2739, DOI 10.1101/gad.1444706	50	411	433	4	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					882	887		10.1038/nature05671	http://dx.doi.org/10.1038/nature05671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17392792				2022-12-24	WOS:000245785700035
J	Clapham, DE				Clapham, David E.			SnapShot; Mammalian TRP channels	CELL			English	Editorial Material									Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp, HHMI, Boston, MA 02115 USA.		Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 					0	108	121	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					220	220		10.1016/j.cell.2007.03.034	http://dx.doi.org/10.1016/j.cell.2007.03.034			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418797	Bronze			2022-12-24	WOS:000245661100023
J	Lee, MG; Norman, J; Shilatifard, A; Shiekhattar, R				Lee, Min Gyu; Norman, Jessica; Shilatifard, Ali; Shiekhattar, Ramin			Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein	CELL			English	Article							HISTONE LYSINE METHYLATION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; ARGININE METHYLATION; PHD FINGER; COMPLEX; METHYLTRANSFERASE; DOMAIN; DEACETYLASE	Histone methylation is a posttranslational modification regulating chromatin structure and gene regulation. BHC110/LSD1 was the first histone demethylase described to reverse dimethyl histone H3 lysine 4 (H3K4). Here we show that JARID1 d, a JmjC-domain-containing protein, specifically demethylates trimethyl H3K4. Detailed mapping analysis revealed that besides the JmjC domain, the BRIGHT and zinc-finger-like C5HC2 domains are required for maximum catalytic activity. Importantly, iso-lation of native JARID1 d complexes from human cells revealed the association of the demethylase with a polycomb-like protein Ring6a/MBLR. Ring6a/MBLR not only directly interacts with JARID1d but also regulates its enzymatic activity. We show that JARID1d and Ring6a occupy human Engrailed 2 gene and regulate its expression and H3K4 methylation levels. Depletion of JARID1d enhanced recruitment of the chromatin remodeling complex, NURF, and the basal transcription machinery near the transcriptional start site, revealing a role for JARID1d in regulation of transcriptional initiation through H3K4 demethylation.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; St Louis Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	The Wistar Institute; Saint Louis University	Shiekhattar, R (corresponding author), Ctr Regulacio Genom, Dr Aiguader,88, Barcelona 08003, Spain.	ramin.shiekhattar@crg.es			NATIONAL CANCER INSTITUTE [R01CA090758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069905] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 090758] Funding Source: Medline; NIGMS NIH HHS [R01 GM069905] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akasaka T, 2002, GENES CELLS, V7, P835, DOI 10.1046/j.1365-2443.2002.00565.x; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gildea JJ, 2000, GENETICS, V156, P645; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, METHODS, V40, P327, DOI 10.1016/j.ymeth.2006.07.030; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	54	187	193	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					877	887		10.1016/j.cell.2007.02.004	http://dx.doi.org/10.1016/j.cell.2007.02.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17320162	Bronze			2022-12-24	WOS:000245073400013
J	Clayton, E; Doupe, DP; Klein, AM; Winton, DJ; Simons, BD; Jones, PH				Clayton, Elizabeth; Doupe, David P.; Klein, Allon M.; Winton, Douglas J.; Simons, Benjamin D.; Jones, Philip H.			A single type of progenitor cell maintains normal epidermis	NATURE			English	Article							LABEL-RETAINING CELLS; STEM-CELLS; MOUSE EPIDERMIS; IN-VIVO; DIVISIONS; SKIN; FOLLICLE; PROLIFERATION; NEUROGENESIS; EPITHELIUM	According to the current model of adult epidermal homeostasis, skin tissue is maintained by two discrete populations of progenitor cells: self-renewing stem cells; and their progeny, known as transit amplifying cells, which differentiate after several rounds of cell division(1-3). By making use of inducible genetic labelling, we have tracked the fate of a representative sample of progenitor cells in mouse tail epidermis at single-cell resolution in vivo at time intervals up to one year. Here we show that clone-size distributions are consistent with a new model of homeostasis involving only one type of progenitor cell. These cells are found to undergo both symmetric and asymmetric division at rates that ensure epidermal homeostasis. The results raise important questions about the potential role of stem cells on tissue maintenance in vivo.	Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Jones, PH (corresponding author), Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England.	phj20@hutchison-mrc.cam.ac.uk	Simons, Benjamin/AAY-8920-2020; Jones, Philip/D-2464-2009; Doupe, David/M-7914-2017	Simons, Benjamin/0000-0002-3875-7071; Jones, Philip/0000-0002-5904-795X; Doupe, David/0000-0002-9748-9388	Medical Research Council [G0300723B] Funding Source: researchfish; MRC [MC_U105370181] Funding Source: UKRI; Medical Research Council [MC_U105370181] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Birner P, 2001, AM J PATHOL, V158, P1991, DOI 10.1016/S0002-9440(10)64670-6; Braun KM, 2004, J INVEST DERM SYMP P, V9, P196, DOI 10.1111/j.1087-0024.2004.09313.x; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Das T, 2003, NEURON, V37, P597, DOI 10.1016/S0896-6273(03)00066-7; Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kameda T, 2003, EXP CELL RES, V283, P167, DOI 10.1016/S0014-4827(02)00031-9; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; LAJTHA LG, 1979, DIFFERENTIATION, V14, P23, DOI 10.1111/j.1432-0436.1979.tb01007.x; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; MACKENZIE IC, 1970, NATURE, V226, P653, DOI 10.1038/226653a0; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Potten C S, 1981, Int Rev Cytol, V69, P271; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Ro S, 2005, EXP DERMATOL, V14, P838, DOI 10.1111/j.1600-0625.2005.00366.x; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Smart FM, 2000, J EXP MED, V191, P737, DOI 10.1084/jem.191.4.737; SMART IHM, 1970, BRIT J DERMATOL, V82, P276, DOI 10.1111/j.1365-2133.1970.tb12437.x; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	29	605	619	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					185	189		10.1038/nature05574	http://dx.doi.org/10.1038/nature05574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17330052				2022-12-24	WOS:000244718100040
J	Lee, JH; Koh, H; Kim, M; Kim, Y; Lee, SY; Karess, RE; Lee, SH; Shong, M; Kim, JM; Kim, J; Chung, JK				Lee, Jun Hee; Koh, Hyongjong; Kim, Myungjin; Kim, Yongsung; Lee, Soo Young; Karess, Roger E.; Lee, Sang-Hee; Shong, Minho; Kim, Jin-Man; Kim, Jaeseob; Chung, Jongkyeong			Energy-dependent regulation of cell structure by AMP-activated protein kinase	NATURE			English	Article							MYOSIN-II; NONMUSCLE MYOSIN; LIGHT-CHAIN; CYTOKINESIS; MUTANTS; ROLES; DISC	AMP-activated protein kinase ( AMPK, also known as SNF1A) has been primarily studied as a metabolic regulator that is activated in response to energy deprivation(1). Although there is relatively ample information on the biochemical characteristics of AMPK, not enough data exist on the in vivo function of the kinase. Here, using the Drosophila model system, we generated the first animal model with no AMPK activity and discovered physiological functions of the kinase. Surprisingly, AMPK-null mutants were lethal with severe abnormalities in cell polarity and mitosis, similar to those of lkb1-null mutants. Constitutive activation of AMPK restored many of the phenotypes of lkb1-null mutants, suggesting that AMPK mediates the polarity- and mitosis-controlling functions of the LKB1 serine/threonine kinase. Interestingly, the regulatory site of non-muscle myosin regulatory light chain (MRLC; also known as MLC2)(2,3) was directly phosphorylated by AMPK. Moreover, the phosphomimetic mutant of MRLC3 rescued the AMPK-null defects in cell polarity and mitosis, suggesting MRLC is a critical downstream target of AMPK. Furthermore, the activation of AMPK by energy deprivation was sufficient to cause dramatic changes in cell shape, inducing complete polarization and brush border formation in the human LS174T cell line, through the phosphorylation of MRLC. Taken together, our results demonstrate that AMPK has highly conserved roles across metazoan species not only in the control of metabolism, but also in the regulation of cellular structures.	Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Cell Growth Regulat, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Korea Basic Sci Inst, Div Electron Microscop Res, Taejon 305333, South Korea; Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon 301721, South Korea; Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon 301721, South Korea; GenExel, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Korea Basic Science Institute (KBSI); Chungnam National University; Chungnam National University	Chung, JK (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Cell Growth Regulat, 373-1 Kusong Dong, Taejon 305701, South Korea.	jchung@kaist.ac.kr	/H-7803-2012; Koh, Hyoungjong/C-1615-2012	KIM, JIN MAN/0000-0003-0905-9730; shong, minho/0000-0002-0247-7115; Lee, Jun Hee/0000-0002-2200-6011; Karess, Roger/0000-0002-7299-0600; Lee, Soo Young/0000-0003-1524-836X; Koh, Hyongjong/0000-0003-2594-4799				Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Edwards KA, 1996, DEVELOPMENT, V122, P1499; HAY BA, 1994, DEVELOPMENT, V120, P2121; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Lee JH, 2006, CELL DEATH DIFFER, V13, P1110, DOI 10.1038/sj.cdd.4401790; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; MARTELLONE AM, 1984, PERSPECT AM HIST, V1, P379; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; MONFAR M, 1995, MOL CELL BIOL, V15, P326, DOI 10.1128/MCB.15.1.326; Pan DA, 2002, BIOCHEM J, V367, P179, DOI 10.1042/BJ20020703; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Sakurada K, 1998, AM J PHYSIOL-CELL PH, V274, pC1563, DOI 10.1152/ajpcell.1998.274.6.C1563	21	333	343	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					1017	U9		10.1038/nature05828	http://dx.doi.org/10.1038/nature05828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17486097				2022-12-24	WOS:000247373100050
J	Reineke, J; Tenzer, S; Rupnik, M; Koschinski, A; Hasselmayer, O; Schrattenholz, A; Schild, H; von Eichel-Streiber, C				Reineke, Jessica; Tenzer, Stefan; Rupnik, Maja; Koschinski, Andreas; Hasselmayer, Oliver; Schrattenholz, Andre; Schild, Hansjoerg; von Eichel-Streiber, Christoph			Autocatalytic cleavage of Clostridium difficile toxin	NATURE			English	Article							INOSITOL HEXAKISPHOSPHATE; PSEUDOMEMBRANOUS COLITIS; RHO-PROTEINS; CELLS; GENE; INTERNALIZATION; GLUCOSYLATION; HOMOLOGY; DISEASE; SITE	Clostridium difficile, the causative agent of nosocomial antibiotic-associated diarrhoea and pseudomembranous colitis, possesses two main virulence factors: the large clostridial cytotoxins A and B. It has been proposed that toxin B is cleaved by a cytosolic factor of the eukaryotic target cell during its cellular uptake. Here we report that cleavage of not only toxin B, but also all other large clostridial cytotoxins, is an autocatalytic process dependent on host cytosolic inositolphosphate cofactors. A covalent inhibitor of aspartate proteases, 1,2-epoxy-3-(p-nitrophenoxy)propane, completely blocked toxin B function on cultured cells and was used to identify its catalytically active protease site. To our knowledge this is the first report on a bacterial toxin that uses eukaryotic signals for induced autoproteolysis to deliver its toxic domain into the cytosol of target cells. On the basis of our data, we present an integrated model for the uptake and inositolphosphate-induced activation of toxin B.	Johannes Gutenberg Univ Mainz, Inst Med Mikrobiol & Hyg, D-55131 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany; Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; Inst Publ Hlth Maribor, SLO-2000 Maribor, Slovenia; Univ Giessen, Rudolf Buchheim Inst Pharmakol, D-35392 Giessen, Germany; ProteoSys AG, D-55129 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Maribor; Justus Liebig University Giessen; ProteoSys AG	von Eichel-Streiber, C (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Mikrobiol & Hyg, Hochhaus Augustuspl, D-55131 Mainz, Germany.	schild@uni-mainz.de; veichel@uni-mainz.de	Tenzer, Stefan/AAE-2180-2020	Tenzer, Stefan/0000-0003-3034-0017				Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; BRAUN V, 1999, PATHOGENICITY ISLAND; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Davey P, 2006, EMERG INFECT DIS, V12, P211, DOI 10.3201/eid1202.05145; EICHELSTREIBER C, 1992, J BACTERIOL, V174, P6707; FERNANDEZPATRON C, 1995, ANAL BIOCHEM, V224, P263, DOI 10.1006/abio.1995.1039; Fishman N, 2006, AM J MED, V119, pS62, DOI 10.1016/j.amjmed.2006.04.004; FLORIN I, 1983, BIOCHIM BIOPHYS ACTA, V763, P383, DOI 10.1016/0167-4889(83)90100-3; FLORIN I, 1986, MICROB PATHOGENESIS, V1, P373, DOI 10.1016/0882-4010(86)90069-0; GEORGE RH, 1978, BRIT MED J, V1, P695, DOI 10.1136/bmj.1.6114.695; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Gorbach SL, 1999, NEW ENGL J MED, V341, P1690, DOI 10.1056/NEJM199911253412211; GREEN GA, 1995, GENE, V161, P57, DOI 10.1016/0378-1119(95)00263-6; HENRIQUES B, 1987, MICROB PATHOGENESIS, V2, P455, DOI 10.1016/0882-4010(87)90052-0; HOFMANN F, 1995, MOL GEN GENET, V247, P670, DOI 10.1007/BF00290398; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Hsu FF, 2003, J MASS SPECTROM, V38, P447, DOI 10.1002/jms.457; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KARLSSON KA, 1995, CURR OPIN STRUC BIOL, V5, P622, DOI 10.1016/0959-440X(95)80054-9; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; McDonald L Clifford, 2005, Infect Control Hosp Epidemiol, V26, P672, DOI 10.1086/502600; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Moos M, 2000, METHOD ENZYMOL, V325, P114; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rupnik M, 2005, J MED MICROBIOL, V54, P113, DOI 10.1099/jmm.0.45810-0; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; SAUERBORN M, 1994, INT J MED MICROBIO S, V24, P510; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; York JD, 2001, ADV ENZYME REGUL, V41, P57, DOI 10.1016/S0065-2571(00)00025-X	46	182	198	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					415	419		10.1038/nature05622	http://dx.doi.org/10.1038/nature05622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17334356				2022-12-24	WOS:000245079500034
J	Corbesier, L; Vincent, C; Jang, SH; Fornara, F; Fan, QZ; Searle, I; Giakountis, A; Farrona, S; Gissot, L; Turnbull, C; Coupland, G				Corbesier, Laurent; Vincent, Coral; Jang, Seonghoe; Fornara, Fabio; Fan, Qingzhi; Searle, Iain; Giakountis, Antonis; Farrona, Sara; Gissot, Lionel; Turnbull, Colin; Coupland, George			FT protein movement contributes to long-distance signaling in floral induction of Arabidopsis	SCIENCE			English	Article							INTEGRATOR FT; CONSTANS; PHLOEM; TRAFFICKING; LEAVES; ACTIVATION; TISSUES; TOMATO; GENES; ROLES	In plants, seasonal changes in day length are perceived in leaves, which initiate long-distance signaling that induces flowering at the shoot apex. The identity of the long-distance signal has yet to be determined. In Arabidopsis, activation of FLOWERING LOCUS T ( FT) transcription in leaf vascular tissue ( phloem) induces flowering. We found that FT messenger RNA is required only transiently in the leaf. In addition, FT fusion proteins expressed specifically in phloem cells move to the apex and move long distances between grafted plants. Finally, we provide evidence that FT does not activate an intermediate messenger in leaves. We conclude that FT protein acts as a long- distance signal that induces Arabidopsis flowering.	Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; Univ London Imperial Coll Sci & Technol, Div Biol, Wye TN25 5AH, Kent, England	Max Planck Society; Imperial College London	Coupland, G (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 0, D-50829 Cologne, Germany.	coupland@mpiz-koeln.mpg.de	Fornara, Fabio/AAL-3306-2020; Searle, Iain/AAE-8869-2019; Turnbull, Colin/B-4742-2008; Fornara, Fabio/B-9978-2012; Searle, Iain/C-9300-2009; Coupland, George/AAP-8609-2020	Fornara, Fabio/0000-0002-1050-0477; Turnbull, Colin/0000-0001-6635-1418; Fornara, Fabio/0000-0002-1050-0477; Searle, Iain/0000-0003-4306-9756; Coupland, George/0000-0001-6988-4172; Farrona, Sara/0000-0002-6855-2237; Giakountis, Antonis/0000-0001-8648-9908				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ayre BG, 2004, PLANT PHYSIOL, V135, P2271, DOI 10.1104/pp.104.040592; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bohlenius H, 2007, SCIENCE, V316, P367; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Giavalisco P, 2006, PROTEOMICS, V6, P896, DOI 10.1002/pmic.200500155; Haritatos E, 2000, PLANT PHYSIOL, V123, P929, DOI 10.1104/pp.123.3.929; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; KNOTT JAMES E., 1934, PROC AMER SOC HORT SCI, V31, P152; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lang A., 1965, ENCYCL PLANT PHYSIOL, VVolume XV/1, P1380; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Searle I, 2004, EMBO J, V23, P1217, DOI 10.1038/sj.emboj.7600117; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Turnbull C., 2004, FLOWERING NEWSLETTER, V37, P3; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; ZEEVAART J. A. D., 1958, MEDEDEL LANDBOUWHOGESCH WAGENINGEN, V58, P1; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541	33	1450	1634	28	521	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1030	1033		10.1126/science.1141752	http://dx.doi.org/10.1126/science.1141752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17446353	Green Published			2022-12-24	WOS:000246554000047
J	D'Souza, G; Kreimer, AR; Viscidi, R; Pawlita, M; Fakhry, C; Koch, WM; Westra, WH; Gillison, ML				D'Souza, Gypsyamber; Kreimer, Aimee R.; Viscidi, Raphael; Pawlita, Michael; Fakhry, Carole; Koch, Wayne M.; Westra, William H.; Gillison, Maura L.			Case-control study of human papillomavirus and oropharyngeal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; ORAL-CANCER; CERVICAL-CANCER; RISK; HEAD; NECK; INFECTION; HYGIENE; TYPE-16; ASSOCIATION	BACKGROUND: Substantial molecular evidence suggests a role for human papillomavirus (HPV) in the pathogenesis of oropharyngeal squamous-cell carcinoma, but epidemiologic data have been inconsistent. METHODS: We performed a hospital-based, case-control study of 100 patients with newly diagnosed oropharyngeal cancer and 200 control patients without cancer to evaluate associations between HPV infection and oropharyngeal cancer. Multivariate logistic-regression models were used for case-control comparisons. RESULTS: A high lifetime number of vaginal-sex partners (26 or more) was associated with oropharyngeal cancer (odds ratio, 3.1; 95% confidence interval [CI], 1.5 to 6.5), as was a high lifetime number of oral-sex partners (6 or more) (odds ratio, 3.4; 95% CI, 1.3 to 8.8). The degree of association increased with the number of vaginal-sex and oral-sex partners (P values for trend, 0.002 and 0.009, respectively). Oropharyngeal cancer was significantly associated with oral HPV type 16 (HPV-16) infection (odds ratio, 14.6; 95% CI, 6.3 to 36.6), oral infection with any of 37 types of HPV (odds ratio, 12.3; 95% CI, 5.4 to 26.4), and seropositivity for the HPV-16 L1 capsid protein (odds ratio, 32.2; 95% CI, 14.6 to 71.3). HPV-16 DNA was detected in 72% (95% CI, 62 to 81) of 100 paraffin-embedded tumor specimens, and 64% of patients with cancer were seropositive for the HPV-16 oncoprotein E6, E7, or both. HPV-16 L1 seropositivity was highly associated with oropharyngeal cancer among subjects with a history of heavy tobacco and alcohol use (odds ratio, 19.4; 95% CI, 3.3 to 113.9) and among those without such a history (odds ratio, 33.6; 95% CI, 13.3 to 84.8). The association was similarly increased among subjects with oral HPV-16 infection, regardless of their tobacco and alcohol use. By contrast, tobacco and alcohol use increased the association with oropharyngeal cancer primarily among subjects without exposure to HPV-16. CONCLUSIONS: Oral HPV infection is strongly associated with oropharyngeal cancer among subjects with or without the established risk factors of tobacco and alcohol use.	Johns Hopkins Univ, Div Viral Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Univ Hosp, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA; NCI, Div Canc Prevent, Bethesda, MD 20892 USA; German Canc Res Ctr, Infect & Canc Control Program, D-6900 Heidelberg, Germany	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; German Cancer Research Center (DKFZ)	Gillison, ML (corresponding author), Johns Hopkins Univ, Div Viral Oncol, Sidney Kimmel Comprehens Canc Ctr, Canc Res Bldg 1,Rm 3M 54A,1650 Orleans St, Baltimore, MD 21231 USA.	gillima@jhmi.edu	Pawlita, Labor/C-9720-2011; Waterboer, Tim/G-1252-2010; Kreimer, Aimee ARK/H-1687-2015	Pawlita, Michael/0000-0002-4720-8306; Viscidi, Raphael/0000-0002-7906-8002	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI050056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016631] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI50056, T32 AI050056] Funding Source: Medline; NIDCR NIH HHS [DE016631-01, R01 DE016631] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BENHAMOU S, 1986, INT J CANCER, V37, P825, DOI 10.1002/ijc.2910370605; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Brown LM, 2001, CANCER-AM CANCER SOC, V92, P2102, DOI 10.1002/1097-0142(20011015)92:8&lt;2102::AID-CNCR1551&gt;3.0.CO;2-9; BUNDGAARD T, 1995, CANCER CAUSE CONTROL, V6, P57, DOI 10.1007/BF00051681; D'Souza G, 2005, J CLIN MICROBIOL, V43, P5526, DOI 10.1128/JCM.43.11.5526-5535.2005; Dahlstrom KR, 2003, CLIN CANCER RES, V9, P2620; Dillner J, 1999, SEMIN CANCER BIOL, V9, P423, DOI 10.1006/scbi.1999.0146; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; Frisch M, 2000, CANCER CAUSE CONTROL, V11, P489, DOI 10.1023/A:1008918223334; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gravitt PE, 2003, J VIROL METHODS, V112, P23, DOI 10.1016/S0166-0934(03)00186-1; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hansson BG, 2005, ACTA OTO-LARYNGOL, V125, P1337, DOI 10.1080/00016480510043945; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hemminki K, 2001, EUR J CANCER PREV, V10, P83, DOI 10.1097/00008469-200102000-00010; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Huang CC, 1998, MODERN PATHOL, V11, P971; Kreimer AR, 2006, INT J CANCER, V118, P2293, DOI 10.1002/ijc.21577; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; MADEN C, 1992, AM J EPIDEMIOL, V135, P1093, DOI 10.1093/oxfordjournals.aje.a116209; MAIER H, 1993, OTOLARYNG HEAD NECK, V108, P655, DOI 10.1177/019459989310800606; Moreno-Lopez LA, 2000, ORAL ONCOL, V36, P170, DOI 10.1016/S1368-8375(99)00084-6; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Mosher William D, 2005, Adv Data, P1; Peyton CL, 2001, J INFECT DIS, V183, P1554, DOI 10.1086/320696; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Smith EM, 2004, JNCI-J NATL CANCER I, V96, P449, DOI 10.1093/jnci/djh074; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Viscidi RP, 2003, J INFECT DIS, V187, P194, DOI 10.1086/346052; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zelmanowicz ADM, 2005, INT J CANCER, V116, P599, DOI 10.1002/ijc.21048; ZHENG TZ, 1990, CANCER CAUSE CONTROL, V1, P235, DOI 10.1007/BF00117475	39	1843	1887	4	163	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1944	1956		10.1056/NEJMoa065497	http://dx.doi.org/10.1056/NEJMoa065497			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494927				2022-12-24	WOS:000246305500006
J	Matthews, BJ; Kim, ME; Flanagan, JJ; Hattori, D; Clemens, JC; Zipursky, SL; Grueber, WB				Matthews, Benjamin J.; Kim, Michelle E.; Flanagan, John J.; Hattori, Daisuke; Clemens, James C.; Zipursky, S. Lawrence; Grueber, Wesley B.			Dendrite self-avoidance is controlled by Dscam	CELL			English	Article							AXON GUIDANCE; DROSOPHILA DSCAM; SENSORY NEURONS; RECEPTOR; ORGANIZATION; DIVERSITY; REVEALS; GENE	Dendrites distinguish between sister branches and those of other cells. Self-recognition can often lead to repulsion, a process termed "self-avoidance." Here we demonstrate that dendrite self-avoidance in Drosophila da sensory neurons requires cell-recognition molecules encoded by the Dscam locus. By alternative splicing, Dscam encodes a vast number of cell-surface proteins of the immunoglobulin superfamily. We demonstrate that interactions between identical Dscam isoforms on the cell surface underlie self-recognition, while the cytoplasmic tail converts this recognition to dendrite repulsion. Sister dendrites expressing the same isoforms engage in homophilic repulsion. By contrast, Dscam diversity ensures that inappropriate repulsive interactions between dendrites sharing the same receptive field do not occur. The selectivity of Dscam-mediated cell interactions is likely to be widely important in the developing fly nervous system, where processes of cells must distinguish between self and nonself during the construction of neural circuits.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Columbia University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Grueber, WB (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA.	wg2l35@columbia.edu		Grueber, Wesley/0000-0001-6751-256X; Zipursky, Stephen/0000-0001-5630-7181; Matthews, Benjamin/0000-0002-8697-699X	NICHD NIH HHS [T32 HD007430] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Crayton ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-16; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Geng W, 2000, GENETICS, V156, P1817; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 1999, J COMP NEUROL, V404, P127, DOI 10.1002/(SICI)1096-9861(19990201)404:1<127::AID-CNE10>3.0.CO;2-M; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; HITCHCOCK PF, 1989, DEVELOPMENT, V106, P589; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KRAMER AP, 1985, J NEUROSCI, V5, P768; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MONTAGUE PR, 1991, J NEUROSCI, V11, P1440; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; R Development Core Team, 2006, R LANG ENV STAT COMP; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Sdrulla AD, 2006, CEREBELLUM, V5, P105, DOI 10.1080/14734220600620908; Sugimura K, 2003, J NEUROSCI, V23, P3752; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	40	256	259	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					593	604		10.1016/j.cell.2007.04.013	http://dx.doi.org/10.1016/j.cell.2007.04.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482551	Bronze			2022-12-24	WOS:000246373600024
J	Samokhvalov, IM; Samokhvalova, NI; Nishikawa, S				Samokhvalov, Igor M.; Samokhvalova, Natalia I.; Nishikawa, Shin-ichi			Cell tracing shows the contribution of the yolk sac to adult haematopoiesis	NATURE			English	Article							STEM-CELLS; DEFINITIVE HEMATOPOIESIS; INTERFERON-GAMMA; REPORTER STRAIN; MOUSE EMBRYO; EXPRESSION; MICE; RECONSTITUTION; RECOMBINATION; CIRCULATION	The first haematopoietic stem cells (HSCs) appear in the aorta-gonad-mesonephros ( AGM) region, major vitelline and umbilical vessels, and placenta; however, whether they arise locally or from immigrant yolk sac precursor cells remains unclear. This issue is best addressed by measuring cell-lineage relationships rather than cell potentials. To undertake long-term in vivo tracing of yolk sac cells, we designed a non-invasive pulse-labelling system based on Cre/loxP recombination. Here we show that in Runx1(+/-) (runt-related transcription factor 1) heterozygous mice, yolk sac cells expressing Runx1 at embryonic day 7.5 develop into fetal lymphoid progenitors and adult HSCs. During mid-gestation the labelled ( embryonic day 7.5) yolk sac cells colonize the umbilical cord, the AGM region and subsequently the embryonic liver. This raises the possibility that some HSCs associated with major embryonic vasculature are derived from yolk sac precursors. We observed virtually no contribution of the labelled cells towards the yolk sac vasculature, indicating early segregation of endothelial and haematopoietic lineages.	RIKEN Kobe, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan	RIKEN	Samokhvalov, IM (corresponding author), RIKEN Kobe, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan.	igors@cdb.riken.jp						BROTHERTON TW, 1979, P NATL ACAD SCI USA, V76, P2853, DOI 10.1073/pnas.76.6.2853; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Igarashi H, 2001, P NATL ACAD SCI USA, V98, P15131, DOI 10.1073/pnas.011513098; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kisanga ER, 2003, J STEROID BIOCHEM, V84, P361, DOI 10.1016/S0960-0760(03)00051-7; LIEN EA, 1991, CANCER RES, V51, P4837; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MINOT CS, 1912, MANUAL HUMAN EMBRYOL, P498; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Palis J, 1999, DEVELOPMENT, V126, P5073; Samokhvalov IM, 2006, GENESIS, V44, P115, DOI 10.1002/gene.20190; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STEINER R, 1973, J CELL PHYSIOL, V81, P323, DOI 10.1002/jcp.1040810305; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Weissman I, 1978, FETAL HEMATOPOIETIC; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Young HA, 1997, BLOOD, V89, P583, DOI 10.1182/blood.V89.2.583; Yu JM, 1999, EXP HEMATOL, V27, P895, DOI 10.1016/S0301-472X(99)00009-0; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	30	329	345	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1056	1061		10.1038/nature05725	http://dx.doi.org/10.1038/nature05725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17377529				2022-12-24	WOS:000245950400044
J	Pappu, R; Schwab, SR; Cornelissen, I; Pereira, JP; Regard, JB; Xu, Y; Camerer, E; Zheng, YW; Huang, Y; Cyster, JG; Coughlin, SR				Pappu, Rajita; Schwab, Susan R.; Cornelissen, Ivo; Pereira, Joao P.; Regard, Jean B.; Xu, Ying; Camerer, Eric; Zheng, Yao-Wu; Huang, Yong; Cyster, Jason G.; Coughlin, Shaun R.			Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate	SCIENCE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; T-CELLS; MIGRATION; METABOLISM; FTY720; SYSTEM; THYMUS; ORGANS; S1P(1); MICE	Lymphocytes require sphingosine-1-phosphate (S1P) receptor-1 to exit lymphoid organs, but the source(s) of extracellular S1P and whether S1P directly promotes egress are unknown. By using mice in which the two kinases that generate S1P were conditionally ablated, we find that plasma S1P is mainly hematopoietic in origin, with erythrocytes a major contributor, whereas lymph S1P is from a distinct radiation-resistant source. Lymphocyte egress from thymus and secondary lymphoid organs was markedly reduced in kinase-deficient mice. Restoration of S1P to plasma rescued egress to blood but not lymph, and the rescue required lymphocyte expression of S1P-receptor-1. Thus, separate sources provide S1P to plasma and lymph to help lymphocytes exit the low-S1P environment of lymphoid organs. Disruption of compartmentalized S1P signaling is a plausible mechanism by which S1P-receptor-1 agonists function as immunosuppressives.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Drug Studies Unit, Dept Biopharmaceut Sci, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu; Shaun.Coughlin@ucsf.edu	Camerer, Eric/K-4161-2017	Pereira, Joao/0000-0002-5694-4938; Schwab, Susan/0000-0002-0834-0822; Camerer, Eric/0000-0002-6271-7125	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065590] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Allende ML, 2002, BBA-MOL CELL BIOL L, V1582, P222, DOI 10.1016/S1388-1981(02)00175-0; Aoki S, 2005, J BIOCHEM, V138, P47, DOI 10.1093/jb/mvi100; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Foss FW, 2007, BIOORGAN MED CHEM, V15, P663, DOI 10.1016/j.bmc.2006.10.060; Hla T, 2003, PHARMACOL RES, V47, P401, DOI 10.1016/S1043-6618(03)00046-X; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; KOTANI M, 1967, Okajimas Folia Anatomica Japonica, V43, P61; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SLOOP CH, 1987, J LIPID RES, V28, P225; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; USHIKI T, 1986, CELL TISSUE RES, V244, P285; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yang LB, 1999, BRIT J HAEMATOL, V107, P282, DOI 10.1046/j.1365-2141.1999.01697.x; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; Yatomi Y, 2001, PROSTAG OTH LIPID M, V64, P107, DOI 10.1016/S0090-6980(01)00103-4; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	26	685	708	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					295	298		10.1126/science.1139221	http://dx.doi.org/10.1126/science.1139221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17363629				2022-12-24	WOS:000245654500056
J	Houwing, S; Kamminga, LM; Berezikov, E; Cronembold, D; Girard, A; van den Elst, H; Filippov, DV; Blaser, H; Raz, E; Moens, CB; Plasterk, RHA; Hannon, GJ; Draper, BW; Ketting, RF				Houwing, Saskia; Kamminga, Leonie M.; Berezikov, Eugene; Cronembold, Daniela; Girard, Angelique; van den Elst, Hans; Filippov, Dmitri V.; Blaser, Heiko; Raz, Erez; Moens, Cecilia B.; Plasterk, Ronald H. A.; Hannon, Gregory J.; Draper, Bruce W.; Ketting, Rene F.			A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in zebrafish	CELL			English	Article							SMALL RNAS; PROCESSING BODIES; DROSOPHILA; SIRNAS; MIGRATION; HOMOLOG; PATHWAY; PROTEIN; TESTES; VASA	Piwi proteins specify an animal-specific subclass of the Argonaute family that, in vertebrates, is specifically expressed in germ cells. We demonstrate that zebrafish Piwi (Ziwi) is expressed in both the male and the female gonad and is a component of a germline-specifying structure called nuage. Loss of Ziwi function results in a progressive loss of germ cells due to apoptosis during larval development. In animals that have reduced Ziwi function, germ cells are maintained but display abnormal levels of apoptosis in adults. In mammals, Piwi proteins associate with approximately 29-nucleotide-long, testis-specific RNA molecules called piRNAs. Here we show that zebrafish piRNAs are present in both ovary and testis. Many of these are derived from transposons, implicating a role for piRNAs in the silencing of repetitive elements in vertebrates. Furthermore, we show that piRNAs are Dicer independent and that their 3' end likely carries a 2'O-Methyl modification.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Calif Davis, Davis, CA 95616 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Univ Munster, ZMBE, Inst Cell Biol, D-48149 Munster, Germany; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98019 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of California System; University of California Davis; Cold Spring Harbor Laboratory; Leiden University; Leiden University - Excl LUMC; Max Planck Society; University of Munster; Fred Hutchinson Cancer Center	Ketting, RF (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	ketting@niob.knaw.nl	Filippov, Dmitri/J-7612-2017; Hannon, Gregory/AAB-3568-2019; Houwing, Saskia/E-4384-2011; Kamminga, Leonie/O-5722-2019; Kamminga, Leonie M/E-1771-2012; Moens, Cecilia/AAN-1536-2020; Berezikov, Eugene/D-3363-2013	Filippov, Dmitri/0000-0002-6978-7425; Kamminga, Leonie M/0000-0002-0508-7796; Berezikov, Eugene/0000-0002-1145-2884; Moens, Cecilia/0000-0002-1099-0728; Ketting, Rene/0000-0001-6161-5621; Draper, Bruce W/0000-0002-4397-7749				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; CARMELL MA, 2007, IN PRESS DEV CELL; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Draper BW, 2004, METHOD CELL BIOL, V77, P91; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; GRUIDL ME, 1996, P NATL ACAD SCI USA, V93, P13937; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hashimoto Y, 2004, DEV BIOL, V268, P152, DOI 10.1016/j.ydbio.2003.12.013; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lingel A, 2005, CURR OPIN STRUC BIOL, V15, P107, DOI 10.1016/j.sbi.2005.01.010; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Rongo C, 1997, COLD SPRING HARB SYM, V62, P1; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tan CH, 2002, MECH DEVELOP, V119, pS221, DOI 10.1016/S0925-4773(03)00120-5; URAMOCHIMIYAGAW.S, 2004, DEVELOPMENT, V131, P839; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Westerfield M, 1993, ZEBRAFISH BOOK; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	53	769	822	5	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					69	82		10.1016/j.cell.2007.03.026	http://dx.doi.org/10.1016/j.cell.2007.03.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418787	Green Submitted, Bronze			2022-12-24	WOS:000245661100012
J	Dalley, JW; Fryer, TD; Brichard, L; Robinson, ESJ; Theobald, DEH; Laane, K; Pena, Y; Murphy, ER; Shah, Y; Probst, K; Abakumova, I; Aigbirhio, FI; Richards, HK; Hong, Y; Baron, JC; Everitt, BJ; Robbins, TW				Dalley, Jeffrey W.; Fryer, Tim D.; Brichard, Laurent; Robinson, Emma S. J.; Theobald, David E. H.; Laeaene, Kristjan; Pena, Yolanda; Murphy, Emily R.; Shah, Yasmene; Probst, Katrin; Abakumova, Irina; Aigbirhio, Franklin I.; Richards, Hugh K.; Hong, Young; Baron, Jean-Claude; Everitt, Barry J.; Robbins, Trevor W.			Nucleus Accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement	SCIENCE			English	Article							SUBSTANCE USE; DRUG-ADDICTION; DOPAMINE; RATS; AVAILABILITY; PERSONALITY; STRIATUM; REINSTATEMENT; VULNERABILITY; ASSOCIATION	Stimulant addiction is often linked to excessive risk taking, sensation seeking, and impulsivity, but in ways that are poorly understood. We report here that a form of impulsivity in rats predicts high rates of intravenous cocaine self-administration and is associated with changes in dopamine (DA) function before drug exposure. Using positron emission tomography, we demonstrated that D2/3 receptor availability is significantly reduced in the nucleus accumbens of impulsive rats that were never exposed to cocaine and that such effects are independent of DA release. These data demonstrate that trait impulsivity predicts cocaine reinforcement and that D2 receptor dysfunction in abstinent cocaine addicts may, in part, be determined by premorbid influences.	Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurosurg Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurol Unit, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Dalley, JW (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Downing St, Cambridge CB2 3EB, England.	jwd20@cam.ac.uk	Robinson, Emma/A-4572-2010; Robbins, Trevor W/A-7551-2008	Robinson, Emma/0000-0002-1299-6541; Dalley, Jeffrey/0000-0002-2282-3660; Murphy, Emily/0000-0002-8162-5306; Robbins, Trevor/0000-0003-0642-5977; Everitt, Barry/0000-0003-4431-6536; baron, jean-claude/0000-0002-5264-2588	Medical Research Council [G0001354B] Funding Source: researchfish; MRC [G0600196, G0001237, G0600986, G0401068, G9439390] Funding Source: UKRI; Medical Research Council [G9439390, G0600196, G0001237, G0001354, G0600986, G0401068] Funding Source: Medline; Wellcome Trust [076244] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams JB, 2003, AM J DRUG ALCOHOL AB, V29, P691, DOI 10.1081/ADA-120023465; BOLIA KI, 1999, J NEUROPSYCHIATRY CL, V11, P361; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; CAINE SB, 1994, J EXP ANAL BEHAV, V61, P213, DOI 10.1901/jeab.1994.61-213; Chakroun N, 2004, ENCEPHALE, V30, P564; Comings DE, 2000, PROG BRAIN RES, V126, P325; Dalley JW, 2005, PSYCHOPHARMACOLOGY, V182, P579, DOI 10.1007/s00213-005-0107-3; Dalley JW, 2005, NEUROPSYCHOPHARMACOL, V30, P525, DOI 10.1038/sj.npp.1300590; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Gosnell BA, 2000, PSYCHOPHARMACOLOGY, V149, P286, DOI 10.1007/s002130000375; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; HOOKS MS, 1994, J NEUROSCI, V14, P6144; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Larson EB, 2005, PHARMACOL BIOCHEM BE, V82, P590, DOI 10.1016/j.pbb.2005.10.015; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; Lyvers M, 2000, EXP CLIN PSYCHOPHARM, V8, P225, DOI 10.1037/1064-1297.8.2.225; Mach RH, 1997, PHARMACOL BIOCHEM BE, V57, P477, DOI 10.1016/S0091-3057(96)00449-2; Mantsch JR, 2001, PSYCHOPHARMACOLOGY, V157, P31, DOI 10.1007/s002130100744; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Morgan AD, 2005, PSYCHOPHARMACOLOGY, V178, P41, DOI 10.1007/s00213-004-1979-3; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; Mukherjee J, 1999, NUCL MED BIOL, V26, P519, DOI 10.1016/S0969-8051(99)00012-8; Nader MA, 2002, NEUROPSYCHOPHARMACOL, V27, P35, DOI 10.1016/S0893-133X(01)00427-4; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Najafabadi MS, 2005, AM J MED GENET B, V134B, P39, DOI 10.1002/ajmg.b.30117; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paine TA, 2003, BEHAV BRAIN RES, V147, P135, DOI 10.1016/S0166-4328(03)00156-6; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perry JL, 2005, PSYCHOPHARMACOLOGY, V178, P193, DOI 10.1007/s00213-004-1994-4; Persico AM, 1996, BIOL PSYCHIAT, V40, P776, DOI 10.1016/0006-3223(95)00483-1; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; PIAZZA PV, 1991, BRAIN RES, V567, P169, DOI 10.1016/0006-8993(91)91452-7; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; Sher KJ, 2000, J CONSULT CLIN PSYCH, V68, P818, DOI 10.1037/0022-006X.68.5.818; Toissaar M, 2006, NEUROSCI LETT, V403, P119, DOI 10.1016/j.neulet.2006.04.023; Uhl GR, 2004, ANN NY ACAD SCI, V1025, P1, DOI 10.1196/annals.1316.001; van der Kam EL, 2005, NEUROPHARMACOLOGY, V48, P685, DOI 10.1016/j.neuropharm.2004.12.014; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	45	881	900	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1267	1270		10.1126/science.1137073	http://dx.doi.org/10.1126/science.1137073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332411	Green Accepted			2022-12-24	WOS:000244564700047
J	Caro, E; Castellano, MM; Gutierrez, C				Caro, Elena; Castellano, M. Mar; Gutierrez, Crisanto			A chromatin link that couples cell division to root epidermis patterning in Arabidopsis	NATURE			English	Article							E2F TRANSCRIPTION FACTOR; CYCLE; PROLIFERATION; REREPLICATION; ORGANIZATION; EXPRESSION; PROTEINS; PATHWAY; GEMININ; KINASE	Cell proliferation and cell fate decisions are strictly coupled processes during plant embryogenesis and organogenesis(1-5). In the Arabidopsis thaliana root epidermis, expression of the homeobox GLABRA2 (GL2) gene determines hair/non-hair cell fate(6,7). This requires signalling of positional information from the underlying cortical layer(8,9), complex transcriptional regulation(10,11) and a change in chromatin accessibility(12). However, the molecular connections among these factors and with cell division are not known. Here we have identified a GL2-expression modulator, GEM, as an interactor of CDT1, a DNA replication protein. GEM also interacts with TTG1 ( TRANSPARENT TESTA GLABRA1), a WD40-repeat protein involved in GL2-dependent cell fate decision, and modulates both cell division and GL2 expression. Here we show that GEM participates in the maintenance of the repressor histone H3K9 methylation status of root patterning genes, providing a link between cell division, fate and differentiation during Arabidopsis root development.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Gutierrez, C (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	cgutierrez@cbm.uam.es	Gutierrez, Crisanto/ABH-8782-2020; Caro, Elena/G-6352-2012; castellano, mar m/L-2063-2014; Caro, Elena/A-8097-2011; Caro, Elena/D-2611-2014	castellano, mar m/0000-0003-0339-4247; Caro, Elena/0000-0002-1034-1621; Gutierrez, Crisanto/0000-0001-8905-8222				Berger F, 1998, DEV BIOL, V194, P235, DOI 10.1006/dbio.1997.8813; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Blilou I, 2002, GENE DEV, V16, P2566, DOI 10.1101/gad.237302; Castellano MD, 2004, PLANT CELL, V16, P2380, DOI 10.1105/tpc.104.022400; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Costa S, 2006, NATURE, V439, P493, DOI 10.1038/nature04269; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; Desvoyes B, 2006, PLANT PHYSIOL, V140, P67, DOI 10.1104/pp.105.071027; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; DOLAN L, 1993, DEVELOPMENT, V119, P71; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Fischer A, 2006, J PLANT PHYSIOL, V163, P358, DOI 10.1016/j.jplph.2005.10.015; Fletcher JC, 2002, BIOESSAYS, V24, P27, DOI 10.1002/bies.10020; Fransz P, 2006, CHROMOSOME RES, V14, P71, DOI 10.1007/s10577-005-1022-5; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Guimil S, 2006, TRENDS PLANT SCI, V11, P601, DOI 10.1016/j.tplants.2006.10.001; Gutierrez C, 2005, NAT CELL BIOL, V7, P535, DOI 10.1038/ncb0605-535; Jenik PD, 2005, PLANT CELL, V17, P3362, DOI 10.1105/tpc.105.036889; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Larkin JC, 2003, ANNU REV PLANT BIOL, V54, P403, DOI 10.1146/annurev.arplant.54.031902.134823; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Menges M, 2002, PLANT J, V30, P203, DOI 10.1046/j.1365-313X.2002.01274.x; Ramirez-Parra E, 2004, PLANT CELL, V16, P2350, DOI 10.1105/tpc.104.023978; Ramirez-Parra E, 2000, FEBS LETT, V486, P73, DOI 10.1016/S0014-5793(00)02239-0; Ryu KH, 2005, DEVELOPMENT, V132, P4765, DOI 10.1242/dev.02055; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Serna L, 2004, PLANT CELL, V16, P2258, DOI 10.1105/tpc.104.160931; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	34	105	117	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					213	U6		10.1038/nature05763	http://dx.doi.org/10.1038/nature05763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17450124				2022-12-24	WOS:000246338700045
J	Welch, EM; Barton, ER; Zhuo, J; Tomizawa, Y; Friesen, WJ; Trifillis, P; Paushkin, S; Patel, M; Trotta, CR; Hwang, SW; Wilde, RG; Karp, G; Takasugi, J; Chen, GM; Jones, S; Ren, H; Moon, YC; Corson, D; Turpoff, AA; Campbell, JA; Conn, MM; Khan, A; Almstead, NG; Hedrick, J; Mollin, A; Risher, N; Weetall, M; Yeh, S; Branstrom, AA; Colacino, JM; Babiak, J; Ju, WD; Hirawat, S; Northcutt, VJ; Miller, LL; Spatrick, P; He, F; Kawana, M; Feng, H; Jacobson, A; Peltz, SW; Sweeney, HL				Welch, Ellen M.; Barton, Elisabeth R.; Zhuo, Jin; Tomizawa, Yuki; Friesen, Westley J.; Trifillis, Panayiota; Paushkin, Sergey; Patel, Meenal; Trotta, Christopher R.; Hwang, Seongwoo; Wilde, Richard G.; Karp, Gary; Takasugi, James; Chen, Guangming; Jones, Stephen; Ren, Hongyu; Moon, Young-Choon; Corson, Donald; Turpoff, Anthony A.; Campbell, Jeffrey A.; Conn, M. Morgan; Khan, Atiyya; Almstead, Neil G.; Hedrick, Jean; Mollin, Anna; Risher, Nicole; Weetall, Marla; Yeh, Shirley; Branstrom, Arthur A.; Colacino, Joseph M.; Babiak, John; Ju, William D.; Hirawat, Samit; Northcutt, Valerie J.; Miller, Langdon L.; Spatrick, Phyllis; He, Feng; Kawana, Masataka; Feng, Huisheng; Jacobson, Allan; Peltz, Stuart W.; Sweeney, H. Lee			PTC124 targets genetic disorders caused by nonsense mutations	NATURE			English	Article							MESSENGER-RNA DECAY; CYSTIC-FIBROSIS; STOP MUTATIONS; TRANSLATION; TERMINATION; TRANSCRIPTS; SUPPRESSION; EFFICIENCY; PATHWAYS; PROTEINS	Nonsense mutations promote premature translational termination and cause anywhere from 5 - 70% of the individual cases of most inherited diseases(1). Studies on nonsense-mediated cystic fibrosis have indicated that boosting specific protein synthesis from < 1% to as little as 5% of normal levels may greatly reduce the severity or eliminate the principal manifestations of disease(2,3). To address the need for a drug capable of suppressing premature termination, we identified PTC124 - a new chemical entity that selectively induces ribosomal readthrough of premature but not normal termination codons. PTC124 activity, optimized using nonsense-containing reporters, promoted dystrophin production in primary muscle cells from humans and mdx mice expressing dystrophin nonsense alleles, and rescued striated muscle function in mdx mice within 2 - 8 weeks of drug exposure. PTC124 was well tolerated in animals at plasma exposures substantially in excess of those required for nonsense suppression. The selectivity of PTC124 for premature termination codons, its well characterized activity profile, oral bioavailability and pharmacological properties indicate that this drug may have broad clinical potential for the treatment of a large group of genetic disorders with limited or no therapeutic options.	PTC Therapeut, South Plainfield, NJ 07080 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	University of Pennsylvania; University of Massachusetts System; University of Massachusetts Worcester	Peltz, SW (corresponding author), PTC Therapeut, 100 Corp Court, South Plainfield, NJ 07080 USA.	speltz@ptcbio.com	Sweeney, H Lee/F-1862-2010		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R42HD048137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027757, R01GM027757] Funding Source: NIH RePORTER; NICHD NIH HHS [R42 HD048137] Funding Source: Medline; NIGMS NIH HHS [R01 GM027757, R37 GM027757] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Grentzmann G, 1998, RNA, V4, P479; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kerem E, 2004, CURR OPIN PULM MED, V10, P547, DOI 10.1097/01.mcp.0000141247.22078.46; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Neville C, 1997, METHOD CELL BIOL, V52, P85, DOI 10.1016/S0091-679X(08)60375-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Politano L, 2003, Acta Myol, V22, P15; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sweeney HL, 1997, METHOD CELL BIOL, V52, P275, DOI 10.1016/S0091-679X(08)60383-0; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; VANDERVELDEN A, 1995, VIROLOGY, V214, P82, DOI 10.1006/viro.1995.9952; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Welch EM, 2000, COLD SPRING HARBOR M, V39, P467; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170	35	778	851	3	82	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					87	U6		10.1038/nature05756	http://dx.doi.org/10.1038/nature05756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17450125				2022-12-24	WOS:000246149300049
J	Grijalva, CG; Nuorti, JP; Arbogast, PG; Martin, SW; Edwards, KM; Griffin, MR				Grijalva, Carlos G.; Nuorti, J. Pekka; Arbogast, Patrick G.; Martin, Stacey W.; Edwards, Kathryn M.; Griffin, Marie R.			Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis	LANCET			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; CHILDREN YOUNGER; DISEASE; PREVENTION; INFLUENZA; EFFICACY; IMPACT; TRIAL; HIV	Background Routine infant immunisation with seven-valent pneumococcal conjugate vaccine (PCV7) began in the USA in 2000. Although invasive pneumococcal disease has declined substantially, the programme's effect on hospital admissions for pneumonia is unknown. We therefore assessed the effect of the programme on rates of all-cause and pneumococcal pneumonia admissions. Methods Data from the Nationwide Inpatient Sample, the largest inpatient database available in the USA, were analysed with an interrupted time-series analysis that used pneumonia (all-cause and pneumococcal) admission rates as the main outcomes. Monthly admission rates estimated for years after the introduction of PCV7 vaccination (2001-2004) were compared with expected rates calculated from pre-PCV7 years (1997-1999). The year of vaccine introduction (2000) was excluded, and rates of admission for dehydration were assessed for comparison. Findings At the end of 2004, all-cause pneumonia admission rates had declined by 39% (95% CI 22-52) for children younger than 2 years, who were the target population of the vaccination programme. This annual decline in all-cause pneumonia admissions of 506 (291-675) per 100 000 children younger than 2 years represented about 41000 pneumonia admissions prevented in 2004. During the 8 study years, 10 659 (2%) children younger than 2 years admitted with pneumonia were coded as having pneumococcal disease; these rates declined by 65% (47-77). This decline represented about 17 fewer admissions per 100 000 children in 2004. Admission rates for dehydration for children younger than 2 years remained stable over the study period. Interpretation The reduction in all-cause pneumonia admissions in children younger than 2 years provides an estimate of the proportion of childhood pneumonias attributable to Streptococcus pneumoniae in the USA that are vaccine preventable. Our results contribute to the growing body of evidence supporting the beneficial effects of the pneumococcal conjugate vaccines in children.	Vanderbilt Univ, Sch Med, Dept Prevent Med, Village Vanderbilt,Suite 2600,1500 21st Ave, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA; VA TN Valley Hlth Care Syst, Mids Geriatr Res Educ, Nashville, TN USA; VA TN Valley Hlth Care Syst, Clin Res Ctr Excellence, Nashville, TN USA; Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Centers for Disease Control & Prevention - USA	Griffin, MR (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Village Vanderbilt,Suite 2600,1500 21st Ave, Nashville, TN 37212 USA.	marie.griffin@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS016784] Funding Source: NIH RePORTER; AHRQ HHS [1R03 HS016784] Funding Source: Medline; PHS HHS [U38/CCU417958] Funding Source: Medline; ATSDR CDC HHS [TS-0825, TS-1392] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); ATSDR CDC HHS		Abramson JS, 2000, PEDIATRICS, V106, P362; *AG HEALTHC RES QU, HEALTHC COST UT PR; *AG HEALTHC RES QU, 1996, HEALTHC COST UT PROJ; *AHRQ, 2002, HCUP FACT BOOK; Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; ANDREWS BE, 1987, Q J MED, V62, P195; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P893; [Anonymous], 2006, MMWR-MORBID MORTAL W, V55, P1065; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; *CDCP, COV IND VACC VACC SE; *CDCP, NAT IMM PROGR VACC C; *CDCP, INFL ACT; Cook T.C., 1979, QUASIEXPERIMENTATION; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Drummond P, 2000, ARCH DIS CHILD, V83, P408, DOI 10.1136/adc.83.5.408; Farha Talal, 2005, Paediatr Respir Rev, V6, P76, DOI 10.1016/j.prrv.2005.03.001; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Grijalva CG, 2006, CLIN INFECT DIS, V43, P680, DOI 10.1086/506945; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Hebert PL, 2005, MED CARE RES REV, V62, P560, DOI 10.1177/1077558705279310; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Little R.J.A., 2002, STAT ANAL MISSING DA; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Melegaro A, 2004, EUR J EPIDEMIOL, V19, P353, DOI 10.1023/B:EJEP.0000024701.94769.98; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Mulholland K, 2005, TROP MED INT HEALTH, V10, P497, DOI 10.1111/j.1365-3156.2005.01430.x; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; NUORTI JP, 2006, 5 INT S PNEUM PNEUM; O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1; Obaro SK, 2006, LANCET INFECT DIS, V6, P150, DOI 10.1016/S1473-3099(06)70411-X; Poehling KA, 2004, PEDIATRICS, V114, P755, DOI 10.1542/peds.2003-0592-F; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; 1998, MMWR MORB MORTAL WKL, V47, P797	45	502	533	0	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1179	1186		10.1016/S0140-6736(07)60564-9	http://dx.doi.org/10.1016/S0140-6736(07)60564-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416262				2022-12-24	WOS:000245595100029
J	Li, QJ; Chau, J; Ebert, PJR; Sylvester, G; Min, H; Liu, G; Braich, R; Manoharan, M; Soutschek, J; Skare, P; Klein, LO; Davis, MM; Chen, CZ				Li, Qi-Jing; Chau, Jacqueline; Ebert, Peter J. R.; Sylvester, Giselle; Min, Hyeyoung; Liu, Gwen; Braich, Ravi; Manoharan, Muthiah; Soutschek, Juergen; Skare, Petra; Klein, Lawrence O.; Davis, Mark M.; Chen, Chang-Zheng			miR-181a is an intrinsic modulator of T cell sensitivity and selection	CELL			English	Article							TYROSINE-PHOSPHATASE; LIGAND RECOGNITION; IN-VIVO; RECEPTOR; MICRORNAS; DISCRIMINATION; ANTIGEN; TCR; ANTAGONISM; MECHANISM	T cell sensitivity to antigen is intrinsically regulated during maturation to ensure proper development of immunity and tolerance, but how this is accomplished remains elusive. Here we show that increasing miR-181a expression in mature T cells augments the sensitivity to peptide antigens, while inhibiting miR-181a expression in the immature T cells reduces sensitivity and impairs both positive and negative selection. Moreover, quantitative regulation of T cell sensitivity by miR-181a enables mature T cells to recognize antagonists-the inhibitory peptide antigens-as agonists. These effects are in part achieved by the downregulation of multiple phosphatases, which leads to elevated steady-state levels of phosphorylated intermediates and a reduction of the T cell receptor signaling threshold. Importantly, higher miR-181a expression correlates with greater T cell sensitivity in immature T cells, suggesting that miR-181a acts as an intrinsic antigen sensitivity "rheostat" during T cell development.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Baxter Lab, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Grad Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Grad Program Biophys, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Inst Stem Cell Canc & Med, Stanford, CA 94305 USA; Alnylam Pharmaceut, Cambridge, MA 02142 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@pmgm2.stanford.edu; czchen@stanford.edu		Davis, Mark/0000-0001-6868-657X; Chen, Chang-Zheng/0000-0002-1620-242X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, R01AI073724] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081612-02, R01 HL081612, R01 HL081612-01, R01 HL081612-03, R01-HL081612] Funding Source: Medline; NIAID NIH HHS [T32 AI007328, R01 AI073724] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Salmond RJ, 2005, J IMMUNOL, V175, P6498, DOI 10.4049/jimmunol.175.10.6498; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Sumen C, 2004, J CELL BIOL, V166, P579, DOI 10.1083/jcb.200404059; Theodosiou A, 2002, GENOME BIOL, V3; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290	44	949	1062	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					147	161		10.1016/j.cell.2007.03.008	http://dx.doi.org/10.1016/j.cell.2007.03.008			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17382377	Bronze			2022-12-24	WOS:000245661100018
J	Taga, ME; Larsen, NA; Howard-Jones, AR; Walsh, CT; Walker, GC				Taga, Michiko E.; Larsen, Nicholas A.; Howard-Jones, Annaleise R.; Walsh, Christopher T.; Walker, Graham C.			BluB cannibalizes flavin to form the lower ligand of vitamin B-12	NATURE			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; REDUCED FLAVIN; COENZYME B-12; BIOSYNTHESIS; 5,6-DIMETHYLBENZIMIDAZOLE; TRANSFORMATION; MONOOXYGENASE; RIBOFLAVIN; MECHANISM	Vitamin B-12 (cobalamin) is among the largest known non-polymeric natural products, and the only vitamin synthesized exclusively by microorganisms(1). The biosynthesis of the lower ligand of vitamin B-12, 5,6-dimethylbenzimidazole (DMB), is poorly understood(1-3). Recently, we discovered that a Sinorhizobium meliloti gene, bluB, is necessary for DMB biosynthesis(4). Here we show that BluB triggers the unprecedented fragmentation and contraction of the bound flavin mononucleotide cofactor and cleavage of the ribityl tail to form DMB and D-erythrose 4-phosphate. Our structural analysis shows that BluB resembles an NAD(P)H-flavin oxidoreductase, except that its unusually tight binding pocket accommodates flavin mononucleotide but not NAD( P) H. We characterize crystallographically an early intermediate along the reaction coordinate, revealing molecular oxygen poised over reduced flavin. Thus, BluB isolates and directs reduced flavin to activate molecular oxygen for its own cannibalization. This investigation of the biosynthesis of DMB provides clarification of an aspect of vitamin B-12 that was otherwise incomplete, and may contribute to a better understanding of vitamin B-12-related disease.	MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Walsh, CT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	christopher_walsh@hms.harvard.edu		/0000-0001-7243-8261	NIGMS NIH HHS [R01 GM031030-25, R01 GM020011-30, R01 GM031030, R01 GM020011] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020011, R01GM031030] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Gatti DL, 1996, BIOCHEMISTRY-US, V35, P567, DOI 10.1021/bi951344i; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HORIG JA, 1980, EUR J BIOCHEM, V105, P587, DOI 10.1111/j.1432-1033.1980.tb04536.x; Keck K, 1998, ARCH MICROBIOL, V171, P66, DOI 10.1007/s002030050679; Koike H, 1998, J MOL BIOL, V280, P259, DOI 10.1006/jmbi.1998.1871; KOLONKO B, 1992, Z NATURFORSCH C, V47, P171; Larsen NA, 2006, BIOCHEMISTRY-US, V45, P10184, DOI 10.1021/bi060950i; Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+; LINGENS B, 1992, EUR J BIOCHEM, V207, P981, DOI 10.1111/j.1432-1033.1992.tb17133.x; Lovering AL, 2001, J MOL BIOL, V309, P203, DOI 10.1006/jmbi.2001.4653; Maggio-Hall LA, 2003, ORG LETT, V5, P2211, DOI 10.1021/ol034530m; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Renz P., 1999, Chemistry and biochemistry of B12., P557; RENZ P, 1970, FEBS LETT, V6, P187, DOI 10.1016/0014-5793(70)80053-9; RENZ P, 1972, FEBS LETT, V22, P124, DOI 10.1016/0014-5793(72)80236-9; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Tanner JJ, 1996, BIOCHEMISTRY-US, V35, P13531, DOI 10.1021/bi961400v; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Warren MJ, 2006, P NATL ACAD SCI USA, V103, P4799, DOI 10.1073/pnas.0601030103	29	124	130	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					449	453		10.1038/nature05611	http://dx.doi.org/10.1038/nature05611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	148MO	17377583	Green Accepted			2022-12-24	WOS:000245079500042
J	Dunne, EF; Unger, ER; Sternberg, M; McQuillan, G; Swan, DC; Patel, SS; Markowitz, LE				Dunne, Eileen F.; Unger, Elizabeth R.; Sternberg, Maya; McQuillan, Geraldine; Swan, David C.; Patel, Sonya S.; Markowitz, Lauri E.			Prevalence of HPV infection among females in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; YOUNG-WOMEN; SELF; TYPE-16; SAMPLES; SEROPREVALENCE; ACCEPTABILITY; EPIDEMIOLOGY; ADOLESCENT	Context Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection. Baseline population prevalence data for HPV infection in the United States before widespread availability of a prophylactic HPV vaccine would be useful. Objective To determine the prevalence of HPV among females in the United States. Design, Setting, and Participants The National Health and Nutrition Examination Survey ( NHANES) uses a representative sample of the US noninstitutionalized civilian population. Females aged 14 to 59 years who were interviewed at home for NHANES 2003-2004 were examined in a mobile examination center and provided a self-collected vaginal swab specimen. Swabs were analyzed for HPV DNA by L1 consensus polymerase chain reaction followed by type-specific hybridization. Demographic and sexual behavior information was obtained from all participants. Main Outcome Measures HPV prevalence by polymerase chain reaction. Results The overall HPV prevalence was 26.8% (95% confidence interval [CI], 23.3%-30.9%) among US females aged 14 to 59 years (n= 1921). HPV prevalence was 24.5% ( 95% CI, 19.6%-30.5%) among females aged 14 to 19 years, 44.8% ( 95% CI, 36.3%-55.3%) among women aged 20 to 24 years, 27.4% ( 95% CI, 21.9%-34.2%) among women aged 25 to 29 years, 27.5% ( 95% CI, 20.8%-36.4%) among women aged 30 to 39 years, 25.2% ( 95% CI, 19.7%-32.2%) among women aged 40 to 49 years, and 19.6% (95% CI, 14.3%-26.8%) among women aged 50 to 59 years. There was a statistically significant trend for increasing HPV prevalence with each year of age from 14 to 24 years ( P <. 001), followed by a gradual decline in prevalence through 59 years (P=. 06). HPV vaccine types 6 and 11 (low-risk types) and 16 and 18 (high-risk types) were detected in 3.4% of female participants; HPV-6 was detected in 1.3% ( 95% CI, 0.8%-2.3%), HPV-11 in 0.1% ( 95% CI, 0.03%-0.3%), HPV-16 in 1.5% ( 95% CI, 0.9%-2.6%), and HPV-18 in 0.8% ( 95% CI, 0.4%-1.5%) of female participants. Independent risk factors for HPV detection were age, marital status, and increasing numbers of lifetime and recent sex partners. Conclusions HPV is common among females in the United States. Our data indicate that the burden of prevalent HPV infection among females was greater than previous estimates and was highest among those aged 20 to 24 years. However, the prevalence of HPV vaccine types was relatively low.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Dunne, EF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-02, Atlanta, GA 30333 USA.	dde9@cdc.gov		Unger, Elizabeth/0000-0002-2925-5635				[Anonymous], 2000, Vital Health Stat 2, P1; Baldwin S, 2005, GYNECOL ONCOL, V97, P612, DOI 10.1016/j.ygyno.2005.02.001; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Casella G., 2021, STAT INFERENCE; Castle PE, 2004, J INFECT DIS, V190, P458, DOI 10.1086/421916; *CDCP, ACIP PROV REC US QUA; Dzuba IG, 2002, J WOMEN HEALTH GEN-B, V11, P265, DOI 10.1089/152460902753668466; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Gravitt PE, 2001, CANCER EPIDEM BIOMAR, V10, P95; Kahn JA, 2005, SEX TRANSM INFECT, V81, P408, DOI 10.1136/sti.2004.012047; Korn E. L., 1999, ANAL HLTH SURVEYS; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lorenzato FR, 2002, AM J OBSTET GYNECOL, V186, P962, DOI 10.1067/mob.2002.122390; Manhart LE, 2006, SEX TRANSM DIS, V33, P502, DOI 10.1097/01.olq.0000204545.89516.0a; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Ogilvie GS, 2005, SEX TRANSM INFECT, V81, P207, DOI 10.1136/sti.2004.011858; Peyton CL, 2001, J INFECT DIS, V183, P1554, DOI 10.1086/320696; Revzina NV, 2005, INT J STD AIDS, V16, P528, DOI 10.1258/0956462054679214; *SAS I INC, 2002, SAS COMP MICR WIND E; Sellors JW, 2000, CAN MED ASSOC J, V163, P513; SHAH BV, 2004, SUDAAN USERS MANUAL; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Tarkowski TA, 2004, J INFECT DIS, V189, P46, DOI 10.1086/380466; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; U.S. Census Bureau, RAT INC POV LEV; Vernon SD, 2000, J CLIN MICROBIOL, V38, P651, DOI 10.1128/JCM.38.2.651-655.2000; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	33	1028	1072	6	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 28	2007	297	8					813	819		10.1001/jama.297.8.813	http://dx.doi.org/10.1001/jama.297.8.813			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	140DS	17327523	Bronze			2022-12-24	WOS:000244485000024
J	Hellman, A; Chess, A				Hellman, Asaf; Chess, Andrew			Gene body-specific methylation on the active X chromosome	SCIENCE			English	Article							DNA METHYLATION; HPRT GENE; INACTIVATION; CELLS; SITES; WIDE; ARABIDOPSIS	Differential DNA methylation is important for the epigenetic regulation of gene expression. Allele-specific methylation of the inactive X chromosome has been demonstrated at promoter CpG islands, but the overall pattern of methylation on the active X (Xa) and inactive X ( Xi) chromosomes is unknown. We performed allele-specific analysis of more than 1000 informative loci along the human X chromosome. The Xa displays more than two times as much allele-specific methylation as Xi. This methylation is concentrated at gene bodies, affecting multiple neighboring CpGs. Before X inactivation, all of these Xa gene body-methylated sites are biallelically methylated. Thus, a bipartite methylation-demethylation program results in Xa-specific hypomethylation at gene promoters and hypermethylation at gene bodies. These results suggest a relationship between global methylation and expression potentiality.	Harvard Univ, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hellman, A (corresponding author), Harvard Univ, Sch Med, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	hellman@chgr.mgh.harvard.edu; chess@chgr.mgh.harvard.edu						ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; Gilbert SL, 1999, P NATL ACAD SCI USA, V96, P13825, DOI 10.1073/pnas.96.24.13825; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; LOCK LF, 1986, MOL CELL BIOL, V6, P914, DOI 10.1128/MCB.6.3.914; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Valley CM, 2006, CURR OPIN GENET DEV, V16, P240, DOI 10.1016/j.gde.2006.04.008; VIEGASPEQUIGNOT E, 1988, P NATL ACAD SCI USA, V85, P7657, DOI 10.1073/pnas.85.20.7657; VUAN E, 2006, CANCER RES, V66, P3443; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; YEN PH, 1984, P NATL ACAD SCI-BIOL, V81, P1759, DOI 10.1073/pnas.81.6.1759; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	24	498	513	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 23	2007	315	5815					1141	1143		10.1126/science.1136352	http://dx.doi.org/10.1126/science.1136352			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17322062				2022-12-24	WOS:000244387600041
J	Zeggini, E; Weedon, MN; Lindgren, CM; Frayling, TM; Elliott, KS; Lango, H; Timpson, NJ; Perry, JRB; Rayner, NW; Freathy, RM; Barrett, JC; Shields, B; Morris, AP; Ellard, S; Groves, CJ; Harries, LW; Marchini, JL; Owen, KR; Knight, B; Cardon, LR; Walker, M; Hitman, GA; Morris, AD; Doney, ASF; McCarthy, MI; Hattersley, AT				Zeggini, Eleftheria; Weedon, Michael N.; Lindgren, Cecilia M.; Frayling, Timothy M.; Elliott, Katherine S.; Lango, Hana; Timpson, Nicholas J.; Perry, John R. B.; Rayner, Nigel W.; Freathy, Rachel M.; Barrett, Jeffrey C.; Shields, Beverley; Morris, Andrew P.; Ellard, Sian; Groves, Christopher J.; Harries, Lorna W.; Marchini, Jonathan L.; Owen, Katharine R.; Knight, Beatrice; Cardon, Lon R.; Walker, Mark; Hitman, Graham A.; Morris, Andrew D.; Doney, Alex S. F.; McCarthy, Mark I.; Hattersley, Andrew T.		WTCCC	Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes	SCIENCE			English	Article							INSULIN-DEGRADING ENZYME; GENE; VARIANT; CDK4; PANCREAS; MICE; MASS; HEX; MAP	The molecular mechanisms involved in the development of type 2 diabetes are poorly understood. Starting from genome-wide genotype data for 1924 diabetic cases and 2938 population controls generated by the Wellcome Trust Case Control Consortium, we set out to detect replicated diabetes association signals through analysis of 3757 additional cases and 5346 controls and by integration of our findings with equivalent data from other international consortia. We detected diabetes susceptibility loci in and around the genes CDKAL1, CDKN2A/CDKN2B, and IGF2BP2 and confirmed the recently described associations at HHEX/IDE and SLC30A8. Our findings provide insight into the genetic architecture of type 2 diabetes, emphasizing the contribution of multiple variants of modest effect. The regions identified underscore the importance of pathways influencing pancreatic beta cell development and function in the etiology of type 2 diabetes.	Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; PEninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Diabet Genet Grp, Exeter EX2 5DW, Devon, England; Univ Bristol, MRC, Ctr Casual Anal Translat Epidemiol, Bristol BS2 8PR, Avon, England; Royal Devon & Exeter NHS FDn Trust, Genet Mol Lab, Exeter EX2 5DW, Devon, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Newcastle, Sch Clin Med Sci, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Barts & London Royal London Hosp, Ctr Diabet & Metab Med, London E1 1BB, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Exeter; University of Exeter; University of Bristol; University of Exeter; University of Oxford; Newcastle University - UK; Barts Health NHS Trust; Royal London Hospital; University of Dundee	McCarthy, MI (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.	mark.mccarthy@drl.ox.ac.uk	Brown, Matthew A/E-5749-2010; Harries, Lorna/D-2241-2014; Doney, Alexander SF/P-7437-2017; Morris, Andrew D/C-2837-2009; Timpson, Nicholas John/O-7548-2015; Hinks, Anne/E-1853-2015; Fox, Laura J/C-6249-2016; Attrill, Lauren/V-1688-2018; Study, GoDARTS/K-9448-2016; eyre, stephen/K-3776-2017; Worthington, Jane/M-9770-2014; Marchini, Jonathan/ABE-9024-2020; Allen, Hana Lango/G-9026-2012; Mathew, Christopher George/G-3434-2015; Lewis, Cathryn/A-5225-2010; McCarthy, Mark/M-3763-2015; Prescott, Natalie/F-6490-2011	Brown, Matthew A/0000-0003-0538-8211; Doney, Alexander SF/0000-0002-6210-5620; Timpson, Nicholas John/0000-0002-7141-9189; Hinks, Anne/0000-0001-8843-3967; eyre, stephen/0000-0002-1251-6974; Worthington, Jane/0000-0003-0544-042X; Marchini, Jonathan/0000-0003-0610-8322; Allen, Hana Lango/0000-0002-7803-8688; Ellard, Sian/0000-0002-7620-5526; Symmons, Deborah/0000-0002-8625-1200; Weedon, Michael/0000-0002-6174-6135; Freathy, Rachel/0000-0003-4152-2238; Frayling, Timothy/0000-0001-8362-2603; Zeggini, Eleftheria/0000-0003-4238-659X; Mathew, Christopher George/0000-0003-4178-1838; Lindgren, Cecilia/0000-0002-4903-9374; Morgan, Ann/0000-0003-1109-624X; Lewis, Cathryn/0000-0002-8249-8476; Forbes, Alastair/0000-0001-7416-9843; Bruce, Ian/0000-0003-3047-500X; Barrett, Jeffrey/0000-0002-1152-370X; Hattersley, Andrew/0000-0001-5620-473X; McCarthy, Mark/0000-0002-4393-0510; Thomson, Wendy/0000-0002-9022-5179; Prescott, Natalie/0000-0002-5901-7371	MRC [G0500070, G0000934] Funding Source: UKRI; Medical Research Council [G0000934, G0500070] Funding Source: Medline; Wellcome Trust [083948, 090532] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Marzo N, 2004, DIABETOLOGIA, V47, P686, DOI 10.1007/s00125-004-1372-0; Mettus RV, 2003, ONCOGENE, V22, P8413, DOI 10.1038/sj.onc.1206888; Moritani M, 2005, MOL CELL ENDOCRINOL, V229, P175, DOI 10.1016/j.mce.2004.08.007; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Pettersson F, 2004, BIOINFORMATICS, V20, P3241, DOI 10.1093/bioinformatics/bth341; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SELA KA, 1997, BIOCHEM BIOPH RES CO, V231, P167; SIADEK R, 2007, NATURE, V445, P881; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; *WELLC TRUST CAS C, IN PRESS NATURE	25	1729	1799	0	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1336	1341		10.1126/science.1142364	http://dx.doi.org/10.1126/science.1142364			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17463249	Green Accepted			2022-12-24	WOS:000246885600050
J	Busino, L; Bassermann, F; Maiolica, A; Lee, C; Nolan, PM; Godinho, SIH; Draetta, GF; Pagano, M				Busino, Luca; Bassermann, Florian; Maiolica, Alessio; Lee, Choogon; Nolan, Patrick M.; Godinho, Sofia I. H.; Draetta, Giulio F.; Pagano, Michele			SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins	SCIENCE			English	Article							TRCP-MEDIATED DEGRADATION; GENE-EXPRESSION; CELL-GROWTH; IN-VIVO; PLAYS; WEB	One component of the circadian clock in mammals is the Clock-Bmal1 heterodimeric transcription factor. Among its downstream targets, two genes, Cry1 and Cry2, encode inhibitors of the Clock-Bmal1 complex that establish a negative-feedback loop. We found that both Cry1 and Cry2 proteins are ubiquitinated and degraded via the SCFFbxl3 ubiquitin ligase complex. This regulation by SCFFbxl3 is a prerequisite for the efficient and timely reactivation of Clock-Bmal1 and the consequent expression of Per1 and Per2, two regulators of the circadian clock that display tumor suppressor activity. Silencing of Fbxl3 produced no effect in Cry1(-/-); Cry2(-/-) cells, which shows that Fbxl3 controls clock oscillations by mediating the degradation of CRY proteins.	NYU, Dept Pathol, Inst Canc, Sch Med, New York, NY 10016 USA; European Inst Oncol, I-20141 Milan, Italy; Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; Merck Res Labs, Boston, MA 02115 USA	New York University; IRCCS European Institute of Oncology (IEO); State University System of Florida; Florida State University; MRC Harwell; Merck & Company	Pagano, M (corresponding author), NYU, Dept Pathol, Inst Canc, Sch Med, 550 1st Ave,MSB 599, New York, NY 10016 USA.	michele.pagano@med.nyu.edu	Nolan, Patrick/W-3918-2019	Nolan, Patrick/0000-0001-5550-0334; pagano, michele/0000-0003-3210-2442	MRC [MC_U142684173, MC_U142684172, MC_UP_1502/1, MC_U142684175] Funding Source: UKRI; Medical Research Council [MC_U142684172, MC_U142684173, MC_UP_1502/1, MC_U142684175] Funding Source: Medline; NCI NIH HHS [R21-CA125173, R37-CA76584] Funding Source: Medline; NIGMS NIH HHS [R01-GM57587] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA076584, R21CA125173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; GODINHO SIH, 2007, IN PRESS SCIENC 0427; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; MATSUO D, 2003, SCIENCE         0821; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; PANDO MP, 2001, SCI SIKE, V2001; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Wallsser JA, 2006, DEV CELL, V10, P539, DOI 10.1016/j.devcel.2006.04.014; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301	22	374	388	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					900	904		10.1126/science.1141194	http://dx.doi.org/10.1126/science.1141194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17463251				2022-12-24	WOS:000246369800041
J	Eichler, EE; Nickerson, DA; Altshuler, D; Bowcock, AM; Brooks, LD; Carter, NP; Church, DM; Felsenfeld, A; Guyer, M; Lee, C; Lupski, JR; Mullikin, JC; Pritchard, JK; Sebat, J; Sherry, ST; Smith, D; Valle, D; Waterston, RH				Eichler, Evan E.; Nickerson, Deborah A.; Altshuler, David; Bowcock, Anne M.; Brooks, Lisa D.; Carter, Nigel P.; Church, Deanna M.; Felsenfeld, Adam; Guyer, Mark; Lee, Charles; Lupski, James R.; Mullikin, James C.; Pritchard, Jonathan K.; Sebat, Jonathan; Sherry, Stephen T.; Smith, Douglas; Valle, David; Waterston, Robert H.		Human Genome Structural Variation	Completing the map of human genetic variation	NATURE			English	Article							COPY-NUMBER POLYMORPHISMS; HUMAN GENOME; STRUCTURAL VARIATION; LINKAGE DISEQUILIBRIUM; SEGMENTAL DUPLICATIONS; DELETION POLYMORPHISMS; Y-CHROMOSOMES; IDENTIFICATION; DISEASE; REARRANGEMENTS		Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Wellcome Trust Sanger Inst, Hinxton CB4 5RW, England; Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21025 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Chicago; Cold Spring Harbor Laboratory; Johns Hopkins University	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Sherry, Stephen/0000-0002-7982-076X; Bowcock, Anne/0000-0001-8691-9090; Sebat, Jonathan/0000-0002-9087-526X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER; Wellcome Trust [077008] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooley T. B., 1925, T AM PEDIATRIC SOCIE, V37, P29; Deeb SS, 2005, CLIN GENET, V67, P369, DOI 10.1111/j.1399-0004.2004.00343.x; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fucharoen S, 2002, INT J HEMATOL, V76, P83, DOI 10.1007/BF03165094; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson J, 2006, J CLIN ENDOCR METAB, V91, P687, DOI 10.1210/jc.2005-1643; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levine P, 1941, J AMER MED ASSOC, V116, P825, DOI 10.1001/jama.1941.02820090025006; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Park J, 2006, CANCER EPIDEM BIOMAR, V15, P1473, DOI 10.1158/1055-9965.EPI-06-0141; Rao YS, 2000, MOL PHARMACOL, V58, P747, DOI 10.1124/mol.58.4.747; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagner F F, 2004, Immunohematology, V20, P23; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Wilson EB, 1911, ARCH MIKROSK ANAT, V77, P249; Wirtenberger M, 2006, AM J HUM GENET, V78, P520, DOI 10.1086/500793	46	146	158	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					161	165		10.1038/447161a	http://dx.doi.org/10.1038/447161a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495918	Green Accepted, Bronze			2022-12-24	WOS:000246338700034
J	Wellen, KE; Fucho, R; Gregor, MF; Furuhashi, M; Morgan, C; Lindstad, T; Vaillancourt, E; Gorgun, CZ; Saatcioglu, F; Hotamisligil, GS				Wellen, Kathryn E.; Fucho, Raquel; Gregor, Margaret F.; Furuhashi, Masato; Morgan, Carlos; Lindstad, Torstein; Vaillancourt, Eric; Gorgun, Cem Z.; Saatcioglu, Fahri; Hotamisligil, Gokhan S.			Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis	CELL			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; ADIPOSE-RELATED PROTEIN; PROSTATE-CANCER; IKK-BETA; MOLECULAR-CLONING; OBESITY; STRESS; GENE; ADIPOCYTES	Metabolic and inflammatory pathways crosstalk at many levels, and, while required for homeostasis, interaction between these pathways can also lead to metabolic dysregulation under conditions of chronic stress. Thus, we hypothesized that mechanisms might exist to prevent overt inflammatory responses during physiological fluctuations in nutrients or under nutrient-rich conditions, and we identified the six-transmembrane protein STAMP2 as a critical modulator of this integrated response system of inflammation and metabolism in adipocytes. Lack of STAMP2 in adipocytes results in aberrant inflammatory responses to both nutrients and acute inflammatory stimuli. Similarly, in whole animals, visceral adipose tissue of STAMP2(-/-) mice exhibits overt inflammation, and these mice develop spontaneous metabolic disease on a regular diet, manifesting insulin resistance, glucose intolerance, mild hyperglycemia, dyslipidemia, and fatty liver disease. We conclude that STAMP2 participates in integrating inflammatory and metabolic responses and thus plays a key role in systemic metabolic homeostasis.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway	Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Fucho, Raquel/A-6684-2016; Vaillancourt, Eric/HGD-0666-2022; Furuhashi, Masato/AAT-5518-2021; Eckhardt, Erik/G-1567-2010	Fucho, Raquel/0000-0002-1774-9099; Vaillancourt, Eric/0000-0002-1810-126X; Furuhashi, Masato/0000-0002-0145-3541; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539, T90DK070078, P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052539-03, R01 DK052539-04, R01 DK052539-02, P30 DK040561, R01 DK052539, R01 DK052539-06, R01 DK052539-09, R01 DK052539-06S1, DK52539, R01 DK052539-05, R01 DK052539-10, R01 DK052539-07, T90 DK070078, P30 DK040561-12, R01 DK052539-08] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Einstein FH, 2005, DIABETES, V54, P672, DOI 10.2337/diabetes.54.3.672; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Fasshauer M, 2004, FEBS LETT, V560, P153, DOI 10.1016/S0014-5793(04)00096-1; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rosen ED, 2000, GENE DEV, V14, P1293; Slagsvold T, 2001, J BIOL CHEM, V276, P31030, DOI 10.1074/jbc.M104310200; Steiner MS, 2000, CANCER RES, V60, P4419; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2004, ENDOCRINOLOGY, V145, P2214, DOI 10.1210/en.2003-1580; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	38	166	180	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					537	548		10.1016/j.cell.2007.02.049	http://dx.doi.org/10.1016/j.cell.2007.02.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482547	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000246373600020
J	van Rooij, E; Sutherland, LB; Qi, XX; Richardson, JA; Hill, J; Olson, EN				van Rooij, Eva; Sutherland, Lillian B.; Qi, Xiaoxia; Richardson, James A.; Hill, Joseph; Olson, Eric N.			Control of stress-dependent cardiac growth and gene expression by a microRNA	SCIENCE			English	Article							MYOSIN HEAVY-CHAIN; THYROID-HORMONE RECEPTOR; HUMAN HEART; TRANSGENIC MICE; HYPERTROPHY; DIFFERENTIATION; HYPOTHYROIDISM; CARDIOMYOPATHY; PROLIFERATION; PHENOTYPE	The heart responds to diverse forms of stress by hypertrophic growth accompanied by fibrosis and eventual diminution of contractility, which results from down-regulation of alpha-myosin heavy chain (alpha MHC) and up-regulation of beta MHC, the primary contractile proteins of the heart. We found that a cardiac-specific microRNA (miR-208) encoded by an intron of the alpha MHC gene is required for cardiomyocyte hypertrophy, fibrosis, and expression of beta MHC in response to stress and hypothyroidism. Thus, the alpha MHC gene, in addition to encoding a major cardiac contractile protein, regulates cardiac growth and gene expression in response to stress and hormonal signaling through miR-208.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu						Abraham WT, 2002, MOL MED, V8, P750, DOI 10.1007/BF03402039; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen WJ, 2000, MOL CELL ENDOCRINOL, V162, P45, DOI 10.1016/S0303-7207(00)00203-3; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kinugawa K, 2001, J CLIN ENDOCR METAB, V86, P5089, DOI 10.1210/jc.86.10.5089; Kinugawa K, 2001, CIRC RES, V89, P591, DOI 10.1161/hh1901.096706; Kiriazis H, 2000, ANNU REV PHYSIOL, V62, P321, DOI 10.1146/annurev.physiol.62.1.321; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; Mansen A, 2001, MOL ENDOCRINOL, V15, P2106, DOI 10.1210/me.15.12.2106; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morkin E, 2000, MICROSC RES TECHNIQ, V50, P522, DOI 10.1002/1097-0029(20000915)50:6<522::AID-JEMT9>3.0.CO;2-U; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Ojamaa K, 2000, ENDOCRINOLOGY, V141, P2139, DOI 10.1210/en.141.6.2139; Pantos C, 2006, HORM METAB RES, V38, P308, DOI 10.1055/s-2006-925404; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; SCHUYLER GT, 1990, BASIC RES CARDIOL, V85, P481, DOI 10.1007/BF01931494; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Vadaszova A, 2004, PHYSIOL RES, V53, pS57; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wei T, 2005, J ENDOCRINOL INVEST, V28, P8, DOI 10.1007/BF03345522; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; YAO JL, 1992, CIRC RES, V71, P831, DOI 10.1161/01.RES.71.4.831; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	38	1285	1349	0	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					575	579		10.1126/science.1139089	http://dx.doi.org/10.1126/science.1139089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17379774				2022-12-24	WOS:000245983100038
J	Jazayeri, M; Movshon, JA				Jazayeri, Mehrdad; Movshon, J. Anthony			A new perceptual illusion reveals mechanisms of sensory decoding	NATURE			English	Article							VISUAL-MOTION; DISCRIMINATION; POPULATIONS; NEURONS; CORTEX; CAT	Perceptual illusions are usually thought to arise from the way sensory signals are encoded by the brain, and indeed are often used to infer the mechanisms of sensory encoding(1). But perceptual illusions might also result from the way the brain decodes sensory information(2), reflecting the strategies that optimize performance in particular tasks. In a fine discrimination task, the most accurate information comes from neurons tuned away from the discrimination boundary(3,4), and observers seem to use signals from these 'displaced' neurons to optimize their performance(5,6,7). We wondered whether using signals from these neurons might also bias perception. In a fine direction discrimination task using moving random-dot stimuli, we found that observers' perception of the direction of motion is indeed biased away from the boundary. This misperception can be accurately described by a decoding model that preferentially weights signals from neurons whose responses best discriminate those directions. In a coarse discrimination task, to which a different decoding rule applies(4), the same stimulus is not misperceived, suggesting that the illusion is a direct consequence of the decoding strategy that observers use to make fine perceptual judgments. The subjective experience of motion is therefore not mediated directly by the responses of sensory neurons, but is only developed after the responses of these neurons are decoded.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Jazayeri, M (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	mjaz@cns.nyu.edu			NATIONAL EYE INSTITUTE [R01EY004440, R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY004440, R01 EY004440-26, R01 EY002017, R01 EY002017-24] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRITTEN KH, 1992, J NEUROSCI, V12, P4745; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Gregory R. L., 1997, EYE BRAIN PSYCHOL SE; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; HUTTENLOCHER J, 1991, PSYCHOL REV, V98, P352, DOI 10.1037/0033-295X.98.3.352; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PATTERSON RD, 1976, J ACOUST SOC AM, V59, P640, DOI 10.1121/1.380914; Rauber HJ, 1998, PERCEPTION, V27, P393, DOI 10.1068/p270393; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6	13	118	118	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					912	915		10.1038/nature05739	http://dx.doi.org/10.1038/nature05739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17410125	Green Accepted			2022-12-24	WOS:000245785700042
J	Allingham, JS; Sproul, LR; Rayment, I; Gilbert, SP				Allingham, John S.; Sproul, Lisa R.; Rayment, Ivan; Gilbert, Susan P.			Vik1 modulates microtubule-Kar3 interactions through a motor domain that lacks an active site	CELL			English	Article							KINESIN-RELATED PROTEIN; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; BUDDING YEAST; PLUS ENDS; KAR3; NCD; DROSOPHILA; CIK1	Conventional kinesin and class V and VI myosins coordinate the mechanochemical cycles of their motor domains for processive movement of cargo along microtubules or actin filaments. It is widely accepted that this coordination is achieved by allosteric communication or mechanical strain between the motor domains, which controls the nucleotide state and interaction with microtubules or actin. However, questions remain about the interplay between the strain and the nucleotide state. We present an analysis of Saccharomyces cerevisiae Kar3/Vik1, a heterodimeric C-terminal Kinesin-14 containing catalytic Kar3 and the nonmotor protein Vik1. The X-ray crystal structure of Vik1 exhibits a similar fold to the kinesin and myosin catalytic head, but lacks an ATP binding site. Vik1 binds more tightly to microtubules than Kar3 and facilitates cooperative microtubule decoration by Kar3/Vik1 heter-odimers, and yet allows motility. These results demand communication between Vik1 and Kar3 via a mechanism that coordinates their interactions with microtubules.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu; spg1@pitt.edu	Allingham, John/AAW-9262-2020; rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Hoverman, Lisa/0000-0002-3396-6982	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR047841, R01AR035186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054141, R37GM054141] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR013790, S10 RR13790] Funding Source: Medline; NIAMS NIH HHS [K02 AR047841, R01 AR035186, K02-AR47841, AR35186] Funding Source: Medline; NIGMS NIH HHS [R37 GM054141, R01 GM054141, GM54141] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso MC, 1998, EMBO J, V17, P945, DOI 10.1093/emboj/17.4.945; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; HATSUMI M, 1992, J CELL SCI, V101, P547; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; KIMBLE M, 1983, J CELL SCI, V62, P301; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Maddox P, 1999, J CELL BIOL, V144, P977, DOI 10.1083/jcb.144.5.977; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Molk JN, 2006, J CELL BIOL, V172, P27, DOI 10.1083/jcb.200510032; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pidoux AL, 1996, MOL BIOL CELL, V7, P1639, DOI 10.1091/mbc.7.10.1639; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Sablin EP, 2004, J BIOL CHEM, V279, P15707, DOI 10.1074/jbc.R300036200; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Song YH, 2001, EMBO J, V20, P6213, DOI 10.1093/emboj/20.22.6213; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Westhead DR, 1999, PROTEIN SCI, V8, P897; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	51	64	64	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1161	1172		10.1016/j.cell.2006.12.046	http://dx.doi.org/10.1016/j.cell.2006.12.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382884	Green Accepted, Bronze			2022-12-24	WOS:000245396200021
J	Pregibon, DC; Toner, M; Doyle, PS				Pregibon, Daniel C.; Toner, Mehmet; Doyle, Patrick S.			Multifunctional encoded particles for high-throughput biomolecule analysis	SCIENCE			English	Article							ARRAY; MICROCARRIERS; TECHNOLOGY; MICROARRAY	High-throughput screening for genetic analysis, combinatorial chemistry, and clinical diagnostics benefits from multiplexing, which allows for the simultaneous assay of several analytes but necessitates an encoding scheme for molecular identification. Current approaches for multiplexed analysis involve complicated or expensive processes for encoding, functionalizing, or decoding active substrates ( particles or surfaces) and often yield a very limited number of analyte-specific codes. We present a method based on continuous-flow lithography that combines particle synthesis and encoding and probe incorporation into a single process to generate multifunctional particles bearing over a million unique codes. By using such particles, we demonstrate a multiplexed, single-fluorescence detection of DNA oligomers with encoded particle libraries that can be scanned rapidly in a flow-through microfluidic channel. Furthermore, we demonstrate with high specificity the same multiplexed detection using individual multiprobe particles.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, BioMEMS Resource Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Doyle, PS (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pdoyle@mit.edu	Abrams, William R/A-5782-2008; Doyle, Patrick S/H-7031-2013	Doyle, Patrick S/0000-0003-2147-9172	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NIBIB NIH HHS [P41 EB002503] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Battersby BJ, 2000, J AM CHEM SOC, V122, P2138, DOI 10.1021/ja993634i; Braeckmans K, 2003, NAT MATER, V2, P169, DOI 10.1038/nmat828; Braeckmans K, 2002, NAT REV DRUG DISCOV, V1, P447, DOI 10.1038/nrd817; Cunin F, 2002, NAT MATER, V1, P39, DOI 10.1038/nmat702; Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617; Evans M, 2003, ASSAY DRUG DEV TECHN, V1, P199; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fenniri H, 2003, J AM CHEM SOC, V125, P10546, DOI 10.1021/ja035665q; Ferguson JA, 2000, ANAL CHEM, V72, P5618, DOI 10.1021/ac0008284; Finkel NH, 2004, ANAL CHEM, V76, p353A; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Fulton RJ, 1997, CLIN CHEM, V43, P1749; Gershon D, 2002, NATURE, V416, P885, DOI 10.1038/416885a; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537; MacBeath G, 2000, SCIENCE, V289, P1760; MCHUGH TM, 1988, J CLIN MICROBIOL, V26, P1957, DOI 10.1128/JCM.26.10.1957-1961.1988; MORAN EJ, 1995, J AM CHEM SOC, V117, P10787, DOI 10.1021/ja00148a039; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; NICOLAOU KC, 1995, ANGEW CHEM INT EDIT, V34, P2289, DOI 10.1002/anie.199522891; Nolan JP, 2002, TRENDS BIOTECHNOL, V20, P9, DOI 10.1016/S0167-7799(01)01844-3; Pregibon DC, 2006, LANGMUIR, V22, P5122, DOI 10.1021/la0534625; Rehman FN, 1999, NUCLEIC ACIDS RES, V27, P649, DOI 10.1093/nar/27.2.649; Rubina AY, 2003, BIOTECHNIQUES, V34, P1008, DOI 10.2144/03345rr01; SERVICE RF, 1995, SCIENCE, V270, P577, DOI 10.1126/science.270.5236.577; Sha MY, 2006, ANAL BIOANAL CHEM, V384, P658, DOI 10.1007/s00216-005-0225-0; Su X, 2005, NANO LETT, V5, P49, DOI 10.1021/nl0484088; Vaino AR, 2000, P NATL ACAD SCI USA, V97, P7692, DOI 10.1073/pnas.97.14.7692; Vasiliskov AV, 1999, BIOTECHNIQUES, V27, P592, DOI 10.2144/99273rr06; Xu HX, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng043; Zhao XW, 2006, CHEM MATER, V18, P2443, DOI 10.1021/cm060283f; Zhi ZL, 2003, ANAL CHEM, V75, P4125, DOI 10.1021/ac034165c	32	599	668	13	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1393	1396		10.1126/science.1134929	http://dx.doi.org/10.1126/science.1134929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347435				2022-12-24	WOS:000244752200028
J	Organ, CL; Shedlock, AM; Meade, A; Pagel, M; Edwards, SV				Organ, Chris L.; Shedlock, Andrew M.; Meade, Andrew; Pagel, Mark; Edwards, Scott V.			Origin of avian genome size and structure in non-avian dinosaurs	NATURE			English	Article							CELL-SIZE; DNA-CONTENT; C-VALUE; EVOLUTION; STRATEGIES; PATTERNS; GROWTH	Avian genomes are small and streamlined compared with those of other amniotes by virtue of having fewer repetitive elements and less non-coding DNA(1,2). This condition has been suggested to represent a key adaptation for flight in birds, by reducing the metabolic costs associated with having large genome and cell sizes(3,4). However, the evolution of genome architecture in birds, or any other lineage, is difficult to study because genomic information is often absent for long-extinct relatives. Here we use a novel bayesian comparative method to show that bone-cell size correlates well with genome size in extant vertebrates, and hence use this relationship to estimate the genome sizes of 31 species of extinct dinosaur, including several species of extinct birds. Our results indicate that the small genomes typically associated with avian flight evolved in the saurischian dinosaur lineage between 230 and 250 million years ago, long before this lineage gave rise to the first birds. By comparison, ornithischian dinosaurs are inferred to have had much larger genomes, which were probably typical for ancestral Dinosauria. Using comparative genomic data, we estimate that genome-wide interspersed mobile elements, a class of repetitive DNA, comprised 5 - 12% of the total genome size in the saurischian dinosaur lineage, but was 7 - 19% of total genome size in ornithischian dinosaurs, suggesting that repetitive elements became less active in the saurischian lineage. These genomic characteristics should be added to the list of attributes previously considered avian but now thought to have arisen in non-avian dinosaurs, such as feathers(5), pulmonary innovations 6, and parental care and nesting	Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	Harvard University; University of Reading	Organ, CL (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	corgan@oeb.harvard.edu	Edwards, Scott V./D-9071-2018	Edwards, Scott V./0000-0003-2535-6217	Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075490] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM075490] Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cavalier-Smith T., 1985, EVOLUTION GENOME SIZ, P104; Ellegren H, 2005, TRENDS ECOL EVOL, V20, P180, DOI 10.1016/j.tree.2005.01.015; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Gilks W.R., 1996, MARKOV CHAIN MONTE C; Gregory T.R., 2005, ANIMAL GENOME SIZE D; Gregory TR, 1999, GENOME RES, V9, P317; Gregory TR, 2001, BLOOD CELL MOL DIS, V27, P830, DOI 10.1006/bcmd.2001.0457; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1995, NATURE, V377, P391, DOI 10.1038/377391a0; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; MORRIS SC, 1988, SCIENCE, V241, P1230, DOI 10.1126/science.241.4870.1230; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; RAUP DM, 1992, EXTINCTION BAD GENES, P3; Shedlock AM, 2006, SYST BIOL, V55, P902, DOI 10.1080/10635150601091924; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; SZARSKI H, 1983, J THEOR BIOL, V105, P201, DOI 10.1016/S0022-5193(83)80002-2; THOMSON KS, 1978, J EXP ZOOL, V205, P315, DOI 10.1002/jez.1402050216; TIERSCH TR, 1991, J HERED, V82, P363, DOI 10.1093/oxfordjournals.jhered.a111105; VANDENBUSSCHE RA, 1995, MAMM GENOME, V6, P521, DOI 10.1007/BF00356168; Waltari E, 2002, AM NAT, V160, P539, DOI 10.1086/342079; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589	30	201	203	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					180	184		10.1038/nature05621	http://dx.doi.org/10.1038/nature05621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344851				2022-12-24	WOS:000244718100039
J	Bowman, JL; Floyd, SK; Sakakibara, K				Bowman, John L.; Floyd, Sandra K.; Sakakibara, Keiko			Green genes - Comparative genomics of the green branch of life	CELL			English	Article							LAND PLANTS; EVOLUTION; ARABIDOPSIS; EUKARYOTES; ORIGINS	As more plant genome sequences become available, researchers are increasingly using comparative genomics to address some of the major questions in plant biology. Such questions include the evolution of photosynthesis and multicellularity, the developmental genetic changes responsible for alterations in body plan, and the origin of important plant innovations such as roots, leaves, and vascular tissue.	Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia	Monash University	Bowman, JL (corresponding author), Monash Univ, Sch Biol Sci, Clayton Campus, Melbourne, Vic 3800, Australia.	john.bowman@sci.monash.edu.au	Sakakibara, Keiko/Q-5748-2018	Sakakibara, Keiko/0000-0003-4420-9351; Bowman, John/0000-0001-7347-3691				Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Floyd SK, 2006, CURR BIOL, V16, P1911, DOI 10.1016/j.cub.2006.07.067; Friedman WE, 2004, AM J BOT, V91, P1726, DOI 10.3732/ajb.91.10.1726; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Harrison CJ, 2005, NATURE, V434, P509, DOI 10.1038/nature03410; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Ohno S., 1970, EVOLUTION GENE DUPLI; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691	18	157	160	2	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					229	234		10.1016/j.cell.2007.04.004	http://dx.doi.org/10.1016/j.cell.2007.04.004			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448980	Bronze			2022-12-24	WOS:000246474600006
J	Lomakin, IB; Xiong, Y; Steitz, TA				Lomakin, Ivan B.; Xiong, Yong; Steitz, Thomas A.			The crystal structure of yeast fatty acid synthase, a cellular machine with eight active sites working together	CELL			English	Article							CARRIER PROTEIN TRANSACYLASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-BINDING; SYNTHETASE; MALONYL; SUBUNIT; BIOSYNTHESIS; REDUCTASE; ENZYME; COMPLEMENTATION	In yeast, the whole metabolic pathway for making 16- and 18-carbon fatty acids is carried out by fatty acid synthase, a 2.6 megadalton molecular-weight macromolecular assembly containing six copies of all eight catalytic centers. We have determined its crystal structure, which illuminates how this enzyme is initially activated and then carries out multiple steps of synthesis in each of six sterically isolated reaction chambers. Six of the catalytic sites are in the wall of the assembly facing an acyl carrier protein (ACP) bound to the ketoacyl synthase domain. Two-dimensional diffusion of substrates to the catalytic sites may be achieved by the electrostatically negative ACP swinging to each of the six electrostatically positive catalytic sites. The phosphopantetheinyl transferase domain lies outside the shell of the assembly, inaccessible to ACP that lies inside, suggesting that the attachment of the pantetheine arm to ACP must occur before complete assembly of the complex.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	yong.xiong@yale.edu; eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009	Lomakin, Ivan/0000-0001-6528-5068	NIGMS NIH HHS [GM22778] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHIRALA SS, 1987, J BIOL CHEM, V262, P4231; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DIETLEIN G, 1975, EUR J BIOCHEM, V58, P177, DOI 10.1111/j.1432-1033.1975.tb02362.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGESER H, 1979, EUR J BIOCHEM, V101, P413, DOI 10.1111/j.1432-1033.1979.tb19734.x; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; FOX JL, 1980, EUR J BIOCHEM, V109, P417, DOI 10.1111/j.1432-1033.1980.tb04810.x; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kolodziej SJ, 1996, J BIOL CHEM, V271, P28422, DOI 10.1074/jbc.271.45.28422; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; LAMBALOT RH, 1996, CHEM BIOL, V3, P9223; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Lupu R, 2006, ENDOCRINOLOGY, V147, P4056, DOI 10.1210/en.2006-0486; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; LYNEN F, 1967, BIOCHEM J, V102, P381, DOI 10.1042/bj1020381; LYNEN F, 1969, METHOD ENZYMOL, V14, P17; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MOHAMED AH, 1988, J BIOL CHEM, V263, P12315; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Rangan VS, 1997, J BIOL CHEM, V272, P11975, DOI 10.1074/jbc.272.18.11975; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Saitoh S, 1996, J CELL BIOL, V134, P949, DOI 10.1083/jcb.134.4.949; SCHRECKENBACH T, 1977, EUR J BIOCHEM, V80, P13, DOI 10.1111/j.1432-1033.1977.tb11850.x; SCHUSTER H, 1995, EUR J BIOCHEM, V228, P417; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Torkko JM, 2003, J BIOL CHEM, V278, P41213, DOI 10.1074/jbc.M307664200; WERKMEISTER K, 1981, EUR J BIOCHEM, V116, P303, DOI 10.1111/j.1432-1033.1981.tb05334.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; WIELAND F, 1978, P NATL ACAD SCI USA, V75, P5792, DOI 10.1073/pnas.75.12.5792; WIELAND F, 1979, EUR J BIOCHEM, V94, P189, DOI 10.1111/j.1432-1033.1979.tb12885.x; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200	49	169	179	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					319	332		10.1016/j.cell.2007.03.013	http://dx.doi.org/10.1016/j.cell.2007.03.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448991	Bronze			2022-12-24	WOS:000246474600019
J	Vijayanand, P; Seumois, G; Pickard, C; Powell, RM; Angco, G; Sammut, D; Gadola, SD; Friedmann, PS; Djukanovic, R				Vijayanand, Pandurangan; Seumois, Gregory; Pickard, Chris; Powell, Robert M.; Angco, Gilbert; Sammut, David; Gadola, Stephan D.; Friedmann, Peter S.; Djukanovic, Ratko			Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRONCHOALVEOLAR LAVAGE; BRONCHIAL-ASTHMA; FLOW-CYTOMETRY; FREQUENCY	BACKGROUND The number of type 2 helper CD4+ T cells is increased in the airways of persons with asthma. Whether the majority of these cells are class II major-histocompatibility-complex-restricted cells or are among the recently identified CD1d-restricted invariant natural killer T cells is a matter of controversy. We studied the frequency of invariant natural killer T cells in the airways of subjects with mild or moderately severe asthma to investigate the possibility of an association between the number of invariant natural killer T cells in the airway and disease severity. We also studied whether an increased number of these cells is a feature of chronic obstructive pulmonary disease (COPD). METHODS We enumerated invariant natural killer T cells by flow cytometry with the use of CD1d tetramers loaded with alpha-galactosylceramide and antibodies specific to the invariant natural killer T-cell receptor in samples of bronchoalveolar-lavage fluid, induced sputum, and bronchial-biopsy specimens obtained from subjects with mild or moderately severe asthma, subjects with COPD, and healthy control subjects. Real-time polymerase-chain-reaction analysis was performed on bronchoalveolar-lavage cells for evidence of gene expression of the invariant natural killer T-cell receptor. RESULTS Fewer than 2% of the T cells obtained from all subjects on airway biopsy, bronchoalveolar lavage, and sputum induction were invariant natural killer T cells, with no significant differences among the three groups of subjects. No expression of messenger RNA for the invariant natural killer T-cell-receptor domains V alpha 24 and V beta 11 was detected in bronchoalveolar-lavage cells from subjects with asthma. CONCLUSIONS Invariant natural killer T cells are found in low numbers in the airways of subjects with asthma, subjects with COPD, and controls.	Univ Southampton, Southampton Gen Hosp, Inflammatory Cell Biol Grp, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; Univ Southampton, Southampton Gen Hosp, Roger Brooke Lab, PrimerDesign, Southampton, Hants, England; Univ Bern, Inselspital, CH-3010 Bern, Switzerland	University of Southampton; University of Southampton; University of Bern	Vijayanand, P (corresponding author), Univ Southampton, Southampton Gen Hosp, Inflammatory Cell Biol Grp, Div Infect Inflammat & Repair, Level F,S Block,Mail Point 810,Tremona Rd, Southampton SO16 6YD, Hants, England.	vijay@soton.ac.uk	Sammut, David/AAM-9164-2021	Djukanovic, Ratko/0000-0001-6039-5612				Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Bousquet J, 2000, CLIN EXP ALLERGY, V30, P2; DJUKANOVIC R, 1991, AM REV RESPIR DIS, V143, P772, DOI 10.1164/ajrccm/143.4_Pt_1.772; Gunther U, 2005, J IMMUNOL, V174, P8219, DOI 10.4049/jimmunol.174.12.8219-a; Gunther U, 2005, J IMMUNOL, V174, P5414, DOI 10.4049/jimmunol.174.9.5414; Hamzaoui A, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/71214; Ho LP, 2005, LANCET, V365, P1062, DOI 10.1016/S0140-6736(05)71143-0; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Lucas M, 2003, J VIROL, V77, P2251, DOI 10.1128/JVI.77.3.2251-2257.2003; Metelitsa LS, 2004, CLIN IMMUNOL, V110, P267, DOI 10.1016/j.clim.2003.11.005; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pham-Thi N, 2006, J ALLERGY CLIN IMMUN, V117, P217, DOI 10.1016/j.jaci.2005.09.052; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Soethout EC, 2004, CLIN DIAGN LAB IMMUN, V11, P795, DOI 10.1128/CDLI.11.4.795-798.2004; Thomas SY, 2006, NEW ENGL J MED, V354, P2613; VIGNOLA RM, 2002, EUR RESPIR J, V37, pS51; Weyde J, 1997, J IMMUNOL METHODS, V207, P115, DOI 10.1016/S0022-1759(97)00103-8; Yang S, 2005, J IMMUNOL, V175, P4914, DOI 10.4049/jimmunol.175.8.4914; 1997, THORAX S, V52, pS1	22	157	167	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1410	1422		10.1056/NEJMoa064691	http://dx.doi.org/10.1056/NEJMoa064691			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153GG	17409322	Bronze			2022-12-24	WOS:000245419600004
J	Albert, I; Mavrich, TN; Tomsho, LP; Qi, J; Zanton, SJ; Schuster, SC; Pugh, BF				Albert, Istvan; Mavrich, Travis N.; Tomsho, Lynn P.; Qi, Ji; Zanton, Sara J.; Schuster, Stephan C.; Pugh, B. Franklin			Translational and rotational settings of H2A.Z nucleosomes across the Saccharomyces cerevisiae genome	NATURE			English	Article							HISTONE H2A; EUKARYOTIC GENOME; YEAST; VARIANT; GENES; WIDE; IDENTIFICATION; PROMOTERS; CORE; MAP	The nucleosome is the fundamental building block of eukaryotic chromosomes. Access to genetic information encoded in chromosomes is dependent on the position of nucleosomes along the DNA. Alternative locations just a few nucleotides apart can have profound effects on gene expression(1). Yet the nucleosomal context in which chromosomal and gene regulatory elements reside remains ill-defined on a genomic scale. Here we sequence the DNA of 322,000 individual Saccharomyces cerevisiae nucleosomes, containing the histone variant H2A.Z, to provide a comprehensive map of H2A.Z nucleosomes in functionally important regions. With a median 4-base-pair resolution, we identify new and established signatures of nucleosome positioning. A single predominant rotational setting and multiple translational settings are evident. Chromosomal elements, ranging from telomeres to centromeres and transcriptional units, are found to possess characteristic nucleosomal architecture that may be important for their function. Promoter regulatory elements, including transcription factor binding sites and transcriptional start sites, show topological relationships with nucleosomes, such that transcription factor binding sites tend to be rotationally exposed on the nucleosome surface near its border. Transcriptional start sites tended to reside about one helical turn inside the nucleosome border. These findings reveal an intimate relationship between chromatin architecture and the underlying DNA sequence it regulates.	Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA.	bfp2@psu.edu	QI, JI/E-2797-2016; Albert, Istvan/J-3734-2015	Albert, Istvan/0000-0001-8366-984X; Mavrich, Travis/0000-0001-9252-5020				Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Pinto I, 2000, EMBO J, V19, P1598, DOI 10.1093/emboj/19.7.1598; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	30	522	539	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					572	576		10.1038/nature05632	http://dx.doi.org/10.1038/nature05632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392789				2022-12-24	WOS:000245242900056
J	Chung, HY; Weinberger, MB; Levine, JB; Kavner, A; Yang, JM; Tolbert, SH; Kaner, RB				Chung, Hsiu-Ying; Weinberger, Michelle B.; Levine, Jonathan B.; Kavner, Abby; Yang, Jenn-Ming; Tolbert, Sarah H.; Kaner, Richard B.			Synthesis of ultra-incompressible superhard rhenium diboride at ambient pressure	SCIENCE			English	Article							LATTICE STRAINS; OSMIUM DIBORIDE; HARD; BORIDES; STATE	The quest to create superhard materials rarely strays from the use of high-pressure synthetic methods, which typically require gigapascals of applied pressure. We report that rhenium diboride (ReB2), synthesized in bulk quantities via arc-melting under ambient pressure, rivals materials produced with high-pressure methods. Microindentation measurements on ReB2 indicated an average hardness of 48 gigapascals under an applied load of 0.49 newton, and scratch marks left on a diamond surface confirmed its superhard nature. Its incompressibility along the c axis was equal in magnitude to the linear incompressibility of diamond. In situ high-pressure x-ray diffraction measurements yielded a bulk modulus of 360 gigapascals, and radial diffraction indicated that ReB2 is able to support a remarkably high differential stress. This combination of properties suggests that this material may find applications in cutting when the formation of carbides prevents the use of traditional materials such as diamond.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tolbert, SH (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	tolbert@chem.ucla.edu; kaner@chem.ucla.edu	Kaner, Richard B./K-1594-2019; Tolbert, Sarah H./L-2321-2016; Kavner, Abby/A-4904-2009	Kaner, Richard B./0000-0003-0345-4924; 				ALEKSANDROV IV, 1987, ZH EKSP TEOR FIZ, V66, P384; Allen PB, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.172102; Amulele GM, 2006, J APPL PHYS, V99, DOI 10.1063/1.2164533; Chiodo S, 2006, CHEM PHYS LETT, V425, P311, DOI 10.1016/j.cplett.2006.05.055; Cumberland RW, 2005, J AM CHEM SOC, V127, P7264, DOI 10.1021/ja043806y; Cynn H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.135701; FINK CG, 1934, T ELECTROCHEM SOC, V66, P381; Gao H, 1999, NATURWISSENSCHAFTEN, V86, P507, DOI 10.1007/s001140050665; Gou HY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208367; HAMPEL CA, 1961, RARE METALS HDB; He DW, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.184121; He DW, 2002, APPL PHYS LETT, V81, P643, DOI 10.1063/1.1494860; Hebbache M, 2006, SOLID STATE COMMUN, V139, P227, DOI 10.1016/j.ssc.2006.05.041; Kaner RB, 2005, SCIENCE, V308, P1268, DOI 10.1126/science.1109830; Kenichi T, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.012101; Kiefer B, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014102; LAPLACA S, 1962, ACTA CRYSTALLOGR, V15, P97, DOI 10.1107/S0365110X62000298; MANGHNAN.MH, 1974, PHYS REV B, V9, P1421, DOI 10.1103/PhysRevB.9.1421; McMillan PF, 2002, NAT MATER, V1, P19, DOI 10.1038/nmat716; MCSKIMIN HJ, 1957, PHYS REV, V105, P116, DOI 10.1103/PhysRev.105.116; Occelli F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.095502; RAO L, 1995, J MATER RES, V10, P353, DOI 10.1557/JMR.1995.0353; RUOFF AL, 1975, J APPL PHYS, V46, P1389, DOI 10.1063/1.321737; SINGH AK, 1993, J APPL PHYS, V73, P4278, DOI 10.1063/1.352809; Singh AK, 1998, J APPL PHYS, V83, P7567, DOI 10.1063/1.367872; Solozhenko VL, 2001, APPL PHYS LETT, V78, P1385, DOI 10.1063/1.1337623; VEGAS A, 1995, Z KRISTALLOGR, V210, P574, DOI 10.1524/zkri.1995.210.8.574	27	656	687	9	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					436	439		10.1126/science.1139322	http://dx.doi.org/10.1126/science.1139322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446399				2022-12-24	WOS:000245813400053
J	Mullighan, CG; Goorha, S; Radtke, I; Miller, CB; Coustan-Smith, E; Dalton, JD; Girtman, K; Mathew, S; Ma, J; Pounds, SB; Su, XP; Pui, CH; Relling, MV; Evans, WE; Shurtleff, SA; Downing, JR				Mullighan, Charles G.; Goorha, Salil; Radtke, Ina; Miller, Christopher B.; Coustan-Smith, Elaine; Dalton, James D.; Girtman, Kevin; Mathew, Susan; Ma, Jing; Pounds, Stanley B.; Su, Xiaoping; Pui, Ching-Hon; Relling, Mary V.; Evans, William E.; Shurtleff, Sheila A.; Downing, James R.			Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia	NATURE			English	Article							B-CELL DEVELOPMENT; ZINC-FINGER PROTEIN; IKAROS GENE; BSAP PAX-5; DELETION; LYMPHOMA; DNA; EXPRESSION; DIFFERENTIATION; TRANSLOCATION	Chromosomal aberrations are a hallmark of acute lymphoblastic leukaemia ( ALL) but alone fail to induce leukaemia. To identify cooperating oncogenic lesions, we performed a genome-wide analysis of leukaemic cells from 242 paediatric ALL patients using high-resolution, single-nucleotide polymorphism arrays and genomic DNA sequencing. Our analyses revealed deletion, amplification, point mutation and structural rearrangement in genes encoding principal regulators of B lymphocyte development and differentiation in 40% of B-progenitor ALL cases. The PAX5 gene was the most frequent target of somatic mutation, being altered in 31.7% of cases. The identified PAX5 mutations resulted in reduced levels of PAX5 protein or the generation of hypomorphic alleles. Deletions were also detected in TCF3 ( also known as E2A), EBF1, LEF1, IKZF1 (IKAROS) and IKZF3 (AIOLOS). These findings suggest that direct disruption of pathways controlling B-cell development and differentiation contributes to B-progenitor ALL pathogenesis. Moreover, these data demonstrate the power of high-resolution, genome-wide approaches to identify new molecular lesions in cancer.	St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Downing, JR (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.	james.downing@stjude.org	Ganesh, Dunna Sai/AGX-5170-2022; Downing, James R./N-8102-2018; Mullighan, Charles/H-3253-2011; Pounds, Stanley B/N-2480-2018; Evans, William E./C-2069-2012; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018	Mullighan, Charles/0000-0002-1871-1850; Pounds, Stanley B/0000-0002-9167-2114; Evans, William E./0000-0002-9333-5322; Pui, Ching-Hon/0000-0003-0303-5658				Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; Cave H, 2001, LEUKEMIA, V15, P371, DOI 10.1038/sj.leu.2402052; Cazzaniga G, 2001, CANCER RES, V61, P4666; Conte N, 2002, ONCOGENE, V21, P5619, DOI 10.1038/sj.onc.1205658; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Heerema NA, 2000, J CLIN ONCOL, V18, P3837, DOI 10.1200/JCO.2000.18.22.3837; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jackson A, 2000, CANCER RES, V60, P2775; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; OKUDA T, 1995, BLOOD, V85, P2321, DOI 10.1182/blood.V85.9.2321.bloodjournal8592321; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Peters UR, 1999, ONCOGENE, V18, P79, DOI 10.1038/sj.onc.1202256; RAIMONDI SC, 1995, BLOOD, V86, P1881, DOI 10.1182/blood.V86.5.1881.bloodjournal8651881; Raynaud S, 1996, BLOOD, V87, P2891, DOI 10.1182/blood.V87.7.2891.bloodjournal8772891; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Strehl S, 2003, LEUKEMIA, V17, P1121, DOI 10.1038/sj.leu.2402923; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Ying H, 1998, J IMMUNOL, V161, P4760	38	1309	1350	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					758	764		10.1038/nature05690	http://dx.doi.org/10.1038/nature05690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17344859				2022-12-24	WOS:000245626800032
J	Stefanovic, S; Hegde, RS				Stefanovic, Sandra; Hegde, Rarnanujan S.			Identification of a targeting factor for posttranslational membrane protein insertion into the ER	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; TAIL-ANCHORED PROTEIN; ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; TRANSLOCATION COMPLEX; MECHANISM; SYNAPTOBREVIN; POLYPEPTIDE; TRANSPORTER; ELONGATION	Hundreds of proteins are anchored in intracellular membranes by a single transmembrane domain (TMD) close to the C terminus. Although these tail-anchored (TA) proteins serve numerous essential roles in cells, components of their targeting and insertion pathways have long remained elusive. Here we reveal a cytosolic TMD recognition complex (TRC) that targets TA proteins for insertion into the ER membrane. The highly conserved, 40 kDa ATPase subunit of TRC (which we termed TRC40) was identified as Asna-1. TRC40/Asna-1 interacts posttranslationally with TA proteins in a TMD-dependent manner for delivery to a proteinaceous receptor at the ER membrane. Subsequent release from TRC40/Asna-1 and insertion into the membrane depends on ATP hydrolysis. Consequently, an ATPase-deficient mutant of TRC40/Asna-1 dominantly inhibited TA protein insertion selectively without influencing other translocation pathways. Thus, TRC40/Asna-1 represents an integral component of a posttranslational pathway of membrane protein insertion whose targeting is mediated by TRC.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Room 101,Bldg 18T,18 Lib Dr, Bethesda, MD 20892 USA.	hegder@mail.nih.gov		Hegde, Ramanujan/0000-0001-8338-852X	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862, Z01HD008862, ZIAHD008752, Z01HD008752] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abell BM, 2003, J BIOL CHEM, V278, P5669, DOI 10.1074/jbc.M209968200; Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; ANDREWS DW, 1989, J CELL BIOL, V108, P797, DOI 10.1083/jcb.108.3.797; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Gupta GD, 2003, FUNGAL GENET BIOL, V40, P271, DOI 10.1016/S1087-1845(03)00109-9; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Kim PK, 1999, J BIOL CHEM, V274, P36876, DOI 10.1074/jbc.274.52.36876; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Kurdi-Haidar B, 1998, J BIOL CHEM, V273, P22173, DOI 10.1074/jbc.273.35.22173; KurdiHaidar B, 1996, GENOMICS, V36, P486, DOI 10.1006/geno.1996.0494; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Metz J, 2006, J BIOL CHEM, V281, P410, DOI 10.1074/jbc.M507481200; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Shen J, 2003, BIOMETALS, V16, P369, DOI 10.1023/A:1022504311669; Steel GJ, 2002, BIOCHEMISTRY-US, V41, P11914, DOI 10.1021/bi026105r; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WALTER P, 1983, METHOD ENZYMOL, V266, P19599; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583; Yabal M, 2003, J BIOL CHEM, V278, P3489, DOI 10.1074/jbc.M210253200	37	301	305	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1147	1159		10.1016/j.cell.2007.01.036	http://dx.doi.org/10.1016/j.cell.2007.01.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382883	Bronze			2022-12-24	WOS:000245396200020
J	Wang, JD; Sanders, GM; Grossman, AD				Wang, Jue D.; Sanders, Glenn M.; Grossman, Alan D.			Nutritional control of elongation of DNA replication by (p)ppGpp	CELL			English	Article							BACILLUS-SUBTILIS SPORULATION; STRINGENT RESPONSE; ESCHERICHIA-COLI; DEVELOPMENTAL REGULATION; STATIONARY-PHASE; CHECKPOINT; PRIMASE; FORK; PROTEIN; RECA	DNA replication is highly regulated in most organisms. Although much research has focused on mechanisms that regulate initiation of replication, mechanisms that regulate elongation of replication are less well understood. We characterized a mechanism that regulates replication elongation in the bacterium Bacillus subtilis. Replication elongation was inhibited within minutes after amino acid starvation, regardless of where the replication forks were located on the chromosome. We found that small nucleotides ppGpp and pppGpp, which are induced upon starvation, appeared to inhibit replication directly by inhibiting primase, an essential component of the replication machinery. The replication forks arrested with (p)ppGpp did not recruit the recombination protein RecA, indicating that the forks are not disrupted. (p)ppGpp appear to be part of a surveillance mechanism that links nutrient availability to replication by rapidly inhibiting replication in starved cells, thereby preventing replication-fork disruption. This control may be important for cells to maintain genomic integrity.	MIT, Dept Biol, Cambridge, MA 02139 USA; Replidyne Inc, Louisville, CO 80027 USA	Massachusetts Institute of Technology (MIT)	Grossman, AD (corresponding author), MIT, Dept Biol, Bldg 68-530, Cambridge, MA 02139 USA.	adg@mit.edu	Wang, Jue/GVU-0480-2022	Wang, Jue/0000-0003-1503-170X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041934, R01GM084003, R37GM041934] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM084003, R01 GM041934, GM 41934, R37 GM041934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Autret S, 1999, MOL MICROBIOL, V31, P1665, DOI 10.1046/j.1365-2958.1999.01299.x; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Barnes MH, 1995, METHOD ENZYMOL, V262, P35; Belitskii B R, 1980, Mol Biol (Mosk), V14, P1342; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; BROWN NC, 1970, P NATL ACAD SCI USA, V67, P1454, DOI 10.1073/pnas.67.3.1454; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; COPELAND JC, 1971, SCIENCE, V172, P159, DOI 10.1126/science.172.3979.159; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Duggin I.G., 2002, BACILLUS SUBTILIS IT, P87; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Foti JJ, 2005, MOL CELL, V17, P549, DOI 10.1016/j.molcel.2005.01.012; Gautam A, 2001, J BIOL CHEM, V276, P8771, DOI 10.1074/jbc.M009538200; Griffiths DJF, 2001, MOL BIOL CELL, V12, P115, DOI 10.1091/mbc.12.1.115; Harwood C.R., 1990, MOL BIOL METHODS BAC; Inaoka T, 2002, J BACTERIOL, V184, P3923, DOI 10.1128/JB.184.14.3923-3930.2002; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lemon K.P., 2002, BACILLUS SUBTILIS IT, P73; Lemon KP, 2000, MOL CELL, V6, P1321, DOI 10.1016/S1097-2765(00)00130-1; LEVINE A, 1995, MOL MICROBIOL, V15, P287, DOI 10.1111/j.1365-2958.1995.tb02243.x; LEVINE A, 1991, J MOL BIOL, V219, P605, DOI 10.1016/0022-2836(91)90657-R; LOPEZ JM, 1981, J BACTERIOL, V146, P605, DOI 10.1128/JB.146.2.605-613.1981; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Maric C, 1999, J MOL BIOL, V291, P775, DOI 10.1006/jmbi.1999.3017; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Schneider DA, 2003, METHOD ENZYMOL, V370, P606; SCHREIBER G, 1995, CURR MICROBIOL, V30, P27, DOI 10.1007/BF00294520; Simmons LA, 2007, P NATL ACAD SCI USA, V104, P1360, DOI 10.1073/pnas.0607123104; Soultanas P, 2005, STRUCTURE, V13, P839, DOI 10.1016/j.str.2005.04.006; Sung HM, 2002, J BACTERIOL, V184, P5641, DOI 10.1128/JB.184.20.5641-5653.2002; TIMSON J, 1975, MUTAT RES, V32, P115, DOI 10.1016/0165-1110(75)90002-0; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; VASANTHA N, 1980, J BACTERIOL, V144, P1119, DOI 10.1128/JB.144.3.1119-1125.1980; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; Wendrich TM, 1997, MOL MICROBIOL, V26, P65, DOI 10.1046/j.1365-2958.1997.5511919.x; WERNER R, 1971, NATURE-NEW BIOL, V233, P99, DOI 10.1038/newbio233099a0; Zhang Z, 1997, MOL CELL BIOL, V17, P6147, DOI 10.1128/MCB.17.10.6147; ZYSKIND JW, 1992, CELL, V69, P5, DOI 10.1016/0092-8674(92)90112-P	51	206	210	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					865	875		10.1016/j.cell.2006.12.043	http://dx.doi.org/10.1016/j.cell.2006.12.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350574	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000245073400012
J	Fyhn, M; Hafting, T; Treves, A; Moser, MB; Moser, EI				Fyhn, Marianne; Hafting, Torkel; Treves, Alessandro; Moser, May-Britt; Moser, Edvard I.			Hippocampal remapping and grid realignment in entorhinal cortex	NATURE			English	Article							PLACE CELLS; PATH-INTEGRATION; MEMORY; REPRESENTATION; INPUT; MAPS; CODES; MODEL	A fundamental property of many associative memory networks is the ability to decorrelate overlapping input patterns before information is stored(1-5). In the hippocampus, this neuronal pattern separation is expressed as the tendency of ensembles of place cells 6 to undergo extensive 'remapping' in response to changes in the sensory or motivational inputs to the hippocampus(7-13). Remapping is expressed under some conditions as a change of firing rates in the presence of a stable place code ('rate remapping')(14), and under other conditions as a complete reorganization of the hippocampal place code in which both place and rate of firing take statistically independent values ('global remapping')(14). Here we show that the nature of hippocampal remapping can be predicted by ensemble dynamics in place-selective grid cells in the medial entorhinal cortex(15,16), one synapse upstream of the hippocampus. Whereas rate remapping is associated with stable grid fields, global remapping is always accompanied by a coordinate shift in the firing vertices of the grid cells. Grid fields of co-localized medial entorhinal cortex cells move and rotate in concert during this realignment. In contrast to the multiple environment-specific representations coded by place cells in the hippocampus, local ensembles of grid cells thus maintain a constant spatial phase structure, allowing position to be represented and updated by the same translation mechanism in all environments encountered by the animal.	Norwegian Univ Sci & Technol, Ctr Biol Memmory, NO-7489 Trondheim, Norway; SISSA, Int Sch Adv Studies, Cognit Neurosci Sector, I-34014 Trieste, Italy	Norwegian University of Science & Technology (NTNU); International School for Advanced Studies (SISSA)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memmory, NO-7489 Trondheim, Norway.	edvard.moser@ntnu.no	Treves, Alessandro/B-2318-2009	Hafting, Torkel/0000-0002-0928-3487; TREVES, Alessandro/0000-0001-7246-5673				Anderson MI, 2003, J NEUROSCI, V23, P8827; Battaglia FP, 1998, PHYS REV E, V58, P7738, DOI 10.1103/PhysRevE.58.7738; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Naber PA, 1997, NEUROREPORT, V8, P2617, DOI 10.1097/00001756-199707280-00039; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	30	432	444	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					190	194		10.1038/nature05601	http://dx.doi.org/10.1038/nature05601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17322902				2022-12-24	WOS:000244718100041
J	McLean, DL; Fan, JY; Higashijima, S; Hale, ME; Fetcho, JR				McLean, David L.; Fan, Jingyi; Higashijima, Shin-ichi; Hale, Melina E.; Fetcho, Joseph R.			A topographic map of recruitment in spinal cord	NATURE			English	Article							LARVAL ZEBRAFISH; MOTONEURONS; INTERNEURONS; NEURONS; NETWORKS; MUSCLES; IDENTIFICATION; COORDINATION; ONTOGENY; IDENTITY	Animals move over a range of speeds by using rhythmic networks of neurons located in the spinal cord(1-6). Here we use electrophysiology and in vivo imaging in larval zebrafish ( Danio rerio) to reveal a systematic relationship between the location of a spinal neuron and the minimal swimming frequency at which the neuron is active. Ventral motor neurons and excitatory interneurons are rhythmically active at the lowest swimming frequencies, with increasingly more dorsal excitatory neurons engaged as swimming frequency rises. Inhibitory interneurons follow the opposite pattern. These inverted patterns of recruitment are independent of cell soma size among interneurons, but may be partly explained by concomitant dorso-ventral gradients in input resistance. Laser ablations of ventral, but not dorsal, excitatory interneurons perturb slow movements, supporting a behavioural role for the topography. Our results reveal an unexpected pattern of organization within zebrafish spinal cord that underlies the production of movements of varying speeds.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Okazaki Inst Integrat Biosci, Natl Inst Nat Sci, Aichi 4448787, Japan; Natl Inst Physiol Sci, Aichi 4448787, Japan	Cornell University; University of Chicago; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Fetcho, JR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jrf49@cornell.edu		Higashijima, Shin-ichi/0000-0001-6350-4992	NINDS NIH HHS [R01 NS026539-25, R01 NS026539] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026539] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bhatt DH, 2007, NEURON, V53, P91, DOI 10.1016/j.neuron.2006.11.011; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Budick SA, 2000, J EXP BIOL, V203, P2565; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; FAN J, 2005, SOC NEUR ABSTR; FETCHO JR, 1987, BRAIN RES REV, V12, P243, DOI 10.1016/0165-0173(87)90001-4; FUIMAN LA, 1988, ANIM BEHAV, V36, P250, DOI 10.1016/S0003-3472(88)80268-9; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Higashijima S, 2004, J COMP NEUROL, V480, P19, DOI 10.1002/cne.20279; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Li WC, 2004, J NEUROSCI, V24, P5840, DOI 10.1523/JNEUROSCI.1633-04.2004; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; MASINO MA, 2005, SOC NEUR ABSTR; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Muller UK, 2004, J EXP BIOL, V207, P853, DOI 10.1242/jeb.00821; MYERS PZ, 1985, J COMP NEUROL, V236, P555, DOI 10.1002/cne.902360411; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; ROBERTS A, 1990, SCI PROG, V74, P31; Stein PSG, 1998, ANN NY ACAD SCI, V860, P142, DOI 10.1111/j.1749-6632.1998.tb09045.x; Thorsen DH, 2004, J EXP BIOL, V207, P4175, DOI 10.1242/jeb.01285; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267	30	256	257	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					71	75		10.1038/nature05588	http://dx.doi.org/10.1038/nature05588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330042				2022-12-24	WOS:000244525600039
J	Martens, S; Kozlov, MM; McMahon, HT				Martens, Sascha; Kozlov, Michael M.; McMahon, Harvey T.			How synaptotagmin promotes membrane fusion	SCIENCE			English	Article							TANDEM C2 DOMAINS; NEUROTRANSMITTER RELEASE; PHOSPHOLIPID-BINDING; TRANSMITTER RELEASE; C(2)A DOMAIN; CA2+; PENETRATION; EXOCYTOSIS; AFFINITY; MODEL	Synaptic vesicles loaded with neurotransmitters are exocytosed in a soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-dependent manner after presynaptic depolarization induces calcium ion (Ca2+) influx. The Ca2+ sensor required for fast fusion is synaptotagmin-1. The activation energy of bilayer-bilayer fusion is very high (approximate to 40 k(B)T). We found that, in response to Ca2+ binding, synaptotagmin-1 could promote SNARE-mediated fusion by lowering this activation barrier by inducing high positive curvature in target membranes on C2-domain membrane insertion. Thus, synaptotagmin-1 triggers the fusion of docked vesicles by local Ca2+-dependent buckling of the plasma membrane together with the zippering of SNAREs. This mechanism may be widely used in membrane fusion.	MRC, Mol Biol Lab, Cambridge CB2 0QH, England; Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	MRC Laboratory Molecular Biology; Tel Aviv University; Sackler Faculty of Medicine	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	hmm@mrc-lmb.cam.ac.uk	Martens, Sascha/C-3693-2011	Martens, Sascha/0000-0003-3786-8199	Medical Research Council [MC_U105178795] Funding Source: Medline; MRC [MC_U105178795] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	26	394	401	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1205	1208		10.1126/science.1142614	http://dx.doi.org/10.1126/science.1142614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17478680	Green Submitted			2022-12-24	WOS:000246724300047
J	Liu, AC; Welsh, DK; Ko, CH; Tran, HG; Zhang, EE; Priest, AA; Buhr, ED; Singer, O; Meeker, K; Verma, IM; Doyle, FJ; Takahashi, JS; Kay, SA				Liu, Andrew C.; Welsh, David K.; Ko, Caroline H.; Tran, Hien G.; Zhang, Eric E.; Priest, Aaron A.; Buhr, Ethan D.; Singer, Oded; Meeker, Kirsten; Verma, Inder M.; Doyle, Francis J., III; Takahashi, Joseph S.; Kay, Steve A.			Intercellular coupling confers robustness against mutations in the SCN circadian clock network	CELL			English	Article							GENE-EXPRESSION; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; PERIOD; MOUSE; RHYTHMS; TIME; SYNCHRONIZATION; OSCILLATORS; MICE	Molecular mechanisms of the mammalian circadian clock have been studied primarily by genetic perturbation and behavioral analysis. Here, we used bioluminescence imaging to monitor Per2 gene expression in tissues and cells from clock mutant mice. We discovered that Per1 and Cry1 are required for sustained rhythms in peripheral tissues and cells, and in neurons dissociated from the suprachiasmatic nuclei (SCN). Per2 is also required for sustained rhythms, whereas Cry2 and Per3 deficiencies cause only period length defects. However, oscillator network interactions in the SCN can compensate for Per1 or Cry1 deficiency, preserving sustained rhythmicity in mutant SCN slices and behavior. Thus, behavior does not necessarily reflect cell-autonomous clock phenotypes. Our studies reveal previously unappreciated requirements for Per1, Per2, and Cry1 in sustaining cellular circadian rhythmicity and demonstrate that SCN intercellular coupling is essential not only to synchronize component cellular oscillators but also for robustness against genetic perturbations.	Scripps Res Inst, Dept Biochem, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	Scripps Research Institute; Novartis; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Howard Hughes Medical Institute; Northwestern University; Northwestern University; University of Toronto; Salk Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Kay, SA (corresponding author), Scripps Res Inst, Dept Biochem, La Jolla, CA 92037 USA.	stevek@scripps.edu	Liu, Andrew C/B-3548-2009; Ko, Caroline/E-6877-2010; Meeker, Kirsten/AAL-1555-2020; Kay, Steve A/F-6025-2011; Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012; Welsh, David K/G-2277-2011; Jansen, Heiko T./A-5770-2008	Liu, Andrew C/0000-0003-1927-0900; Kay, Steve A/0000-0002-0402-2878; Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Jansen, Heiko T./0000-0003-0178-396X; Meeker, Kirsten/0000-0002-2080-8459; Zhang, Eric/0000-0002-4472-7493; Buhr, Ethan/0000-0002-9250-6644	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM074868] Funding Source: Medline; NIMH NIH HHS [P50 MH074924-02, U01 MH061915, U01 MH061915-05, R01 MH051573, P50 MH074924, K08 MH067657] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573, P50MH074924, K08MH067657, U01MH061915] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; MURAKAMI N, 1991, BRAIN RES, V545, P347, DOI 10.1016/0006-8993(91)91312-O; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shen HM, 1997, J NEUROSCI, V17, P5221; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2005, METHOD ENZYMOL, V393, P269, DOI 10.1016/S0076-6879(05)93011-5; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	49	512	521	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					605	616		10.1016/j.cell.2007.02.047	http://dx.doi.org/10.1016/j.cell.2007.02.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482552	Bronze, Green Accepted			2022-12-24	WOS:000246373600025
J	Funk, JL; Vitousek, PM				Funk, Jennifer L.; Vitousek, Peter M.			Resource-use efficiency and plant invasion in low-resource systems	NATURE			English	Article							COMMUNITY STRUCTURE; CONSTRUCTION COST; INVASIBILITY; GRASSLAND; LEAF; INVASIVENESS; AVAILABILITY; ASSIMILATION; RESTORATION; RESPONSES	No species can maximize growth, reproduction and competitive ability across all environments, so the success of invasive species is habitat-dependent. Nutrient-rich habitats often experience more invasion than resource-poor habitats(1-4), a pattern consistent with traits generally associated with successful invaders ( high growth rates, early reproduction and many offspring(5-8)). However, invaders do colonize resource-poor environments, and the mechanisms that allow their success in these systems are poorly understood. Traits associated with resource conservation are widespread among species adapted to resource-poor environments(9-11), and invasive species may succeed in low-resource environments by employing resource conservation traits such as high resource-use efficiency ( RUE; carbon assimilation per unit of resource). We investigated RUE in invasive and native species from three habitats in Hawaii where light, water or nutrient availability was limiting to plant growth. Here we show that across multiple growth forms and broad taxonomic diversity invasive species were generally more efficient than native species at using limiting resources on short timescales and were similarly efficient when RUE measures were integrated over leaf lifespans. Our data challenge the idea that native species generally outperform invasive species under conditions of low resource availability(3), and suggest that managing resource levels is not always an effective strategy for invasive species control.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Funk, JL (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	funk@stanford.edu	Funk, Jennifer/B-6328-2009; Funk, Jennifer/AAL-6185-2021; Funk, Jennifer/AAX-9325-2021	Funk, Jennifer/0000-0002-1916-5513; 				Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Blumenthal D, 2005, SCIENCE, V310, P243, DOI 10.1126/science.1114851; Blumenthal DM, 2003, ECOL APPL, V13, P605, DOI 10.1890/1051-0761(2003)013[0605:SCACWA]2.0.CO;2; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Burns JH, 2006, ECOL APPL, V16, P1367, DOI 10.1890/1051-0761(2006)016[1367:RAEATA]2.0.CO;2; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; D'Antonio C.M., 1999, ECOSYSTEMOSF DKTURBE, P413; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Gross KL, 2005, ECOLOGY, V86, P476, DOI 10.1890/04-0122; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Nagel JM, 2005, NEW PHYTOL, V166, P513, DOI 10.1111/j.1469-8137.2005.01341.x; PYSEK P, 1995, PLANT INVASIONS, P39; Reed HE, 2005, ECOL APPL, V15, P1560, DOI 10.1890/04-0407; Reich PB, 2004, ECOL MONOGR, V74, P3, DOI 10.1890/02-4047; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Suding KN, 2004, OECOLOGIA, V141, P526, DOI 10.1007/s00442-004-1678-0; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; VITOUSEK PM, 1993, BIOGEOCHEMISTRY, V23, P197, DOI 10.1007/BF00023752; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; WILLIAMS K, 1987, PLANT CELL ENVIRON, V10, P725	30	583	653	27	481	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1079	1081		10.1038/nature05719	http://dx.doi.org/10.1038/nature05719			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460672				2022-12-24	WOS:000245950400049
J	Tawk, M; Araya, C; Lyons, DA; Reugels, AM; Girdler, GC; Bayley, PR; Hyde, DR; Tada, M; Clarke, JDW				Tawk, Marcel; Araya, Claudio; Lyons, Dave A.; Reugels, Alexander M.; Girdler, Gemma C.; Bayley, Philippa R.; Hyde, David R.; Tada, Masazumi; Clarke, Jonathan D. W.			A mirror-symmetric cell division that orchestrates neuroepithelial morphogenesis	NATURE			English	Article							SPINAL-CORD; GASTRULATION; MIGRATION; ORIENTATION; STRABISMUS; EXTENSION; MOVEMENTS; REQUIRES; CLOSURE; FATE	The development of cell polarity is an essential prerequisite for tissue morphogenesis during embryogenesis, particularly in the development of epithelia(1,2). In addition, oriented cell division can have a powerful influence on tissue morphogenesis(3). Here we identify a novel mode of polarized cell division that generates pairs of neural progenitors with mirror-symmetric polarity in the developing zebrafish neural tube and has dramatic consequences for the organization of embryonic tissue. We show that during neural rod formation the polarity protein Pard3 is localized to the cleavage furrow of dividing progenitors, and then mirror-symmetrically inherited by the two daughter cells. This allows the daughter cells to integrate into opposite sides of the developing neural tube. Furthermore, these mirror-symmetric divisions have powerful morphogenetic influence: when forced to occur in ectopic locations during neurulation, they orchestrate the development of mirror-image pattern formation and the consequent generation of ectopic neural tubes.	UCL, London WC1E 6BT, England; Univ Cologne, Inst Entwicklungsbiol, D-50923 Cologne, Germany; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA	University of London; University College London; University of Cologne; University of Notre Dame; University of Notre Dame	Clarke, JDW (corresponding author), UCL, Gower St, London WC1E 6BT, England.	jonathan.clarke@ucl.ac.uk	Tawk, Marcel/M-2913-2018; Zebrafish, UCL/A-3125-2009; Clarke, Jonathan/C-5347-2009; Tada, Masazumi/A-1431-2009	Tawk, Marcel/0000-0003-4267-4743; Lyons, David/0000-0003-1166-4454	Biotechnology and Biological Sciences Research Council [BB/C516952/1] Funding Source: Medline; Medical Research Council [G0001188, G9900989] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0001188, G9900989] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Papan C, 1997, DEV GENES EVOL, V207, P71, DOI 10.1007/s004270050093; Papan C, 1999, DEV GENES EVOL, V209, P135, DOI 10.1007/s004270050237; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Tada M, 2000, DEVELOPMENT, V127, P2227; von Trotha JW, 2006, DEV DYNAM, V235, P967, DOI 10.1002/dvdy.20715; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	21	157	159	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					797	800		10.1038/nature05722	http://dx.doi.org/10.1038/nature05722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17392791				2022-12-24	WOS:000245626800041
J	Buschman, TJ; Miller, EK				Buschman, Timothy J.; Miller, Earl K.			Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; SELECTIVE VISUAL-ATTENTION; NEURAL MECHANISMS; SPATIAL ATTENTION; NEURONAL-ACTIVITY; EYE-MOVEMENTS; CORTEX; SYNCHRONIZATION; MODULATION; MACAQUE	Attention can be focused volitionally by "top-down" signals derived from task demands and automatically by "bottom-up" signals from salient stimuli. The frontal and parietal cortices are involved, but their neural activity has not been directly compared. Therefore, we recorded from them simultaneously in monkeys. Prefrontal neurons reflected the target location first during top-down attention, whereas parietal neurons signaled it earlier during bottom-up attention. Synchrony between frontal and parietal areas was stronger in lower frequencies during top-down attention and in higher frequencies during bottom-up attention. This result indicates that top-down and bottom-up signals arise from the frontal and sensory cortex, respectively, and different modes of attention may emphasize synchrony at different frequencies.	MIT, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Miller, EK (corresponding author), MIT, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ekmiller@mit.edu	Buschman, Timothy J/B-3056-2009; Miller, Earl K./AAE-8187-2019	Buschman, Timothy J/0000-0003-1298-2761; Miller, Earl K./0000-0002-0582-6958	NINDS NIH HHS [R01NS035145] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035145] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eglin M, 1991, CEREB CORTEX, V1, P262, DOI 10.1093/cercor/1.3.262; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0	27	1500	1578	16	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1860	1862		10.1126/science.1138071	http://dx.doi.org/10.1126/science.1138071			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395832	Green Submitted			2022-12-24	WOS:000245280100048
J	Steg, PG; Bhatt, DL; Wilson, PWF; D'Agostino, R; Ohman, EM; Rother, J; Liau, CS; Hirsch, AT; Mas, JL; Ikeda, Y; Pencina, MJ; Goto, S				Steg, Ph. Gabriel; Bhatt, Deepak L.; Wilson, Peter W. F.; D'Agostino, Ralph, Sr.; Ohman, E. Magnus; Roether, Joachim; Liau, Chiau-Suong; Hirsch, Alan T.; Mas, Jean-Louis; Ikeda, Yasuo; Pencina, Michael J.; Goto, Shinya		REACH Registry Investigators	One-year cardiovascular event rates in outpatients with atherothrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; PERIPHERAL ARTERIAL-DISEASE; TRANSIENT ISCHEMIC ATTACK; ATHEROSCLEROTIC VASCULAR-DISEASE; ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; RISK-FACTORS; NATIONAL-REGISTRY; GLOBAL REGISTRY; UNITED-STATES	Context Few data document current cardiovascular (CV) event rates in stable patients with atherothrombosis in a community setting. Differential event rates for patients with documented coronary artery disease (CAD), cerebrovascular disease (CVD), or peripheral arterial disease (PAD) or those at risk of these diseases have not been previously evaluated in a single international cohort. Objective To establish contemporary, international, 1-year CV event rates in outpatients with established arterial disease or with multiple risk factors for atherothrombosis. Design, Setting, and Participants The Reduction of Atherothrombosis for Continued Health (REACH) Registry is an international, prospective cohort of 68 236 patients with either established atherosclerotic arterial disease (CAD, PAD, CVD; n = 55 814) or at least 3 risk factors for atherothrombosis (n = 12 422), who were enrolled from 5587 physician practices in 44 countries in 2003- 2004. Main Outcome Measures Rates of CV death, myocardial infarction (MI), and stroke. Results As of July 2006, 1-year outcomes were available for 95.22% (n = 64 977) of participants. Cardiovascular death, MI, or stroke rates were 4.24% overall: 4.69% for those with established atherosclerotic arterial disease vs 2.15% for patients with multiple risk factors only. Among patients with established disease, CV death, MI, or stroke rates were 4.52% for patients with CAD, 6.47% for patients with CVD, and 5.35% for patients with PAD. The incidences of the end point of CV death, MI, or stroke or of hospitalization for atherothrombotic event(s) were 15.20% for CAD, 14.53% for CVD, and 21.14% for PAD patients with established disease. These event rates increased with the number of symptomatic arterial disease locations, ranging from 5.31% for patients with risk factors only to 12.58% for patients with 1, 21.14% for patients with 2, and 26.27% for patients with 3 symptomatic arterial disease locations (P < .001 for trend). Conclusions In this large, contemporary, international study, outpatients with established atherosclerotic arterial disease, or at risk of atherothrombosis, experienced relatively high annual CV event rates. Multiple disease locations increased the 1-year risk of CV events.	Hop Bichat Claude Bernard, Dept Cardiol, F-75018 Paris, France; Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; Boston Univ, Dept Math & Stat, Stat & Consulting Unit, Boston, MA 02215 USA; Duke Univ, Div Cardiol, Durham, NC 27710 USA; Klinikum Minden, Dept Neurol, Minden, Germany; Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; Univ Minnesota, Sch Publ Hlth, Minneapolis Heart Inst Fdn, Minneapolis, MN USA; Hop St Anne, Ctr Raymond Garcin, Serv Neurol, F-75674 Paris, France; Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; Tokai Univ, Sch Med, Dept Med, Kanagawa 2591100, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Cleveland Clinic Foundation; Emory University; Boston University; Duke University; Ruhr University Bochum; National Taiwan University; National Taiwan University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Minneapolis Heart Institute Foundation; University of Minnesota System; University of Minnesota Twin Cities; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Keio University; Tokai University	Steg, PG (corresponding author), Hop Bichat Claude Bernard, Dept Cardiol, 46 Rue Henri Huchard, F-75018 Paris, France.	gabriel.steg@bch.aphp.fr	STEG, Philippe Gabriel/Z-1567-2019; Wilson, Peter W.F./J-2455-2016; Goto, Shinya/AAU-6045-2020; Statsenko, Mikhail E./N-7573-2015	Goto, Shinya/0000-0002-6821-1504; Statsenko, Mikhail E./0000-0002-3306-0312; Pencina, Michael/0000-0001-5798-8855; STEG, Philippe Gabriel/0000-0001-6896-2941				Adams RJ, 2003, STROKE, V34, P2310, DOI 10.1161/01.STR.0000090125.28466.E2; Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; Arima H, 2006, STROKE, V37, P1497, DOI 10.1161/01.STR.0000221212.36860.c9; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Brown DL, 2005, STROKE, V36, P1285, DOI 10.1161/01.STR.0000165926.74213.e3; Budaj A, 2005, CIRCULATION, V111, P3242, DOI 10.1161/CIRCULATIONAHA.104.512806; CHANG IM, 1982, J CHRON DIS, V35, P669, DOI 10.1016/0021-9681(82)90019-4; Creager MA, 2004, CIRCULATION, V109, P2634, DOI 10.1161/01.CIR.0000128522.98016.19; Davidoff F, STRENGTHENING REPORT; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Diehm C, 2006, EUR HEART J, V27, P1743, DOI 10.1093/eurheartj/ehl092; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2004, ANGIOLOGY, V55, P233, DOI 10.1177/000331970405500301; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; MAYNARD C, 1995, AM J CARDIOL, V76, P548, DOI 10.1016/S0002-9149(99)80152-0; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Menotti A, 1996, STROKE, V27, P381, DOI 10.1161/01.STR.27.3.381; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Sacco RL, 2006, CIRCULATION, V113, pE409, DOI 10.1161/circ.113.10.e409; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Touze E, 2005, STROKE, V36, P2748, DOI 10.1161/01.STR.0000190118.02275.33; Vickrey BG, 2002, STROKE, V33, P901, DOI 10.1161/hs0402.105246; Wilterdink JL, 1998, NEUROLOGY, V51, pS23, DOI 10.1212/WNL.51.3_Suppl_3.S23; Witt BJ, 2005, ANN INTERN MED, V143, P785, DOI 10.7326/0003-4819-143-11-200512060-00006; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	35	990	1079	2	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2007	297	11					1197	1206		10.1001/jama.297.11.1197	http://dx.doi.org/10.1001/jama.297.11.1197			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	147XO	17374814				2022-12-24	WOS:000245039300023
J	Rasch, B; Buechel, C; Gais, S; Born, J				Rasch, Bjoern; Buechel, Christian; Gais, Steffen; Born, Jan			Odor cues during slow-wave sleep prompt declarative memory consolidation	SCIENCE			English	Article							REACTIVATION; HIPPOCAMPUS; ACTIVATION; SYSTEMS	Sleep facilitates memory consolidation. A widely held model assumes that this is because newly encoded memories undergo covert reactivation during sleep. We cued new memories in humans during sleep by presenting an odor that had been presented as context during prior learning, and so showed that reactivation indeed causes memory consolidation during sleep. Re-exposure to the odor during slow-wave sleep (SWS) improved the retention of hippocampus-dependent declarative memories but not of hippocampus-independent procedural memories. Odor re-exposure was ineffective during rapid eye movement sleep or wakefulness or when the odor had been omitted during prior learning. Concurring with these findings, functional magnetic resonance imaging revealed significant hippocampal activation in response to odor re-exposure during SWS.	Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, D-20246 Hamburg, Germany	University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rasch, B (corresponding author), Univ Lubeck, Dept Neuroendocrinol, Ratzeburger Allee 160-23A, D-23538 Lubeck, Germany.	rasch@kfg.uni-luebeck.de; born@kfg.uni-luebeck.de	Born, Jan/K-2596-2016; Rasch, Björn/A-3119-2015	Born, Jan/0000-0002-1847-6248; Rasch, Björn/0000-0001-7607-3415				Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Carskadon MA, 2004, SLEEP, V27, P402; Chu S, 2002, MEM COGNITION, V30, P511, DOI 10.3758/BF03194952; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Gordon W.C., 1981, P319; Herz RS, 2004, NEUROPSYCHOLOGIA, V42, P371, DOI 10.1016/j.neuropsychologia.2003.08.009; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Parker A, 2001, APPL COGNITIVE PSYCH, V15, P159, DOI 10.1002/1099-0720(200103/04)15:2<159::AID-ACP694>3.0.CO;2-D; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Sommer T, 2005, LEARN MEMORY, V12, P343, DOI 10.1101/lm.90405; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zelano C, 2005, NEURON, V48, P431, DOI 10.1016/j.neuron.2005.10.009	29	744	777	8	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1426	1429		10.1126/science.1138581	http://dx.doi.org/10.1126/science.1138581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	143UP	17347444				2022-12-24	WOS:000244752200038
J	Ryan, PG; Bloomer, P; Moloney, CL; Grant, TJ; Delport, W				Ryan, Peter G.; Bloomer, Paulette; Moloney, Coleen L.; Grant, Tyron J.; Delport, Wayne			Ecological speciation in South Atlantic island finches	SCIENCE			English	Article							TRISTAN-DA-CUNHA; DARWINS FINCHES; INACCESSIBLE ISLAND; SYMPATRIC SPECIATION; DISRUPTIVE SELECTION; HYBRIDIZATION; EVOLUTION; PERSPECTIVE; NESOSPIZA; OCEAN	Examples of sympatric speciation in nature are rare and hotly debated. We describe the parallel speciation of finches on two small islands in the Tristan da Cunha archipelago in the South Atlantic Ocean. Nesospiza buntings are a classic example of a simple adaptive radiation, with two species on each island: an abundant small-billed dietary generalist and a scarce large-billed specialist. Their morphological diversity closely matches the available spectrum of seed sizes, and genetic evidence suggests that they evolved independently on each island. Speciation is complete on the smaller island, where there is a single habitat with strongly bimodal seed size abundance, but is incomplete on the larger island, where a greater diversity of habitats has resulted in three lineages. Our study suggests that the buntings have undergone parallel ecological speciation.	Univ Cape Town, Natl Res Fdn Ctr Excellence, Dept Sci & Technol, Percy FitzPatrick Inst, ZA-7701 Rondebosch, South Africa; Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, South Africa	National Research Foundation - South Africa; University of Cape Town; University of Pretoria	Ryan, PG (corresponding author), Univ Cape Town, Natl Res Fdn Ctr Excellence, Dept Sci & Technol, Percy FitzPatrick Inst, ZA-7701 Rondebosch, South Africa.	Peter.Ryan@uct.ac.za	Bloomer, Paulette/F-5501-2010; Moloney, Coleen/B-4363-2009; Delport, Wayne/C-1744-2008	Bloomer, Paulette/0000-0002-6357-0153; Moloney, Coleen/0000-0001-6663-8814; Ryan, Peter/0000-0002-3356-2056				ABBOTT I, 1978, J ZOOL, V184, P119; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Burger R, 2006, AM NAT, V167, P190, DOI 10.1086/499375; Burns KJ, 2002, EVOLUTION, V56, P1240; Coyne JA, 2004, SPECIATION, V37; Dieckmann U., 2004, ADAPTIVE SPECIATION; Gavrilets S, 2003, EVOLUTION, V57, P2197; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Grant PR, 2004, EVOLUTION, V58, P1588; Kopp M, 2006, EVOLUTION, V60, P1537; Lack D., 1947, DARWINS FINCHES; Mayr E., 1982, GROWTH BIOL THOUGHT; OLLIER CD, 1984, Z GEOMORPHOL, V28, P367; Petren K, 2005, MOL ECOL, V14, P2943, DOI 10.1111/j.1365-294X.2005.02632.x; Polechova J, 2005, EVOLUTION, V59, P1194; PREECE RC, 1986, J BIOGEOGR, V13, P1, DOI 10.2307/2844847; ROUX JP, 1992, BOTHALIA, V22, P93, DOI 10.4102/abc.v22i1.828; Ryan PG, 2001, CONDOR, V103, P429, DOI 10.1650/0010-5422(2001)103[0429:MHIAHB]2.0.CO;2; RYAN PG, 1994, AUK, V111, P314, DOI 10.2307/4088596; RYAN PG, 1992, THESIS U CAPE TOWN; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; SMITH TB, 1993, NATURE, V363, P618, DOI 10.1038/363618a0; Sorenson MD, 2003, NATURE, V424, P928, DOI 10.1038/nature01863; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Zink RM, 2002, AUK, V119, P864, DOI 10.1642/0004-8038(2002)119[0864:ANPOTE]2.0.CO;2	28	106	114	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1420	1423		10.1126/science.1138829	http://dx.doi.org/10.1126/science.1138829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347442				2022-12-24	WOS:000244752200036
J	McCann, K				McCann, Kevin			Protecting biostructure	NATURE			English	Editorial Material									Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada	University of Guelph	McCann, K (corresponding author), Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada.							Tewfik A, 2005, ECOLOGY, V86, P2726, DOI 10.1890/04-1537	1	141	145	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					29	29		10.1038/446029a	http://dx.doi.org/10.1038/446029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330028	Bronze			2022-12-24	WOS:000244525600022
J	Butler, MA; Sawyer, SA; Losos, JB				Butler, Marguerite A.; Sawyer, Stanley A.; Losos, Jonathan B.			Sexual dimorphism and adaptive radiation in Anolis lizards	NATURE			English	Article							ECOLOGICAL CAUSES; HABITAT USE; SIZE; EVOLUTION; DIVERSIFICATION; FEATURES	Sexual dimorphism is widespread and substantial throughout the animal world(1,2). It is surprising, then, that such a pervasive source of biological diversity has not been integrated into studies of adaptive radiation, despite extensive and growing attention to both phenomena(1,3-7). Rather, most studies of adaptive radiation either group individuals without regard to sex or focus solely on one sex. Here we show that sexual differences contribute substantially to the ecomorphological diversity produced by the adaptive radiations of West Indian Anolis lizards: within anole species, males and females occupy mostly non-overlapping parts of morphological space; the overall extent of sexual variation is large relative to interspecific variation; and the degree of variation depends on ecological type. Thus, when sexual dimorphism in ecologically relevant traits is substantial, ignoring its contribution may significantly underestimate the adaptive component of evolutionary radiation. Conversely, if sexual dimorphism and interspecific divergence are alternative means of ecological diversification, then the degree of sexual dimorphism may be negatively related to the extent of adaptive radiation.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA; Washington Univ, Dept Math, St Louis, MO 63130 USA	University of Hawaii System; University of Hawaii Manoa; Washington University (WUSTL); Washington University (WUSTL)	Butler, MA (corresponding author), Univ Hawaii Manoa, Dept Zool, 2538 McCarthy Mall, Honolulu, HI 96822 USA.	mbutler@hawaii.edu	Butler, Marguerite/B-6700-2011	Butler, Marguerite/0000-0002-2039-5965				Andersson Malte, 1994; Bolnick DI, 2003, EVOLUTION, V57, P2433, DOI 10.1554/02-595; Butler MA, 2000, EVOLUTION, V54, P259, DOI 10.1111/j.0014-3820.2000.tb00026.x; Butler MA, 2002, ECOL MONOGR, V72, P541, DOI 10.1890/0012-9615(2002)072[0541:MSDSSA]2.0.CO;2; DAYAN T, 1994, ECOLOGY, V75, P1063, DOI 10.2307/1939430; Delph LF, 2005, AM NAT, V166, pS1, DOI 10.1086/462434; DUONG TK, 2005, KERNAL SMOOTHING VER; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; LOSOS JB, 1993, OECOLOGIA, V95, P525, DOI 10.1007/BF00317437; LOSOS JB, 2004, ADAPTIVE SPECIATION, P335; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoener T.W., 1977, P35; SCHOENER TW, 1967, SCIENCE, V155, P474, DOI 10.1126/science.155.3761.474; SCHOENER TW, 1969, SYST ZOOL, V18, P386, DOI 10.2307/2412183; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Stamps JA, 1983, LIZARD ECOLOGY, P169; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Waxman D, 2005, J EVOLUTION BIOL, V18, P1139, DOI 10.1111/j.1420-9101.2005.00948.x; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18	30	162	174	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					202	205		10.1038/nature05774	http://dx.doi.org/10.1038/nature05774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495925				2022-12-24	WOS:000246338700042
J	Thai, TH; Calado, DP; Casola, S; Ansel, KM; Xiao, CC; Xue, YZ; Murphy, A; Frendewey, D; Valenzuela, D; Kutok, JL; Schmidt-Supprian, M; Rajewsky, N; Yancopoulos, G; Rao, A; Rajewsky, K				Thai, To-Ha; Calado, Dinis Pedro; Casola, Stefano; Ansel, K. Mark; Xiao, Changchun; Xue, Yingzi; Murphy, Andrew; Frendewey, David; Valenzuela, David; Kutok, Jeffery L.; Schmidt-Supprian, Marc; Rajewsky, Nikolaus; Yancopoulos, George; Rao, Anjana; Rajewsky, Klaus			Regulation of the germinal center response by microRNA-155	SCIENCE			English	Article							VIRUS-INDUCED LYMPHOMAS; B-CELL PROLIFERATION; HIGH EXPRESSION; NONCODING RNA; GENE; MICE; LYMPHOTOXIN; RECEPTOR; ENCODES; BETA	MicroRNAs are small RNA species involved in biological control at multiple levels. Using genetic deletion and transgenic approaches, we show that the evolutionarily conserved microRNA-155 (miR-155) has an important role in the mammalian immune system, specifically in regulating T helper cell differentiation and the germinal center reaction to produce an optimal T cell-dependent antibody response. miR-155 exerts this control, at least in part, by regulating cytokine production. These results also suggest that individual microRNAs can exert critical control over mammalian differentiation processes in vivo.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; IFOM FIRC Inst Mol Oncol, I-20139 Milan, Italy; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; IFOM - FIRC Institute of Molecular Oncology; Regeneron; Harvard University; Brigham & Women's Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Schmidt-Supprian, Marc/F-5893-2011; Casola, Stefano/O-3922-2014; Casola, Stefano/AAN-8319-2021; Calado, Dinis/U-8379-2019	Schmidt-Supprian, Marc/0000-0002-8543-6166; Casola, Stefano/0000-0001-5580-0986; Calado, Dinis/0000-0001-8239-7184; Frendewey, David/0000-0003-2305-3490; Rajewsky, Klaus/0000-0002-6633-6370; Rajewsky, Nikolaus/0000-0002-4785-4332; Murphy, Andrew/0000-0003-4152-4081	NIAID NIH HHS [AI064345] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064345] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Esposito G, 2000, P NATL ACAD SCI USA, V97, P1166, DOI 10.1073/pnas.97.3.1166; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang Y, 2001, J IMMUNOL, V166, P330, DOI 10.4049/jimmunol.166.1.330	24	1172	1281	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					604	608		10.1126/science.1141229	http://dx.doi.org/10.1126/science.1141229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463289				2022-12-24	WOS:000245983100047
J	Cui, HC; Levesque, MP; Vernoux, T; Jung, JW; Paquette, AJ; Gallagher, KL; Wang, JY; Blilou, I; Scheres, B; Benfey, PN				Cui, Hongchang; Levesque, Mitchell P.; Vernoux, Teva; Jung, Jee W.; Paquette, Alice J.; Gallagher, Kimberly L.; Wang, Jean Y.; Blilou, Ikram; Scheres, Ben; Benfey, Philip N.			An evolutionarily conserved mechanism delimiting SHR movement defines a single layer of endodermis in plants	SCIENCE			English	Article							ASYMMETRIC CELL-DIVISION; ARABIDOPSIS ROOT; SCARECROW GENE; INTERCELLULAR MOVEMENT; RADIAL ORGANIZATION; EXPRESSION; TRAFFICKING; PROTEIN; NETWORKS; MERISTEM	Intercellular protein movement plays a critical role in animal and plant development. SHORTROOT (SHR) is a moving transcription factor essential for endodermis specification in the Arabidopsis root. Unlike diffusible animal morphogens, which form a gradient across multiple cell layers, SHR movement is limited to essentially one cell layer. However, the molecular mechanism is unknown. We show that SCARECROW (SCR) blocks SHR movement by sequestering it into the nucleus through protein-protein interaction and a safeguard mechanism that relies on a SHR/SCR-dependent positive feedback loop for SCR transcription. Our studies with SHR and SCR homologs from rice suggest that this mechanism is evolutionarily conserved, providing a plausible explanation why nearly all plants have a single layer of endodermis.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Univ Utrecht, Dept Mol Genet, NL-3584 CH Utrecht, Netherlands	Duke University; Duke University; Utrecht University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Vernoux, Teva/J-1695-2019; Cui, Hongchang/ABD-3278-2021	Vernoux, Teva/0000-0002-8257-4088; Cui, Hongchang/0000-0002-9870-748X; Blilou, Ikram/0000-0001-8003-3782; Scheres, Ben/0000-0001-5400-9578	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM043778] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Benfey PN, 2001, PLANT PHYSIOL, V125, P109, DOI 10.1104/pp.125.1.109; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; DOLAN L, 1993, DEVELOPMENT, V119, P71; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Kamiya N, 2003, PLANT J, V36, P45, DOI 10.1046/j.1365-313X.2003.01856.x; Kim JY, 2002, P NATL ACAD SCI USA, V99, P4103, DOI 10.1073/pnas.052484099; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lee JY, 2003, SCIENCE, V299, P392, DOI 10.1126/science.1077813; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Lim J, 2000, PLANT CELL, V12, P1307, DOI 10.1105/tpc.12.8.1307; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sassa N, 2001, PLANT CELL PHYSIOL, V42, P385, DOI 10.1093/pcp/pce048; SCHERES B, 1995, DEVELOPMENT, V121, P53; Sena G, 2004, DEVELOPMENT, V131, P2817, DOI 10.1242/dev.01144; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Weinl C, 2005, PLANT CELL, V17, P1704, DOI 10.1105/tpc.104.030486; Wu XL, 2003, DEVELOPMENT, V130, P3735, DOI 10.1242/dev.00577	27	397	444	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					421	425		10.1126/science.1139531	http://dx.doi.org/10.1126/science.1139531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446396				2022-12-24	WOS:000245813400049
J	Frayling, TM; Timpson, NJ; Weedon, MN; Zeggini, E; Freathy, RM; Lindgren, CM; Perry, JRB; Elliott, KS; Lango, H; Rayner, NW; Shields, B; Harries, LW; Barrett, JC; Ellard, S; Groves, CJ; Knight, B; Patch, AM; Ness, AR; Ebrahim, S; Lawlor, DA; Ring, SM; Ben-Shlomo, Y; Jarvelin, MR; Sovio, U; Bennett, AJ; Melzer, D; Ferrucci, L; Loos, RJF; Barroso, I; Wareham, NJ; Karpe, F; Owen, KR; Cardon, LR; Walker, M; Hitman, GA; Palmer, CNA; Doney, ASF; Morris, AD; Smith, GD; Hattersley, AT; McCarthy, MI				Frayling, Timothy M.; Timpson, Nicholas J.; Weedon, Michael N.; Zeggini, Eleftheria; Freathy, Rachel M.; Lindgren, Cecilia M.; Perry, John R. B.; Elliott, Katherine S.; Lango, Hana; Rayner, Nigel W.; Shields, Beverley; Harries, Lorna W.; Barrett, Jeffrey C.; Ellard, Sian; Groves, Christopher J.; Knight, Bridget; Patch, Ann-Marie; Ness, Andrew R.; Ebrahim, Shah; Lawlor, Debbie A.; Ring, Susan M.; Ben-Shlomo, Yoav; Jarvelin, Marjo-Riitta; Sovio, Ulla; Bennett, Amanda J.; Melzer, David; Ferrucci, Luigi; Loos, Ruth J. F.; Barroso, Ines; Wareham, Nicholas J.; Karpe, Fredrik; Owen, Katharine R.; Cardon, Lon R.; Walker, Mark; Hitman, Graham A.; Palmer, Colin N. A.; Doney, Alex S. F.; Morris, Andrew D.; Smith, George Davey; Hattersley, Andrew T.; McCarthy, Mark I.		Wellcome Trust Case Control	A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity	SCIENCE			English	Article							ENPP1; GAD2	Obesity is a serious international health problem that increases the risk of several common diseases. The genetic factors predisposing to obesity are poorly understood. A genome-wide search for type 2 diabetes-susceptibility genes identified a common variant in the FTO ( fat mass and obesity associated) gene that predisposes to diabetes through an effect on body mass index (BMI). An additive association of the variant with BMI was replicated in 13 cohorts with 38,759 participants. The 16% of adults who are homozygous for the risk allele weighed about 3 kilograms more and had 1.67-fold increased odds of obesity when compared with those not inheriting a risk allele. This association was observed from age 7 years upward and reflects a specific increase in fat mass.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford, England; Univ Bristol, MRC, Ctr Casual Anal Translat Epidemiol, Bristol, Avon, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; Royal Devon & Exeter Natl Hlth Serv Fdn Trust, Mol Genet Lab, Exeter, Devon, England; Univ Bristol, Dept Oral & Dent Sci, Sch Dent, Bristol, Avon, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; Univ Bristol, Dept Social Med, Bristol, Avon, England; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ Oulu, Dept Publ Hlth Sci & Gen Practice, FIN-90014 Oulu, Finland; Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter, Devon, England; NIA, Lonitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA; Strangeways Res Labs, MRC, Epidemiol Unit, Cambridge, England; Sanger Inst, Metab Dis Grp, Wellcome Trust, Cambridge, England; Univ Newcastle, Diabet Res Grp, Sch Clin Med Sci, Newcastle Upon Tyne, Tyne & Wear, England; Barts & London Royal London Hosp, Dept Diabet & Metab Med, London, England; Univ Dundee, Populat Pharmacogenet Grp, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Diabet Res Grp, Div Med & Therapeut,Sch Med, Dundee DD1 9SY, Scotland	University of Exeter; University of Oxford; Wellcome Centre for Human Genetics; University of Bristol; University of Oxford; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; Imperial College London; University of Oulu; University of Exeter; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wellcome Trust Sanger Institute; Newcastle University - UK; Barts Health NHS Trust; Royal London Hospital; University of Dundee; University of Dundee	Hattersley, AT (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Magdalen Rd, Exeter, Devon, England.	Andrew.Hattersley@pms.ac.uk	Patch, Ann-Marie/C-4201-2018; Timpson, Nicholas John/O-7548-2015; Berryman, Katie/J-4236-2014; Attrill, Lauren/V-1688-2018; Davey Smith, George/A-7407-2013; Morris, Andrew D/C-2837-2009; Allen, Hana Lango/G-9026-2012; Doney, Alexander SF/P-7437-2017; Palmer, Colin NA/C-7053-2008; Ben-Shlomo, Yoav/ABD-2004-2021; Fox, Laura J/C-6249-2016; Study, GoDARTS/K-9448-2016; Ness, Andy R/M-7612-2013; Patch, Ann-Marie/F-8060-2011; Sovio, Ulla/H-8532-2019; Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022; Harries, Lorna/D-2241-2014; McCarthy, Mark/M-3763-2015; Lunnon, Katie/C-4638-2012	Patch, Ann-Marie/0000-0001-6121-4019; Timpson, Nicholas John/0000-0002-7141-9189; Davey Smith, George/0000-0002-1407-8314; Allen, Hana Lango/0000-0002-7803-8688; Doney, Alexander SF/0000-0002-6210-5620; Palmer, Colin NA/0000-0002-6415-6560; Ben-Shlomo, Yoav/0000-0001-6648-3007; Ness, Andy R/0000-0003-3548-9523; Sovio, Ulla/0000-0002-0799-1105; Loos, Ruth J F/0000-0002-8532-5087; s, hema/0000-0002-3440-9475; Weedon, Michael/0000-0002-6174-6135; Freathy, Rachel/0000-0003-4152-2238; McCarthy, Mark/0000-0002-4393-0510; Barrett, Jeffrey/0000-0002-1152-370X; Melzer, David/0000-0002-0170-3838; Frayling, Timothy/0000-0001-8362-2603; Harries, Lorna/0000-0001-7791-8061; Zeggini, Eleftheria/0000-0003-4238-659X; bennett, amanda/0000-0003-2140-8710; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hattersley, Andrew/0000-0001-5620-473X; Lawlor, Debbie A/0000-0002-6793-2262; Karpe, Fredrik/0000-0002-2751-1770; Lunnon, Katie/0000-0001-7570-6065; Ellard, Sian/0000-0002-7620-5526; Lindgren, Cecilia/0000-0002-4903-9374; Barroso, Ines/0000-0001-5800-4520	MRC [G0000934, MC_U106188470, G0600705, G0500070] Funding Source: UKRI; Medical Research Council [MC_U106188470, G0600705, G0000934, G9815508, MC_U106179471, G0500070] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [Z01AG000965, Z01AG000631] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Boutin P, 2003, PLOS BIOL, V1, P361, DOI 10.1371/journal.pbio.0000068; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Groves CJ, 2006, DIABETES, V55, P1884, DOI 10.2337/db05-1674; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Swarbrick MM, 2005, PLOS BIOL, V3, P1662, DOI 10.1371/journal.pbio.0030315; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Weedon MN, 2006, DIABETES, V55, P3175, DOI 10.2337/db06-0410; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196	16	3132	3327	6	561	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					889	894		10.1126/science.1141634	http://dx.doi.org/10.1126/science.1141634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17434869	Green Accepted, Green Published			2022-12-24	WOS:000246369800038
J	Almany, GR; Berumen, ML; Thorrold, SR; Planes, S; Jones, GP				Almany, Glenn R.; Berumen, Michael L.; Thorrold, Simon R.; Planes, Serge; Jones, Geoffrey P.			Local replenishment of coral reef fish populations in a marine reserve	SCIENCE			English	Article							DISPERSAL DISTANCE; SELF-RECRUITMENT; LARVAE; CONNECTIVITY; RETENTION; DESIGN; CONSEQUENCES; MECHANISMS; HOME	The scale of larval dispersal of marine organisms is important for the design of networks of marine protected areas. We examined the fate of coral reef fish larvae produced at a small island reserve, using a mass-marking method based on maternal transmission of stable isotopes to offspring. Approximately 60% of settled juveniles were spawned at the island, for species with both short (< 2 weeks) and long (> 1 month) pelagic larval durations. If natal homing of larvae is a common life-history strategy, the appropriate spatial scales for the management and conservation of coral reefs are likely to be much smaller than previously assumed.	James Cook Univ N Queensland, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Ecole Prat Hautes Etud, CNRS, Joint Res Unit 5244, Ctr Biol & Ecol Trop & Mediterraneene, F-66850 Perpignan, France	James Cook University; James Cook University; University of Arkansas System; University of Arkansas Fayetteville; Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia	Almany, GR (corresponding author), James Cook Univ N Queensland, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	glenn.almany@jcu.edu.au	Berumen, Michael L/F-7745-2011; Thorrold, Simon R/B-7565-2012; Jones, Geoffrey P./E-9306-2010; PLANES, Serge/ABF-1360-2021	Berumen, Michael L/0000-0003-2463-2742; Thorrold, Simon R/0000-0002-1533-7517; Jones, Geoffrey P./0000-0002-6244-1245; 				Botsford LW, 2001, ECOL LETT, V4, P144; Botsford LW, 2005, B MAR SCI, V76, P245; Botsford LW, 2003, ECOL APPL, V13, pS25; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hilborn R, 2006, CAN J FISH AQUAT SCI, V63, P642, DOI 10.1139/f05-243; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Lecchini D, 2005, OECOLOGIA, V143, P326, DOI 10.1007/s00442-004-1805-y; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Palumbi SR, 2003, ECOL APPL, V13, pS146; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shanks AL, 2003, ECOL APPL, V13, pS159; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Strathmann RR, 2002, B MAR SCI, V70, P377; Swearer SE, 2002, B MAR SCI, V70, P251; Thorrold SR, 2006, CAN J FISH AQUAT SCI, V63, P1193, DOI 10.1139/F06-048; Thorrold SR, 2002, B MAR SCI, V70, P291; Warner RR, 2002, B MAR SCI, V70, P245	24	438	444	0	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					742	744		10.1126/science.1140597	http://dx.doi.org/10.1126/science.1140597			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478720				2022-12-24	WOS:000246181400045
J	Barabe, F; Kennedy, JA; Hope, KJ; Dick, JE				Barabe, Frederic; Kennedy, James A.; Hope, Kristin J.; Dick, John E.			Modeling the initiation and progression of human acute leukemia in mice	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; GENE REARRANGEMENT; STEM-CELLS; MLL; LINEAGE; TRANSLOCATIONS; TRANSFORMATION; TUMORIGENESIS; PROGENITORS	Our understanding of leukemia development and progression has been hampered by the lack of in vivo models in which disease is initiated from primary human hematopoietic cells. We showed that upon transplantation into immunodeficient mice, primitive human hematopoietic cells expressing a mixed-lineage leukemia (MLL) fusion gene generated myeloid or lymphoid acute leukemias, with features that recapitulated human diseases. Analysis of serially transplanted mice revealed that the disease is sustained by leukemia-initiating cells (L-ICs) that have evolved over time from a primitive cell type with a germline immunoglobulin heavy chain (IgH) gene configuration to a cell type containing rearranged IgH genes. The L-ICs retained both myeloid and lymphoid lineage potential and remained responsive to microenvironmental cues. The properties of these cells provide a biological basis for several clinical hallmarks of MLL leukemias.	Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; Hop Enfants Jesus, Dept Hematol, Quebec City, PQ G1J 1Z4, Canada; CHU Laval, Ctr Hosp Univ Quebec, Res Ctr Infect Dis, Quebec City, PQ G1V 4G2, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Laval University; Laval University; Laval University; University of Toronto	Dick, JE (corresponding author), Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca		Dick, John/0000-0002-9527-8317; Hope, Kristin/0000-0003-1449-4948				Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Forestier E, 2006, J PEDIAT HEMATOL ONC, V28, P486, DOI 10.1097/01.mph.0000212972.90877.28; Germano Giuseppe, 2006, Haematologica, V91, pECR09; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Jiang JG, 2005, LEUKEMIA LYMPHOMA, V46, P1223, DOI 10.1080/10428190500086055; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Metzler M, 2006, ONCOGENE, V25, P3093, DOI 10.1038/sj.onc.1209636; PUI CH, 1994, J CLIN ONCOL, V12, P909, DOI 10.1200/JCO.1994.12.5.909; Rego EM, 1998, CYTOMETRY, V34, P22, DOI 10.1002/(SICI)1097-0320(19980215)34:1<22::AID-CYTO4>3.0.CO;2-G; Rich JN, 2001, CANCER RES, V61, P3556; Ridge SA, 1995, LEUKEMIA, V9, P2023; Rubnitz JE, 1999, J CLIN ONCOL, V17, P191, DOI 10.1200/JCO.1999.17.1.191; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Zeisig BB, 2003, ONCOGENE, V22, P1629, DOI 10.1038/sj.onc.1206104	25	257	272	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					600	604		10.1126/science.1139851	http://dx.doi.org/10.1126/science.1139851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463288				2022-12-24	WOS:000245983100046
J	Sansom, OJ; Meniel, VS; Muncan, V; Phesse, TJ; Wilkins, JA; Reed, KR; Vass, JK; Athineos, D; Clevers, H; Clarke, AR				Sansom, Owen J.; Meniel, Valerie S.; Muncan, Vanesa; Phesse, Toby J.; Wilkins, Julie A.; Reed, Karen R.; Vass, J. Keith; Athineos, Dimitris; Clevers, Hans; Clarke, Alan R.			Myc deletion rescues Apc deficiency in the small intestine	NATURE			English	Article							BETA-CATENIN; C-MYC; COLORECTAL-CANCER; APOPTOSIS; EXPRESSION; TARGET; CELLS; GENE; IDENTIFICATION; EPITHELIUM	The APC gene encodes the adenomatous polyposis coli tumour suppressor protein, germline mutation of which characterizes familial adenomatous polyposis (FAP), an autosomal intestinal cancer syndrome(1). Inactivation of APC is also recognized as the key early event in the development of sporadic colorectal cancers(2,3), and its loss results in constitutive activity of the beta-catenin-Tcf4 transcription complex(3). The proto-oncogene c-MYC has been identified as a target of the Wnt pathway in colorectal cancer cells in vitro(4), in normal crypts in vivo(5) and in intestinal epithelial cells acutely transformed on in vivo deletion of the APC gene(6); however, the significance of this is unclear. Therefore, to elucidate the role Myc has in the intestine after Apc loss, we have simultaneously deleted both Apc and Myc in the adult murine small intestine. Here we show that loss of Myc rescued the phenotypes of perturbed differentiation, migration, proliferation and apoptosis, which occur on deletion of Apc. Remarkably, this rescue occurred in the presence of high levels of nuclear beta-catenin. Array analysis revealed that Myc is required for the majority of Wnt target gene activation following Apc loss. These data establish Myc as the critical mediator of the early stages of neoplasia following Apc loss.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Cardiff Wales, Cardiff Sch Biosci, Cardiff CF10 3US, Wales; Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Beatson Institute; Cardiff University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Sansom, OJ (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Reed, Karen/B-8813-2011; clarke, alan r/P-2820-2014; Clarke, Alan R/A-6256-2008	Reed, Karen/0000-0002-7467-1718; Phesse, Toby/0000-0001-9568-4916; Athineos, Dimitris/0000-0001-5298-7941; Clarke, Alan/0000-0002-4281-426X; Sansom, Owen J./0000-0001-9540-3010	Medical Research Council [G0301154] Funding Source: Medline; MRC [G0301154] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hay T, 2005, ONCOGENE, V24, P3842, DOI 10.1038/sj.onc.1208533; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li Q, 1999, MOL CELL BIOL, V19, P5339; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Sansom OJ, 2005, J BIOL CHEM, V280, P28463, DOI 10.1074/jbc.M500191200; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0	23	475	481	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					676	679		10.1038/nature05674	http://dx.doi.org/10.1038/nature05674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377531	Bronze			2022-12-24	WOS:000245438300042
J	Armanios, MY; Chen, JJL; Cogan, JD; Alder, JK; Ingersoll, RG; Markin, C; Lawson, WE; Xie, MY; Vulto, I; Phillips, JA; Lansdorp, PM; Greider, CW; Loyd, JE				Armanios, Mary Y.; Chen, Julian J. -L.; Cogan, Joy D.; Alder, Jonathan K.; Ingersoll, Roxann G.; Markin, Cheryl; Lawson, William E.; Xie, Mingyi; Vulto, Irma; Phillips, John A., III; Lansdorp, Peter M.; Greider, Carol W.; Loyd, James E.			Telomerase mutations in families with idiopathic pulmonary fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; APLASTIC-ANEMIA; CATALYTIC SUBUNIT; RNA; GENE; IDENTIFICATION; ANTICIPATION; SENESCENCE; SEQUENCE	BACKGROUND Idiopathic pulmonary fibrosis is progressive and often fatal; causes of familial clustering of the disease are unknown. Germ-line mutations in the genes hTERT and hTR, encoding telomerase reverse transcriptase and telomerase RNA, respectively, cause autosomal dominant dyskeratosis congenita, a rare hereditary disorder associated with premature death from aplastic anemia and pulmonary fibrosis. METHODS To test the hypothesis that familial idiopathic pulmonary fibrosis may be caused by short telomeres, we screened 73 probands from the Vanderbilt Familial Pulmonary Fibrosis Registry for mutations in hTERT and hTR. RESULTS Six probands (8%) had heterozygous mutations in hTERT or hTR; mutant telomerase resulted in short telomeres. Asymptomatic subjects with mutant telomerase also had short telomeres, suggesting that they may be at risk for the disease. We did not identify any of the classic features of dyskeratosis congenita in five of the six families. CONCLUSIONS Mutations in the genes encoding telomerase components can appear as familial idiopathic pulmonary fibrosis. Our findings support the idea that pathways leading to telomere shortening are involved in the pathogenesis of this disease.	Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Arizona State Univ, Dept Chem & Biochem, Temple, TX USA; Arizona State Univ, Sch Life Sci, Temple, TX USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vet Affairs Med Ctr, Nashville, TN 37212 USA; Univ British Columbia, Terry Fox Lab, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, British Columbia Canc Agcy, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Arizona State University; Arizona State University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Armanios, MY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, 1650 Orleans St,CRB 186, Baltimore, MD 21231 USA.	marmani1@jhmi.edu	Chen, Julian J.-L./D-6488-2014; Alder, Jonathan/AAF-3540-2020	Chen, Julian J.-L./0000-0002-7253-2722; Cogan, Joy/0000-0001-8106-1216; , Roxann/0000-0002-4266-613X; Loyd, James/0000-0002-5042-7390; Alder, Jonathan/0000-0003-3741-6512; Lansdorp, Peter/0000-0001-7435-1071; Greider, Carol/0000-0002-5494-8126	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI029524, R01AI029524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027406] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00095] Funding Source: Medline; NHLBI NIH HHS [K08 HL085406] Funding Source: Medline; NIAID NIH HHS [AI29524] Funding Source: Medline; NIA NIH HHS [R01 AG027406] Funding Source: Medline; PHS HHS [K08 118416, K08 85406] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Agusti C, 2002, AM J RESP CRIT CARE, V166, P426; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; BAERLOCHER GM, IN PRESS NAT PROTOC; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Dokal I, 2003, BLOOD REV, V17, P217, DOI 10.1016/S0268-960X(03)00020-1; Drosopoulos WC, 2005, J BIOL CHEM, V280, P32801, DOI 10.1074/jbc.M506319200; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Knight S, 1998, BRIT J HAEMATOL, V103, P990, DOI 10.1046/j.1365-2141.1998.01103.x; Lawson William E, 2006, Proc Am Thorac Soc, V3, P345, DOI 10.1513/pats.200512-137TK; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Loyd JE, 2003, AM J RESP CELL MOL, V29, pS47; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; *NAT I ENV HLTH SC, TERT TEL REV TRANSCR; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	38	892	938	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1317	1326		10.1056/NEJMoa066157	http://dx.doi.org/10.1056/NEJMoa066157			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392301	Bronze			2022-12-24	WOS:000245221000005
J	Barrangou, R; Fremaux, C; Deveau, H; Richards, M; Boyaval, P; Moineau, S; Romero, DA; Horvath, P				Barrangou, Rodolphe; Fremaux, Christophe; Deveau, Helene; Richards, Melissa; Boyaval, Patrick; Moineau, Sylvain; Romero, Dennis A.; Horvath, Philippe			CRISPR provides acquired resistance against viruses in prokaryotes	SCIENCE			English	Article							DNA; REPEATS; ELEMENTS; STRAIN; EVOLUTIONARY; SEQUENCES; BACTERIA; SYSTEM; GENES; PHAGE	Clustered regularly interspaced short palindromic repeats (CRISPR) are a distinctive feature of the genomes of most Bacteria and Archaea and are thought to be involved in resistance to bacteriophages. We found that, after viral challenge, bacteria integrated new spacers derived from phage genomic sequences. Removal or addition of particular spacers modified the phage-resistance phenotype of the cell. Thus, CRISPR, together with associated cas genes, provided resistance against phages, and resistance specificity is determined by spacer-phage sequence similarity.	Danisco France SAS, F-86220 Dange St Romain, France; Danisco USA Inc, Madison, WI 53716 USA; Univ Laval, Dept Biochem & Microbiol, Felix Herelle Reference Ctr Bacterial Viruses, Grp Rech Ecol Buccale,Fac Sci & Genie, Ste Foy, PQ G1K 7P4, Canada	Laval University	Horvath, P (corresponding author), Danisco France SAS, Boite Postale 10, F-86220 Dange St Romain, France.	philippe.horvath@danisco.com	HORVATH, Philippe/K-5266-2015; Moineau, Sylvain/N-3578-2013; Moineau, Sylvain/I-7231-2019; Barrangou, Rodolphe/I-2878-2014	HORVATH, Philippe/0000-0003-2015-8123; Moineau, Sylvain/0000-0002-2832-5101; Barrangou, Rodolphe/0000-0002-0648-3504				Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Brussow H, 2001, ANNU REV MICROBIOL, V55, P283, DOI 10.1146/annurev.micro.55.1.283; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; DeBoy RT, 2006, J BACTERIOL, V188, P2364, DOI 10.1128/JB.188.7.2364-2374.2006; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; HAIT DH, 2005, PLOS COMPUT BIOL, V1, pE60; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Levesque C, 2005, APPL ENVIRON MICROB, V71, P4057, DOI 10.1128/AEM.71.7.4057-4068.2005; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mongodin EF, 2005, J BACTERIOL, V187, P4935, DOI 10.1128/JB.187.14.4935-4944.2005; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Russell WM, 2001, APPL ENVIRON MICROB, V67, P4361, DOI 10.1128/AEM.67.9.4361-4364.2001; Sturino JM, 2006, NAT REV MICROBIOL, V4, P395, DOI 10.1038/nrmicro1393	19	3527	4016	100	2195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1709	1712		10.1126/science.1138140	http://dx.doi.org/10.1126/science.1138140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379808				2022-12-24	WOS:000245106900039
J	Greenman, C; Stephens, P; Smith, R; Dalgliesh, GL; Hunter, C; Bignell, G; Davies, H; Teague, J; Butler, A; Edkins, S; O'Meara, S; Vastrik, I; Schmidt, EE; Avis, T; Barthorpe, S; Bhamra, G; Buck, G; Choudhury, B; Clements, J; Cole, J; Dicks, E; Forbes, S; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jenkinson, A; Jones, D; Menzies, A; Mironenko, T; Perry, J; Raine, K; Richardson, D; Shepherd, R; Small, A; Tofts, C; Varian, J; Webb, T; West, S; Widaa, S; Yates, A; Cahill, DP; Louis, DN; Goldstraw, P; Nicholson, AG; Brasseur, F; Looijenga, L; Weber, BL; Chiew, YE; Defazio, A; Greaves, MF; Green, AR; Campbell, P; Birney, E; Easton, DF; Chenevix-Trench, G; Tan, MH; Khoo, SK; Teh, BT; Yuen, ST; Leung, SY; Wooster, R; Futreal, PA; Stratton, MR				Greenman, Christopher; Stephens, Philip; Smith, Raffaella; Dalgliesh, Gillian L.; Hunter, Christopher; Bignell, Graham; Davies, Helen; Teague, Jon; Butler, Adam; Edkins, Sarah; O'Meara, Sarah; Vastrik, Imre; Schmidt, Esther E.; Avis, Tim; Barthorpe, Syd; Bhamra, Gurpreet; Buck, Gemma; Choudhury, Bhudipa; Clements, Jody; Cole, Jennifer; Dicks, Ed; Forbes, Simon; Gray, Kris; Halliday, Kelly; Harrison, Rachel; Hills, Katy; Hinton, Jon; Jenkinson, Andy; Jones, David; Menzies, Andy; Mironenko, Tatiana; Perry, Janet; Raine, Keiran; Richardson, Dave; Shepherd, Rebecca; Small, Alexandra; Tofts, Calli; Varian, Jennifer; Webb, Tony; West, Sofie; Widaa, Sara; Yates, Andy; Cahill, Daniel P.; Louis, David N.; Goldstraw, Peter; Nicholson, Andrew G.; Brasseur, Francis; Looijenga, Leendert; Weber, Barbara L.; Chiew, Yoke-Eng; deFazio, Anna; Greaves, Mel F.; Green, Anthony R.; Campbell, Peter; Birney, Ewan; Easton, Douglas F.; Chenevix-Trench, Georgia; Tan, Min-Han; Khoo, Sok Kean; Teh, Bin Tean; Yuen, Siu Tsan; Leung, Suet Yi; Wooster, Richard; Futreal, P. Andrew; Stratton, Michael R.			Patterns of somatic mutation in human cancer genomes	NATURE			English	Article							KINASE GENE FAMILY; HUMAN LUNG-CANCER; COLORECTAL CANCERS; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; BREAST-CANCER; BETA RECEPTOR; PROTEIN; TITIN; INACTIVATION	Cancers arise owing to mutations in a subset of genes that confer growth advantage. The availability of the human genome sequence led us to propose that systematic resequencing of cancer genomes for mutations would lead to the discovery of many additional cancer genes. Here we report more than 1,000 somatic mutations found in 274 megabases (Mb) of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers. There was substantial variation in the number and pattern of mutations in individual cancers reflecting different exposures, DNA repair defects and cellular origins. Most somatic mutations are likely to be 'passengers' that do not contribute to oncogenesis. However, there was evidence for 'driver' mutations contributing to the development of the cancers studied in approximately 120 genes. Systematic sequencing of cancer genomes therefore reveals the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.	Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; EMBL, European Bioinformat Inst, Cambridge CB10 1SD, England; Massachusetts Gen Hosp, Neurosurg Serv, Mol Pathol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Royal Brompton Hosp, London SW3 6NP, England; Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Erasmus MC, Daniel den Hoed Canc Ctr, Josephine Nefkens Inst, Lab Pathol Expt Pathooncol, NL-3000 DR Rotterdam, Netherlands; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Westmead Hosp, Dept Gynaecol Oncol, Westmead, NSW 2145, Australia; Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia; Inst Canc Res, Sutton SM2 5NG, Surrey, England; Addenbrookes NHS Trust, Dept Haematol, Cambridge CB2 0QQ, England; Univ Cambridge, Cambridge CB2 0QQ, England; Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Univ Queensland, Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld 4029, Australia; Van Andel Res Inst, Grand Rapids, MI 49503 USA; Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Royal Brompton Hospital; Ludwig Institute for Cancer Research; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Pennsylvania; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of London; Institute of Cancer Research - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; University of Cambridge; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland; Van Andel Institute; University of Hong Kong	Futreal, PA (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Yuen, Siu/K-6311-2014; Choudhury, Bhudipa/D-3863-2011; Tan, Min Han/D-9205-2014; deFazio, Anna/D-3939-2013; Dalgliesh, Gillian/B-7799-2008; DeFazio, Anna/O-2385-2019; Chenevix-Trench, Georgia/AAV-2014-2020; Looijenga, Leendert/B-8145-2019; Leung, Suet Yi/C-4340-2009; Vastrik, Imre/C-2690-2009; Leung, Suet Yi/T-9620-2019	Choudhury, Bhudipa/0000-0002-1392-6414; Tan, Min Han/0000-0002-0644-3457; deFazio, Anna/0000-0003-0057-4744; Dalgliesh, Gillian/0000-0001-8526-5064; DeFazio, Anna/0000-0003-0057-4744; Chenevix-Trench, Georgia/0000-0002-1878-2587; Looijenga, Leendert/0000-0002-8146-1911; Green, Anthony/0000-0002-9795-0218; Teh, Bin Tean/0000-0003-1514-1124; Hunter, Christopher/0000-0002-1335-0881; Buck, Gemma/0000-0001-5289-1050; Gray, Kristian/0000-0002-7035-7107; Avis, Tim/0000-0001-6120-5729; Raine, Keiran/0000-0002-5634-1539; Yates, Andrew/0000-0002-8886-4772; Leung, Suet Yi/0000-0001-8614-4619; Birney, Ewan/0000-0001-8314-8497; Cahill, Daniel/0000-0003-2552-6546; Jenkinson, Andrew/0000-0002-0703-6984; Vastrik, Imre/0000-0001-6658-9311; Richardson, David/0000-0003-0247-9118	Wellcome Trust [077012, 088340] Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Brose MS, 2002, CANCER RES, V62, P6997; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Irusta PM, 2002, J BIOL CHEM, V277, P38627, DOI 10.1074/jbc.M204890200; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Karran P, 2003, BIOCHIMIE, V85, P1149, DOI 10.1016/j.biochi.2003.10.007; Kushida Tatsuya, 2006, Pac Symp Biocomput, P152; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lonardi S, 2005, CANCER TREAT REV, V31, P79, DOI 10.1016/j.ctrv.2004.12.005; Machado C, 2000, J CELL BIOL, V151, P639, DOI 10.1083/jcb.151.3.639; Machado C, 1998, J CELL BIOL, V141, P321, DOI 10.1083/jcb.141.2.321; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Teng DHF, 1997, CANCER RES, V57, P4177; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Yang ZH, 2003, GENETICS, V165, P695; Zastrow MS, 2006, J CELL SCI, V119, P239, DOI 10.1242/jcs.02728	39	2206	2790	1	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					153	158		10.1038/nature05610	http://dx.doi.org/10.1038/nature05610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344846	Green Accepted			2022-12-24	WOS:000244718100033
J	Engelbrecht, BMJ; Comita, LS; Condit, R; Kursar, TA; Tyree, MT; Turner, BL; Hubbell, SP				Engelbrecht, Bettina M. J.; Comita, Liza S.; Condit, Richard; Kursar, Thomas A.; Tyree, Melvin T.; Turner, Benjamin L.; Hubbell, Stephen P.			Drought sensitivity shapes species distribution patterns in tropical forests	NATURE			English	Article							RAIN-FOREST; FLORISTIC COMPOSITION; HABITAT ASSOCIATIONS; NEOTROPICAL FOREST; CLIMATIC GRADIENT; MOIST FOREST; DIVERSITY; SEEDLINGS; TREES; TOLERANCE	Although patterns of tree species distributions along environmental gradients have been amply documented in tropical forests(1-7), mechanisms causing these patterns are seldom known. Efforts to evaluate proposed mechanisms have been hampered by a lack of comparative data on species' reactions to relevant axes of environmental variation(1). Here we show that differential drought sensitivity shapes plant distributions in tropical forests at both regional and local scales. Our analyses are based on experimental field assessments of drought sensitivity of 48 species of trees and shrubs, and on their local and regional distributions within a network of 122 inventory sites spanning a rainfall gradient across the Isthmus of Panama. Our results suggest that niche differentiation with respect to soil water availability is a direct determinant of both local- and regional-scale distributions of tropical trees. Changes in soil moisture availability caused by global climate change and forest fragmentation are therefore likely to alter tropical species distributions, community composition and diversity.	Smithsonian Trop Res Inst, Balboa 03092, Panama; Univ Kaiserslautern, Dept Plant Ecol & Systemat, D-67663 Kaiserslautern, Germany; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; US Forest Serv, USDA, Burlington, VT 05402 USA; Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2E3, Canada	Smithsonian Institution; Smithsonian Tropical Research Institute; University of Kaiserslautern; University System of Georgia; University of Georgia; Utah System of Higher Education; University of Utah; United States Department of Agriculture (USDA); United States Forest Service; University of Alberta	Engelbrecht, BMJ (corresponding author), Smithsonian Trop Res Inst, Apartado 0843, Balboa 03092, Panama.	engelbrb@si.edu	Turner, Benjamin L/E-5940-2011; Engelbrecht, Bettina/E-9914-2012	Turner, Benjamin L/0000-0002-6585-0722; Comita, Liza/0000-0002-9169-1331				Bongers F, 1999, J VEG SCI, V10, P371, DOI 10.2307/3237066; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; CONDIT R, 2005, BARRO COLORADO FORES; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; Engelbrecht BMJ, 2005, TREES-STRUCT FUNCT, V19, P312, DOI 10.1007/s00468-004-0393-0; Engelbrecht BMJ, 2003, OECOLOGIA, V136, P383, DOI 10.1007/s00442-003-1290-8; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hubbell Stephen P., 2001, V32, pi; Huston M. A., 1994, BIOL DIVERSITY; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Malhi Y, 2004, PHILOS T R SOC B, V359, P549, DOI 10.1098/rstb.2003.1449; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; PEREZ R, 2005, RIO CHAGRES PANAMA M; Potts MD, 2003, J ECOL, V91, P467, DOI 10.1046/j.1365-2745.2003.00779.x; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; Schimper AFW., 1903, PLANT GEOGRAPHY PHYS; *SMITHS TROP RES I, 2006, ACP PHYS MON DOWNL; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Tyree MT, 2003, PLANT PHYSIOL, V132, P1439, DOI 10.1104/pp.102.018937; Veenendaal E. M., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P163; Veenendaal EM, 1996, FUNCT ECOL, V10, P501, DOI 10.2307/2389943; Walsh R.P.D., 1996, PW RICHARDS 1996 TRO, P159; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; WELDEN CW, 1991, ECOLOGY, V72, P35, DOI 10.2307/1938900	30	736	780	20	511	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					80	U2		10.1038/nature05747	http://dx.doi.org/10.1038/nature05747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476266				2022-12-24	WOS:000246149300047
J	Reese, TA; Liang, HE; Tager, AM; Luster, AD; Van Rooijen, N; Voehringer, D; Locksley, RM				Reese, Tiffany A.; Liang, Hong-Erh; Tager, Andrew M.; Luster, Andrew D.; Van Rooijen, Nico; Voehringer, David; Locksley, Richard M.			Chitin induces accumulation in tissue of innate immune cells associated with allergy	NATURE			English	Article							ACIDIC MAMMALIAN CHITINASE; TYPE-2 IMMUNITY; LEUKOTRIENE B-4; IN-VIVO; RECEPTOR; MACROPHAGES; GENE; CHITOTRIOSIDASE; IDENTIFICATION; INFLAMMATION	Allergic and parasitic worm immunity is characterized by infiltration of tissues with interleukin (IL)-4- and IL-13-expressing cells, including T-helper-2 cells, eosinophils and basophils(1). Tissue macrophages assume a distinct phenotype, designated alternatively activated macrophages(2). Relatively little is known about the factors that trigger these host responses. Chitin, a widespread environmental biopolymer of N-acetyl-beta-D-glucosamine, provides structural rigidity to fungi, crustaceans, helminths and insects(3). Here, we show that chitin induces the accumulation in tissue of IL-4- expressing innate immune cells, including eosinophils and basophils, when given to mice. Tissue infiltration was unaffected by the absence of Toll-like-receptor-mediated lipopolysaccharide recognition but did not occur if the injected chitin was pre-treated with the IL-4- and IL-13-inducible mammalian chitinase, AMCase(4), or if the chitin was injected into mice that overexpressed AMCase. Chitin mediated alternative macrophage activation in vivo and the production of leukotriene B-4, which was required for optimal immune cell recruitment. Chitin is a recognition element for tissue infiltration by innate cells implicated in allergic and helminth immunity and this process can be negatively regulated by a vertebrate chitinase.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Immunol Microbiol, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Vrije Univ Amsterdam, Dept Mol Cell Biol, NL-1091 BT Amsterdam, Netherlands	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Vrije Universiteit Amsterdam	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu	Luster, Andrew/ABE-6504-2020; Voehringer, David/K-2776-2019; Van Rooijen, Nico/Z-1578-2019	Luster, Andrew/0000-0001-9679-7912; Reese, Tiffany/0000-0003-2325-6546	NIAID NIH HHS [R37 AI040618, R01 AI026918, R37 AI026918-20, R37 AI026918, R01 AI030663] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R37AI026918, R37AI040618, R01AI030663] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Cartier Andre, 2004, Int J Circumpolar Health, V63 Suppl 2, P333; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; GLASSER SW, 1991, AM J PHYSIOL, V261, P349; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Jin HM, 1998, GENOMICS, V54, P316, DOI 10.1006/geno.1998.5593; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Machado ER, 2005, J IMMUNOL, V175, P3892, DOI 10.4049/jimmunol.175.6.3892; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nair MG, 2006, J IMMUNOL, V177, P1393, DOI 10.4049/jimmunol.177.3.1393; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Prada JAH, 2006, NAT IMMUNOL, V7, P875, DOI 10.1038/ni1359; Ramalingam TR, 2005, CURR OPIN ALLERGY CL, V5, P392, DOI 10.1097/01.all.0000182542.30100.6f; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Shibata Y, 2000, J IMMUNOL, V164, P1314, DOI 10.4049/jimmunol.164.3.1314; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Usami Y, 1998, J BIOMED MATER RES, V42, P517; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang YH, 2005, DEV BIOL, V285, P330, DOI 10.1016/j.ydbio.2005.06.037; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	31	578	602	6	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					92	U7		10.1038/nature05746	http://dx.doi.org/10.1038/nature05746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17450126	Green Accepted			2022-12-24	WOS:000246149300050
J	Fukuda, R; Zhang, HF; Kim, JW; Shimoda, L; Dang, CV; Semenza, GL				Fukuda, Ryo; Zhang, Huafeng; Kim, Jung-whan; Shimoda, Larissa; Dang, Chi V.; Semenza, Gregg L.			HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells	CELL			English	Article							INDUCIBLE FACTOR 1-ALPHA; PAS DOMAIN PROTEIN-1; C-OXIDASE; SACCHAROMYCES-CEREVISIAE; GROWTH-FACTOR; FACTOR-I; EXPRESSION; FACTOR-1; YEAST; GENE	O-2 is the ultimate electron acceptor for mitochondrial respiration, a process catalyzed by cytochrome c oxidase (COX). In yeast, COX subunit composition is regulated by COX5a and COX5b gene transcription in response to high and low O-2, respectively. Here we demonstrate that in mammalian cells, expression of the COX4-1 and COX4-2 isoforms is O-2 regulated. Under conditions of reduced O-2 availability, hypoxia-inducible factor 1 (HIF-1) reciprocally regulates COX4 subunit expression by activating transcription of the genes encoding COX4-2 and LON, a mitochondrial protease that is required for COX4-1 degradation. The effects of manipulating COX4 subunit expression on COX activity, ATP production, O-2 consumption, and reactive oxygen species generation indicate that the COX4 subunit switch is a homeostatic response that optimizes the efficiency of respiration at different O-2 concentrations. Thus, mammalian cells respond to hypoxia by altering COX subunit composition, as previously observed in yeast, but by a completely different molecular mechanism.	Johns Hopkins Univ, Sch Med, Vasc Biol Program, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Vasc Biol Program, Inst Cell Engn, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Zhang, Huafeng/A-7188-2012; Dang, Chi/Y-3375-2019	Kim, Jung-whan/0000-0002-7829-1480; Dang, Chi/0000-0002-4031-2522				ALLEN LA, 1995, J BIOL CHEM, V270, P110, DOI 10.1074/jbc.270.1.110; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Burke PV, 1998, J EXP BIOL, V201, P1163; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hervouet E, 2006, BIOCHEM BIOPH RES CO, V344, P1086, DOI 10.1016/j.bbrc.2006.04.014; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kwast KE, 1998, J EXP BIOL, V201, P1177; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; LOWRY CV, 1984, P NATL ACAD SCI-BIOL, V81, P6129, DOI 10.1073/pnas.81.19.6129; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; Napiwotzki J, 1998, BIOL CHEM, V379, P335, DOI 10.1515/bchm.1998.379.3.335; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; WATERLAND RA, 1991, J BIOL CHEM, V266, P4180; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	43	883	918	7	81	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					111	122		10.1016/j.cell.2007.01.047	http://dx.doi.org/10.1016/j.cell.2007.01.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418790	Bronze			2022-12-24	WOS:000245661100015
J	Somesh, BP; Sigurdsson, S; Saeki, H; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Somesh, Baggavalli P.; Sigurdsson, Stefan; Saeki, Hideaki; Erdjument-Bromage, Hediye; Tempst, Paul; Svejstrup, Jesper Q.			Communication between distant sites in RNA polymerase II through ubiquitylation factors and the polymerase CTD	CELL			English	Article							UBIQUITIN-PROTEIN LIGASE; COUPLED DNA-REPAIR; STRUCTURAL BASIS; LARGE SUBUNIT; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; IN-VIVO; COMPLEX; DEGRADATION; RESOLUTION	Transcriptional arrest triggers ubiquitylation of RNA polymerase II (RNAPII). We mapped the yeast RNAPII ubiquitylation sites and found that they play an important role in elongation and the DNA-damage response. One site lies in a protein domain that is unordered in free RNAPII, but ordered in the elongating form, helping explain the preferential ubiguitylation of this form. The other site is > 125 Angstroms away, yet mutation of either site affects ubiquitylation of the other, in vitro and in vivo. The basis for this remarkable coupling was uncovered: an Rsp5 (E3) dimer assembled on the RNAPII C-terminal domain (CTD). The ubiquitylation sites bind Ubc5 (E2), which in turn binds Rsp5 to allow modification. Evidence for folding of the CTD compatible with this mechanism of communication between distant sites is provided. These data reveal the specificity and mechanism of RNAPII ubiquitylation and demonstrate that Us can play a crucial role in substrate recognition.	Canc Res UK London Res Inst, Mech & Transcript Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cancer Research UK; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Mech & Transcript Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk	Sigurdsson, Stefan/L-9820-2015	Sigurdsson, Stefan/0000-0002-5284-0058; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Svejstrup, Jesper/0000-0003-4964-6147; Tempst, Paul/0000-0002-6680-3987				Archambault J, 1998, J BACTERIOL, V180, P2590, DOI 10.1128/JB.180.10.2590-2598.1998; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Boeger H, 2005, FEBS LETT, V579, P899, DOI 10.1016/j.febslet.2004.11.027; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; LI Y, 1994, P NATL ACAD SCI USA, V91, P2362, DOI 10.1073/pnas.91.6.2362; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	27	59	60	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					57	68		10.1016/j.cell.2007.01.046	http://dx.doi.org/10.1016/j.cell.2007.01.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418786	Bronze			2022-12-24	WOS:000245661100011
J	Passino, MA; Adams, RA; Sikorski, SL; Akassoglou, K				Passino, Melissa A.; Adams, Ryan A.; Sikorski, Shoana L.; Akassoglou, Katerina			Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75(NTR)	SCIENCE			English	Article							HEPATOCYTE GROWTH-FACTOR; PLASMINOGEN DEFICIENCY; LIVER-REGENERATION; ACTIN CYTOSKELETON; SIGNALING PATHWAYS; APOPTOSIS; RAT; P75; RHO; EXPRESSION	Differentiation of hepatic stellate cells (HSCs) to extracellular matrix- and growth factor-producing cells supports liver regeneration through promotion of hepatocyte proliferation. We show that the neurotrophin receptor p75(NTR), a tumor necrosis factor receptor superfamily member expressed in HSCs after fibrotic and cirrhotic liver injury in humans, is a regulator of liver repair. In mice, depletion of p75(NTR) exacerbated liver pathology and inhibited hepatocyte proliferation in vivo. p75(NTR-/-) HSCs failed to differentiate to myofibroblasts and did not support hepatocyte proliferation. Moreover, inhibition of p75(NTR) signaling to the small guanosine triphosphatase Rho resulted in impaired HSC differentiation. Our results identify signaling from p75(NTR) to Rho as a mechanism for the regulation of HSC differentiation to regeneration-promoting cells that support hepatocyte proliferation in the diseased liver.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Akassoglou, K (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	akass@ucsd.edu		Akassoglou, Katerina/0000-0002-2632-1465	NIGMS NIH HHS [5T32-GM07752] Funding Source: Medline; NINDS NIH HHS [NS051470, P30-NS047101] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS051470] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balabaud C, 2004, J HEPATOL, V40, P1023, DOI 10.1016/j.jhep.2004.04.003; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; HU ZY, 1993, AM J PATHOL, V142, P1823; Kato M, 1999, J HEPATOL, V31, P91, DOI 10.1016/S0168-8278(99)80168-8; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; LOMENHOERTH C, 1995, J NEUROCHEM, V64, P1780; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Majdan M, 1997, J NEUROSCI, V17, P6988; Ng VL, 2001, J HEPATOL, V35, P781, DOI 10.1016/S0168-8278(01)00212-4; Novo E, 2006, GUT, V55, P1174, DOI 10.1136/gut.2005.082701; Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Uyama N, 2002, J HEPATOL, V36, P590, DOI 10.1016/S0168-8278(02)00023-5; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Zampieri N, 2006, BIOCHEM SOC T, V34, P607, DOI 10.1042/BST0340607	28	139	152	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1853	1856		10.1126/science.1137603	http://dx.doi.org/10.1126/science.1137603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395831				2022-12-24	WOS:000245280100046
J	Kim, TH; Abdullaev, ZK; Smith, AD; Ching, KA; Loukinov, DI; Green, RD; Zhang, MQ; Lobanenkov, VV; Ren, B				Kim, Tae Hoon; Abdullaev, Ziedulla K.; Smith, Andrew D.; Ching, Keith A.; Loukinov, Dmitri I.; Green, Roland D.; Zhang, Michael Q.; Lobanenkov, Victor V.; Ren, Bing			Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome	CELL			English	Article							ENHANCER-BLOCKING ACTIVITY; TRANSCRIPTION-FACTOR; X-INACTIVATION; WIDE ANALYSIS; H19 GENE; METHYLATION; BOUNDARIES; PROMOTER; SEQUENCE; RECEPTOR	Insulator elements affect gene expression by preventing the spread of heterochromatin and restricting transcriptional enhancers from activation of unrelated promoters. In vertebrates, insulator's function requires association with the CCCTC-binding factor (CTCF), a protein that recognizes long and diverse nucleotide sequences. While insulators are critical in gene regulation, only a few have been reported. Here, we describe 13,804 CTCF-binding sites in potential insulators of the human genome, discovered experimentally in primary human fibroblasts. Most of these sequences are located far from the transcriptional start sites, with their distribution strongly correlated with genes. The majority of them fit to a consensus motif highly conserved and suitable for predicting possible insulators driven by CTCF in other vertebrate genomes. In addition, CTCF localization is largely invariant across different cell types. Our results provide a resource for investigating insulator function and possible other general and evolutionarily conserved activities of CTCF sites.	Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; NIAID, Rockville, MD 20852 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NimbleGen Syst Inc, Madison, WI 53711 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cold Spring Harbor Laboratory; Roche Holding; Roche NimbleGen	Kim, TH (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St,SHMl 142B,POB 208005, New Haven, CT 06120 USA.	taehoon.kim@yale.edu; biren@ucsd.edu	Smith, Andrew D./G-4104-2013; Lobanenkov, Victor V./AGQ-8903-2022; Lobanenkov, Victor/ABD-5710-2021	Smith, Andrew D./0000-0002-3337-1970; Kim, Tae Hoon/0000-0003-3950-7557; Lobanenkov, Victor/0000-0001-6665-3635	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R21CA116365-01, R21 CA116365, R33CA105829, F32CA108313, F32 CA108313, R33 CA105829] Funding Source: Medline; NCRR NIH HHS [P41 RR 08605, P41 RR008605] Funding Source: Medline; NHGRI NIH HHS [U01 HG003151, R01 HG001696, U01HG003151, HG001696] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA108313, R21CA116365, R33CA105829] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696, U01HG003151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000860] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Dunn KL, 2003, BIOCHEM CELL BIOL, V81, P161, DOI 10.1139/o03-052; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 1998, GENE CHROMOSOME CANC, V22, P26, DOI 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9; Gerasimova TI, 2001, ANNU REV GENET, V35, P193, DOI 10.1146/annurev.genet.35.102401.090349; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Jeong S, 2004, NAT GENET, V36, P1036, DOI 10.1038/ng1004-1036; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith DR, 2005, WORD IMAGE, V21, P1, DOI 10.1080/0266628052000307175; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	53	762	790	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1231	1245		10.1016/j.cell.2006.12.048	http://dx.doi.org/10.1016/j.cell.2006.12.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382889	Green Accepted, Bronze			2022-12-24	WOS:000245396200026
J	Bazigou, E; Apitz, H; Johansson, J; Loren, CE; Hirst, EMA; Chen, PL; Palmer, RH; Salecker, I				Bazigou, Eleni; Apitz, Holger; Johansson, Jana; Loren, Christina E.; Hirst, Elizabeth M. A.; Chen, Pei-Ling; Palmer, Ruth H.; Salecker, Iris			Anterograde jelly belly and Alk receptor tyrosine kinase signaling mediates retinal axon targeting in Drosophila	CELL			English	Article							ANAPLASTIC LYMPHOMA KINASE; NON-HODGKINS-LYMPHOMA; VISUAL-SYSTEM; GLIAL-CELLS; NERVOUS-SYSTEM; SYNAPTIC SPECIFICITY; NEURONAL DEVELOPMENT; PHOTORECEPTOR AXONS; LAYER-SELECTION; ROLLING PEBBLES	Anaplastic lymphoma kinase (Alk) has been proposed to regulate neuronal development based on its expression pattern in vertebrates and invertebrates; however, its function in vivo is unknown. We demonstrate that Alk and its ligand Jelly belly (Jeb) play a central role as an anterograde, signaling pathway mediating neuronal circuit assembly in the Drosophila visual system. Alk is expressed and required in target neurons in the optic lobe, whereas Jeb is primarily generated by photoreceptor axons and functions in the eye to control target selection of R1-R6 axons in the lamina and R8 axons in the medulla. Impaired Jeb/Alk function affects layer-specific expression of three cell-adhesion molecules, Dumbfounded/Kirre, Roughest/IrreC, and Flamingo, in the medulla. Moreover, loss of flamingo in target neurons causes some R8-axon targeting errors observed in jeb and Alk mosaic animals. Together, these findings suggest that Jeb/Alk signaling helps R-cell axons to shape their environment for target recognition.	Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden; Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Umea University; MRC National Institute for Medical Research; Stanford University	Palmer, RH (corresponding author), Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden.	ruth.palmer@ucmp.umu.se; isaleck@nimr.mrc.ac.uk	Chen, Phang-Lang/J-5031-2013; Salecker, Iris/V-1228-2018	Apitz, Holger/0000-0003-0551-2403; Salecker, Iris/0000-0003-3775-7763	MRC [MC_U117581332] Funding Source: UKRI; Medical Research Council [MC_U117581332] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GONG QH, 1995, NEURON, V14, P91, DOI 10.1016/0896-6273(95)90243-0; HALTER DA, 1995, DEVELOPMENT, V121, P317; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Huang Z, 1998, DEVELOPMENT, V125, P3753; Hurley SP, 2006, J COMP NEUROL, V495, P202, DOI 10.1002/cne.20887; Ito K, 1997, DEVELOPMENT, V124, P761; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Mast JD, 2006, SEMIN CELL DEV BIOL, V17, P42, DOI 10.1016/j.semcdb.2005.11.004; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Meinertzhagen Ian A., 1993, P1363; Meiniel A, 2001, MICROSC RES TECHNIQ, V52, P484, DOI 10.1002/1097-0029(20010301)52:5<484::AID-JEMT1034>3.0.CO;2-0; Menon SD, 2005, J CELL BIOL, V169, P909, DOI 10.1083/jcb.200501126; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; MISMER D, 1987, GENETICS, V116, P565; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oh SW, 2003, GENETICS, V163, P195; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; RAYMOND PA, 1983, J NEUROSCI, V3, P1092; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Souttou B, 2001, J BIOL CHEM, V276, P9526, DOI 10.1074/jbc.M007333200; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Stute C, 2004, DEVELOPMENT, V131, P743, DOI 10.1242/dev.00972; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weiss JB, 2001, CELL, V107, P387, DOI 10.1016/S0092-8674(01)00540-2; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Ye B, 2005, TRENDS CELL BIOL, V15, P64, DOI 10.1016/j.tcb.2004.12.003; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	66	111	113	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					961	975		10.1016/j.cell.2007.02.024	http://dx.doi.org/10.1016/j.cell.2007.02.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350579	Bronze			2022-12-24	WOS:000245073400019
J	Saxena, R; Voight, BF; Lyssenko, V; Burtt, NP; de Bakker, PIW; Chen, H; Roix, JJ; Kathiresan, S; Hirschhorn, JN; Daly, MJ; Hughes, TE; Groop, L; Altshuler, D; Almgren, P; Florez, JC; Meyer, J; Ardlie, K; Bostrom, KB; Isomaa, B; Lettre, G; Lindblad, U; Lyon, HN; Melander, O; Newton-Cheh, C; Nilsson, P; Orho-Melander, M; Rastam, L; Speliotes, EK; Taskinen, MR; Tuomi, T; Guiducci, C; Berglund, A; Carlson, J; Gianniny, L; Hackett, R; Hall, L; Holmkvist, J; Laurila, E; Sjogren, M; Sterner, M; Surti, A; Svensson, M; Svensson, M; Tewhey, R; Blumenstiel, B; Parkin, M; DeFelice, M; Barry, R; Brodeur, W; Camarata, J; Chia, N; Fava, M; Gibbons, J; Handsaker, B; Healy, C; Nguyen, K; Gates, C; Sougnez, C; Gage, D; Nizzari, M; Gabriel, SB; Chirn, GW; Ma, QC; Parikh, H; Richardson, D; Ricke, D; Purcell, S				Saxena, Richa; Voight, Benjamin F.; Lyssenko, Valeriya; Burtt, Noel P.; de Bakker, Paul I. W.; Chen, Hong; Roix, Jeffrey J.; Kathiresan, Sekar; Hirschhorn, Joel N.; Daly, Mark J.; Hughes, Thomas E.; Groop, Leif; Altshuler, David; Almgren, Peter; Florez, Jose C.; Meyer, Joanne; Ardlie, Kristin; Bostroem, Kristina Bengtsson; Isomaa, Bo; Lettre, Guillaume; Lindblad, Ulf; Lyon, Helen N.; Melander, Olle; Newton-Cheh, Christopher; Nilsson, Peter; Orho-Melander, Marju; Rastam, Lennart; Speliotes, Elizabeth K.; Taskinen, Marja-Riitta; Tuomi, Tiinamaija; Guiducci, Candace; Berglund, Anna; Carlson, Joyce; Gianniny, Lauren; Hackett, Rachel; Hall, Liselotte; Holmkvist, Johan; Laurila, Esa; Sjoegren, Marketa; Sterner, Maria; Surti, Aarti; Svensson, Margareta; Svensson, Malin; Tewhey, Ryan; Blumenstiel, Brendan; Parkin, Melissa; DeFelice, Matthew; Barry, Rachel; Brodeur, Wendy; Camarata, Jody; Chia, Nancy; Fava, Mary; Gibbons, John; Handsaker, Bob; Healy, Claire; Nguyen, Kieu; Gates, Casey; Sougnez, Carrie; Gage, Diane; Nizzari, Marcia; Gabriel, Stacey B.; Chirn, Gung-Wei; Ma, Qicheng; Parikh, Hemang; Richardson, Delwood; Ricke, Darrell; Purcell, Shaun		Diabet Genetics Initiative Broad In; Novartis Inst BioMedical Res	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels	SCIENCE			English	Article							RNA-BINDING PROTEIN; MACULAR DEGENERATION; RISK LOCI; OVEREXPRESSION; SUSCEPTIBILITY; GLUCOKINASE; POPULATION; VARIANTS; GENE; AGE	New strategies for prevention and treatment of type 2 diabetes (T2D) require improved insight into disease etiology. We analyzed 386,731 common single-nucleotide polymorphisms (SNPs) in 1464 patients with T2D and 1467 matched controls, each characterized for measures of glucose metabolism, lipids, obesity, and blood pressure. With collaborators (FUSION and WTCCC/UKT2D), we identified and confirmed three loci associated with T2D - in a noncoding region near CDKN2A and CDKN2B, in an intron of IGF2BP2, and an intron of CDKAL1 - and replicated associations near HHEX and in SLC30A8 found by a recent whole-genome association study. We identified and confirmed association of a SNP in an intron of glucokinase regulatory protein (GCKR) with serum triglycerides. The discovery of associated variants in unsuspected genes and outside coding regions illustrates the ability of genome-wide association studies to provide potentially important clues to the pathogenesis of common diseases.	Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Diabet & Endocrinol Res Unit, Malmo, Sweden; Novartis Inst Biomed Res, Diabet & Metab Dis Area, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Univ Helsinki, Univ Helsinki Hosp, Dept Med, Helsinki, Finland; Skaraborg Inst, Skovde, Sweden; Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland; Folkhalsan Res Ctr, Helsinki, Finland; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Community Med Res Unit, Malmo, Sweden; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Med Res Unit, Malmo, Sweden; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Lund University; Skane University Hospital; Novartis; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hughes, TE (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02142 USA.	thomase.hughes@novartis.com; leif.groop@med.lu.se; altshuler@molbio.mgh.harvard.edu	Altshuler, David M/A-4476-2009; Voight, Benjamin/F-1775-2011; Taskinen, Marja-Riitta/AAN-5432-2020; de Bakker, Paul IW/B-8730-2009; Ricke, Darrell O./GNP-5137-2022; Saxena, Richa/AAG-7279-2020; Daly, Mark J/B-2453-2017; Handsaker, Bob/AAX-9095-2021; Parikh, Hemang/AAY-7174-2021	Altshuler, David M/0000-0002-7250-4107; Taskinen, Marja-Riitta/0000-0002-6229-3588; de Bakker, Paul IW/0000-0001-7735-7858; Daly, Mark J/0000-0002-0949-8752; Handsaker, Bob/0000-0002-3128-3547; Voight, Benjamin/0000-0002-6205-9994; Melander, Olle/0000-0002-2581-484X; Saxena, Richa/0000-0003-2233-1065; Ricke, Darrell/0000-0002-2842-2809; Tuomi, Tiinamaija/0000-0002-8306-6202	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK067288, F32DK079466, K23DK080145, K23DK065978] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG004171] Funding Source: Medline; NHLBI NIH HHS [K23-HL083102] Funding Source: Medline; NIDDK NIH HHS [K23 DK080145, K23 DK067288, F32 DK079466, K23 DK080145-01, K23 DK65978-04, F32 DK079466-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; KIMURA M, 1973, GENETICS, V75, P199; KOLOWSKI IK, 2006, AM J HUM GENET, V78, P410; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; Spagnoli FM, 2006, DEV BIOL, V292, P442, DOI 10.1016/j.ydbio.2006.01.022; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wagner M, 2003, GASTROENTEROLOGY, V124, P1901, DOI 10.1016/S0016-5085(03)00402-5; *WELLC TRUST CAS C, IN PRESS NATURE; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	2243	2333	2	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1331	1336		10.1126/science.1142358	http://dx.doi.org/10.1126/science.1142358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17463246				2022-12-24	WOS:000246885600049
J	Kim, SY; Ferrell, JE				Kim, Sun Young; Ferrell, James E., Jr.			Substrate competition as a source of ultrasensitivity in the inactivation of Wee1	CELL			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE REGULATION; LAEVIS EGG EXTRACTS; PHOSPHORYLATES CDC2; SWITCH-LIKE; MULTISITE PHOSPHORYLATION; DUAL PHOSPHORYLATION; BIOCHEMICAL SYSTEMS; BIOLOGICAL-SYSTEMS; INHIBITORY KINASE	The mitotic regulators Wee1 and Cdk1 can inactivate each other through inhibitory phosphorylations. This double-negative feedback loop is part of a bistable trigger that makes the transition into mitosis abrupt and decisive. To generate a bistable response, some component of a double-negative feedback loop must exhibit an ultrasensitive response to its upstream regulator. Here, we experimentally demonstrate that Wee1 exhibits a highly ultrasensitive response to Cdk1. Several mechanisms can, in principle, give rise to ultrasensitivity, including zero-order effects, multisite phosphorylation, and competition mechanisms. We found that the ultrasensitivity in the inactivation of Wee1 arises mainly through two competition mechanisms: competition between two sets of phosphorylation sites in Wee1 and between Wee1 and other high-affinity Cdk1 targets. Based on these findings, we were able to reconstitute a highly ultrasensitive Wee1 response with purified components. Competition provides a simple way of generating the equivalent of a highly cooperative allosteric response.	Stanford Univ, Sch Med, Ctr Clin Sci Res, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Ctr Clin Sci Res, Dept Chem & Syst Biol, 269 W Campus Dr,Room 3155, Stanford, CA 94305 USA.	james.ferrell@stanford.edu	Kim, Sun/GSN-4867-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46383] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Chen MZ, 1997, MOL CELL BIOL, V17, P1904, DOI 10.1128/MCB.17.4.1904; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Fattaey A, 1997, Prog Cell Cycle Res, V3, P233; Ferrell JE, 1998, TRENDS BIOCHEM SCI, V23, P461, DOI 10.1016/S0968-0004(98)01316-4; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Georgi AB, 2002, CURR BIOL, V12, P105, DOI 10.1016/S0960-9822(01)00662-5; GOLDBETER A, 1982, Q REV BIOPHYS, V15, P555, DOI 10.1017/S0033583500003449; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; MEINKE MH, 1986, P NATL ACAD SCI USA, V83, P2865, DOI 10.1073/pnas.83.9.2865; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NOVAK B, 1993, J CELL SCI, V106, P1153; PARKER LL, 1995, P NATL ACAD SCI USA, V92, P9638, DOI 10.1073/pnas.92.21.9638; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Patra D, 1996, GENE DEV, V10, P1503, DOI 10.1101/gad.10.12.1503; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shou WY, 1996, MOL BIOL CELL, V7, P457, DOI 10.1091/mbc.7.3.457; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; SU JY, 1995, P NATL ACAD SCI USA, V92, P10187, DOI 10.1073/pnas.92.22.10187; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Thomas R, 1981, SPRINGER SERIES SYNE, V9, P180; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Tyson JJ, 1996, TRENDS BIOCHEM SCI, V21, P89; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; WALTER CF, 1970, J THEOR BIOL, V27, P259, DOI 10.1016/0022-5193(70)90141-4; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Wells NJ, 1999, J CELL SCI, V112, P3361	60	182	183	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1133	1145		10.1016/j.cell.2007.01.039	http://dx.doi.org/10.1016/j.cell.2007.01.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382882	Bronze			2022-12-24	WOS:000245396200019
J	Sutter, NB; Bustamante, CD; Chase, K; Gray, MM; Zhao, KY; Zhu, L; Padhukasahasram, B; Karlins, E; Davis, S; Jones, PG; Quignon, P; Johnson, GS; Parker, HG; Fretwell, N; Mosher, DS; Lawler, DF; Satyaraj, E; Nordborg, M; Lark, KG; Wayne, RK; Ostrander, EA				Sutter, Nathan B.; Bustamante, Carlos D.; Chase, Kevin; Gray, Melissa M.; Zhao, Keyan; Zhu, Lan; Padhukasahasram, Badri; Karlins, Eric; Davis, Sean; Jones, Paul G.; Quignon, Pascale; Johnson, Gary S.; Parker, Heidi G.; Fretwell, Neale; Mosher, Dana S.; Lawler, Dennis F.; Satyaraj, Ebenezer; Nordborg, Magnus; Lark, K. Gordon; Wayne, Robert K.; Ostrander, Elaine A.			A single IGF1 allele is a major determinant of small size in dogs	SCIENCE			English	Article							BODY-SIZE; WILD CANIDS; GROWTH; MORPHOLOGY; ORIGINS	The domestic dog exhibits greater diversity in body size than any other terrestrial vertebrate. We used a strategy that exploits the breed structure of dogs to investigate the genetic basis of size. First, through a genome-wide scan, we identified a major quantitative trait locus (QTL) on chromosome 15 influencing size variation within a single breed. Second, we examined genetic variation in the 15-megabase interval surrounding the QTL in small and giant breeds and found marked evidence for a selective sweep spanning a single gene (IGF1), encoding insulin-like growth factor 1. A single IGF1 single-nucleotide polymorphism haplotype is common to all small breeds and nearly absent from giant breeds, suggesting that the same causal sequence variant is a major contributor to body size in all small dogs.	NHGRI, Bethesda, MD 20892 USA; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Calif Los Angeles, Dept Ecol & Environm Biol, Los Angeles, CA 90095 USA; Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; WALTHAM Ctr Pet Nutr, Melton Mowbray LE14 4RT, Leics, England; Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; Nestle Res Ctr NRC STL, St Louis, MO 63164 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cornell University; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of Southern California; Mars; WALTHAM Petcare Science Institute; University of Missouri System; University of Missouri Columbia	Ostrander, EA (corresponding author), NHGRI, Bldg 50,Room 5349,50 S Dr MSC 8000, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov	Parker, Heidi/C-6954-2008; Davis, Sean/AAD-1801-2021; Fiumefreddo, Andrea/T-2977-2019; Gray, Melissa/B-5025-2008	Davis, Sean/0000-0002-8991-6458; Gray, Melissa/0000-0002-1756-5468; Ostrander, Elaine/0000-0001-6075-9738; Bustamante, Carlos D./0000-0002-4187-7920; Karlins, Eric/0000-0002-7541-393X; Nordborg, Magnus/0000-0001-7178-9748; Parker, Heidi G./0000-0002-9707-6380; Zhao, Keyan/0000-0002-8800-2304	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536, P50HG002790, Z01HG200325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063056] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG002790, 5T32 HG002536] Funding Source: Medline; NIGMS NIH HHS [R01 GM063056, R01 GM063056-06] Funding Source: Medline; PHS HHS [063056] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Chase K, 2005, GENOME RES, V15, P1820, DOI 10.1101/gr.3712705; Chase K, 2002, P NATL ACAD SCI USA, V99, P9930, DOI 10.1073/pnas.152333099; Cohen P, 2006, HORM RES, V65, P3, DOI 10.1159/000090640; EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V106, P448, DOI 10.1530/acta.0.1060448; Epstein H., 1971, ORIGIN DOMESTIC ANIM; Favier RP, 2001, J ENDOCRINOL, V170, P479, DOI 10.1677/joe.0.1700479; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Olsen S.J., 1985, ORIGINS DOMESTIC DOG; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Saetre P, 2004, MOL BRAIN RES, V126, P198, DOI 10.1016/j.molbrainres.2004.05.003; Sampson J, 2006, COLD SPRING HARB MON, V44, P19; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; TCHERNOV E, 1991, J ANTHROPOL ARCHAEOL, V10, P54, DOI 10.1016/0278-4165(91)90021-O; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wang W, 2005, GENOME RES, V15, P1798, DOI 10.1101/gr.3765505; WAYNE RK, 1986, J ZOOL, V210, P381; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; WAYNE RK, 1986, J MORPHOL, V187, P301, DOI 10.1002/jmor.1051870304; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Woods KA, 1997, ACTA PAEDIATR, V86, P39	28	465	485	1	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					112	115		10.1126/science.1137045	http://dx.doi.org/10.1126/science.1137045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412960	Green Accepted			2022-12-24	WOS:000245470500044
J	Tan, X; Calderon-Villalobos, LIA; Sharon, M; Zheng, CX; Robinson, CV; Estelle, M; Zheng, N				Tan, Xu; Calderon-Villalobos, Luz Irina A.; Sharon, Michal; Zheng, Changxue; Robinson, Carol V.; Estelle, Mark; Zheng, Ning			Mechanism of auxin perception by the TIR1 ubiquitin ligase	NATURE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; GENE FAMILY-MEMBERS; BOX PROTEIN TIR1; INOSITOL HEXAKISPHOSPHATE; AUX/IAA PROTEINS; PLANT-GROWTH; DEGRADATION; PATHWAY	Auxin is a pivotal plant hormone that controls many aspects of plant growth and development. Perceived by a small family of F-box proteins including transport inhibitor response 1 (TIR1), auxin regulates gene expression by promoting SCF ubiquitin-ligase-catalysed degradation of the Aux/IAA transcription repressors, but how the TIR1 F-box protein senses and becomes activated by auxin remains unclear. Here we present the crystal structures of the Arabidopsis TIR1 - ASK1 complex, free and in complexes with three different auxin compounds and an Aux/IAA substrate peptide. These structures show that the leucine-rich repeat domain of TIR1 contains an unexpected inositol hexakisphosphate co-factor and recognizes auxin and the Aux/IAA polypeptide substrate through a single surface pocket. Anchored to the base of the TIR1 pocket, auxin binds to a partially promiscuous site, which can also accommodate various auxin analogues. Docked on top of auxin, the Aux/IAA substrate peptide occupies the rest of the TIR1 pocket and completely encloses the hormone-binding site. By filling in a hydrophobic cavity at the protein interface, auxin enhances the TIR1 - substrate interactions by acting as a 'molecular glue'. Our results establish the first structural model of a plant hormone receptor.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of Washington; University of Washington Seattle; University of Cambridge; Indiana University System; Indiana University Bloomington	Zheng, N (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Tan, Xu/E-7170-2011; Estelle, Mark/ABD-6742-2021; Villalobos, Luz Irina A Calderón/L-5876-2016	Tan, Xu/0000-0003-4861-4573; Sharon, Michal/0000-0003-3933-0595; robinson, carol/0000-0001-7829-5505; Calderon Villalobos, Luz Irina A./0000-0002-6093-1478				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2004, TRENDS PLANT SCI, V9, P302, DOI 10.1016/j.tplants.2004.04.003; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; FARRIMOND JA, 1978, NATURE, V274, P401, DOI 10.1038/274401a0; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hoy M, 2002, P NATL ACAD SCI USA, V99, P6773, DOI 10.1073/pnas.102157499; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONSSON A, 1961, ENCY PLANT PHYSL, V14, P959; KAETHNER TM, 1977, NATURE, V267, P19, DOI 10.1038/267019a0; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; KOBE B, 1993, J MOL BIOL, V231, P137, DOI 10.1006/jmbi.1993.1263; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	43	1054	1137	12	246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					640	645		10.1038/nature05731	http://dx.doi.org/10.1038/nature05731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410169				2022-12-24	WOS:000245438300033
J	Zhang, F; Wang, LP; Brauner, M; Liewald, JF; Kay, K; Watzke, N; Wood, PG; Bamberg, E; Nagel, G; Gottschalk, A; Deisseroth, K				Zhang, Feng; Wang, Li-Ping; Brauner, Martin; Liewald, Jana F.; Kay, Kenneth; Watzke, Natalie; Wood, Phillip G.; Bamberg, Ernst; Nagel, Georg; Gottschalk, Alexander; Deisseroth, Karl			Multimodal fast optical interrogation of neural circuitry	NATURE			English	Article							CHLORIDE PUMP HALORHODOPSIN; GREEN-ALGAE; IN-VIVO; MAMMALIAN NEURONS; EXCITABLE CELLS; REMOTE-CONTROL; ION CHANNELS; LIGHT; ACTIVATION; CHANNELRHODOPSIN-2	Our understanding of the cellular implementation of systems-level neural processes like action, thought and emotion has been limited by the availability of tools to interrogate specific classes of neural cells within intact, living brain tissue. Here we identify and develop an archaeal light-driven chloride pump (NpHR) from Natronomonas pharaonis for temporally precise optical inhibition of neural activity. NpHR allows either knockout of single action potentials, or sustained blockade of spiking. NpHR is compatible with ChR2, the previous optical excitation technology we have described, in that the two opposing probes operate at similar light powers but with well-separated action spectra. NpHR, like ChR2, functions in mammals without exogenous cofactors, and the two probes can be integrated with calcium imaging in mammalian brain tissue for bidirectional optical modulation and readout of neural activity. Likewise, NpHR and ChR2 can be targeted together to Caenorhabditis elegans muscle and cholinergic motor neurons to control locomotion bidirectionally. NpHR and ChR2 form a complete system for multimodal, high-speed, genetically targeted, all-optical interrogation of living neural circuits.	Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Goethe Univ Frankfurt, Frankfurt Bioctr N220, Inst Biochem, D-60438 Frankfurt, Germany; Goethe Univ Frankfurt, Frankfurt Bioctr N220, Inst Biophys Chem, Dept Biochem Chem & Pharm, D-60438 Frankfurt, Germany; Max Planck Inst Biophys, D-60438 Frankfurt, Germany; Univ Wuezburg, D-97082 Wuezburg, Germany	Stanford University; Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Gottschalk, Alexander/D-3155-2011; Wang, Liping/B-2827-2012; Wang, Liping/ABF-6317-2020; Macrae, Rhiannon/AAX-1536-2020; Ritter, Stefanie L/D-9312-2012	Gottschalk, Alexander/0000-0002-1197-6119; Wang, Liping/0000-0001-6893-3809; Nagel, Georg/0000-0001-8174-8712				ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brun S, 2003, MOL THER, V7, P782, DOI 10.1016/S1525-0016(03)00097-2; Chambers JJ, 2006, J NEUROPHYSIOL, V96, P2792, DOI 10.1152/jn.00318.2006; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; DUSCHL A, 1988, J BIOL CHEM, V263, P17016; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; GRYGORCZYK R, 1989, METHOD ENZYMOL, V173, P453; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; HEGEMANN P, 1985, BIOCHIM BIOPHYS ACTA, V819, P195, DOI 10.1016/0005-2736(85)90174-9; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Isles AR, 2001, J NEUROBIOL, V47, P183, DOI 10.1002/neu.1026; Jensen O, 1996, LEARN MEMORY, V3, P257, DOI 10.1101/lm.3.2-3.257; Johns DC, 1999, J NEUROSCI, V19, P1691; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	48	1248	1345	8	331	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					633	U4		10.1038/nature05744	http://dx.doi.org/10.1038/nature05744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410168				2022-12-24	WOS:000245438300032
J	Dion, MF; Kaplan, T; Kim, M; Buratowski, S; Friedman, N; Rando, OJ				Dion, Michael F.; Kaplan, Tommy; Kim, Minkyu; Buratowski, Stephen; Friedman, Nir; Rando, Oliver J.			Dynamics of replication-independent histone turnover in budding yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; PHO5 PROMOTER; IN-VIVO; CHROMATIN; BOUNDARIES; H2A.Z; MARKS; EUCHROMATIN; ELONGATION	Chromatin plays roles in processes governed by different time scales. To assay the dynamic behavior of chromatin in living cells, we used genomic tiling arrays to measure histone H3 turnover in G1-arrested Saccharomyces cerevisiae at single-nucleosome resolution over 4% of the genome, and at lower (similar to 265 base pair) resolution over the entire genome. We find that nucleosomes at promoters are replaced more rapidly than at coding regions and that replacement rates over coding regions correlate with polymerase density. In addition, rapid histone turnover is found at known chromatin boundary elements. These results suggest that rapid histone turnover serves to functionally separate chromatin domains and prevent spread of histone states.	Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Mol Genet & Biotechnol, Fac Med, IL-91120 Jerusalem, Israel; Harvard Univ, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Oliver.Rando@umassmed.edu	Kaplan, Tommy/T-2528-2017; Friedman, Nir/H-9692-2012; Kim, Minkyu/AAZ-8535-2021	Kaplan, Tommy/0000-0002-1892-5461; Friedman, Nir/0000-0002-9678-3550; Kim, Minkyu/0000-0001-9317-1658; Dion, Michael/0000-0002-0434-4236				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chiu YH, 2003, GENETICS, V165, P115; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Linger J, 2006, EUKARYOT CELL, V5, P1780, DOI 10.1128/EC.00202-06; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Schermer UJ, 2005, MOL CELL, V19, P279, DOI 10.1016/j.molcel.2005.05.028; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Yu Q, 2003, NUCLEIC ACIDS RES, V31, P1224, DOI 10.1093/nar/gkg200; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	26	413	420	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1405	1408		10.1126/science.1134053	http://dx.doi.org/10.1126/science.1134053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347438				2022-12-24	WOS:000244752200032
J	Lovering, AL; de Castro, LH; Lim, D; Strynadka, NCJ				Lovering, Andrew L.; de Castro, Liza H.; Lim, Daniel; Strynadka, Natalie C. J.			Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis	SCIENCE			English	Article							KINETIC CHARACTERIZATION; CRYSTAL-STRUCTURE; GLYCOSYLTRANSFERASE MODULE; STAPHYLOCOCCUS-AUREUS; VANCOMYCIN RESISTANCE; BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; PROTEINS; PBP1B	Peptidoglycan glycosyltransferases (GTs) catalyze the polymerization step of cell-wall biosynthesis, are membrane-bound, and are highly conserved across all bacteria. Long considered the "holy grail" of antibiotic research, they represent an essential and easily accessible drug target for antibiotic-resistant bacteria, including methicillin-resistant Staphylococcus aureus. We have determined the 2.8 angstrom structure of a bifunctional cell-wall cross-linking enzyme, including its transpeptidase and GT domains, both unliganded and complexed with the substrate analog moenomycin. The peptidoglycan GTs adopt a fold distinct from those of other GT classes. The structures give insight into critical features of the catalytic mechanism and key interactions required for enzyme inhibition.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V5Z 1M9, Canada.	natalie@byron.biochem.ubc.ca		Lovering, Andrew/0000-0002-1856-7975				Barrett D, 2005, J BACTERIOL, V187, P2215, DOI 10.1128/JB.187.6.2215-2217.2005; Barrett DS, 2004, BIOCHEMISTRY-US, V43, P12375, DOI 10.1021/bi049142m; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Butaye P, 2001, ANTIMICROB AGENTS CH, V45, P1374, DOI 10.1128/AAC.45.5.1374-1378.2001; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Evrard C, 1998, J MOL BIOL, V276, P151, DOI 10.1006/jmbi.1997.1499; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Goldman RC, 2000, CURR MED CHEM, V7, P801; Halliday J, 2006, BIOCHEM PHARMACOL, V71, P957, DOI 10.1016/j.bcp.2005.10.030; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Leung AKW, 2001, BIOCHEMISTRY-US, V40, P5665, DOI 10.1021/bi0028035; Ritzeler O, 1997, TETRAHEDRON, V53, P1675, DOI 10.1016/S0040-4020(96)01115-5; Schwartz B, 2002, BIOCHEMISTRY-US, V41, P12552, DOI 10.1021/bi026205x; Terrak M, 1999, MOL MICROBIOL, V34, P350, DOI 10.1046/j.1365-2958.1999.01612.x; Terrak M, 2006, J BACTERIOL, V188, P2528, DOI 10.1128/JB.188.7.2528-2532.2006; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; Welzel P, 2005, CHEM REV, V105, P4610, DOI 10.1021/cr040634e; WELZEL P, 1987, TETRAHEDRON, V43, P585, DOI 10.1016/S0040-4020(01)89992-0	18	222	233	5	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 9	2007	315	5817					1402	1405		10.1126/science.1136611	http://dx.doi.org/10.1126/science.1136611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17347437				2022-12-24	WOS:000244752200031
J	Lamsa, KP; Heeroma, JH; Somogyi, P; Rusakov, DA; Kullmann, DM				Lamsa, Karri P.; Heeroma, Joost H.; Somogyi, Peter; Rusakov, Dmitri A.; Kullmann, Dimitri M.			Anti-Hebbian long-term potentiation in the hippocampal feedback inhibitory circuit	SCIENCE			English	Article							AMPA RECEPTORS; INWARD RECTIFICATION; THETA OSCILLATIONS; IN-VIVO; INTERNEURONS; EXPRESSION; ACTIVATION; SYNAPSES; INPUT; MODEL	Long-term potentiation (LTP), which approximates Hebb's postulate of associative learning, typically requires depolarization-dependent glutamate receptors of the NMDA (N-methyl-D-aspartate) subtype. However, in some neurons, LTP depends instead on calcium-permeable AMPA-type receptors. This is paradoxical because intracellular polyamines block such receptors during depolarization. We report that LTP at synapses on hippocampal interneurons mediating feedback inhibition is "anti-Hebbian": It is induced by presynaptic activity but prevented by postsynaptic depolarization. Anti-Hebbian LTP may occur in interneurons that are silent during periods of intense pyramidal cell firing, such as sharp waves, and lead to their altered activation during theta activity.	UCL, Inst Neurol, London WC1N 3BG, England; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3HT, England	University of London; University College London; University of Oxford	Kullmann, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Lamsa, Karri/T-2025-2019; Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021; Heeroma, Joost/AFI-8727-2022; Heeroma, Joost/AAF-4310-2022; Heeroma, Joost/C-1749-2008	Kullmann, Dimitri M/0000-0001-6696-3545; Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Lamsa, Karri/0000-0002-4609-1337	MRC [G0501424, G116/147, G0400627, MC_U138135973, G0600368] Funding Source: UKRI; Medical Research Council [G116/147, MC_U138135973, G0400627(76527), G0400627, G0600368(77987), G0600368, G0501424, G0400627(71256)] Funding Source: Medline; Wellcome Trust [071179] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Hebb Donald O., 1949, ORG BEHAV; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Laezza F, 2004, J NEUROPHYSIOL, V92, P3575, DOI 10.1152/jn.00425.2004; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; Lamsa K, 2005, NAT NEUROSCI, V8, P916, DOI 10.1038/nn1486; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Mainen ZF, 1998, NAT NEUROSCI, V1, P579, DOI 10.1038/2812; Nyiri G, 2003, NEUROSCIENCE, V119, P347, DOI 10.1016/S0306-4522(03)00157-X; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Topolnik L, 2005, J NEUROSCI, V25, P990, DOI 10.1523/JNEUROSCI.4388-04.2005; Washburn MS, 1997, J NEUROSCI, V17, P9393	25	181	186	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1262	1266		10.1126/science.1137450	http://dx.doi.org/10.1126/science.1137450			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332410	Green Accepted			2022-12-24	WOS:000244564700046
J	Elbaum, R; Zaltzman, L; Burgert, I; Fratzl, P				Elbaum, Rivka; Zaltzman, Liron; Burgert, Ingo; Fratzl, Peter			The role of wheat awns in the seed dispersal unit	SCIENCE			English	Article							BIOLOGICAL SIGNIFICANCE; DIASPORE MORPHOLOGY; GRASSES; CELLULOSE; STRAW; WOOD	The dispersal unit of wild wheat bears two pronounced awns that balance the unit as it falls. We discovered that the awns are also able to propel the seeds on and into the ground. The arrangement of cellulose fibrils causes bending of the awns with changes in humidity. Silicified hairs that cover the awns allow propulsion of the unit only in the direction of the seeds. This suggests that the dead tissue is analogous to a motor. Fueled by the daily humidity cycle, the awns induce the motility required for seed dispersal.	Max Planck Inst Colloids & Interfaces, Biomat Dept, Golm, Germany; Tel Hai Acad Coll, Dept Biotechnol, Upper Galilee, Israel	Max Planck Society; Tel Hai Academy College	Elbaum, R (corresponding author), Max Planck Inst Colloids & Interfaces, Biomat Dept, Golm, Germany.	elbaum@mpikg.mpg.de; fratzl@mpikg.mpg.de	Fratzl, Peter/H-9095-2012; Elbaum, Rivka/AAR-3482-2020	Fratzl, Peter/0000-0003-4437-7830; 				CAVE ID, 1969, WOOD SCI TECHNOL, V3, P40, DOI 10.1007/BF00349983; CHAMBERS JC, 1991, ECOLOGY, V72, P1668, DOI 10.2307/1940966; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Dawson J, 1997, NATURE, V390, P668, DOI 10.1038/37745; GRUNDBACHER FJ, 1963, BOT REV, V29, P366, DOI 10.1007/BF02860824; HARPER J. L., 1970, Annual review of ecology and systematics., V1, P327, DOI 10.1146/annurev.es.01.110170.001551; Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019; Liu RG, 2005, CELLULOSE, V12, P25, DOI 10.1023/B:CELL.0000049346.28276.95; ODOGHERTY MJ, 1995, J AGR ENG RES, V62, P133, DOI 10.1006/jaer.1995.1072; PEART MH, 1987, J ECOL, V75, P569, DOI 10.2307/2260435; PEART MH, 1979, J ECOL, V67, P843, DOI 10.2307/2259218; PEART MH, 1981, J ECOL, V69, P425, DOI 10.2307/2259677; PEART MH, 1984, J ECOL, V72, P437, DOI 10.2307/2260057; Reiterer A, 1999, PHILOS MAG A, V79, P2173, DOI 10.1080/01418619908210415; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; STAMP NE, 1989, AM J BOT, V76, P555, DOI 10.2307/2444350; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214; WITZTUM A, 1995, J THEOR BIOL, V176, P531, DOI 10.1006/jtbi.1995.0219; ZOHARY MICHAEL, 1937, BEIH BOT CENTRALBL ABT A, V56, P1	19	414	427	13	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					884	886		10.1126/science.1140097	http://dx.doi.org/10.1126/science.1140097			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495170				2022-12-24	WOS:000246369800036
J	Nugent, FS; Penick, EC; Kauer, JA				Nugent, Fereshteh S.; Penick, Esther C.; Kauer, Julie A.			Opioids block long-term potentiation of inhibitory synapses	NATURE			English	Article							VENTRAL TEGMENTAL AREA; GAMMA-VINYL-GABA; DOPAMINE NEURONS; NITRIC-OXIDE; SYNAPTIC-TRANSMISSION; SINGLE EXPOSURE; COCAINE; MORPHINE; RELEASE; LTP	Excitatory brain synapses are strengthened or weakened in response to specific patterns of synaptic activation, and these changes in synaptic strength are thought to underlie persistent pathologies such as drug addiction, as well as learning(1). In contrast, there are few examples of synaptic plasticity of inhibitory GABA (gamma-aminobutyric acid)-releasing synapses. Here we report long-term potentiation of GABA(A)-mediated synaptic transmission (LTPGABA) onto dopamine neurons of the rat brain ventral tegmental area, a region required for the development of drug addiction. This novel form of LTP is heterosynaptic, requiring postsynaptic NMDA (N-methyl-D-aspartate) receptor activation at glutamate synapses, but resulting from increased GABA release at neighbouring inhibitory nerve terminals. NMDA receptor activation produces nitric oxide, a retrograde signal released from the postsynaptic dopamine neuron. Nitric oxide initiates LTPGABA by activating guanylate cyclase in GABA-releasing nerve terminals. Exposure to morphine both in vitro and in vivo prevents LTPGABA. Whereas brief treatment with morphine in vitro blocks LTPGABA by inhibiting presynaptic glutamate release, in vivo exposure to morphine persistently interrupts signalling from nitric oxide to guanylate cyclase. These neuroadaptations to opioid drugs might contribute to early stages of addiction, and may potentially be exploited therapeutically using drugs targeting GABA(A) receptors.	Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University	Kauer, JA (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	Julie_Kauer@brown.edu		Nugent, Fereshteh/0000-0002-8840-6923; Kauer, Julie/0000-0002-3362-1642	NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021973] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Barrett AC, 2005, J PHARMACOL EXP THER, V315, P858, DOI 10.1124/jpet.105.086033; Bonci A, 1996, NEURON, V16, P631, DOI 10.1016/S0896-6273(00)80082-3; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Brodie JD, 2003, SYNAPSE, V50, P261, DOI 10.1002/syn.10278; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Klejbor I, 2004, FOLIA HISTOCHEM CYTO, V42, P83; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Safo PK, 2006, CEREBELLUM, V5, P134, DOI 10.1080/14734220600791477; Schulteis G, 1997, PSYCHOPHARMACOLOGY, V129, P56, DOI 10.1007/s002130050162; Shew T, 2000, J NEUROPHYSIOL, V83, P3388, DOI 10.1152/jn.2000.83.6.3388; Shoji Y, 1999, J NEUROSCI, V19, P2347; Stern JE, 2001, AM J PHYSIOL-REG I, V280, pR1815, DOI 10.1152/ajpregu.2001.280.6.R1815; Stromberg MF, 2001, PHARMACOL BIOCHEM BE, V68, P291, DOI 10.1016/S0091-3057(00)00456-1; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vanderschuren LJMJ, 2001, EUR J NEUROSCI, V14, P1533, DOI 10.1046/j.0953-816x.2001.01775.x; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; YIM CY, 1980, BRAIN RES, V181, P301; Yu D, 2005, J COMP NEUROL, V483, P278, DOI 10.1002/cne.20416; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	30	233	239	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1086	1090		10.1038/nature05726	http://dx.doi.org/10.1038/nature05726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460674				2022-12-24	WOS:000245950400051
J	Helgadottir, A; Thorleifsson, G; Manolescu, A; Gretarsdottir, S; Blondal, T; Jonasdottir, A; Jonasdottir, A; Sigurdsson, A; Baker, A; Palsson, A; Masson, G; Gudbjartsson, DF; Magnusson, KP; Andersen, K; Levey, AI; Backman, VM; Matthiasdottir, S; Jonsdottir, T; Palsson, S; Einarsdottir, H; Gunnarsdottir, S; Gylfason, A; Vaccarino, V; Hooper, WC; Reilly, MP; Granger, CB; Austin, H; Rader, DJ; Shah, SH; Quyyumi, AA; Gulcher, JR; Thorgeirsson, G; Thorsteinsdottir, U; Kong, A; Stefansson, K				Helgadottir, Anna; Thorleifsson, Gudmar; Manolescu, Andrei; Gretarsdottir, Solveig; Blondal, Thorarinn; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Sigurdsson, Asgeir; Baker, Adam; Palsson, Arnar; Masson, Gisli; Gudbjartsson, Daniel F.; Magnusson, Kristinn P.; Andersen, Karl; Levey, Allan I.; Backman, Valgerdur M.; Matthiasdottir, Sigurborg; Jonsdottir, Thorbjorg; Palsson, Stefan; Einarsdottir, Helga; Gunnarsdottir, Steinunn; Gylfason, Arnaldur; Vaccarino, Viola; Hooper, W. Craig; Reilly, Muredach P.; Granger, Christopher B.; Austin, Harland; Rader, Daniel J.; Shah, Svati H.; Quyyumi, Arshed A.; Gulcher, Jeffrey R.; Thorgeirsson, Gudmundur; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			A common variant on chromosome 9p21 affects the risk of myocardial infarction	SCIENCE			English	Article							GENOMEWIDE LINKAGE; HEART-DISEASE; ATHEROSCLEROSIS; ASSOCIATION	The global endemic of cardiovascular diseases calls for improved risk assessment and treatment. Here, we describe an association between myocardial infarction ( MI) and a common sequence variant on chromosome 9p21. This study included a total of 4587 cases and 12,767 controls. The identified variant, adjacent to the tumor suppressor genes CDKN2A and CDKN2B, was associated with the disease with high significance. Approximately 21% of individuals in the population are homozygous for this variant, and their estimated risk of suffering myocardial infarction is 1.64 times as great as that of noncarriers. The corresponding risk is 2.02 times as great for early-onset cases. The population attributable risk is 21% for MI in general and 31% for early-onset cases.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Reykjavik, Iceland; Emory Univ, Sch Med, Atlanta, GA 30322 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Duke Univ, Sch Med, Durham, NC 27710 USA	Landspitali National University Hospital; Emory University; University of Pennsylvania; Duke University	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	augustine.kong@decode.is; kstefans@decode.is	Girelli, Domenico/B-1183-2008; , Viola/AAW-5600-2020; Magnusson, Kristinn P Pétur/X-4907-2019; Palsson, Arnar/M-2742-2015; Magnusson, Kristinn/A-6479-2011; Stefansson, Kari/AAE-7187-2019; Levey, Allan/F-2104-2011; Manolescu, Andrei/G-4565-2014; Granger, Christopher B/D-3458-2014	Girelli, Domenico/0000-0001-9684-1899; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Palsson, Arnar/0000-0002-6525-8112; Magnusson, Kristinn/0000-0003-4528-6826; Levey, Allan/0000-0002-3153-502X; Manolescu, Andrei/0000-0002-0713-4664; Granger, Christopher B/0000-0002-0045-3291; Reilly, Muredach/0000-0002-3035-9386; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857				Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MANTEL N, 1959, J NATL CANCER I, V22, P719; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x; Zintzaras E, 2006, J HUM GENET, V51, P1015, DOI 10.1007/s10038-006-0053-x	10	1246	1313	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1491	1493		10.1126/science.1142842	http://dx.doi.org/10.1126/science.1142842			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17478679				2022-12-24	WOS:000247066400047
J	Siepka, SM; Yoo, SH; Park, J; Song, WM; Kumar, V; Hu, YN; Lee, C; Takahashi, JS				Siepka, Sandra M.; Yoo, Seung-Hee; Park, Junghea; Song, Weimin; Kumar, Vivek; Hu, Yinin; Lee, Choogon; Takahashi, Joseph S.			Circadian mutant overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression	CELL			English	Article							SCF UBIQUITIN LIGASE; CLOCK; DEGRADATION; TIME; TRANSCRIPTION; BEHAVIOR; RHYTHM; OSCILLATIONS; MUTAGENESIS; COMPONENTS	Using a forward genetics ENU mutagenesis screen for recessive mutations that affect circathan rhythmicity in the mouse, we isolated a long period (similar to 26 hr) circadian mutant named Overtime (Ovtm). Positional cloning and genetic complementation reveal that Ovtm is encoded by the F-box protein FBXL3, a component of the SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligase complex. The Ovtm mutation causes an isoleucine to threonine (1364T) substitution leading to a loss of function in FBXL3, which interacts specifically with the CRYPTOCHROME (CRY) proteins. In Ovtm mice, expression of the PERIOD proteins PER1 and PER2 is reduced; however, the CRY proteins CRY1 and CRY2 are unchanged. The loss of FBXL3 function leads to a stabilization of the CRY proteins, which in turn leads to a global transcriptional repression of the Per and Cry genes. Thus, Fbxl3(ovtm) defines a molecular link between CRY turnover and CLOCK/BMAL1-dependent circadian transcription to modulate circadian period.	Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Florida State Univ, Coll Med, Dept Biol Sci, Tallahassee, FL 32306 USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; Northwestern University; State University System of Florida; Florida State University	Takahashi, JS (corresponding author), Northwestern Univ, Howard Hughes Med Inst, 2205 Tech Dr, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Hu, Yinin/0000-0002-4324-9530; Kumar, Vivek/0000-0001-6643-7465	NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH061915, R01MH078024, P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053616] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Harmon FG, 2003, CURR BIOL, V13, P2091, DOI 10.1016/j.cub.2003.11.019; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Peterson KA, 2002, GENOMICS, V80, P172, DOI 10.1006/geno.2002.6818; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2005, METHOD ENZYMOL, V393, P219, DOI 10.1016/S0076-6879(05)93007-3; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; [No title captured]	46	397	415	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					1011	1023		10.1016/j.cell.2007.04.030	http://dx.doi.org/10.1016/j.cell.2007.04.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17462724	Green Accepted, Bronze			2022-12-24	WOS:000247084600019
J	Zaph, C; Troy, AE; Taylor, BC; Berman-Booty, LD; Guild, KJ; Du, YR; Yost, EA; Gruber, AD; May, MJ; Greten, FR; Eckmann, L; Karin, M; Artis, D				Zaph, Colby; Troy, Amy E.; Taylor, Betsy C.; Berman-Booty, Lisa D.; Guild, Katherine J.; Du, Yurong; Yost, Evan A.; Gruber, Achim D.; May, Michael J.; Greten, Florian R.; Eckmann, Lars; Karin, Michael; Artis, David			Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis	NATURE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; KAPPA-B ACTIVATION; CHRONIC INFLAMMATION; DENDRITIC CELLS; INHIBITION; INVOLVEMENT; INFECTIONS; RESISTANCE; SURVIVAL	Intestinal epithelial cells ( IECs) provide a primary physical barrier against commensal and pathogenic microorganisms in the gastrointestinal ( GI) tract, but the influence of IECs on the development and regulation of immunity to infection is unknown(1). Here we show that IEC-intrinsic I kappa B kinase ( IKK)-beta-dependent gene expression is a critical regulator of responses of dendritic cells and CD4(+) T cells in the GI tract. Mice with an IEC-specific deletion of IKK-beta show a reduced expression of the epithelial-cell-restricted cytokine thymic stromal lymphopoietin in the intestine and, after infection with the gut-dwelling parasite Trichuris, fail to develop a pathogen-specific CD4(+) T helper type 2 (T(H)2) response and are unable to eradicate infection. Further, these animals show exacerbated production of dendritic-cell-derived interleukin-12/23p40 and tumour necrosis factor-alpha, increased levels of CD4(+) T-cell-derived interferon-gamma and interleukin-17, and develop severe intestinal inflammation. Blockade of proinflammatory cytokines during Trichuris infection ablates the requirement for IKK-beta in IECs to promote CD4(+) T(H)2 cell-dependent immunity, identifying an essential function for IECs in tissue-specific conditioning of dendritic cells and limiting type 1 cytokine production in the GI tract. These results indicate that the balance of IKK-beta-dependent gene expression in the intestinal epithelium is crucial in intestinal immune homeostasis by promoting mucosal immunity and limiting chronic inflammation.	Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; Free Univ Berlin, Dept Vet Pathol, D-14163 Berlin, Germany; Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Pennsylvania; University of Pennsylvania; Free University of Berlin; University of California System; University of California San Diego; University of California System; University of California San Diego	Artis, D (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	dartis@vet.upenn.edu	Gruber, Achim D./ABA-4514-2021; Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080; Zaph, Colby/0000-0002-9889-9848; May, Michael/0000-0002-2485-3716; Artis, David/0000-0002-1753-4100	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Jang MH, 2004, P NATL ACAD SCI USA, V101, P6110, DOI 10.1073/pnas.0400969101; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Schopf LR, 2002, J IMMUNOL, V168, P2383, DOI 10.4049/jimmunol.168.5.2383; Tilney LG, 2005, J EXP ZOOL PART A, V303A, P927, DOI 10.1002/jez.a.214; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360	28	416	430	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					552	556		10.1038/nature05590	http://dx.doi.org/10.1038/nature05590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17322906				2022-12-24	WOS:000245242900052
J	Brennecke, J; Aravin, AA; Stark, A; Dus, M; Kellis, M; Sachidanandam, R; Hannon, GJ				Brennecke, Julius; Aravin, Alexei A.; Stark, Alexander; Dus, Monica; Kellis, Manolis; Sachidanandam, Ravi; Hannon, Gregory J.			Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila	CELL			English	Article							R HYBRID DYSGENESIS; P-ELEMENTS; SUBTELOMERIC HETEROCHROMATIN; CYTOTYPE DETERMINATION; MOLECULAR-BASIS; COPY NUMBER; MELANOGASTER; PIWI; GENE; FLAMENCO	Drosophila Piwi-family proteins have been implicated in transposon control. Here, we examine piwi-interacting RNAs (piRNAs) associated with each Drosophila Piwi protein and find that Piwi and Aubergine bind RNAs that are predominantly antisense to transposons, whereas Ago3 complexes contain predominantly sense piRNAs. As in mammals, the majority of Drosophila piRNAs are derived from discrete genomic loci. These loci comprise mainly defective transposon sequences, and some have previously been identified as master regulators of transposon activity. Our data suggest that heterochromatic piRNA loci interact with potentially active, euchromatic transposons to form an adaptive system for transposon control. Complementary relationships between sense and antisense piRNA populations suggest an amplification loop wherein each piRNA-directed cleavage event generates the 5' end of a new piRNA. Thus, sense piRNAs, formed following cleavage of transposon mRNAs may enhance production of antisense piRNAs, complementary to active elements, by directing cleavage of transcripts from master control loci.	Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; MIT, Broad Inst, Ctr Genome Res, Cambridge, MA 02141 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hannon, GJ (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Kellis, Manolis/ABE-7385-2020; Stark, Alexander/D-1473-2012; Brennecke, Julius/C-1626-2015; Hannon, Gregory/AAB-3568-2019; Brennecke, Julius/T-5883-2019; sachidanandam, ravi/Q-6916-2019	Kellis, Manolis/0000-0001-7113-9630; Stark, Alexander/0000-0003-2611-0841; Brennecke, Julius/0000-0002-5141-0814; Brennecke, Julius/0000-0002-5141-0814; sachidanandam, ravi/0000-0001-9844-4459				Abad JP, 2004, MOL BIOL EVOL, V21, P1613, DOI 10.1093/molbev/msh174; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; BIEMONT C, 1990, GENET RES, V56, P3, DOI 10.1017/S0016672300028822; Blumenstiel JP, 2005, P NATL ACAD SCI USA, V102, P15965, DOI 10.1073/pnas.0508192102; BREGLIANO JC, 1980, SCIENCE, V207, P606, DOI 10.1126/science.6766221; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; BUCHETON A, 1995, TRENDS GENET, V11, P349, DOI 10.1016/S0168-9525(00)89105-2; BUCHETON A, 1990, TRENDS GENET, V6, P16, DOI 10.1016/0168-9525(90)90044-7; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Castro JP, 2004, GENETICA, V121, P107, DOI 10.1023/B:GENE.0000040382.48039.a2; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Desset S, 2003, GENETICS, V164, P501; ENGELS WR, 1979, GENETICS, V92, P161; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Harris AN, 2001, DEVELOPMENT, V128, P2823; HOSKINS RA, 2002, GENOME BIOL, V0003; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; KARPEN GH, 1992, GENETICS, V132, P737; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KIDWELL MG, 1977, GENETICS, V86, P813; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Marin L, 2000, GENETICS, V155, P1841; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; MISRA S, 1990, CELL, V62, P269, DOI 10.1016/0092-8674(90)90365-L; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; PELISSON A, 1987, MOL GEN GENET, V207, P306, DOI 10.1007/BF00331594; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; PELISSON A, 1981, MOL GEN GENET, V183, P123, DOI 10.1007/BF00270149; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PRUDHOMME N, 1995, GENETICS, V139, P697; Reiss D, 2004, MOL GENET GENOMICS, V272, P336, DOI 10.1007/s00438-004-1061-1; Robert V, 2001, GENETICS, V158, P701; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1998, GENETICS, V149, P1857; RONSSERAY S, 1991, GENETICS, V129, P501; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smyth DR, 1997, CURR BIOL, V7, pR793, DOI 10.1016/S0960-9822(06)00407-6; Stuart JR, 2002, GENETICS, V162, P1641; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	56	1719	1802	9	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1089	1103		10.1016/j.cell.2007.01.043	http://dx.doi.org/10.1016/j.cell.2007.01.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17346786	Bronze			2022-12-24	WOS:000245396200016
J	Christensen, J; Agger, K; Cloos, PAC; Pasini, D; Rose, S; Sennels, L; Rappsilber, J; Hansen, KH; Salcini, AE; Helin, K				Christensen, Jesper; Agger, Karl; Cloos, Paul A. C.; Pasini, Diego; Rose, Simon; Sennels, Lau; Rappsilber, Juri; Hansen, Klaus H.; Salcini, Anna Elisabetta; Helin, Kristian			RBP2 belongs to a family of demethylases, specific for tri- and dimethylated lysine 4 on histone 3	CELL			English	Article							ESCAPES X-INACTIVATION; BINDING; METHYLATION; GENE; PROTEINS; TRANSCRIPTION; TRITHORAX; HOMOLOG; METHYLTRANSFERASE; INTERACTS	Methylation of histones; has been regarded as a stable modification defining the epigenetic program of the cell, which regulates chromatin structure and transcription. However, the recent discovery of histone demethylases has challenged the stable nature of histone methylation. Here we demonstrate that the JARID1 proteins RBP2, PLU1, and SMCX are histone demethylases specific for di- and trimethylated histone 3 lysine 4 (H3K4). Consistent with a role for the JARID1 Drosophila homolog Lid in regulating expression of homeotic genes during development, we show that RBP2 is displaced from Hox genes during embryonic stem (ES) cell differentiation correlating with an increase of their H3K4me3 levels and expression. Furthermore, we show that mutation or RNAi depletion of the C. elegans JARID1 homolog rbr-2 leads to increased levels of H3K4me3 during larval development and defects in vulva formation. Taken together, these results suggest that H3K4me3/me2 demethylation regulated by the JARID1 family plays an important role during development.	Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Copenhagen; University of Copenhagen; University of Edinburgh	Helin, K (corresponding author), Univ Copenhagen, Ctr Epigenet, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	lisa.salcini@bric.dk; kristian.helin@bric.dk	Salcini, Anna Elisabetta/G-4472-2017; Hu, Ruogu/B-2203-2008; Rappsilber, Juri/ABF-3328-2020; Pasini, Diego/J-9674-2012; Rappsilber, Juri/B-7265-2015; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Pasini, Diego/0000-0002-9879-6486; Rappsilber, Juri/0000-0001-5999-1310; Helin, Kristian/0000-0003-1975-6097; Cloos, Paul/0000-0001-5863-0054; Salcini, Anna Elisabetta/0000-0001-5828-2512; Hansen, Klaus/0000-0001-9657-8816				AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRENNER S, 1974, GENETICS, V77, P71; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; CLARK SG, 1994, GENETICS, V137, P987; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Fay DS, 2000, GENESIS, V26, P279, DOI 10.1002/(SICI)1526-968X(200004)26:4<279::AID-GENE100>3.0.CO;2-C; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gildea JJ, 2000, GENETICS, V156, P645; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Heard E, 2004, COLD SPRING HARB SYM, V69, P89, DOI 10.1101/sqb.2004.69.89; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Mao SF, 1997, ONCOGENE, V14, P1531, DOI 10.1038/sj.onc.1200988; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roesch A, 2006, J INVEST DERMATOL, V126, P1850, DOI 10.1038/sj.jid.5700324; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Vogt T, 1999, LAB INVEST, V79, P1615; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	51	399	425	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1063	1076		10.1016/j.cell.2007.02.003	http://dx.doi.org/10.1016/j.cell.2007.02.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17320161	Bronze			2022-12-24	WOS:000245396200014
J	Tamaki, S; Matsuo, S; Wong, HL; Yokoi, S; Shimamoto, K				Tamaki, Shojiro; Matsuo, Shoichi; Wong, Hann Ling; Yokoi, Shuji; Shimamoto, Ko			Hd3a protein is a mobile flowering signal in rice	SCIENCE			English	Article							PHOTOPERIODIC CONTROL; INTEGRATOR FT; SHOOT APEX; ARABIDOPSIS; PHLOEM; ACTIVATION; ORTHOLOG; CONSTANS; TISSUES; GROWTH	Florigen, the mobile signal that moves from an induced leaf to the shoot apex and causes flowering, has eluded identification since it was first proposed 70 years ago. Understanding the nature of the mobile flowering signal would provide a key insight into the molecular mechanism floral induction. Recent studies suggest that the Arabidopsis FLOWERING LOCUS T ( FT) gene is a candidate for encoding florigen. We show that the protein encoded by Hd3a, a rice ortholog of moves from the leaf to the shoot apical meristem and induces flowering in rice. These results suggest that the Hd3a protein may be the rice florigen.	Nara Inst Sci & Technol, Plant Mol Genet Lab, Ikoma 6300101, Japan	Nara Institute of Science & Technology	Yokoi, S (corresponding author), Nara Inst Sci & Technol, Plant Mol Genet Lab, 8916-5 Takayama, Ikoma 6300101, Japan.	simamoto@bs.naist.jp	Yokoi, Shuji/L-3988-2019; Wong, Hann Ling/S-8148-2017; Ding, Cheng-Qiang/B-6287-2011; Yokoi, Shuji/B-4102-2012	Yokoi, Shuji/0000-0001-9358-1876; Wong, Hann Ling/0000-0001-8903-1812; 				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101; Asano T, 2002, PLANT CELL PHYSIOL, V43, P668, DOI 10.1093/pcp/pcf083; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bohlenius H, 2007, SCIENCE, V316, P367; Chailakhyan MK., 1936, C R ACAD SCI URSS, V13, P79; Corbesier L, 2005, PLANT CELL ENVIRON, V28, P54, DOI 10.1111/j.1365-3040.2005.01283.x; Giavalisco P, 2006, PROTEOMICS, V6, P896, DOI 10.1002/pmic.200500155; Guivarch A, 1996, TRANSGENIC RES, V5, P3, DOI 10.1007/BF01979917; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Lang A., 1965, ENCYCL PLANT PHYSIOL, VVolume XV/1, P1380; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Thomas B., 1997, PHOTOPERIODISM PLANT; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541; Zeevaart JAD, 2006, PLANT CELL, V18, P1783, DOI 10.1105/tpc.106.043513	28	825	924	14	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1033	1036		10.1126/science.1141753	http://dx.doi.org/10.1126/science.1141753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17446351				2022-12-24	WOS:000246554000048
J	Lu, BX; Su, YH; Das, S; Liu, J; Xia, JS; Ren, DJ				Lu, Boxun; Su, Yanhua; Das, Sudipto; Liu, Jin; Xia, Jingsheng; Ren, Dejian			The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm	CELL			English	Article							VOLTAGE-GATED SODIUM; ION SELECTIVITY; PERMEATION; CURRENTS; DETERMINANTS; MECHANISMS	Sodium plays a key role in determining the basal excitability of the nervous systems through the resting '' leak '' Na+ permeabilities, but the molecular identities of the TTX- and Cs+-resistant Na+ leak conductance are totally unknown. Here we show that this conductance is formed by the protein NALCN, a substantially uncharacterized member of the sodium/calcium channel family. Unlike any of the other 20 family members, NALCN forms a voltage-independent, nonselective cation channel. NALCN mutant mice have a severely disrupted respiratory rhythm and die within 24 hours of birth. Brain stem-spinal cord recordings. reveal reduced neuronal firing. The TTX- and Cs+-resistant background Na+ leak current is absent in the mutant hippocampal neurons. The resting membrane potentials of the mutant neurons are relatively insensitive to changes in extracellular Na+ concentration. Thus, NALCN, a nonselective cation channel, forms the background Na+ leak conductance and controls neuronal excitability.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ren, DJ (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Atherton JF, 2005, J NEUROSCI, V25, P8272, DOI 10.1523/JNEUROSCI.1475-05.2005; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; DiPasquale E, 1996, DEV BRAIN RES, V91, P121, DOI 10.1016/0165-3806(95)00170-0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eggermann E, 2003, J NEUROSCI, V23, P1557; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Franks CJ, 2002, J NEUROPHYSIOL, V87, P954, DOI 10.1152/jn.00233.2001; Goldin AL, 2002, J EXP BIOL, V205, P575; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; HOM R, 2002, J GEN PHYSIOL, V120, P449; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; JONES SW, 1989, NEURON, V3, P153, DOI 10.1016/0896-6273(89)90028-7; KIM MS, 1993, FEBS LETT, V318, P145, DOI 10.1016/0014-5793(93)80009-J; KRISHNAN KS, 1990, P NATL ACAD SCI USA, V87, P8632, DOI 10.1073/pnas.87.21.8632; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Mir B, 1997, GENETICS, V147, P701; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Nicholls J., 2001, NEURON BRAIN; NILIUS B, 2005, SCI STKE; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2000, J NEUROSCI, V20, P9004; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; SIMASKO SM, 1994, AM J PHYSIOL, V266, pC709, DOI 10.1152/ajpcell.1994.266.3.C709; Strohl KP, 2003, RESP PHYSIOL NEUROBI, V135, P179, DOI 10.1016/S1569-9048(03)00036-3; TANG SQ, 1993, J BIOL CHEM, V268, P13026; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300; Viemari JC, 2003, EUR J NEUROSCI, V17, P1233, DOI 10.1046/j.1460-9568.2003.02561.x; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; YU FH, 2004, SCI STKE 2004	44	222	228	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					371	383		10.1016/j.cell.2007.02.041	http://dx.doi.org/10.1016/j.cell.2007.02.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448995	Bronze			2022-12-24	WOS:000246474600023
J	Costa-Mattioli, M; Gobert, D; Stern, E; Gamache, K; Colina, R; Cuello, C; Sossin, W; Kaufman, R; Pelletier, J; Rosenblum, K; Krnjevic, K; Lacaille, JC; Nader, K; Sonenberg, N				Costa-Mattioli, Mauro; Gobert, Delphine; Stern, Elad; Gamache, Karine; Colina, Rodney; Cuello, Claudio; Sossin, Wayne; Kaufman, Randal; Pelletier, Jerrf; Rosenblum, Kobi; Krnjevic, Kresimir; Lacaille, Jean-Claude; Nader, Karim; Sonenberg, Nahum			eIF2 alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory	CELL			English	Article							MESSENGER-RNA TRANSLATION; PROTEIN-SYNTHESIS; POTENTIATION; MECHANISMS; RECONSOLIDATION; CONSOLIDATION; REINITIATION; NEUROSCIENCE; ENHANCEMENT; INHIBITION	The late phase of long-term potentiation (LTP) and memory (LTM) requires new gene expression, but the molecular mechanisms that underlie these processes are not fully understood. Phosphorylation of eIF2 alpha inhibits general translation but selectively stimulates translation of ATF4, a repressor of CREB-mediated late-LTP (L-LTP) and LTM. We used a pharmacogenetic bidirectional approach to examine the role of eIF2 alpha phosphorylation in synaptic plasticity and behavioral learning. We show that in eIF2 alpha(+/S51A) mice, in which eIF2 alpha phosphorylation is reduced, the threshold for eliciting L-LTP in hippocampal slices is lowered, and memory is enhanced. In contrast, only early-LTP is evoked by repeated tetanic stimulation and LTM is impaired, when eIF2 alpha phosphorylation is increased by injecting into the hippocampus a small molecule, Sal003, which prevents the dephosphorylation of eIF2 alpha. These findings highlight the importance of a single phosphorylation site in eIF2 alpha as a key regulator of L-LTP and LTM formation.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Psychol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Pharmacol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; Univ Haifa, Ctr Brain & Behav, IL-30905 Haifa, Israel; Univ Michigan, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; University of Haifa; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Costa-Mattioli, M (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.	mauro.costa-mattioli@mail.mcgill.ca; nahum.sonenberg@mcgill.ca		Colina, Rodney/0000-0003-3731-5383	Canadian Institutes of Health Research [15121] Funding Source: Medline; NCI NIH HHS [R01 CA154916] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA154916] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; COTE SL, 1993, IMMUNOHISTOCHEMISTRY, V2; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Schafe GE, 1999, LEARN MEMORY, V6, P97; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SHEFFIELD FD, 1950, J COMP PHYSIOL PSYCH, V43, P471, DOI 10.1037/h0061365; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Small SA, 2000, NEURON, V28, P653, DOI 10.1016/S0896-6273(00)00144-6; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248	41	348	367	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					195	206		10.1016/j.cell.2007.01.050	http://dx.doi.org/10.1016/j.cell.2007.01.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418795	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000245661100021
J	Gange, AC; Gange, EG; Sparks, TH; Boddy, L				Gange, A. C.; Gange, E. G.; Sparks, T. H.; Boddy, L.			Rapid and recent changes in fungal fruiting patterns	SCIENCE			English	Article							PLANTS; EUROPE		Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Belvedere, Salisbury SP5 3DZ, Wilts, England; NERC, Ctr Ecol & Hydrol, Monks Wood PE28 2LS, Cambs, England; Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales	University of London; Royal Holloway University London; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Cardiff University	Gange, AC (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	a.gange@rhul.ac.uk	Boddy, Lynne/A-7250-2010	Boddy, Lynne/0000-0003-1845-6738; Sparks, Tim/0000-0003-4382-7051	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; LAST FT, 1979, NATURE, V280, P168, DOI 10.1038/280168a0; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233	6	155	165	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					71	71		10.1126/science.1137489	http://dx.doi.org/10.1126/science.1137489			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412949				2022-12-24	WOS:000245470500032
J	Fine, M; Tchernov, D				Fine, Maoz; Tchernov, Dan			Scleractinian coral species survive and recover from decalcification	SCIENCE			English	Article							EVOLUTION; CARBON		Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; Hebrew Univ Jerusalem, Dept Evolut Systemat & Ecol, IL-91904 Jerusalem, Israel; Interuniv Inst Marine Sci, IL-88103 Elat, Israel	Bar Ilan University; Hebrew University of Jerusalem	Fine, M (corresponding author), Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel.	finema@mail.biu.ac.il	Tchernov, Dan/AAE-2545-2021; Fine, Maoz/S-5582-2019	Tchernov, Dan/0000-0003-1135-8270; Fine, Maoz/0000-0003-4911-4562				Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Hoegh-Guldberg O, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002528; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632	8	201	213	5	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1811	1811		10.1126/science.1137094	http://dx.doi.org/10.1126/science.1137094			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395821				2022-12-24	WOS:000245280100032
J	Kurtovic, A; Widmer, A; Dickson, BJ				Kurtovic, Amina; Widmer, Alexandre; Dickson, Barry J.			A single class of olfactory neurons mediates behavioural responses to a Drosophila sex pheromone	NATURE			English	Article							MALE COURTSHIP BEHAVIOR; SILKMOTH BOMBYX-MORI; ANTENNAL LOBE; HELIOTHIS-VIRESCENS; MELANOGASTER; RECEPTOR; BRAIN; REPRESENTATION; SYSTEM; MOTH	Insects, like many other animals, use sex pheromones to coordinate their reproductive behaviours(1). Volatile pheromones are detected by odorant receptors expressed in olfactory receptor neurons ( ORNs). Whereas fruit odours typically activate multiple ORN classes(2), pheromones are thought to act through single dedicated classes of ORN3. This model predicts that activation of such an ORN class should be sufficient to trigger the appropriate behavioural response. Here we show that the Drosophila melanogaster male-specific pheromone 11-cis-vaccenyl acetate ( cVA) acts through the receptor Or67d to regulate both male and female mating behaviour. Mutant males that lack Or67d inappropriately court other males, whereas mutant females are less receptive to courting males. These data suggest that cVA has opposite effects in the two sexes: inhibiting mating behaviour in males but promoting mating behaviour in females. Replacing Or67d with moth pheromone receptors renders these ORNs sensitive to the corresponding moth pheromones. In such flies, moth pheromones elicit behavioural responses that mimic the normal response to cVA. Thus, activation of a single ORN class is both necessary and sufficient to mediate behavioural responses to the Drosophila sex pheromone cVA.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Kozaric, Amina/0000-0002-6063-7260				Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JEFFERIS GSX, 2007, IN PRESS CELL; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2005, EUR J NEUROSCI, V21, P2167, DOI 10.1111/j.1460-9568.2005.04058.x; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MANE SD, 1983, SCIENCE, V222, P419, DOI 10.1126/science.222.4622.419; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; ROELOFS WL, 1974, LIFE SCI, V14, P1555, DOI 10.1016/0024-3205(74)90166-0; Rollmann SM, 2005, J NEUROBIOL, V63, P146, DOI 10.1002/neu.20123; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Schurmann FW, 2000, ACTA BIOL HUNG, V51, P355; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	30	486	504	7	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					542	546		10.1038/nature05672	http://dx.doi.org/10.1038/nature05672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392786				2022-12-24	WOS:000245242900050
J	Jefferis, GSXE; Potter, CJ; Chan, AI; Marin, EC; Rohlfing, T; Maurer, CR; Luo, LQ				Jefferis, Gregory S. X. E.; Potter, Christopher J.; Chan, Alexander Im.; Marin, Elizabeth C.; Rohlfing, Torsten; Maurer, Calvin R., Jr.; Luo, Liqun			Comprehensive maps of Drosophila higher offactory centers: Spatially segregated fruit and pheromone representation	CELL			English	Article							MALE COURTSHIP BEHAVIOR; ANTENNAL LOBE; MUSHROOM BODY; OLFACTORY CORTEX; MOSAIC ANALYSIS; BOMBYX-MORI; NEURONS; MELANOGASTER; BRAIN; ORGANIZATION	In Drosophila, similar to 50 classes of olfactory receptor neurons (ORNs) send axons to 50 corresponding glomeruli in the antennal lobe. Uniglomerular projection neurons (PNs) relay olfactory information to the mushroom body (MB) and lateral horn (LH). Here, we combine single-cell labeling and image registration to create high-resolution, quantitative maps of the MB and LH for 35 input PN channels and several groups of LH neurons. We find (1) PN inputs to the MB are stereotyped as previously shown for the LH; (2) PN partners of ORNs from different sensillar groups are clustered in the LH; (3) fruit odors are represented mostly in the posterior-dorsal LH, whereas candidate pheromone-responsive PNs project to the anterior-ventral LH; (4) dendrites of single LH neurons each overlap with specific subsets of PN axons. Our results suggest that the LH is organized according to biological values of olfactory input.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Cambridge, Dept Zool, Cambridge CB2 2EJ, England; SRI Int, Program Neurosci, Menlo Pk, CA 94025 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Cambridge; SRI International	Jefferis, GSXE (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	gsxej2@cam.ac.uk	Potter, Christopher John/H-5884-2019; Rohlfing, Torsten/A-1146-2007; Jefferis, Gregory/C-6386-2012	Potter, Christopher John/0000-0002-5223-8112; Luo, Liqun/0000-0001-5467-9264; Jefferis, Gregory/0000-0002-0587-9355	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005965, R37AA005965, U01AA013521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA005965, R37 AA005965, AA05965, AA13521, U01 AA013521] Funding Source: Medline; NIDCD NIH HHS [R01 DC005982, R01-DC005982] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Ito K, 1997, DEVELOPMENT, V124, P761; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; KURTOVIC A, 2007, IN PRESS NATURE; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Penfield W, 1950, CEREBRAL CORTEX MAN; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Rohlfing T, 2003, IEEE T INF TECHNOL B, V7, P16, DOI 10.1109/TITB.2003.808506; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; Schafer WR, 2005, CURR BIOL, V15, pR723, DOI 10.1016/j.cub.2005.08.020; Seki Y, 2005, J COMP NEUROL, V481, P340, DOI 10.1002/cne.20392; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867; Young P, 2004, CURR OPIN NEUROBIOL, V14, P642, DOI 10.1016/j.conb.2004.08.007; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	51	410	418	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1187	1203		10.1016/j.cell.2007.01.040	http://dx.doi.org/10.1016/j.cell.2007.01.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382886	hybrid, Green Published			2022-12-24	WOS:000245396200023
J	Sawaya, MR; Sambashivan, S; Nelson, R; Ivanova, MI; Sievers, SA; Apostol, MI; Thompson, MJ; Balbirnie, M; Wiltzius, JJW; McFarlane, HT; Madsen, AO; Riekel, C; Eisenberg, D				Sawaya, Michael R.; Sambashivan, Shilpa; Nelson, Rebecca; Ivanova, Magdalena I.; Sievers, Stuart A.; Apostol, Marcin I.; Thompson, Michael J.; Balbirnie, Melinda; Wiltzius, Jed J. W.; McFarlane, Heather T.; Madsen, Anders O.; Riekel, Christian; Eisenberg, David			Atomic structures of amyloid cross-beta spines reveal varied steric zippers	NATURE			English	Article							X-RAY-DIFFRACTION; URE2P PRION FILAMENTS; FIBRIL FORMATION; SEEDING SPECIFICITY; FORMING PEPTIDE; SHEET STRUCTURE; CORE STRUCTURE; MODEL; DIVERSITY; PROTEINS	Amyloid fibrils formed from different proteins, each associated with a particular disease, contain a common cross-beta spine. The atomic architecture of a spine, from the fibril-forming segment GNNQQNY of the yeast prion protein Sup35, was recently revealed by X-ray microcrystallography. It is a pair of beta-sheets, with the facing side chains of the two sheets interdigitated in a dry 'steric zipper'. Here we report some 30 other segments from fibril-forming proteins that form amyloid-like fibrils, microcrystals, or usually both. These include segments from the Alzheimer's amyloid-beta and tau proteins, the PrP prion protein, insulin, islet amyloid polypeptide ( IAPP), lysozyme, myoglobin, alpha-synuclein and beta(2)-microglobulin, suggesting that common structural features are shared by amyloid diseases at the molecular level. Structures of 13 of these microcrystals all reveal steric zippers, but with variations that expand the range of atomic architectures for amyloid-like fibrils and offer an atomic-level hypothesis for the basis of prion strains.	Univ Calif Los Angeles, DOE Inst Genom & Proteom, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Copenhagen, Ctr Crystallog Studies, Dept Chem, DK-2100 Copenhagen, Denmark; European Synchrotron Radiat Facil, BP 220, F-38043 Grenoble, France	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of Copenhagen; European Synchrotron Radiation Facility (ESRF)	Eisenberg, D (corresponding author), Univ Calif Los Angeles, DOE Inst Genom & Proteom, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Madsen, Anders Østergaard/B-4760-2015	Madsen, Anders Østergaard/0000-0001-5422-8076; Sawaya, Michael/0000-0003-0874-9043; Thompson, Michael/0000-0002-2914-1080				ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Diaz-Avalos R, 2003, J MOL BIOL, V330, P1165, DOI 10.1016/S0022-2836(03)00659-4; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; HALVERSON K, 1990, BIOCHEMISTRY-US, V29, P2639, DOI 10.1021/bi00463a003; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Serpell LC, 2000, J MOL BIOL, V299, P225, DOI 10.1006/jmbi.2000.3650; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008	46	1714	1740	8	439	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					453	457		10.1038/nature05695	http://dx.doi.org/10.1038/nature05695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17468747				2022-12-24	WOS:000246693100042
J	Lareau, LF; Inada, M; Green, RE; Wengrod, JC; Brenner, SE				Lareau, Liana F.; Inada, Maki; Green, Richard E.; Wengrod, Jordan C.; Brenner, Steven E.			Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements	NATURE			English	Article							MESSENGER-RNA DECAY; PROTEIN-KINASE; HUMAN GENOME; IDENTIFICATION; EVENTS; EXPRESSION; ENHANCERS; DROSOPHILA; ROLES; EXON	The human and mouse genomes share a number of long, perfectly conserved nucleotide sequences, termed ultraconserved elements(1). Whereas these regions can act as transcriptional enhancers when upstream of genes, those within genes are less well understood. In particular, the function of ultraconserved elements that overlap alternatively spliced exons of genes encoding RNA-binding proteins is unknown(1,2). Here we report that in every member of the human SR family of splicing regulators, highly or ultraconserved elements are alternatively spliced, either as alternative 'poison cassette exons' containing early in-frame stop codons, or as alternative introns in the 3' untranslated region. These alternative splicing events target the resulting messenger RNAs for degradation by means of an RNA surveillance pathway called nonsense-mediated mRNA decay. Mouse orthologues of the human SR proteins exhibit the same unproductive splicing patterns. Three SR proteins have been previously shown to direct splicing of their own transcripts, and one of these is known to autoregulate its expression by coupling alternative splicing with decay(3-5); our results suggest that unproductive splicing is important for regulation of the entire SR family. We find that unproductive splicing associated with conserved regions has arisen independently in different SR genes, suggesting that splicing factors may readily acquire this form of regulation.	Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Brenner, SE (corresponding author), Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA.	brenner@compbio.berkeley.edu	Brenner, Steven E/A-8729-2008	Brenner, Steven E/0000-0001-7559-6185; Green, Richard/0000-0003-0516-5827				Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Garcia-Sacristan A, 2005, CELL RES, V15, P495, DOI 10.1038/sj.cr.7290319; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; Iida K, 2006, MOL BIOL EVOL, V23, P1085, DOI 10.1093/molbev/msj118; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jumaa H, 1997, EMBO J, V16, P5077, DOI 10.1093/emboj/16.16.5077; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kumar S, 2005, EMBO J, V24, P2646, DOI 10.1038/sj.emboj.7600723; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lejeune F, 2001, J BIOL CHEM, V276, P7850, DOI 10.1074/jbc.M009510200; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Morrison M, 1997, P NATL ACAD SCI USA, V94, P9782, DOI 10.1073/pnas.94.18.9782; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zorio DAR, 1997, MOL CELL BIOL, V17, P946, DOI 10.1128/MCB.17.2.946	30	434	437	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					926	929		10.1038/nature05676	http://dx.doi.org/10.1038/nature05676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17361132	Green Published			2022-12-24	WOS:000245785700045
J	Engel, GS; Calhoun, TR; Read, EL; Ahn, TK; Mancal, T; Cheng, YC; Blankenship, RE; Fleming, GR				Engel, Gregory S.; Calhoun, Tessa R.; Read, Elizabeth L.; Ahn, Tae-Kyu; Mancal, Tomas; Cheng, Yuan-Chung; Blankenship, Robert E.; Fleming, Graham R.			Evidence for wavelike energy transfer through quantum coherence in photosynthetic systems	NATURE			English	Article							2-DIMENSIONAL FEMTOSECOND SPECTROSCOPY; BACTERIOCHLOROPHYLL PROTEIN; ELECTRONIC SPECTROSCOPY; CHLOROBIUM-TEPIDUM; ANTENNA COMPLEXES; DYNAMICS; ECHOES; MODEL	Photosynthetic complexes are exquisitely tuned to capture solar light efficiently, and then transmit the excitation energy to reaction centres, where long term energy storage is initiated. The energy transfer mechanism is often described by semiclassical models that invoke 'hopping' of excited-state populations along discrete energy levels(1,2). Two-dimensional Fourier transform electronic spectroscopy(3-5) has mapped(6) these energy levels and their coupling in the Fenna - Matthews - Olson (FMO) bacteriochlorophyll complex, which is found in green sulphur bacteria and acts as an energy 'wire' connecting a large peripheral light-harvesting antenna, the chlorosome, to the reaction centre(7-9). The spectroscopic data clearly document the dependence of the dominant energy transport pathways on the spatial properties of the excited-state wavefunctions of the whole bacteriochlorophyll complex(6,10). But the intricate dynamics of quantum coherence, which has no classical analogue, was largely neglected in the analyses - even though electronic energy transfer involving oscillatory populations of donors and acceptors was first discussed more than 70 years ago(11), and electronic quantum beats arising from quantum coherence in photosynthetic complexes have been predicted(12,13) and indirectly observed(14). Here we extend previous two-dimensional electronic spectroscopy investigations of the FMO bacteriochlorophyll complex, and obtain direct evidence for remarkably long-lived electronic quantum coherence playing an important part in energy transfer processes within this system. The quantum coherence manifests itself in characteristic, directly observable quantum beating signals among the excitons within the Chlorobium tepidum FMO complex at 77 K. This wavelike characteristic of the energy transfer within the photosynthetic complex can explain its extreme efficiency, in that it allows the complexes to sample vast areas of phase space to find the most efficient path.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); Washington University (WUSTL)	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	grfleming@lbl.gov	Ahn, Tae Kyu/A-5838-2013; Calhoun, Tessa/AHI-1645-2022; Cheng, Yuan-Chung/A-6566-2008; Engel, Gregory/C-1108-2012; Mančal, Tomáš/B-9688-2014	Ahn, Tae Kyu/0000-0002-7474-6513; Calhoun, Tessa/0000-0002-4952-0010; Cheng, Yuan-Chung/0000-0003-0125-4267; Engel, Gregory/0000-0002-6740-5243; Mančal, Tomáš/0000-0003-1736-3054; Read, Elizabeth/0000-0002-9186-284X				Abramavicius D, 2004, PHYS CHEM CHEM PHYS, V6, P3097, DOI 10.1039/b315252a; [Anonymous], 2002, PHOTOSYNTHETICA; [Anonymous], 1932, ANN PHYS; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Brixner T, 2004, OPT LETT, V29, P884, DOI 10.1364/OL.29.000884; Camara-Artigas A, 2003, PHOTOSYNTH RES, V75, P49, DOI 10.1023/A:1022406703110; Cho MH, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1955444; Cho MH, 2005, J PHYS CHEM B, V109, P10542, DOI 10.1021/jp050788d; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; DREYER J, 2003, B KOR CHEM SOC, V24, P1091; FENNA RE, 1975, NATURE, V258, P573, DOI 10.1038/258573a0; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Hochstrasser RM, 2001, CHEM PHYS, V266, P273, DOI 10.1016/S0301-0104(01)00232-4; JANG SJ, 2004, PHYS REV LETT, V92, P9312; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; JOO T, 1995, OPT LETT, V20, P389, DOI 10.1364/OL.20.000389; Kempe J, 2003, CONTEMP PHYS, V44, P307, DOI 10.1080/00107151031000110776; Knox RS, 1996, PHOTOSYNTH RES, V48, P35, DOI 10.1007/BF00040993; Leegwater JA, 1996, J PHYS CHEM-US, V100, P14403, DOI 10.1021/jp961448i; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Li YF, 1997, J MOL BIOL, V271, P456, DOI 10.1006/jmbi.1997.1189; Novoderezhkin V, 2003, J PHYS CHEM B, V107, P11534, DOI 10.1021/jp035432l; Pisliakov AV, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2200705; Renger T, 2001, PHYS REP, V343, P138, DOI 10.1016/S0370-1573(00)00078-8; Savikhin S, 1997, CHEM PHYS, V223, P303, DOI 10.1016/S0301-0104(97)00223-1; van Amerongen H., 2000, PHOTOSYNTHETIC EXCIT; Vulto SIE, 1999, J PHYS CHEM B, V103, P8153, DOI 10.1021/jp984702a; [No title captured]	30	2326	2352	15	746	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					782	786		10.1038/nature05678	http://dx.doi.org/10.1038/nature05678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429397	Green Submitted			2022-12-24	WOS:000245626800037
J	Vasudevan, S; Steitz, JA				Vasudevan, Shobha; Steitz, Joan A.			AU-rich-element-mediated upregulation of translation by FXR1 and argonaute 2	CELL			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA DEGRADATION; MICRORNA-DEPENDENT LOCALIZATION; MENTAL-RETARDATION PROTEIN; X-RELATED PROTEIN; FACTOR-ALPHA; CELL-CYCLE; GW BODIES; BINDING PROTEINS; EXPRESSION	AU-rich elements (AREs), present in mRNA 3'-UTRs, are potent posttranscriptional regulatory signals that can rapidly effect changes in mRNA stability and translation, thereby dramatically altering gene expression with clinical and developmental consequences. In human cell lines, the TNF alpha ARE enhances translation relative to mRNA levels upon serum starvation, which induces cell-cycle arrest. An in vivo crosslinking-coupled affinity purification method was developed to isolate ARE-associated complexes from activated versus basal translation conditions. We surprisingly found two microRNP-related proteins, fragile-X-mental-retardation-related protein 1 (FXR1) and Argonaute 2 (AGO2), that associate with the ARE exclusively during translation activation. Through tethering and shRNA-knockdown experiments, we provide direct evidence for the translation activation function of both FXR1 and AGO2 and demonstrate their interdependence for upregulation. This novel cell-growth-dependent translation activation role for FXR1 and AGO2 allows new insights into ARE-mediated signaling and connects two important posttranscriptional regulatory systems in an unexpected way.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem,BCMM, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem,BCMM, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026154, R01GM026154] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM026154, GM26154] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson K, 2000, CYTOKINE, V12, P1784, DOI 10.1006/cyto.2000.0784; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Barreau C, 2006, RNA, V12, P1790, DOI 10.1261/rna.191706; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boonstra J, 2003, J CELL BIOCHEM, V90, P244, DOI 10.1002/jcb.10617; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brewer G, 2002, AGEING RES REV, V1, P607, DOI 10.1016/S1568-1637(02)00023-5; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Dube M, 2000, BMC Genet, V1, P4, DOI 10.1186/1471-2156-1-4; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; HASKILL S, 1988, J IMMUNOL, V140, P1690; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; JEOUNG DI, 1995, J BIOL CHEM, V270, P18367, DOI 10.1074/jbc.270.31.18367; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kirkpatrick LL, 1999, GENOMICS, V59, P193, DOI 10.1006/geno.1999.5868; Kirkpatrick LL, 2001, GENOMICS, V78, P169, DOI 10.1006/geno.2001.6667; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lian SL, 2006, CELL CYCLE, V5, P242, DOI 10.4161/cc.5.3.2410; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mientjes EJ, 2004, HUM MOL GENET, V13, P1291, DOI 10.1093/hmg/ddh150; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moneo V, 2003, J CELL BIOCHEM, V89, P484, DOI 10.1002/jcb.10529; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Park-Lee S, 2003, J BIOL CHEM, V278, P39801, DOI 10.1074/jbc.M307105200; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pomorski P, 2004, CELL MOTIL CYTOSKEL, V57, P143, DOI 10.1002/cm.10159; ROY AL, 1988, BIOCHEMISTRY-US, V27, P8203, DOI 10.1021/bi00421a033; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Sirenko OI, 1997, MOL CELL BIOL, V17, P3898, DOI 10.1128/MCB.17.7.3898; Srisawat C, 2002, METHODS, V26, P156, DOI 10.1016/S1046-2023(02)00018-X; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wilhelm JE, 2005, BIOL CELL, V97, P235, DOI 10.1042/BC20040097; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Zou C, 1998, GENE, V211, P187, DOI 10.1016/S0378-1119(98)00107-3	65	463	499	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1105	1118		10.1016/j.cell.2007.01.038	http://dx.doi.org/10.1016/j.cell.2007.01.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382880	Green Accepted, Bronze			2022-12-24	WOS:000245396200017
J	Jin, Y; Mailloux, CM; Gowan, K; Riccardi, SL; LaBerge, G; Bennett, DC; Fain, PR; Spritz, RA				Jin, Ying; Mailloux, Christina M.; Gowan, Katherine; Riccardi, Sheri L.; LaBerge, Greggory; Bennett, Dorothy C.; Fain, Pamela R.; Spritz, Richard A.			NALP1 in vitiligo-associated multiple autoimmune disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLD AUTOINFLAMMATORY SYNDROME; SUSCEPTIBILITY LOCI; GENE; EPIDEMIOLOGY; MUTATIONS; FAMILY; ONSET; SLEV1; HLA	Background: Autoimmune and autoinflammatory diseases involve interactions between genetic risk factors and environmental triggers. We searched for a gene on chromosome 17p13 that contributes to a group of epidemiologically associated autoimmune and autoinflammatory diseases. The group includes various combinations of generalized vitiligo, autoimmune thyroid disease, latent autoimmune diabetes in adults, rheumatoid arthritis, psoriasis, pernicious anemia, systemic lupus erythematosus, and Addison's disease. Methods: We tested 177 single-nucleotide polymorphisms (SNPs) spanning the 17p13 linkage peak for association with disease and identified a strong candidate gene. We then sequenced DNA in and around the gene to identify additional SNPs. We carried out a second round of tests of association using some of these additional SNPs, thus elucidating the association with disease in the gene and its extended promoter region in fine detail. Results: Association analyses resulted in our identifying as a candidate gene NALP1, which encodes NACHT leucine-rich-repeat protein 1, a regulator of the innate immune system. Fine-scale association mapping with the use of DNA from affected families and additional SNPs in and around NALP1 showed an association of specific variants with vitiligo alone, with an extended autoimmune and autoinflammatory disease phenotype, or with both. Conditional logistic-regression analysis of NALP1 SNPs indicated that at least two variants contribute independently to the risk of disease. Conclusions: DNA sequence variants in the NALP1 region are associated with the risk of several epidemiologically associated autoimmune and autoinflammatory diseases, implicating the innate immune system in the pathogenesis of these disorders.	Univ Colorado Denver, Human Med Genet Program, Aurora, CO 80045 USA; Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO USA; Univ London, St Georges, Div Basic Med Sci, London, England	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; St Georges University London; University of London	Spritz, RA (corresponding author), Univ Colorado Denver, Human Med Genet Program, POB 6511,Mailstop 8300, Aurora, CO 80045 USA.	richard.spritz@uchsc.edu	Bennett, Dorothy C/C-2418-2008	Bennett, Dorothy C/0000-0002-3639-7527	NIAID NIH HHS [AI46374] Funding Source: Medline; NIAMS NIH HHS [AR45584] Funding Source: Medline; NIDDK NIH HHS [DK57538] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI046374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057538] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brand Oliver, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009981; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Johansson CM, 2004, HUM GENET, V115, P230, DOI 10.1007/s00439-004-1145-3; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; KUMMER JA, IN PRESS J HISTOCHEM; Laberge G, 2005, PIGM CELL RES, V18, P300, DOI 10.1111/j.1600-0749.2005.00242.x; Liu F, 2004, CELL SIGNAL, V16, P1013, DOI 10.1016/j.cellsig.2004.02.006; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Nath SK, 2001, AM J HUM GENET, V69, P1401, DOI 10.1086/324470; NIH (National Institutes of Health), 2005, PROGR AUT DIS RES; Nordlund JJ, 2006, PIGMENTARY SYSTEM, P551, DOI DOI 10.1002/9780470987100.CH30.; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Schug J., 1997, CBILTR19971001V00 U; Spritz RA, 2004, AM J HUM GENET, V74, P188, DOI 10.1086/381134; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tu CX, 2003, J DERMATOL SCI, V31, P73, DOI 10.1016/S0923-1811(02)00151-2; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463	38	459	483	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 22	2007	356	12					1216	1225		10.1056/NEJMoa061592	http://dx.doi.org/10.1056/NEJMoa061592			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148UP	17377159	Green Accepted, Bronze			2022-12-24	WOS:000245101900006
J	Ishii, N; Nakahigashi, K; Baba, T; Robert, M; Soga, T; Kanai, A; Hirasawa, T; Naba, M; Hirai, K; Hoque, A; Ho, PY; Kakazu, Y; Sugawara, K; Igarashi, S; Harada, S; Masuda, T; Sugiyama, N; Togashi, T; Hasegawa, M; Takai, Y; Yugi, K; Arakawa, K; Iwata, N; Toya, Y; Nakayama, Y; Nishioka, T; Shimizu, K; Mori, H; Tomita, M				Ishii, Nobuyoshi; Nakahigashi, Kenji; Baba, Tomoya; Robert, Martin; Soga, Tomoyoshi; Kanai, Akio; Hirasawa, Takashi; Naba, Miki; Hirai, Kenta; Hoque, Aminul; Ho, Pei Yee; Kakazu, Yuji; Sugawara, Kaori; Igarashi, Saori; Harada, Satoshi; Masuda, Takeshi; Sugiyama, Naoyuki; Togashi, Takashi; Hasegawa, Miki; Takai, Yuki; Yugi, Katsuyuki; Arakawa, Kazuharu; Iwata, Nayuta; Toya, Yoshihiro; Nakayama, Yoichi; Nishioka, Takaaki; Shimizu, Kazuyuki; Mori, Hirotada; Tomita, Masaru			Multiple high-throughput analyses monitor the response of E-coli to perturbations	SCIENCE			English	Article							METABOLIC NETWORK; INTEGRATION; ROBUSTNESS; GENOMICS; STRESS; SYSTEM	Analysis of cellular components at multiple levels of biological information can provide valuable functional insights. We performed multiple high-throughput measurements to study the response of Escherichia coli cells to genetic and environmental perturbations. Analysis of metabolic enzyme gene disruptants revealed unexpectedly small changes in messenger RNA and proteins for most disruptants. Overall, metabolite levels were also stable, reflecting the rerouting of fluxes in the metabolic network. In contrast, E. coli actively regulated enzyme levels to maintain a stable metabolic state in response to changes in growth rate. E. coli thus seems to use complementary strategies that result in a metabolic network robust against perturbations.	Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa 2528520, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka 8208502, Japan; Human Metabolome Technol Inc, Tsuruoka, Japan	Keio University; Keio University; Nara Institute of Science & Technology; Kyoto University; Kyushu Institute of Technology	Tomita, M (corresponding author), Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan.	mt@sfc.keio.ac.jp	Mori, Hirotada/B-4934-2011; Ho, Pei Yee/G-6841-2012; Robert, Martin/B-3970-2009; Soga, Tomoyoshi/B-8105-2014; Hirasawa, Takashi/G-4458-2016; Kanai, Akio/C-4921-2014; Shimizu, Kazuyuki/GVT-4698-2022	Robert, Martin/0000-0002-7082-5142; Soga, Tomoyoshi/0000-0001-9502-2509; Hirasawa, Takashi/0000-0002-5183-2953; Kanai, Akio/0000-0002-6362-2419; Shimizu, Kazuyuki/0000-0002-4847-0197; Arakawa, Kazuharu/0000-0002-2893-4919; Toya, Yoshihiro/0000-0001-9670-6961; Sugiyama, Naoyuki/0000-0001-7633-8495				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; DALDAL F, 1983, J MOL BIOL, V168, P285, DOI 10.1016/S0022-2836(83)80019-9; Fong SS, 2006, J BIOL CHEM, V281, P8024, DOI 10.1074/jbc.M510016200; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Mukhopadhyay A, 2006, J BACTERIOL, V188, P4068, DOI 10.1128/JB.01921-05; SKINNER AJ, 1974, J BACTERIOL, V118, P1183, DOI 10.1128/JB.118.3.1183-1185.1974; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Toyoda T, 2004, BIOINFORMATICS, V20, P1759, DOI 10.1093/bioinformatics/bth165; Vemuri GN, 2005, MICROBIOL MOL BIOL R, V69, P197, DOI 10.1128/MMBR.69.2.197-216.2005	19	504	516	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					593	597		10.1126/science.1132067	http://dx.doi.org/10.1126/science.1132067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17379776				2022-12-24	WOS:000245983100044
J	Guan, CB; Xu, HT; Jin, M; Yuan, XB; Poo, MM				Guan, Chen-bing; Xu, Hua-tai; Jin, Ming; Yuan, Xiao-bing; Poo, Mu-ming			Long-range Ca2+ signaling from growth cone to soma mediates reversal of neuronal migration induced by Slit-2	CELL			English	Article							RHO-FAMILY GTPASES; LEECH RETZIUS NEURONS; NERVE GROWTH; AXON GUIDANCE; ENDOPLASMIC-RETICULUM; DIRECTIONAL GUIDANCE; REGULATED FORMATION; TARGET CONTACT; IN-VIVO; CALCIUM	Neuronal migration and growth-cone extension are both guided by extracellular factors in the developing brain, but whether these two forms of guidance are mechanistically linked is unclear. Application of a Slit-2 gradient in front of the leading process of cultured cerebellar granule cells led to the collapse of the growth cone and the reversal of neuronal migration, an event preceded by a propagating Ca2+ wave from the growth cone to the soma. The Ca2+ wave was required for the Slit-2 effect and was sufficient by itself to induce the reversal of migration. The Slit-2-induced reversal of migration required active RhoA, which was accumulated at the front of the migrating neuron, and this polarized RhoA distribution was reversed during the migration reversal induced by either the Slit-2 gradient or the Ca (2+) wave. Thus, longrange Ca (2+) signaling coordinates the Slit-2induced changes in motility at two distant parts of migrating neurons by regulating RhoA distribution.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Helen Willis Inst Neurosci, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of California System; University of California Berkeley	Poo, MM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	yuanxb@ion.ac.cn; mpoo@berkeley.edu		Yuan, Xiaobing/0000-0002-1632-8460	NINDS NIH HHS [NS22764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; DeBiasio RL, 1996, MOL BIOL CELL, V7, P1259, DOI 10.1091/mbc.7.8.1259; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; GILKEY JC, 1978, J CELL BIOL, V76, P448, DOI 10.1083/jcb.76.2.448; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HEATH JP, 1983, NATURE, V302, P532, DOI 10.1038/302532a0; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; JELLIES J, 1987, J NEUROSCI, V7, P2618; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Johnson LA, 2000, J NEUROBIOL, V43, P365, DOI 10.1002/1097-4695(20000615)43:4<365::AID-NEU5>3.3.CO;2-7; KATER SB, 1991, J NEUROSCI, V11, P891; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; LOER CM, 1987, J NEUROSCI, V7, P2630; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Meinhardt H, 1999, J CELL SCI, V112, P2867; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Sutko JL, 1997, PHARMACOL REV, V49, P53; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; Ward ME, 2005, MOL CELL NEUROSCI, V30, P378, DOI 10.1016/j.mcn.2005.08.002; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; ZHENG JQ, 1994, J CELL BIOL, V127, P1693, DOI 10.1083/jcb.127.6.1693	61	113	122	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					385	395		10.1016/j.cell.2007.01.051	http://dx.doi.org/10.1016/j.cell.2007.01.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448996	Bronze			2022-12-24	WOS:000246474600024
J	Gibbs, RA; Rogers, J; Katze, MG; Bumgarner, R; Weinstock, GM; Mardis, ER; Remington, KA; Strausberg, RL; Venter, JC; Wilson, RK; Batzer, MA; Bustamante, CD; Eichler, EE; Hahn, MW; Hardison, RC; Makova, KD; Miller, W; Milosavljevic, A; Palermo, RE; Siepel, A; Sikela, JM; Attaway, T; Bell, S; Bernard, KE; Buhay, CJ; Chandrabose, MN; Dao, M; Davis, C; Delehaunty, KD; Ding, Y; Dinh, HH; Dugan-Rocha, S; Fulton, LA; Gabisi, RA; Garner, TT; Godfrey, J; Hawes, AC; Hernandez, J; Hines, S; Holder, M; Hume, J; Jhangiani, SN; Joshi, V; Khan, ZM; Kirkness, EF; Cree, A; Fowler, RG; Lee, S; Lewis, LR; Li, ZW; Liu, YS; Moore, SM; Muzny, D; Nazareth, LV; Ngo, DN; Okwuonu, GO; Pai, G; Parker, D; Paul, HA; Pfannkoch, C; Pohl, CS; Rogers, YH; Ruiz, SJ; Sabo, A; Santibanez, J; Schneider, BW; Smith, SM; Sodergren, E; Svatek, AF; Utterback, TR; Vattathil, S; Warren, W; White, CS; Chinwalla, AT; Feng, Y; Halpern, AL; Hillier, LW; Huang, XQ; Minx, P; Nelson, JO; Pepin, KH; Qin, X; Sutton, GG; Venter, E; Walenz, BP; Wallis, JW; Worley, KC; Yang, SP; Jones, SM; Marra, MA; Rocchi, M; Schein, JE; Baertsch, R; Clarke, L; Csuros, M; Glasscock, J; Harris, RA; Haviak, P; Jackson, AR; Jiang, HY; Liu, Y; Messina, DN; Shen, YF; Song, HXZ; Wylie, T; Zhang, L; Birney, E; Han, K; Konkel, MK; Lee, JN; Smit, AFA; Ullmer, B; Wang, H; Xing, J; Burhans, R; Cheng, Z; Karro, JE; Ma, J; Raney, B; She, XW; Cox, MJ; Demuth, JP; Dumas, LJ; Han, SG; Hopkins, J; Karimpour-Fard, A; Kim, YH; Pollack, JR; Vinar, T; Addo-Quaye, C; Degenhardt, J; Denby, A; Hubisz, MJ; Indap, A; Kosiol, C; Lahn, BT; Lawson, HA; Marklein, A; Nielsen, R; Vallender, EJ; Clark, AG; Ferguson, B; Hernandez, RD; Hirani, K; Kehrer-Sawatzki, H; Kolb, J; Patil, S; Pu, LL; Ren, Y; Smith, DG; Wheeler, DA; Schenck, I; Ball, EV; Chen, R; Cooper, DN; Giardine, B; Hsu, F; Kent, WJ; Lesk, A; Nelson, DL; O'Brien, WE; Prufer, K; Stenson, PD; Wallace, JC; Ke, H; Liu, XM; Wang, P; Xiang, AP; Yang, F; Barber, GP; Haussler, D; Karolchik, D; Kern, AD; Kuhn, RM; Smith, KE; Zwieg, AS				Gibbs, Richard A.; Rogers, Jeffrey; Katze, Michael G.; Bumgarner, Roger; Weinstock, George M.; Mardis, Elaine R.; Remington, Karin A.; Strausberg, Robert L.; Venter, J. Craig; Wilson, Richard K.; Batzer, Mark A.; Bustamante, Carlos D.; Eichler, Evan E.; Hahn, Matthew W.; Hardison, Ross C.; Makova, Kateryna D.; Miller, Webb; Milosavljevic, Aleksandar; Palermo, Robert E.; Siepel, Adam; Sikela, James M.; Attaway, Tony; Bell, Stephanie; Bernard, Kelly E.; Buhay, Christian J.; Chandrabose, Mimi N.; Dao, Marvin; Davis, Clay; Delehaunty, Kimberly D.; Ding, Yan; Dinh, Huyen H.; Dugan-Rocha, Shannon; Fulton, Lucinda A.; Gabisi, Ramatu Ayiesha; Garner, Toni T.; Godfrey, Jennifer; Hawes, Alicia C.; Hernandez, Judith; Hines, Sandra; Holder, Michael; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Khan, Ziad Mohid; Kirkness, Ewen F.; Cree, Andrew; Fowler, R. Gerald; Lee, Sandra; Lewis, Lora R.; Li, Zhangwan; Liu, Yih-shin; Moore, Stephanie M.; Muzny, Donna; Nazareth, Lynne V.; Ngo, Dinh Ngoc; Okwuonu, Geoffrey O.; Pai, Grace; Parker, David; Paul, Heidie A.; Pfannkoch, Cynthia; Pohl, Craig S.; Rogers, Yu-Hui; Ruiz, San Juana; Sabo, Aniko; Santibanez, Jireh; Schneider, Brian W.; Smith, Scott M.; Sodergren, Erica; Svatek, Amanda F.; Utterback, Teresa R.; Vattathil, Selina; Warren, Wesley; White, Courtney Sherell; Chinwalla, Asif T.; Feng, Yucheng; Halpern, Aaron L.; Hillier, LaDeana W.; Huang, Xiaoqiu; Minx, Pat; Nelson, Joanne O.; Pepin, Kymberlie H.; Qin, Xiang; Sutton, Granger G.; Venter, Eli; Walenz, Brian P.; Wallis, John W.; Worley, Kim C.; Yang, Shiaw-Pyng; Jones, Steven M.; Marra, Marco A.; Rocchi, Mariano; Schein, Jacqueline E.; Baertsch, Robert; Clarke, Laura; Csuros, Miklos; Glasscock, Jarret; Harris, R. Alan; Haviak, Paul; Jackson, Andrew R.; Jiang, Huaiyang; Liu, Yue; Messina, David N.; Shen, Yufeng; Song, Henry Xing-Zhi; Wylie, Todd; Zhang, Lan; Birney, Ewan; Han, Kyudong; Konkel, Miriam K.; Lee, Jungnam; Smit, Arlan F. A.; Ullmer, Brygg; Wang, Hui; Xing, Jinchuan; Burhans, Richard; Cheng, Ze; Karro, John E.; Ma, Jian; Raney, Brian; She, Xinwei; Cox, Michael J.; Demuth, Jeffrey P.; Dumas, Laura J.; Han, Sang-Gook; Hopkins, Janet; Karimpour-Fard, Anis; Kim, Young H.; Pollack, Jonathan R.; Vinar, Tomas; Addo-Quaye, Charles; Degenhardt, Jeremiah; Denby, Alexandra; Hubisz, Melissa J.; Indap, Amit; Kosiol, Carolin; Lahn, Bruce T.; Lawson, Heather A.; Marklein, Alison; Nielsen, Rasmus; Vallender, Eric J.; Clark, Andrew G.; Ferguson, Betsy; Hernandez, Ryan D.; Hirani, Kashif; Kehrer-Sawatzki, Hildegard; Kolb, Jessica; Patil, Shobha; Pu, Ling-Ling; Ren, Yanru; Smith, David Glenn; Wheeler, David A.; Schenck, Ian; Ball, Edward V.; Chen, Rui; Cooper, David N.; Giardine, Belinda; Hsu, Fan; Kent, W. James; Lesk, Arthur; Nelson, David L.; O'Brien, William E.; Prufer, Kay; Stenson, Peter D.; Wallace, James C.; Ke, Hui; Liu, Xiao-Ming; Wang, Peng; Xiang, Andy Peng; Yang, Fan; Barber, Galt P.; Haussler, David; Karolchik, Donna; Kern, Andy D.; Kuhn, Robert M.; Smith, Kayla E.; Zwieg, Ann S.		Rhesus Macaque Genome Sequencing Consortium	Evolutionary and biomedical insights from the rhesus macaque genome	SCIENCE			English	Article							PRIMATE SEGMENTAL DUPLICATIONS; SUBSTITUTION; SEQUENCE; DATABASE; MODELS; SITES; MOUSE; DNA; INFORMATION; DIVERGENCE	The rhesus macaque ( Macaca mulatta) is an abundant primate species that diverged from the ancestors of Homo sapiens about 25 million years ago. Because they are genetically and physiologically similar to humans, rhesus monkeys are the most widely used nonhuman primate in basic and applied biomedical research. We determined the genome sequence of an Indian-origin Macaca mulatta female and compared the data with chimpanzees and humans to reveal the structure of ancestral primate genomes and to identify evidence for positive selection and lineage-specific expansions and contractions of gene families. A comparison of sequences from individual animals was used to investigate their underlying genetic diversity. The complete description of the macaque genome blueprint enhances the utility of this animal model for biomedical research and improves our understanding of the basic biology of the species.	Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; J Craig Veriter Inst, Rockville, MD 20850 USA; Louisiana State Univ, Ctr Biomodular Multiscale Syst, Dept Biol Sci, Biol Computat & Visualizat Ctr, Baton Rouge, LA 70803 USA; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Indiana Univ, Sch Informat, Bloomington, IN 47405 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Univ Colorado, Dept Pharmacol, Human Med Genet Program, Denver, CO USA; Univ Colorado, Dept Pharmacol, Program Neurosci, Denver, CO USA; Ctr Hlth Sci, Aurora, CO 80045 USA; Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Univ Bari, Dept Genet & Microbiol, Bari, Italy; Univ Calif Santa Cruz, Genome Sci Ctr, Santa Cruz, CA 95060 USA; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Montreal, Dept Informat & Rech Operat, Montreal, PQ H3C 3J7, Canada; Inst Syst Biol, Seattle, WA 98103 USA; Louisiana State Univ, Dept Comp Sci, Ctr Computat & Technol, Baton Rouge, LA 70803 USA; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80202 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Copenhagen, Inst Biol, DK-1017 Copenhagen, Denmark; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Oregon Reg Primate Res Ctr, Genet Res & Informat Program, Beaverton, OR 97006 USA; Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, Wales; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Guangzhou 510080, Peoples R China; S China Primate Res & Dev Ctr, Guangzhou 510080, Peoples R China; Howard Hughes Med Inst, Santa Cruz, CA 95060 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Biomedical Research Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL); Louisiana State University System; Louisiana State University; Cornell University; University of Washington; University of Washington Seattle; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Iowa State University; British Columbia Cancer Agency; Universita degli Studi di Bari Aldo Moro; University of California System; University of California Santa Cruz; Wellcome Trust Sanger Institute; Universite de Montreal; Institute for Systems Biology (ISB); Louisiana State University System; Louisiana State University; Utah System of Higher Education; University of Utah; University of California System; University of California Santa Cruz; University of Colorado System; University of Colorado Denver; Stanford University; University of Chicago; University of Copenhagen; Cornell University; Oregon Health & Science University; Oregon National Primate Research Center; Ulm University; Cardiff University; Max Planck Society; Sun Yat Sen University; Howard Hughes Medical Institute	Gibbs, RA (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	agibbs@bcm.edu	Bumgarner, Roger/AAA-6846-2020; Jones, Steven J/C-3621-2009; Bumgarner, Roger E/K-3531-2015; Mardis, Elaine/W-2202-2019; Schein, Jacquie E/G-3674-2015; Vinar, Tomas/I-3695-2014; Messina, Dave/B-2405-2009; Weinstock, George M/C-6314-2013; Marra, Marco A/B-5987-2008; Hardison, Ross C/G-1142-2010; Xing, Jinchuan/A-2489-2012; Wilson, Richard K./AAF-4139-2019; Vallender, Eric/A-2450-2008; Ma, Jian/A-9838-2008; Han, Kyudong/AAF-1788-2019; Cooper, David N/H-4384-2011; Harris, R. Alan/AAI-2784-2020; Addo-Quaye, Charles/J-3694-2016; Wheeler, David A/M-9740-2018; Raney, Brian/ABE-6267-2020; Nielsen, Rasmus/D-4405-2009	Jones, Steven J/0000-0003-3394-2208; Bumgarner, Roger E/0000-0002-8168-6985; Vinar, Tomas/0000-0003-3898-3447; Weinstock, George M/0000-0002-2997-4592; Marra, Marco A/0000-0001-7146-7175; Hardison, Ross C/0000-0003-4084-7516; Wilson, Richard K./0000-0002-1992-1358; Vallender, Eric/0000-0003-3506-0540; Ma, Jian/0000-0002-4202-5834; Han, Kyudong/0000-0001-6791-2408; Cooper, David N/0000-0002-8943-8484; Harris, R. Alan/0000-0002-7333-4752; Addo-Quaye, Charles/0000-0003-0598-5980; Wheeler, David A/0000-0002-9056-6299; Nielsen, Rasmus/0000-0003-0513-6591; Hahn, Matthew/0000-0002-5731-8808; Lawson, Heather/0000-0002-3550-5485; Worley, Kim/0000-0002-0282-1000; Rocchi, Mariano/0000-0002-9451-5616; Messina, David/0000-0002-2287-2761; Indap, Amit/0000-0002-3322-4735; Siepel, Adam/0000-0002-3557-7219; Hubisz, Melissa/0000-0002-9561-6830; Clarke, Laura/0000-0002-5989-6898; Birney, Ewan/0000-0001-8314-8497; Clark, Andrew/0000-0001-7159-8511; Chinwalla, Asif/0000-0001-7831-3996; Lesk, Arthur/0000-0002-2596-0601	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003068, R01HG002939, U54HG003079] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Baas T, 2006, J VIROL, V80, P10813, DOI 10.1128/JVI.00851-06; Bailey JA, 2003, COLD SPRING HARB SYM, V68, P115, DOI 10.1101/sqb.2003.68.115; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Barton NH, 2006, CURR BIOL, V16, pR647, DOI 10.1016/j.cub.2006.07.032; Bartosch-Harlid A, 2003, EVOLUTION, V57, P2398, DOI 10.1554/03-036; Betancourt AJ, 2004, GENETICS, V168, P2261, DOI 10.1534/genetics.104.030999; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Chismar JD, 2002, BIOTECHNIQUES, V33, P516, DOI 10.2144/02333st01_11836a; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Gao LZ, 2003, TRENDS GENET, V19, P678, DOI 10.1016/j.tig.2003.10.002; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goetting-Minesky MP, 2006, J MOL EVOL, V63, P537, DOI 10.1007/s00239-005-0308-8; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Groves CP, 2001, PRIMATE TAXONOMY; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Han K, 2007, SCIENCE, V316, P238, DOI 10.1126/science.1139462; Harris RA, 2007, SCIENCE, V316, P235, DOI 10.1126/science.1139477; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; *I MED GEN CARD, 2006, HUM GEN MUT DAT; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kalafus KJ, 2004, GENOME RES, V14, P672, DOI 10.1101/gr.1963804; Kehrer-Sawatzki H, 2007, HUM GENET, V120, P759, DOI 10.1007/s00439-006-0270-6; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lynch M, 2001, GENETICS, V159, P1789; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Makova KD, 2004, GENOME RES, V14, P567, DOI 10.1101/gr.1971104; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Milosavljevic A, 2005, GENOME RES, V15, P292, DOI 10.1101/gr.3162505; Murphy WJ, 2005, GENOMICS, V86, P383, DOI 10.1016/j.ygeno.2005.05.013; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 1998, GENETICS, V148, P929; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; Spindel ER, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-160; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Umeda S, 2005, INVEST OPHTH VIS SCI, V46, P683, DOI 10.1167/iovs.04-1031; van Baren MJ, 2006, GENOME RES, V16, P678, DOI 10.1101/gr.4766206; Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615; Wallace JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-28; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WIENBERG J, 1992, CHROMOSOMA, V101, P265, DOI 10.1007/BF00346004; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zahn LM, 2007, SCIENCE, V316, P215, DOI 10.1126/science.316.5822.215	71	986	1045	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					222	234		10.1126/science.1139247	http://dx.doi.org/10.1126/science.1139247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431167	Green Submitted			2022-12-24	WOS:000245654500037
J	Palla, G; Barabasi, AL; Vicsek, T				Palla, Gergely; Barabasi, Albert-Laszlo; Vicsek, Tamas			Quantifying social group evolution	NATURE			English	Article							COMMUNITY STRUCTURE; NETWORK STRUCTURE; COLLABORATION	The rich set of interactions between individuals in society(1-7) results in complex community structure, capturing highly connected circles of friends, families or professional cliques in a social network(3,7-10). Thanks to frequent changes in the activity and communication patterns of individuals, the associated social and communication network is subject to constant evolution(7,11-16). Our knowledge of the mechanisms governing the underlying community dynamics is limited, but is essential for a deeper understanding of the development and self-optimization of society as a whole(17-22). We have developed an algorithm based on clique percolation(23,24) that allows us to investigate the time dependence of overlapping communities on a large scale, and thus uncover basic relationships characterizing community evolution. Our focus is on networks capturing the collaboration between scientists and the calls between mobile phone users. We find that large groups persist for longer if they are capable of dynamically altering their membership, suggesting that an ability to change the group composition results in better adaptability. The behaviour of small groups displays the opposite tendency - the condition for stability is that their composition remains unchanged. We also show that knowledge of the time commitment of members to a given community can be used for estimating the community's lifetime. These findings offer insight into the fundamental differences between the dynamics of small groups and large institutions.	HAS, Stat & Biol Phys Res Grp, H-1117 Budapest, Hungary; Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46566 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46566 USA; Univ Notre Dame, Dept Comp Sci, Notre Dame, IN 46566 USA; Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary	Hungarian Academy of Sciences; University of Notre Dame; University of Notre Dame; University of Notre Dame; Eotvos Lorand University	Vicsek, T (corresponding author), HAS, Stat & Biol Phys Res Grp, Pazmany P Stny 1A, H-1117 Budapest, Hungary.	vicsek@angel.elte.hu	Barabasi, Albert-Laszlo/S-6474-2017; Palla, Gergely/H-1767-2016; Vicsek, Tamas/A-3305-2009	Palla, Gergely/0000-0002-3406-4200; Barabasi, Albert/0000-0002-4028-3522				Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Csermely P., 2006, WEAK LINKS; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Ebel Holger, 2002, Complexity, V8, P24, DOI 10.1002/cplx.10066; Everett M.G., 1998, CONNECTIONS, V21, P49; FAUST K, 2005, MODELS METHODS SOCIA, pCH7; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; Hopcroft J, 2004, P NATL ACAD SCI USA, V101, P5249, DOI 10.1073/pnas.0307750100; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Li CG, 2005, J PHYS A-MATH GEN, V38, P9741, DOI 10.1088/0305-4470/38/45/002; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; ONNEAL JP, 2006, STRUCTURE TIE STRENG; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pollner P, 2006, EUROPHYS LETT, V73, P478, DOI 10.1209/epl/i2005-10414-6; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Shiffrin RM, 2004, P NATL ACAD SCI USA, V101, P5183, DOI 10.1073/pnas.0307852100; Wagner CS, 2005, RES POLICY, V34, P1608, DOI 10.1016/j.respol.2005.08.002; Warner S., 2003, Library Hi Tech, V21, P151, DOI 10.1108/07378830310479794; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Yeung YY, 2005, AM J PHYS, V73, P145, DOI 10.1119/1.1775799	29	1004	1094	7	316	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					664	667		10.1038/nature05670	http://dx.doi.org/10.1038/nature05670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	153LZ	17410175	Green Submitted			2022-12-24	WOS:000245438300039
J	Melcak, I; Hoelz, A; Blobel, G				Melcak, Ivo; Hoelz, Andre; Blobel, Guenter			Structure of Nup58/45 suggests flexible nuclear pore diameter by intermolecular sliding	SCIENCE			English	Article							IMPORTIN-BETA; P62 COMPLEX; FG REPEAT; EXPORT; TRANSPORT; PROTEINS; CONFIGURATIONS; VISUALIZATION; GLYCOPROTEINS; NUCLEOPORINS	The nucleoporins Nup58 and Nup45 are part of the central transport channel of the nuclear pore complex, which is thought to have a flexible diameter. In the crystal structure of an alpha-helical region of mammalian Nup58/45, we identified distinct tetramers, each consisting of two antiparallel hairpin dimers. The intradimeric interface is hydrophobic, whereas dimer-dimer association occurs through large hydrophilic residues. These residues are laterally displaced in various tetramer conformations, which suggests an intermolecular sliding by 11 angstroms. We propose that circumferential sliding plays a role in adjusting the diameter of the central transport channel.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Hoelz, A (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.	hoelza@rockefeller.edu; blobel@rockefeller.edu	Hoelz, Andre/AAB-6978-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111461] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM111461] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKEY CW, 1989, J CELL BIOL, V109, P971, DOI 10.1083/jcb.109.3.971; AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Hu TH, 1998, GENE, V221, P245, DOI 10.1016/S0378-1119(98)00467-3; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Kiseleva E, 1996, J MOL BIOL, V260, P304, DOI 10.1006/jmbi.1996.0401; Kiseleva E, 1998, J CELL SCI, V111, P223; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; REICHELT R, 1990, J CELL BIOL, V110, pB83; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; STOFFTER D, 2003, J MOL BIOL, V32, P119; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705	28	94	95	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 23	2007	315	5819					1729	1732		10.1126/science.1135730	http://dx.doi.org/10.1126/science.1135730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17379812				2022-12-24	WOS:000245106900045
J	Savaldi-Goldstein, S; Peto, C; Chory, J				Savaldi-Goldstein, Sigal; Peto, Charles; Chory, Joanne			The epidermis both drives and restricts plant shoot growth	NATURE			English	Article							ARABIDOPSIS-THALIANA; BRASSINOSTEROID BIOSYNTHESIS; STEM ELONGATION; LEAF-SHAPE; GENE; EXPRESSION; CYTOCHROME-P450; CELLS; WALL	The size of an organism is genetically determined, yet how a plant or animal achieves its final size is largely unknown. The shoot of higher plants has a simple conserved body plan based on three major tissue systems: the epidermal (L1), sub-epidermal (L2) and inner ground and vascular (L3) tissues. Which tissue system drives or restricts growth has been a subject of debate for over a century(1-4). Here, we use dwarf, brassinosteroid biosynthesis and brassinosteroid response mutants in conjunction with tissue-specific expression of these components as tools to examine the role of the epidermis in shoot growth. We show that expression of the brassinosteroid receptor or a brassinosteroid biosynthetic enzyme in the epidermis, but not in the vasculature, of null mutants is sufficient to rescue their dwarf phenotypes. Brassinosteroid signalling from the epidermis is not sufficient to establish normal vascular organization. Moreover, shoot growth is restricted when brassinosteroids are depleted from the epidermis and brassinosteroids act locally within a leaf. We conclude that the epidermis both promotes and restricts shoot growth by providing a nonautonomous signal to the ground tissues.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Neuronal Struct & Funct Lab, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu						Baima S, 1995, DEVELOPMENT, V121, P4171; Bishop GJ, 1996, PLANT CELL, V8, P959, DOI 10.1105/tpc.8.6.959; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Choe SW, 1999, PLANT CELL, V11, P207, DOI 10.1105/tpc.11.2.207; DALE JE, 1988, ANNU REV PLANT PHYS, V39, P267, DOI 10.1146/annurev.arplant.39.1.267; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GREEN PB, 1994, J EXP BOT, V45, P1775, DOI 10.1093/jxb/45.Special_Issue.1775; Kurata T, 2005, CURR OPIN PLANT BIOL, V8, P600, DOI 10.1016/j.pbi.2005.09.005; Kutschera U, 2001, PLANT BIOLOGY, V3, P466, DOI 10.1055/s-2001-17731; Nakamura S, 2003, REC RES DEV MAGNET M, V1, P1; Nakaya M, 2002, PLANT CELL PHYSIOL, V43, P239, DOI 10.1093/pcp/pcf024; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Peters WS, 1996, BOT ACTA, V109, P264, DOI 10.1111/j.1438-8677.1996.tb00572.x; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Symons GM, 2004, PLANT PHYSIOL, V135, P2196, DOI 10.1104/pp.104.043034; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Turk EM, 2003, PLANT PHYSIOL, V133, P1643, DOI 10.1104/pp.103.030882; Turner S, 2003, ARABIDOPSIS BOOK, pe0073, DOI 10.1199/tab.0073; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	26	309	321	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					199	202		10.1038/nature05618	http://dx.doi.org/10.1038/nature05618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17344852				2022-12-24	WOS:000244718100043
J	Liu, C; Li, SM; Liu, TH; Borjigin, J; Lin, JD				Liu, Chang; Li, Siming; Liu, Tiecheng; Borjigin, Jimo; Lin, Jiandie D.			Transcriptional coactivator PGC-1a integrates the mammalian clock and energy metabolism	NATURE			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; CIRCADIAN GENE-EXPRESSION; OSCILLATORS; PGC-1-ALPHA; HOMEOSTASIS; COMPONENT; LIVER	The mammalian clock regulates major aspects of energy metabolism, including glucose and lipid homeostasis and mitochondrial oxidative metabolism(1,2). The biochemical basis for coordinated control of the circadian clock and diverse metabolic pathways is not well understood. Here we show that PGC-1 alpha (Ppargc1a), a transcriptional coactivator that regulates energy metabolism(3-9), is rhythmically expressed in the liver and skeletal muscle of mice. PGC-1 alpha stimulates the expression of clock genes, notably Bmal1 (Arntl) and Rev-erba (Nr1d1), through coactivation of the ROR family of orphan nuclear receptors. Mice lacking PGC-1 alpha show abnormal diurnal rhythms of activity, body temperature and metabolic rate. The disruption of physiological rhythms in these animals is correlated with aberrant expression of clock genes and those involved in energy metabolism. Analyses of PGC-1 alpha-deficient fibroblasts and mice with liver-specific knockdown of PGC-1 alpha indicate that it is required for cell-autonomous clock function. We have thus identified PGC-1 alpha as a key component of the circadian oscillator that integrates the mammalian clock and energy metabolism.	Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lin, JD (corresponding author), Univ Michigan, Med Ctr, Inst Life Sci, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jdlin@umich.edu	Borjigin, Jimo/GXA-3484-2022					Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	30	473	497	3	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					477	U4		10.1038/nature05767	http://dx.doi.org/10.1038/nature05767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17476214	Green Published			2022-12-24	WOS:000246693100048
J	Myers, RA; Baum, JK; Shepherd, TD; Powers, SP; Peterson, CH				Myers, Ransom A.; Baum, Julia K.; Shepherd, Travis D.; Powers, Sean P.; Peterson, Charles H.			Cascading effects of the loss of apex predatory sharks from a coastal ocean	SCIENCE			English	Article							LOWER CHESAPEAKE BAY; TROPHIC CASCADES; INTERACTION STRENGTH; RHINOPTERA-BONASUS; MARINE ECOSYSTEMS; COWNOSE RAY; FOOD WEBS; SCALLOPS; EXTINCTIONS; COLLAPSE	Impacts of chronic overfishing are evident in population depletions worldwide, yet indirect ecosystem effects induced by predator removal from oceanic food webs remain unpredictable. As abundances of all 11 great sharks that consume other elasmobranchs (rays, skates, and small sharks) fell over the past 35 years, 12 of 14 of these prey species increased in coastal northwest Atlantic ecosystems. Effects of this community restructuring have cascaded downward from the cownose ray, whose enhanced predation on its bay scallop prey was sufficient to terminate a century-long scallop fishery. Analogous top-down effects may be a predictable consequence of eliminating entire functional groups of predators.	Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL 36528 USA; Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA	University of North Carolina; University of North Carolina Chapel Hill; Dalhousie University; University of South Alabama; Dauphin Island Sea Lab	Baum, JK (corresponding author), Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA.	baum@mscs.dal.ca; cpeters@email.unc.edu	Baum, Julia K/A-4693-2008	Powers, Sean/0000-0002-4770-9944; Baum, Julia/0000-0002-9827-1612				Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; BLAYLOCK RA, 1993, ESTUARIES, V16, P255, DOI 10.2307/1352498; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; FAHRENTHOLD DA, 2004, WASHINGTON POST 0824; FOWLER SL, 2005, RAYS CHIMAERAS STATU; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Grusha, 2005, THESIS COLL WILLIAM; Ha D., 2006, THESIS COLL WILLIAM; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; ORTH R J, 1975, Chesapeake Science, V16, P205, DOI 10.2307/1350896; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1980, J ANIM ECOL, V49, P667; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Peterson CH, 1996, MAR ECOL PROG SER, V132, P93, DOI 10.3354/meps132093; PETERSON CH, 1989, J EXP MAR BIOL ECOL, V127, P121, DOI 10.1016/0022-0981(89)90179-2; Peterson CH, 2001, OECOLOGIA, V129, P349, DOI 10.1007/s004420100742; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; SMITH JW, 1985, ESTUARIES, V8, P305, DOI 10.2307/1351491; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Yamaguchi A, 2005, ENVIRON BIOL FISH, V74, P229, DOI 10.1007/s10641-005-0217-0	26	879	900	20	1155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1846	1850		10.1126/science.1138657	http://dx.doi.org/10.1126/science.1138657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395829				2022-12-24	WOS:000245280100044
J	Krzemien, J; Dubois, L; Makki, R; Meister, M; Vincent, A; Crozatier, M				Krzemien, Joanna; Dubois, Laurence; Makki, Rami; Meister, Marie; Vincent, Alain; Crozatier, Michele			Control of blood cell homeostasis in Drosophila larvae by the posterior signalling centre	NATURE			English	Article							STEM-CELLS; HEMATOPOIESIS; NICHE; MELANOGASTER; INSIGHTS; DELTA	Drosophila haemocytes ( blood cells) originate from a specialized haematopoietic organ - the lymph gland. Larval haematopoietic progenitors (prohaemocytes) give rise to three types of circulating haemocytes: plasmatocytes, crystal cells and lamellocytes. Lamellocytes, which are devoted to encapsulation of large foreign bodies, only differentiate in response to specific immune threats, such as parasitization by wasps. Here we show that a small cluster of signalling cells, termed the PSC ( posterior signalling centre)(1), controls the balance between multipotent prohaemocytes and differentiating haemocytes, and is necessary for the massive differentiation of lamellocytes that follows parasitization. Communication between the PSC and haematopoietic progenitors strictly depends on the PSC-restricted expression of Collier, the Drosophila orthologue of mammalian early B-cell factor. PSC cells act, in a non-cell-autonomous manner, to maintain JAK/STAT signalling activity in prohaemocytes, preventing their premature differentiation. Serrate-mediated Notch signalling from the PSC is required to maintain normal levels of col transcription. The key role of the PSC in controlling blood cell homeostasis is reminiscent of interactions between haematopoietic progenitors and their microenvironment in vertebrates(2 - 4), thus further highlighting the interest of Drosophila as a model system for studying the evolution of haematopoiesis and cellular innate immunity.	Univ Toulouse 3, CNRS, UMR 5547, Ctr Dev Biol, F-31062 Toulouse 09, France; Univ Toulouse 3, CNRS, IFR 109, Ctr Dev Biol, F-31062 Toulouse, France; Jagiellonian Univ, Inst Zool, PL-30060 Krakow, Poland; CNRS, UPR 9022, IBMC, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Jagiellonian University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Crozatier, M (corresponding author), Univ Toulouse 3, CNRS, UMR 5547, Ctr Dev Biol, 118 Route Narbonne, F-31062 Toulouse 09, France.	crozat@cict.fr	Vincent, Alain/AAE-4712-2019; Makki, Rami/F-9236-2012					Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bataille L, 2005, DEVELOPMENT, V132, P4635, DOI 10.1242/dev.02034; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 1999, DEVELOPMENT, V126, P1495; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; KIMBLE J, 2005, WORMBOOK; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; RIZKI RM, 1984, P NATL ACAD SCI-BIOL, V81, P6154, DOI 10.1073/pnas.81.19.6154; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sepp KJ, 1999, GENETICS, V151, P1093; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Sun X, 1996, DEVELOPMENT, V122, P2465; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	28	242	251	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					325	328		10.1038/nature05650	http://dx.doi.org/10.1038/nature05650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361184				2022-12-24	WOS:000244892900047
J	Anand, S; Barnighausen, T				Anand, Sudhir; Baernighausen, Till			Health workers and vaccination coverage in developing countries: an econometric analysis	LANCET			English	Article							IMMUNIZATION COVERAGE; HUMAN-RESOURCES; MEASLES; DETERMINANTS; ERADICATION; CHILDREN; BANGLADESH; EDUCATION; POLIO; AREA	Background Vaccine-preventable diseases cause more than 1 million deaths among children in developing countries every year. Although health workers are needed to do vaccinations, the role of human resources for health as a determinant of vaccination coverage at the population level has not been investigated. our aim was to test whether health worker density was positively associated with childhood vaccination coverage in developing countries. Methods We did cross-country multiple regression analyses with coverage of three vaccinations-measles-containing vaccine (MCV); diphtheria, tetanus, and pertussis (DTP3); and poliomyelitis (polio3)-as dependent variables. Aggregate health worker density was an independent variable in one set of regressions; doctor and nurse densities were used separately in another set. We controlled for national income per person, female adult literacy, and land area. Findings Health worker density was significantly associated with coverage of all three vaccinations (MCV p=0.0024; DTP3 p=0.0004; polio3 p=0.0008). However, when the effects of doctors and nurses were assessed separately, we found that nurse density was significantly associated with coverage of all three vaccinations (MCV p=0.0097; DTP3 p=0.0083; polio3 p=0.0089), but doctor density was not (MCV p=0.7953; DTP3 p=0.7971; polio3 p=0.7885). Female adult literacy was positively associated, and land area negatively associated, with vaccination coverage. National income per person had no effect on coverage. Interpretation A higher density of health workers (nurses) increases the availability of vaccination services over time and space, making it more likely that children will be vaccinated. After controlling for other determinants, the level of income does not contribute to improved immunisation coverage. Health workers can be a major constraining factor on vaccination coverage in developing countries.	Univ Oxford St Catherines Coll, Dept Econ, Oxford OX1 3UJ, England; Harvard Univ, Cambridge, MA 02138 USA; Univ KwaZulu Natal, Africa Ctr hlth & Populat Studies, Mtubatuba, South Africa; Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	University of Oxford; Harvard University; University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health	Anand, S (corresponding author), Univ Oxford St Catherines Coll, Dept Econ, Oxford OX1 3UJ, England.	sudhir.anand@economics.ox.ac.uk	Bärnighausen, Till/Y-2388-2019					Abuwa P N, 1997, West Afr J Med, V16, P174; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Aylward RB, 2005, B WORLD HEALTH ORGAN, V83, P268; BERRY DJ, 1991, S AFR MED J, V79, P433; BOERMA JT, 1994, QUALITY DATA CHILD I; Brown J., 2002, WP0253 MEASURE U N C; BRUGHA R, 1995, HEALTH POLICY PLANN, V10, P312, DOI 10.1093/heapol/10.3.312; Chowdhury AMR, 2003, J HEALTH POPUL NUTR, V21, P193; COETZEE N, 1990, S AFR MED J, V78, P733; CUTTS FT, 1991, INT J EPIDEMIOL, V20, P1099, DOI 10.1093/ije/20.4.1099; CUTTS FT, 1989, INT J EPIDEMIOL, V18, P427, DOI 10.1093/ije/18.2.427; Dayan GH, 2004, VACCINE, V22, P475, DOI 10.1016/j.vaccine.2003.07.007; de Quadros CA, 2002, MED MICROBIOL IMMUN, V191, P75, DOI 10.1007/s00430-002-0120-7; DEFO BK, 1994, SOC BIOL, V41, P181; DIALLO K, 2004, METHODOLOGICAL NOTE; Dubois CA, 2006, HEALTH ECON POLICY L, V1, P59, DOI 10.1017/S1744133105001027; Ekwueme DU, 2000, ARCH PEDIAT ADOL MED, V154, P797, DOI 10.1001/archpedi.154.8.797; ENGLAND S, 2001, CHM WORKING PAPER SE; Gauri V, 2002, WORLD DEV, V30, P2109, DOI 10.1016/S0305-750X(02)00151-1; *GAVI, 2003, 11 GAVI BOARD M HUM; *GAVI, 2005, ANN DEATHS 2002 VACC; *GAVI, 2005, GAVI OBJ; *GAVI, 2005, KEY EUR NAT JOIN UK; Gilling C M, 1989, Nurse Educ Today, V9, P82, DOI 10.1016/0260-6917(89)90058-0; HADI AS, 1994, J ROY STAT SOC B MET, V56, P393; JLI (Joint Learning Initiative), 2004, HUM RES HLTH OV CRIS; Kamau N, 2001, East Afr Med J, V78, P590; Khaleghian P, 2004, SOC SCI MED, V59, P163, DOI 10.1016/j.socscimed.2003.10.013; Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1; Luman ET, 2003, PEDIATRICS, V111, P1215; *MACR INT, 2007, DEM HLTH SURV STATC; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; Nokes DJ, 1997, TRENDS MICROBIOL, V5, P14, DOI 10.1016/S0966-842X(97)81769-6; Nolte A, 1995, Curationis, V18, P49; NUTTER DO, 1983, J MED EDUC, V58, P555; OBERMEYER CM, 1993, J BIOSOC SCI, V25, P371, DOI 10.1017/S0021932000020708; PILLAI VK, 1992, J BIOSOC SCI, V24, P201, DOI 10.1017/S0021932000019738; REES H, 1991, S AFR MED J, V80, P378; Rolls C, 1996, Aust Coll Midwives Inc J, V9, P18, DOI 10.1016/S1031-170X(96)80007-9; Steele F, 1996, J ROY STAT SOC A STA, V159, P289, DOI 10.2307/2983175; STREATFIELD K, 1990, DEMOGRAPHY, V27, P447, DOI 10.2307/2061378; Stronegger WJ, 1998, ZBL HYG UMWELTMED, V201, P437; Ughade S N, 2000, J Indian Med Assoc, V98, P4; *UNDP, 1993, HUM DEV REP 1993 200; United Nations Development Programme (UNDP), 2007, MILL DEV GOALS TRACK; Uzicanin A, 2004, VACCINE, V22, P3419, DOI 10.1016/j.vaccine.2004.02.042; *WHO, 2002, COR INF DEV IMM POL; *WHO, 2005, GLOB POL IN 2004 ANN; *WHO, IMM PRACT PRACT RES; *WHO, 2004, WHO EST HLTH PERS PH; *WHO, 2005, EC IMM GUI LIT OTH R; *WHO, 2005, IMM COV; *WHO, 2004, EST ANN DEATHS DIS A; *WORLD BANK, 2006, WORLD DEV IND; World Health Organization, 2006, WORK HLTH WORLD HLTH; World Health Organization, 2005, GLOB ATL HLTH WORKF GLOB ATL HLTH WORKF; Zeleke SA, 2000, LANCET, V356, pS21, DOI 10.1016/S0140-6736(00)92007-5	57	163	165	2	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2007	369	9569					1277	1285		10.1016/S0140-6736(07)60599-6	http://dx.doi.org/10.1016/S0140-6736(07)60599-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164YA	17434403				2022-12-24	WOS:000246269700030
J	Marco, E; Wedlich-Soldner, R; Li, R; Altschuler, SJ; Wu, LF				Marco, Eugenio; Wedlich-Soldner, Roland; Li, Rong; Altschuler, Steven J.; Wu, Lani F.			Endocytosis optimizes the dynamic localization of membrane proteins that regulate cortical polarity	CELL			English	Article							BUDDING YEAST; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CELL POLARITY; MYOSIN; GROWTH; CDC42P; POLARIZATION; DIFFUSION; TRANSPORT	Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing transport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes.Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing transport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes.Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing transport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes. Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing tranport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes.	Univ Texas, SW Med Ctr, Dept Pharmacol, Div Syst Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Green Ctr, Div Syst Biol, Dallas, TX 75390 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Stowers Inst Med Res, Kansas City, MO 64112 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Max Planck Society; Stowers Institute for Medical Research	Altschuler, SJ (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Div Syst Biol, Dallas, TX 75390 USA.	steven.altschuler@utsouthwestern.edu; lani.wu@utsouthwestern.edu	Marco, Eugenio/F-4583-2011	Marco, Eugenio/0000-0002-3675-263X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071794] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071794-03, R01 GM071794] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Berg, 2018, RANDOM WALKS BIOL; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; BRETSCHER MS, 1983, EMBO J, V2, P599, DOI 10.1002/j.1460-2075.1983.tb01469.x; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Irazoqui JE, 2005, MOL BIOL CELL, V16, P1296, DOI 10.1091/mbc.E04-05-0430; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; KARPOVA TS, 1995, J CELL BIOL, V131, P1483, DOI 10.1083/jcb.131.6.1483; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Mayer B, 2005, CURR BIOL, V15, P1847, DOI 10.1016/j.cub.2005.08.067; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Pyenta PS, 2003, J PHYS CHEM A, V107, P8310, DOI 10.1021/jp030005t; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Slaughter B, 2006, CURR OPIN CELL BIOL, V18, P47, DOI 10.1016/j.ceb.2005.11.003; Snaith HA, 2003, NATURE, V423, P647, DOI 10.1038/nature01672; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	45	166	166	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					411	422		10.1016/j.cell.2007.02.043	http://dx.doi.org/10.1016/j.cell.2007.02.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448998	Green Accepted, Bronze			2022-12-24	WOS:000246474600026
J	Sevier, CS; Qu, HJ; Heldman, N; Gross, E; Fass, D; Kaiser, CA				Sevier, Carolyn S.; Qu, Hongjing; Heldman, Nimrod; Gross, Einav; Fass, Deborah; Kaiser, Chris A.			Modulation of cellular disulfide-bond formation and the ER redox environment by feedback-regulation of Ero1	CELL			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; PROTEIN; GLUTATHIONE; ISOMERASE; PATHWAY; OXIDASE; YEAST; PAIRS	Introduction of disulfide bonds into proteins entering the secretory pathway is catalyzed by Ero1p, which generates disulfide bonds de novo, and Pdi1p, which transfers disulfides to substrate proteins. A sufficiently oxidizing environment must be maintained in the endoplasmic reticulum (ER) to allow for disulfide formation, but a pool of reduced thiols is needed for isomerization of incorrectly paired disulfides. We have found that hyperoxidation of the ER is prevented by attenuation of Ero1p activity through noncatalytic cysteine pairs. Deregulated Ero1p mutants lacking certain cysteines show increased enzyme activity, a decreased lag phase in kinetic assays, and growth defects in vivo. We hypothesize that noncatalytic cysteine pairs in Ero1p sense the level of potential substrates in the ER and correspondingly modulate Ero1p activity as part of a homeostatic regulatory system governing the thiol-disulfide balance in the ER.	MIT, Dept Biol, Cambridge, MA 02139 USA; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Massachusetts Institute of Technology (MIT); Weizmann Institute of Science	Kaiser, CA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ckaiser@mit.edu	Gross, Einav/AAS-7417-2021	Sevier, Carolyn/0000-0003-3245-6988	NIGMS NIH HHS [GM46941, R01 GM046941] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046941] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; STEPHEN DWS, 1995, MOL MICROBIOL, V16, P415, DOI 10.1111/j.1365-2958.1995.tb02407.x; Takemori Y, 2006, MOL GENET GENOMICS, V275, P89, DOI 10.1007/s00438-005-0065-9; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2	30	185	190	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					333	344		10.1016/j.cell.2007.02.039	http://dx.doi.org/10.1016/j.cell.2007.02.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448992	Bronze			2022-12-24	WOS:000246474600020
J	Mandal, L; Martinez-Agosto, JA; Evans, CJ; Hartenstein, V; Banerjee, U				Mandal, Lolitika; Martinez-Agosto, Julian A.; Evans, Cory J.; Hartenstein, Volker; Banerjee, Utpal			A Hedgehog- and Antennapedia-dependent niche maintains Drosophila haematopoietic precursors	NATURE			English	Article							STEM-CELL NICHE; LYMPH-GLAND; MEIS1; BLOOD; AORTA	The Drosophila melanogaster lymph gland is a haematopoietic organ(1-3) in which pluripotent blood cell progenitors proliferate and mature into differentiated haemocytes. Previous work(4) has defined three domains, the medullary zone, the cortical zone and the posterior signalling centre (PSC), within the developing third-instar lymph gland. The medullary zone is populated by a core of undifferentiated, slowly cycling progenitor cells, whereas mature haemocytes comprising plasmatocytes, crystal cells and lamellocytes are peripherally located in the cortical zone. The PSC comprises a third region that was first defined as a small group of cells expressing the Notch ligand Serrate(5). Here we show that the PSC is specified early in the embryo by the homeotic gene Antennapedia (Antp) and expresses the signalling molecule Hedgehog. In the absence of the PSC or the Hedgehog signal, the precursor population of the medullary zone is lost because cells differentiate prematurely. We conclude that the PSC functions as a haematopoietic niche that is essential for the maintenance of blood cell precursors in Drosophila. Identification of this system allows the opportunity for genetic manipulation and direct in vivo imaging of a haematopoietic niche interacting with blood precursors.	Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu	Martinez-Agosto, Julian A/I-9435-2019	Martinez-Agosto, Julian A/0000-0001-6776-6949; MANDAL, LOLITIKA/0000-0002-7711-6090	NHLBI NIH HHS [K08 HL087026-01, L40 HL090710-02, K08 HL087026, L40 HL090710] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087026] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT MK, 1986, GENETICS, V114, P919; Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; El Shatoury H. H., 1955, Roux Archiv fuer Entwicklungsmechanik Organismen, V147, P489, DOI 10.1007/BF00576000; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Kimble Judith, 2005, WormBook, P1; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lo PCH, 2002, DEV BIOL, V251, P307, DOI 10.1006/dbio.2002.0839; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Rizki T.M., 1978, P397; Ryan KM, 2005, MECH DEVELOP, V122, P1023, DOI 10.1016/j.mod.2005.04.007; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	30	214	220	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					320	324		10.1038/nature05585	http://dx.doi.org/10.1038/nature05585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17361183	Green Accepted			2022-12-24	WOS:000244892900046
J	Painter, HJ; Morrisey, JM; Mather, MW; Vaidya, AB				Painter, Heather J.; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.			Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum	NATURE			English	Article							CRYPTOSPORIDIUM-PARVUM; MALARIA PARASITES; GENOME SEQUENCE; GENE-TRANSFER; EVOLUTION; DIHYDROOROTATE; BIOSYNTHESIS; ATOVAQUONE; INHIBITORS; YEASTS	The origin of all mitochondria can be traced to the symbiotic arrangement that resulted in the emergence of eukaryotes in a world that was exclusively populated by prokaryotes(1-3). This arrangement, however, has been in continuous genetic flux: the varying degrees of gene loss and transfer from the mitochondrial genome in different eukaryotic lineages seem to signify an ongoing 'conflict' between the host and the symbiont. Eukaryotic parasites belonging to the phylum Apicomplexa provide an excellent example to support this view. These organisms contain the smallest mitochondrial genomes known(4,5), with an organization that differs among various genera; one genus, Cryptosporidium, seems to have lost the entire mitochondrial genome(6,7). Here we show that erythrocytic stages of the human malaria parasite Plasmodium falciparum seem to maintain an active mitochondrial electron transport chain to serve just one metabolic function: regeneration of ubiquinone required as the electron acceptor for dihydroorotate dehydrogenase, an essential enzyme for pyrimidine biosynthesis. Transgenic P. falciparum parasites expressing Saccharomyces cerevisiae dihydroorotate dehydrogenase, which does not require ubiquinone as an electron acceptor(8), were completely resistant to inhibitors of mitochondrial electron transport. Maintenance of mitochondrial membrane potential, however, was essential in these parasites, as indicated by their hypersensitivity to proguanil, a drug that collapsed the membrane potential in the presence of electron transport inhibitors. Thus, acquisition of just one enzyme can render mitochondrial electron transport nonessential in erythrocytic stages of P. falciparum.	Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA	Drexel University	Vaidya, AB (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA.	avaidya@drexelmed.edu		Mather, Michael/0000-0002-1062-0137	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028398] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI028398] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; FRY M, 1990, COMP BIOCHEM PHYS B, V96, P775, DOI 10.1016/0305-0491(90)90230-Q; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; GUTTERIDGE WE, 1979, BIOCHIM BIOPHYS ACTA, V582, P390, DOI 10.1016/0304-4165(79)90131-4; Keithly JS, 2005, J EUKARYOT MICROBIOL, V52, P132, DOI 10.1111/j.1550-7408.2005.04-3317.x; LANE N, 2005, POWER SEX SUICIDE MI; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; Nicholls D., 2002, BIOENERGETICS, V3; O'Donnell RA, 2002, EMBO J, V21, P1231, DOI 10.1093/emboj/21.5.1231; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Srivastava IK, 1999, ANTIMICROB AGENTS CH, V43, P1334, DOI 10.1128/AAC.43.6.1334; Striepen B, 2004, P NATL ACAD SCI USA, V101, P3154, DOI 10.1073/pnas.0304686101; VAIDYA AB, 1987, MOL BIOCHEM PARASIT, V22, P249, DOI 10.1016/0166-6851(87)90056-9; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; Vaidya AB, 2005, CURR TOP MICROBIOL, V295, P233; VAIDYA AB, 1993, MOL BIOCHEM PARASIT, V58, P33, DOI 10.1016/0166-6851(93)90088-F; Vaidya AB, 2000, DRUG RESIST UPDATE, V3, P283, DOI 10.1054/drup.2000.0157; Vaidya Akhil B., 1998, P355; van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440; Wilson RJM, 1997, MICROBIOL MOL BIOL R, V61, P1; Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977	30	347	355	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 1	2007	446	7131					88	91		10.1038/nature05572	http://dx.doi.org/10.1038/nature05572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17330044				2022-12-24	WOS:000244525600043
J	Scott, LJ; Mohlke, KL; Bonnycastle, LL; Willer, CJ; Li, Y; Duren, WL; Erdos, MR; Stringham, HM; Chines, PS; Jackson, AU; Prokunina-Olsson, L; Ding, CJ; Swift, AJ; Narisu, N; Hu, T; Pruim, R; Xiao, R; Li, XY; Conneely, KN; Riebow, NL; Sprau, AG; Tong, M; White, PP; Hetrick, KN; Barnhart, MW; Bark, CW; Goldstein, JL; Watkins, L; Xiang, F; Saramies, J; Buchanan, TA; Watanabe, RM; Valle, TT; Kinnunen, L; Abecasis, GR; Pugh, EW; Doheny, KF; Bergman, RN; Tuomilehto, J; Collins, FS; Boehnke, M				Scott, Laura J.; Mohlke, Karen L.; Bonnycastle, Lori L.; Willer, Cristen J.; Li, Yun; Duren, William L.; Erdos, Michael R.; Stringham, Heather M.; Chines, Peter S.; Jackson, Anne U.; Prokunina-Olsson, Ludmila; Ding, Chia-Jen; Swift, Amy J.; Narisu, Narisu; Hu, Tianle; Pruim, Randall; Xiao, Rui; Li, Xiao-Yi; Conneely, Karen N.; Riebow, Nancy L.; Sprau, Andrew G.; Tong, Maurine; White, Peggy P.; Hetrick, Kurt N.; Barnhart, Michael W.; Bark, Craig W.; Goldstein, Janet L.; Watkins, Lee; Xiang, Fang; Saramies, Jouko; Buchanan, Thomas A.; Watanabe, Richard M.; Valle, Timo T.; Kinnunen, Leena; Abecasis, Gonalo R.; Pugh, Elizabeth W.; Doheny, Kimberly F.; Bergman, Richard N.; Tuomilehto, Jaakko; Collins, Francis S.; Boehnke, Michael			A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants	SCIENCE			English	Article							BODY-MASS INDEX; ZINC TRANSPORTER; RISK LOCI; INSULIN; GENE; EXPRESSION; IDENTIFICATION	Identifying the genetic variants that increase the risk of type 2 diabetes (T2D) in humans has been a formidable challenge. Adopting a genome-wide association strategy, we genotyped 1161 Finnish T2D cases and 1174 Finnish normal glucose tolerant (NGT) controls with >315,000 single-nucleotide polymorphisms (SNPs) and imputed genotypes for an additional >2 million autosomal SNPs. We carried out association analysis with these SNPs to identify genetic variants that predispose to T2D, compared our T2D association results with the results of two similar studies, and genotyped 80 SNPs in an additional 1215 Finnish T2D cases and 1258 Finnish NGT controls. We identify T2D-associated variants in an intergenic region of chromosome 11p12, contribute to the identification of T2D-associated variants near the genes IGF2BP2 and CDKAL1 and the region of CDKN2A and CDKN2B, and confirm that variants near TCF7L2, SLC30A8, HHEX, FTO, PPARG, and KCNJ11 are associated with T2D risk. This brings the number of T2D loci now confidently identified to at least 10.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr State Genet, Ann Arbor, MI 48109 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; Calvin Coll, Dept Math & Stat, Grand Rapids, MI 49546 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Ctr Inherited Dis Res, Baltimore, MD 21224 USA; Savitaipale Hlth Ctr, Savitaipate 54800, Finland; Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet Unit, SF-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Calvin University; Johns Hopkins University; University of Southern California; University of Southern California; University of Southern California; Finland National Institute for Health & Welfare; University of Helsinki	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	francisc@mail.nih.gov; boehnke@umich.edu	Prokunina-Olsson, Ludmila/A-8240-2019; Kinnunen, Leena/B-7059-2012; Narisu, Narisu/T-6908-2019; Abecasis, Goncalo R/B-7840-2010; Prokunina-Olsson, Ludmila/V-7960-2019; Hu, Tianle/H-9105-2012	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Kinnunen, Leena/0000-0001-8739-4812; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Willer, Cristen/0000-0001-5645-4966; Abecasis, Goncalo/0000-0003-1509-1825; Bergman, Richard/0000-0003-1539-4471	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG000024, Z01 HG000024-13] Funding Source: Medline; NHGRI NIH HHS [R01 HG002651-01, T32 HG000040, R01 HG002651, N01 HG065403, N01HG65403, HG002651] Funding Source: Medline; NHLBI NIH HHS [U01 HL084729-01, U01 HL084729, HL084729] Funding Source: Medline; NIDA NIH HHS [U54 DA021519-02, U54 DA021519] Funding Source: Medline; NIDDK NIH HHS [R01 DK029867, U01 DK062370, DK072193, DK062370, R56 DK062370, R01 DK062370, R01 DK062370-04, R01 DK072193, R01 DK072193-04] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; LI Y, UNPUB; Neel J. V, 1976, GENETICS DIABETES ME, P1; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silander K, 2004, DIABETES, V53, P821, DOI 10.2337/diabetes.53.3.821; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; *WELLC TRUST CAS C, IN PRESS NATURE; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	31	2125	2226	0	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1341	1345		10.1126/science.1142382	http://dx.doi.org/10.1126/science.1142382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17463248	Green Submitted, Green Accepted			2022-12-24	WOS:000246885600051
J	Vincent, JL; Patel, GH; Fox, MD; Snyder, AZ; Baker, JT; Van Essen, DC; Zempel, JM; Snyder, LH; Corbetta, M; Raichle, ME				Vincent, J. L.; Patel, G. H.; Fox, M. D.; Snyder, A. Z.; Baker, J. T.; Van Essen, D. C.; Zempel, J. M.; Snyder, L. H.; Corbetta, M.; Raichle, M. E.			Intrinsic functional architecture in the anaesthetized monkey brain	NATURE			English	Article							MACAQUE MONKEY; PARIETAL LOBE; DEFAULT MODE; CONNECTIONS; NETWORKS; CORTEX; ORGANIZATION; DYNAMICS; IMAGES; AREAS	The traditional approach to studying brain function is to measure physiological responses to controlled sensory, motor and cognitive paradigms. However, most of the brain's energy consumption is devoted to ongoing metabolic activity not clearly associated with any particular stimulus or behaviour(1). Functional magnetic resonance imaging studies in humans aimed at understanding this ongoing activity have shown that spontaneous fluctuations of the blood-oxygen-level-dependent signal occur continuously in the resting state. In humans, these fluctuations are temporally coherent within widely distributed cortical systems that recapitulate the functional architecture of responses evoked by experimentally administered tasks(2-6\). Here, we show that the same phenomenon is present in anaesthetized monkeys even at anaesthetic levels known to induce profound loss of consciousness. We specifically demonstrate coherent spontaneous fluctuations within three well known systems ( oculomotor, somatomotor and visual) and the 'default' system, a set of brain regions thought by some to support uniquely human capabilities. Our results indicate that coherent system fluctuations probably reflect an evolutionarily conserved aspect of brain functional organization that transcends levels of consciousness.	Washington Univ, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard University; Massachusetts General Hospital	Raichle, ME (corresponding author), Washington Univ, Dept Radiol, St Louis, MO 63110 USA.	marc@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Fox, Michael D./AAZ-3928-2020; Snyder, Lawrence H/A-4593-2017; Kennedy, Kristen M/B-4699-2008; Patel, Gaurav/AAW-3195-2021; Vincent, Justin L/B-5033-2012; anand, amit/A-7222-2009	Fox, Michael D./0000-0001-8848-6399; Kennedy, Kristen M/0000-0001-5373-9026; Patel, Gaurav/0000-0003-0028-2098; CORBETTA, MAURIZIO/0000-0001-8295-3304; Baker, Justin/0000-0002-6629-2195	NINDS NIH HHS [F31 NS051972] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Baker JT, 2006, CEREB CORTEX, V16, P447, DOI 10.1093/cercor/bhi124; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Black KJ, 2004, METHOD ENZYMOL, V385, P91; Brodmann K., 1994, LOCALISATION CEREBRA; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; GATTASS R, 1988, J NEUROSCI, V8, P1831; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lancaster JL, 1995, HUM BRAIN MAPP, V3, P209, DOI 10.1002/hbm.460030305; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Llinas R.R., 2001, I VORTEX NEURONS SEL; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; MORCOM AM, IN PRESS NEUROIMAGE; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tulving E., 2005, MISSING LINK COGNITI, P3, DOI [10.1093/acprof:oso/9780195161564.003.0001, DOI 10.1093/ACPROF:OSO/9780195161564.003.0001]; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1982, J NEUROSCI, V2, P265; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001	33	1316	1341	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					83	U4		10.1038/nature05758	http://dx.doi.org/10.1038/nature05758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476267	Green Published			2022-12-24	WOS:000246149300048
J	Friis-Moller, N; Reiss, P; Sabin, CA; Weber, R; Monforte, AD; El-Sadr, W; De Wit, S; Kirk, O; Fontas, E; Law, MG; Phillips, A; Lundgren, JD				Friis-Moller, Nina; Reiss, Peter; Sabin, Caroline A.; Weber, Rainer; Monforte, Antonella d'Arminio; El-Sadr, Wafaa; De Wit, Stephane; Kirk, Ole; Fontas, Eric; Law, Matthew G.; Phillips, Andrew; Lundgren, Jens D.		DAD Study Grp	Class of antiretroviral drugs and the risk of myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HIV PROTEASE INHIBITORS; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; THERAPY; COHORT; LIPIDS; HAART; ATHEROSCLEROSIS; MORTALITY	BACKGROUND: We have previously demonstrated an association between combination antiretroviral therapy and the risk of myocardial infarction. It is not clear whether this association differs according to the class of antiretroviral drugs. We conducted a study to investigate the association of cumulative exposure to protease inhibitors and nonnucleoside reverse-transcriptase inhibitors with the risk of myocardial infarction. METHODS: We analyzed data collected through February 2005 from our prospective observational study of 23,437 patients infected with the human immunodeficiency virus. The incidence rates of myocardial infarction during the follow-up period were calculated, and the associations between myocardial infarction and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors were determined. RESULTS: Three hundred forty-five patients had a myocardial infarction during 94,469 person-years of observation. The incidence of myocardial infarction increased from 1.53 per 1000 person-years in those not exposed to protease inhibitors to 6.01 per 1000 person-years in those exposed to protease inhibitors for more than 6 years. After adjustment for exposure to the other drug class and established cardiovascular risk factors (excluding lipid levels), the relative rate of myocardial infarction per year of protease-inhibitor exposure was 1.16 (95% confidence interval [CI], 1.10 to 1.23), whereas the relative rate per year of exposure to nonnucleoside reverse-transcriptase inhibitors was 1.05 (95% CI, 0.98 to 1.13). Adjustment for serum lipid levels further reduced the effect of exposure to each drug class to 1.10 (95% CI, 1.04 to 1.18) and 1.00 (95% CI, 0.93 to 1.09), respectively. CONCLUSIONS: Increased exposure to protease inhibitors is associated with an increased risk of myocardial infarction, which is partly explained by dyslipidemia. We found no evidence of such an association for nonnucleoside reverse-transcriptase inhibitors; however, the number of person-years of observation for exposure to this class of drug was less than that for exposure to protease inhibitors.	Univ Copenhagen, Panum Inst, Copenhagen HIV Program, DK-2200 Copenhagen N, Denmark; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; UCL Royal Free & Univ Coll London, London, England; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Milan, Milan, Italy; Columbia Univ, Harlem Hosp, New York, NY USA; Univ Bordeaux 2, INSERM, E0338, F-33076 Bordeaux, France; Univ Bordeaux 2, INSERM, U593, F-33076 Bordeaux, France; Ctr Hosp Univ St Pierre, Brussels, Belgium; Univ Copenhagen, Copenhagen, Denmark; Ctr Hosp Univ Nice, Nice, France; Hop Archet, Nice, France; Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; University of Zurich; University Zurich Hospital; University of Milan; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Copenhagen; CHU Nice; CHU Nice; University of New South Wales Sydney; Kirby Institute	Lundgren, JD (corresponding author), Univ Copenhagen, Panum Inst, Copenhagen HIV Program, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	jdl@cphiv.dk	Sabin, Caroline/C-2464-2008; Streinu-Cercel, Adrian/M-5835-2017; Torres, Ferran/D-1296-2011; kirk, ole/ABB-4746-2021; Phillips, Andrew N/B-4427-2008; Weber, Rainer/D-5175-2012; Lundgren, Jens/AAE-6876-2019; VALLET, Yannick/F-9979-2011	Sabin, Caroline/0000-0001-5173-2760; Streinu-Cercel, Adrian/0000-0001-6382-5067; Torres, Ferran/0000-0002-7355-7913; Phillips, Andrew N/0000-0003-2384-4807; Collins, Simon/0000-0002-3537-2432; Law, Matthew/0000-0002-3540-8837; Lundgren, Jens/0000-0001-8901-7850; Friis-Moller, Nina/0000-0002-7449-7393	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042170, U01AI046362] Funding Source: NIH RePORTER; NIAID NIH HHS [5U01AI042170-10, 5U01AI046362-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allred KF, 2006, J BIOL CHEM, V281, P1419, DOI 10.1074/jbc.M506046200; CONSTANS J, 1994, EUR J CLIN INVEST, V24, P416, DOI 10.1111/j.1365-2362.1994.tb02185.x; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Dieleman JP, 2002, AIDS, V16, P737, DOI 10.1097/00002030-200203290-00009; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fontas E, 2004, J INFECT DIS, V189, P1056, DOI 10.1086/381783; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; FriisMoller N, 2004, NEW ENGL J MED, V350, P955; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Iloeje UH, 2005, HIV MED, V6, P37, DOI 10.1111/j.1468-1293.2005.00265.x; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2002, ANTIVIR THER, V7, P21; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pernerstorfer-Schoen H, 2001, AIDS, V15, P725, DOI 10.1097/00002030-200104130-00008; PHILLIPS A, 2007, 14 C RETR OPP INF LO; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; SABIN C, 2005, 12 C RETR OPP INF BO; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Sax PE, 2004, JAIDS-J ACQ IMM DEF, V37, P1434; Sax PE, 2004, JAIDS-J ACQ IMM DEF, V37, P1111, DOI 10.1097/01.qai.0000138420.38995.86; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; van der Valk M, 2001, AIDS, V15, P2407, DOI 10.1097/00002030-200112070-00008; van Leth F, 2004, PLOS MED, V1, P237, DOI 10.1371/journal.pmed.0010073; van Leth F, 2004, PLOS MED, V1, P64, DOI 10.1371/journal.pmed.0010019; WHO MONICA Project, 1999, MONICA MAN 4; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898	32	1104	1129	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1723	1735		10.1056/NEJMoa062744	http://dx.doi.org/10.1056/NEJMoa062744			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160LQ	17460226	Green Published, Bronze			2022-12-24	WOS:000245942600007
J	Quinn, AE; Georges, A; Sarre, SD; Guarino, F; Ezaz, T; Graves, JAM				Quinn, Alexander E.; Georges, Arthur; Sarre, Stephen D.; Guarino, Fiorenzo; Ezaz, Tariq; Graves, Jennifer A. Marshall			Temperature sex reversal implies sex gene dosage in a reptile	SCIENCE			English	Article									Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; Australian Natl Univ, Res Sch Biol Sci, Comparat Genom Grp, Canberra, ACT 2601, Australia	University of Canberra; Australian National University	Quinn, AE (corresponding author), Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia.	quinn@aerg.canberra.edu.au	Graves, Jennifer A.M./A-1387-2008; Sarre, Stephen D/C-6795-2011; Georges, Arthur/D-2153-2009; Ezaz, Tariq/D-9875-2011; Quinn, Alexander/C-2778-2013	Georges, Arthur/0000-0003-2428-0361; Ezaz, Tariq/0000-0003-4763-1347; Guarino, Fiorenzo/0000-0002-1458-7389; Graves, Jennifer/0000-0001-6480-7856; Sarre, Stephen D./0000-0002-7158-2517				Bull J. J., 1983, EVOLUTION SEX DETERM; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Shine R, 2002, ECOL LETT, V5, P486, DOI 10.1046/j.1461-0248.2002.00351.x; Valenzuela N., 2004, TEMPERATURE DEPENDEN; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407	6	204	211	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					411	411		10.1126/science.1135925	http://dx.doi.org/10.1126/science.1135925			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446395	Green Submitted			2022-12-24	WOS:000245813400046
J	Sebat, J; Lakshmi, B; Malhotra, D; Troge, J; Lese-Martin, C; Walsh, T; Yamrom, B; Yoon, S; Krasnitz, A; Kendall, J; Leotta, A; Pai, D; Zhang, R; Lee, YH; Hicks, J; Spence, SJ; Lee, AT; Puura, K; Lehtimaki, T; Ledbetter, D; Gregersen, PK; Bregman, J; Sutcliffe, JS; Jobanputra, V; Chung, W; Warburton, D; King, MC; Skuse, D; Geschwind, DH; Gilliam, TC; Ye, K; Wigler, M				Sebat, Jonathan; Lakshmi, B.; Malhotra, Dheeraj; Troge, Jennifer; Lese-Martin, Christa; Walsh, Tom; Yamrom, Boris; Yoon, Seungtai; Krasnitz, Alex; Kendall, Jude; Leotta, Anthony; Pai, Deepa; Zhang, Ray; Lee, Yoon-Ha; Hicks, James; Spence, Sarah J.; Lee, Annette T.; Puura, Kaija; Lehtimaeki, Terho; Ledbetter, David; Gregersen, Peter K.; Bregman, Joel; Sutcliffe, James S.; Jobanputra, Vaidehi; Chung, Wendy; Warburton, Dorothy; King, Mary-Claire; Skuse, David; Geschwind, Daniel H.; Gilliam, T. Conrad; Ye, Kenny; Wigler, Michael			Strong association of de novo copy number mutations with autism	SCIENCE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COMMON FRAGILE SITES; DELETION; GENE	We tested the hypothesis that de novo copy number variation (CNV) is associated with autism spectrum disorders (ASDs). We performed comparative genomic hybridization (CGH) on the genomic DNA of patients and unaffected subjects to detect copy number variants not present in their respective parents. Candidate genomic regions were validated by higher-resolution CGH, paternity testing, cytogenetics, fluorescence in situ hybridization, and microsatellite genotyping. Confirmed de novo CNVs were significantly associated with autism ( P = 0.0005). Such CNVs were identified in 12 out of 118 (10%) of patients with sporadic autism, in 2 out of 77 (3%) of patients with an affected first-degree relative, and in 2 out of 196 (1%) of controls. Most de novo CNVs were smaller than microscopic resolution. Affected genomic regions were highly heterogeneous and included mutations of single genes. These findings establish de novo germline mutation as a more significant risk factor for ASD than previously recognized.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Univ Washington, Dept Med & Genome Sci, Seattle, WA 98195 USA; NIMH, Pediat & Neurodev Psychiat Branch, NIH, Bethesda, MD 20892 USA; N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; Univ Tampere, Sch Med, Dept Child Psychiat, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland; N Shore Long Isl Jewish Hlth Syst, Fay J Lindner Ctr Autism & Dev Disorders, Bethpage, NY 11714 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; Columbia Univ, Dept Pediat, New York, NY 10027 USA; UCL, Inst Child Hlth, Behav & Brain Sci Unit, London WC1N 1EH, England; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet,Interdept Program Neurosci, Los Angeles, CA 90095 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Cold Spring Harbor Laboratory; Emory University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Northwell Health; Tampere University; Tampere University; Tampere University Hospital; Northwell Health; Vanderbilt University; Columbia University; Columbia University; University of London; University College London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago; Yeshiva University; Albert Einstein College of Medicine	Wigler, M (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	sebat@cshl.edu; wigler@cshl.edu	Sutcliffe, James S/C-1348-2012; Puura, Kaija/ADG-7880-2022; Ye, Kenny/U-2341-2019; Lehtimäki, Terho/AAD-1094-2022; Ye, Kenny/GSM-7731-2022; Warfield, Simon/B-3352-2009	Sutcliffe, James S/0000-0001-5200-6007; Ye, Kenny/0000-0002-1466-855X; Lehtimäki, Terho/0000-0002-2555-4427; Warfield, Simon/0000-0002-7659-3880; King, Mary-Claire/0000-0001-9426-1743; Wigler, Michael/0000-0003-4396-1971; Sebat, Jonathan/0000-0002-9087-526X; Walsh, Tom/0000-0002-8875-0310	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, R01MH076431, R01MH061009] Funding Source: NIH RePORTER; NIMH NIH HHS [MH076431, MH64547, R01 MH064547, R01 MH061009, R01 MH076431-01, MH61009, R01 MH076431] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; *EUR CONS TUB SCLE, 1993, CELL, V75, P130; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Ghaziuddin M, 1999, J AUTISM DEV DISORD, V29, P259, DOI 10.1023/A:1023088207468; GOSPE SM, 1989, NEUROLOGY, V39, P1277, DOI 10.1212/WNL.39.10.1277; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Igarashi T, 2001, J AM SOC NEPHROL, V12, P713, DOI 10.1681/ASN.V124713; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klauck SM, 2006, EUR J HUM GENET, V14, P714, DOI 10.1038/sj.ejhg.5201610; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Manning MA, 2004, PEDIATRICS, V114, P451, DOI 10.1542/peds.114.2.451; ORYE E, 1971, LANCET, V2, P1376; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757	30	1954	2143	27	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					445	449		10.1126/science.1138659	http://dx.doi.org/10.1126/science.1138659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17363630	Green Accepted			2022-12-24	WOS:000245813400056
J	Wang, M; Ramos, BP; Paspalas, CD; Shu, YS; Simen, A; Duque, A; Vijayraghavan, S; Brennan, A; Dudley, A; Nou, E; Mazer, JA; McCormick, DA; Arnsten, AFT				Wang, Min; Ramos, Brian P.; Paspalas, Constantinos D.; Shu, Yousheng; Simen, Arthur; Duque, Alvaro; Vijayraghavan, Susheel; Brennan, Avis; Dudley, Anne; Nou, Eric; Mazer, James A.; McCormick, David A.; Arnsten, Amy F. T.			alpha 2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex	CELL			English	Article							PROTEIN-KINASE-A; COGNITIVE DECLINE; PYRAMIDAL NEURONS; DOPAMINE D1; PERFORMANCE; MECHANISMS; GUANFACINE; MONKEYS; EXCITABILITY; DENDRITES	Spatial working memory (WM; i.e., '' scratchpad '' memory) is constantly updated to guide behavior based on representational knowledge of spatial position. It is maintained by spatially tuned, recurrent excitation within networks of prefrontal cortical (PFC) neurons, evident during delay periods in WM tasks. Stimulation of postsynaptic alpha 2A adrenoceptors (alpha 2A-ARs) is critical for WM. We report that alpha 2A-AR stimulation strengthens WM through inhibition of cAMP, closing Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channels and strengthening the functional connectivity of PFC networks. Ultrastructurally, HCN channels and alpha 2A-ARs were colocalized in dendritic spines in PFC. In electrophysiological studies, either alpha 2A-AR stimulation, cAMP inhibition or HCN channel blockade enhanced spatially tuned delay-related firing of PFC neurons. Conversely, delay-related network firing collapsed under conditions of excessive cAMP. In behavioral studies, either blockade or knockdown of HCN1 channels in PFC improved WM performance. These data reveal a powerful mechanism for rapidly altering the strength of WM networks in PFC.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Univ Crete, Sch Med, Div Neuroanat, Iraklion, Greece	Yale University; Yale University; Yale University; University of Crete	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA.	amy.arnsten@yale.edu	Shu, Yousheng/AAC-3881-2020; Paspalas, Constantinos/G-2327-2014; Kobelt, Liza/F-5926-2011	Shu, Yousheng/0000-0002-2834-2876; 	NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006036] Funding Source: NIH RePORTER; NCRR NIH HHS [K12RR17594] Funding Source: Medline; NIA NIH HHS [R37 AG006036, R37 AG06036] Funding Source: Medline; NIMH NIH HHS [P50MH068789] Funding Source: Medline; NINDS NIH HHS [R37 NS026143] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMSTEN AF, 1988, J NEUROSCI, V8, P4287; Aoki C, 1998, CEREB CORTEX, V8, P269, DOI 10.1093/cercor/8.3.269; Arnsten AFT, 2000, PROG BRAIN RES, V126, P183; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Chen C, 2004, EUR J NEUROSCI, V19, P643, DOI 10.1111/j.0953-816X.2003.03174.x; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Franowicz JS, 2002, J NEUROSCI, V22, P8771; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1990, J NEUROSCI, V10, P2125; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Jakala P, 1999, NEUROPSYCHOPHARMACOL, V20, P460, DOI 10.1016/S0893-133X(98)00127-4; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; LARSEN JK, 1978, PHYSIOL PSYCHOL, V6, P15; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Li BM, 1999, NEUROPSYCHOPHARMACOL, V21, P601, DOI 10.1016/S0893-133X(99)00070-6; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Mao ZM, 1999, BIOL PSYCHIAT, V46, P1259, DOI 10.1016/S0006-3223(99)00139-0; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; MCCLURE MM, 2006, IN PRESS BIOL PSYCHI; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Miller EK, 1996, J NEUROSCI, V16, P5154; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Paspalas CD, 2004, J NEUROSCI, V24, P5292, DOI 10.1523/JNEUROSCI.0195-04.2004; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Runyan JD, 2005, LEARN MEMORY, V12, P232, DOI 10.1101/lm.92405; Scahill L, 2001, AM J PSYCHIAT, V158, P1067, DOI 10.1176/appi.ajp.158.7.1067; Shu YS, 2003, J NEUROSCI, V23, P10388; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; Taylor FB, 2001, J CLIN PSYCHOPHARM, V21, P223, DOI 10.1097/00004714-200104000-00015; Taylor JR, 1999, J NEUROSCI, V19; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846	45	449	463	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					397	410		10.1016/j.cell.2007.03.015	http://dx.doi.org/10.1016/j.cell.2007.03.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448997	Bronze			2022-12-24	WOS:000246474600025
J	Bankovich, AJ; Raunser, S; Juo, ZS; Walz, T; Davis, MM; Garcia, KC				Bankovich, Alexander J.; Raunser, Stefan; Juo, Z. Sean; Walz, Thomas; Davis, Mark M.; Garcia, K. Christopher			Structural insight into pre-B cell receptor function	SCIENCE			English	Article							SURROGATE LIGHT-CHAIN; HEAVY-CHAIN; V-H; LAMBDA-5; LYMPHOCYTES; REPERTOIRE; DIVERSITY; VPREB; GENE; MECHANISMS	The pre-B cell receptor (pre-BCR) serves as a checkpoint in B cell development. In the 2.7 angstrom structure of a human pre-BCR Fab-like fragment, consisting of an antibody heavy chain (HC) paired with the surrogate light chain, the "unique regions" of VpreB and lambda 5 replace the complementarity-determining region 3 (CDR3) loop of an antibody light chain and appear to "probe" the HC CDR3, potentially influencing the selection of the antibody repertoire. Biochemical analysis indicates that the pre-BCR is impaired in its ability to recognize antigen, which, together with electron microscopic visualization of a pre-BCR dimer, suggests ligand-independent oligomerization as the likely signaling mechanism.	Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Harvard Medical School	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Raunser, Stefan/AHE-1573-2022	Davis, Mark/0000-0001-6868-657X; Raunser, Stefan/0000-0001-9373-3016; Walz, Thomas/0000-0003-2606-2835; Bankovich, Alexander/0000-0003-2368-4479	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; DECKER DJ, 1991, J IMMUNOL, V146, P350; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KEYNA U, 1995, J IMMUNOL, V155, P5536; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; KUDO A, 1989, PROGR IMMUNOLOGY, V7, P339; Lanig H, 2004, MOL IMMUNOL, V40, P1263, DOI 10.1016/j.molimm.2003.11.030; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Milili M, 1996, EUR J IMMUNOL, V26, P63, DOI 10.1002/eji.1830260110; Minegishi Y, 1999, P NATL ACAD SCI USA, V96, P3041, DOI 10.1073/pnas.96.6.3041; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; tenBoekel E, 1997, IMMUNITY, V7, P357; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Wang LD, 2003, IMMUNOLOGY, V110, P411, DOI 10.1111/j.1365-2567.2003.01756.x; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	28	74	90	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					291	294		10.1126/science.1139412	http://dx.doi.org/10.1126/science.1139412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431183				2022-12-24	WOS:000245654500055
J	Sarkar, AK; Luijten, M; Miyashima, S; Lenhard, M; Hashimoto, T; Nakajima, K; Scheres, B; Heidstra, R; Laux, T				Sarkar, Ananda K.; Luijten, Marijn; Miyashima, Shunsuke; Lenhard, Michael; Hashimoto, Takashi; Nakajima, Keiji; Scheres, Ben; Heidstra, Renze; Laux, Thomas			Conserved factors regulate signalling in Arabidopsis thaliana shoot and root stem cell organizers	NATURE			English	Article							TRANSCRIPTION FACTOR; MERISTEM; WUSCHEL; GENE; FATE; MAINTENANCE; EMBRYO; PLANTS; NICHE; CLV3	Throughout the lifespan of a plant, which in some cases can last more than one thousand years, the stem cell niches in the root and shoot apical meristems provide cells for the formation of complete root and shoot systems, respectively. Both niches are superficially different and it has remained unclear whether common regulatory mechanisms exist. Here we address whether root and shoot meristems use related factors for stem cell maintenance. In the root niche the quiescent centre cells, surrounded by the stem cells, express the homeobox gene WOX5 (WUSCHEL-RELATED HOMEOBOX 5)(1), a homologue of the WUSCHEL (WUS) gene that non-cell-autonomously maintains stem cells in the shoot meristem(2). Loss of WOX5 function in the root meristem stem cell niche causes terminal differentiation in distal stem cells and, redundantly with other regulators, also provokes differentiation of the proximal meristem. Conversely, gain of WOX5 function blocks differentiation of distal stem cell descendents that normally differentiate. Importantly, both WOX5 and WUS maintain stem cells in either a root or shoot context. Together, our data indicate that stem cell maintenance signalling in both meristems employs related regulators.	Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany; Univ Utrecht, Dept Mol Cell Biol, NL-3584 CH Utrecht, Netherlands; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	University of Freiburg; Utrecht University; Nara Institute of Science & Technology	Laux, T (corresponding author), Univ Freiburg, Inst Biol 3, Schanzlestr 1, D-79104 Freiburg, Germany.	laux@biologie.uni-freiburg.de	Miyashima, Shunsuke/AAV-1196-2021; Lenhard, Michael/J-1554-2015	Miyashima, Shunsuke/0000-0001-8267-3978; Nakajima, Keiji/0000-0002-1580-3354; Scheres, Ben/0000-0001-5400-9578				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; BERLETH T, 1993, DEVELOPMENT, V118, P575; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hamada S, 2000, PLANT J, V24, P91, DOI 10.1046/j.1365-313x.2000.00858.x; Hobe M, 2003, DEV GENES EVOL, V213, P371, DOI 10.1007/s00427-003-0329-5; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willemsen V, 1998, DEVELOPMENT, V125, P521	24	701	758	11	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					811	814		10.1038/nature05703	http://dx.doi.org/10.1038/nature05703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429400				2022-12-24	WOS:000245626800044
J	Meyer, JR; Kassen, R				Meyer, Justin R.; Kassen, Rees			The effects of competition and predation on diversification in a model adaptive radiation	NATURE			English	Article							PROMOTES DIVERGENCE; EVOLUTION; DIVERSITY; PREY	Much of life's diversity is thought to have arisen through successive rounds of adaptive radiation - the rapid diversification of a lineage into a range of ecologically and phenotypically distinct species(1-3). Both resource competition and predation have been suggested as mechanisms driving this process(4,5), although the former is better studied than the latter(6,7). Here we show experimentally how predation by a protist, Tetrahymena thermophila, affects diversification in a model adaptive radiation of the bacterial prey, Pseudomonas fluorescens. We estimate the frequency-dependent fitness functions of competing niche-specialist prey in the presence and absence of predation, and use these to test hypotheses about the extent ( measured as the number of new genotypes) and rate of diversification. Competition and predation independently generated diversifying selection that we show is capable of driving prey diversification to similar extents but at different rates, diversification being markedly delayed in the presence of predators. The cause of this delay stems from weaker diversifying selection due to the reduction in prey density caused by predation. Our results suggest that predation may play an under-appreciated role in driving adaptive radiations.	Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Meyer, JR (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.	justin.raymond.meyer@gmail.com						BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; CLARKE B, 1988, FREQUENCY DEPENDENT; Fryer G., 1972, CICHLID FISHES GREAT; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Grant P.R., 1998, EVOLUTION ISLANDS; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Jablonski D, 1999, SCIENCE, V284, P2114, DOI 10.1126/science.284.5423.2114; Kassen R, 2004, NATURE, V431, P984, DOI 10.1038/nature02923; Lack D., 1947, DARWINS FINCHES; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rundle HD, 2003, P NATL ACAD SCI USA, V100, P14943, DOI 10.1073/pnas.2036360100; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schrag SJ, 1996, AM NAT, V148, P348, DOI 10.1086/285929; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Travisano M, 2000, AM NAT, V156, pS35, DOI 10.1086/303414; Vamosi SM, 2005, CAN J ZOOL, V83, P894, DOI 10.1139/Z05-063; VANVALEN L, 1974, J THEOR BIOL, V44, P19, DOI 10.1016/S0022-5193(74)80026-3; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337	30	152	153	2	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 22	2007	446	7134					432	435		10.1038/nature05599	http://dx.doi.org/10.1038/nature05599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148MO	17377581				2022-12-24	WOS:000245079500038
J	Gunawardane, LS; Saito, K; Nishida, KM; Miyoshi, K; Kawamura, Y; Nagami, T; Siomi, H; Siomi, MC				Gunawardane, Lalith S.; Saito, Kuniaki; Nishida, Kazumichi M.; Miyoshi, Keita; Kawamura, Yoshinori; Nagami, Tomoko; Siomi, Haruhiko; Siomi, Mikiko C.			A slicer-mediated mechanism for repeat-associated siRNA 5 ' end formation in Drosophila	SCIENCE			English	Article							RNA INTERFERENCE; ARGONAUTE; GERMLINE; PIWI	In Drosophila, repeat-associated small interfering RNAs (rasiRNAs) are produced in the germ line by a Dicer-independent pathway and function through the PIWI subfamily of Argonautes to ensure silencing of retrotransposons. We sequenced small RNAs associated with the PIWI subfamily member AGO3. Although other members of PIWI, Aubergine (Aub) and Piwi, associated with rasiRNAs derived mainly from the antisense strand of retrotransposons, AGO3-associated rasiRNAs arose mainly from the sense strand. Aub- and Piwi-associated rasiRNAs showed a strong preference for uracil at their 5' ends, and AGO3-associated rasiRNAs showed a strong preference for adenine at nucleotide 10. Comparisons between AGO3- and Aub- associated rasiRNAs revealed pairs of rasiRNAs showing complementarities in their first 10 nucleotides. Aub and AGO3 exhibited Slicer activity in vitro. These data support a model in which formation of a 5' terminus within rasiRNA precursors is guided by rasiRNAs originating from transcripts of the other strand in concert with the Slicer activity of PIWI.	Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan	Tokushima University	Siomi, MC (corresponding author), Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan.	siomi@genome.tokushima-u.ac.jp	Siomi, Haruhiko/A-7020-2015; Saito, Kuniaki/A-6967-2015	Siomi, Haruhiko/0000-0001-8690-3822; Saito, Kuniaki/0000-0001-8233-9283				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Harris AN, 2001, DEVELOPMENT, V128, P2823; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kavi HH, 2005, FEBS LETT, V579, P5940, DOI 10.1016/j.febslet.2005.08.069; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vagin Vasily V, 2004, RNA Biol, V1, P54; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	20	844	886	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1587	1590		10.1126/science.1140494	http://dx.doi.org/10.1126/science.1140494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17322028				2022-12-24	WOS:000244934800056
J	Lupski, JR				Lupski, James R.			Structural variation in the human genome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COPY-NUMBER		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.							Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731	5	89	94	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	2007	356	11					1169	1171		10.1056/NEJMcibr067658	http://dx.doi.org/10.1056/NEJMcibr067658			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	145PO	17360997				2022-12-24	WOS:000244877200013
J	Boots, M; Mealor, M				Boots, Michael; Mealor, Michael			Local interactions select for lower pathogen infectivity	SCIENCE			English	Article							INDIAN MEAL MOTH; PLODIA-INTERPUNCTELLA; GRANULOSIS-VIRUS; EVOLUTION; VIRULENCE; TRANSMISSION; POPULATION; COOPERATION; DYNAMICS	Theory suggests that the current rapid increase in connectivity and consequential changes in the structure of human, agricultural, and wildlife populations may select for parasite strains with higher infectivity. We carried out a test of this spatial theory by experimentally altering individual host movement rates in a model host/pathogen system by altering the viscosity of their environment. In our microevolutionary selection experiments, the infectivity of the virus was, as predicted by the theory, reduced in the most viscous populations. We therefore provide empirical support for the theory that population structure affects the evolution of infectious organisms.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Boots, M (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	m.boots@sheffield.ac.uk			Natural Environment Research Council [NE/A503439/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Boots M, 2000, ECOL LETT, V3, P181; BOOTS M, 1993, FUNCT ECOL, V7, P528, DOI 10.2307/2390128; Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Boots M, 1998, ECOL ENTOMOL, V23, P118, DOI 10.1046/j.1365-2311.1998.00115.x; BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102; DIECKMANN U, 2002, ADAPTIVE DYNAMICS IN; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; EWALD PW, 1993, SCI AM, V268, P86, DOI 10.1038/scientificamerican0493-86; EWALD PW, 1991, EPIDEMIOL INFECT, V106, P83, DOI 10.1017/S0950268800056478; Ewald PW, 1994, EVOLUTION INFECT DIS; FERRIERE R, 1995, P ROY SOC B-BIOL SCI, V259, P77, DOI 10.1098/rspb.1995.0012; Ferriere R, 1996, AM NAT, V147, P692, DOI 10.1086/285875; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; Haraguchi Y, 2000, J THEOR BIOL, V203, P85, DOI 10.1006/jtbi.1999.1065; JOHN DT, 1994, J PARASITOL, V80, P149, DOI 10.2307/3283359; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; RAND DA, 1995, P ROY SOC B-BIOL SCI, V259, P55, DOI 10.1098/rspb.1995.0009; SAIT SM, 1994, J ANIM ECOL, V63, P861, DOI 10.2307/5263; SAIT SM, 1994, J ANIM ECOL, V63, P541, DOI 10.2307/5220; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730	24	146	148	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 2	2007	315	5816					1284	1286		10.1126/science.1137126	http://dx.doi.org/10.1126/science.1137126			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332415				2022-12-24	WOS:000244564700052
J	Kozlowski, C; Srayko, M; Nedelec, F				Kozlowski, Cleopatra; Srayko, Martin; Nedelec, Francois			Cortical microtubule contacts position the spindle in C. elegans embryos	CELL			English	Article							ASYMMETRIC CELL-DIVISION; CAENORHABDITIS-ELEGANS; MITOTIC SPINDLE; FORCE GENERATION; PAR PROTEINS; POLARITY; IDENTIFICATION; CENTROSOMES; DYNAMICS; CORTEX	Interactions between microtubules and the cell cortex play a critical role in positioning organelles in a variety of biological contexts. Here we used Caenorhabditis elegans as a model system to study how cortex-microtubule interactions position the mitotic spindle in response to polarity cues. Imaging EBP-2::GFP and YFP::octubulin revealed that microtubules shrink soon after cortical contact, from which we propose that cortical adaptors mediate microtubule depolymerization energy into pulling forces. We also observe association of dynamic microtubules to form astral fibers that persist, despite the catastrophe events of individual microtubules. Computer simulations show that these effects, which are crucially determined by microtubule dynamics, can explain anaphase spindle oscillations and posterior displacement in 3D.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Nedelec, F (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	nedelec@embl.de	Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019; Srayko, Martin/A-3755-2014	Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Srayko, Martin/0000-0003-0196-0364				Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; McCarthy EK, 2006, CURR OPIN CELL BIOL, V18, P79, DOI 10.1016/j.ceb.2005.12.006; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Praitis V, 2001, GENETICS, V157, P1217; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103	34	161	164	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					499	510		10.1016/j.cell.2007.03.027	http://dx.doi.org/10.1016/j.cell.2007.03.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482544	Bronze			2022-12-24	WOS:000246373600017
J	Mulugu, S; Bai, WL; Fridy, PC; Bastidas, RJ; Otto, JC; Dollins, DE; Haystead, TA; Ribeiro, AA; York, JD				Mulugu, Sashidhar; Bai, Wenli; Fridy, Peter C.; Bastidas, Robert J.; Otto, James C.; Dollins, D. Eric; Haystead, Timothy A.; Ribeiro, Anthony A.; York, John D.			A conserved family of enzymes that phosphorylate inositol hexakisphosphate	SCIENCE			English	Article							MESSENGER-RNA EXPORT; ARP2/3 COMPLEX; SACCHAROMYCES-CEREVISIAE; ACTIN; PYROPHOSPHATES; PHOSPHATES; TETRAKISPHOSPHATE; POLYPHOSPHATES; DICTYOSTELIUM; METABOLISM	Inositol pyrophosphates are a diverse group of high-energy signaling molecules whose cellular roles remain an active area of study. We report a previously uncharacterized class of inositol pyrophosphate synthase and find it is identical to yeast Vip1 and Asp1 proteins, regulators of actin-related protein-2/3 (ARP 2/3) complexes. Vip1 and Asp1 acted as enzymes that encode inositol hexakisphosphate (IP6) and inositol heptakisphosphate (IP7) kinase activities. Alterations in kinase activity led to defects in cell growth, morphology, and interactions with ARP complex members. The functionality of Asp1 and Vip1 may provide cells with increased signaling capacity through metabolism of IP6.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, NMR Ctr, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	York, JD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, DUMC 3813, Durham, NC 27710 USA.	yorkj@duke.edu		Fridy, Peter/0000-0002-8208-9154	NCI NIH HHS [2-P30-CA14236-3, P30-CA-14236] Funding Source: Medline; NHLBI NIH HHS [R01-HL-55672] Funding Source: Medline; NIDDK NIH HHS [R33-DK-070272] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070272] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; EUROPEFINNER GN, 1991, BIOCHEM BIOPH RES CO, V181, P191, DOI 10.1016/S0006-291X(05)81400-7; Feoktistova A, 1999, GENETICS, V152, P895; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Grishin NV, 1999, J MOL BIOL, V291, P239, DOI 10.1006/jmbi.1999.2973; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Laussmann T, 1996, BIOCHEM J, V315, P715, DOI 10.1042/bj3150715; Laussmann T, 1998, FEBS LETT, V426, P145, DOI 10.1016/S0014-5793(98)00329-9; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2000, FEBS LETT, V468, P28, DOI 10.1016/S0014-5793(00)01194-7; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; SHEARS SB, 1995, J BIOL CHEM, V270, P10489, DOI 10.1074/jbc.270.18.10489; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	30	181	190	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					106	109		10.1126/science.1139099	http://dx.doi.org/10.1126/science.1139099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412958				2022-12-24	WOS:000245470500042
J	Patel, SS; Belmont, BJ; Sante, JM; Rexach, MF				Patel, Samir S.; Belmont, Brian J.; Sante, Joshua M.; Rexach, Michael F.			Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex	CELL			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS; FG NUCLEOPORINS; PERMEABILITY; ARCHITECTURE; DETERMINANT; SYSTEM; DOMAIN	Nuclear pore complexes (NPCs) form aqueous conduits in the nuclear envelope and gate the diffusion of large proteins between the cytoplasm and nucleoplasm. NPC proteins (nucleoporins) that contain phenylalanine-glycine motifs in filamentous, natively unfolded domains (FG domains) line the diffusion conduit of the NPC, but their role in the size-selective barrier is unclear. We show that deletion of individual FG domains in yeast relaxes the NPC permeability barrier. At the molecular level, the FG domains of five nucleoporins anchored at the NPC center form a cohesive meshwork of filaments through hydrophobic interactions, which involve phenylalanines in FG motifs and are dispersed by aliphatic alcohols. In contrast, the FG domains of four peripherally anchored nucleoporins are generally noncohesive. The results support a two-gate model of NPC architecture featuring a central diffusion gate formed by a meshwork of cohesive FG nucleoporin filaments and a peripheral gate formed by repulsive FG nucleoporin filaments.	Univ Calif Santa Cruz, MCD Biol, Santa Cruz, CA 95064 USA; Stanford Univ, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Stanford University	Rexach, MF (corresponding author), Univ Calif Santa Cruz, MCD Biol, Santa Cruz, CA 95064 USA.	rexach@biology.ucsc.edu		Belmont, Brian/0000-0002-8314-4565; Patel, Samir/0000-0002-9489-5516				Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Feldherr CM, 1997, J CELL SCI, V110, P3065; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gillen KM, 1998, J CELL SCI, V111, P3235; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kenna MA, 1996, MOL CELL BIOL, V16, P2025; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Rhee Y, 2000, NAT BIOTECHNOL, V18, P433, DOI 10.1038/74500; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; YANG MJ, 1995, NUCLEIC ACIDS RES, V23, P1152, DOI 10.1093/nar/23.7.1152; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	28	370	373	3	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					83	96		10.1016/j.cell.2007.01.044	http://dx.doi.org/10.1016/j.cell.2007.01.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418788	Bronze			2022-12-24	WOS:000245661100013
J	Chait, R; Craney, A; Kishony, R				Chait, Remy; Craney, Allison; Kishony, Roy			Antibiotic interactions that select against resistance	NATURE			English	Article							TETRACYCLINE-RESISTANCE; ESCHERICHIA-COLI; EXPRESSION; ELEMENTS; PROMOTER; FITNESS; GENE	Multidrug combinations are increasingly important in combating the spread of antibiotic-resistance in bacterial pathogens(1-3). On a broader scale, such combinations are also important in understanding microbial ecology and evolution(4,5). Although the effects of multidrug combinations on bacterial growth have been studied extensively, relatively little is known about their impact on the differential selection between sensitive and resistant bacterial populations(1,6,7). Normally, the presence of a drug confers an advantage on its resistant mutants incompetition with the sensitive wild-type population(1). Here we show, by using a direct competition assay between doxycycline-resistant and doxycycline-sensitive Escherichia coli, that this differential selection can be inverted in a hyper-antagonistic class of drug combinations. Used in such a combination, a drug can render the combined treatment selective against the drug's own resistance allele. Further, this inversion of selection seems largely insensitive to the underlying resistance mechanism and occurs, at sublethal concentrations, while maintaining inhibition of the wild type. These seemingly paradoxical results can be rationalized in terms of a simple geometric argument. Our findings demonstrate a previously unappreciated feature of the fitness landscape for the evolution of resistance and point to a trade-off between the effect of drug interactions on absolute potency and the relative competitive selection that they impose on emerging resistant populations.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu		Chait, Remy/0000-0003-0876-3187				Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; CHAO L, 1978, NATURE, V271, P385, DOI 10.1038/271385a0; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Drlica K., 2003, QUINOLONE ANTIMICROB, P19; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraser T R, 1872, Br Med J, V2, P457; Golan DE, 2005, PRINCIPLES PHARM PAT; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; KISHONY R, 2003, J BIOL, V2, DOI UNSP 14.1-14.10; KLEIN M, 1953, J BACTERIOL, V65, P454, DOI 10.1128/JB.65.4.454-465.1953; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; LENSKI RE, 1994, MOL ECOL, V3, P127, DOI 10.1111/j.1365-294X.1994.tb00113.x; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; SINGER M, 1989, MICROBIOL REV, V53, P1; Tsui WHW, 2004, CHEM BIOL, V11, P1307, DOI 10.1016/j.chembiol.2004.07.010; Walsh C., 2003, ANTIBIOTICS ACTIONS, P335; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Whittle G, 2003, APPL ENVIRON MICROB, V69, P4151, DOI 10.1128/AEM.69.7.4151-4158.2003; Yang WR, 2004, J BIOL CHEM, V279, P52346, DOI 10.1074/jbc.M409573200; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039	30	313	324	4	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					668	671		10.1038/nature05685	http://dx.doi.org/10.1038/nature05685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410176				2022-12-24	WOS:000245438300040
J	Suzuki, K; Okuno, T; Yamamoto, M; Pasterkamp, RJ; Takegahara, N; Takamatsu, H; Kitao, T; Takagi, J; Rennert, PD; Kolodkin, AL; Kumanogoh, A; Kikutani, H				Suzuki, Kazuhiro; Okuno, Tatsusada; Yamamoto, Midori; Pasterkamp, R. Jeroen; Takegahara, Noriko; Takamatsu, Hyota; Kitao, Tomoe; Takagi, Junichi; Rennert, Paul D.; Kolodkin, Alex L.; Kumanogoh, Atsushi; Kikutani, Hitoshi			Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha 1 beta 1 integrin	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLLAGEN-BINDING INTEGRINS; EXPRESSION; FAMILY; HYPERSENSITIVITY; ALPHA(1)BETA(1); TRANSMEMBRANE; ARTHRITIS; ADHESION; COLITIS	Semaphorins are axon guidance factors that assist growing axons in finding appropriate targets and forming synapses(1). Emerging evidence suggests that semaphorins are involved not only in embryonic development but also in immune responses(2). Semaphorin 7A (Sema7A; also known as CD108)(3,4), which is a glycosylphosphatidylinositol-anchored semaphorin, promotes axon outgrowth through beta 1-integrin receptors and contributes to the formation of the lateral olfactory tract(5). Although Sema7A has been shown to stimulate human monocytes(6), its function as a negative regulator of T-cell responses has also been reported(7). Thus, the precise function of Sema7A in the immune system remains unclear. Here we show that Sema7A, which is expressed on activated T cells, stimulates cytokine production in monocytes and macrophages through alpha 1 beta 1 integrin ( also known as very late antigen-1) as a component of the immunological synapse, and is critical for the effector phase of the inflammatory immune response. Sema7A-deficient (Sema7a(-/-)) mice are defective in cell-mediated immune responses such as contact hypersensitivity and experimental autoimmune encephalomyelitis. Although antigen-specific and cytokine-producing effector T cells can develop and migrate into antigen-challenged sites in Sema7a(-/-) mice, Sema7a(-/-) T cells fail to induce contact hypersensitivity even when directly injected into the antigen-challenged sites. Thus, the interaction between Sema7A and alpha 1 beta 1 integrin is crucial at the site of inflammation. These findings not only identify a function of Sema7A as an effector molecule in T-cell-mediated inflammation, but also reveal a mechanism of integrin-mediated immune regulation.	JST, Dept Mol Immunol, Suita, Osaka 5650871, Japan; JST, CREST Program, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan; Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, NL-3584 CG Utrecht, Netherlands; Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 5650871, Japan; Biogen Idec Inc, Cambridge, MA 01746 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Osaka University; Osaka University; Utrecht University; Utrecht University Medical Center; Osaka University; Biogen; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Kumanogoh, A (corresponding author), JST, Dept Mol Immunol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	kumanogo@ragtime.biken.osaka-u.ac.jp; kikutani@ragtime.biken.osaka-u.ac.jp	Takegahara, Noriko/AAP-1694-2021; Kumanogoh, Atsushi/C-7354-2009; Suzuki, Kazuhiro/B-3886-2012; Kikutani, Hitoshi/C-9525-2009; Kitao, Tomoe/AHE-0728-2022	Kitao, Tomoe/0000-0003-1366-4861; Suzuki, Kazuhiro/0000-0002-9081-538X; Pasterkamp, Jeroen/0000-0003-1631-6440				Andreasen SO, 2003, J IMMUNOL, V171, P2804, DOI 10.4049/jimmunol.171.6.2804; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Ben-Horin S, 2004, CLIN IMMUNOL, V113, P119, DOI 10.1016/j.clim.2004.06.007; Czopik AK, 2006, IMMUNITY, V24, P591, DOI 10.1016/j.immuni.2006.03.013; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Fiorucci S, 2002, IMMUNITY, V17, P769, DOI 10.1016/S1074-7613(02)00476-4; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256; McInnes IB, 1997, NAT MED, V3, P189, DOI 10.1038/nm0297-189; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; RICHES DWH, 1991, J BIOL CHEM, V266, P24785; Riminton DS, 1998, J EXP MED, V187, P1517, DOI 10.1084/jem.187.9.1517; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428	27	196	210	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					680	684		10.1038/nature05652	http://dx.doi.org/10.1038/nature05652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377534				2022-12-24	WOS:000245438300043
J	Day, M				Day, Michael			Mapping the alternative	BRITISH MEDICAL JOURNAL			English	Article												miday@f2s.com						*DEP HLTH, 2007, TRUST ASS SAF REG HL; *HOUS LORDS SEL CO, 2000, 6 HOUS LORDS SEL COM; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Vincent C, 2001, BRIT MED J, V323, P467, DOI 10.1136/bmj.323.7311.467	4	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2007	334	7600					929	931		10.1136/bmj.39192.475382.AD	http://dx.doi.org/10.1136/bmj.39192.475382.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478842	Green Published			2022-12-24	WOS:000246343800033
J	Ferguson, SM; Brasnjo, G; Hayashi, M; Wolfel, M; Collesi, C; Giovedi, S; Raimondi, A; Gong, LW; Ariel, P; Paradise, S; O'Toole, E; Flavell, R; Cremona, O; Miesenbock, G; Ryan, TA; De Camilli, P				Ferguson, Shawn M.; Brasnjo, Gabor; Hayashi, Mitsuko; Woelfel, Markus; Collesi, Chiara; Giovedi, Silvia; Raimondi, Andrea; Gong, Liang-Wei; Ariel, Pablo; Paradise, Summer; O'Toole, Eileen; Flavell, Richard; Cremona, Ottavio; Miesenboeck, Gero; Ryan, Timothy A.; De Camilli, Pietro			A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis	SCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; KISS-AND-RUN; TRANSMITTER RELEASE; MEMBRANE; MUTATIONS; PROTEINS; KINETICS; FUSION; MODES; BLOCK	Dynamin 1 is a neuron-specific guanosine triphosphatase thought to be critically required for the fission reaction of synaptic vesicle endocytosis. Unexpectedly, mice lacking dynamin 1 were able to form functional synapses, even though their postnatal viability was limited. However, during spontaneous network activity, branched, tubular plasma membrane invaginations accumulated, capped by clathrin-coated pits, in synapses of dynamin 1-knockout mice. Synaptic vesicle endocytosis was severely impaired during strong exogenous stimulation but resumed efficiently when the stimulus was terminated. Thus, dynamin 1-independent mechanisms can support limited synaptic vesicle endocytosis, but dynamin 1 is needed during high levels of neuronal activity.	Yale Univ, Sch Med, Howard Hughes Med Inst, Kavli Inst Neurosci, New Haven, CT 06510 USA; Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10021 USA; FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy; Univ Vita Salute San Raffaele, Milan, Italy; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Cornell University; Rockefeller University; IFOM - FIRC Institute of Molecular Oncology; Vita-Salute San Raffaele University; University of Colorado System; University of Colorado Boulder	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Kavli Inst Neurosci, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Raimondi, Andrea/AAN-2475-2020; Giovedì, Silvia/AAB-7614-2019; Ryan, Timothy/AAO-8286-2020; Cremona, Ottavio/AAB-8793-2019; Collesi, Chiara/AAB-8979-2019	Cremona, Ottavio/0000-0001-9462-1040; GIOVEDI', SILVIA/0000-0001-7949-4274; COLLESI, CHIARA/0000-0003-3909-422X; Miesenboeck, Gero/0000-0003-2940-3228; Ariel, Pablo/0000-0002-8494-0379; Ryan, Timothy/0000-0003-2533-9548; Raimondi, Andrea/0000-0002-4563-386X	NCI NIH HHS [CA46128] Funding Source: Medline; NCRR NIH HHS [RR-000592] Funding Source: Medline; NIDA NIH HHS [DA018343, DA17297, P30 DA018343] Funding Source: Medline; NIDDK NIH HHS [DK45735] Funding Source: Medline; NINDS NIH HHS [NS36251, R01 NS036942, NS036942] Funding Source: Medline; Telethon [D.061] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036942, R01NS036942, R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343, R01DA017297] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cook T, 1996, J NEUROCHEM, V67, P927; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; ITOH T, 2000, BIOCHIM BIOPHYS ACTA, V1761, P897; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	36	374	388	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					570	574		10.1126/science.1140621	http://dx.doi.org/10.1126/science.1140621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463283				2022-12-24	WOS:000245983100037
J	Lau, KS; Partridge, EA; Grigorian, A; Silvescu, CI; Reinhold, VN; Demetriou, M; Dennis, JW				Lau, Ken S.; Partridge, Emily A.; Grigorian, Ani; Silvescu, Cristina I.; Reinhold, Vernon N.; Demetriou, Michael; Dennis, James W.			Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation	CELL			English	Article							ACETYLGLUCOSAMINYLTRANSFERASE-V; CAENORHABDITIS-ELEGANS; LINKED GLYCOSYLATION; MATHEMATICAL-MODEL; TGF-BETA; RECEPTOR; GROWTH; MICE; BIOSYNTHESIS; ENDOCYTOSIS	The number of N-glycans (n) is a distinct feature of each glycoprotein sequence and cooperates with the physical properties of the Golgi N-glycan-branching pathway to regulate surface glycoprotein levels. The Golgi pathway is ultrasensitive to hexosamine flux for the production of tri- and tetra-antennary N-glycans, which bind to galectins and form a molecular lattice that opposes glycoprotein endocytosis. Glycoproteins with few N-glycans (e.g., T beta R, CTLA-4, and GLUT4) exhibit enhanced cell-surface expression with switch-like responses to increasing hexosamine concentration, whereas glycoproteins with high numbers of N-glycans (e.g., EGFR, IGFR, FGFR, and PDGFR) exhibit hyperbolic responses. Computational and experimental data reveal that these features allow nutrient flux stimulated by growth-promoting high-n receptors to drive arrest/differentiation programs by increasing surface levels of low-n glycoproteins. We have identified a mechanism for metabolic regulation of cellular transition between growth and arrest in mammals arising from apparent coevolution of N-glycan number and branching.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L5, Canada; Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5G 1L5, Canada; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurol, Irvine, CA 92862 USA; Univ New Hampshire, Durham, NH 03824 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of California System; University of California Irvine; University of California System; University of California Irvine; University System Of New Hampshire; University of New Hampshire	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave R988, Toronto, ON M5G 1X5, Canada.	dennis@mshri.on.ca	Dennis, James/E-7268-2013; Lau, Ken/I-7958-2019	Lau, Ken/0000-0001-8438-0319; Demetriou, Michael/0000-0002-2224-7798				Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Al-Hasani H, 2002, J CELL SCI, V115, P131; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Broschat KO, 2002, J BIOL CHEM, V277, P14764, DOI 10.1074/jbc.M201056200; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Chikuma Shunsuke, 2002, Mol Interv, V2, P205, DOI 10.1124/mi.2.4.205; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DO KY, 1994, J BIOL CHEM, V269, P23456; Ehrlich M, 2001, J CELL SCI, V114, P1777; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Granovsky M, 2000, NAT MED, V6, P306; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; KUMAR R, 1989, MOL CELL BIOL, V9, P5713, DOI 10.1128/MCB.9.12.5713; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; SOBKO A, 2006, SCI STKE, pRE9; Takamatsu S, 1999, CANCER RES, V59, P3949; Tsao TS, 1996, DIABETES, V45, P28, DOI 10.2337/diabetes.45.1.28; Umana P, 1997, BIOTECHNOL BIOENG, V55, P890, DOI 10.1002/(SICI)1097-0290(19970920)55:6<890::AID-BIT7>3.0.CO;2-B; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; VILAR J, 2006, PLOS COMPUT BIOL, V2; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Warren CE, 2002, J BIOL CHEM, V277, P22829, DOI 10.1074/jbc.M201390200; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	51	630	660	3	97	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					123	134		10.1016/j.cell.2007.01.049	http://dx.doi.org/10.1016/j.cell.2007.01.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418791	Bronze			2022-12-24	WOS:000245661100016
J	Morris, SC; Caron, JB				Morris, Simon Conway; Caron, Jean-Bernard			Halwaxiids and the early evolution of the lophotrochozoans	SCIENCE			English	Article							WIWAXIA-CORRUGATA MATTHEW; BURGESS SHALE; FOSSIL; MOLLUSKS; MICRINA; WALCOTT; YUNNAN; CHINA	Halkieriids and wiwaxiids are cosmopolitan sclerite-bearing metazoans from the Lower and Middle Cambrian. Although they have similar scleritomes, their phylogenetic position is contested. A new scleritomous fossil from the Burgess Shale has the prominent anterior shell of the halkieriids but also bears wiwaxiid-like sclerites. This new fossil defines the monophyletic halwaxiids and indicates that they have a key place in early lophotrochozoan history.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	University of Cambridge; Royal Ontario Museum	Morris, SC (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	sc113@esc.cam.ac.uk; jcaron@rom.ca		Caron, Jean-Bernard/0000-0002-1670-5502				Aris-Brosou S, 2003, MOL BIOL EVOL, V20, P1947, DOI 10.1093/molbev/msg226; Bengtson S, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P101; BENGTSON S, 1992, LETHAIA, V25, P401, DOI 10.1111/j.1502-3931.1992.tb01644.x; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; BUTTERFIELD NJ, 1990, PALEOBIOLOGY, V16, P287, DOI 10.1017/S0094837300010009; Caron JB, 2006, PALAIOS, V21, P451, DOI 10.2110/palo.2003.P05-070R; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Conway Morris S., 1995, N JB GEOL PALAONTOL, V195, P319; DURHAM JW, 1974, J PALEONTOL, V48, P750; Eibye-Jacobsen D, 2004, LETHAIA, V37, P317, DOI 10.1080/00241160410002027; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Gould S. J., 1989, WONDERFUL LIFE BURGE; JELL PA, 1981, ALCHERINGA, V5, P85, DOI 10.1080/03115518108565423; Li GX, 2004, J PALEONTOL, V78, P900, DOI 10.1666/0022-3360(2004)078<0900:TAMTFT>2.0.CO;2; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; MORRIS SC, 1985, PHILOS T R SOC B, V307, P507, DOI 10.1098/rstb.1985.0005; Morris SC, 2006, PHILOS T R SOC B, V361, P1069, DOI 10.1098/rstb.2006.1846; Qian Y., 1989, FOSS STRAT, V24, P156; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Shu DG, 2004, NATURE, V430, P422, DOI 10.1038/nature02648; Siegmund H, 1997, LETHAIA, V30, P285; Vinther J, 2005, ZOOL SCR, V34, P81, DOI 10.1111/j.1463-6409.2005.00177.x; Williams A, 2002, PALAEONTOLOGY, V45, P845, DOI 10.1111/1475-4983.00264	25	89	94	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1255	1258		10.1126/science.1137187	http://dx.doi.org/10.1126/science.1137187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17332408				2022-12-24	WOS:000244564700044
J	Greene, CH; Pershing, AJ				Greene, Charles H.; Pershing, Andrew J.			Climate drives sea change	SCIENCE			English	Editorial Material							MAINE; GULF; VARIABILITY		Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA; Univ Maine, Portland, ME 04101 USA; Gulf Maine Res Inst, Portland, ME 04101 USA	Cornell University; University of Maine System; University of Maine Orono; Gulf of Maine Research Institute	Greene, CH (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA.	chg2@cornell.edu						Belkin IM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019334; Durbin EG, 2003, MAR ECOL PROG SER, V254, P81, DOI 10.3354/meps254081; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Hakkinen S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015243; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Morison J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026826; Mountain DG, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001044; Pershing AJ, 2005, ICES J MAR SCI, V62, P1511, DOI 10.1016/j.icesjms.2005.04.025; Smith PC, 2001, DEEP-SEA RES PT II, V48, P37, DOI 10.1016/S0967-0645(00)00081-3; Steele M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002009; Vilhalmsson Hjalmar, 2005, P691; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	13	187	200	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1084	1085		10.1126/science.1136495	http://dx.doi.org/10.1126/science.1136495			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138UA	17322049				2022-12-24	WOS:000244387600023
J	Barnes, AP; Lilley, BN; Pan, YA; Plummer, LJ; Powell, AW; Raines, AN; Sanes, JR; Polleux, F				Barnes, Anthony P.; Lilley, Brendan N.; Pan, Y. Albert; Plummer, Lisa J.; Powell, Ashton W.; Raines, Alexander N.; Sanes, Joshua R.; Polleux, Franck			LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons	CELL			English	Article							SERINE/THREONINE PROTEIN-KINASE; DOUBLECORTIN-LIKE-KINASE; NEURITE OUTGROWTH; TUMOR-SUPPRESSOR; MICROTUBULE AFFINITY; HIPPOCAMPAL-NEURONS; MIGRATORY BEHAVIOR; CEREBRAL-CORTEX; AXON FORMATION; POLARITY	The polarization of axon and dendrites underlies the ability of neurons to integrate and transmit information in the brain. We show here that the serine/threonine kinase LKB1, previously implicated in the establishment of epithelial polarity and control of cell growth, is required for axon specification during neuronal polarization in the mammalian cerebral cortex. LKB1 polarizing activity requires its association with the pseudokinase Strado alpha and phosphorylation by kinases such as PKA and p90RSK, which transduce neurite outgrowth-promoting cues. Once activated, LKB1 phosphorylates and thereby activates SAD-A and SAD-B kinases, which are also required for neuronal polarization in the cerebral cortex. SAD kinases, in turn, phosphorylate effectors such as microtubule-associated proteins that implement polarization. Thus, we provide evidence in vivo and in vitro for a multikinase pathway that links extracellular signals to the intracellular machinery required for axon specification.	Univ N Carolina, Ctr Neurosci, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Neurodev Disorders Res Ctr, Chapel Hill, NC 27599 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard University	Polleux, F (corresponding author), Univ N Carolina, Ctr Neurosci, Dept Pharmacol, Chapel Hill, NC 27599 USA.	polleux@med.unc.edu	Polleux, Franck/H-9948-2014	Polleux, Franck/0000-0003-4313-0481; Barnes, Anthony/0000-0002-4598-9591	NINDS NIH HHS [P30 NS45892-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Chang SL, 2000, J NEUROSCI METH, V97, P1, DOI 10.1016/S0165-0270(99)00190-9; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kawano H, 1999, J COMP NEUROL, V408, P147, DOI 10.1002/(SICI)1096-9861(19990531)408:2<147::AID-CNE1>3.0.CO;2-L; Kempf M, 1996, J NEUROSCI, V16, P5583; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martone ME, 2003, NEUROINFORMATICS, V1, P379, DOI 10.1385/NI:1:4:379; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Miyoshi H, 2002, CANCER RES, V62, P2261; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Polleux F, 1997, J COMP NEUROL, V385, P95; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; POLLEUX F, 2002, SCI STKE, V136, pPL9; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Wong EV, 1996, J BIOL CHEM, V271, P18217, DOI 10.1074/jbc.271.30.18217; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yu WQ, 2000, J NEUROSCI, V20, P5782, DOI 10.1523/JNEUROSCI.20-15-05782.2000	68	311	323	0	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					549	563		10.1016/j.cell.2007.03.025	http://dx.doi.org/10.1016/j.cell.2007.03.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482548	Green Submitted, Bronze			2022-12-24	WOS:000246373600021
J	Kostelansky, MS; Schluter, C; Tam, YYC; Lee, S; Ghirlando, R; Beach, B; Conibear, E; Hurley, JH				Kostelansky, Michael S.; Schluter, Cayetana; Tam, Yuen Yi C.; Lee, Sangho; Ghirlando, Rodolfo; Beach, Bridgette; Conibear, Elizabeth; Hurley, James H.			Molecular architecture and functional model of the complete yeast ESCRT-I heterotetramer	CELL			English	Article							SORTING COMPLEX; UBIQUITIN RECOGNITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TRANSPORT; PROTEINS; TSG101; DOMAIN; COMPONENT; PATHWAY	The endosomal sorting complex required for transport-1 (ESCRT-1) complex, which is conserved from yeast to humans, directs the lysosomal degradation of ubiquitinated transmembrane proteins and the budding of the HIV virus. Yeast ESCRT-1 contains four subunits, Vps23, Vps28, Vps37, and Mvb12. The crystal structure of the heterotetrameric ESCRT-1 complex reveals a highly asymmetric complex of 1:1:1:1 subunit stoichiometry. The core complex is nearly 18 nm long and consists of a headpiece attached to a 13 nm stalk. The stalk is important for cargo sorting by ESCRT-1 and is proposed to serve as a spacer regulating the correct disposition of cargo and other ESCRT components. Hydrodynamic constraints and crystallographic structures were used to generate a model of intact ESCRT-1 in solution. The results show how ESCRT-1 uses a combination of a rigid stalk and flexible tethers to interact with lipids, cargo, and other ESCRT complexes over a span of similar to 25 nm.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Child & Family Research Institute; University of British Columbia	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Ghirlando, Rodolfo/A-8880-2009; Lee, Sangho/P-4204-2018; Conibear, Elizabeth/G-5297-2010	Lee, Sangho/0000-0003-3886-4579; Conibear, Elizabeth/0000-0001-5129-0499	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK033007, Z01DK036118, Z01DK036123] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK036118-14] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chu T, 2006, J CELL BIOL, V175, P815, DOI 10.1083/jcb.200608053; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Conibear E, 2002, MOL CELL, V10, P215, DOI 10.1016/S1097-2765(02)00601-9; Curtiss M, 2007, MOL BIOL CELL, V18, P636, DOI 10.1091/mbc.E06-07-0588; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gill DJ, 2007, EMBO J, V26, P600, DOI 10.1038/sj.emboj.7601501; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kostelansky MS, 2006, CELL, V125, P113, DOI 10.1016/j.cell.2006.01.049; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Oestreich AJ, 2007, MOL BIOL CELL, V18, P646, DOI 10.1091/mbc.E06-07-0601; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047	43	118	127	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					485	498		10.1016/j.cell.2007.03.016	http://dx.doi.org/10.1016/j.cell.2007.03.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17442384	Green Accepted, Bronze			2022-12-24	WOS:000246373600016
J	Han, JH; Kushner, SA; Yiu, AP; Cole, CJ; Matynia, A; Brown, RA; Neve, RL; Guzowski, JF; Silva, AJ; Josselyn, SA				Han, Jin-Hee; Kushner, Steven A.; Yiu, Adelaide P.; Cole, Christy J.; Matynia, Anna; Brown, Robert A.; Neve, Rachael L.; Guzowski, John F.; Silva, Alcino J.; Josselyn, Sheena A.			Neuronal competition and selection during memory formation	SCIENCE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; FEAR MEMORIES; IN-VIVO; AMYGDALA; CREB; EXPRESSION; OVEREXPRESSION; PLASTICITY; ACTIVATOR	Competition between neurons is necessary for refining neural circuits during development and may be important for selecting the neurons that participate in encoding memories in the adult brain. To examine neuronal competition during memory formation, we conducted experiments with mice in which we manipulated the function of CREB ( adenosine 3',5'-monophosphate response element-binding protein) in subsets of neurons. Changes in CREB function influenced the probability that individual lateral amygdala neurons were recruited into a fear memory trace. Our results suggest a competitive model underlying memory formation, in which eligible neurons are selected to participate in a memory trace as a function of their relative CREB activity at the time of learning.	Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Harvard Univ, Sch Med, Dept Psychiat, Mol Neurogenet Lab, Belmont, MA 02478 USA; Univ Calif Irvine, Sch Biol Sci, Irvine, CA 92697 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University; New York State Psychiatry Institute; Harvard University; University of California System; University of California Irvine	Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sheena.josselyn@sickkids.ca	Silva, Alcino/ABD-7684-2021; Han, Jin-Hee/C-2069-2011	Silva, Alcino/0000-0002-1587-4558; Kushner, Steven/0000-0002-9777-3338; Han, Jin-Hee/0000-0002-2139-5596; Silva, Alcino/0000-0001-5525-0494	NIA NIH HHS [AG13622] Funding Source: Medline; NICHD NIH HHS [P01HD33098] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD033098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013622, U01AG013622, R01AG013622] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Jasnow AM, 2005, BEHAV NEUROSCI, V119, P1125, DOI 10.1037/0735-7044.119.4.1125; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; WAITEREIT R, 2001, J NEUROSCI, V21, P5484; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	27	422	444	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					457	460		10.1126/science.1139438	http://dx.doi.org/10.1126/science.1139438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446403				2022-12-24	WOS:000245813400059
J	Fox, MA; Sanes, JR; Borza, DB; Eswarakumar, VP; Fassler, R; Hudson, BG; John, SWM; Ninomiya, Y; Pedchenko, V; Pfaff, SL; Rheault, MN; Sado, Y; Segal, Y; Werle, MJ; Umemori, H				Fox, Michael A.; Sanes, Joshua R.; Borza, Dorin-Bogdan; Eswarakumar, Veraragavan P.; Faessler, Reinhard; Hudson, Billy G.; John, Simon W. M.; Ninomiya, Yoshifumi; Pedchenko, Vadim; Pfaff, Samuel L.; Rheault, Michelle N.; Sado, Yoshikazu; Segal, Yoav; Werle, Michael J.; Umemori, Hisashi			Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; NEUROMUSCULAR-JUNCTION; BASEMENT-MEMBRANE; IV COLLAGEN; ALPORT-SYNDROME; NEUROTRANSMITTER RELEASE; NONCOLLAGENOUS DOMAINS; CALCIUM-CHANNEL; XVIII COLLAGEN; MUTANT MICE	Target-derived factors organize synaptogenesis by promoting differentiation of nerve terminals at synaptic sites. Several candidate organizing molecules have been identified based on their bioactivities in vitro, but little is known about their roles in vivo. Here, we show that three sets of organizers act sequentially to pattern motor nerve terminals: FGFs, beta 2 laminins, and collagen alpha(IV) chains. FGFs of the 7/10/22 subfamily and broadly distributed collagen IV chains (alpha 1/2) promote clustering of synaptic vesicles as nerve terminals form. beta 2 laminins concentrated at synaptic sites are dispensable for embryonic development of nerve terminals but are required for their postnatal maturation. Synapse-specific collagen IV chains (alpha 3-6) accumulate only after synapses are mature and are required for synaptic maintenance. Thus, multiple target-derived signals permit discrete control of the formation, maturation, and maintenance of presynaptic specializations.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Okayama Univ, Dept Mol Biol & Biochem, Okayama 700, Japan; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Univ Minnesota, Dept Med, Div Renal, Minneapolis, MN 55455 USA; Shigei Med Res Inst, Div Immunol, Okayama 7010202, Japan; Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Harvard University; Yale University; Vanderbilt University; Max Planck Society; Howard Hughes Medical Institute; Jackson Laboratory; Okayama University; Salk Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Kansas; University of Kansas Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	Borza, Dorin-Bogdan/AAF-2156-2020; Pedchenko, Vadim/A-6873-2009	Borza, Dorin-Bogdan/0000-0003-4568-279X; Eswarakumar, V.P./0000-0001-7941-8714; Hudson, Billy/0000-0002-5420-4100; Eswarakumar, Jacob/0000-0003-0784-0507; Umemori, Hisashi/0000-0001-7198-2062; Rheault, Michelle N./0000-0003-2494-3970; Fox, Michael/0000-0002-1649-7782				Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; HENDERSON CE, 1996, NERVE CELL CULTURE P, P69; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; LEIN PJ, 1991, J CELL BIOL, V113, P417, DOI 10.1083/jcb.113.2.417; LUPA MT, 1990, DEV BIOL, V142, P31, DOI 10.1016/0012-1606(90)90148-C; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; OOHASHI T, 1995, J BIOL CHEM, V270, P26863, DOI 10.1074/jbc.270.45.26863; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Smirnov SP, 2005, J BIOL CHEM, V280, P41449, DOI 10.1074/jbc.M508939200; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Sons MS, 2006, NEUROSCIENCE, V138, P433, DOI 10.1016/j.neuroscience.2005.11.040; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Urbano FJ, 2002, MOL MEMBR BIOL, V19, P293, DOI 10.1080/0968768021000035087; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	56	187	198	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					179	193		10.1016/j.cell.2007.02.035	http://dx.doi.org/10.1016/j.cell.2007.02.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418794	Bronze			2022-12-24	WOS:000245661100020
J	Prall, OWJ; Menon, MK; Solloway, MJ; Watanabe, Y; Zaffran, S; Bajolle, F; Biben, C; McBride, JJ; Robertson, BR; Chaulet, H; Stennard, FA; Wise, N; Schaft, D; Wolstein, O; Furtado, MB; Shiratori, H; Chien, KR; Hamada, H; Black, BL; Saga, Y; Robertson, EJ; Buckingham, ME; Harvey, RP				Prall, Owen W. J.; Menon, Mary K.; Solloway, Mark J.; Watanabe, Yusuke; Zaffran, Stephane; Bajolle, Fanny; Biben, Christine; McBride, Jim J.; Robertson, Bronwyn R.; Chaulet, Herve; Stennard, Fiona A.; Wise, Natalie; Schaft, Daniel; Wolstein, Orit; Furtado, Milena B.; Shiratori, Hidetaka; Chien, Kenneth R.; Hamada, Hiroshi; Black, Brian L.; Saga, Yumiko; Robertson, Elizabeth J.; Buckingham, Margaret E.; Harvey, Richard P.			An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation	CELL			English	Article							HOMEOBOX GENE NKX2-5; TRANSCRIPTION FACTOR NKX2-5; OUTFLOW TRACT; ASYMMETRIC EXPRESSION; SIGNALING PATHWAY; EMBRYOS LACKING; FIELD; MUTATIONS; CELLS; DISEASE	During heart development the second heart field (SHF) provides progenitor cells for most cardiomyocytes and expresses the homeodomain factor Nkx2-5. We now show that feedback repression of Bmp2/Smad1 signaling by Nkx2-5 critically regulates SHF proliferation and outflow tract (OFT) morphology. In the cardiac fields of Nkx2-5 mutants, genes controlling cardiac specification (including Bmp2) and maintenance of the progenitor state were upregulated, leading initially to progenitor overspecification, but subsequently to failed SHF proliferation and OFT truncation. In Smad1 mutants, SHF proliferation and deployment to the OFT were increased, while Smad1 deletion in Nkx2-5 mutants rescued SHF proliferation and OFT development. In Nkx2-5 hyponnorphic mice, which recapitulate human congenital heart disease (CHD), OFT anomalies were also rescued by Smad1 deletion. Our findings demonstrate that Nkx2-5 orchestrates the transition between periods of cardiac induction, progenitor proliferation, and OFT morphogenesis via a Smadl dependent negative feedback loop, which may be a frequent molecular target in CHD.	Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; Univ New S Wales, Fac Life Sci, Kensington, NSW 2053, Australia; Univ New S Wales, Fac Med, Kensington, NSW 2053, Australia; Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, Paris, France; Garvan Inst Med Res, Sydney, NSW 2010, Australia; Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW, Australia; Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Garvan Institute of Medical Research; University of New South Wales Sydney; Osaka University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Oxford; Wellcome Centre for Human Genetics	Harvey, RP (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia.	r.harvey@victorchang.unsw.edu.au	Zaffran, Stéphane/S-7454-2019; Zaffran, Stéphane/I-2955-2016; Hamada, Hiroshi/N-6374-2015	Zaffran, Stéphane/0000-0002-0811-418X; Zaffran, Stéphane/0000-0002-0811-418X; Hamada, Hiroshi/0000-0002-7196-5948; Black, Brian/0000-0002-6664-8913; Harvey, Richard/0000-0002-9950-9792	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047858] Funding Source: NIH RePORTER; NICHD NIH HHS [R21 HD047858-01, R21 HD047858, HD 047858] Funding Source: Medline; Wellcome Trust [059312] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elliott DA, 2003, J AM COLL CARDIOL, V41, P2072, DOI 10.1016/S0735-1097(03)00420-0; Elliott DA, 2006, DEVELOPMENT, V133, P1311, DOI 10.1242/dev.02305; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hu TH, 2004, DEVELOPMENT, V131, P5491, DOI 10.1242/dev.01399; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Kelly RG, 1997, DEV BIOL, V187, P183, DOI 10.1006/dbio.1997.8577; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2005, TRENDS CARDIOVAS MED, V15, P51, DOI 10.1016/j.tcm.2005.02.001; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lien CL, 2002, DEV BIOL, V244, P257, DOI 10.1006/dbio.2002.0603; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Ross RS, 1996, DEVELOPMENT, V122, P1799; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vitelli F, 2002, DEVELOPMENT, V129, P4605; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yelbuz TM, 2002, CIRCULATION, V106, P504, DOI 10.1161/01.CIR.0000023044.44974.8A; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE; Zhang WJ, 2002, J BIOL CHEM, V277, P45435, DOI 10.1074/jbc.M208056200	41	381	399	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					947	959		10.1016/j.cell.2007.01.042	http://dx.doi.org/10.1016/j.cell.2007.01.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350578	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000245073400018
J	Tahiliani, M; Mei, PC; Fang, R; Leonor, T; Rutenberg, M; Shimizu, F; Li, J; Rao, A; Shi, YJ				Tahiliani, Mamta; Mei, Pinchao; Fang, Rui; Leonor, Thiago; Rutenberg, Michael; Shimizu, Fumiko; Li, Jing; Rao, Anjana; Shi, Yujiang			The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation	NATURE			English	Article							RESTRICTIVE SILENCER FACTOR; DOMAIN-CONTAINING PROTEINS; TRANSCRIPTIONAL REGULATION; CO-REPRESSOR; CHANNEL; JMJC; EXPRESSION; DISORDERS; MUTATIONS; EPILEPSY	Gene transcription is critically influenced by chromatin structure and the modification status of histone tails(1). Methylation of lysine residues in histone tails is dynamically regulated by the opposing activities of histone methyltransferases and histone demethylases(2). Here we show that JARID1C/SMCX, a JmjC-domain-containing protein implicated in X-linked mental retardation and epilepsy(3,4), possesses H3K4 tri-demethylase activity and functions as a transcriptional repressor. An SMCX complex isolated from HeLa cells contains additional chromatin modifiers (the histone deacetylases HDAC1 and HDAC2, and the histone H3K9 methyltransferase G9a) and the transcriptional repressor REST(5), suggesting a direct role for SMCX in chromatin dynamics and REST-mediated repression. Chromatin immunoprecipitation reveals that SMCX and REST co-occupy the neuron-restrictive silencing elements in the promoters of a subset of REST target genes. RNA-interference-mediated depletion of SMCX derepresses several of these targets and simultaneously increases H3K4 trimethylation at the sodium channel type 2A (SCN2A) and synapsin I (SYN1) promoters. We propose that loss of SMCX activity impairs REST-mediated neuronal gene regulation, thereby contributing to SMCX-associated X-linked mental retardation.	Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; Brigham & Womens Hosp, BCMP, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; CBR Inst Biomed Res, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); State University System of Florida; University of Florida	Shi, YJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	yujiang_shi@hms.harvard.edu	Hu, Ruogu/B-2203-2008	Li, Jing/0000-0001-7699-4249; Mei, Pinchao/0000-0002-1564-0372	NIGMS NIH HHS [R01 GM078458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdolmaleky HM, 2005, AM J PHARMACOGENOMIC, V5, P149, DOI 10.2165/00129785-200505030-00002; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; Kuwahara K, 2005, J PHARMACOL SCI, V99, P211, DOI 10.1254/jphs.FMJ05002X4; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; LEE N, 2007, NATURE STRUCT MOL BI; Lohoff FW, 2006, NEUROPSYCHOPHARMACOL, V31, P2739, DOI 10.1038/sj.npp.1301196; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lubec G, 2003, J NEURAL TRANSM-SUPP, P215; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Schousboe A, 2004, EUR J PHARMACOL, V500, P281, DOI 10.1016/j.ejphar.2004.07.032; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	38	321	337	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					601	+		10.1038/nature05823	http://dx.doi.org/10.1038/nature05823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17468742				2022-12-24	WOS:000246842000051
J	Beeson, TD; Mastracchio, A; Hong, JB; Ashton, K; MacMillan, DWC				Beeson, Teresa D.; Mastracchio, Anthony; Hong, Jun-Bae; Ashton, Kate; MacMillan, David W. C.			Enantioselective organocatalysis using SOMO activation	SCIENCE			English	Article							ORGANIC CATALYSIS; TRANSITION-METAL; RADICAL-CATION; STRATEGIES; ENAMINES	The asymmetric alpha-addition of relatively nonpolar hydrocarbon substrates, such as allyl and aryl groups, to aldehydes and ketones remains a largely unsolved problem in organic synthesis, despite the wide potential utility of direct routes to such products. We reasoned that well-established chiral amine catalysis, which activates aldehydes toward electrophile addition by enamine formation, could be expanded to this important reaction class by applying a single-electron oxidant to create a transient radical species from the enamine. We demonstrated the concept of singly occupied molecular orbital (SOMO) activation with a highly selective alpha-allylation of aldehydes, and we here present preliminary results for enantioselective heteroarylations and cyclization/halogenation cascades.	Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Princeton University; California Institute of Technology	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078201] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078201-01-01, R01 GM078201] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; [Anonymous], [No title captured]; CRABTREE RH, 2000, ORGANOMETALLIC CHEM; Ibrahem I, 2006, ANGEW CHEM INT EDIT, V45, P1952, DOI 10.1002/anie.200504021; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Kirchgessner M, 2006, J ORG CHEM, V71, P9849, DOI 10.1021/jo061809i; Lee HB, 2001, J AM CHEM SOC, V123, P11322, DOI 10.1021/ja017043f; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; LeTadicBiadatti MH, 1996, J CHEM SOC PERK T 2, P1467, DOI 10.1039/p29960001467; Lide D.R., 1995, HDB CHEM PHYS, P220; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; List B, 2006, CHEM COMMUN, P819, DOI 10.1039/b514296m; MULLER K, 1981, HELV CHIM ACTA, V64, P2497, DOI 10.1002/hlca.19810640802; NARASAKA K, 1992, CHEM LETT, P2099, DOI 10.1246/cl.1992.2099; NOYORI R, 1994, ASYMMETRIC CATALYSIS, P123; Ojima I., 2000, CATALYTIC ASYMMETRIC; Renaud P., 2001, RADICALS ORGANIC SYN, V2, P144; SEYDENPENNE J, 1995, CHIRAL AUXILIARIES L, P166; Sibi MP, 2007, J AM CHEM SOC, V129, P395, DOI 10.1021/ja066425o; Sutterer A, 2000, J AM CHEM SOC, V122, P5636, DOI 10.1021/ja001063k; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Trost BM, 2003, CHEM REV, V103, P2921, DOI 10.1021/cr020027w; VIEHE HG, 1988, PURE APPL CHEM, V60, P1635, DOI 10.1351/pac198860111635; Yamamoto H., 2000, LEWIS ACIDS ORGANIC, V1	24	531	534	9	390	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					582	585		10.1126/science. 1142696	http://dx.doi.org/10.1126/science. 1142696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	160ZC	17395791				2022-12-24	WOS:000245983100040
J	Goshima, G; Wollman, R; Goodwin, SS; Zhang, N; Scholey, JM; Vale, RD; Stuurman, N				Goshima, Gohta; Wollman, Roy; Goodwin, Sarah S.; Zhang, Nan; Scholey, Jonathan M.; Vale, Ronald D.; Stuurman, Nico			Genes required for mitotic spindle assembly in Drosophila S2 cells	SCIENCE			English	Article							ABNORMAL-SPINDLE; KINETOCHORE; MITOSIS; PROTEIN; CANCER; IDENTIFICATION; MELANOGASTER; INSTABILITY; PROGRESSION; COMPONENTS	The formation of a metaphase spindle, a bipolar microtubule array with centrally aligned chromosomes, is a prerequisite for the faithful segregation of a cell's genetic material. Using a full-genome RNA interference screen of Drosophila S2 cells, we identified about 200 genes that contribute to spindle assembly, more than half of which were unexpected. The screen, in combination with a variety of secondary assays, led to new insights into how spindle microtubules are generated; how centrosomes are positioned; and how centrioles, centrosomes, and kinetochores are assembled.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; Marine Biol Lab, Physiol Course, Woods Hole, MA 02543 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Marine Biological Laboratory - Woods Hole	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Stuurman, Nico/AAV-4894-2021	Stuurman, Nico/0000-0002-6179-8613; Goodwin, Sarah/0000-0003-4686-0914	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM038499, R37 GM038499-21] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Fung SM, 2002, DEVELOPMENT, V129, P347; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Morales-Mulia S, 2005, MOL BIOL CELL, V16, P3176, DOI 10.1091/mbc.E04-12-1110; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Rieder CL, 2003, SCIENCE, V300, P91, DOI 10.1126/science.1082177; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	35	418	433	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					417	421		10.1126/science.1141314	http://dx.doi.org/10.1126/science.1141314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17412918	Green Accepted			2022-12-24	WOS:000245813400048
J	Asara, JM; Schweitzer, MH; Freimark, LM; Phillips, M; Cantley, LC				Asara, John M.; Schweitzer, Mary H.; Freimark, Lisa M.; Phillips, Matthew; Cantley, Lewis C.			Protein sequences from mastodon and Tyrannosaurus rex revealed by mass spectrometry	SCIENCE			English	Article							OSTEOCALCIN PROTEIN; SOFT-TISSUE; PRESERVATION; COLLAGEN; BONES; DNA	Fossilized bones from extinct taxa harbor the potential for obtaining protein or DNA sequences that could reveal evolutionary links to extant species. We used mass spectrometry to obtain protein sequences from bones of a 160,000- to 600,000-year-old extinct mastodon (Mammut americanum) and a 68-million-year-old dinosaur (Tyrannosaurus rex). The presence of T. rex sequences indicates that their peptide bonds were remarkably stable. Mass spectrometry can thus be used to determine unique sequences from ancient organisms from peptide fragmentation patterns, a valuable tool to study the evolution and adaptation of ancient taxa from which genomic sequences are unlikely to be obtained.	Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; N Carolina Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Montana State University System; Montana State University Bozeman; University of North Carolina; North Carolina State University; Harvard University; Harvard Medical School	Asara, JM (corresponding author), Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA.	jasara@bidmc.harvard.edu	Smejda, Ladislav/B-8474-2008; schweitzer, mary h/A-6756-2010; Cantley, Lewis C/D-1800-2014; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; Cantley, Lewis C/0000-0002-1298-7653; 				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bhattacharjee A, 2005, IUBMB LIFE, V57, P161, DOI 10.1080/15216540500090710; Collins MJ, 2000, GEOLOGY, V28, P1139, DOI 10.1130/0091-7613(2000)28<1139:SRODOO>2.0.CO;2; Dayhoff M.O., 1978, ATLAS PROTEIN SEQ ST; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Hill CL, 2006, QUATERN INT, V142, P87, DOI 10.1016/j.quaint.2005.03.007; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; MARIN M, 2003, NAT BIOTECHNOL, V21, P255; Nielsen-Marsh CM, 2005, P NATL ACAD SCI USA, V102, P4409, DOI 10.1073/pnas.0500450102; Nielsen-Marsh CM, 2002, GEOLOGY, V30, P1099, DOI 10.1130/0091-7613(2002)030<1099:SPOOPA>2.0.CO;2; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Ostrom PH, 2006, GEOCHIM COSMOCHIM AC, V70, P2034, DOI 10.1016/j.gca.2006.01.004; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Schweitzer MH, 2002, J MOL EVOL, V55, P696, DOI 10.1007/s00239-002-2365-6; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; Tauber MM, 2000, APPL ENVIRON MICROB, V66, P1634, DOI 10.1128/AEM.66.4.1634-1638.2000; TUROSS N, 1988, GEOCHIM COSMOCHIM AC, V52, P929, DOI 10.1016/0016-7037(88)90364-X; Yang H, 1996, P NATL ACAD SCI USA, V93, P1190, DOI 10.1073/pnas.93.3.1190	25	200	210	2	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					280	285		10.1126/science.1137614	http://dx.doi.org/10.1126/science.1137614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431180				2022-12-24	WOS:000245654500052
J	Tse, D; Langston, RF; Kakeyama, M; Bethus, I; Spooner, PA; Wood, ER; Witter, MP; Morris, RGM				Tse, Dorothy; Langston, Rosamund F.; Kakeyama, Masaki; Bethus, Ingrid; Spooner, Patrick A.; Wood, Emma R.; Witter, Menno P.; Morris, Richard G. M.			Schemas and memory consolidation	SCIENCE			English	Article							REMOTE SPATIAL MEMORY; LONG-TERM-MEMORY; COMPLEMENTARY-LEARNING-SYSTEMS; RETROGRADE-AMNESIA; HIPPOCAMPAL-LESIONS; IBOTENATE LESIONS; COGNITIVE MEMORY; RATS; ORGANIZATION; DAMAGE	Memory encoding occurs rapidly, but the consolidation of memory in the neocortex has long been held to be a more gradual process. We now report, however, that systems consolidation can occur extremely quickly if an associative "schema" into which new information is incorporated has previously been created. In experiments using a hippocampal-dependent paired-associate task for rats, the memory of flavor-place associations became persistent over time as a putative neocortical schema gradually developed. New traces, trained for only one trial, then became assimilated and rapidly hippocampal-independent. Schemas also played a causal role in the creation of lasting associative memory representations during one-trial learning. The concept of neocortical schemas may unite psychological accounts of knowledge structures with neurobiological theories of systems memory consolidation.	Univ Edinburgh, Ctr Cognit & Neural Syst, Lab Cognit Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Tokyo, Grad Sch, Div Environm Hlth SCi, Ctr Dis Biol & Integrat Med,Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Med Tech Res Ctr, Ctr Biol Memory, NO-7489 Trondheim, Norway	University of Edinburgh; University of Edinburgh; University of Tokyo; University of Tokyo	Morris, RGM (corresponding author), Univ Edinburgh, Ctr Cognit & Neural Syst, Lab Cognit Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland.	r.g.m.morris@ed.ac.uk	Morris, Richard G M/C-9982-2013	MORRIS, Richard G M/0000-0001-8661-1520; Kakeyama, Masaki/0000-0001-9063-9673; Tse, Dorothy/0000-0003-2263-8139; Langston, Rosamund/0000-0002-4668-3105; Bethus, Ingrid/0000-0001-8356-6963	MRC [G9200370] Funding Source: UKRI; Medical Research Council [G9200370] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bartlett F. C., 1932, REMEMBERING; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bayley PJ, 2002, J NEUROSCI, V22, P5741; BOLHUIS JJ, 1994, Q J EXP PSYCHOL-B, V47, P129; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bransford J., 1979, HUMAN COGNITION LEAR; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Craik K. J. W., 1943, NATURE EXPLANATION; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; DUDAI Y, 2001, ADV COGNITIVE SCI, P147; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; GREENOUGH WT, 1992, MINN SYM CHILD PSYCH, V24, P155; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hebb Donald O., 1949, ORG BEHAV; Johnson-Laird P. N., 1983, MENTAL MODELS COGNIT; Kesner RP, 2005, BEHAV NEUROSCI, V119, P781, DOI 10.1037/0735-7044.119.3.781; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGONIGLE BO, 1977, NATURE, V267, P694, DOI 10.1038/267694a0; McNaughton, 2003, SLEEP BRAIN PLASTICI, P225, DOI DOI 10.1093/ACPROF:OSO/9780198574002.003.0013; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sutherland RJ, 2001, HIPPOCAMPUS, V11, P27, DOI 10.1002/1098-1063(2001)11:1<27::AID-HIPO1017>3.0.CO;2-4; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Winocur G, 2005, NAT NEUROSCI, V8, P273, DOI 10.1038/nn1401; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	53	736	742	2	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					76	82		10.1126/science.1135935	http://dx.doi.org/10.1126/science.1135935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412951	Green Published			2022-12-24	WOS:000245470500034
J	Jenni, S; Leibundgut, M; Boehringer, D; Frick, C; Mikolasek, B; Ban, N				Jenni, Simon; Leibundgut, Marc; Boehringer, Daniel; Frick, Christian; Mikolasek, Bohdan; Ban, Nenad			Structure of fungal fatty acid synthase and implications for iterative substrate shuttling	SCIENCE			English	Article							MULTIFUNCTIONAL ENZYME TYPE-2; CARRIER PROTEIN TRANSACYLASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-SITE; PALMITOYL TRANSFERASE; MULTIENZYME COMPLEX; YEAST; SYNTHETASE; MALONYL	We report crystal structures of the 2.6-megadalton alpha(6)beta(6) heterododecameric fatty acid synthase from Thermomyces lanuginosus at 3.1 angstrom resolution. The alpha and beta polypeptide chains form the six catalytic domains required for fatty acid synthesis and numerous expansion segments responsible for extensive intersubunit connections. Detailed views of all active sites provide insights into substrate specificities and catalytic mechanisms and reveal their unique characteristics, which are due to the integration into the multienzyme. The mode of acyl carrier protein attachment in the reaction chamber, together with the spatial distribution of active sites, suggests that iterative substrate shuttling is achieved by a relatively restricted circular motion of the carrier domain in the multifunctional enzyme.	ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mol.biol.ethz.ch						Asturias FJ, 2005, NAT STRUCT MOL BIOL, V12, P225, DOI 10.1038/nsmb899; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; ENGESER H, 1979, EUR J BIOCHEM, V101, P407, DOI 10.1111/j.1432-1033.1979.tb19733.x; ENGESER H, 1979, EUR J BIOCHEM, V101, P413, DOI 10.1111/j.1432-1033.1979.tb19734.x; FOX JL, 1980, EUR J BIOCHEM, V109, P417, DOI 10.1111/j.1432-1033.1980.tb04810.x; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Hubbard PA, 2003, J BIOL CHEM, V278, P37553, DOI 10.1074/jbc.M304642200; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kolodziej SJ, 1997, J STRUCT BIOL, V120, P158, DOI 10.1006/jsbi.1997.3911; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; LEIBUNDGUT M, 2006, SCIENCE, V316, pR30; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; LYNEN F, 1967, BIOCHEM J, V102, P381, DOI 10.1042/bj1020381; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; RADFORD SE, 1989, J BIOL CHEM, V264, P767; Rangan VS, 1997, J BIOL CHEM, V272, P11975, DOI 10.1074/jbc.272.18.11975; SCHUSTER H, 1995, EUR J BIOCHEM, V228, P417; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; STOOPS JK, 1980, P NATL ACAD SCI-BIOL, V77, P4544, DOI 10.1073/pnas.77.8.4544; STOOPS JK, 1992, P NATL ACAD SCI USA, V89, P6585, DOI 10.1073/pnas.89.14.6585; STOOPS JK, 1978, J BIOL CHEM, V253, P4464; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WERKMEISTER K, 1981, EUR J BIOCHEM, V116, P303, DOI 10.1111/j.1432-1033.1981.tb05334.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; WIELAND F, 1978, P NATL ACAD SCI USA, V75, P5792, DOI 10.1073/pnas.75.12.5792	40	170	181	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					254	261		10.1126/science.1138248	http://dx.doi.org/10.1126/science.1138248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431175				2022-12-24	WOS:000245654500045
J	Galburt, EA; Grill, SW; Wiedmann, A; Lubkowska, L; Choy, J; Nogales, E; Kashlev, M; Bustamante, C				Galburt, Eric A.; Grill, Stephan W.; Wiedmann, Anna; Lubkowska, Lucyna; Choy, Jason; Nogales, Eva; Kashlev, Mikhail; Bustamante, Carlos			Backtracking determines the force sensitivity of RNAP II in a factor-dependent manner	NATURE			English	Article							ELONGATION-FACTOR TFIIS; POLYMERASE-II; TRANSCRIPT-CLEAVAGE; ARREST; DNA; MECHANISM; RESOLUTION; COMPLEXES; MOLECULES; BACTERIAL	RNA polymerase II ( RNAP II) is responsible for transcribing all messenger RNAs in eukaryotic cells during a highly regulated process that is conserved from yeast to human 1, and that serves as a central control point for cellular function. Here we investigate the transcription dynamics of single RNAP II molecules from Saccharomyces cerevisiae against force and in the presence and absence of TFIIS, a transcription elongation factor known to increase transcription through nucleosomal barriers(2\). Using a single-molecule dual-trap optical-tweezers assay combined with a novel method to enrich for active complexes, we found that the response of RNAP II to a hindering force is entirely determined by enzyme backtracking(3-6). Surprisingly, RNAP II molecules ceased to transcribe and were unable to recover from backtracks at a force of 7.5 +/- 2 pN, only one-third of the force determined for Escherichia coli RNAP(7,8). We show that backtrack pause durations follow a t(-3/2) power law, implying that during backtracking RNAP II diffuses in discrete base-pair steps, and indicating that backtracks may account for most of RNAP II pauses. Significantly, addition of TFIIS rescued backtracked enzymes and allowed transcription to proceed up to a force of 16.9 +/- 3.4 pN. Taken together, these results describe a regulatory mechanism of transcription elongation in eukaryotes by which transcription factors modify the mechanical performance of RNAP II, allowing it to operate against higher loads.	Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; NCI, Ctr Canc Res, Frederick, MD 21702 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bustamante, C (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Grill, Stephan/D-9427-2012	Galburt, Eric/0000-0003-4314-3215; Bustamante, Carlos/0000-0002-2970-0073				Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Li PTX, 2006, BIOPHYS J, V90, P250, DOI 10.1529/biophysj.105.068049; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653	28	214	221	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					820	823		10.1038/nature05701	http://dx.doi.org/10.1038/nature05701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17361130				2022-12-24	WOS:000245626800046
J	Harpole, WS; Tilman, D				Harpole, W. Stanley; Tilman, David			Grassland species loss resulting from reduced niche dimension	NATURE			English	Article							RESOURCE COMPETITION; LIMITING RESOURCES; DIVERSITY; BIODIVERSITY; ECOSYSTEM; RICHNESS; PRODUCTIVITY; ENRICHMENT; ECOLOGY	Intact ecosystems contain large numbers of competing but coexisting species. Although numerous alternative theories have provided potential explanations for this high biodiversity, there have been few field experiments testing between these theories. In particular, theory predicts that higher diversity of coexisting competitors could result from greater niche dimensionality(1), for example larger numbers of limiting resources or factors. Alternatively, diversity could be independent of niche dimensionality because large numbers of species can coexist when limited by just one or two factors if species have appropriate trade-offs(2). Here we show that plant coexistence and diversity result from the 'niche dimensionality' of a habitat. Plant species numbers decreased with increasing numbers of added limiting soil resources ( soil moisture, nitrogen, phosphorus and base cations), which is consistent with theoretical predictions that an increased supply of multiple limiting resources can reduce niche dimension. An observational field study gave similar results. The niche dimension hypothesis also explained diversity changes in the classic Park Grass Experiment at Rothamsted. Our results provide an alternative mechanistic explanation for the effects of nutrient eutrophication on the diversity of terrestrial, freshwater and marine ecosystems.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of California System; University of California Irvine; University of Minnesota System; University of Minnesota Twin Cities	Harpole, WS (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA.	wharpole@uci.edu	Harpole, William S/C-2814-2013; Tilman, David/ABD-5309-2021	Harpole, William S/0000-0002-3404-9174; 				Baer SG, 2003, ECOLOGY, V84, P724, DOI 10.1890/0012-9658(2003)084[0724:SRRPAD]2.0.CO;2; Braakhekke WG, 1999, J VEG SCI, V10, P187, DOI 10.2307/3237140; Brenchley W.E., 1958, PARK GRASS PLOTS ROT; Chase J.M., 2009, ECOLOGICAL NICHES LI; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; DITOMMASO A, 1989, VEGETATIO, V84, P9, DOI 10.1007/BF00054662; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Grover JP, 2004, ECOL MONOGR, V74, P533, DOI 10.1890/03-4073; Herbert DA, 2004, ECOSYSTEMS, V7, P296, DOI 10.1007/s10021-003-0233-x; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Lawes JB, 1882, PHILOS T R SOC LONDO, V173, P1181, DOI DOI 10.1098/RSTL.1882.0029; Leibold MA, 1999, EVOL ECOL RES, V1, P73; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; SILVERTOWN J, 1980, J APPL ECOL, V17, P491, DOI 10.2307/2402344; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	24	381	418	18	442	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					791	793		10.1038/nature05684	http://dx.doi.org/10.1038/nature05684			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17384633				2022-12-24	WOS:000245626800039
J	Ono, M; Yaguchi, H; Ohkura, N; Kitabayashi, I; Nagamura, Y; Nomura, T; Miyachi, Y; Tsukada, T; Sakaguchi, S				Ono, Masahiro; Yaguchi, Hiroko; Ohkura, Naganari; Kitabayashi, Issay; Nagamura, Yuko; Nomura, Takashi; Miyachi, Yoshiki; Tsukada, Toshihiko; Sakaguchi, Shimon			Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1	NATURE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; RUNX1 BINDING-SITE; INTERLEUKIN-2 GENE; LEUKEMIA; DIFFERENTIATION; SUSCEPTIBILITY; HEMATOPOIESIS; COOPERATION; ACTIVATION	Naturally arising CD25(+)CD4(+) regulatory T cells (T-R cells) are engaged in the maintenance of immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses, such as autoimmune disease and allergy(1-3). T-R cells specifically express the transcription factor Foxp3, a key regulator of T-R-cell development and function. Ectopic expression of Foxp3 in conventional T cells is indeed sufficient to confer suppressive activity, repress the production of cytokines such as interleukin-2 (IL-2) and interferon-gamma (IFN-gamma), and upregulate T-R-cell-associated molecules such as CD25, cytotoxic T-lymphocyte-associated antigen-4, and glucocorticoid-induced TNF-receptor-family-related protein(4-7). However, the method by which Foxp3 controls these molecular events has yet to be explained. Here we show that the transcription factor AML1 ( acute myeloid leukaemia 1)/Runx1 (Runt-related transcription factor 1), which is crucially required for normal haematopoiesis including thymic T-cell development(8-11), activates IL-2 and IFN-gamma gene expression in conventional CD4(+) T cells through binding to their respective promoters. In natural T-R cells, Foxp3 interacts physically with AML1. Several lines of evidence support a model in which the interaction suppresses IL-2 and IFN-gamma production, upregulates T-R-cell-associated molecules, and exerts suppressive activity. This transcriptional control of T-R-cell function by an interaction between Foxp3 and AML1 can be exploited to control physiological and pathological T-cell-mediated immune responses.	Kyoto Univ, Grad Sch Med, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; Natl Canc Ctr, Res Inst, Div Mol Oncol, Chuo Ku, Tokyo 1040045, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Natl Canc Ctr, Res Inst, Tumor Endocrinol Project, Chuo Ku, Tokyo 1040045, Japan	Kyoto University; Kyoto University; National Cancer Center - Japan; Japan Science & Technology Agency (JST); National Cancer Center - Japan	Sakaguchi, S (corresponding author), Kyoto Univ, Grad Sch Med, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009; Ono, Masahiro/H-2378-2011; Kitabayashi, Issay/G-2204-2017	Ono, Masahiro/0000-0002-9284-7326; Kitabayashi, Issay/0000-0002-8409-0407				Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kanno Y, 1998, MOL CELL BIOL, V18, P4252, DOI 10.1128/MCB.18.7.4252; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; NOVAK TJ, 1990, NUCLEIC ACIDS RES, V18, P4523, DOI 10.1093/nar/18.15.4523; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Ono M, 2006, J IMMUNOL, V176, P4748, DOI 10.4049/jimmunol.176.8.4748; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165	28	494	523	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					685	689		10.1038/nature05673	http://dx.doi.org/10.1038/nature05673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17377532				2022-12-24	WOS:000245438300044
J	Hatakeyama, S; Sugaya, N; Ito, M; Yamazaki, M; Ichikawa, M; Kimura, K; Kiso, M; Shimizu, H; Kawakami, C; Koike, K; Mitamura, K; Kawaoka, Y				Hatakeyama, Shuji; Sugaya, Norio; Ito, Mutsumi; Yamazaki, Masahiko; Ichikawa, Masataka; Kimura, Kazuhiro; Kiso, Maki; Shimizu, Hideaki; Kawakami, Chiharu; Koike, Kazuhiko; Mitamura, Keiko; Kawaoka, Yoshihiro			Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-VITRO; OSELTAMIVIR; RESISTANT; ZANAMIVIR; SUSCEPTIBILITIES; SEQUENCE; MUTATION	Context Very little is known about the frequency of generation and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Furthermore, transmission of resistant virus, whether influenza A or B, has not been recognized to date. Objective To assess the prevalence and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Design, Setting, and Patients Investigation of the neuraminidase inhibitor sensitivity of influenza B isolates from 74 children before and after oseltamivir therapy and from 348 untreated patients with influenza ( including 66 adults) seen at 4 community hospitals in Japan during the 2004-2005 influenza season. Four hundred twenty-two viruses from untreated patients and 74 samples from patients after oseltamivir therapy were analyzed. Main Outcome Measure Sialidase inhibition assay was used to test the drug sensitivities of influenza B viruses. The neuraminidase and hemagglutinin genes of viruses showing reduced sensitivity to neuraminidase inhibitors were sequenced to identify mutations that have the potential to confer reduced sensitivity to these drugs. Results In 1 (1.4%) of the 74 children who had received oseltamivir, we identified a variant with reduced drug sensitivity possessing a Gly402Ser neuraminidase substitution. We also identified variants with reduced sensitivity carrying an Asp198Asn, Ile222Thr, or Ser250Gly mutation in 7 (1.7%) of the 422 viruses from untreated patients. Review of the clinical and viral genetic information available on these 7 patients indicated that 4 were likely infected in a community setting, while the remaining 3 were probably infected through contact with siblings shedding the mutant viruses. Conclusions In this population, influenza B viruses with reduced sensitivity to neuraminidase inhibitors do not arise as frequently as resistant influenza A viruses. However, they appear to be transmitted within communities and families, requiring continued close monitoring.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Med, Dept Infect Dis, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan; Keiyu Hosp, Dept Pediat, Kanagawa, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; Zama Childrens Clin, Kanagawa, Japan; Isehara Kyodo Hosp, Dept Pediat, Isehara, Kanagawa, Japan; Kawasaki City Inst Publ Hlth, Kanagawa, Japan; Yokohama City Inst Hlth, Kanagawa, Japan; Eiju Gen Hosp, Dept Pediat, Tokyo, Japan; Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kawaoka@ims.u-tokyo.ac.jp						[Anonymous], 2005, PRINCIPLES PRACTICE; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Cass LMR, 1999, CLIN PHARMACOKINET, V36, P21, DOI 10.2165/00003088-199936001-00003; COLMAN PM, 1993, J VIROL, V67, P2972, DOI 10.1128/JVI.67.6.2972-2980.1993; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; HARPER SA, 2005, MMWR-MORBID MORTAL W, V54, P750; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Le QM, 2005, NATURE, V438, P754, DOI 10.1038/438754b; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Oo C, 2003, EUR J CLIN PHARMACOL, V59, P411, DOI 10.1007/s00228-003-0639-6; Pillay D, 1998, BMJ-BRIT MED J, V317, P660, DOI 10.1136/bmj.317.7159.660; *ROCH, 2005, FACTSH TAM; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P156	30	170	189	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1435	1442		10.1001/jama.297.13.1435	http://dx.doi.org/10.1001/jama.297.13.1435			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405969				2022-12-24	WOS:000245404100020
J	Follows, MJ; Dutkiewicz, S; Grant, S; Chisholm, SW				Follows, Michael J.; Dutkiewicz, Stephanie; Grant, Scott; Chisholm, Sallie W.			Emergent biogeography of microbial communities in a model ocean	SCIENCE			English	Article							PROCHLOROCOCCUS ECOTYPES; MARINE; PHYTOPLANKTON	A marine ecosystem model seeded with many phytoplankton types, whose physiological traits were randomly assigned from ranges defined by field and laboratory data, generated an emergent community structure and biogeography consistent with observed global phytoplankton distributions. The modeled organisms included types analogous to the marine cyanobacterium Prochlorococcus. Their emergent global distributions and physiological properties simultaneously correspond to observations. This flexible representation of community structure can be used to explore relations between ecosystems, biogeochemical cycles, and climate change.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Hawaii System; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Follows, MJ (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 54-1514 MIT, Cambridge, MA 02139 USA.	mick@mit.edu	chen, qi/C-8585-2011; Follows, Michael/G-9824-2011	Chisholm, Sallie/0000-0003-1480-2445				Anderson TR, 2005, J PLANKTON RES, V27, P1073, DOI 10.1093/plankt/fbi076; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Dandonneau Y, 2006, DEEP-SEA RES PT I, V53, P689, DOI 10.1016/j.dsr.2006.01.002; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Gregg WW, 2003, DEEP-SEA RES PT II, V50, P3143, DOI 10.1016/j.dsr2.2003.07.013; Hood RR, 2006, DEEP-SEA RES PT II, V53, P459, DOI 10.1016/j.dsr2.2006.01.025; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kleidon A, 2000, GLOB CHANGE BIOL, V6, P507, DOI 10.1046/j.1365-2486.2000.00332.x; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; Litchman E, 2006, BIOGEOSCIENCES, V3, P585, DOI 10.5194/bg-3-585-2006; Lomas MW, 2006, LIMNOL OCEANOGR, V51, P2453, DOI 10.4319/lo.2006.51.5.2453; Margalef R., 1968, PERSPECTIVES ECOLOGI; Moore JK, 2001, DEEP-SEA RES PT II, V49, P403, DOI 10.1016/S0967-0645(01)00108-4; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; THOMPSON PA, 1989, LIMNOL OCEANOGR, V34, P1014, DOI 10.4319/lo.1989.34.6.1014; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wunsch C, 2007, PHYSICA D, V230, P197, DOI 10.1016/j.physd.2006.09.040; Zubkov MV, 2000, PROG OCEANOGR, V45, P369, DOI 10.1016/S0079-6611(00)00008-2	27	566	571	7	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1843	1846		10.1126/science.1138544	http://dx.doi.org/10.1126/science.1138544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395828				2022-12-24	WOS:000245280100043
J	Stone, L; Olinky, R; Huppert, A				Stone, Lewi; Olinky, Ronen; Huppert, Amit			Seasonal dynamics of recurrent epidemics	NATURE			English	Article							CHAOS; MEASLES; MODEL; ENGLAND	Seasonality is a driving force that has a major effect on the spatiotemporal dynamics of natural systems and their populations(1-5). This is especially true for the transmission of common infectious diseases ( such as influenza, measles, chickenpox and pertussis), and is of great relevance for host-parasite relationships in general(1-23). Here we gain further insights into the nonlinear dynamics of recurrent diseases through the analysis of the classical seasonally forced SIR ( susceptible, infectious or recovered) epidemic model(6,7). Ouranalysis differs from other modelling studies in that the focus is more on post-epidemic dynamics than the outbreak itself. Despite the mathematical intractability of the forced SIR model, we identify a new threshold effect and give clear analytical conditions for predicting the occurrence of either a future epidemic outbreak, or a 'skip'-a year in which an epidemic fails to initiate. The threshold is determined by the population's susceptibility measured after the last outbreak and the rate at which new susceptible individuals are recruited into the population. Moreover, the time of occurrence ( that is, the phase) of an outbreak proves to be a useful parameter that carries important epidemiological information. In forced systems, seasonal changes can prevent late-peaking diseases ( that is, those having high phase) from spreading widely, thereby increasing population susceptibility, and controlling the triggering and intensity of future epidemics. These principles yield forecasting tools that should have relevance for the study of newly emerging and re-emerging diseases controlled by seasonal vectors.	Tel Aviv Univ, Fac Life Sci, Dept Zool, Biomath Unit, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Porter Sch Environm Studies, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Stone, L (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Zool, Biomath Unit, IL-69978 Tel Aviv, Israel.	lewi@post.tau.ac.il		Stone, Lewi/0000-0002-6465-579X				Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; Andreasen V, 2003, J MATH BIOL, V46, P504, DOI 10.1007/s00285-002-0186-2; ARON JL, 1984, J THEOR BIOL, V110, P665, DOI 10.1016/S0022-5193(84)80150-2; Billings L, 2002, J MATH BIOL, V44, P31, DOI 10.1007/s002850100110; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; Casagrandi R, 2006, MATH BIOSCI, V200, P152, DOI 10.1016/j.mbs.2005.12.029; Dietz K, 1976, MATH MODELS MED, P1; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; ENGBERT R, 1994, CHAOS SOLITON FRACT, V4, P1147, DOI 10.1016/0960-0779(94)90028-0; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P211, DOI 10.1098/rspb.1998.0284; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Huppert A, 2005, J THEOR BIOL, V236, P276, DOI 10.1016/j.jtbi.2005.03.012; Keeling MJ, 2001, PHYSICA D, V148, P317, DOI 10.1016/S0167-2789(00)00187-1; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Madden LV, 2002, BIOSCIENCE, V52, P65, DOI 10.1641/0006-3568(2002)052[0065:APDATA]2.0.CO;2; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; OLINKY R, UNPUB P NATL ACAD SC; OLSEN LF, 1988, THEOR POPUL BIOL, V33, P344, DOI 10.1016/0040-5809(88)90019-6; OLSEN LF, 1990, SCIENCE, V249, P499, DOI 10.1126/science.2382131; Pascual M, 2005, PLOS MED, V2, P18, DOI 10.1371/journal.pmed.0020005; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; SCHAFFER WM, 1985, J THEOR BIOL, V112, P403, DOI 10.1016/S0022-5193(85)80294-0; SCHWARTZ IB, 1983, J MATH BIOL, V18, P233, DOI 10.1007/BF00276090; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0	30	202	210	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					533	536		10.1038/nature05638	http://dx.doi.org/10.1038/nature05638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392785				2022-12-24	WOS:000245242900048
J	Iwase, S; Lan, F; Bayliss, P; de la Torre-Ubieta, L; Huarte, M; Qi, HH; Whetstine, JR; Bonni, A; Roberts, TM; Shi, Y				Iwase, Shigeki; Lan, Fei; Bayliss, Peter; de la Torre-Ubieta, Luis; Huarte, Maite; Qi, Hank H.; Whetstine, Johnathan R.; Bonni, Azad; Roberts, Thomas M.; Shi, Yang			The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases	CELL			English	Article							DOMAIN-CONTAINING PROTEINS; METHYLATION PATTERNS; ANDROGEN-RECEPTOR; MAMMALIAN-CELLS; ARID PROTEINS; BREAST-CANCER; JARID1C GENE; JMJD2 FAMILY; TRANSCRIPTION; CHROMATIN	Histone methylation regulates chromatin structure and transcription. The recently identified histone demethylase lysine-specific demethylase 1 (LSD1) is chemically restricted to demethylation of only mono- and di- but not tri-methylated histone H3 lysine 4 (H3K4me3). We show that the X-linked mental retardation (XLMR) gene SMCX (JARID1C), which encodes a JmjC-domain protein, reversed H3K4me3 to di- and mono- but not unmethylated products. Other SMCX family members, including SMCY, RBP2, and PLU-1, also demethylated H3K4me3. SMCX bound H3K9me3 via its N-terminal PHD (plant homeodomain) finger, which may help coordinate H3K4 demethylation and H3K9 methylation in transcriptional repression. Significantly, several XLMR-patient point mutations reduced SMCX demethylase activity and binding to H3K9me3 peptides, respectively. Importantly, studies in zebrafish and primary mammalian neurons demonstrated a role for SMCX in neuronal survival and dendritic development and a link to the demethylase activity. Our findings thus identify a family of H3K4me3 demethylases and uncover a critical link between histone modifications and XLMR.	Harvard Univ, Sch Med, Dana Farber Inst, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dana Farber Inst, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	Hu, Ruogu/B-2203-2008; Huarte, Maite/J-6903-2014; Iwase, Shigeki/J-8294-2019	Huarte, Maite/0000-0003-3753-6493; Iwase, Shigeki/0000-0003-2280-7422; Qi, Hank/0000-0002-3401-4940; de la Torre-Ubieta, Luis/0000-0001-8059-6243; Bayliss, Peter/0000-0003-4807-6365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070095, R01GM071004, R01GM058012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021, R01NS051255] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 071004, GM 58012, GM 70095] Funding Source: Medline; NINDS NIH HHS [NS41021, NS051255] Funding Source: Medline; PHS HHS [NCI118487] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; YIN CY, 2006, IN PRESS DEB BI 1219; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	50	500	517	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1077	1088		10.1016/j.cell.2007.02.017	http://dx.doi.org/10.1016/j.cell.2007.02.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17320160	Bronze			2022-12-24	WOS:000245396200015
J	Fu, ZQ; Guo, M; Jeong, BR; Tian, F; Elthon, TE; Cerny, RL; Staiger, D; Alfano, JR				Fu, Zheng Qing; Guo, Ming; Jeong, Byeong-ryool; Tian, Fang; Elthon, Thomas E.; Cerny, Ronald L.; Staiger, Dorothee; Alfano, James R.			A type III effector ADP-ribosylates RNA-binding proteins and quells plant immunity	NATURE			English	Article							PROGRAMMED CELL-DEATH; SECRETION SYSTEM EFFECTORS; PV. TOMATO DC3000; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; TYROSINE-PHOSPHATASE; BACTERIAL TOXINS; IDENTIFICATION; GENE	The bacterial plant pathogen Pseudomonas syringae injects effector proteins into host cells through a type III protein secretion system to cause disease. The enzymatic activities of most of P. syringae effectors and their targets remain obscure. Here we show that the type III effector HopU1 is a mono-ADP-ribosyltransferase (ADP-RT). HopU1 suppresses plant innate immunity in a manner dependent on its ADP-RT active site. The HopU1 substrates in Arabidopsis thaliana extracts were RNA-binding proteins that possess RNA-recognition motifs (RRMs). A. thaliana knockout lines defective in the glycine-rich RNA-binding protein GRP7 ( also known as AtGRP7), a HopU1 substrate, were more susceptible than wild-type plants to P. syringae. The ADP-ribosylation of GRP7 by HopU1 required two arginines within the RRM, indicating that this modification may interfere with GRP7' s ability to bind RNA. Our results suggest a pathogenic strategy where the ADP-ribosylation of RNA-binding proteins quells host immunity by affecting RNA metabolism and the plant defence transcriptome.	Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68588 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; Univ Bielefeld, D-33501 Bielefeld, Germany	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Bielefeld	Alfano, JR (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68588 USA.	jalfano2@unl.edu	Jeong, Byeong-ryool/N-1661-2019	Jeong, Byeong-ryool/0000-0003-0642-1650; Staiger, Dorothee/0000-0002-1341-1381				Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bretz JR, 2003, MOL MICROBIOL, V49, P389, DOI 10.1046/j.1365-2958.2003.03616.x; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; Espinosa A, 2004, CELL MICROBIOL, V6, P1027, DOI 10.1111/j.1462-5822.2004.00452.x; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GOMEZ J, 1988, NATURE, V334, P262, DOI 10.1038/334262a0; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guo M, 2005, J BACTERIOL, V187, P4257, DOI 10.1128/JB.187.12.4257-4269.2005; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Han S, 2002, INT J MED MICROBIOL, V291, P523; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Naqvi SMS, 1998, PLANT MOL BIOL, V37, P571, DOI 10.1023/A:1006031316476; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; OHTA M, 1995, PLANT MOL BIOL, V27, P529, DOI 10.1007/BF00019319; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Staiger D, 2003, PLANT J, V33, P361, DOI 10.1046/j.1365-313X.2003.01629.x; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; VANNOCKER S, 1993, PLANT MOL BIOL, V21, P695, DOI 10.1007/BF00014552; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007	42	274	292	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					284	U1		10.1038/nature05737	http://dx.doi.org/10.1038/nature05737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17450127				2022-12-24	WOS:000246520300037
J	Godinho, SIH; Maywood, ES; Shaw, L; Tucci, V; Barnard, AR; Busino, L; Pagano, M; Kendall, R; Quwailid, MM; Romero, MR; O'Neill, J; Chesham, JE; Brooker, D; Lalanne, Z; Hastings, MH; Nolan, PM				Godinho, Sofia I. H.; Maywood, Elizabeth S.; Shaw, Linda; Tucci, Valter; Barnard, Alun R.; Busino, Luca; Pagano, Michele; Kendall, Rachel; Quwailid, Mohamed M.; Romero, M. Rosario; O'Neill, John; Chesham, Johanna E.; Brooker, Debra; Lalanne, Zuzanna; Hastings, Michael H.; Nolan, Patrick M.			The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period	SCIENCE			English	Article							DEGRADATION; RHYTHM; CLOCK; FAMILY; GENE	By screening N-ethyl-N-nitrosourea-mutagenized animals for alterations in rhythms of wheel-running activity, we identified a mouse mutation, after hours (Afh). The mutation, a Cys(358)Ser substitution in Fbxl3, an F-box protein with leucine-rich repeats, results in long free-running rhythms of about 27 hours in homozygotes. Circadian transcriptional and translational oscillations are attenuated in Afh mice. The Afh allele significantly affected Per2 expression and delayed the rate of Cry protein degradation in Per2:: Luciferase tissue slices. Our in vivo and in vitro studies reveal a central role for Fbxl3 in mammalian circadian timekeeping.	MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England; NYU, Dept Pathol, Inst Canc, Sch Med, New York, NY 10016 USA	MRC Harwell; MRC Laboratory Molecular Biology; New York University	Nolan, PM (corresponding author), MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England.	p.nolan@har.mrc.ac.uk	Nolan, Patrick/W-3918-2019	Nolan, Patrick/0000-0001-5550-0334; O'Neill, John Stuart/0000-0003-2204-6096; Tucci, Valter/0000-0002-3796-3826; Hastings, Michael Harvey/0000-0001-8576-6651; pagano, michele/0000-0003-3210-2442	Medical Research Council [MC_U142684172, MC_U142684175, MC_U142684173, MC_U105170643, MC_UP_1502/1] Funding Source: Medline; MRC [MC_U142684172, MC_UP_1502/1, MC_U105170643, MC_U142684175, MC_U142684173] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bacon Y, 2004, GENES BRAIN BEHAV, V3, P196, DOI 10.1111/j.1601-183X.2004.00070.x; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	20	353	366	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					897	900		10.1126/science.1141138	http://dx.doi.org/10.1126/science.1141138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17463252				2022-12-24	WOS:000246369800040
J	Waite, JH; Young, DT; Cravens, TE; Coates, AJ; Crary, FJ; Magee, B; Westlake, J				Waite, J. H., Jr.; Young, D. T.; Cravens, T. E.; Coates, A. J.; Crary, F. J.; Magee, B.; Westlake, J.			The process of tholin formation in Titan's upper atmosphere	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SOOT FORMATION; CHEMISTRY; BENZENE; PHOTOCHEMISTRY; MOLECULES; METHANE; IONS	Titan's lower atmosphere has long been known to harbor organic aerosols (tholins) presumed to have been formed from simple molecules, such as methane and nitrogen (CH4 and N-2). Up to now, it has been assumed that tholins were formed at altitudes of several hundred kilometers by processes as yet unobserved. Using measurements from a combination of mass/charge and energy/ charge spectrometers on the Cassini spacecraft, we have obtained evidence for tholin formation at high altitudes (similar to 1000 kilometers) in Titan's atmosphere. The observed chemical mix strongly implies a series of chemical reactions and physical processes that lead from simple molecules (CH4 and N-2) to larger, more complex molecules ( 80 to 350 daltons) to negatively charged massive molecules (similar to 8000 daltons), which we identify as tholins. That the process involves massive negatively charged molecules and aerosols is completely unexpected.	SW Res Inst, Space Sci & Engn Div, San Antonio, TX 78238 USA; Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; UCL, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; Univ Texas, Dept Phys & Astron, San Antonio, TX 78249 USA	Southwest Research Institute; University of Kansas; University of London; University College London; University of Texas System	Waite, JH (corresponding author), SW Res Inst, Space Sci & Engn Div, 6220 Culebra Rd, San Antonio, TX 78238 USA.	hwaite@swri.edu; bmagee@swri.edu	Westlake, Joseph/G-2732-2015; Coates, Andrew/C-2396-2008; Westlake, Joseph/AAZ-9404-2020	Westlake, Joseph/0000-0003-0472-8640; Coates, Andrew/0000-0002-6185-3125; Westlake, Joseph/0000-0003-0472-8640	Science and Technology Facilities Council [PP/E001173/1] Funding Source: researchfish; UK Space Agency [PP/D00084X/1] Funding Source: researchfish; STFC [PP/E001173/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Anicich V.G., 2003, JPL PUBLICATION; Anicich VG, 2006, J AM SOC MASS SPECTR, V17, P544, DOI 10.1016/j.jasms.2005.11.022; Anicich VG, 1997, PLANET SPACE SCI, V45, P897, DOI 10.1016/S0032-0633(97)00053-6; BOHME DK, 1992, CHEM REV, V92, P1487, DOI 10.1021/cr00015a002; CALCOTE HF, 1990, PURE APPL CHEM, V62, P815, DOI 10.1351/pac199062050815; Clarke MC, 2006, SCHIZOPHRENIA BULL, V32, P3, DOI 10.1093/schbul/sbj028; COATES AJ, 2006, EOS T AM GEOPHYS U S, V87, P52; COUSTENIS A, IN PRESS ICARUS; Cravens TE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023249; CROVISIER J, 1994, J GEOPHYS RES-PLANET, V99, P3777, DOI 10.1029/93JE02088; CRUICKSHANK DP, IN PRESS ICARUS; DELAHAYE V, 2005, THESIS U MICHIGAN AN; Frenklach M, 2002, PHYS CHEM CHEM PHYS, V4, P2028, DOI 10.1039/b110045a; Friedson AJ, 2002, ICARUS, V158, P389, DOI 10.1006/icar.2002.6885; GOETZ CK, 1989, REV GEOPHYS, V27, P271; Kivelson M., 1995, INTRO SPACE PHYS; LIANG MC, 2006, 38 ANN M DIV PLAN SC; Linstrom P. J., 2020, NIST STANDARD REFERE; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; McLain JL, 2004, J PHYS CHEM A, V108, P6704, DOI [10.1021/jp040215l, 10.1021/jp0402151]; Moses JI, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002411; Moustefaoui T, 1998, FARADAY DISCUSS, V109, P71, DOI 10.1039/a800490k; NAKASHIMA N, 1983, J CHEM PHYS, V79, P2727, DOI 10.1063/1.446176; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Richter H, 2000, PROG ENERG COMBUST, V26, P565, DOI 10.1016/S0360-1285(00)00009-5; SAGAN C, 1979, NATURE, V277, P102, DOI 10.1038/277102a0; SHINDO K, 1966, J CHEM PHYS, V45, P2292, DOI 10.1063/1.1727923; Tokmakov IV, 1999, J PHYS CHEM A, V103, P3636, DOI 10.1021/jp983140s; Vuitton V, 2006, ASTROPHYS J, V647, pL175, DOI 10.1086/507467; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wilson EH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001896; YELLE RV, 2006, ICARUS, V72, P468; YOKOYAMA A, 1990, J CHEM PHYS, V92, P4222, DOI 10.1063/1.457780; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; Zhang XH, 2006, CHEM COMMUN, P758, DOI 10.1039/b515843e	37	484	487	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					870	875		10.1126/science.1139727	http://dx.doi.org/10.1126/science.1139727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495166				2022-12-24	WOS:000246369800032
J	Fischer, A; Sananbenesi, F; Wang, XY; Dobbin, M; Tsai, LH				Fischer, Andre; Sananbenesi, Farahnaz; Wang, Xinyu; Dobbin, Matthew; Tsai, Li-Huei			Recovery of learning and memory is associated with chromatin remodelling	NATURE			English	Article							ENVIRONMENTAL ENRICHMENT; MOUSE MODEL; PLASTICITY; ACETYLATION; EXPRESSION; DISEASE; ROLES; CDK5; MICE; P25	Neurodegenerative diseases of the central nervous system are often associated with impaired learning and memory, eventually leading to dementia. An important aspect in pre-clinical research is the exploration of strategies to re-establish learning ability and access to long-term memories. By using a mouse model that allows temporally and spatially restricted induction of neuronal loss, we show here that environmental enrichment reinstated learning behaviour and re-established access to long-term memories after significant brain atrophy and neuronal loss had already occurred. Environmental enrichment correlated with chromatin modifications ( increased histone-tail acetylation). Moreover, increased histone acetylation by inhibitors of histone deacetylases induced sprouting of dendrites, an increased number of synapses, and reinstated learning behaviour and access to long-term memories. These data suggest that inhibition of histone deacetylases might be a suitable therapeutic avenue for neurodegenerative diseases associated with learning and memory impairment, and raises the possibility of recovery of long-term memories in patients with dementia.	MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Howard Hughes Med Inst, Cambridge, MA 02139 USA; Riken MIT Neurosci Res Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; RIKEN	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Vassar St,Bldg 46, Cambridge, MA 02139 USA.	andre.fischer@mpi-mail.mpg.de; lhtsai@mit.edu	Fischer, Andre/AAU-7487-2021	Fischer, Andre/0000-0001-8546-1161				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Bradshaw J, 2004, J NEUROL NEUROSUR PS, V75, P382, DOI 10.1136/jnnp.2002.002576; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; HORN D, 1993, NEURAL COMPUT, V5, P736, DOI 10.1162/neco.1993.5.5.736; Horn D, 1996, NEURAL COMPUT, V8, P1227, DOI 10.1162/neco.1996.8.6.1227; Iacomino G, 2001, BIOCHEM BIOPH RES CO, V285, P1280, DOI 10.1006/bbrc.2001.5323; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; LI RW, 2006, BMC GENOMICS, V14, P1; Need AC, 2003, GENES BRAIN BEHAV, V2, P132, DOI 10.1034/j.1601-183X.2003.00020.x; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Ruppin E, 1996, SCHIZOPHRENIA BULL, V22, P105, DOI 10.1093/schbul/22.1.105; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCOVILLE WB, 1957, NEUROPSYCHIATRY CLIN, V1, P103; Tabuchi Y, 2006, FEBS LETT, V580, P3035, DOI 10.1016/j.febslet.2006.04.048; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	29	871	955	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					178	U2		10.1038/nature05772	http://dx.doi.org/10.1038/nature05772			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17468743				2022-12-24	WOS:000246338700036
J	Giordano, TP; Henderson, L; Landgren, O; Chiao, EY; Kramer, JR; El-Serag, H; Engels, EA				Giordano, Thomas P.; Henderson, Louise; Landgren, Ola; Chiao, Elizabeth Y.; Kramer, Jennifer R.; El-Serag, Hashem; Engels, Eric A.			Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADMINISTRATION MEDICAL SYSTEM; THYROID-CANCER; UNITED-STATES; WALDENSTROM MACROGLOBULINEMIA; MONOCLONAL GAMMOPATHY; INFECTION; PREVALENCE; CRYOGLOBULINEMIA; ASCERTAINMENT; REGRESSION	Context Hepatitis C virus (HCV) infection causes liver cancer and cirrhosis and may also increase the risk of other tumors, particularly hematopoietic malignancies and thyroid cancer. Previous studies have been too small to adequately assess these risks. Objective To test the hypothesis that HCV infection is associated with increased risk for hematological malignancies, related lymphoproliferative disorders, and thyroid cancer. Design, Setting, and Patients A retrospective cohort study of users of US Veterans Affairs health care facilities from 1997-2004, which included 146 394 patients infected with HCV who had at least 2 visits with a diagnostic code for HCV infection, and 572 293 patients uninfected with HCV. To assemble the HCV-uninfected cohort, we randomly selected up to 4 patients per patient infected with HCV from all veterans who matched on age, sex, and baseline visit date and type (inpatient or outpatient). Individuals with human immunodeficiency virus were excluded. Main Outcome Measures Risks of hematopoietic malignancies, related lymphoproliferative precursor diseases, and thyroid cancer, adjusting for selection factors, race, era of military service, and use of medical services. Results The mean (SD) age of the patients was 52 (8) years, and 97% were men. Risks for non-Hodgkin lymphoma (n = 1359), Waldenstrom macroglobulinemia (n = 165), and cryoglobulinemia (n = 551) were increased with HCV infection (adjusted hazard ratio [ HR], 1.28; 95% confidence interval [ CI], 1.12-1.45; adjusted HR, 2.76; 95% CI, 2.01-3.79; and adjusted HR, 3.98; 95% CI, 3.36-4.72; respectively). We found no significantly increased risk for other hematological malignancies. Although thyroiditis risk was slightly increased, risk for thyroid cancer (n = 320) was not (adjusted HR, 0.72; 95% CI, 0.52-0.99). Adjusted P values for non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, cryoglobulinemia, and thyroiditis were all < .0038, the Bonferroni threshold for statistical significance considering multiple comparisons. Conclusions Hepatitis C virus infection confers a 20% to 30% increased risk of non-Hodgkin lymphoma overall, and a 3-fold higher risk of Waldenstrom macroglobulinemia, a low-grade lymphoma. Risks were also increased for cryoglobulinemia. These results support an etiological role for HCV in causing lymphoproliferation and causing non-Hodgkin lymphoma.	Michael E DeBakey Vet Affairs Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Hlth Serv Res & Dev Serv, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; NCI, NIH, Rockville, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giordano, TP (corresponding author), Michael E DeBakey Vet Affairs Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Hlth Serv Res & Dev Serv, VA152,2002 Holcombe Blvd, Houston, TX 77030 USA.	tpg@bcm.tmc.edu		Chiao, Elizabeth/0000-0001-5752-2916; Giordano, Thomas/0000-0002-9346-5530	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [K23CA124318] Funding Source: Medline; NIMH NIH HHS [K23MH67505] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K23CA124318, Z01CP010176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH067505] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Amin J, 2006, J HEPATOL, V45, P197, DOI 10.1016/j.jhep.2006.02.014; Antonelli A, 1999, JAMA-J AM MED ASSOC, V281, P1588, DOI 10.1001/jama.281.17.1588; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bini EJ, 2004, ARCH INTERN MED, V164, P2371, DOI 10.1001/archinte.164.21.2371; Dal Maso L, 2006, CANCER EPIDEM BIOMAR, V15, P2078, DOI 10.1158/1055-9965.EPI-06-0308; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; Duberg AS, 2005, HEPATOLOGY, V41, P652, DOI 10.1002/hep.20608; El-Serag HB, 2002, HEPATOLOGY, V36, P1439, DOI 10.1053/jhep.2002.37191; Engels EA, 2004, INT J CANCER, V111, P76, DOI 10.1002/ijc.20021; FISHER SG, 1995, AM J EPIDEMIOL, V141, P242, DOI 10.1093/oxfordjournals.aje.a117426; Fujino Y, 2004, INT J CANCER, V112, P722, DOI 10.1002/ijc.20440; HARRIS RE, 1989, CANCER-AM CANCER SOC, V64, P1160, DOI 10.1002/1097-0142(19890901)64:5<1160::AID-CNCR2820640533>3.0.CO;2-B; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; HOLM LE, 1985, NEW ENGL J MED, V312, P601, DOI 10.1056/NEJM198503073121001; Huang MJ, 1999, CLIN ENDOCRINOL, V50, P503, DOI 10.1046/j.1365-2265.1999.00686.x; Izumi T, 1996, AM J HEMATOL, V52, P238, DOI 10.1002/(SICI)1096-8652(199607)52:3<238::AID-AJH25>3.0.CO;2-A; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Mazzaro C, 1996, CANCER, V77, P2604, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V; Montella M, 2000, INT J CANCER, V87, P611, DOI 10.1002/1097-0215(20000815)87:4&lt;611::AID-IJC24&gt;3.0.CO;2-N; NAMBOODIRI KK, 1991, CANCER-AM CANCER SOC, V68, P1123, DOI 10.1002/1097-0142(19910901)68:5<1123::AID-CNCR2820680540>3.0.CO;2-L; Negri E, 2004, INT J CANCER, V111, P1, DOI 10.1002/ijc.20205; Page WF, 1996, ANN EPIDEMIOL, V6, P102, DOI 10.1016/1047-2797(95)00126-3; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; SANTINI GF, 1993, BLOOD, V82, P2932; Veneri D, 2004, AM J HEMATOL, V77, P421, DOI 10.1002/ajh.20219	27	244	255	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					2010	2017		10.1001/jama.297.18.2010	http://dx.doi.org/10.1001/jama.297.18.2010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488966	Bronze			2022-12-24	WOS:000246301800023
J	Belenky, P; Racette, FG; Bogan, KL; McClure, JM; Smith, JS; Brenner, C				Belenky, Peter; Racette, Frances G.; Bogan, Katrina L.; McClure, Julie M.; Smith, Jeffrey S.; Brenner, Charles			Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD(+)	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; NUCLEOSIDE HYDROLASE; AXONAL DEGENERATION; N-RIBOHYDROLASE; PROTEIN SIR2; GENE; PHOSPHORYLASE; LONGEVITY; EXPRESSION	Although NAD(+) biosynthesis is required for Sir2 functions and replicative lifespan in yeast, alterations in NAD(+) precursors have been reported to accelerate aging but not to extend lifespan. In eukaryotes, nicotinamide riboside is a newly discovered NAD(+) precursor that is converted to nicotinamide mononucleotide by specific nicotinamide riboside kinases, Nrk1 and Nrk2. In this study, we discovered that exogenous nicotinamide riboside promotes Sir2-dependent repression of recombination, improves gene silencing, and extends lifespan without calorie restriction. The mechanism of action of nicotinamide riboside is totally dependent on increased net NAD+ synthesis through two pathways, the Nrk1 pathway and the Urh1/ Pnp1/Meu1 pathway, which is Nrk1 independent. Additionally, the two nicotinamide riboside salvage pathways contribute to NAD(+) metabolism in the absence of nicotinamide-riboside supplementation. Thus, like calorie restriction in the mouse, nicotinamide riboside elevates NAD(+) and increases Sir2 function.	Dartmouth Med Sch, Dept Biochem & Genet, Lebanon, NH 03756 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; Univ Virginia, Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of Virginia	Smith, JS (corresponding author), Dartmouth Med Sch, Dept Biochem & Genet, Rubin 733-HB7937, Lebanon, NH 03756 USA.	jss5y@virginia.edu; charles.brenner@dartmouth.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Belenky, Peter/0000-0002-1682-945X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, R01GM075240] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM75240, T32 GM008136] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKSOY S, 1994, J BIOL CHEM, V269, P14835; Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brachmann CB, 1998, YEAST, V14, P115; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Burke D., 2000, METHODS YEAST GENETI; Catz P, 2005, J CHROMATOGR B, V829, P123, DOI 10.1016/j.jchromb.2005.10.003; Degano M, 1996, BIOCHEMISTRY-US, V35, P5971, DOI 10.1021/bi952999m; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GROSSMAN L, 1958, J BIOL CHEM, V231, P717; Guarente L, 2000, GENE DEV, V14, P1021; Harden A, 1906, P R SOC LOND B-CONTA, V77, P405, DOI 10.1098/rspb.1906.0029; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; IMAI T, 1987, ARCH BIOCHEM BIOPHYS, V254, P253, DOI 10.1016/0003-9861(87)90101-9; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaneko S, 2006, J NEUROSCI, V26, P9794, DOI 10.1523/JNEUROSCI.2116-06.2006; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; KREHL WA, 1945, SCIENCE, V101, P489, DOI 10.1126/science.101.2628.489; Kurtz JE, 2002, CURR GENET, V41, P132, DOI 10.1007/s00294-002-0296-9; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lecoq K, 2001, J BACTERIOL, V183, P4910, DOI 10.1128/JB.183.16.4910-4913.2001; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; Mitterbauer R, 2002, APPL ENVIRON MICROB, V68, P1336, DOI 10.1128/AEM.68.3.1336-1343.2002; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; ROWEN JW, 1951, J BIOL CHEM, V193, P497; Sandmeier JJ, 2002, GENETICS, V160, P877; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schramm VL, 2002, BBA-MOL BASIS DIS, V1587, P107, DOI 10.1016/S0925-4439(02)00073-X; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; WielgusKutrowska B, 1997, EUR J BIOCHEM, V243, P408, DOI 10.1111/j.1432-1033.1997.0408a.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	66	278	293	5	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					473	484		10.1016/j.cell.2007.03.024	http://dx.doi.org/10.1016/j.cell.2007.03.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482543	Bronze			2022-12-24	WOS:000246373600015
J	Burg, TP; Godin, M; Knudsen, SM; Shen, W; Carlson, G; Foster, JS; Babcock, K; Manalis, SR				Burg, Thomas P.; Godin, Michel; Knudsen, Scott M.; Shen, Wenjiang; Carlson, Greg; Foster, John S.; Babcock, Ken; Manalis, Scott R.			Weighing of biomolecules, single cells and single nanoparticles in fluid	NATURE			English	Article							RESONANT MASS SENSOR; DENSITY SENSOR	Nanomechanical resonators enable the measurement of mass with extraordinary sensitivity(1-7). Previously, samples as light as 7 zeptograms ( 1 zg = 10(-21) g) have been weighed in vacuum, and proton-level resolution seems to be within reach(8). Resolving small mass changes requires the resonator to be light and to ring at a very pure tone - that is, with a high quality factor(9). In solution, viscosity severely degrades both of these characteristics, thus preventing many applications in nanotechnology and the life sciences where fluid is required(10). Although the resonant structure can be designed to minimize viscous loss, resolution is still substantially degraded when compared to measurements made in air or vacuum(11-14). An entirely different approach eliminates viscous damping by placing the solution inside a hollow resonator that is surrounded by vacuum(15,16). Here we demonstrate that suspended microchannel resonators can weigh single nanoparticles, single bacterial cells and sub-monolayers of adsorbed proteins in water with sub-femtogram resolution ( 1 Hz bandwidth). Central to these results is our observation that viscous loss due to the fluid is negligible compared to the intrinsic damping of our silicon crystal resonator. The combination of the low resonator mass ( 100 ng) and high quality factor ( 15,000) enables an improvement in mass resolution of six orders of magnitude over a high-end commercial quartz crystal microbalance(17). This gives access to intriguing applications, such as mass-based flow cytometry, the direct detection of pathogens, or the non-optical sizing and mass density measurement of colloidal particles.	MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA; Innovat Micro Technol, Santa Barbara, CA 93117 USA; Affin Biosensors, Santa Barbara, CA 93117 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Manalis, SR (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	scottm@media.mit.edu		Godin, Michel/0000-0002-9360-0675	NIGMS NIH HHS [P50 GM068762] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal A, 2006, ANAL CHEM, V78, P1061, DOI 10.1021/ac051801t; AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6; Backmann N, 2005, P NATL ACAD SCI USA, V102, P14587, DOI 10.1073/pnas.0504917102; Braun T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031907; Burg TP, 2006, J MICROELECTROMECH S, V15, P1466, DOI 10.1109/JMEMS.2006.883568; Burg TP, 2003, APPL PHYS LETT, V83, P2698, DOI 10.1063/1.1611625; Ekinci KL, 2004, J APPL PHYS, V95, P2682, DOI 10.1063/1.1642738; Enoksson P, 1996, SENSOR ACTUAT A-PHYS, V54, P558, DOI 10.1016/S0924-4247(97)80014-3; Forsen E, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999838; Gupta A, 2004, APPL PHYS LETT, V84, P1976, DOI 10.1063/1.1667011; Ilic B, 2004, J APPL PHYS, V95, P3694, DOI 10.1063/1.1650542; Lange D, 2002, ANAL CHEM, V74, P3084, DOI 10.1021/ac011269j; Lavrik NV, 2003, APPL PHYS LETT, V82, P2697, DOI 10.1063/1.1569050; Lucklum R, 2006, ANAL BIOANAL CHEM, V384, P667, DOI 10.1007/s00216-005-0236-x; Myszka DG, 2004, ANAL BIOCHEM, V329, P316, DOI 10.1016/j.ab.2004.03.028; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Ono T, 2003, REV SCI INSTRUM, V74, P1240, DOI 10.1063/1.1536262; Pang W, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2213975; *Q SENS, MOD D3000 SPEC; Sarid D, 1994, SCANNING FORCE MICRO; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; THUNDAT T, 1995, APPL PHYS LETT, V66, P1695, DOI 10.1063/1.113896; Weinberg MS, 2003, J MICROELECTROMECH S, V12, P567, DOI 10.1109/JMEMS.2003.818452; Westberg D, 1997, J MICROMECH MICROENG, V7, P253, DOI 10.1088/0960-1317/7/3/047; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang YT, 2006, NANO LETT, V6, P583, DOI 10.1021/nl052134m; Zhang H, 2005, J MICROELECTROMECH S, V14, P699, DOI 10.1109/JMEMS.2005.845405	30	902	946	13	379	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1066	1069		10.1038/nature05741	http://dx.doi.org/10.1038/nature05741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460669	Green Published			2022-12-24	WOS:000245950400046
J	Gedik, N; Yang, DS; Logvenov, G; Bozovic, I; Zewail, AH				Gedik, Nuh; Yang, Ding-Shyue; Logvenov, Gennady; Bozovic, Ivan; Zewail, Ahmed H.			Nonequilibrium phase transitions in cuprates observed by ultrafast electron crystallography	SCIENCE			English	Article							SINGLE-CRYSTAL; DIFFRACTION; MICROSCOPY; CHEMISTRY; ENERGY; OXIDES; STATE	Nonequilibrium phase transitions, which are defined by the formation of macroscopic transient domains, are optically dark and cannot be observed through conventional temperature- or pressure-change studies. We have directly determined the structural dynamics of such a nonequilibrium phase transition in a cuprate superconductor. Ultrafast electron crystallography with the use of a tilted optical geometry technique afforded the necessary atomic-scale spatial and temporal resolutions. The observed transient behavior displays a notable "structural isosbestic" point and a threshold effect for the dependence of c-axis expansion (Delta c) on fluence ( F), with Delta c/F = 0.02 angstrom/(millijoule per square centimeter). This threshold for photon doping occurs at similar to 0.12 photons per copper site, which is unexpectedly close to the density ( per site) of chemically doped carriers needed to induce superconductivity.	CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA; Brookhaven Natl Lab, Upton, NY 11973 USA	California Institute of Technology; United States Department of Energy (DOE); Brookhaven National Laboratory	Zewail, AH (corresponding author), CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Yang, Ding-Shyue/A-8648-2010	Yang, Ding-Shyue/0000-0003-2713-9128; gaber, sarah/0000-0002-5995-7291				Bargheer M, 2006, CHEMPHYSCHEM, V7, P783, DOI 10.1002/cphc.200500591; Basov DN, 2005, REV MOD PHYS, V77, P721, DOI 10.1103/RevModPhys.77.721; Baum P, 2006, P NATL ACAD SCI USA, V103, P16105, DOI 10.1073/pnas.0607451103; BLOEMBERGEN N, 1994, AIP CONF P, V288, P3; Bozovic I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.132503; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; Bressler C, 2004, CHEM REV, V104, P1781, DOI 10.1021/cr0206667; Cavalleri A, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.011004; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Grinolds MS, 2006, P NATL ACAD SCI USA, V103, P18427, DOI 10.1073/pnas.0609233103; KUMAGAI K, 1988, PHYS REV LETT, V60, P724, DOI 10.1103/PhysRevLett.60.724; MARCUS RA, 1993, ANGEW CHEM INT EDIT, V32, P1111, DOI 10.1002/anie.199311113; McMillan PF, 2005, PHILOS T R SOC A, V363, P311, DOI 10.1098/rsta.2004.1512; MOKHTARI A, 1990, NATURE, V348, P225, DOI 10.1038/348225a0; Moller KB, 1998, CHEM PHYS LETT, V295, P1, DOI 10.1016/S0009-2614(98)00927-0; Pergament A, 2006, J PHYS A-MATH GEN, V39, P4619, DOI 10.1088/0305-4470/39/17/S48; Perkins JD, 1998, PHYS REV B, V58, P9390, DOI 10.1103/PhysRevB.58.9390; PIVETEAU B, 1991, PHYS REV B, V43, P493, DOI 10.1103/PhysRevB.43.493; RAMDAS S, 1980, NATURE, V284, P153, DOI 10.1038/284153a0; Rousse A, 2001, REV MOD PHYS, V73, P17, DOI 10.1103/RevModPhys.73.17; Ruan CY, 2004, SCIENCE, V304, P80, DOI 10.1126/science.1094818; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; SUZUKI M, 1989, PHYS REV B, V39, P2312, DOI 10.1103/PhysRevB.39.2312; Thomas JM, 2005, ANGEW CHEM INT EDIT, V44, P5563, DOI 10.1002/anie.200501466; THOMAS JM, 1974, PHILOS T R SOC A, V277, P251, DOI 10.1098/rsta.1974.0051; vonderLinde D, 1997, APPL SURF SCI, V109, P1, DOI 10.1016/S0169-4332(96)00611-3; WANG ZL, 1996, REFLECTION ELECT MIC; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Yang DS, 2007, J PHYS CHEM C, V111, P4889, DOI 10.1021/jp067466+; Yonemitsu K, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.011008; Yu JD, 1996, PHYS REV B, V54, P7455, DOI 10.1103/PhysRevB.54.7455; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748; ZOU X, 2006, ELECT CRYSTALLOGRAPH; [No title captured]	35	188	189	0	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					425	429		10.1126/science.1138834	http://dx.doi.org/10.1126/science.1138834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446397				2022-12-24	WOS:000245813400050
J	Yin, H; Slusky, JS; Berger, BW; Walters, RS; Vilaire, G; Litvinov, RI; Lear, JD; Caputo, GA; Bennett, JS; DeGrado, WF				Yin, Hang; Slusky, Joanna S.; Berger, Bryan W.; Walters, Robin S.; Vilaire, Gaston; Litvinov, Rustem I.; Lear, James D.; Caputo, Gregory A.; Bennett, Joel S.; DeGrado, William F.			Computational design of peptides that target transmembrane helices	SCIENCE			English	Article							MEMBRANE-PROTEINS; INTEGRIN ACTIVATION; ESCHERICHIA-COLI; DOMAIN; BINDING; RECEPTOR; MOTIFS; AFFINITY; STATE; HETERODIMERIZATION	A variety of methods exist for the design or selection of antibodies and other proteins that recognize the water-soluble regions of proteins; however, companion methods for targeting transmembrane (TM) regions are not available. Here, we describe a method for the computational design of peptides that target TM helices in a sequence-specific manner. To illustrate the method, peptides were designed that specifically recognize the TM helices of two closely related integrins (alpha(IIb)beta(3) and alpha(v)beta(3)) in micelles, bacterial membranes, and mammalian cells. These data show that sequence-specific recognition of helices in TM proteins can be achieved through optimization of the geometric complementarity of the target-host complex.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	DeGrado, WF (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	wdegrado@mail.med.upenn.edu	Berger, Bryan/D-7985-2014; YIN, HANG/O-2097-2014; Litvinov, Rustem/E-5291-2011	Berger, Bryan/0000-0002-6135-8677; YIN, HANG/0000-0002-9762-4818; Litvinov, Rustem/0000-0003-0643-1496; Caputo, Gregory/0000-0002-4510-2815; Slusky, Joanna/0000-0003-0842-6340	NATIONAL CANCER INSTITUTE [T32CA101968] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P50HL054500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054616, T32GM008275, R01GM054616, R01GM060610] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA101968] Funding Source: Medline; NHLBI NIH HHS [HL54500, HL40387, P01 HL040387] Funding Source: Medline; NIGMS NIH HHS [GM54616, 5T32 GM08275, GM60610, T32 GM008275] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Binz HK, 2005, CURR OPIN BIOTECH, V16, P459, DOI 10.1016/j.copbio.2005.06.005; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; Doura AK, 2004, J MOL BIOL, V343, P1487, DOI 10.1016/j.jmb.2004.09.011; Ebie AZ, 2007, J MOL BIOL, V366, P517, DOI 10.1016/j.jmb.2006.11.035; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; FAIRMAN R, 1993, P NATL ACAD SCI USA, V90, P10429, DOI 10.1073/pnas.90.22.10429; Freeman-Cook LL, 2004, J MOL BIOL, V338, P907, DOI 10.1016/j.jmb.2004.03.044; Gerber D, 2005, FASEB J, V19, P1190, DOI 10.1096/fj.04-3498fje; Gerber D, 2004, J BIOL CHEM, V279, P21177, DOI 10.1074/jbc.M400847200; Gerber D, 2004, J MOL BIOL, V339, P243, DOI 10.1016/j.jmb.2004.03.004; Ghirlanda G, 1998, J MOL BIOL, V281, P379, DOI 10.1006/jmbi.1998.1912; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Litvinov RI, 2003, J BIOL CHEM, V278, P51285, DOI 10.1074/jbc.M304581200; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Manolios N, 1997, NAT MED, V3, P84, DOI 10.1038/nm0197-84; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Partridge AW, 2003, J BIOL CHEM, V278, P22056, DOI 10.1074/jbc.M210685200; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Winter G, 1998, FEBS LETT, V430, P92, DOI 10.1016/S0014-5793(98)00628-0; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200	43	232	238	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1817	1822		10.1126/science.1136782	http://dx.doi.org/10.1126/science.1136782			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395823				2022-12-24	WOS:000245280100035
J	Bhattacharya, T; Daniels, M; Heckerman, D; Foley, B; Frahm, N; Kadie, C; Carlson, J; Yusim, K; McMahon, B; Gaschen, B; Mallal, S; Mullins, JI; Nickle, DC; Herbeck, J; Rousseau, C; Learn, GH; Miura, T; Brander, C; Walker, B; Korber, B				Bhattacharya, Tanmoy; Daniels, Marcus; Heckerman, David; Foley, Brian; Frahm, Nicole; Kadie, Carl; Carlson, Jonathan; Yusim, Karina; McMahon, Ben; Gaschen, Brian; Mallal, Simon; Mullins, James I.; Nickle, David C.; Herbeck, Joshua; Rousseau, Christine; Learn, Gerald H.; Miura, Toshiyuki; Brander, Christian; Walker, Bruce; Korber, Bette			Founder effects in the assessment of HIV polymorphisms and HLA allele associations	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ESCAPE; RESPONSES; CTL; EPITOPES; FITNESS; GAG; MUTATIONS; DIVERSITY; VARIANTS	Escape from T cell-mediated immune responses affects the ongoing evolution of rapidly evolving viruses such as HIV. By applying statistical approaches that account for phylogenetic relationships among viral sequences, we show that viral lineage effects rather than immune escape often explain apparent human leukocyte antigen (HLA)-mediated immune-escape mutations defined by older analysis methods. Phylogenetically informed methods identified immune-susceptible locations with greatly improved accuracy, and the associations we identified with these methods were experimentally validated. This approach has practical implications for understanding the impact of host immunity on pathogen evolution and for defining relevant variants for inclusion in vaccine antigens.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Microsoft Corp, Res, Machine Learning & Appl Stat Grp, Redmond, WA 98052 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA 02129 USA; Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA, Australia; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; Microsoft; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Royal Perth Hospital; University of Western Australia; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Korber, B (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	btk@lanl.gov	Learn, Jerry/E-3356-2012; Learn, Gerald H/B-6934-2011; Mallal, Simon Alexander/HDM-9561-2022; Foley, Brian T/N-4527-2018; Nickle, David/ABF-2727-2020; Bhattacharya, Tanmoy/J-8956-2013	Learn, Gerald H/0000-0003-0434-7733; Mallal, Simon Alexander/0000-0002-7036-1309; Foley, Brian T/0000-0002-1086-0296; Bhattacharya, Tanmoy/0000-0002-1060-652X; Korber, Bette/0000-0002-2026-5757; Walker, Bruce/0000-0002-8506-6740; Brander, Christian/0000-0002-0548-5778; Mcmahon, Benjamin/0000-0002-8226-1276	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, P01AI057005] Funding Source: NIH RePORTER; NIAID NIH HHS [AI27757, AI57005] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Ammaranond P, 2005, AIDS RES HUM RETROV, V21, P395, DOI 10.1089/aid.2005.21.395; Corbet S, 2003, J GEN VIROL, V84, P2409, DOI 10.1099/vir.0.19152-0; De Groot AS, 2003, VACCINE, V21, P4486, DOI 10.1016/S0264-410X(03)00390-6; FRAHM N, 2005, HIV MOL IMMUNOLOGY, P3; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; MARSH S, 2000, HLA FACTSBOOK, P99; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Mehra N, 2001, TISSUE ANTIGENS, V57, P502, DOI 10.1034/j.1399-0039.2001.057006502.x; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Peyerl FW, 2004, J VIROL, V78, P13901, DOI 10.1128/JVI.78.24.13901-13910.2004; Rodriguez William R, 2004, J Transl Med, V2, P15, DOI 10.1186/1479-5876-2-15; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wells RS, 1997, IMMUNOGENETICS, V46, P173, DOI 10.1007/s002510050259; Yu XG, 2002, AIDS, V16, P321, DOI 10.1097/00002030-200202150-00002; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	20	204	214	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1583	1586		10.1126/science.1131528	http://dx.doi.org/10.1126/science.1131528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363674				2022-12-24	WOS:000244934800055
J	Weir, JT; Schluter, D				Weir, Jason T.; Schluter, Dolph			The latitudinal gradient in recent speciation and extinction rates of birds and mammals	SCIENCE			English	Article							NEW-WORLD BIRDS; DIVERSITY GRADIENT; DIVERSIFICATION; EVOLUTION; BIODIVERSITY; PATTERNS	Although the tropics harbor greater numbers of species than do temperate zones, it is not known whether the rates of speciation and extinction also follow a latitudinal gradient. By sampling birds and mammals, we found that the distribution of the evolutionary ages of sister species-pairs of species in which each is the other's closest relative-adheres to a latitudinal gradient. The time to divergence for sister species is shorter at high latitudes and longer in the tropics. Birth-death models fitting these data estimate that the highest recent speciation and extinction rates occur at high latitudes and decline toward the tropics. These results conflict with the prevailing view that links high tropical diversity to elevated tropical speciation rates. Instead, our findings suggest that faster turnover at high latitudes contributes to the latitudinal diversity gradient.	Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Weir, JT (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada.	weir@zoology.ubc.ca	Weir, Jason/A-2920-2009	Schluter, Dolph/0000-0003-1683-7836				[Anonymous], 1878, TROPICAL NATURE OTHE; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Bohm M, 2005, BIOL J LINN SOC, V85, P235, DOI 10.1111/j.1095-8312.2005.00488.x; Buzas MA, 2002, P NATL ACAD SCI USA, V99, P7841, DOI 10.1073/pnas.122241499; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cardillo M, 1999, P ROY SOC B-BIOL SCI, V266, P1221, DOI 10.1098/rspb.1999.0766; Crame JA, 2002, PALEOBIOLOGY, V28, P184; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HONEYCUTT RL, 1995, J MOL EVOL, V40, P260, DOI 10.1007/BF00163231; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Ricklefs RE, 2006, ECOLOGY, V87, P2468, DOI 10.1890/0012-9658(2006)87[2468:GVITDR]2.0.CO;2; Ricklefs Robert E., 2005, P16; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Weir JT, 2006, EVOLUTION, V60, P842; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Yule G. V., 1924, Philosophical Transactions of the Royal Society London B, V213, P21	23	395	408	3	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2007	315	5818					1574	1576		10.1126/science.1135590	http://dx.doi.org/10.1126/science.1135590			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17363673				2022-12-24	WOS:000244934800052
J	Klose, RJ; Yan, Q; Tothova, Z; Yamane, K; Erdjument-Bromage, H; Tempst, P; Gilliland, DG; Zhang, Y; Kaelin, WG				Klose, Robert J.; Yan, Qin; Tothova, Zuzana; Yamane, Kenichi; Erdjument-Bromage, Hediye; Tempst, Paul; Gilliland, D. Gary; Zhang, Yi; Kaelin, William G., Jr.			The retinoblastoma binding protein RBP2 is an H3K4 demethylase	CELL			English	Article							HISTONE H3; MYELOID PROGENITOR; OXIDATIVE DEMETHYLATION; LYSINE-4 METHYLATION; STRUCTURAL BASIS; MOLECULAR-BASIS; JARID1C GENE; PHD FINGER; FAMILY; DOMAIN	Changes in histone methylation status regulate chromatin structure and DNA-dependent processes such as transcription. Recent studies indicate that, analogous to other histone modifications, histone methylation is reversible. Retinoblastoma binding protein 2 (RBP2), a nuclear protein implicated in the regulation of transcription and differentiation by the retinoblastoma tumor suppressor protein, contains a JmjC domain recently defined as a histone demethylase signature motif. Here we report that RBP2 is a demethylase that specifically catalyzes demethylation on H3K4, whose methylation is normally associated with transcriptionally active genes. RBP2-/- mouse cells displayed enhanced transcription of certain cytokine genes, which, in the case of SDF1, was associated with increased H3K4 trimethylation. Furthermore, RBP2 specifically demethylated H3K4 in biochemical and cell-based assays. These studies provide mechanistic insights into transcriptional regulation by RBP2 and provide the first example of a mammalian enzyme capable of erasing trimethylated H3K4.	Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Linenberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol,Dept Med, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu; william_kaelin@dfci.harvard.edu	Yan, Qin/E-8893-2012; Hu, Ruogu/B-2203-2008	Yan, Qin/0000-0003-4077-453X; Zhang, Yi/0000-0002-2789-0811; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [CA 076120] Funding Source: Medline; NIGMS NIH HHS [GM 68804] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gildea JJ, 2000, GENETICS, V156, P645; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; KIM YW, 1994, MOL CELL BIOL, V14, P7256, DOI 10.1128/MCB.14.11.7256; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Osoegawa K, 2000, GENOME RES, V10, P116; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; QUARTIN RS, 1994, J VIROL, V68, P1334, DOI 10.1128/JVI.68.3.1334-1341.1994; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012	60	333	346	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					889	900		10.1016/j.cell.2007.02.013	http://dx.doi.org/10.1016/j.cell.2007.02.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17320163	Bronze			2022-12-24	WOS:000245073400014
J	Aravin, AA; Sachidanandam, R; Girard, A; Fejes-Toth, K; Hannon, GJ				Aravin, Alexei A.; Sachidanandam, Ravi; Girard, Angelique; Fejes-Toth, Katalin; Hannon, Gregory J.			Developmentally regulated piRNA clusters implicate MILI in transposon control	SCIENCE			English	Article							SMALL RNAS; METHYLATION; MAINTENANCE; EXPRESSION; GENE	Nearly half of the mammalian genome is composed of repeated sequences. In Drosophila, Piwi proteins exert control over transposons. However, mammalian Piwi proteins, MIWI and MILI, partner with Piwi-interacting RNAs (piRNAs) that are depleted of repeat sequences, which raises questions about a role for mammalian Piwi's in transposon control. A search for murine small RNAs that might program Piwi proteins for transposon suppression revealed developmentally regulated piRNA loci, some of which resemble transposon master control loci of Drosophila. We also find evidence of an adaptive amplification loop in which MILI catalyzes the formation of piRNA 5' ends. Mili mutants derepress LINE-1 (L1) and intracisternal A particle and lose DNA methylation of L1 elements, demonstrating an evolutionarily conserved role for PIWI proteins in transposon suppression.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	sachidanandam, ravi/Q-6916-2019; Hannon, Gregory/AAB-3568-2019	sachidanandam, ravi/0000-0001-9844-4459; 				Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUCHETON A, 1995, TRENDS GENET, V11, P349, DOI 10.1016/S0168-9525(00)89105-2; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	20	716	759	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					744	747		10.1126/science.1142612	http://dx.doi.org/10.1126/science.1142612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17446352				2022-12-24	WOS:000246181400046
J	Koussevitzky, S; Nott, A; Mockler, TC; Hong, F; Sachetto-Martins, G; Surpin, M; Lim, IJ; Mittler, R; Chory, J				Koussevitzky, Shai; Nott, Ajit; Mockler, Todd C.; Hong, Fangxin; Sachetto-Martins, Gilberto; Surpin, Marci; Lim, Il Jason; Mittler, Ron; Chory, Joanne			Signals from chloroplasts converge to regulate nuclear gene expression	SCIENCE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CHELATASE H-SUBUNIT; ABSCISIC-ACID; BINDING PROTEIN; ARABIDOPSIS; STRESS; MITOCHONDRIAL; PATHWAYS; REVEALS; GLUCOSE	Plastid-to-nucleus retrograde signaling coordinates nuclear gene expression with chloroplast function and is essential for the photoautotrophic life-style of plants. Three retrograde signals have been described, but little is known of their signaling pathways. We show here that GUN1, a chloroplast-localized pentatricopeptide-repeat protein, and ABI4, an Apetala 2 (AP2)-type transcription factor, are common to all three pathways. ABI4 binds the promoter of a retrograde-regulated gene through a conserved motif found in close proximity to a light-regulatory element. We propose a model in which multiple indicators of aberrant plastid function in Arabidopsis are integrated upstream of GUN1 within plastids, which leads to ABI4-mediated repression of nuclear-encoded genes.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Nevada System of Higher Education (NSHE); University of Nevada Reno; Hebrew University of Jerusalem	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Sachetto-Martins, Gilberto/AAT-4095-2021; Mittler, Ron/ABE-6496-2020; Sachetto-Martins, Gilberto/AAN-6328-2020		NIGMS NIH HHS [F32 GM 69090, F32 GM 18172] Funding Source: Medline; PHS HHS [DRG-1865-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018172, F32GM069090] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arroyo A, 2003, PLANT PHYSIOL, V133, P231, DOI 10.1104/pp.103.021089; Aubourg S, 2000, PLANT MOL BIOL, V42, P603, DOI 10.1023/A:1006352315928; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; Dojcinovic D, 2005, PLANT MOL BIOL, V58, P159, DOI 10.1007/s11103-005-5390-1; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gray JC, 2003, PHILOS T R SOC B, V358, P135, DOI 10.1098/rstb.2002.1180; Gray JC, 2003, TRENDS GENET, V19, P526, DOI 10.1016/j.tig.2003.08.001; Hattori T, 2002, PLANT CELL PHYSIOL, V43, P136, DOI 10.1093/pcp/pcf014; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Ikeda TM, 1999, MOL CELL BIOL, V19, P8113; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Leister D, 2005, GENE, V354, P110, DOI 10.1016/j.gene.2005.03.039; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; McCormac AC, 2004, PLANT J, V40, P672, DOI 10.1111/j.1365-313X.2004.02243.x; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Moreira D, 1999, TRENDS BIOCHEM SCI, V24, P298, DOI 10.1016/S0968-0004(99)01419-X; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; OELMULLER R, 1986, PLANTA, V168, P482, DOI 10.1007/BF00392267; Oswald O, 2001, P NATL ACAD SCI USA, V98, P2047, DOI 10.1073/pnas.021449998; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Richly E, 2003, EMBO REP, V4, P491, DOI 10.1038/sj.embor.embor828; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rock CD, 2000, NEW PHYTOL, V148, P357, DOI 10.1046/j.1469-8137.2000.00769.x; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Soderman EM, 2000, PLANT PHYSIOL, V124, P1752, DOI 10.1104/pp.124.4.1752; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Vinti G, 2000, PLANT J, V24, P883, DOI 10.1046/j.1365-313x.2000.00936.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x	40	651	698	7	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					715	719		10.1126/science. 1140516	http://dx.doi.org/10.1126/science. 1140516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17395793				2022-12-24	WOS:000246181400037
J	Rodriguez, A; Vigorito, E; Clare, S; Warren, MV; Couttet, P; Soond, DR; van Dongen, S; Grocock, RJ; Das, PP; Miska, EA; Vetrie, D; Okkenhaug, K; Enright, AJ; Dougan, G; Turner, M; Bradley, A				Rodriguez, Antony; Vigorito, Elena; Clare, Simon; Warren, Madhuri V.; Couttet, Philippe; Soond, Dalya R.; van Dongen, Stijn; Grocock, Russell J.; Das, Partha P.; Miska, Eric A.; Vetrie, David; Okkenhaug, Klaus; Enright, Anton J.; Dougan, Gordon; Turner, Martin; Bradley, Allan			Requirement of bic/microRNA-155 for normal immune function	SCIENCE			English	Article							GENOME-WIDE SEARCH; C-MAF; SUSCEPTIBILITY LOCI; GENE; MICRORNAS; IDENTIFICATION; CHROMOSOME-21; POPULATION; EXPRESSION; RESPONSES	MicroRNAs are a class of small RNAs that are increasingly being recognized as important regulators of gene expression. Although hundreds of microRNAs are present in the mammalian genome, genetic studies addressing their physiological roles are at an early stage. We have shown that mice deficient for bic/microRNA-155 are immunodeficient and display increased lung airway remodeling. We demonstrate a requirement of bic/microRNA-155 for the function of B and T lymphocytes and dendritic cells. Transcriptome analysis of bic/microRNA-155-deficient CD4(+) T cells identified a wide spectrum of microRNA-155-regulated genes, including cytokines, chemokines, and transcription factors. Our work suggests that bic/microRNA-155 plays a key role in the homeostasis and function of the immune system.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge CB2 4AT, England; Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Turner, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	martin.turner@bbsrc.ac.uk; abradley@sanger.ac.uk	Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019; Turner, Martin/N-9976-2014; Enright, Anton/F-3094-2011; Couttet, Philippe/AAH-5489-2019	Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Turner, Martin/0000-0002-3801-9896; Enright, Anton/0000-0002-6090-3100; Couttet, Philippe/0000-0002-5255-6647; Bradley, Allan/0000-0002-2349-8839; Vetrie, David/0000-0003-2075-4662; Miska, Eric/0000-0002-4450-576X; Das, Partha Pratim/0000-0003-3544-2629	Medical Research Council [G117/424] Funding Source: Medline; Wellcome Trust [077187] Funding Source: Medline; BBSRC [BBS/E/B/0000M206] Funding Source: UKRI; MRC [G117/424, G0601618] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blumenthal MN, 2006, J ALLERGY CLIN IMMUN, V117, P79, DOI 10.1016/j.jaci.2005.09.038; Bu LM, 2006, ALLERGY, V61, P617, DOI 10.1111/j.1398-9995.2006.01072.x; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Clare S, 2003, INFECT IMMUN, V71, P5881, DOI 10.1128/IAI.71.10.5881-5891.2003; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hwang ES, 2002, P NATL ACAD SCI USA, V99, P13026, DOI 10.1073/pnas.202474499; Jindal SK, 2005, CURR OPIN PULM MED, V11, P438, DOI 10.1097/01.mcp.0000170522.71497.61; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai CK, 2006, SEMIN RESP CRIT CARE, V27, P613, DOI 10.1055/s-2006-957333; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mastroeni P, 2001, VET J, V161, P132, DOI 10.1053/tvjl.2000.0502; MUIJO SA, 2005, J EXP MED, V202, P261; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186	27	1491	1655	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					608	611		10.1126/science.1139253	http://dx.doi.org/10.1126/science.1139253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463290	Green Accepted			2022-12-24	WOS:000245983100048
J	Munch, J; Standker, L; Adermann, K; Schuz, A; Schindler, M; Chinnadurai, R; Pohlmann, S; Chaipan, C; Biet, T; Peters, T; Meyer, B; Wilhelm, D; Lu, H; Jing, WG; Jiang, SB; Forssmann, WG; Kirchhoff, F				Muench, Jan; Staendker, Ludger; Adermann, Knut; Schuz, Axel; Schindler, Michael; Chinnadurai, Raghavan; Poehlmann, Stefan; Chaipan, Chawaree; Biet, Thorsten; Peters, Thomas; Meyer, Bernd; Wilhelm, Dennis; Lu, Hong; Jing, Weiguo; Jiang, Shibo; Forssmann, Wolf-Georg; Kirchhoff, Frank			Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ALPHA-1-ANTITRYPSIN DEFICIENCY; MONOCLONAL-ANTIBODY; RESISTANCE; INFECTION; REPLICATION; METALLOPROTEINASE; GLYCOPROTEIN-41; TRANSCRIPTION; MACROPHAGES	A variety of molecules in human blood have been implicated in the inhibition of HIV-1. However, it remained elusive which circulating natural compounds are most effective in controlling viral replication in vivo. To identify natural HIV-1 inhibitors we screened a comprehensive peptide library generated from human hemofiltrate. The most potent fraction contained a 20-residue peptide, designated VIRUS-INHIBITORY PEPTIDE (VIRIP), corresponding to the C-proximal region of alpha 1 -antitrypsin, the most abundant circulating serine protease inhibitor. We found that VIRIP inhibits a wide variety of HIV-1 strains including those resistant to current antiretroviral drugs. Further analysis demonstrated that VIRIP blocks HIV-1 entry by interacting with the gp41 fusion peptide and showed that a few amino acid changes increase its antiretroviral potency by two orders of magnitude. Thus, as a highly specific natural inhibitor of the HIV-1 gp41 fusion peptide, VIRIP may lead to the development of another class of antiretroviral drugs.	IPF PharmaCeut GmbH, D-30625 Hannover, Germany; Univ Ulm, Inst Virol, D-89081 Ulm, Germany; VIRO Pharmaceut GmbH & Co KG, D-30625 Hannover, Germany; Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany; Med Univ Lubeck, Inst Chem, D-23538 Lubeck, Germany; Univ Hamburg, Fac Sci, D-20146 Hamburg, Germany; New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; Hannover Med Sch, Ctr Pharmacol, D-30625 Hannover, Germany	Ulm University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Lubeck; University of Hamburg; New York Blood Center; Hannover Medical School	Forssmann, WG (corresponding author), IPF PharmaCeut GmbH, D-30625 Hannover, Germany.	wgforssmann@ipf-pharmaceuticals.de; frank.kirchhoff@uniklinik-ulm.de	Abrams, William R/A-5782-2008; Meyer, Bernd/A-8828-2008; Kirchhoff, Frank/O-8367-2018; Pöhlmann, Stefan/H-2395-2011; Peters, Thomas/AAE-1509-2022; Schindler, Michael/C-1647-2015; Peters, Thomas/GQB-3622-2022; Jiang, Shibo/L-4500-2014	Kirchhoff, Frank/0000-0002-7052-2360; Pöhlmann, Stefan/0000-0001-6086-9136; Peters, Thomas/0000-0002-7570-8260; Schindler, Michael/0000-0001-8989-5813; Jiang, Shibo/0000-0001-8283-7135; Jan, Munch/0000-0001-7316-7141				ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; BRANTLY ML, 1988, AM REV RESPIR DIS, V138, P327, DOI 10.1164/ajrccm/138.2.327; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; DESROCHERS PE, 1988, J CLIN INVEST, V81, P1646, DOI 10.1172/JCI113500; Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Forssmann WG, 1992, PEPTIDE CHEM, P553; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Helmerhorst EJ, 1999, FEBS LETT, V449, P105, DOI 10.1016/S0014-5793(99)00411-1; Hiebenthal-Millow K, 2002, VIROLOGY, V292, P169, DOI 10.1006/viro.2001.1282; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG S, 2000, P SOC PHOTO-OPT INS, V3926, P212, DOI DOI 10.1117/12.380514; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Jiang SB, 2002, CURR PHARM DESIGN, V8, P563; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; KUSHNER I, 1988, METHOD ENZYMOL, V163, P373; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Mark S, 1999, J CHROMATOGR A, V852, P197, DOI 10.1016/S0021-9673(99)00356-8; Miyazaki Y, 2002, AIDS RES HUM RETROV, V18, P469, DOI 10.1089/088922202753614236; MOBLEY PW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P251, DOI 10.1016/0925-4439(92)90098-8; Mobley PW, 2001, AIDS RES HUM RETROV, V17, P311, DOI 10.1089/08892220150503681; Moore R A, 2000, BMC Fam Pract, V1, P1, DOI 10.1186/1471-2296-1-1; Munch J, 2002, ANTIMICROB AGENTS CH, V46, P982, DOI 10.1128/AAC.46.4.982-990.2002; Prechtel AT, 2005, J GEN VIROL, V86, P1645, DOI 10.1099/vir.0.80852-0; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Schulz-Knappe P, 1996, Eur J Med Res, V1, P223; SchulzKnappe P, 1997, J CHROMATOGR A, V776, P125, DOI 10.1016/S0021-9673(97)00152-0; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Walter H, 2000, ANTIVIR THER, V5, P249	47	189	211	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					263	275		10.1016/j.cell.2007.02.042	http://dx.doi.org/10.1016/j.cell.2007.02.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448989	Bronze			2022-12-24	WOS:000246474600015
J	Collins, SR; Miller, KM; Maas, NL; Roguev, A; Fillingham, J; Chu, CS; Schuldiner, M; Gebbia, M; Recht, J; Shales, M; Ding, HM; Xu, H; Han, JH; Ingvarsdottir, K; Cheng, B; Andrews, B; Boone, C; Berger, SL; Hieter, P; Zhang, ZG; Brown, GW; Ingles, CJ; Emili, A; Allis, CD; Toczyski, DP; Weissman, JS; Greenblatt, JF; Krogan, NJ				Collins, Sean R.; Miller, Kyle M.; Maas, Nancy L.; Roguev, Assen; Fillingham, Jeffrey; Chu, Clement S.; Schuldiner, Maya; Gebbia, Marinella; Recht, Judith; Shales, Michael; Ding, Huiming; Xu, Hong; Han, Junhong; Ingvarsdottir, Kristin; Cheng, Benjamin; Andrews, Brenda; Boone, Charles; Berger, Shelley L.; Hieter, Phil; Zhang, Zhiguo; Brown, Grant W.; Ingles, C. James; Emili, Andrew; Allis, C. David; Toczyski, David P.; Weissman, Jonathan S.; Greenblatt, Jack F.; Krogan, Nevan J.			Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map	NATURE			English	Article							H3 LYSINE-56 ACETYLATION; HISTONE H3; H3K56 ACETYLATION; CELL-CYCLE; MEDIATOR; DNA; INTEGRITY; PATHWAY; HST3; ASF1	Defining the functional relationships between proteins is critical for understanding virtually all aspects of cell biology. Large-scale identification of protein complexes has provided one important step towards this goal; however, even knowledge of the stoichiometry, affinity and lifetime of every protein - protein interaction would not reveal the functional relationships between and within such complexes. Genetic interactions can provide functional information that is largely invisible to protein - protein interaction data sets. Here we present an epistatic miniarray profile (E-MAP)(1) consisting of quantitative pairwise measurements of the genetic interactions between 743 Saccharomyces cerevisiae genes involved in various aspects of chromosome biology ( including DNA replication/ repair, chromatid segregation and transcriptional regulation). This E-MAP reveals that physical interactions fall into two well-represented classes distinguished by whether or not the individual proteins act coherently to carry out a common function. Thus, genetic interaction data make it possible to dissect functionally multi-protein complexes, including Mediator, and to organize distinct protein complexes into pathways. In one pathway defined here, we show that Rtt109 is the founding member of a novel class of histone acetyltransferases responsible for Asf1-dependent acetylation of histone H3 on lysine 56. This modification, in turn, enables a ubiquitin ligase complex containing the cullin Rtt101 to ensure genomic integrity during DNA replication.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Canc Res Inst, San Francisco, CA 94115 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; Rockefeller Univ, Lab Cromatin Biol, New York, NY 10021 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Wistar Inst Anat & Biol, Gene Express & REgulat Program, Philadelphia, PA 19104 USA; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; Rockefeller University; Mayo Clinic; The Wistar Institute; University of British Columbia; University of Toronto	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu; jack.greenblatt@utoronto.ca	Han, Junhong/L-5264-2013; Schuldiner, Maya/C-9488-2009	Ingvarsdottir, Kristin/0000-0001-9915-1164; Collins, Sean/0000-0002-4276-5840; Berger, Shelley/0000-0001-5398-4400; Han, Junhong/0000-0002-3371-8698; Weissman, Jonathan/0000-0003-2445-670X; Recht, Judith/0000-0003-3572-0457; Miller, Kyle/0000-0002-4544-0013; Brown, Grant/0000-0002-9002-5003; Schuldiner, Maya/0000-0001-9947-115X				Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Luke B, 2006, CURR BIOL, V16, P786, DOI 10.1016/j.cub.2006.02.071; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034; [No title captured]	30	691	696	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					806	810		10.1038/nature05649	http://dx.doi.org/10.1038/nature05649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17314980				2022-12-24	WOS:000245626800043
J	Evans, MJ; von Hahn, T; Tscherne, DM; Syder, AJ; Panis, M; Wolk, B; Hatziioannou, T; McKeating, JA; Bieniasz, PD; Rice, CM				Evans, Matthew J.; von Hahn, Thomas; Tscherne, Donna M.; Syder, Andrew J.; Panis, Maryline; Woelk, Benno; Hatziioannou, Theodora; McKeating, Jane A.; Bieniasz, Paul D.; Rice, Charles M.			Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry	NATURE			English	Article							TIGHT JUNCTIONS; CELL ENTRY; LIVER-TRANSPLANTATION; CHOLESTATIC HEPATITIS; VIRAL-INFECTION; RECEPTOR; GLYCOPROTEINS; REPLICATION; CD81; TETRASPANIN	Hepatitis C virus (HCV) is a leading cause of cirrhosis and liver cancer worldwide. A better understanding of the viral life cycle, including the mechanisms of entry into host cells, is needed to identify novel therapeutic targets. Although HCV entry requires the CD81 co-receptor, and other host molecules have been implicated, at least one factor critical to this process remains unknown (reviewed in refs 1 - 3). Using an iterative expression cloning approach we identified claudin-1 (CLDN1), a tight junction component that is highly expressed in the liver(4), as essential for HCV entry. CLDN1 is required for HCV infection of human hepatoma cell lines and is the first factor to confer susceptibility to HCV when ectopically expressed in non-hepatic cells. Discrete residues within the first extracellular loop (EL1) of CLDN1, but not protein interaction motifs in intracellular domains, are critical for HCV entry. Moreover, antibodies directed against an epitope inserted in the CLDN1 EL1 block HCV infection. The kinetics of this inhibition indicate that CLDN1 acts late in the entry process, after virus binding and interaction with the HCV co-receptor CD81. With CLDN1 we have identified a novel key factor for HCV entry and a new target for antiviral drug development.	Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Rockefeller University; Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10021 USA.	ricec@mail.rockefeller.edu		McKeating, Jane/0000-0002-7229-5886; Evans, Matthew/0000-0002-4991-3877	Medical Research Council [G0801976, G0400802] Funding Source: Medline; MRC [G0400802] Funding Source: UKRI; Medical Research Council [G9818340B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Barth H, 2006, HEPATOLOGY, V44, P527, DOI 10.1002/hep.21321; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Borlak J, 2005, ONCOGENE, V24, P1809, DOI 10.1038/sj.onc.1208196; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Doughty AL, 1998, LIVER TRANSPLANT SUR, V4, P15, DOI 10.1002/lt.500040102; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Heiskala M, 2001, TRAFFIC, V2, P92, DOI 10.1034/j.1600-0854.2001.020203.x; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Kato T, 2005, J VIROL, V79, P592, DOI 10.1128/JVI.79.1.592-596.2005; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Schluger LK, 1996, HEPATOLOGY, V23, P971, DOI 10.1002/hep.510230505; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tiwari-Woodruff SK, 2001, J CELL BIOL, V153, P295, DOI 10.1083/jcb.153.2.295; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004	29	926	1000	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					801	805		10.1038/nature05654	http://dx.doi.org/10.1038/nature05654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17325668				2022-12-24	WOS:000245626800042
J	Siripala, AD; Welch, MD				Siripala, Anosha D.; Welch, Matthew D.			SnapShot: Actin regulators II	CELL			English	Editorial Material														Siripala, Anosha/0000-0003-4073-9195	NIGMS NIH HHS [R01 GM059609, R01 GM059609-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM059609-07, R01 GM059609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	23	23	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					1014	1014		10.1016/j.cell.2007.02.021	http://dx.doi.org/10.1016/j.cell.2007.02.021			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350583	Bronze			2022-12-24	WOS:000245073400023
J	Strandberg, TE; Pitkala, KH				Strandberg, Timo E.; Pitkala, Kaisu H.			Frailty in elderly people	LANCET			English	Editorial Material							OLDER-ADULTS; CATABOLISM; HEALTH		Univ Oulu, FIN-90014 Oulu, Finland; Univ Helsinki, Helsinki, Finland	University of Oulu; University of Helsinki	Strandberg, TE (corresponding author), Univ Oulu, FIN-90014 Oulu, Finland.	timo.strandberg@oulu.fi		Pitkala, Kaisu/0000-0001-9659-6985; Clegg, Andrew/0000-0001-5972-1097; Iliffe, Stephen/0000-0003-2806-3997; young, john/0000-0003-4085-9306	The Dunhill Medical Trust [RCP/DMT 2ND ROUND (2)] Funding Source: Medline	The Dunhill Medical Trust(Dunhill Medical Trust)		Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Boockvar KS, 2006, JAMA-J AM MED ASSOC, V296, P2245, DOI 10.1001/jama.296.18.2245; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Ferrucci L, 2002, J Endocrinol Invest, V25, P10; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Omwancha J, 2006, CURR OPIN INVEST DR, V7, P873; Ozaki A, 2007, J AM GERIATR SOC, V55, P95, DOI 10.1111/j.1532-5415.2006.01019.x; Purser JL, 2006, J AM GERIATR SOC, V54, P1674, DOI 10.1111/j.1532-5415.2006.00914.x; Roubenoff R, 2003, CURR OPIN CLIN NUTR, V6, P295, DOI 10.1097/01.mco.0000068965.34812.62; Sanders PM, 2005, BRIT J CANCER, V93, P425, DOI 10.1038/sj.bjc.6602725; Sullivan DH, 2007, J AM GERIATR SOC, V55, P20, DOI 10.1111/j.1532-5415.2006.01010.x	14	1172	1251	5	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1328	1329		10.1016/S0140-6736(07)60613-8	http://dx.doi.org/10.1016/S0140-6736(07)60613-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	23395245				2022-12-24	WOS:000245856100009
